data_1jns_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1jns _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 27.3 m . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.225 0.536 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' A' ' 51' ' ' GLU . . . -143.26 159.02 43.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.075 -1.015 . . . . 0.0 110.039 177.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 50' ' ' GLY . . . -94.62 123.71 38.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.268 -0.895 . . . . 0.0 109.145 174.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.581 ' HB1' ' CE1' ' A' ' 61' ' ' PHE . . . -137.24 134.99 36.81 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.709 -1.244 . . . . 0.0 111.884 -169.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.529 ' CD2' ' HA ' ' A' ' 48' ' ' ASP . 33.8 mt -109.32 137.07 47.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.39 -0.819 . . . . 0.0 109.371 170.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.626 ' NE2' ' CE1' ' A' ' 61' ' ' PHE . 22.2 m170 -130.87 132.38 45.12 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.932 -1.105 . . . . 0.0 111.0 -176.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.554 ' HB ' ' CG2' ' A' ' 85' ' ' ILE . 84.4 mt -118.64 129.89 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.947 -1.095 . . . . 0.0 109.567 169.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.565 HD22 ' CD2' ' A' ' 84' ' ' HIS . 2.7 tm? -110.0 120.41 42.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.361 -0.837 . . . . 0.0 109.896 178.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.1 t -103.94 128.97 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.179 -0.951 . . . . 0.0 110.053 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -68.5 -39.96 81.05 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.464 -0.773 . . . . 0.0 110.96 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -119.79 140.54 50.59 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.018 -1.051 . . . . 0.0 110.595 -175.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.443 ' HG2' ' CZ ' ' A' ' 83' ' ' TYR . 93.3 mt-10 -59.97 -39.99 87.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.527 -0.733 . . . . 0.0 110.939 -175.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.1 -41.86 68.75 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.024 -1.048 . . . . 0.0 110.343 -175.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.409 ' C ' HD21 ' A' ' 16' ' ' LEU . 8.1 tt -67.84 -38.56 83.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.124 -0.985 . . . . 0.0 109.648 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.441 ' O ' HD22 ' A' ' 20' ' ' LEU . . . -58.66 -45.82 88.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.294 -0.879 . . . . 0.0 110.314 178.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.5 tp -60.06 -46.25 90.16 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.121 -0.987 . . . . 0.0 109.766 175.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 23' ' ' GLN . 47.9 t0 -59.97 -40.0 87.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.332 -0.855 . . . . 0.0 109.929 178.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.544 ' CD2' HD12 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -62.37 -53.54 53.45 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.357 -0.839 . . . . 0.0 109.471 177.675 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.544 HD12 ' CD2' ' A' ' 20' ' ' LEU . 0.3 OUTLIER -54.57 -48.55 71.93 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.475 -0.766 . . . . 0.0 109.557 -176.717 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -65.1 -40.51 94.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.435 -0.791 . . . . 0.0 109.987 174.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.443 ' NE2' ' CD2' ' A' ' 33' ' ' LEU . 62.7 tt0 -61.54 -40.03 93.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.44 -0.787 . . . . 0.0 110.297 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.523 HG12 ' CD1' ' A' ' 33' ' ' LEU . 92.4 mt -67.07 -39.99 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.278 -0.889 . . . . 0.0 110.111 178.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -64.53 -54.54 30.65 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.948 -1.095 . . . . 0.0 110.226 176.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -60.01 -43.44 95.23 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.216 -0.927 . . . . 0.0 110.967 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.563 ' O ' ' CB ' ' A' ' 28' ' ' ALA . . . -105.55 -59.43 0.64 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -177.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.563 ' CB ' ' O ' ' A' ' 27' ' ' GLY . . . 83.92 104.65 0.05 Allowed 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 121.554 0.692 . . . . 0.0 110.053 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.427 ' CG ' ' O ' ' A' ' 28' ' ' ALA . 3.8 m-20 -175.08 70.48 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.582 -0.698 . . . . 0.0 109.501 -176.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -60.01 -44.24 94.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.925 . . . . 0.0 110.781 -174.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.59 -54.03 31.5 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 119.813 -1.184 . . . . 0.0 110.272 -177.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -66.7 -40.08 88.31 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.991 -1.299 . . . . 0.0 110.861 -175.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.523 ' CD1' HG12 ' A' ' 24' ' ' ILE . 64.5 mt -61.59 -42.94 99.58 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.91 -1.119 . . . . 0.0 110.266 178.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.524 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -59.98 -49.25 78.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 0.0 110.381 178.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -59.98 -47.19 86.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.103 -0.998 . . . . 0.0 110.653 -174.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -67.38 -50.08 61.22 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.971 -1.08 . . . . 0.0 110.998 -177.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 55.3 m170 -69.98 -39.92 75.64 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.047 -1.033 . . . . 0.0 111.103 -173.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.531 ' O ' ' CG2' ' A' ' 39' ' ' ILE . 22.9 t -60.08 -42.06 93.78 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.001 -1.062 . . . . 0.0 110.338 -174.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.531 ' CG2' ' O ' ' A' ' 38' ' ' SER . 21.3 tt 38.02 31.57 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.624 -0.673 . . . . 0.0 110.877 177.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.458 ' SG ' ' OG ' ' A' ' 38' ' ' SER . 15.5 p -120.25 166.15 16.07 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.253 -0.904 . . . . 0.0 110.206 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -53.05 -23.12 20.85 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.968 1.51 . . . . 0.0 110.273 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -107.58 21.27 17.71 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.276 -0.89 . . . . 0.0 109.836 177.006 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.4 -51.37 27.07 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 174.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 48.9 mttp -63.03 -40.03 96.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.442 -1.034 . . . . 0.0 110.849 176.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.466 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 11.9 tpt180 -102.59 -44.6 5.29 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.928 -1.108 . . . . 0.0 110.642 -172.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -63.75 -33.38 87.08 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.224 -1.551 . . . . 0.0 109.224 175.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.36 0.11 55.72 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 175.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.529 ' HA ' ' CD2' ' A' ' 7' ' ' LEU . 49.7 t0 -170.82 71.96 0.05 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.24 -1.153 . . . . 0.0 108.916 178.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 11.0 mt -76.15 -6.94 53.54 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.622 -0.674 . . . . 0.0 109.814 -177.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 5' ' ' ALA . . . 70.39 -139.06 29.97 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -174.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 4.8 mt-10 -101.59 132.1 47.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.397 -1.061 . . . . 0.0 110.643 178.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.52 ' CE2' ' HB2' ' A' ' 6' ' ' ALA . 5.3 p90 -145.38 160.64 41.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.678 -0.639 . . . . 0.0 109.333 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 . . . . . 0 N--CA 1.493 1.71 0 O-C-N 121.039 -1.038 . . . . 0.0 110.526 -175.235 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.429 ' O ' ' C ' ' A' ' 60' ' ' ALA . 9.5 Cg_endo . . . . . 0 N--CA 1.485 1.004 0 N-CA-C 110.407 -0.651 . . . . 0.0 110.407 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 59' ' ' PRO . . . -41.23 -35.29 0.59 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.455 -0.778 . . . . 0.0 110.212 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.626 ' CE1' ' NE2' ' A' ' 8' ' ' HIS . 90.4 t80 -60.08 -41.34 92.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.288 -0.883 . . . . 0.0 110.72 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.427 ' O ' HG12 ' A' ' 65' ' ' VAL . 53.0 t0 -60.01 -41.54 92.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.023 -1.048 . . . . 0.0 109.96 -178.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.441 ' O ' ' HB2' ' A' ' 67' ' ' SER . 62.7 tttm -55.09 -58.56 7.15 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.338 -0.851 . . . . 0.0 110.777 178.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 61' ' ' PHE . 2.9 p -70.0 -42.5 79.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.04 -1.038 . . . . 0.0 111.319 -170.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.427 HG12 ' O ' ' A' ' 62' ' ' ASP . 3.6 p -57.79 -28.26 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.388 -1.445 . . . . 0.0 109.584 174.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -92.33 -10.76 37.12 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.049 -1.032 . . . . 0.0 109.873 173.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.463 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 4.8 t -93.43 -66.21 0.94 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.409 -0.807 . . . . 0.0 109.715 175.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.42 ' SG ' ' O ' ' A' ' 64' ' ' VAL . 24.1 p -76.01 155.97 84.38 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.37 -0.831 . . . . 0.0 110.245 177.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.452 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 53.7 Cg_endo -79.27 148.11 20.99 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.993 1.523 . . . . 0.0 110.223 175.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.52 HG23 ' N ' ' A' ' 71' ' ' LEU . 6.3 p -54.63 168.4 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.146 -0.971 . . . . 0.0 109.887 177.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.52 ' N ' HG23 ' A' ' 70' ' ' VAL . 1.3 mp 58.24 22.25 9.03 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.34 -0.85 . . . . 0.0 110.188 -176.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.452 ' HB3' ' O ' ' A' ' 69' ' ' PRO . 1.4 tp10 -130.77 94.3 29.16 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.254 -0.904 . . . . 0.0 110.251 -179.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -51.07 109.6 0.33 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.927 1.488 . . . . 0.0 109.809 177.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 94.3 m -115.65 130.02 56.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.208 -0.932 . . . . 0.0 110.069 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 140.77 -171.53 24.03 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -176.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.52 ' HG3' ' CD1' ' A' ' 21' ' ' LEU . 41.5 Cg_endo -69.88 138.66 50.6 Favored 'Cis proline' 0 C--N 1.312 -1.373 0 C-N-CA 121.749 -2.188 . . . . 0.0 110.89 -0.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.42 ' HB2' ' O ' ' A' ' 84' ' ' HIS . 95.2 mt -92.94 172.89 8.04 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.52 -0.738 . . . . 0.0 110.484 -176.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -99.18 126.58 44.99 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.064 -1.023 . . . . 0.0 110.67 177.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.578 HG23 ' CE1' ' A' ' 84' ' ' HIS . 8.8 t -146.29 165.1 30.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.272 -0.893 . . . . 0.0 109.817 175.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -59.65 -40.0 86.26 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.104 -0.998 . . . . 0.0 110.769 -175.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -66.38 -15.37 63.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.135 -0.978 . . . . 0.0 110.331 -177.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.441 ' CA ' HD21 ' A' ' 10' ' ' LEU . . . 141.17 -135.69 7.05 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.036 -1.625 . . . . 0.0 109.036 -178.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.443 ' CZ ' ' HG2' ' A' ' 14' ' ' GLU . 4.3 m-85 -97.1 125.12 41.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.135 -1.215 . . . . 0.0 110.131 176.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.578 ' CE1' HG23 ' A' ' 79' ' ' THR . 7.4 m170 -102.73 115.97 31.65 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.607 -0.683 . . . . 0.0 110.345 177.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.554 ' CG2' ' HB ' ' A' ' 9' ' ' ILE . 4.4 tt -104.66 128.38 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.512 -1.367 . . . . 0.0 109.392 168.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.448 HG23 ' CE1' ' A' ' 61' ' ' PHE . 53.0 mt -118.96 125.72 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.369 -0.832 . . . . 0.0 111.051 -172.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.492 ' HB3' ' HB2' ' A' ' 7' ' ' LEU . 18.8 tttm -99.97 125.8 46.04 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.334 -0.854 . . . . 0.0 109.215 171.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.514 ' CG1' ' HA ' ' A' ' 70' ' ' VAL . 21.3 t -101.43 136.49 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.177 -0.952 . . . . 0.0 110.121 -175.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 91' ' ' ARG . 88.9 mt -140.04 147.04 39.76 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.241 -0.912 . . . . 0.0 109.227 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.495 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 98.0 m-85 62.66 -55.35 0.16 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.598 -0.689 . . . . 0.0 111.732 174.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.504 ' N ' ' O ' ' A' ' 89' ' ' LEU . 68.5 ttp85 . . . . . 0 N--CA 1.493 1.719 0 O-C-N 120.93 -1.106 . . . . 0.0 110.859 -178.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 81.8 p . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 121.307 0.575 . . . . 0.0 110.601 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.452 ' HB2' ' CD ' ' A' ' 91' ' ' ARG . . . -140.52 150.53 43.83 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.422 -0.799 . . . . 0.0 110.265 -178.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . . . -95.66 137.84 34.16 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.122 -0.986 . . . . 0.0 109.71 177.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -148.54 130.88 15.62 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.92 -1.112 . . . . 0.0 111.517 -173.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.512 ' C ' ' CD2' ' A' ' 8' ' ' HIS . 78.1 mt -105.21 147.54 27.91 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.202 -0.936 . . . . 0.0 109.144 169.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.512 ' CD2' ' C ' ' A' ' 7' ' ' LEU . 35.1 m-70 -138.34 125.26 21.19 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.749 -1.219 . . . . 0.0 111.303 -177.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.576 HG13 ' CE1' ' A' ' 30' ' ' PHE . 81.5 mt -110.04 129.97 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.016 -1.052 . . . . 0.0 109.857 169.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.428 ' CD1' ' C ' ' A' ' 10' ' ' LEU . 1.0 OUTLIER -110.38 119.97 40.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -0.894 . . . . 0.0 110.365 178.435 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.525 ' CG1' HD22 ' A' ' 16' ' ' LEU . 2.9 t -104.03 135.29 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.421 -0.8 . . . . 0.0 109.954 177.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -67.51 -37.12 82.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.273 -0.892 . . . . 0.0 110.769 -176.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -129.75 149.73 51.37 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.013 -1.054 . . . . 0.0 110.871 -175.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.467 ' HB2' ' CZ ' ' A' ' 83' ' ' TYR . 89.0 tt0 -59.97 -42.8 94.94 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.384 -0.822 . . . . 0.0 111.049 -178.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -55.08 -42.35 72.7 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.022 -1.049 . . . . 0.0 110.293 -177.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.525 HD22 ' CG1' ' A' ' 11' ' ' VAL . 3.6 tt -67.97 -39.83 83.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.211 -0.931 . . . . 0.0 109.341 177.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.442 ' N ' HG12 ' A' ' 11' ' ' VAL . . . -57.99 -46.8 84.62 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.32 -0.863 . . . . 0.0 109.737 175.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.434 ' CD1' ' HG2' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -59.99 -42.62 94.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.153 -0.967 . . . . 0.0 109.6 173.925 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -60.44 -45.44 93.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.414 -0.803 . . . . 0.0 109.904 175.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.462 HD23 HG22 ' A' ' 11' ' ' VAL . 7.9 tp -64.01 -44.23 93.25 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.406 -0.809 . . . . 0.0 109.972 176.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.549 ' CD2' ' HD3' ' A' ' 76' ' ' PRO . 3.6 mp -58.95 -46.15 88.74 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.547 -0.721 . . . . 0.0 110.008 -175.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -62.71 -40.05 95.95 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.627 -0.671 . . . . 0.0 110.109 177.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 72.9 tp60 -60.05 -39.9 87.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 0.0 109.939 -178.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.515 ' CG1' ' CD1' ' A' ' 33' ' ' LEU . 96.7 mt -65.06 -46.84 90.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.274 -0.891 . . . . 0.0 110.122 177.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 64.3 mttt -60.78 -44.17 97.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.136 -0.978 . . . . 0.0 109.557 175.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -59.12 -64.58 0.89 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.348 -0.845 . . . . 0.0 110.343 176.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.553 ' O ' ' CB ' ' A' ' 28' ' ' ALA . . . -105.24 -40.02 2.16 Favored Glycine 0 N--CA 1.483 1.79 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 -171.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.553 ' CB ' ' O ' ' A' ' 27' ' ' GLY . . . 77.46 105.49 0.07 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.716 -0.873 . . . . 0.0 109.942 -177.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -175.37 73.17 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.346 -0.846 . . . . 0.0 109.867 -177.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.576 ' CE1' HG13 ' A' ' 9' ' ' ILE . 23.6 t80 -59.95 -42.76 94.75 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.56 -0.712 . . . . 0.0 110.511 -175.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.82 -49.99 60.63 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -176.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.459 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 74.1 mttt -65.44 -39.95 92.69 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.973 -1.31 . . . . 0.0 110.049 -177.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.515 ' CD1' ' CG1' ' A' ' 24' ' ' ILE . 84.9 mt -64.95 -39.94 94.26 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.206 -0.934 . . . . 0.0 110.027 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.523 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -57.4 -50.2 73.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.218 -0.926 . . . . 0.0 110.034 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.437 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 21.4 mmtp -59.98 -43.4 95.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.276 -0.89 . . . . 0.0 110.745 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 32' ' ' LYS . 99.7 mttt -70.0 -43.16 71.96 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.09 -1.006 . . . . 0.0 111.424 -172.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 32.1 m80 -93.33 -36.0 12.76 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.97 -1.081 . . . . 0.0 110.912 -174.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.524 ' O ' ' CG2' ' A' ' 39' ' ' ILE . 31.6 t -60.03 -52.95 63.19 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.088 -1.007 . . . . 0.0 110.606 -174.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.524 ' CG2' ' O ' ' A' ' 38' ' ' SER . 13.6 tt 38.46 39.28 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.589 -0.695 . . . . 0.0 110.711 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.498 ' SG ' ' N ' ' A' ' 43' ' ' GLY . 12.8 p -127.88 163.61 42.23 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.214 -0.929 . . . . 0.0 109.841 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.46 ' HD2' ' HB2' ' A' ' 40' ' ' CYS . 5.7 Cg_endo -52.34 -27.87 32.68 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.722 1.38 . . . . 0.0 110.188 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.526 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.7 OUTLIER -101.03 14.59 31.47 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.893 . . . . 0.0 109.767 174.675 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.498 ' N ' ' SG ' ' A' ' 40' ' ' CYS . . . -77.08 -55.0 4.55 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 176.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.448 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 28.5 ttpt -60.03 -40.01 87.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.481 -1.011 . . . . 0.0 110.226 177.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.447 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 3.3 tpp180 -98.31 -44.27 6.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.097 -1.002 . . . . 0.0 110.615 -176.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -60.66 -33.74 83.51 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.38 -3.04 37.22 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 176.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.468 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 38.5 p-10 -167.93 62.45 0.07 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.267 -1.137 . . . . 0.0 109.279 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.461 ' HG ' ' HA2' ' A' ' 46' ' ' GLY . 6.2 mt -70.03 -29.09 66.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.637 -0.664 . . . . 0.0 110.317 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.81 -119.32 6.2 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -177.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.438 ' HG3' ' C ' ' A' ' 4' ' ' ALA . 82.5 tt0 -133.02 130.03 38.91 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.209 -1.171 . . . . 0.0 110.475 -175.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -127.05 -178.82 4.56 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.107 -0.995 . . . . 0.0 109.941 175.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 26.6 mmt85 . . . . . 0 N--CA 1.492 1.656 0 O-C-N 120.995 -1.066 . . . . 0.0 110.183 -173.497 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.5 ' O ' ' N ' ' A' ' 62' ' ' ASP . 14.4 Cg_endo . . . . . 0 N--CA 1.487 1.124 0 N-CA-C 110.559 -0.593 . . . . 0.0 110.559 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 59' ' ' PRO . . . -41.17 -34.32 0.45 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.357 -0.839 . . . . 0.0 110.218 -178.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.633 ' CZ ' ' CG2' ' A' ' 65' ' ' VAL . 63.8 t80 -60.05 -39.75 87.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.274 -0.892 . . . . 0.0 110.388 177.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.5 ' N ' ' O ' ' A' ' 59' ' ' PRO . 8.0 t70 -60.0 -48.88 79.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.135 -0.978 . . . . 0.0 110.187 -176.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 67' ' ' SER . 38.8 tptt -59.91 -50.03 75.37 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.149 -0.969 . . . . 0.0 110.206 178.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.461 ' HA ' ' HB3' ' A' ' 67' ' ' SER . 7.5 p -77.43 -41.19 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.103 -0.998 . . . . 0.0 111.554 -174.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.633 ' CG2' ' CZ ' ' A' ' 61' ' ' PHE . 1.9 p -56.32 -27.15 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.357 -1.464 . . . . 0.0 109.305 174.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -94.61 -7.58 40.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.493 -0.754 . . . . 0.0 109.859 176.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.461 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 8.9 t -93.95 -62.04 1.42 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.502 -0.749 . . . . 0.0 109.925 178.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.471 ' HB3' ' OG1' ' A' ' 74' ' ' THR . 27.4 p -71.11 156.51 91.83 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.278 -0.889 . . . . 0.0 110.418 177.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.518 ' O ' ' N ' ' A' ' 71' ' ' LEU . 43.6 Cg_endo -82.22 79.22 3.16 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.998 1.525 . . . . 0.0 110.785 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.544 ' O ' ' CD1' ' A' ' 71' ' ' LEU . 10.9 p 20.19 47.19 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.345 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 177.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.544 ' CD1' ' O ' ' A' ' 70' ' ' VAL . 0.3 OUTLIER -167.17 -40.25 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.453 -0.779 . . . . 0.0 111.068 178.263 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.444 ' HG3' ' HD2' ' A' ' 69' ' ' PRO . 23.5 mm-40 -70.03 130.93 89.34 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 120.836 -1.165 . . . . 0.0 110.732 -173.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -67.48 95.49 0.39 Allowed 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.76 1.4 . . . . 0.0 109.271 172.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.471 ' OG1' ' HB3' ' A' ' 68' ' ' CYS . 21.1 m -94.42 139.77 30.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.154 -0.966 . . . . 0.0 110.451 -172.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.49 -170.36 22.36 Favored Glycine 0 N--CA 1.485 1.919 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.549 ' HD3' ' CD2' ' A' ' 21' ' ' LEU . 42.9 Cg_endo -74.66 124.17 9.71 Favored 'Cis proline' 0 C--N 1.311 -1.437 0 C-N-CA 121.933 -2.111 . . . . 0.0 110.28 0.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.454 ' HG ' ' N ' ' A' ' 78' ' ' HIS . 39.7 tp -94.01 160.3 14.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.278 -0.889 . . . . 0.0 110.123 -174.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.454 ' N ' ' HG ' ' A' ' 77' ' ' LEU . 47.1 t-80 -78.77 123.91 27.66 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.029 -1.044 . . . . 0.0 110.579 -178.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.579 HG23 ' CE1' ' A' ' 84' ' ' HIS . 7.0 t -133.75 164.79 26.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.265 -0.897 . . . . 0.0 109.505 172.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.04 -29.85 68.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.121 -0.987 . . . . 0.0 110.29 -177.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -83.01 -4.91 58.83 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.143 -0.973 . . . . 0.0 110.745 -176.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.473 ' O ' HG21 ' A' ' 79' ' ' THR . . . 133.35 -139.29 10.81 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 -177.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.474 ' HB3' ' HB2' ' A' ' 76' ' ' PRO . 95.8 m-85 -101.98 121.47 42.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.043 -1.269 . . . . 0.0 110.264 178.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.579 ' CE1' HG23 ' A' ' 79' ' ' THR . 34.3 m170 -103.55 128.79 50.73 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.09 -1.006 . . . . 0.0 110.895 178.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.537 HG22 ' CE2' ' A' ' 30' ' ' PHE . 4.5 tt -113.18 119.98 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.963 -1.086 . . . . 0.0 108.947 167.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.453 HD12 HG11 ' A' ' 64' ' ' VAL . 85.5 mt -114.84 131.75 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.919 -1.113 . . . . 0.0 111.322 -168.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.457 ' HB3' ' HB2' ' A' ' 7' ' ' LEU . 26.5 ttmt -100.01 124.12 45.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.345 -0.847 . . . . 0.0 109.614 173.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.521 ' CG1' ' HA ' ' A' ' 70' ' ' VAL . 57.7 t -113.85 131.5 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.15 -0.969 . . . . 0.0 110.438 -172.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.509 ' O ' ' N ' ' A' ' 91' ' ' ARG . 57.2 mt -138.04 170.76 15.47 Favored 'General case' 0 C--N 1.309 -1.154 0 O-C-N 121.186 -0.946 . . . . 0.0 109.867 -177.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.447 ' O ' ' HB2' ' A' ' 91' ' ' ARG . 45.9 m-85 54.07 -76.93 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.752 -0.593 . . . . 0.0 112.069 171.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.526 ' HG3' ' CG2' ' A' ' 70' ' ' VAL . 19.1 mmm180 . . . . . 0 N--CA 1.496 1.874 0 O-C-N 120.799 -1.188 . . . . 0.0 110.794 -172.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.45 ' O ' ' O ' ' A' ' 91' ' ' ARG . 69.6 p . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.246 0.546 . . . . 0.0 110.005 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 51' ' ' GLU . . . -112.99 128.59 56.54 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -0.93 . . . . 0.0 109.952 178.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 89' ' ' LEU . . . -91.49 126.25 36.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.41 -0.806 . . . . 0.0 109.213 176.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.579 ' CB ' ' NE2' ' A' ' 8' ' ' HIS . . . -135.23 126.09 27.46 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 118.915 -1.114 . . . . 0.0 111.486 -170.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.462 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 58.3 mt -102.68 137.91 40.28 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.144 -0.973 . . . . 0.0 109.132 169.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.579 ' NE2' ' CB ' ' A' ' 6' ' ' ALA . 38.1 m-70 -131.09 131.07 43.94 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.905 -1.122 . . . . 0.0 111.088 -176.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.483 ' HB ' ' CG2' ' A' ' 85' ' ' ILE . 71.3 mt -114.37 124.98 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.98 -1.075 . . . . 0.0 109.456 168.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.59 ' HG ' ' CD2' ' A' ' 84' ' ' HIS . 0.3 OUTLIER -97.67 101.27 12.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.323 -0.86 . . . . 0.0 109.505 179.496 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.539 ' O ' ' CB ' ' A' ' 12' ' ' LYS . 3.6 t -67.63 -50.96 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.202 -0.936 . . . . 0.0 110.514 -175.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.539 ' CB ' ' O ' ' A' ' 11' ' ' VAL . 28.8 tttt 80.61 -17.26 0.59 Allowed 'General case' 0 N--CA 1.503 2.21 0 O-C-N 122.027 -0.42 . . . . 0.0 110.942 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -138.45 135.03 34.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.805 -1.185 . . . . 0.0 110.582 177.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -59.97 -45.23 93.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.458 -0.776 . . . . 0.0 110.285 177.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.7 mttm -59.83 -40.48 88.62 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.237 -0.914 . . . . 0.0 109.938 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.462 ' HB3' HG13 ' A' ' 11' ' ' VAL . 5.0 tt -67.87 -39.75 83.68 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.376 -0.827 . . . . 0.0 109.577 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.472 ' N ' HG11 ' A' ' 11' ' ' VAL . . . -59.5 -43.93 93.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.233 -0.917 . . . . 0.0 109.775 175.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.486 ' O ' HD11 ' A' ' 21' ' ' LEU . 0.1 OUTLIER -60.0 -40.87 90.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.352 -0.842 . . . . 0.0 110.056 175.495 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -60.83 -49.73 76.3 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.993 -1.067 . . . . 0.0 110.147 176.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.593 ' CD1' ' N ' ' A' ' 21' ' ' LEU . 0.4 OUTLIER -69.13 -50.34 48.83 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.135 -0.978 . . . . 0.0 110.915 -175.667 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.609 ' CD1' ' N ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -58.87 -29.63 67.13 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 120.742 -1.224 . . . . 0.0 108.961 -173.055 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.609 ' N ' ' CD1' ' A' ' 21' ' ' LEU . 87.9 tt0 -64.65 -39.93 94.54 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.36 -0.838 . . . . 0.0 109.931 170.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.402 ' HB3' ' O ' ' A' ' 20' ' ' LEU . 68.4 tp60 -60.05 -45.11 93.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.356 -0.84 . . . . 0.0 111.351 -173.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.519 ' O ' ' N ' ' A' ' 28' ' ' ALA . 27.6 mt -61.07 -47.96 91.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.041 -1.037 . . . . 0.0 110.592 -173.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.8 mttp -60.28 -49.01 79.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.943 -1.098 . . . . 0.0 110.256 177.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -60.01 -58.39 8.73 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.099 -1.001 . . . . 0.0 110.287 176.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.558 ' O ' ' CB ' ' A' ' 28' ' ' ALA . . . -105.6 -46.76 1.18 Allowed Glycine 0 N--CA 1.484 1.849 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 -172.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.613 ' O ' ' CB ' ' A' ' 29' ' ' ASP . . . 79.71 170.33 0.17 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.795 -0.826 . . . . 0.0 110.078 -176.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.613 ' CB ' ' O ' ' A' ' 28' ' ' ALA . 87.4 m-20 109.48 85.91 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.911 0 C-N-CA 124.656 1.182 . . . . 0.0 109.662 -174.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.512 ' CZ ' ' CB ' ' A' ' 73' ' ' PRO . 6.5 m-85 -60.02 -49.61 77.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.239 -0.913 . . . . 0.0 110.447 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.37 -46.28 94.19 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -177.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 33.1 tttp -62.84 -40.0 96.09 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.112 -1.228 . . . . 0.0 110.152 -177.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.452 HD23 HD11 ' A' ' 24' ' ' ILE . 47.3 tp -62.92 -40.03 96.34 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.213 -0.929 . . . . 0.0 110.337 177.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.483 ' O ' ' CB ' ' A' ' 38' ' ' SER . . . -59.66 -49.97 75.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.073 -1.017 . . . . 0.0 110.269 -178.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 46.8 tttm -60.05 -47.49 85.64 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.935 -1.103 . . . . 0.0 110.615 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -60.66 -42.28 96.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.134 -0.979 . . . . 0.0 111.03 -173.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 10.3 m80 -104.01 -4.38 23.4 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.928 -1.107 . . . . 0.0 111.022 -174.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.526 ' O ' ' CG2' ' A' ' 39' ' ' ILE . 1.2 t -60.04 -46.07 90.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.072 -1.017 . . . . 0.0 110.645 -177.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.526 ' CG2' ' O ' ' A' ' 38' ' ' SER . 16.0 tt 38.86 29.75 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.621 -0.674 . . . . 0.0 110.494 -177.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.449 ' N ' ' O ' ' A' ' 38' ' ' SER . 13.4 t -131.7 135.63 27.13 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.358 -0.839 . . . . 0.0 110.032 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -51.6 -31.09 38.8 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.907 1.477 . . . . 0.0 110.776 -176.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 46' ' ' GLY . 0.3 OUTLIER -99.94 11.74 38.54 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.154 -0.966 . . . . 0.0 110.318 -179.695 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.47 ' HA3' ' OG ' ' A' ' 38' ' ' SER . . . -104.92 -62.87 0.65 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -60.07 -39.98 87.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.139 -1.212 . . . . 0.0 109.823 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -102.41 -33.33 9.59 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.444 -0.785 . . . . 0.0 110.029 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.474 ' O ' ' HG ' ' A' ' 49' ' ' LEU . . . -99.51 -4.78 55.96 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 -177.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.477 ' O ' HD13 ' A' ' 49' ' ' LEU . . . -51.31 -50.43 40.72 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.601 -1.799 . . . . 0.0 108.601 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -71.91 106.76 4.35 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.197 -1.178 . . . . 0.0 109.644 170.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.477 HD13 ' O ' ' A' ' 47' ' ' GLY . 0.8 OUTLIER -108.98 1.1 20.4 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.11 -0.994 . . . . 0.0 110.166 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.79 -134.09 25.52 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 13.7 mt-10 -121.47 138.47 54.27 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.298 -1.119 . . . . 0.0 111.234 -176.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.435 ' CZ ' ' HB1' ' A' ' 6' ' ' ALA . 0.7 OUTLIER -121.72 173.1 7.67 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.399 -0.813 . . . . 0.0 109.555 173.548 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 9.6 ptp85 . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.057 -1.027 . . . . 0.0 110.021 -178.751 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 60' ' ' ALA . 3.0 Cg_endo . . . . . 0 N--CA 1.483 0.86 0 N-CA-C 110.41 -0.65 . . . . 0.0 110.41 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 59' ' ' PRO . . . -43.14 -36.12 1.58 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.233 -0.917 . . . . 0.0 110.441 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.494 ' CZ ' HG22 ' A' ' 65' ' ' VAL . 71.9 t80 -59.99 -40.02 87.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.188 -0.945 . . . . 0.0 110.656 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.458 ' O ' HG11 ' A' ' 65' ' ' VAL . 29.4 t0 -59.97 -49.97 75.59 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.136 -0.977 . . . . 0.0 110.331 -177.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.462 ' O ' ' HB2' ' A' ' 67' ' ' SER . 33.9 tttt -60.0 -50.03 75.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.07 -1.019 . . . . 0.0 110.541 177.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.53 ' CG2' ' HB ' ' A' ' 74' ' ' THR . 14.6 p -72.27 -44.93 63.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.025 -1.047 . . . . 0.0 111.082 -173.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.504 ' N ' HG12 ' A' ' 64' ' ' VAL . 1.9 p -55.58 -28.44 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.458 -1.402 . . . . 0.0 109.162 173.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -93.43 -10.63 34.45 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.328 -0.858 . . . . 0.0 109.897 175.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.479 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 7.4 t -93.84 -57.27 2.6 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.381 -0.825 . . . . 0.0 109.963 175.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.506 ' CB ' ' OG1' ' A' ' 74' ' ' THR . 84.6 m -111.63 122.88 36.12 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.292 -0.88 . . . . 0.0 110.012 177.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -61.73 -179.65 0.41 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.797 1.42 . . . . 0.0 110.643 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.526 ' CG1' ' HB2' ' A' ' 91' ' ' ARG . 31.4 m -61.87 161.43 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.357 -0.839 . . . . 0.0 110.924 -175.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 70' ' ' VAL . 5.5 mp 58.55 23.58 10.99 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.584 -0.698 . . . . 0.0 110.367 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -129.76 72.2 81.99 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.304 -0.872 . . . . 0.0 109.545 175.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.512 ' CB ' ' CZ ' ' A' ' 30' ' ' PHE . 65.1 Cg_exo -44.55 122.07 3.7 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.025 1.54 . . . . 0.0 110.071 -177.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.53 ' HB ' ' CG2' ' A' ' 64' ' ' VAL . 94.7 m -119.99 130.06 54.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.215 -0.928 . . . . 0.0 110.264 -175.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.442 ' HA3' HG13 ' A' ' 85' ' ' ILE . . . 137.33 -171.44 23.16 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 178.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.459 ' HG3' ' HB1' ' A' ' 17' ' ' ALA . 40.5 Cg_endo -68.24 153.89 88.57 Favored 'Cis proline' 0 C--N 1.313 -1.3 0 C-N-CA 121.695 -2.21 . . . . 0.0 110.297 1.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.498 ' HG ' ' N ' ' A' ' 78' ' ' HIS . 25.0 tp -132.94 157.68 44.52 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.986 -1.071 . . . . 0.0 110.576 -171.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.498 ' N ' ' HG ' ' A' ' 77' ' ' LEU . 44.8 m80 -62.91 132.73 53.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.305 -0.872 . . . . 0.0 110.685 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.53 ' CG2' ' O ' ' A' ' 82' ' ' GLY . 5.0 t -148.25 159.17 44.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.269 -0.895 . . . . 0.0 109.809 173.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.02 -26.93 66.47 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.209 -0.932 . . . . 0.0 110.118 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -88.59 -1.54 58.11 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.355 -0.841 . . . . 0.0 110.675 -176.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.53 ' O ' ' CG2' ' A' ' 79' ' ' THR . . . 129.66 -123.67 4.18 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -177.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.442 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 96.0 m-85 -114.18 122.49 46.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.193 -1.18 . . . . 0.0 110.189 178.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.59 ' CD2' ' HG ' ' A' ' 10' ' ' LEU . 41.3 m170 -109.33 120.43 42.49 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.321 -0.862 . . . . 0.0 110.823 177.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.483 ' CG2' ' HB ' ' A' ' 9' ' ' ILE . 7.7 tt -103.19 116.81 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.474 -1.391 . . . . 0.0 109.077 165.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.456 HG23 ' CE1' ' A' ' 8' ' ' HIS . 85.5 mt -114.63 130.01 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.923 -1.111 . . . . 0.0 111.007 -170.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.462 ' HB3' ' HB2' ' A' ' 7' ' ' LEU . 22.9 tttm -100.16 120.7 40.28 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.427 -0.795 . . . . 0.0 109.232 174.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 90.9 t -101.17 139.23 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.085 -1.01 . . . . 0.0 110.609 -173.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.557 ' O ' ' CB ' ' A' ' 90' ' ' TYR . 84.8 mt -138.29 120.63 15.91 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 121.329 -0.857 . . . . 0.0 109.707 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.557 ' CB ' ' O ' ' A' ' 89' ' ' LEU . 2.5 m-85 82.33 -24.68 0.17 Allowed 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.586 -0.697 . . . . 0.0 111.217 175.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.526 ' HB2' ' CG1' ' A' ' 70' ' ' VAL . 35.1 ttm180 . . . . . 0 N--CA 1.493 1.72 0 O-C-N 120.866 -1.146 . . . . 0.0 110.371 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 35.4 p . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.204 0.525 . . . . 0.0 110.238 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.458 ' CB ' ' HG2' ' A' ' 91' ' ' ARG . . . -146.86 165.14 30.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.351 -0.843 . . . . 0.0 109.824 176.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -99.21 134.12 42.51 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.197 -0.94 . . . . 0.0 109.639 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.516 ' HB1' ' CE1' ' A' ' 52' ' ' PHE . . . -135.92 128.01 29.75 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.708 -1.245 . . . . 0.0 111.828 -171.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.527 ' CD2' ' HA ' ' A' ' 48' ' ' ASP . 75.5 mt -108.82 141.09 41.35 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.188 -0.945 . . . . 0.0 109.201 168.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.57 ' CE1' HG23 ' A' ' 86' ' ' ILE . 26.3 m-70 -135.37 125.82 26.71 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.787 -1.195 . . . . 0.0 111.081 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.553 ' HB ' ' CG2' ' A' ' 85' ' ' ILE . 87.6 mt -110.14 130.05 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.91 -1.119 . . . . 0.0 110.211 170.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.525 ' HG ' ' CD2' ' A' ' 84' ' ' HIS . 0.7 OUTLIER -105.08 120.01 40.45 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.457 -0.777 . . . . 0.0 109.942 178.408 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.473 HG13 ' CD2' ' A' ' 16' ' ' LEU . 2.0 t -108.29 129.67 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.229 -0.919 . . . . 0.0 109.631 178.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -68.4 -39.46 81.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.258 -0.901 . . . . 0.0 110.558 -176.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -120.7 141.4 50.45 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.16 -0.962 . . . . 0.0 110.79 -177.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.582 ' HB2' ' CZ ' ' A' ' 83' ' ' TYR . 83.5 tt0 -60.0 -40.06 87.92 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.476 -0.765 . . . . 0.0 110.877 -178.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -55.88 -41.79 74.96 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.082 -1.011 . . . . 0.0 110.41 -174.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.473 ' CD2' HG13 ' A' ' 11' ' ' VAL . 1.4 tp -68.28 -40.01 81.96 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.214 -0.929 . . . . 0.0 109.563 177.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.72 -42.3 92.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.422 -0.799 . . . . 0.0 110.097 177.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.5 tp -60.06 -42.71 95.08 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.158 -0.964 . . . . 0.0 109.352 173.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.459 ' HB3' ' O ' ' A' ' 16' ' ' LEU . 56.1 t0 -59.99 -40.01 87.71 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -0.888 . . . . 0.0 109.387 174.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.512 HD13 ' CD1' ' A' ' 24' ' ' ILE . 0.6 OUTLIER -62.36 -43.28 99.2 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.494 -0.754 . . . . 0.0 109.463 175.68 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.523 ' CD2' ' HD3' ' A' ' 76' ' ' PRO . 4.0 mp -59.99 -49.61 77.0 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.765 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.439 ' HA ' ' OE1' ' A' ' 22' ' ' GLU . 51.7 tp10 -61.13 -40.0 92.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.287 -0.883 . . . . 0.0 109.85 173.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -61.14 -41.68 97.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.435 -0.791 . . . . 0.0 110.559 -176.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.527 ' O ' ' N ' ' A' ' 28' ' ' ALA . 33.0 mt -67.49 -40.08 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.007 -1.058 . . . . 0.0 110.281 176.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 21' ' ' LEU . 30.3 mttm -62.9 -53.93 46.5 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.099 -1.001 . . . . 0.0 109.987 -177.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -60.75 -50.78 72.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.194 -0.941 . . . . 0.0 110.048 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.554 ' O ' ' CB ' ' A' ' 28' ' ' ALA . . . -105.97 -54.56 0.71 Allowed Glycine 0 N--CA 1.487 2.043 0 N-CA-C 110.014 -1.235 . . . . 0.0 110.014 -173.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.614 ' O ' ' CB ' ' A' ' 29' ' ' ASP . . . 79.83 172.24 0.15 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.869 -0.783 . . . . 0.0 109.922 -176.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.614 ' CB ' ' O ' ' A' ' 28' ' ' ALA . 95.9 m-20 114.73 78.09 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.013 0 C-N-CA 124.859 1.264 . . . . 0.0 109.618 -175.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -60.03 -49.96 75.61 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.269 -0.895 . . . . 0.0 110.778 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.7 -49.91 65.35 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -175.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.46 ' HB2' ' HB3' ' A' ' 29' ' ' ASP . 94.6 mttt -64.59 -39.8 94.39 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.995 -1.297 . . . . 0.0 110.218 -175.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.49 ' HG ' ' CD2' ' A' ' 37' ' ' HIS . 9.8 tt -65.32 -40.04 93.23 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.176 -0.952 . . . . 0.0 110.127 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.541 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -59.81 -50.21 74.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.186 -0.946 . . . . 0.0 110.165 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.5 tttt -59.99 -50.0 75.44 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.382 -0.824 . . . . 0.0 110.717 -178.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.47 ' O ' HG12 ' A' ' 39' ' ' ILE . 88.8 tttt -65.93 -47.28 75.22 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.181 -0.949 . . . . 0.0 111.202 -174.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.49 ' CD2' ' HG ' ' A' ' 33' ' ' LEU . 67.2 m-70 -80.78 -50.01 10.4 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.874 -1.141 . . . . 0.0 111.674 -171.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.465 ' O ' ' C ' ' A' ' 39' ' ' ILE . 53.9 m -60.54 -40.07 90.19 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.915 -1.116 . . . . 0.0 110.765 -173.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.527 ' CG2' ' O ' ' A' ' 39' ' ' ILE . 31.9 mm 32.04 46.18 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 CA-C-O 121.5 0.667 . . . . 0.0 110.985 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.5 ' SG ' ' N ' ' A' ' 43' ' ' GLY . 17.0 p -133.79 170.14 12.1 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.348 -0.845 . . . . 0.0 109.945 -177.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.453 ' HD2' ' HB2' ' A' ' 40' ' ' CYS . 52.6 Cg_exo -49.96 -30.39 24.01 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.851 1.448 . . . . 0.0 109.982 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.481 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 6.1 p -108.84 27.29 9.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.22 -0.925 . . . . 0.0 109.61 173.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.5 ' N ' ' SG ' ' A' ' 40' ' ' CYS . . . -103.16 -67.16 0.75 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 108.607 -1.797 . . . . 0.0 108.607 176.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -59.99 -40.09 87.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -1.178 . . . . 0.0 109.961 172.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.451 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 13.7 tpt180 -99.8 -41.2 7.36 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.331 -0.856 . . . . 0.0 110.554 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.488 ' HA2' ' HG ' ' A' ' 49' ' ' LEU . . . -76.6 -22.81 71.71 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.32 -4.32 56.16 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 175.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.527 ' HA ' ' CD2' ' A' ' 7' ' ' LEU . 38.3 t0 -173.83 70.31 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.249 -1.148 . . . . 0.0 109.27 178.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.488 ' HG ' ' HA2' ' A' ' 46' ' ' GLY . 7.3 mt -70.08 -29.2 66.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.61 -0.681 . . . . 0.0 110.077 -176.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 111.78 -143.33 17.36 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -113.17 136.12 53.07 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.383 -1.069 . . . . 0.0 110.455 -177.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.546 ' CD1' ' N ' ' A' ' 52' ' ' PHE . 0.0 OUTLIER -148.6 168.44 22.78 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.305 -0.872 . . . . 0.0 109.707 175.373 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.486 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 75.1 ttt180 . . . . . 0 N--CA 1.493 1.691 0 O-C-N 120.737 -1.227 . . . . 0.0 110.546 -172.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo . . . . . 0 N--CA 1.482 0.81 0 N-CA-C 110.247 -0.713 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -43.95 -37.85 3.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.293 -0.879 . . . . 0.0 110.544 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.414 ' O ' HG13 ' A' ' 65' ' ' VAL . 37.7 t80 -59.9 -40.26 88.16 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.074 -1.016 . . . . 0.0 110.386 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.427 ' O ' HG13 ' A' ' 65' ' ' VAL . 32.9 t0 -59.97 -46.05 90.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.103 -0.998 . . . . 0.0 109.932 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -59.96 -49.99 75.51 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.293 -0.879 . . . . 0.0 110.623 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.511 HG13 ' N ' ' A' ' 65' ' ' VAL . 8.9 p -73.2 -45.4 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.03 -1.044 . . . . 0.0 111.144 -174.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.511 ' N ' HG13 ' A' ' 64' ' ' VAL . 5.5 p -57.46 -24.24 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.359 -1.463 . . . . 0.0 109.156 172.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -97.29 -1.5 44.54 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.365 -0.834 . . . . 0.0 109.904 175.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.466 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 22.8 t -96.58 -67.42 0.85 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.449 -0.782 . . . . 0.0 109.573 174.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 73.4 m -92.48 128.54 44.12 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.29 -0.881 . . . . 0.0 110.063 175.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -50.62 165.81 0.38 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.815 1.429 . . . . 0.0 110.353 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.506 HG13 ' CB ' ' A' ' 91' ' ' ARG . 31.4 m -59.8 169.1 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.265 -0.897 . . . . 0.0 110.726 -178.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' A' ' 70' ' ' VAL . 5.4 mp 59.94 26.17 15.4 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.699 -0.626 . . . . 0.0 110.583 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.06 90.96 37.6 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.085 -1.01 . . . . 0.0 110.17 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -52.22 110.64 0.47 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.771 1.406 . . . . 0.0 109.55 176.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 94.2 m -119.92 129.97 54.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.08 -1.012 . . . . 0.0 110.536 -173.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.499 ' HA2' ' CD2' ' A' ' 77' ' ' LEU . . . 148.41 -169.95 28.98 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.523 ' HD3' ' CD2' ' A' ' 21' ' ' LEU . 44.1 Cg_endo -75.6 139.16 59.51 Favored 'Cis proline' 0 C--N 1.313 -1.292 0 C-N-CA 121.854 -2.144 . . . . 0.0 110.481 1.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.499 ' CD2' ' HA2' ' A' ' 75' ' ' GLY . 1.1 mm? -98.15 174.83 6.33 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.241 -0.912 . . . . 0.0 110.699 -177.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.443 ' CD2' ' CE2' ' A' ' 83' ' ' TYR . 53.3 m170 -109.66 127.54 54.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.283 -0.885 . . . . 0.0 110.887 -176.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.575 HG23 ' CG ' ' A' ' 84' ' ' HIS . 11.1 t -140.42 168.77 19.02 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.457 -0.777 . . . . 0.0 109.775 174.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -59.95 -40.12 87.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.097 -1.002 . . . . 0.0 110.484 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -64.25 -16.69 62.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.086 -1.009 . . . . 0.0 110.583 -177.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.44 ' O ' HG22 ' A' ' 79' ' ' THR . . . 140.67 -143.62 13.68 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 -177.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.582 ' CZ ' ' HB2' ' A' ' 14' ' ' GLU . 68.9 m-85 -97.16 122.65 40.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.136 -1.214 . . . . 0.0 110.181 178.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.575 ' CG ' HG23 ' A' ' 79' ' ' THR . 24.7 m170 -105.79 120.07 40.77 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.46 -0.775 . . . . 0.0 110.603 178.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.553 ' CG2' ' HB ' ' A' ' 9' ' ' ILE . 6.5 tt -109.71 121.64 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.683 -1.261 . . . . 0.0 109.248 167.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.57 HG23 ' CE1' ' A' ' 8' ' ' HIS . 88.2 mt -115.53 130.04 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.108 -0.995 . . . . 0.0 111.289 -170.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.479 ' HB3' ' HB2' ' A' ' 7' ' ' LEU . 20.7 tttm -102.96 132.02 49.5 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.438 -0.789 . . . . 0.0 108.913 171.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.473 HG21 ' HA ' ' A' ' 70' ' ' VAL . 20.0 m -119.78 138.58 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.026 -1.046 . . . . 0.0 110.546 -176.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.534 ' O ' ' N ' ' A' ' 91' ' ' ARG . 58.5 mt -140.02 -167.34 2.28 Favored 'General case' 0 C--N 1.309 -1.186 0 O-C-N 121.291 -0.881 . . . . 0.0 109.901 -173.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.44 ' C ' ' O ' ' A' ' 89' ' ' LEU . 53.5 m-85 30.41 -85.63 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.865 -177.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.534 ' N ' ' O ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 O-C-N 120.697 -1.252 . . . . 0.0 109.837 -175.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.412 HG21 ' HG2' ' A' ' 53' ' ' ARG . 67.9 p . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.214 0.53 . . . . 0.0 110.089 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.435 ' C ' ' HG3' ' A' ' 51' ' ' GLU . . . -130.71 154.78 47.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.054 -1.029 . . . . 0.0 110.463 -178.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.606 ' CB ' ' CD1' ' A' ' 90' ' ' TYR . . . -98.07 136.59 38.1 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.226 -0.921 . . . . 0.0 109.757 177.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.564 ' CB ' ' NE2' ' A' ' 8' ' ' HIS . . . -147.58 123.12 10.43 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.719 -1.238 . . . . 0.0 112.098 -172.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.601 ' N ' ' CD1' ' A' ' 7' ' ' LEU . 4.0 mp -96.17 147.0 24.2 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.024 -1.048 . . . . 0.0 108.995 167.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.564 ' NE2' ' CB ' ' A' ' 6' ' ' ALA . 37.5 m-70 -136.35 137.02 40.17 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.773 -1.204 . . . . 0.0 111.287 -175.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.544 ' HB ' ' CG2' ' A' ' 85' ' ' ILE . 79.3 mt -118.93 129.9 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.127 -0.983 . . . . 0.0 109.799 168.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.532 ' HG ' ' CD2' ' A' ' 84' ' ' HIS . 0.4 OUTLIER -102.16 118.08 36.14 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.509 -0.745 . . . . 0.0 110.262 -179.115 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.529 ' CG1' HD21 ' A' ' 16' ' ' LEU . 2.2 t -108.09 127.74 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.323 -0.861 . . . . 0.0 109.891 177.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -69.95 -39.95 75.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.352 -0.842 . . . . 0.0 110.296 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -120.03 140.36 51.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.216 -0.928 . . . . 0.0 110.496 -175.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -59.89 -39.95 87.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.382 -0.823 . . . . 0.0 110.617 -176.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -52.16 -41.48 62.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.086 -1.009 . . . . 0.0 110.254 -175.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.529 HD21 ' CG1' ' A' ' 11' ' ' VAL . 7.9 tt -67.73 -44.08 78.46 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.029 -1.045 . . . . 0.0 109.912 177.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.521 ' CB ' ' HG3' ' A' ' 76' ' ' PRO . . . -59.91 -45.93 90.98 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.249 -0.907 . . . . 0.0 109.936 177.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.495 ' O ' HD11 ' A' ' 21' ' ' LEU . 10.1 tp -60.99 -39.18 88.68 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.932 -1.105 . . . . 0.0 109.405 170.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.424 ' HB3' ' O ' ' A' ' 16' ' ' LEU . 48.6 t0 -62.25 -49.79 74.29 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 120.999 -1.063 . . . . 0.0 110.312 176.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.591 ' CD1' ' N ' ' A' ' 21' ' ' LEU . 0.7 OUTLIER -69.94 -47.2 63.31 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.019 -1.051 . . . . 0.0 110.788 -175.574 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.615 ' CD1' ' N ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -59.96 -29.29 68.32 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.012 -1.055 . . . . 0.0 108.864 -173.185 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.615 ' N ' ' CD1' ' A' ' 21' ' ' LEU . 85.7 tt0 -61.87 -42.66 99.33 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.407 -0.808 . . . . 0.0 110.137 173.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.79 -39.99 95.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.298 -0.876 . . . . 0.0 110.574 -176.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.55 HD12 ' CE2' ' A' ' 30' ' ' PHE . 97.6 mt -61.89 -45.44 98.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -0.86 . . . . 0.0 109.824 -178.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 36.7 mttm -61.06 -46.26 91.4 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.228 -0.92 . . . . 0.0 109.716 176.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -59.95 -61.34 2.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.382 -0.824 . . . . 0.0 110.485 177.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.543 ' O ' ' CB ' ' A' ' 28' ' ' ALA . . . -104.87 -39.58 2.3 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -172.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.543 ' CB ' ' O ' ' A' ' 27' ' ' GLY . . . 81.19 102.56 0.06 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.953 -0.734 . . . . 0.0 110.142 -178.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -175.74 67.05 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.421 -0.799 . . . . 0.0 110.128 -177.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.577 ' CG ' ' HD3' ' A' ' 87' ' ' LYS . 2.0 m-85 -59.98 -44.15 94.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -0.923 . . . . 0.0 110.838 -178.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.4 -43.63 98.48 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -177.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -65.09 -40.2 94.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.175 -1.191 . . . . 0.0 110.345 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.552 HD23 ' CD2' ' A' ' 37' ' ' HIS . 88.9 mt -66.33 -39.93 89.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.112 -0.992 . . . . 0.0 110.491 178.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.467 ' HB3' HG12 ' A' ' 9' ' ' ILE . . . -60.0 -46.42 89.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.107 -0.996 . . . . 0.0 110.027 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -60.0 -50.21 74.61 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.363 -0.835 . . . . 0.0 110.785 -177.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.465 ' O ' HG13 ' A' ' 39' ' ' ILE . 51.3 mttt -75.91 -47.89 23.5 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.023 -1.048 . . . . 0.0 111.249 -174.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.552 ' CD2' HD23 ' A' ' 33' ' ' LEU . 60.9 m-70 -71.78 -40.04 69.51 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.932 -1.105 . . . . 0.0 111.198 -174.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.515 ' OG ' ' CA ' ' A' ' 43' ' ' GLY . 16.5 t -61.02 -50.04 74.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.035 -1.041 . . . . 0.0 111.045 -172.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.484 ' C ' ' O ' ' A' ' 38' ' ' SER . 96.3 mt 31.98 49.06 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 CA-C-O 121.318 0.58 . . . . 0.0 111.037 -177.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.501 ' SG ' ' N ' ' A' ' 43' ' ' GLY . 16.4 p -143.3 161.94 45.14 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.402 -0.811 . . . . 0.0 110.229 -176.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.459 ' HD2' ' HB2' ' A' ' 40' ' ' CYS . 6.1 Cg_endo -53.0 -26.12 30.79 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.947 1.498 . . . . 0.0 110.779 -178.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.535 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -109.05 19.77 19.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.074 -1.016 . . . . 0.0 110.087 177.816 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.515 ' CA ' ' OG ' ' A' ' 38' ' ' SER . . . -77.81 -53.13 5.09 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 108.583 -1.807 . . . . 0.0 108.583 172.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 61.8 mttt -60.21 -40.05 88.76 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.301 -1.117 . . . . 0.0 110.354 176.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.428 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 9.5 tpp180 -94.99 -41.22 9.26 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.982 -1.074 . . . . 0.0 110.262 -177.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -67.04 -28.09 73.67 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 178.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.86 -4.46 54.53 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 177.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.439 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 51.4 t0 -173.95 70.96 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.266 -1.138 . . . . 0.0 109.135 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.506 ' CD1' ' CD2' ' A' ' 8' ' ' HIS . 7.5 mt -69.94 -27.73 64.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.445 -0.784 . . . . 0.0 110.66 -174.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.56 -145.28 16.14 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 -176.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.435 ' HG3' ' C ' ' A' ' 4' ' ' ALA . 59.5 tt0 -113.14 132.14 55.57 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.161 -1.199 . . . . 0.0 110.544 -177.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.483 ' CE2' ' HB3' ' A' ' 6' ' ' ALA . 1.9 p90 -136.83 161.95 34.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.34 -0.85 . . . . 0.0 109.768 177.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.412 ' HG2' HG21 ' A' ' 3' ' ' THR . 82.8 mtp180 . . . . . 0 N--CA 1.497 1.894 0 O-C-N 120.942 -1.099 . . . . 0.0 111.155 -173.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.41 ' O ' ' C ' ' A' ' 60' ' ' ALA . 13.0 Cg_endo . . . . . 0 N--CA 1.484 0.934 0 N-CA-C 110.245 -0.714 . . . . 0.0 110.245 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.412 ' O ' ' HB3' ' A' ' 63' ' ' LYS . . . -41.17 -34.29 0.45 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.48 -0.762 . . . . 0.0 110.399 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.47 ' O ' HG11 ' A' ' 64' ' ' VAL . 68.5 t80 -60.0 -39.99 87.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.114 -0.991 . . . . 0.0 110.005 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -59.92 -39.97 87.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.309 -0.87 . . . . 0.0 109.511 179.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 60' ' ' ALA . 87.7 tttt -57.49 -40.56 78.88 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.466 -0.771 . . . . 0.0 110.379 176.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.523 HG13 ' N ' ' A' ' 65' ' ' VAL . 14.3 p -91.77 -41.9 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.974 -1.079 . . . . 0.0 111.52 -173.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.523 ' N ' HG13 ' A' ' 64' ' ' VAL . 2.5 p -52.65 -27.16 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.53 -1.356 . . . . 0.0 109.805 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -99.83 5.66 45.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.172 -0.955 . . . . 0.0 109.88 176.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.465 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 37.5 t -99.61 -80.06 0.48 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.382 -0.824 . . . . 0.0 110.181 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 84.3 m -78.51 156.95 77.98 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.153 -0.967 . . . . 0.0 110.352 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.539 ' O ' ' O ' ' A' ' 70' ' ' VAL . 38.6 Cg_endo -79.07 69.78 7.78 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.069 1.562 . . . . 0.0 110.585 179.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.539 ' O ' ' O ' ' A' ' 69' ' ' PRO . 8.4 p 29.4 -174.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 178.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.533 ' CD1' HG13 ' A' ' 70' ' ' VAL . 0.0 OUTLIER 23.6 41.67 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.607 0 O-C-N 120.821 -1.174 . . . . 0.0 113.364 -164.139 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' A' ' 70' ' ' VAL . 9.7 tt0 -134.04 100.86 12.84 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.766 -1.209 . . . . 0.0 109.91 171.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.515 ' HB3' ' CZ ' ' A' ' 30' ' ' PHE . 50.9 Cg_exo -47.42 103.84 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.908 1.478 . . . . 0.0 110.38 -176.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.458 ' HB ' HG22 ' A' ' 64' ' ' VAL . 50.6 m -98.99 134.2 42.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.322 -0.861 . . . . 0.0 110.504 -177.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.458 ' HA3' HG13 ' A' ' 85' ' ' ILE . . . 135.78 -172.65 22.17 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 176.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.521 ' HG3' ' CB ' ' A' ' 17' ' ' ALA . 43.5 Cg_endo -70.13 127.95 12.11 Favored 'Cis proline' 0 N--CA 1.49 1.277 0 C-N-CA 121.798 -2.167 . . . . 0.0 110.292 2.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 62.3 tp -95.37 155.91 16.54 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.252 -0.905 . . . . 0.0 110.763 -174.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -71.41 123.97 23.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.335 -0.853 . . . . 0.0 110.514 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.582 HG22 ' CE1' ' A' ' 84' ' ' HIS . 12.9 t -140.12 156.11 46.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.205 -0.934 . . . . 0.0 109.727 174.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -60.12 -32.07 70.66 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.118 -0.989 . . . . 0.0 110.927 -175.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -75.68 -8.79 57.69 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.015 -1.053 . . . . 0.0 110.365 -178.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.504 ' O ' ' CG2' ' A' ' 79' ' ' THR . . . 138.34 -132.88 6.0 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 -175.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -107.86 125.78 51.88 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.092 -1.24 . . . . 0.0 110.1 175.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.582 ' CE1' HG22 ' A' ' 79' ' ' THR . 45.6 m170 -106.96 124.18 49.25 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.143 -0.973 . . . . 0.0 110.367 175.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.544 ' CG2' ' HB ' ' A' ' 9' ' ' ILE . 9.9 tt -108.54 125.47 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 118.719 -1.192 . . . . 0.0 109.398 168.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 86.0 mt -120.08 130.67 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.016 -1.052 . . . . 0.0 111.785 -167.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.577 ' HD3' ' CG ' ' A' ' 30' ' ' PHE . 13.5 mtmm -93.06 126.83 38.35 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.1 -1.0 . . . . 0.0 109.12 168.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.514 ' CG1' HG21 ' A' ' 70' ' ' VAL . 59.3 t -109.93 130.07 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.029 -1.044 . . . . 0.0 110.458 -175.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 91' ' ' ARG . 87.7 mt -139.71 -155.25 0.57 Allowed 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.272 -0.893 . . . . 0.0 110.109 -178.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.606 ' CD1' ' CB ' ' A' ' 5' ' ' ALA . 16.9 m-85 32.82 -89.0 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 O-C-N 122.104 -0.372 . . . . 0.0 111.268 -178.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.524 ' N ' ' O ' ' A' ' 89' ' ' LEU . 13.5 tpt180 . . . . . 0 N--CA 1.493 1.678 0 O-C-N 120.878 -1.139 . . . . 0.0 110.62 177.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 67.6 m . . . . . 0 N--CA 1.493 1.71 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.508 ' HA ' ' HA ' ' A' ' 91' ' ' ARG . . . -150.42 158.48 44.2 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.816 -1.178 . . . . 0.0 111.247 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.459 ' CA ' ' HG3' ' A' ' 51' ' ' GLU . . . -101.25 136.96 40.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.491 -0.755 . . . . 0.0 109.45 176.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.516 ' HB2' ' NE2' ' A' ' 8' ' ' HIS . . . -150.19 129.74 13.07 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.981 -1.075 . . . . 0.0 111.224 -177.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.497 ' CD2' ' HA ' ' A' ' 48' ' ' ASP . 72.6 mt -99.5 135.09 41.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.253 -0.904 . . . . 0.0 109.168 169.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.57 ' CD2' HG12 ' A' ' 86' ' ' ILE . 40.8 m170 -130.34 129.39 43.1 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.025 -1.047 . . . . 0.0 110.827 -176.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.538 ' HB ' ' CG2' ' A' ' 85' ' ' ILE . 84.6 mt -114.45 129.8 69.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.179 -0.951 . . . . 0.0 109.547 169.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.49 ' CD1' ' C ' ' A' ' 10' ' ' LEU . 1.8 tm? -106.8 114.92 29.31 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.291 -0.88 . . . . 0.0 110.138 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.523 ' CG1' ' HB3' ' A' ' 16' ' ' LEU . 2.3 t -101.3 128.97 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.312 -0.868 . . . . 0.0 109.925 177.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -67.33 -40.04 85.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.306 -0.871 . . . . 0.0 110.705 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -109.02 138.99 44.5 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.06 -1.025 . . . . 0.0 111.159 -174.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -60.09 -41.24 92.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.556 -0.715 . . . . 0.0 110.182 176.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -56.06 -43.76 78.22 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.257 -0.902 . . . . 0.0 109.848 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.523 ' HB3' ' CG1' ' A' ' 11' ' ' VAL . 3.2 tt -67.84 -36.02 79.6 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.342 -0.849 . . . . 0.0 109.5 177.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.454 ' HA ' ' HB3' ' A' ' 20' ' ' LEU . . . -57.52 -44.33 84.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.945 -1.097 . . . . 0.0 109.603 172.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.502 ' O ' HD13 ' A' ' 21' ' ' LEU . 0.1 OUTLIER -60.04 -39.95 87.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.204 -0.935 . . . . 0.0 109.901 173.159 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 16' ' ' LEU . 60.4 t0 -61.06 -40.83 95.16 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.677 -1.264 . . . . 0.0 109.101 171.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.55 ' C ' ' CD1' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -64.17 -80.69 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.551 -0.718 . . . . 0.0 110.445 179.826 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.54 HD12 ' N ' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -49.99 -20.01 0.84 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.21 -1.556 . . . . 0.0 110.497 -164.719 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.54 ' N ' HD12 ' A' ' 21' ' ' LEU . 50.2 tp10 -64.49 -39.99 94.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.682 -1.262 . . . . 0.0 110.189 173.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.42 ' N ' ' O ' ' A' ' 20' ' ' LEU . 85.4 mm-40 -60.44 -41.74 94.68 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.284 -0.885 . . . . 0.0 111.221 -172.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.52 ' O ' ' N ' ' A' ' 28' ' ' ALA . 1.7 mp -64.3 -43.67 97.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.016 -1.053 . . . . 0.0 110.768 -173.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -61.84 -50.05 73.82 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 120.775 -1.203 . . . . 0.0 110.164 178.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -63.26 -57.3 10.89 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.128 -0.983 . . . . 0.0 110.521 176.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.571 ' O ' ' CB ' ' A' ' 28' ' ' ALA . . . -104.53 -39.98 2.29 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -172.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.571 ' CB ' ' O ' ' A' ' 27' ' ' GLY . . . 82.99 -153.52 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.23 0 O-C-N 122.109 -0.642 . . . . 0.0 110.476 -179.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.486 ' HB2' ' O ' ' A' ' 28' ' ' ALA . 2.7 m-20 61.38 75.66 0.4 Allowed 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 122.082 0.944 . . . . 0.0 110.558 175.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.517 ' CZ ' HG13 ' A' ' 9' ' ' ILE . 62.8 t80 -59.97 -48.15 82.9 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.82 -0.55 . . . . 0.0 110.931 -178.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.0 -41.51 97.95 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -175.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.432 ' HD2' ' CG ' ' A' ' 29' ' ' ASP . 82.0 mttt -66.34 -39.94 89.54 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.042 -1.269 . . . . 0.0 110.194 -178.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.576 ' O ' ' CD2' ' A' ' 37' ' ' HIS . 49.1 mt -64.91 -40.07 94.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.066 -1.021 . . . . 0.0 110.206 178.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.486 ' O ' ' CB ' ' A' ' 38' ' ' SER . . . -59.57 -47.11 86.86 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.076 -1.015 . . . . 0.0 109.862 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -59.93 -40.9 90.46 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.032 -1.042 . . . . 0.0 110.431 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.8 mtpt -73.02 -52.08 15.76 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.013 -1.054 . . . . 0.0 111.764 -175.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.576 ' CD2' ' O ' ' A' ' 33' ' ' LEU . 7.4 p80 -106.01 -17.43 14.34 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.406 -1.434 . . . . 0.0 112.111 -167.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.525 ' O ' ' CG2' ' A' ' 39' ' ' ILE . 64.9 p -60.02 -50.06 75.22 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.621 -1.3 . . . . 0.0 110.301 -173.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.525 ' CG2' ' O ' ' A' ' 38' ' ' SER . 17.3 tt 38.34 31.2 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.692 -0.63 . . . . 0.0 110.466 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.51 ' SG ' ' N ' ' A' ' 43' ' ' GLY . 20.4 p -125.61 169.04 12.17 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.316 -0.865 . . . . 0.0 110.307 -176.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.456 ' HD2' ' HB2' ' A' ' 40' ' ' CYS . 41.0 Cg_exo -51.76 -34.61 55.1 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.893 1.47 . . . . 0.0 110.729 -175.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.535 ' O ' ' CA ' ' A' ' 46' ' ' GLY . 1.2 p -107.01 16.59 24.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.154 -0.966 . . . . 0.0 109.891 177.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.51 ' N ' ' SG ' ' A' ' 40' ' ' CYS . . . -79.98 -60.0 2.5 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 108.681 -1.768 . . . . 0.0 108.681 176.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -59.94 -40.37 88.73 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.424 -1.045 . . . . 0.0 110.488 176.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.442 ' HG3' HD22 ' A' ' 49' ' ' LEU . 17.0 tpt180 -104.95 -44.38 4.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.097 -1.002 . . . . 0.0 110.93 -175.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.535 ' CA ' ' O ' ' A' ' 42' ' ' SER . . . -62.37 -29.1 72.25 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.79 0.48 44.22 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 177.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.497 ' HA ' ' CD2' ' A' ' 7' ' ' LEU . 40.6 t0 -169.65 76.25 0.09 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.132 -1.217 . . . . 0.0 109.101 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.442 HD22 ' HG3' ' A' ' 45' ' ' ARG . 10.6 mt -91.28 -6.19 53.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.573 -0.704 . . . . 0.0 110.196 -175.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.95 -131.26 28.13 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 -173.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.477 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 54.8 mp0 -116.63 145.95 43.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.101 -1.235 . . . . 0.0 110.546 177.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.503 ' CE2' ' HB3' ' A' ' 6' ' ' ALA . 0.3 OUTLIER -130.19 164.14 25.15 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.321 -0.862 . . . . 0.0 110.552 176.14 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 87.7 mtt180 . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.528 -0.732 . . . . 0.0 110.434 -175.307 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo . . . . . 0 N--CA 1.48 0.724 0 N-CA-C 110.845 -0.483 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.55 -39.35 79.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -0.893 . . . . 0.0 110.216 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.48 ' HA ' HD11 ' A' ' 86' ' ' ILE . 59.5 t80 -59.92 -41.69 92.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.284 -0.885 . . . . 0.0 110.451 178.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -60.02 -47.24 86.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.232 -0.918 . . . . 0.0 109.878 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.459 ' O ' ' HB2' ' A' ' 67' ' ' SER . 96.9 mttt -59.88 -44.23 94.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.285 -0.885 . . . . 0.0 110.419 178.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.511 ' CG1' ' N ' ' A' ' 65' ' ' VAL . 6.2 p -83.57 -44.96 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.12 -0.987 . . . . 0.0 111.221 -172.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.511 ' N ' ' CG1' ' A' ' 64' ' ' VAL . 5.0 p -55.43 -24.3 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.206 -1.558 . . . . 0.0 109.142 172.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -92.86 -15.2 26.71 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.332 -0.855 . . . . 0.0 109.661 175.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.462 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 9.4 t -93.18 -47.61 6.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.378 -0.826 . . . . 0.0 109.936 175.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.514 ' CB ' ' OG1' ' A' ' 74' ' ' THR . 29.3 p -102.98 136.92 19.16 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.352 -0.843 . . . . 0.0 109.965 175.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -66.55 171.61 10.44 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.796 1.419 . . . . 0.0 110.261 178.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.473 ' CG1' ' HD3' ' A' ' 91' ' ' ARG . 12.7 m -57.69 171.41 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.372 -0.83 . . . . 0.0 110.422 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.461 HD12 HG21 ' A' ' 70' ' ' VAL . 4.3 mp 38.85 39.71 0.37 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.583 -0.698 . . . . 0.0 110.764 -177.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -137.78 83.98 23.04 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.162 -0.961 . . . . 0.0 110.01 177.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -50.08 124.87 13.55 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.027 1.541 . . . . 0.0 109.981 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.514 ' OG1' ' CB ' ' A' ' 68' ' ' CYS . 96.5 m -135.22 138.09 43.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.293 -0.879 . . . . 0.0 110.21 -177.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.455 ' HA3' HG13 ' A' ' 85' ' ' ILE . . . 147.92 -172.72 28.18 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -178.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -70.49 173.29 47.84 Favored 'Cis proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.77 -2.179 . . . . 0.0 110.59 -0.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.45 HD12 HG21 ' A' ' 64' ' ' VAL . 25.2 mt -133.57 175.33 9.52 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.243 -0.911 . . . . 0.0 110.224 -178.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -95.97 119.53 34.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.059 -1.026 . . . . 0.0 110.753 -175.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.418 HG22 ' O ' ' A' ' 82' ' ' GLY . 15.2 t -140.94 163.41 33.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.42 -0.8 . . . . 0.0 109.779 176.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -59.99 -39.99 87.64 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.979 -1.075 . . . . 0.0 110.437 -178.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -60.06 -18.38 46.23 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.222 -0.923 . . . . 0.0 110.451 179.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.418 ' O ' HG22 ' A' ' 79' ' ' THR . . . 134.1 -130.56 5.64 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 -177.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -93.06 121.06 34.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.085 -1.244 . . . . 0.0 110.245 177.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.415 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 1.0 OUTLIER -102.64 116.16 32.03 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.432 -0.793 . . . . 0.0 110.502 177.17 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.538 ' CG2' ' HB ' ' A' ' 9' ' ' ILE . 7.8 tt -108.62 126.28 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.86 -1.15 . . . . 0.0 109.427 170.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.57 HG12 ' CD2' ' A' ' 8' ' ' HIS . 89.5 mt -120.1 129.94 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.119 -0.988 . . . . 0.0 111.735 -167.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.476 ' HB3' ' HB2' ' A' ' 7' ' ' LEU . 27.8 tttt -101.08 129.84 47.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.225 -0.922 . . . . 0.0 109.165 169.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 18.0 t -100.82 139.98 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.075 -1.016 . . . . 0.0 110.414 -175.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' A' ' 91' ' ' ARG . 88.7 mt -141.68 170.15 16.27 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.434 ' C ' ' O ' ' A' ' 89' ' ' LEU . 77.8 m-85 33.37 -87.28 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 O-C-N 122.212 -0.305 . . . . 0.0 111.665 -178.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.533 ' N ' ' O ' ' A' ' 89' ' ' LEU . 1.8 ttp180 . . . . . 0 N--CA 1.492 1.671 0 O-C-N 120.7 -1.25 . . . . 0.0 109.502 -176.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.464 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 11.5 p . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.475 ' O ' ' HA ' ' A' ' 51' ' ' GLU . . . -127.8 150.56 49.77 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.86 -1.15 . . . . 0.0 109.954 176.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' ' 50' ' ' GLY . . . -89.71 121.63 32.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.32 -0.862 . . . . 0.0 109.62 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.552 ' HB3' ' CZ ' ' A' ' 52' ' ' PHE . . . -131.81 131.9 43.28 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 118.992 -1.083 . . . . 0.0 111.651 -169.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.469 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 85.7 mt -99.96 134.01 43.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.288 -0.882 . . . . 0.0 108.991 169.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.555 ' CD2' HG12 ' A' ' 86' ' ' ILE . 49.7 m170 -128.51 129.67 46.38 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.833 -1.167 . . . . 0.0 111.116 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.544 ' HB ' ' CG2' ' A' ' 85' ' ' ILE . 80.0 mt -116.69 128.65 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.07 -1.019 . . . . 0.0 109.718 169.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.472 HD22 ' N ' ' A' ' 11' ' ' VAL . 2.4 tm? -106.58 120.32 41.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.274 -0.891 . . . . 0.0 109.911 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.517 HG12 ' CD2' ' A' ' 16' ' ' LEU . 2.3 t -106.77 125.45 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.312 -0.867 . . . . 0.0 110.282 -178.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -70.03 -37.86 75.71 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.373 -0.829 . . . . 0.0 110.499 175.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -106.48 136.8 45.6 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.086 -1.009 . . . . 0.0 111.061 -173.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.568 ' HG2' ' CZ ' ' A' ' 83' ' ' TYR . 97.1 mt-10 -59.99 -39.99 87.62 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.356 -0.84 . . . . 0.0 110.294 175.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -56.24 -44.51 79.69 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -0.913 . . . . 0.0 110.035 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.517 ' CD2' HG12 ' A' ' 11' ' ' VAL . 7.9 tt -68.56 -39.93 80.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.296 -0.877 . . . . 0.0 109.935 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.521 ' O ' ' CD1' ' A' ' 21' ' ' LEU . . . -58.2 -41.85 84.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.178 -0.951 . . . . 0.0 109.384 176.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.407 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -60.04 -45.36 93.08 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.075 -1.016 . . . . 0.0 109.365 171.257 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.435 ' HB3' ' O ' ' A' ' 16' ' ' LEU . 55.1 t0 -60.03 -42.49 94.5 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.417 -0.802 . . . . 0.0 110.11 176.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.527 ' HG ' ' N ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -64.49 -47.05 80.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.237 -0.915 . . . . 0.0 109.523 178.09 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.527 ' N ' ' HG ' ' A' ' 20' ' ' LEU . 0.4 OUTLIER -56.53 -47.41 79.46 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.496 -0.753 . . . . 0.0 109.797 -178.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 18' ' ' LEU . 99.0 mt-10 -61.2 -39.65 91.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.55 -0.719 . . . . 0.0 110.141 177.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 50.4 tp60 -59.94 -47.19 86.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.281 -0.887 . . . . 0.0 110.817 -172.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.573 HG21 ' CE2' ' A' ' 30' ' ' PHE . 2.3 mt -66.48 -43.54 90.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.055 -1.028 . . . . 0.0 110.888 -176.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -61.3 -44.26 97.51 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.702 -1.249 . . . . 0.0 109.983 -178.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -60.8 -65.33 0.71 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.149 -0.969 . . . . 0.0 110.491 175.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.578 ' O ' ' CB ' ' A' ' 28' ' ' ALA . . . -105.86 -34.84 3.15 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -172.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.578 ' CB ' ' O ' ' A' ' 27' ' ' GLY . . . 87.09 -147.05 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.338 0 O-C-N 122.373 -0.486 . . . . 0.0 110.328 -178.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.535 ' CB ' ' O ' ' A' ' 28' ' ' ALA . 0.5 OUTLIER 75.91 65.35 0.06 Allowed 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.308 0.575 . . . . 0.0 110.523 176.324 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.573 ' CE2' HG21 ' A' ' 24' ' ' ILE . 7.2 m-85 -60.03 -41.91 93.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.355 -0.841 . . . . 0.0 110.572 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.23 -53.82 33.93 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.176 -1.169 . . . . 0.0 110.176 -176.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.422 ' HD2' ' CG ' ' A' ' 29' ' ' ASP . 97.9 mttt -66.5 -39.98 89.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.011 -1.288 . . . . 0.0 110.555 -174.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.402 HD13 ' O ' ' A' ' 28' ' ' ALA . 88.7 mt -63.81 -40.06 95.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.097 -1.002 . . . . 0.0 109.915 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.452 ' HB2' HG12 ' A' ' 9' ' ' ILE . . . -59.98 -47.71 84.7 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.403 -0.811 . . . . 0.0 110.323 177.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -60.09 -43.14 95.74 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.271 -0.893 . . . . 0.0 110.654 -176.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 49.2 tttt -69.31 -53.79 17.88 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.037 -1.039 . . . . 0.0 110.98 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -70.39 -40.03 74.17 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.054 -1.029 . . . . 0.0 111.535 -172.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.526 ' O ' ' CG2' ' A' ' 39' ' ' ILE . 21.0 t -60.0 -43.55 95.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.882 -1.136 . . . . 0.0 110.187 -174.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.526 ' CG2' ' O ' ' A' ' 38' ' ' SER . 16.8 tt 38.26 32.04 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.655 -0.653 . . . . 0.0 110.747 176.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.489 ' SG ' ' N ' ' A' ' 43' ' ' GLY . 16.3 p -127.42 166.38 23.42 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.055 -1.028 . . . . 0.0 110.379 -176.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -51.99 -35.69 61.91 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.993 1.522 . . . . 0.0 110.56 -178.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.53 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -97.64 18.75 14.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.983 -1.073 . . . . 0.0 109.743 174.544 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.489 ' N ' ' SG ' ' A' ' 40' ' ' CYS . . . -77.2 -54.26 4.83 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 108.303 -1.919 . . . . 0.0 108.303 172.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -60.86 -39.98 91.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.527 -0.984 . . . . 0.0 110.657 176.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.476 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 11.7 tpp180 -97.95 -45.21 6.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.177 -0.952 . . . . 0.0 110.154 -177.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -68.3 -30.3 73.48 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 178.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.41 -1.37 57.35 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 176.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -171.89 68.29 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.3 -1.118 . . . . 0.0 108.85 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 7.2 mt -70.03 -28.1 65.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.54 -0.725 . . . . 0.0 110.347 -174.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 5' ' ' ALA . . . 98.92 -144.18 17.05 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.351 -1.499 . . . . 0.0 109.351 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.475 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 3.5 mt-10 -99.54 130.78 45.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.528 -0.983 . . . . 0.0 110.571 -178.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.552 ' CZ ' ' HB3' ' A' ' 6' ' ' ALA . 3.3 p90 -149.02 168.41 23.2 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.241 -0.912 . . . . 0.0 110.875 178.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.464 ' HB2' ' HA ' ' A' ' 3' ' ' THR . 32.2 ttt85 . . . . . 0 N--CA 1.494 1.727 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 173.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.519 ' O ' ' N ' ' A' ' 62' ' ' ASP . 6.5 Cg_endo . . . . . 0 N--CA 1.486 1.07 0 N-CA-C 110.997 -0.424 . . . . 0.0 110.997 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 59' ' ' PRO . . . -42.01 -33.76 0.61 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.284 -0.885 . . . . 0.0 110.019 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -62.48 -39.75 94.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.334 -0.854 . . . . 0.0 110.028 177.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 59' ' ' PRO . 51.5 t0 -60.04 -40.0 87.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.34 -0.85 . . . . 0.0 110.536 -177.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 67' ' ' SER . 49.4 mttm -58.15 -48.49 80.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.093 -1.004 . . . . 0.0 111.434 -174.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.472 ' HA ' ' HB3' ' A' ' 67' ' ' SER . 2.4 p -94.73 -37.64 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.725 -1.235 . . . . 0.0 111.561 -173.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.2 p -54.82 -26.18 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.532 -1.355 . . . . 0.0 109.788 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.485 ' CD2' ' O ' ' A' ' 66' ' ' PHE . 50.7 t80 -100.68 0.05 38.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.315 -0.866 . . . . 0.0 110.127 176.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.476 ' HB2' ' O ' ' A' ' 63' ' ' LYS . 41.2 t -94.03 -74.58 0.53 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.263 -0.898 . . . . 0.0 110.37 -176.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.482 ' O ' ' N ' ' A' ' 70' ' ' VAL . 94.5 m -100.27 142.8 25.3 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.244 -0.91 . . . . 0.0 110.388 -178.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.501 ' O ' HD12 ' A' ' 71' ' ' LEU . 35.4 Cg_exo -56.47 81.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.053 1.554 . . . . 0.0 110.222 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.55 ' HA ' ' CG1' ' A' ' 88' ' ' VAL . 16.8 m 13.41 65.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.391 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.538 ' CD1' ' O ' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -166.95 -47.41 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.456 -0.778 . . . . 0.0 110.315 177.583 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -83.34 148.05 54.76 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.229 -0.92 . . . . 0.0 110.434 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -70.52 141.32 41.88 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.105 1.582 . . . . 0.0 110.622 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.445 ' HB ' ' CG2' ' A' ' 64' ' ' VAL . 94.5 m -138.01 137.8 38.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.25 -0.906 . . . . 0.0 110.189 178.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 140.89 -167.11 25.75 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.464 ' HD3' ' CD2' ' A' ' 21' ' ' LEU . 43.1 Cg_endo -72.1 140.6 66.84 Favored 'Cis proline' 0 C--N 1.315 -1.231 0 C-N-CA 121.783 -2.174 . . . . 0.0 110.586 1.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.464 HD13 HD13 ' A' ' 86' ' ' ILE . 96.2 mt -90.89 170.39 10.12 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.39 -0.819 . . . . 0.0 109.998 -177.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -106.82 123.67 48.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.857 -1.152 . . . . 0.0 110.898 -177.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.1 t -138.59 164.77 28.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.371 -0.83 . . . . 0.0 109.338 173.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -56.74 -39.76 74.53 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.941 -1.099 . . . . 0.0 110.253 -175.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -60.05 -26.98 66.56 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.183 -0.948 . . . . 0.0 110.535 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 149.26 -137.76 6.47 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -176.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.568 ' CZ ' ' HG2' ' A' ' 14' ' ' GLU . 66.3 m-85 -98.64 124.86 43.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.992 -1.299 . . . . 0.0 110.367 177.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.456 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 1.9 m170 -101.7 114.17 27.99 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.475 -0.766 . . . . 0.0 110.309 174.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.544 ' CG2' ' HB ' ' A' ' 9' ' ' ILE . 3.1 tt -102.05 118.84 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 120.761 -1.212 . . . . 0.0 109.408 170.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.555 HG12 ' CD2' ' A' ' 8' ' ' HIS . 96.1 mt -112.07 129.98 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.462 -0.774 . . . . 0.0 111.017 -172.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.469 ' HB3' ' HB2' ' A' ' 7' ' ' LEU . 10.5 ttmm -105.17 127.08 52.74 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.868 -1.145 . . . . 0.0 109.31 168.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.55 ' CG1' ' HA ' ' A' ' 70' ' ' VAL . 26.8 t -110.29 139.97 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.208 -0.933 . . . . 0.0 110.335 -173.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.529 ' CD2' ' O ' ' A' ' 88' ' ' VAL . 81.1 mt -148.9 177.15 9.81 Favored 'General case' 0 C--N 1.308 -1.203 0 O-C-N 121.336 -0.852 . . . . 0.0 109.402 -177.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.472 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER 67.49 -61.01 0.37 Allowed 'General case' 0 C--N 1.293 -1.859 0 O-C-N 121.422 -0.799 . . . . 0.0 111.389 167.23 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.472 ' HD2' HG23 ' A' ' 70' ' ' VAL . 61.7 ttt-85 . . . . . 0 N--CA 1.495 1.784 0 O-C-N 121.04 -1.038 . . . . 0.0 110.567 -174.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 67.4 p . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 121.117 0.484 . . . . 0.0 110.262 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' A' ' 91' ' ' ARG . . . -138.56 143.44 39.42 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.192 -0.942 . . . . 0.0 110.264 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -94.53 130.32 40.98 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.315 -0.866 . . . . 0.0 109.145 173.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.579 ' HB2' ' CZ ' ' A' ' 52' ' ' PHE . . . -146.8 134.91 21.57 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.845 -1.159 . . . . 0.0 111.534 -171.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.503 ' C ' ' CD2' ' A' ' 8' ' ' HIS . 88.6 mt -107.35 149.88 27.34 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.298 -0.876 . . . . 0.0 109.581 173.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.64 ' CD2' ' CD1' ' A' ' 49' ' ' LEU . 21.2 m-70 -136.39 143.4 43.97 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.795 -1.19 . . . . 0.0 111.634 -176.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.527 HG12 ' CB ' ' A' ' 34' ' ' ALA . 91.1 mt -130.96 130.77 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.005 -1.059 . . . . 0.0 109.575 166.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.576 ' HG ' ' CD2' ' A' ' 84' ' ' HIS . 0.3 OUTLIER -104.72 119.96 40.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.428 -0.795 . . . . 0.0 110.053 179.782 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.451 HG23 HD21 ' A' ' 20' ' ' LEU . 2.5 t -105.04 126.6 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.17 -0.956 . . . . 0.0 110.266 178.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 26.2 mmtm -69.19 -40.01 78.33 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.479 -0.763 . . . . 0.0 110.32 177.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -109.32 140.54 42.86 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.217 -0.927 . . . . 0.0 110.918 -173.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -60.13 -47.46 85.81 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.409 -0.807 . . . . 0.0 110.36 175.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -59.35 -40.71 87.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.276 -0.89 . . . . 0.0 110.335 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.442 HD23 HG12 ' A' ' 11' ' ' VAL . 2.5 tt -67.84 -39.98 83.8 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.312 -0.867 . . . . 0.0 109.627 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.447 ' O ' ' CD1' ' A' ' 21' ' ' LEU . . . -59.02 -43.76 91.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -0.923 . . . . 0.0 109.815 175.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.487 ' HA ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -59.93 -43.1 95.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.192 -0.943 . . . . 0.0 109.942 175.299 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -60.01 -41.63 92.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.402 -0.811 . . . . 0.0 110.162 178.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.522 ' CD1' HD11 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -64.18 -46.09 85.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.161 -0.962 . . . . 0.0 109.825 178.666 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.543 ' CD1' ' CD ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -58.21 -50.03 75.0 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.329 -0.857 . . . . 0.0 110.428 -178.05 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -60.01 -36.93 78.27 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.213 -0.93 . . . . 0.0 110.261 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 52.8 tp60 -59.99 -40.01 87.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.189 -0.944 . . . . 0.0 110.374 -175.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.561 HD12 ' CZ ' ' A' ' 30' ' ' PHE . 3.9 mt -63.73 -41.96 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.112 -0.993 . . . . 0.0 110.715 -178.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -59.96 -45.69 91.86 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.824 -1.172 . . . . 0.0 109.565 176.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -59.78 -67.37 0.39 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.169 -0.957 . . . . 0.0 110.375 173.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.568 ' O ' ' CB ' ' A' ' 28' ' ' ALA . . . -106.54 -35.03 2.94 Favored Glycine 0 N--CA 1.487 2.067 0 C-N-CA 120.057 -1.068 . . . . 0.0 110.617 -170.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.568 ' CB ' ' O ' ' A' ' 27' ' ' GLY . . . 85.37 -156.91 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.402 0 O-C-N 122.001 -0.705 . . . . 0.0 110.196 -174.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.552 ' CB ' ' O ' ' A' ' 28' ' ' ALA . 0.7 OUTLIER 78.7 71.59 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 CA-C-O 121.487 0.66 . . . . 0.0 110.563 176.865 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.561 ' CZ ' HD12 ' A' ' 24' ' ' ILE . 1.7 m-85 -62.43 -42.21 99.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.203 -0.935 . . . . 0.0 110.664 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.29 -44.4 97.54 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 -176.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.6 mmtt -63.79 -39.96 95.51 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.162 -1.199 . . . . 0.0 110.082 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.559 ' CD1' HG13 ' A' ' 24' ' ' ILE . 85.9 mt -62.55 -39.92 95.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.107 -0.995 . . . . 0.0 110.355 176.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.527 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -58.17 -48.65 79.62 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.095 -1.003 . . . . 0.0 110.186 -178.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -59.24 -49.08 79.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.281 -0.887 . . . . 0.0 110.159 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -70.0 -43.04 72.22 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.297 -0.877 . . . . 0.0 111.473 -176.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -80.07 -49.99 10.98 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.031 -1.043 . . . . 0.0 111.217 -173.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.531 ' O ' ' CG2' ' A' ' 39' ' ' ILE . 54.1 m -60.12 -39.91 87.89 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.053 -1.029 . . . . 0.0 111.064 -172.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.531 ' CG2' ' O ' ' A' ' 38' ' ' SER . 10.9 tp 39.02 28.95 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.528 -0.733 . . . . 0.0 110.375 -178.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.469 ' N ' ' O ' ' A' ' 38' ' ' SER . 17.5 p -122.8 160.16 50.29 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.328 -0.857 . . . . 0.0 109.823 -178.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -52.68 -20.68 12.99 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.84 1.442 . . . . 0.0 110.42 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.525 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -106.58 16.41 24.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.181 -0.949 . . . . 0.0 110.205 176.885 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.49 -51.41 5.61 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.611 -1.796 . . . . 0.0 108.611 172.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.468 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 48.5 tttp -60.02 -39.99 87.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.423 -1.045 . . . . 0.0 110.259 177.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.473 ' HA ' ' OD1' ' A' ' 48' ' ' ASP . 20.7 tpt180 -96.68 -42.05 8.21 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.369 -0.832 . . . . 0.0 110.479 -177.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -63.25 -28.98 73.12 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.94 0.16 53.13 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 176.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.473 ' OD1' ' HA ' ' A' ' 45' ' ' ARG . 43.8 p-10 -170.15 62.75 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.249 -1.147 . . . . 0.0 109.183 -177.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.64 ' CD1' ' CD2' ' A' ' 8' ' ' HIS . 10.3 mt -69.98 -29.23 66.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.398 -0.814 . . . . 0.0 110.749 -175.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.21 -145.06 17.49 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -178.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -112.27 136.38 51.77 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.19 -1.182 . . . . 0.0 110.217 -178.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.579 ' CZ ' ' HB2' ' A' ' 6' ' ' ALA . 0.1 OUTLIER -133.79 -166.1 1.73 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.299 -0.876 . . . . 0.0 109.705 174.411 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 . . . . . 0 N--CA 1.494 1.772 0 O-C-N 120.845 -1.159 . . . . 0.0 109.865 -178.576 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo . . . . . 0 N--CA 1.485 1.004 0 N-CA-C 110.408 -0.651 . . . . 0.0 110.408 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -44.8 -29.43 0.79 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.24 -0.912 . . . . 0.0 110.574 -179.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.471 ' O ' HG12 ' A' ' 64' ' ' VAL . 59.4 t80 -60.01 -44.29 94.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.082 -1.011 . . . . 0.0 110.177 178.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -59.93 -42.0 93.02 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.05 -1.031 . . . . 0.0 109.549 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.493 ' O ' ' N ' ' A' ' 67' ' ' SER . 93.4 mttt -60.02 -47.42 85.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.512 -0.743 . . . . 0.0 111.011 -178.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.503 HG11 ' N ' ' A' ' 65' ' ' VAL . 10.3 p -73.02 -46.57 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 120.872 -1.143 . . . . 0.0 110.98 -175.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.503 ' N ' HG11 ' A' ' 64' ' ' VAL . 9.8 p -60.2 -22.05 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.208 -1.558 . . . . 0.0 109.662 170.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -90.41 -13.62 34.59 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.85 -1.156 . . . . 0.0 109.366 171.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.493 ' N ' ' O ' ' A' ' 63' ' ' LYS . 12.4 t -87.5 -61.85 1.63 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.464 -0.773 . . . . 0.0 108.917 172.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.474 ' O ' ' O ' ' A' ' 65' ' ' VAL . 31.3 p -82.5 133.31 50.09 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 120.876 -1.14 . . . . 0.0 109.087 167.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.507 ' O ' ' NH1' ' A' ' 91' ' ' ARG . 41.3 Cg_exo -52.28 -68.66 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.713 1.375 . . . . 0.0 110.671 -174.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.536 HG21 ' CD1' ' A' ' 71' ' ' LEU . 7.6 p -179.01 162.16 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -177.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.536 ' CD1' HG21 ' A' ' 70' ' ' VAL . 3.3 mp 42.76 32.96 0.43 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.897 -1.127 . . . . 0.0 109.946 -170.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.487 ' CG ' ' O ' ' A' ' 70' ' ' VAL . 8.4 mm-40 -130.9 79.98 70.49 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.667 -0.646 . . . . 0.0 109.918 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -47.07 126.64 11.63 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 123.859 1.452 . . . . 0.0 110.012 -178.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.401 ' OG1' ' HB3' ' A' ' 68' ' ' CYS . 70.7 m -135.38 139.37 44.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.182 -0.949 . . . . 0.0 110.432 -176.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.94 -170.82 25.13 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.543 ' CD ' ' CD1' ' A' ' 21' ' ' LEU . 42.0 Cg_endo -69.53 136.46 38.39 Favored 'Cis proline' 0 C--N 1.314 -1.262 0 C-N-CA 121.767 -2.18 . . . . 0.0 110.455 0.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.453 HD11 ' HB ' ' A' ' 64' ' ' VAL . 1.0 OUTLIER -95.29 142.69 27.4 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.221 -0.924 . . . . 0.0 110.433 -175.017 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -64.75 130.06 42.12 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.107 -0.995 . . . . 0.0 110.633 -176.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.574 HG22 ' CE1' ' A' ' 84' ' ' HIS . 9.5 t -144.66 160.24 41.51 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.283 -0.886 . . . . 0.0 110.375 178.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.568 ' HG3' ' CD2' ' A' ' 81' ' ' PHE . 20.1 pt20 -63.06 -16.22 59.19 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.263 -0.898 . . . . 0.0 110.879 -177.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.568 ' CD2' ' HG3' ' A' ' 80' ' ' GLN . 98.4 m-85 -95.01 6.27 49.56 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.003 -1.061 . . . . 0.0 110.457 -178.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 126.39 -115.4 2.26 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 -175.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.44 ' HB3' ' HB2' ' A' ' 76' ' ' PRO . 69.2 m-85 -140.41 126.97 20.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.09 -1.241 . . . . 0.0 110.287 175.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.576 ' CD2' ' HG ' ' A' ' 10' ' ' LEU . 42.1 m170 -103.31 127.57 50.61 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.522 -0.736 . . . . 0.0 110.676 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.522 ' CG2' ' HB ' ' A' ' 9' ' ' ILE . 8.4 tt -109.15 129.59 63.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 120.605 -1.309 . . . . 0.0 109.065 166.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.54 HG22 ' CE1' ' A' ' 8' ' ' HIS . 72.2 mt -130.18 135.1 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.015 -1.053 . . . . 0.0 110.701 -169.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 6' ' ' ALA . 12.5 mtpt -97.91 139.16 34.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.45 -0.781 . . . . 0.0 109.58 176.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 28.0 t -109.74 137.47 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.473 -0.767 . . . . 0.0 110.146 -178.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.526 ' HB3' ' CD2' ' A' ' 90' ' ' TYR . 92.3 mt -144.34 135.79 25.64 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.064 -1.022 . . . . 0.0 109.551 178.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.526 ' CD2' ' HB3' ' A' ' 89' ' ' LEU . 70.9 m-85 65.31 -63.42 0.2 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.332 -0.855 . . . . 0.0 111.076 177.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.507 ' NH1' ' O ' ' A' ' 69' ' ' PRO . 33.7 ttp180 . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.049 -1.032 . . . . 0.0 110.214 -175.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.494 1.774 0 CA-C-O 121.029 0.442 . . . . 0.0 109.972 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.54 ' O ' ' CD1' ' A' ' 52' ' ' PHE . . . -151.45 154.81 37.31 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.107 -0.995 . . . . 0.0 110.623 -174.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.418 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -101.32 140.0 36.22 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.009 -1.057 . . . . 0.0 109.14 171.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.515 ' HB2' ' NE2' ' A' ' 8' ' ' HIS . . . -159.04 154.55 25.9 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.859 -1.151 . . . . 0.0 111.29 -178.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 82.2 mt -109.91 149.99 29.09 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.434 -0.791 . . . . 0.0 109.142 172.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.581 ' CD2' ' CD1' ' A' ' 49' ' ' LEU . 46.5 m-70 -137.2 133.55 35.29 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.789 -1.194 . . . . 0.0 111.383 -177.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.536 ' HB ' ' CG2' ' A' ' 85' ' ' ILE . 87.3 mt -120.01 120.99 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.113 -0.992 . . . . 0.0 109.605 168.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.516 HD21 ' CD2' ' A' ' 84' ' ' HIS . 2.7 tm? -104.07 120.08 40.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.477 -0.765 . . . . 0.0 109.817 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.529 ' CG1' HD21 ' A' ' 16' ' ' LEU . 2.4 t -103.81 130.08 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.29 -0.881 . . . . 0.0 110.346 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -65.93 -40.08 91.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.459 -0.776 . . . . 0.0 110.551 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -119.54 140.02 51.2 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.126 -0.984 . . . . 0.0 110.531 -175.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.464 ' HB2' ' CE1' ' A' ' 83' ' ' TYR . 86.8 tt0 -59.91 -39.99 87.32 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.372 -0.83 . . . . 0.0 110.352 -178.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.6 mttt -52.46 -47.42 66.48 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.188 -0.945 . . . . 0.0 110.069 -176.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.529 HD21 ' CG1' ' A' ' 11' ' ' VAL . 8.4 tt -68.71 -37.07 79.22 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.104 -0.997 . . . . 0.0 109.546 176.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.507 ' N ' HG12 ' A' ' 11' ' ' VAL . . . -56.94 -49.29 76.1 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.042 -1.036 . . . . 0.0 109.522 176.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.471 ' HA ' HD12 ' A' ' 21' ' ' LEU . 0.9 OUTLIER -58.31 -40.44 82.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.15 -0.969 . . . . 0.0 109.579 174.573 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.475 ' HB3' ' O ' ' A' ' 16' ' ' LEU . 51.5 t0 -60.0 -39.98 87.66 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.096 -1.002 . . . . 0.0 109.671 174.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.547 ' HG ' ' N ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -62.91 -44.27 96.55 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.16 -0.963 . . . . 0.0 109.668 178.125 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.547 ' N ' ' HG ' ' A' ' 20' ' ' LEU . 1.3 mt -59.9 -50.14 74.93 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.381 -0.824 . . . . 0.0 110.07 -178.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -62.87 -39.92 95.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.314 -0.867 . . . . 0.0 110.247 177.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.462 ' O ' ' N ' ' A' ' 27' ' ' GLY . 64.9 tp60 -60.07 -40.95 91.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.305 -0.872 . . . . 0.0 110.311 -177.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.517 ' O ' ' N ' ' A' ' 28' ' ' ALA . 85.5 mt -67.32 -40.35 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.179 -0.95 . . . . 0.0 109.795 177.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -63.85 -59.96 3.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.139 -0.976 . . . . 0.0 109.598 176.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -60.32 -52.37 65.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.438 -0.789 . . . . 0.0 110.866 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 28' ' ' ALA . . . -106.18 -13.0 24.21 Favored Glycine 0 N--CA 1.487 2.041 0 C-N-CA 119.647 -1.263 . . . . 0.0 110.597 -166.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 24' ' ' ILE . . . 34.1 95.37 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.751 -0.853 . . . . 0.0 111.459 -177.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -171.68 86.35 0.09 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.466 -0.771 . . . . 0.0 109.827 -176.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.471 ' CG ' ' HE3' ' A' ' 87' ' ' LYS . 3.9 m-85 -69.8 -40.12 76.18 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.325 -0.859 . . . . 0.0 110.764 -176.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.36 -52.08 53.81 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -63.73 -41.1 98.12 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.185 -1.185 . . . . 0.0 110.513 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.523 HD22 ' CD1' ' A' ' 20' ' ' LEU . 33.0 tp -61.74 -50.06 73.91 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.074 -1.016 . . . . 0.0 110.716 -175.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.521 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -59.95 -47.88 83.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.198 -0.939 . . . . 0.0 110.383 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 50.3 mttm -60.02 -49.78 76.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.212 -0.93 . . . . 0.0 110.592 -176.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.445 ' O ' HG13 ' A' ' 39' ' ' ILE . 57.2 tptt -69.72 -52.5 24.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.156 -0.965 . . . . 0.0 111.235 -175.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -83.21 -40.28 19.85 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.913 -1.117 . . . . 0.0 111.583 -170.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.47 ' O ' ' C ' ' A' ' 39' ' ' ILE . 18.4 t -60.01 -45.2 93.54 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.973 -1.08 . . . . 0.0 110.443 -176.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.47 ' C ' ' O ' ' A' ' 38' ' ' SER . 80.2 mt 34.14 45.76 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 CA-C-O 121.322 0.582 . . . . 0.0 110.769 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.512 ' SG ' ' N ' ' A' ' 43' ' ' GLY . 17.2 p -133.91 160.04 70.09 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.254 -0.904 . . . . 0.0 110.093 -177.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.41 ' HD2' ' HB2' ' A' ' 40' ' ' CYS . 6.7 Cg_endo -54.02 -23.8 29.88 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.962 1.506 . . . . 0.0 110.522 -177.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.511 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -109.12 20.54 18.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.085 -1.009 . . . . 0.0 110.084 176.902 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.512 ' N ' ' SG ' ' A' ' 40' ' ' CYS . . . -79.11 -59.65 2.7 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 176.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -60.02 -33.91 72.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.41 -1.053 . . . . 0.0 110.39 176.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.448 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 16.0 tpt180 -91.57 -39.73 11.74 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.109 -0.994 . . . . 0.0 110.158 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -70.75 -29.02 69.9 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 177.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.97 0.54 58.06 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 173.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -168.76 63.34 0.06 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.291 -1.123 . . . . 0.0 109.134 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.581 ' CD1' ' CD2' ' A' ' 8' ' ' HIS . 12.7 mt -70.12 -28.89 65.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.599 -0.688 . . . . 0.0 110.155 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.27 -136.02 12.69 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.231 -1.547 . . . . 0.0 109.231 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -113.66 148.16 36.82 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.382 -1.069 . . . . 0.0 110.171 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.54 ' CD1' ' O ' ' A' ' 4' ' ' ALA . 0.0 OUTLIER -131.45 160.41 35.23 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.205 -0.934 . . . . 0.0 109.879 -172.382 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 36.5 ptt-85 . . . . . 0 N--CA 1.494 1.756 0 O-C-N 121.297 -0.877 . . . . 0.0 110.468 -173.802 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 60' ' ' ALA . 32.9 Cg_endo . . . . . 0 N--CA 1.484 0.916 0 N-CA-C 111.059 -0.4 . . . . 0.0 111.059 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 59' ' ' PRO . . . -42.67 -34.64 0.93 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.116 -0.99 . . . . 0.0 110.469 -174.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.434 ' CE2' ' CE1' ' A' ' 52' ' ' PHE . 56.1 t80 -60.0 -44.07 94.79 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.233 -0.917 . . . . 0.0 110.092 -179.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.522 ' OD1' ' CD1' ' A' ' 66' ' ' PHE . 56.5 t0 -68.31 -45.26 73.48 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.295 -0.878 . . . . 0.0 110.553 -178.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' A' ' 67' ' ' SER . 11.3 tptt -56.36 -50.15 72.37 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.031 -1.043 . . . . 0.0 110.269 -176.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.461 ' HA ' ' HB3' ' A' ' 67' ' ' SER . 5.8 p -69.5 -46.73 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.089 -1.007 . . . . 0.0 111.443 -173.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.508 HG11 ' CD1' ' A' ' 66' ' ' PHE . 6.8 p -58.15 -26.14 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.297 -1.502 . . . . 0.0 109.468 173.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.522 ' CD1' ' OD1' ' A' ' 62' ' ' ASP . 17.4 m-85 -96.2 -1.78 47.59 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.21 -0.931 . . . . 0.0 110.148 174.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' ' 63' ' ' LYS . 9.4 t -97.41 -59.03 1.87 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.348 -0.845 . . . . 0.0 109.67 173.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.458 ' HB3' ' OG1' ' A' ' 74' ' ' THR . 23.0 p -107.08 147.72 35.66 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.4 -0.813 . . . . 0.0 110.146 177.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -71.68 171.27 16.74 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 124.046 1.551 . . . . 0.0 110.682 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.531 HG21 ' N ' ' A' ' 71' ' ' LEU . 7.1 p -58.7 158.6 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.465 -0.772 . . . . 0.0 110.145 178.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.531 ' N ' HG21 ' A' ' 70' ' ' VAL . 3.2 mp 56.75 39.55 29.59 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.195 -0.941 . . . . 0.0 110.0 -175.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.419 ' C ' ' OE1' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -148.36 93.63 4.34 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.366 -0.834 . . . . 0.0 110.115 -179.907 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -63.15 130.52 29.13 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.981 1.516 . . . . 0.0 110.164 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.458 ' OG1' ' HB3' ' A' ' 68' ' ' CYS . 33.3 m -135.88 140.49 44.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.288 -0.882 . . . . 0.0 110.415 -178.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 149.16 -169.83 29.51 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.219 -1.553 . . . . 0.0 109.219 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.528 ' HD3' ' CD2' ' A' ' 21' ' ' LEU . 46.7 Cg_endo -76.03 136.36 44.24 Favored 'Cis proline' 0 C--N 1.313 -1.329 0 C-N-CA 121.825 -2.156 . . . . 0.0 110.663 -1.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 41.2 mt -93.36 -173.22 3.16 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.319 -0.863 . . . . 0.0 109.962 178.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -111.74 121.22 44.49 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.997 -1.064 . . . . 0.0 111.306 -173.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.45 HG21 ' CG ' ' A' ' 84' ' ' HIS . 9.8 t -138.06 164.28 29.48 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.274 -0.891 . . . . 0.0 109.438 170.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -54.92 -36.53 65.33 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.141 -0.975 . . . . 0.0 110.618 -175.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -63.13 -30.37 71.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.062 -1.024 . . . . 0.0 110.78 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 152.07 -135.58 5.06 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -177.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.464 ' O ' HD22 ' A' ' 10' ' ' LEU . 39.0 m-85 -93.98 131.12 39.76 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.35 -1.088 . . . . 0.0 109.96 177.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.516 ' CD2' HD21 ' A' ' 10' ' ' LEU . 0.1 OUTLIER -111.93 113.25 25.45 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.432 -0.792 . . . . 0.0 110.999 -178.863 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.536 ' CG2' ' HB ' ' A' ' 9' ' ' ILE . 4.5 tt -110.03 132.46 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.881 -1.137 . . . . 0.0 109.117 169.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.542 HG22 ' CE1' ' A' ' 8' ' ' HIS . 89.1 mt -135.98 140.12 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.598 -1.314 . . . . 0.0 111.899 -168.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.471 ' HE3' ' CG ' ' A' ' 30' ' ' PHE . 15.1 mttm -92.65 142.26 27.56 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.387 -0.821 . . . . 0.0 110.038 170.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.484 ' CG1' ' HD3' ' A' ' 91' ' ' ARG . 59.7 t -109.72 133.69 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.768 -0.582 . . . . 0.0 109.983 178.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.493 ' O ' ' HB2' ' A' ' 90' ' ' TYR . 81.0 mt -141.89 129.09 20.99 Favored 'General case' 0 C--N 1.308 -1.2 0 O-C-N 121.005 -1.059 . . . . 0.0 109.947 -176.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.493 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 42.2 m-85 65.29 -55.29 0.32 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.228 -0.92 . . . . 0.0 111.587 173.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.517 ' NE ' ' HB ' ' A' ' 70' ' ' VAL . 84.6 mtm180 . . . . . 0 N--CA 1.495 1.792 0 O-C-N 121.037 -1.04 . . . . 0.0 110.894 -177.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.53 HG21 ' CB ' ' A' ' 53' ' ' ARG . 14.8 p . . . . . 0 N--CA 1.493 1.696 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.433 ' C ' ' HG3' ' A' ' 51' ' ' GLU . . . -149.96 153.61 36.88 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.839 -1.163 . . . . 0.0 111.029 -178.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.446 ' HB1' ' HB2' ' A' ' 90' ' ' TYR . . . -96.69 131.46 43.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.424 -0.798 . . . . 0.0 109.253 174.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.576 ' CB ' ' NE2' ' A' ' 8' ' ' HIS . . . -147.41 122.73 10.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.834 -1.166 . . . . 0.0 111.688 -172.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.593 ' N ' ' CD1' ' A' ' 7' ' ' LEU . 3.5 mp -97.07 141.16 30.55 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.173 -0.954 . . . . 0.0 109.283 170.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.576 ' NE2' ' CB ' ' A' ' 6' ' ' ALA . 25.8 m-70 -134.54 128.17 32.78 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.887 -1.133 . . . . 0.0 110.947 -175.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.532 ' HB ' ' CG2' ' A' ' 85' ' ' ILE . 76.4 mt -109.96 129.96 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 120.882 -1.136 . . . . 0.0 110.136 168.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.583 ' HG ' ' CD2' ' A' ' 84' ' ' HIS . 0.3 OUTLIER -101.68 118.61 37.3 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.552 -0.717 . . . . 0.0 109.711 178.648 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.479 HG11 ' O ' ' A' ' 13' ' ' GLU . 2.0 t -101.48 127.21 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.243 -0.911 . . . . 0.0 110.125 -177.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.1 mttp -69.28 -40.01 78.0 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.308 -0.87 . . . . 0.0 110.313 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.479 ' O ' HG11 ' A' ' 11' ' ' VAL . 14.5 pt-20 -132.52 152.21 51.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.295 -0.878 . . . . 0.0 110.26 -178.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.508 ' HG3' ' CZ ' ' A' ' 83' ' ' TYR . 95.2 mt-10 -59.04 -39.9 83.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.29 -0.881 . . . . 0.0 110.409 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -51.31 -44.62 61.97 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.191 -0.943 . . . . 0.0 110.34 -176.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.475 HD23 HG12 ' A' ' 11' ' ' VAL . 9.7 tt -68.89 -40.0 79.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.044 -1.035 . . . . 0.0 109.715 177.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.461 ' O ' HD13 ' A' ' 21' ' ' LEU . . . -59.87 -44.43 94.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.307 -0.871 . . . . 0.0 110.14 177.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.85 -45.8 89.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.218 -0.926 . . . . 0.0 109.819 178.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 23' ' ' GLN . 53.1 t0 -60.03 -42.2 93.86 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.345 -0.847 . . . . 0.0 110.187 177.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.522 ' CD1' HD13 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -66.47 -43.56 85.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.147 -0.97 . . . . 0.0 110.047 -179.711 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.521 ' N ' ' HG ' ' A' ' 20' ' ' LEU . 0.3 OUTLIER -55.26 -59.93 4.1 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.38 -0.825 . . . . 0.0 110.072 -177.869 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -63.9 -40.0 95.48 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.394 -0.816 . . . . 0.0 110.707 177.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.569 ' NE2' ' CD2' ' A' ' 33' ' ' LEU . 62.2 tt0 -60.11 -29.49 68.64 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.118 -0.989 . . . . 0.0 110.185 -176.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.533 ' O ' ' CA ' ' A' ' 28' ' ' ALA . 91.6 mt -68.2 -40.01 82.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 120.687 -1.258 . . . . 0.0 109.606 173.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.4 tttp -66.69 -60.09 3.01 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.097 -1.002 . . . . 0.0 110.696 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.55 ' OD1' ' N ' ' A' ' 27' ' ' GLY . 47.3 p30 -62.16 -33.68 74.96 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.105 -0.997 . . . . 0.0 110.501 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.575 ' O ' ' CB ' ' A' ' 28' ' ' ALA . . . -106.23 -65.3 0.63 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.575 ' CB ' ' O ' ' A' ' 27' ' ' GLY . . . 85.58 95.51 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.254 0 CA-C-O 121.624 0.725 . . . . 0.0 110.615 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -177.1 80.01 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.61 -0.681 . . . . 0.0 109.651 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.558 ' CG ' ' HE2' ' A' ' 87' ' ' LYS . 5.5 m-85 -60.1 -47.77 84.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.876 . . . . 0.0 110.903 -174.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.05 -50.33 68.8 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 119.715 -1.231 . . . . 0.0 110.045 -176.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -66.6 -40.04 88.66 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.131 -1.217 . . . . 0.0 110.78 -175.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.569 ' CD2' ' NE2' ' A' ' 23' ' ' GLN . 83.8 mt -66.3 -40.19 89.84 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.164 -0.96 . . . . 0.0 110.562 -178.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.515 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -60.06 -50.03 75.34 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.049 -1.032 . . . . 0.0 110.198 177.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -60.02 -49.95 75.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.229 -0.919 . . . . 0.0 111.158 -177.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.0 tttp -70.08 -45.17 67.6 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.005 -1.06 . . . . 0.0 111.165 -172.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -81.61 -32.02 32.19 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.101 -1.0 . . . . 0.0 110.832 -174.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.49 ' CB ' ' O ' ' A' ' 34' ' ' ALA . 27.5 t -60.19 -44.92 94.71 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.121 -0.987 . . . . 0.0 111.31 -173.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.41 ' C ' ' O ' ' A' ' 38' ' ' SER . 73.6 mt 44.69 25.93 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 120.904 -1.122 . . . . 0.0 109.762 -173.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.456 ' SG ' ' HD2' ' A' ' 41' ' ' PRO . 35.8 t -117.43 143.27 31.76 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.391 -0.818 . . . . 0.0 109.943 -178.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.456 ' HD2' ' SG ' ' A' ' 40' ' ' CYS . 52.7 Cg_exo -49.21 -20.92 3.85 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.849 1.447 . . . . 0.0 110.655 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.514 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -109.12 19.92 18.94 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.182 -0.949 . . . . 0.0 109.81 176.877 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' A' ' 47' ' ' GLY . . . -75.05 -59.46 3.65 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 174.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -60.05 -39.97 87.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.389 -1.066 . . . . 0.0 110.573 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -94.14 -42.3 9.06 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.924 -1.11 . . . . 0.0 110.413 -176.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -70.6 -24.52 76.8 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 174.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 43' ' ' GLY . . . -74.4 -1.0 59.76 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 173.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.444 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 49.0 t0 -173.06 70.29 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.352 -1.087 . . . . 0.0 109.122 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.465 ' HG ' ' HA2' ' A' ' 46' ' ' GLY . 11.9 mt -72.47 -6.59 44.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.633 -0.667 . . . . 0.0 110.156 -176.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.55 -121.9 6.2 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -176.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.433 ' HG3' ' C ' ' A' ' 4' ' ' ALA . 71.3 tt0 -126.92 140.21 52.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.231 -1.158 . . . . 0.0 110.412 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.574 ' CE2' ' HB1' ' A' ' 6' ' ' ALA . 2.4 p90 -142.63 169.16 18.09 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.302 -0.874 . . . . 0.0 110.263 178.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.53 ' CB ' HG21 ' A' ' 3' ' ' THR . 34.3 ptt180 . . . . . 0 N--CA 1.491 1.591 0 O-C-N 120.979 -1.076 . . . . 0.0 111.628 -172.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo . . . . . 0 C--O 1.215 -0.662 0 CA-C-O 121.009 0.337 . . . . 0.0 111.363 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.98 -39.25 85.06 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.034 -1.041 . . . . 0.0 110.334 -178.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.504 ' HA ' ' CG1' ' A' ' 64' ' ' VAL . 66.4 t80 -59.95 -37.85 80.74 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.321 -0.862 . . . . 0.0 110.344 -178.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.452 ' O ' HG11 ' A' ' 65' ' ' VAL . 55.2 t0 -59.96 -48.6 81.02 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.061 -1.025 . . . . 0.0 110.102 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 67' ' ' SER . 24.3 tptm -60.09 -51.13 70.93 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.048 -1.033 . . . . 0.0 110.46 178.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.504 ' CG1' ' HA ' ' A' ' 61' ' ' PHE . 8.8 p -70.26 -46.99 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.049 -1.032 . . . . 0.0 111.173 -174.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.452 HG11 ' O ' ' A' ' 62' ' ' ASP . 3.8 p -53.95 -28.87 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.59 -1.319 . . . . 0.0 109.268 174.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -95.62 -10.56 29.12 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.223 -0.923 . . . . 0.0 110.252 175.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.483 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 7.7 t -91.08 -69.23 0.74 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.246 -0.909 . . . . 0.0 109.951 176.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.446 ' SG ' ' OG1' ' A' ' 74' ' ' THR . 83.7 m -91.19 127.48 51.17 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.214 -0.929 . . . . 0.0 109.83 176.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.469 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 24.5 Cg_exo -58.69 160.95 16.05 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.797 1.42 . . . . 0.0 109.949 178.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.521 HG22 ' CD1' ' A' ' 71' ' ' LEU . 7.1 p -58.71 173.48 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.081 -1.012 . . . . 0.0 109.912 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.521 ' CD1' HG22 ' A' ' 70' ' ' VAL . 2.8 mp 58.7 19.7 7.07 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.298 -0.877 . . . . 0.0 109.964 -174.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.469 ' HB3' ' O ' ' A' ' 69' ' ' PRO . 4.1 tt0 -140.07 80.97 19.32 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.28 -0.888 . . . . 0.0 109.937 177.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.427 ' HG3' ' HG3' ' A' ' 87' ' ' LYS . 53.0 Cg_exo -48.88 131.88 25.81 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.948 1.499 . . . . 0.0 109.972 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.487 ' HB ' ' CG2' ' A' ' 64' ' ' VAL . 92.5 m -133.08 139.01 46.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.185 -0.947 . . . . 0.0 110.407 -176.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.457 ' HA3' HG13 ' A' ' 85' ' ' ILE . . . 145.71 -173.52 26.04 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.486 ' CD ' HD21 ' A' ' 21' ' ' LEU . 43.7 Cg_endo -75.24 137.59 51.01 Favored 'Cis proline' 0 C--N 1.314 -1.276 0 C-N-CA 121.791 -2.171 . . . . 0.0 110.538 -1.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 59.3 tp -96.53 156.35 16.38 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.243 -0.911 . . . . 0.0 110.45 -176.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -85.12 123.24 30.41 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.154 -0.966 . . . . 0.0 111.06 -175.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.579 HG21 ' CE1' ' A' ' 84' ' ' HIS . 10.3 t -141.53 164.93 28.89 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.269 -0.894 . . . . 0.0 109.806 173.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.501 ' CG ' ' CD2' ' A' ' 81' ' ' PHE . 20.1 pt20 -59.93 -31.62 70.02 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.044 -1.035 . . . . 0.0 111.016 -175.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.501 ' CD2' ' CG ' ' A' ' 80' ' ' GLN . 97.9 m-85 -75.91 -8.02 55.94 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.027 -1.045 . . . . 0.0 110.531 -176.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.464 ' O ' HG22 ' A' ' 79' ' ' THR . . . 137.47 -143.58 14.77 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 -175.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.508 ' CZ ' ' HG3' ' A' ' 14' ' ' GLU . 96.1 m-85 -107.32 122.35 46.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.899 -1.353 . . . . 0.0 109.89 174.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.583 ' CD2' ' HG ' ' A' ' 10' ' ' LEU . 60.9 m170 -99.17 121.74 41.43 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.131 -0.981 . . . . 0.0 110.363 175.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.532 ' CG2' ' HB ' ' A' ' 9' ' ' ILE . 6.1 tt -107.68 121.66 60.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 C-N-CA 118.599 -1.24 . . . . 0.0 109.569 168.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.417 HD11 HG12 ' A' ' 64' ' ' VAL . 83.4 mt -114.1 130.02 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.241 -0.912 . . . . 0.0 111.081 -169.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.558 ' HE2' ' CG ' ' A' ' 30' ' ' PHE . 21.4 ttmm -98.04 126.58 43.54 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.106 -0.996 . . . . 0.0 109.258 169.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.457 ' O ' HD22 ' A' ' 89' ' ' LEU . 61.9 t -106.54 134.93 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.296 -0.877 . . . . 0.0 110.204 -175.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.514 ' O ' ' N ' ' A' ' 91' ' ' ARG . 92.7 mt -140.13 161.31 37.95 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.348 -0.845 . . . . 0.0 109.131 -178.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.498 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 25.6 m-85 62.45 -61.45 0.12 Allowed 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.03 0.443 . . . . 0.0 111.04 177.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.514 ' N ' ' O ' ' A' ' 89' ' ' LEU . 14.1 tpt180 . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.001 -1.062 . . . . 0.0 110.209 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.531 ' CB ' ' HG2' ' A' ' 51' ' ' GLU . 27.3 p . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 121.08 0.467 . . . . 0.0 110.375 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 91' ' ' ARG . . . -109.95 151.24 27.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.097 -1.002 . . . . 0.0 109.886 175.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.473 ' HB2' ' O ' ' A' ' 89' ' ' LEU . . . -90.76 122.69 33.71 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.699 -0.8 . . . . 0.0 109.651 -178.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.58 ' HB1' ' CZ ' ' A' ' 52' ' ' PHE . . . -130.84 119.7 22.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.102 -0.999 . . . . 0.0 111.325 -172.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.545 ' HB2' ' CG ' ' A' ' 87' ' ' LYS . 83.2 mt -106.5 151.28 25.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.288 -0.882 . . . . 0.0 108.839 169.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.499 ' CD2' ' O ' ' A' ' 46' ' ' GLY . 0.3 OUTLIER -168.66 170.53 9.38 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 118.287 -1.365 . . . . 0.0 112.158 -178.716 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.444 ' HB ' ' CG2' ' A' ' 85' ' ' ILE . 87.0 mt -139.97 138.81 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.876 -0.515 . . . . 0.0 109.65 178.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.578 ' HG ' ' CD2' ' A' ' 84' ' ' HIS . 0.5 OUTLIER -100.42 120.08 39.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.364 -0.835 . . . . 0.0 110.218 -178.731 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.505 ' N ' HD22 ' A' ' 10' ' ' LEU . 2.4 t -112.74 128.44 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.204 -0.935 . . . . 0.0 109.964 178.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -69.43 -40.04 77.48 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.371 -0.831 . . . . 0.0 110.618 -178.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -130.43 155.81 45.79 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.023 -1.048 . . . . 0.0 110.728 -176.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.513 ' HG3' ' CZ ' ' A' ' 83' ' ' TYR . 95.7 mt-10 -60.09 -40.0 88.09 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.478 -0.764 . . . . 0.0 110.744 -178.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -55.4 -43.33 75.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.144 -0.973 . . . . 0.0 110.068 -175.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.448 ' HB3' ' CG1' ' A' ' 11' ' ' VAL . 5.9 tt -69.89 -41.01 75.32 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.086 -1.009 . . . . 0.0 109.378 174.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.47 ' O ' HD11 ' A' ' 21' ' ' LEU . . . -60.05 -41.32 92.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.407 -0.808 . . . . 0.0 110.098 175.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.408 ' HA ' HD13 ' A' ' 21' ' ' LEU . 0.2 OUTLIER -60.02 -42.27 94.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.329 -0.857 . . . . 0.0 109.474 178.051 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.461 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 47.8 t0 -59.94 -43.56 94.9 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.243 -0.91 . . . . 0.0 110.037 174.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.541 ' HG ' ' N ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -63.02 -46.78 85.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.113 -0.992 . . . . 0.0 109.79 179.996 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.541 ' N ' ' HG ' ' A' ' 20' ' ' LEU . 0.9 OUTLIER -59.83 -49.94 75.74 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.395 -0.816 . . . . 0.0 110.185 -178.58 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -60.77 -43.13 98.43 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.326 -0.859 . . . . 0.0 110.637 -177.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 19' ' ' ASP . 96.5 mm-40 -60.59 -42.59 97.05 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.184 -0.948 . . . . 0.0 110.606 -177.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.505 ' O ' ' N ' ' A' ' 28' ' ' ALA . 88.1 mt -64.84 -44.09 96.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.15 -0.969 . . . . 0.0 109.937 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -61.08 -47.14 87.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.175 -0.953 . . . . 0.0 109.665 175.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -59.81 -60.93 3.05 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.43 -0.794 . . . . 0.0 110.331 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.563 ' O ' ' CB ' ' A' ' 28' ' ' ALA . . . -105.21 -41.64 1.89 Allowed Glycine 0 N--CA 1.485 1.93 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -173.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.563 ' CB ' ' O ' ' A' ' 27' ' ' GLY . . . 80.19 99.4 0.06 Allowed 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.837 -0.802 . . . . 0.0 110.075 -177.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.426 ' CG ' ' HD2' ' A' ' 32' ' ' LYS . 1.8 m-20 -175.7 82.82 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.273 -0.892 . . . . 0.0 110.177 -176.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.563 ' CG ' ' HE3' ' A' ' 87' ' ' LYS . 9.9 m-85 -65.87 -45.58 81.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.151 -0.968 . . . . 0.0 110.752 -178.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.09 -49.26 80.51 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -177.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.426 ' HD2' ' CG ' ' A' ' 29' ' ' ASP . 60.7 mttm -64.96 -40.0 94.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -1.169 . . . . 0.0 110.049 -177.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.517 ' CD2' HD11 ' A' ' 20' ' ' LEU . 63.2 tp -61.81 -40.24 94.55 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.226 -0.921 . . . . 0.0 110.352 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.518 ' O ' ' CB ' ' A' ' 38' ' ' SER . . . -60.03 -49.95 75.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.067 -1.021 . . . . 0.0 110.135 177.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -59.97 -43.63 94.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.774 -1.204 . . . . 0.0 110.689 -176.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -69.95 -43.03 72.41 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.897 -1.127 . . . . 0.0 111.662 -175.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.508 ' CD2' HD11 ' A' ' 33' ' ' LEU . 83.8 m-70 -105.77 -28.29 10.76 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.686 -1.259 . . . . 0.0 111.691 -169.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.52 ' O ' ' CG1' ' A' ' 39' ' ' ILE . 54.3 p -60.01 -44.29 94.65 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.724 -1.235 . . . . 0.0 110.763 -171.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.52 ' CG1' ' O ' ' A' ' 38' ' ' SER . 46.5 pt 36.31 31.63 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.614 -0.679 . . . . 0.0 110.918 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.479 ' N ' ' O ' ' A' ' 38' ' ' SER . 38.2 t -125.83 144.23 47.77 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.125 -0.984 . . . . 0.0 110.247 -175.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.464 ' HD2' ' SG ' ' A' ' 40' ' ' CYS . 58.1 Cg_exo -44.7 -24.85 1.28 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.819 1.431 . . . . 0.0 110.753 178.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.484 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 0.2 OUTLIER -109.88 19.79 18.7 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.142 -0.974 . . . . 0.0 110.196 178.566 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 40' ' ' CYS . . . -95.63 -57.72 1.17 Allowed Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 175.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -59.93 -39.99 87.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.34 -1.094 . . . . 0.0 109.872 175.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 20.9 tpt180 -101.39 -37.15 8.59 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.328 -0.857 . . . . 0.0 110.58 -177.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.499 ' O ' ' CD2' ' A' ' 8' ' ' HIS . . . -82.88 -9.02 85.03 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -177.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.36 1.52 56.35 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 173.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.439 ' HA ' ' CD2' ' A' ' 7' ' ' LEU . 38.7 t0 -165.76 67.25 0.12 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.35 -1.088 . . . . 0.0 108.475 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.441 ' HG ' ' HA2' ' A' ' 46' ' ' GLY . 7.0 mt -69.99 -27.41 64.68 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.794 -0.566 . . . . 0.0 110.146 -175.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.34 -146.96 16.64 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.531 ' HG2' ' CB ' ' A' ' 3' ' ' THR . 49.9 tt0 -110.75 128.58 55.79 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.26 -1.141 . . . . 0.0 110.011 -178.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.58 ' CZ ' ' HB1' ' A' ' 6' ' ' ALA . 3.5 p90 -144.88 -178.02 5.82 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.178 -0.951 . . . . 0.0 110.584 -176.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.528 ' HB2' ' HA ' ' A' ' 3' ' ' THR . 51.8 ttt-85 . . . . . 0 N--CA 1.495 1.789 0 O-C-N 120.93 -1.106 . . . . 0.0 110.23 173.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.477 ' O ' ' N ' ' A' ' 62' ' ' ASP . 29.0 Cg_endo . . . . . 0 N--CA 1.486 1.071 0 N-CA-C 110.709 -0.535 . . . . 0.0 110.709 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 59' ' ' PRO . . . -41.77 -37.39 1.22 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.381 -0.824 . . . . 0.0 110.029 -177.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.542 ' CE2' HG22 ' A' ' 65' ' ' VAL . 67.7 t80 -59.97 -43.66 94.95 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.308 -0.87 . . . . 0.0 110.056 177.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.477 ' N ' ' O ' ' A' ' 59' ' ' PRO . 54.0 t0 -60.0 -43.75 94.99 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.295 -0.878 . . . . 0.0 110.284 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 67' ' ' SER . 34.3 mttt -58.23 -50.02 75.05 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.163 -0.961 . . . . 0.0 109.735 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.508 HG11 ' N ' ' A' ' 65' ' ' VAL . 7.5 p -69.5 -41.32 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.451 -0.781 . . . . 0.0 110.763 -177.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.542 HG22 ' CE2' ' A' ' 61' ' ' PHE . 11.4 t -55.54 -31.85 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.727 -1.233 . . . . 0.0 108.929 171.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.408 ' HB2' ' O ' ' A' ' 62' ' ' ASP . 24.6 m-85 -102.37 10.32 39.16 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.621 -0.674 . . . . 0.0 110.258 177.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.501 ' N ' ' O ' ' A' ' 63' ' ' LYS . 8.1 t -103.27 -58.29 1.9 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.151 -0.968 . . . . 0.0 109.898 173.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.448 ' SG ' ' OG1' ' A' ' 74' ' ' THR . 29.8 m -115.39 145.34 34.14 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.309 -0.869 . . . . 0.0 110.303 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.519 ' O ' ' N ' ' A' ' 71' ' ' LEU . 13.5 Cg_exo -64.98 76.52 0.21 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.807 1.425 . . . . 0.0 110.582 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.534 ' CG1' ' HG3' ' A' ' 91' ' ' ARG . 8.2 m 21.29 45.89 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.337 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 176.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.531 ' CD1' ' O ' ' A' ' 70' ' ' VAL . 0.3 OUTLIER -166.55 46.86 0.07 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.45 -0.781 . . . . 0.0 110.057 178.259 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -170.66 123.97 0.6 Allowed Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.348 -0.845 . . . . 0.0 110.148 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -55.63 119.07 5.96 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.746 1.392 . . . . 0.0 110.196 178.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.448 ' OG1' ' SG ' ' A' ' 68' ' ' CYS . 74.9 m -126.61 128.35 46.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.197 -0.939 . . . . 0.0 110.219 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.455 ' HA3' HG13 ' A' ' 85' ' ' ILE . . . 145.85 -177.81 23.99 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.519 ' HD3' ' CD2' ' A' ' 21' ' ' LEU . 42.4 Cg_endo -71.02 161.61 89.44 Favored 'Cis proline' 0 C--N 1.313 -1.313 0 C-N-CA 121.754 -2.186 . . . . 0.0 110.463 -0.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.527 ' CD2' ' N ' ' A' ' 78' ' ' HIS . 8.0 tt -134.92 155.26 51.02 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.274 -0.891 . . . . 0.0 110.158 -175.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.527 ' N ' ' CD2' ' A' ' 77' ' ' LEU . 42.0 m80 -73.42 129.37 37.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.168 -0.958 . . . . 0.0 110.768 -176.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.576 HG22 ' CE1' ' A' ' 84' ' ' HIS . 9.0 t -144.2 163.42 33.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.367 -0.833 . . . . 0.0 109.848 175.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -60.0 -24.34 64.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.194 -0.941 . . . . 0.0 110.185 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.578 ' HB2' ' CE1' ' A' ' 84' ' ' HIS . 97.8 m-85 -86.68 -0.68 56.73 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.196 -0.94 . . . . 0.0 110.926 -175.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.458 ' O ' HG23 ' A' ' 79' ' ' THR . . . 123.64 -137.72 11.07 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 -174.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.513 ' CZ ' ' HG3' ' A' ' 14' ' ' GLU . 59.2 m-85 -100.16 130.04 46.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.1 -1.235 . . . . 0.0 109.948 173.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.578 ' CD2' ' HG ' ' A' ' 10' ' ' LEU . 19.3 m170 -116.86 124.12 48.73 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.23 -0.918 . . . . 0.0 110.537 178.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.455 HG13 ' HA3' ' A' ' 75' ' ' GLY . 8.5 tt -110.07 130.06 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.925 -1.11 . . . . 0.0 109.596 170.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.476 HG12 ' HB2' ' A' ' 8' ' ' HIS . 20.5 mt -138.45 137.84 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.996 -1.065 . . . . 0.0 110.824 -172.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.563 ' HE3' ' CG ' ' A' ' 30' ' ' PHE . 15.8 ptpt -111.16 135.08 52.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.772 -1.205 . . . . 0.0 109.313 168.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.486 ' HB ' ' HA ' ' A' ' 70' ' ' VAL . 37.6 t -110.49 144.17 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.253 -0.905 . . . . 0.0 110.345 -171.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.554 ' O ' ' CB ' ' A' ' 90' ' ' TYR . 63.2 mt -140.09 129.52 24.06 Favored 'General case' 0 C--N 1.31 -1.126 0 O-C-N 121.027 -1.046 . . . . 0.0 110.21 -175.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.554 ' CB ' ' O ' ' A' ' 89' ' ' LEU . 14.5 t80 81.27 -24.99 0.17 Allowed 'General case' 0 N--CA 1.507 2.391 0 O-C-N 121.4 -0.813 . . . . 0.0 111.833 169.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.534 ' HG3' ' CG1' ' A' ' 70' ' ' VAL . 7.0 ttm-85 . . . . . 0 N--CA 1.491 1.598 0 O-C-N 120.867 -1.146 . . . . 0.0 109.771 -175.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.431 ' OG1' ' OE2' ' A' ' 51' ' ' GLU . 46.0 p . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.227 0.537 . . . . 0.0 110.038 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.441 ' C ' ' HG3' ' A' ' 51' ' ' GLU . . . -134.59 142.26 46.88 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.166 -0.959 . . . . 0.0 110.241 178.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.456 ' HB2' ' HB2' ' A' ' 89' ' ' LEU . . . -93.44 119.97 33.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.242 -0.911 . . . . 0.0 108.952 175.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.573 ' HB1' ' CZ ' ' A' ' 52' ' ' PHE . . . -134.32 119.3 18.51 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.637 -1.289 . . . . 0.0 111.505 -168.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.6 ' N ' ' CD1' ' A' ' 7' ' ' LEU . 4.2 mp -96.63 146.98 24.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.177 -0.952 . . . . 0.0 109.288 171.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.43 ' CE1' HG22 ' A' ' 86' ' ' ILE . 56.2 m-70 -137.85 126.39 23.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.05 -1.031 . . . . 0.0 110.624 -176.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.57 ' HB ' ' CG2' ' A' ' 85' ' ' ILE . 68.8 mt -103.18 125.6 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 120.868 -1.145 . . . . 0.0 109.714 169.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.494 ' CD1' ' C ' ' A' ' 10' ' ' LEU . 2.7 tm? -103.43 119.98 39.94 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.605 -0.685 . . . . 0.0 109.684 177.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.495 HG13 ' CD2' ' A' ' 16' ' ' LEU . 3.0 t -111.84 132.34 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.319 -0.863 . . . . 0.0 110.286 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -65.99 -40.01 90.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.377 -0.827 . . . . 0.0 110.399 179.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -119.78 139.24 52.63 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.139 -0.976 . . . . 0.0 110.822 -173.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -60.04 -47.22 86.76 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.556 -0.715 . . . . 0.0 111.282 -177.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.3 mttp -53.31 -36.54 61.36 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.14 -0.975 . . . . 0.0 110.185 -173.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.495 ' CD2' HG13 ' A' ' 11' ' ' VAL . 8.4 tt -65.26 -40.07 93.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.254 -0.904 . . . . 0.0 109.419 176.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.458 ' O ' HD11 ' A' ' 21' ' ' LEU . . . -58.97 -46.46 88.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.384 -0.823 . . . . 0.0 109.994 176.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.98 -44.62 94.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.235 -0.916 . . . . 0.0 109.874 177.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -59.97 -43.41 95.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.147 -0.971 . . . . 0.0 109.754 175.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.468 ' O ' HG12 ' A' ' 24' ' ' ILE . 2.6 tp -64.14 -45.55 88.0 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.43 -0.793 . . . . 0.0 109.948 177.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.529 ' CD2' ' HD3' ' A' ' 76' ' ' PRO . 1.9 mp -57.99 -49.58 76.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.38 -0.825 . . . . 0.0 109.866 -174.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -61.03 -37.0 81.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.274 -0.891 . . . . 0.0 109.689 172.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.455 ' HB3' ' O ' ' A' ' 20' ' ' LEU . 60.5 tt0 -59.96 -34.79 73.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.456 -0.777 . . . . 0.0 110.443 -174.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.521 ' O ' ' N ' ' A' ' 28' ' ' ALA . 45.4 mm -59.92 -49.57 83.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.092 -1.005 . . . . 0.0 109.325 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -60.68 -46.43 90.4 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.097 -1.002 . . . . 0.0 109.789 178.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -60.08 -53.25 60.04 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.291 -0.88 . . . . 0.0 110.327 177.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.539 ' O ' ' CB ' ' A' ' 28' ' ' ALA . . . -104.48 -54.71 0.77 Allowed Glycine 0 N--CA 1.486 1.992 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -173.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.539 ' CB ' ' O ' ' A' ' 27' ' ' GLY . . . 79.19 95.03 0.06 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.862 -0.787 . . . . 0.0 110.58 178.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.466 ' OD2' ' HD2' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -177.6 80.42 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.422 -0.799 . . . . 0.0 109.751 -178.814 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.577 ' CG ' ' HD2' ' A' ' 87' ' ' LYS . 11.9 m-85 -60.09 -49.97 75.56 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.319 -0.863 . . . . 0.0 111.187 -174.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.08 -50.13 58.94 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.722 -1.228 . . . . 0.0 110.126 -174.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.466 ' HD2' ' OD2' ' A' ' 29' ' ' ASP . 32.3 mttm -66.57 -40.01 88.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.086 -1.244 . . . . 0.0 110.383 -175.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.486 ' CD1' HD13 ' A' ' 24' ' ' ILE . 67.7 mt -66.44 -40.01 89.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.062 -1.024 . . . . 0.0 110.477 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.534 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -59.22 -51.91 67.94 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.087 -1.008 . . . . 0.0 110.082 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -60.14 -45.84 91.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.327 -0.858 . . . . 0.0 110.722 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -68.32 -47.38 67.7 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.11 -0.994 . . . . 0.0 110.848 -175.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.464 ' CE1' HD22 ' A' ' 33' ' ' LEU . 35.4 m170 -74.79 -45.18 45.31 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.148 -0.97 . . . . 0.0 110.765 -175.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.517 ' O ' ' N ' ' A' ' 40' ' ' CYS . 25.4 t -60.39 -46.27 90.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.203 -0.935 . . . . 0.0 110.133 -179.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.472 HG23 ' O ' ' A' ' 38' ' ' SER . 13.3 tt 36.02 30.04 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-O 121.445 0.64 . . . . 0.0 110.774 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.517 ' N ' ' O ' ' A' ' 38' ' ' SER . 14.2 p -121.56 171.63 5.91 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.286 -0.884 . . . . 0.0 110.024 -178.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.471 ' HD2' ' HB2' ' A' ' 40' ' ' CYS . 43.7 Cg_exo -48.94 -31.35 20.0 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.647 1.341 . . . . 0.0 110.352 -177.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.6 OUTLIER -101.65 15.11 29.96 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.306 -0.871 . . . . 0.0 110.028 177.788 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.29 -58.86 3.78 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.754 -1.738 . . . . 0.0 108.754 174.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.1 tptt -59.91 -40.08 87.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -1.114 . . . . 0.0 110.551 177.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.459 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 11.1 tpt180 -98.29 -41.1 8.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.085 -1.009 . . . . 0.0 110.567 -175.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -70.24 -30.33 69.58 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -178.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.48 -5.56 50.57 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.417 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 25.1 t0 -172.67 72.16 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.332 -1.099 . . . . 0.0 108.586 179.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 6.8 mt -70.03 -27.1 64.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.456 -0.777 . . . . 0.0 110.177 -173.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 113.58 -154.71 16.78 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.441 ' HG3' ' C ' ' A' ' 4' ' ' ALA . 84.6 tt0 -106.55 129.83 54.43 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.291 -1.123 . . . . 0.0 109.845 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.573 ' CZ ' ' HB1' ' A' ' 6' ' ' ALA . 0.1 OUTLIER -131.57 173.47 11.08 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.051 -1.031 . . . . 0.0 110.704 178.044 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 20.6 ptt180 . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.323 -0.861 . . . . 0.0 110.229 179.308 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.485 0.975 0 CA-C-O 121.049 0.354 . . . . 0.0 111.286 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.09 -38.45 79.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.009 -1.057 . . . . 0.0 109.938 -178.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.428 ' CE1' HG21 ' A' ' 65' ' ' VAL . 63.2 t80 -59.99 -38.79 83.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.268 -0.895 . . . . 0.0 110.282 174.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.415 ' O ' HG11 ' A' ' 65' ' ' VAL . 48.8 t0 -60.03 -43.75 95.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.204 -0.935 . . . . 0.0 110.117 -176.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 67' ' ' SER . 23.6 tttm -60.07 -47.03 87.58 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.216 -0.927 . . . . 0.0 110.417 177.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.514 HG13 ' N ' ' A' ' 65' ' ' VAL . 13.1 p -79.25 -44.47 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.024 -1.047 . . . . 0.0 111.347 -173.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.514 ' N ' HG13 ' A' ' 64' ' ' VAL . 4.4 p -53.56 -25.8 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.361 -1.462 . . . . 0.0 109.008 173.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -94.97 -13.22 25.5 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.513 -0.742 . . . . 0.0 109.939 176.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.466 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 8.0 t -93.38 -61.65 1.52 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.354 -0.841 . . . . 0.0 110.053 177.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.458 ' SG ' ' OG1' ' A' ' 74' ' ' THR . 78.6 m -99.98 132.01 23.47 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.38 -0.825 . . . . 0.0 110.272 178.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.471 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 12.1 Cg_endo -61.31 159.93 29.08 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.861 1.453 . . . . 0.0 110.082 178.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.522 HG22 ' CD1' ' A' ' 71' ' ' LEU . 8.1 p -60.46 177.41 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.198 -0.939 . . . . 0.0 109.891 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.522 ' CD1' HG22 ' A' ' 70' ' ' VAL . 4.7 mp 45.48 40.02 5.25 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.639 -1.288 . . . . 0.0 109.981 -168.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.471 ' HB3' ' O ' ' A' ' 69' ' ' PRO . 0.4 OUTLIER -150.57 89.65 4.4 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.384 -0.822 . . . . 0.0 109.729 175.497 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -59.26 126.55 21.19 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.827 1.435 . . . . 0.0 109.782 -177.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.458 ' OG1' ' SG ' ' A' ' 68' ' ' CYS . 53.3 m -130.7 136.72 49.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.095 -1.003 . . . . 0.0 110.453 -177.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.475 ' HA3' HG13 ' A' ' 85' ' ' ILE . . . 152.27 -171.38 31.54 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -178.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.529 ' HD3' ' CD2' ' A' ' 21' ' ' LEU . 41.7 Cg_endo -84.77 134.03 19.45 Favored 'Cis proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.209 -1.996 . . . . 0.0 110.42 3.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 74.8 mt -93.0 -178.52 4.82 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.254 -0.904 . . . . 0.0 110.735 -172.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -102.66 125.37 49.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.072 -1.018 . . . . 0.0 110.712 -176.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.539 HG23 ' CE1' ' A' ' 84' ' ' HIS . 12.5 t -140.05 162.43 35.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.428 -0.795 . . . . 0.0 109.813 176.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -60.05 -39.95 87.72 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.101 -0.999 . . . . 0.0 110.364 -178.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.406 ' C ' HD23 ' A' ' 10' ' ' LEU . 96.8 m-85 -70.31 -5.56 28.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.208 -0.933 . . . . 0.0 110.61 -177.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.443 ' O ' HG21 ' A' ' 79' ' ' THR . . . 134.43 -137.47 9.3 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.423 ' O ' ' HA ' ' A' ' 10' ' ' LEU . 75.1 m-85 -96.1 130.67 43.07 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.165 -1.197 . . . . 0.0 110.241 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.539 ' CE1' HG23 ' A' ' 79' ' ' THR . 6.0 m170 -107.89 112.43 25.04 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.674 -0.641 . . . . 0.0 110.643 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.57 ' CG2' ' HB ' ' A' ' 9' ' ' ILE . 2.5 tt -104.86 120.32 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.527 -1.358 . . . . 0.0 109.076 167.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.458 HD11 HG12 ' A' ' 64' ' ' VAL . 88.2 mt -110.02 130.02 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.936 -1.103 . . . . 0.0 111.298 -169.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.577 ' HD2' ' CG ' ' A' ' 30' ' ' PHE . 63.0 tttm -101.71 126.41 48.56 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 172.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.488 HG11 ' HA ' ' A' ' 70' ' ' VAL . 24.5 t -103.42 136.46 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.13 -0.981 . . . . 0.0 110.297 -176.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.525 ' O ' ' HB2' ' A' ' 90' ' ' TYR . 58.0 mt -130.58 119.91 23.22 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.416 -0.802 . . . . 0.0 109.349 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.525 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 44.3 m-85 72.55 -58.9 0.58 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.648 -0.658 . . . . 0.0 110.856 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.416 ' CB ' ' HB ' ' A' ' 70' ' ' VAL . 67.1 ttp85 . . . . . 0 N--CA 1.494 1.728 0 O-C-N 121.234 -0.916 . . . . 0.0 110.622 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 91' ' ' ARG . 35.6 p . . . . . 0 N--CA 1.494 1.735 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.477 ' O ' ' HA ' ' A' ' 51' ' ' GLU . . . -109.88 131.24 55.24 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.173 -0.955 . . . . 0.0 110.549 -175.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' A' ' 50' ' ' GLY . . . -99.32 122.05 41.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.405 -0.809 . . . . 0.0 109.64 177.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.518 ' CB ' ' NE2' ' A' ' 8' ' ' HIS . . . -140.05 132.03 27.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.856 -1.153 . . . . 0.0 111.212 -175.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.489 ' CD1' ' HD2' ' A' ' 87' ' ' LYS . 86.7 mt -98.32 139.78 33.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.138 -0.976 . . . . 0.0 108.806 168.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.518 ' NE2' ' CB ' ' A' ' 6' ' ' ALA . 34.7 m-70 -135.17 117.97 16.15 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.805 -1.185 . . . . 0.0 110.754 -177.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.532 HG12 ' CB ' ' A' ' 34' ' ' ALA . 92.6 mt -105.17 126.62 60.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.35 -0.844 . . . . 0.0 109.869 172.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.577 ' HG ' ' CD2' ' A' ' 84' ' ' HIS . 0.3 OUTLIER -101.8 117.94 35.89 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.561 -0.712 . . . . 0.0 109.898 -179.757 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.522 ' CG1' HD23 ' A' ' 16' ' ' LEU . 2.2 t -108.23 125.3 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.229 -0.919 . . . . 0.0 109.747 177.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.2 mmtp -68.48 -39.39 81.38 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.44 -0.788 . . . . 0.0 110.17 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -111.43 138.11 48.35 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.186 -0.946 . . . . 0.0 110.699 -178.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.576 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 88.8 tt0 -59.97 -42.12 93.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.366 -0.833 . . . . 0.0 109.939 177.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -56.94 -40.53 76.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.395 -0.816 . . . . 0.0 110.139 -178.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.522 HD23 ' CG1' ' A' ' 11' ' ' VAL . 5.5 tt -68.82 -40.04 79.72 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.025 -1.047 . . . . 0.0 109.301 174.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.481 ' O ' ' CD1' ' A' ' 21' ' ' LEU . . . -59.95 -40.72 89.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.386 -0.821 . . . . 0.0 110.021 175.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.465 ' HA ' HD12 ' A' ' 21' ' ' LEU . 0.2 OUTLIER -59.94 -41.67 92.37 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.15 -0.969 . . . . 0.0 109.695 175.973 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -60.03 -44.75 94.42 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.32 -0.863 . . . . 0.0 110.246 176.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.524 ' HG ' ' N ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -64.11 -43.74 94.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.075 -1.015 . . . . 0.0 109.544 178.51 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.524 ' N ' ' HG ' ' A' ' 20' ' ' LEU . 0.3 OUTLIER -56.19 -49.92 72.67 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.499 -0.75 . . . . 0.0 109.697 -179.588 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -61.7 -40.01 93.51 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.391 -0.818 . . . . 0.0 110.134 175.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.46 ' O ' ' N ' ' A' ' 27' ' ' GLY . 70.0 tp60 -60.1 -39.9 87.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.271 -0.893 . . . . 0.0 110.945 -174.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.518 ' O ' ' N ' ' A' ' 28' ' ' ALA . 96.7 mt -62.76 -40.55 89.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.104 -0.997 . . . . 0.0 110.289 -176.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -65.42 -58.75 5.09 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.964 -1.085 . . . . 0.0 110.067 175.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -60.05 -39.96 87.78 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.34 -0.85 . . . . 0.0 110.799 178.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.548 ' O ' ' CB ' ' A' ' 28' ' ' ALA . . . -104.0 -63.03 0.68 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -176.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.548 ' CB ' ' O ' ' A' ' 27' ' ' GLY . . . 81.79 93.04 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.175 0 O-C-N 122.06 -0.671 . . . . 0.0 110.508 178.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 179.74 78.32 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.423 -0.798 . . . . 0.0 109.952 -178.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.495 ' CZ ' HG23 ' A' ' 85' ' ' ILE . 17.1 t80 -61.12 -39.98 92.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.318 -0.864 . . . . 0.0 110.72 -174.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.44 ' O ' ' HG3' ' A' ' 35' ' ' LYS . . . -66.01 -53.65 29.04 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -176.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.435 ' HE3' ' HE3' ' A' ' 36' ' ' LYS . 82.5 tttt -64.8 -41.55 95.72 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.111 -1.229 . . . . 0.0 110.523 -178.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 85.7 mt -65.89 -40.04 91.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.238 -0.914 . . . . 0.0 109.931 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.532 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -60.25 -48.87 79.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.365 -0.835 . . . . 0.0 110.347 178.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.44 ' HG3' ' O ' ' A' ' 31' ' ' GLY . 72.4 mttt -59.99 -46.34 89.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 0.0 110.391 -175.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.435 ' HE3' ' HE3' ' A' ' 32' ' ' LYS . 41.5 mttt -69.41 -50.82 42.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.094 -1.004 . . . . 0.0 111.074 -176.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 53.9 m170 -70.05 -39.97 75.4 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.124 -0.985 . . . . 0.0 111.073 -173.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.527 ' O ' ' CG2' ' A' ' 39' ' ' ILE . 14.5 t -59.99 -45.6 92.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.037 -1.04 . . . . 0.0 110.313 -175.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.527 ' CG2' ' O ' ' A' ' 38' ' ' SER . 20.4 tt 38.73 34.18 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.589 -0.695 . . . . 0.0 110.603 178.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.489 ' HB2' ' HD2' ' A' ' 41' ' ' PRO . 15.0 p -127.36 165.68 27.91 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.288 -0.883 . . . . 0.0 109.764 -178.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.489 ' HD2' ' HB2' ' A' ' 40' ' ' CYS . 2.0 Cg_endo -49.2 -33.24 27.29 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.626 1.329 . . . . 0.0 110.172 179.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.2 OUTLIER -92.8 8.69 38.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.145 -0.972 . . . . 0.0 110.308 176.834 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 40' ' ' CYS . . . -56.17 -54.45 35.5 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.591 -1.804 . . . . 0.0 108.591 177.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -61.22 -39.97 92.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.355 -1.085 . . . . 0.0 110.658 175.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.468 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -94.16 -68.91 0.78 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.124 -0.985 . . . . 0.0 110.353 -173.589 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -52.82 -38.12 53.44 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.95 -5.52 52.87 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 176.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.472 ' HA ' ' CD2' ' A' ' 7' ' ' LEU . 50.2 t0 -172.34 71.12 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.35 -1.088 . . . . 0.0 108.856 178.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 7.0 mt -69.85 -25.26 63.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.544 -0.722 . . . . 0.0 109.911 -174.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 5' ' ' ALA . . . 82.79 -137.69 17.04 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.074 -1.611 . . . . 0.0 109.074 -178.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.477 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 1.8 mt-10 -102.27 129.65 48.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.443 -1.033 . . . . 0.0 110.635 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.488 ' CZ ' ' HB3' ' A' ' 6' ' ' ALA . 1.5 p90 -134.62 159.2 41.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.544 -0.722 . . . . 0.0 109.799 178.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.459 ' HG2' HG23 ' A' ' 3' ' ' THR . 78.1 mtm180 . . . . . 0 N--CA 1.492 1.671 0 O-C-N 120.839 -1.163 . . . . 0.0 111.352 -170.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo . . . . . 0 C--O 1.215 -0.66 0 CA-C-O 121.052 0.355 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.468 ' CA ' HD22 ' A' ' 77' ' ' LEU . . . -61.81 -42.69 99.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.091 -1.006 . . . . 0.0 110.553 178.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.47 ' O ' HG11 ' A' ' 64' ' ' VAL . 60.9 t80 -60.06 -40.17 88.55 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.141 -0.975 . . . . 0.0 110.647 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 66' ' ' PHE . 54.8 t0 -63.34 -42.85 98.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.012 -1.055 . . . . 0.0 109.69 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.473 ' O ' ' OG ' ' A' ' 67' ' ' SER . 59.0 mttm -57.7 -55.77 30.61 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.285 -0.885 . . . . 0.0 110.266 178.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.493 ' HA ' ' HB2' ' A' ' 67' ' ' SER . 2.7 p -70.0 -43.83 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.016 -1.052 . . . . 0.0 111.775 -172.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.443 HG13 ' O ' ' A' ' 62' ' ' ASP . 4.8 p -55.26 -27.11 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.223 -1.548 . . . . 0.0 108.94 174.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.447 ' HB2' ' O ' ' A' ' 62' ' ' ASP . 0.1 OUTLIER -94.97 -8.7 36.21 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.261 -0.899 . . . . 0.0 110.582 175.468 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.493 ' HB2' ' HA ' ' A' ' 64' ' ' VAL . 24.1 m -93.19 -41.89 9.66 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.003 -1.06 . . . . 0.0 110.042 176.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 88.2 m -120.71 150.58 52.87 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.166 -0.959 . . . . 0.0 110.205 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -73.41 156.34 50.29 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.977 1.514 . . . . 0.0 109.955 178.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.525 HG23 ' CD1' ' A' ' 71' ' ' LEU . 7.2 p -58.03 172.63 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.171 -0.956 . . . . 0.0 109.855 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.525 ' CD1' HG23 ' A' ' 70' ' ' VAL . 3.6 mp 57.44 39.78 27.8 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.413 -0.804 . . . . 0.0 110.077 -174.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -155.84 117.28 2.28 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.116 -0.99 . . . . 0.0 110.394 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 87' ' ' LYS . 30.6 Cg_endo -68.98 132.74 25.25 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.828 1.436 . . . . 0.0 110.182 179.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.438 ' HB ' HG22 ' A' ' 64' ' ' VAL . 87.0 m -139.58 147.15 40.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.157 -0.965 . . . . 0.0 110.295 -178.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.453 ' HA3' HG13 ' A' ' 85' ' ' ILE . . . 134.44 -176.11 20.07 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -178.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.52 ' CD ' HD11 ' A' ' 21' ' ' LEU . 44.1 Cg_endo -74.57 135.97 42.86 Favored 'Cis proline' 0 C--N 1.314 -1.271 0 C-N-CA 121.79 -2.171 . . . . 0.0 110.557 -0.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.468 HD22 ' CA ' ' A' ' 60' ' ' ALA . 59.8 tp -94.94 155.08 16.91 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.26 -0.9 . . . . 0.0 110.435 -178.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -77.89 119.74 21.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -0.891 . . . . 0.0 110.459 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.58 HG23 ' CE1' ' A' ' 84' ' ' HIS . 10.8 t -134.21 165.57 24.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.214 -0.929 . . . . 0.0 109.55 173.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -59.97 -39.58 86.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.113 -0.992 . . . . 0.0 110.047 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -66.75 -11.55 55.15 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.226 -0.921 . . . . 0.0 110.717 -177.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.468 ' O ' HG21 ' A' ' 79' ' ' THR . . . 132.32 -139.75 11.22 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 -176.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.576 ' CE2' ' HB2' ' A' ' 14' ' ' GLU . 75.5 m-85 -102.64 122.14 43.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.108 -1.23 . . . . 0.0 110.291 178.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.58 ' CE1' HG23 ' A' ' 79' ' ' THR . 41.2 m170 -104.98 122.64 46.27 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.196 -0.94 . . . . 0.0 110.422 175.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.527 ' CG2' ' HB ' ' A' ' 9' ' ' ILE . 3.5 tt -103.52 119.23 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 118.376 -1.329 . . . . 0.0 109.361 167.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.449 ' CG2' ' CE1' ' A' ' 8' ' ' HIS . 85.5 mt -114.77 130.02 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.095 -1.003 . . . . 0.0 110.707 -170.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.489 ' HD2' ' CD1' ' A' ' 7' ' ' LEU . 34.9 ttmt -96.96 126.08 41.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.135 -0.978 . . . . 0.0 109.164 171.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.479 HG11 HG22 ' A' ' 70' ' ' VAL . 48.5 t -107.61 123.19 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.382 -0.824 . . . . 0.0 109.959 -175.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.545 ' O ' ' CB ' ' A' ' 90' ' ' TYR . 60.1 mt -134.36 113.04 11.5 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.522 -0.736 . . . . 0.0 109.317 -176.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.545 ' CB ' ' O ' ' A' ' 89' ' ' LEU . 2.9 m-85 81.91 -43.37 0.16 Allowed 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.718 -0.614 . . . . 0.0 110.444 -178.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.472 ' O ' ' O ' ' A' ' 3' ' ' THR . 4.4 ttm180 . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.082 -1.011 . . . . 0.0 109.983 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.41 ' O ' ' C ' ' A' ' 91' ' ' ARG . 19.3 p . . . . . 0 N--CA 1.494 1.732 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -140.16 142.81 35.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.913 -1.117 . . . . 0.0 110.732 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.424 ' HB2' ' HB2' ' A' ' 89' ' ' LEU . . . -97.24 126.98 42.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.267 -0.895 . . . . 0.0 108.907 171.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.582 ' CB ' ' NE2' ' A' ' 8' ' ' HIS . . . -136.67 130.82 32.72 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.661 -1.274 . . . . 0.0 112.112 -168.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.511 ' C ' ' CD2' ' A' ' 8' ' ' HIS . 75.2 mt -103.48 144.42 31.42 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.263 -0.898 . . . . 0.0 109.411 167.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.582 ' NE2' ' CB ' ' A' ' 6' ' ' ALA . 10.0 m-70 -136.28 142.59 43.95 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.797 -1.19 . . . . 0.0 111.121 -175.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.549 ' HB ' ' CG2' ' A' ' 85' ' ' ILE . 96.7 mt -129.14 131.9 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.133 -0.98 . . . . 0.0 109.953 170.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.471 ' HG ' ' CD2' ' A' ' 84' ' ' HIS . 0.3 OUTLIER -103.27 121.9 43.66 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.507 -0.746 . . . . 0.0 110.068 179.382 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.53 ' CG1' HD21 ' A' ' 16' ' ' LEU . 2.7 t -110.25 133.15 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.088 -1.008 . . . . 0.0 110.142 178.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.2 mttt -68.33 -40.02 81.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.238 -0.914 . . . . 0.0 110.646 -178.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -120.14 142.0 49.34 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.152 -0.968 . . . . 0.0 110.977 -176.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.575 ' HB2' ' CZ ' ' A' ' 83' ' ' TYR . 88.6 tt0 -59.99 -42.99 95.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.447 -0.783 . . . . 0.0 110.172 178.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -57.47 -40.06 77.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.682 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.53 HD21 ' CG1' ' A' ' 11' ' ' VAL . 5.5 tt -67.99 -40.28 83.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.2 -0.938 . . . . 0.0 109.704 177.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.45 ' N ' HG12 ' A' ' 11' ' ' VAL . . . -59.94 -44.1 94.59 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -0.933 . . . . 0.0 110.061 175.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.01 -43.24 95.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.303 -0.873 . . . . 0.0 109.707 175.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -59.99 -41.46 92.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.312 -0.867 . . . . 0.0 109.586 174.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.0 tp -63.08 -45.47 91.99 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.573 0.702 . . . . 0.0 109.88 176.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.532 HD11 ' CD1' ' A' ' 85' ' ' ILE . 2.4 mp -59.96 -44.98 94.1 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.659 -0.651 . . . . 0.0 110.376 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.5 tp10 -60.59 -40.07 90.4 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.421 -0.8 . . . . 0.0 110.411 -178.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -60.39 -41.14 93.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.277 -0.89 . . . . 0.0 110.133 -177.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.533 ' CG1' HD13 ' A' ' 33' ' ' LEU . 24.8 mt -67.14 -43.09 88.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.36 -0.837 . . . . 0.0 110.801 -178.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -60.2 -47.97 83.73 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.869 -1.145 . . . . 0.0 110.395 -175.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.7 -62.55 1.79 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.004 -1.06 . . . . 0.0 110.345 176.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.565 ' O ' ' CB ' ' A' ' 28' ' ' ALA . . . -105.76 -39.23 2.22 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -172.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.618 ' O ' ' CB ' ' A' ' 29' ' ' ASP . . . 81.47 -176.79 0.05 Allowed 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.811 -0.817 . . . . 0.0 109.623 -173.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.618 ' CB ' ' O ' ' A' ' 28' ' ' ALA . 95.9 m-20 115.11 71.84 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.954 0 C-N-CA 124.822 1.249 . . . . 0.0 109.623 -175.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.563 ' CG ' ' HE3' ' A' ' 87' ' ' LYS . 7.6 m-85 -63.42 -39.77 95.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.266 -0.897 . . . . 0.0 110.32 176.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.64 -55.75 28.16 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 -177.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.2 mttp -66.52 -40.62 89.27 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.923 -1.339 . . . . 0.0 110.912 -176.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.533 HD13 ' CG1' ' A' ' 24' ' ' ILE . 34.9 mt -66.59 -40.06 88.7 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.045 -1.035 . . . . 0.0 110.19 -179.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.526 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -59.98 -46.2 90.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.096 -1.003 . . . . 0.0 110.029 177.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -60.06 -48.89 79.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.273 -0.892 . . . . 0.0 110.44 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -64.11 -46.57 83.62 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.181 -0.949 . . . . 0.0 110.941 -174.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 57.1 m-70 -73.95 -44.93 53.27 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.917 -1.114 . . . . 0.0 111.334 -175.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.533 ' O ' ' CG2' ' A' ' 39' ' ' ILE . 6.7 t -59.97 -48.16 82.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.977 -1.077 . . . . 0.0 110.707 -172.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.533 ' CG2' ' O ' ' A' ' 38' ' ' SER . 20.1 tt 38.33 32.24 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.588 -0.695 . . . . 0.0 110.837 179.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.487 ' SG ' ' N ' ' A' ' 43' ' ' GLY . 18.7 p -128.71 164.2 40.0 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.143 -0.973 . . . . 0.0 110.366 -176.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' A' ' 40' ' ' CYS . 1.7 Cg_endo -50.66 -29.11 24.43 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.951 1.501 . . . . 0.0 110.454 178.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.485 ' O ' ' CA ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -100.57 17.93 20.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.065 -1.022 . . . . 0.0 109.65 175.4 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.487 ' N ' ' SG ' ' A' ' 40' ' ' CYS . . . -79.51 -57.85 3.03 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 175.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.467 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 86.8 tttt -59.99 -39.53 86.03 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.383 -1.069 . . . . 0.0 110.04 177.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.0 tpt180 -95.71 -42.36 8.42 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.089 -1.007 . . . . 0.0 110.767 -177.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.485 ' CA ' ' O ' ' A' ' 42' ' ' SER . . . -70.13 -25.63 75.36 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.86 -1.04 58.12 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 175.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' A' ' 44' ' ' LYS . 45.7 p-10 -171.01 66.85 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.326 -1.102 . . . . 0.0 108.755 -178.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.535 ' CD1' ' CD2' ' A' ' 8' ' ' HIS . 7.5 mt -69.96 -26.27 64.03 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.51 -0.744 . . . . 0.0 109.924 -175.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.03 -145.48 17.8 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 -178.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -109.95 137.57 47.55 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.226 -1.161 . . . . 0.0 110.383 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.526 ' CE2' ' HB3' ' A' ' 6' ' ' ALA . 3.4 p90 -148.09 163.01 38.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.434 -0.791 . . . . 0.0 110.1 -178.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.24 -0.913 . . . . 0.0 109.354 176.899 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.447 ' O ' ' N ' ' A' ' 61' ' ' PHE . 14.2 Cg_endo . . . . . 0 N--CA 1.485 0.982 0 N-CA-C 110.205 -0.729 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 59' ' ' PRO . . . -39.76 -28.98 0.05 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.585 -0.697 . . . . 0.0 110.628 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.447 ' N ' ' O ' ' A' ' 59' ' ' PRO . 62.5 t80 -60.03 -44.56 94.55 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.161 -0.962 . . . . 0.0 110.204 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.465 ' O ' HG12 ' A' ' 65' ' ' VAL . 47.8 t0 -59.93 -40.05 87.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.156 -0.965 . . . . 0.0 109.723 176.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 67' ' ' SER . 79.9 tttt -58.55 -41.92 86.72 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.387 -0.821 . . . . 0.0 110.348 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.5 ' CG2' ' N ' ' A' ' 65' ' ' VAL . 0.9 OUTLIER -77.69 -46.43 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.122 -0.986 . . . . 0.0 110.667 -177.153 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.5 ' N ' ' CG2' ' A' ' 64' ' ' VAL . 0.3 OUTLIER -56.14 -25.12 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.502 -1.374 . . . . 0.0 109.201 172.776 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -95.21 -5.17 44.46 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.493 -0.754 . . . . 0.0 109.917 175.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.469 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 29.7 t -96.32 -44.54 7.19 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.418 -0.801 . . . . 0.0 110.14 178.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 56.5 m -131.68 152.38 80.29 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.353 -0.842 . . . . 0.0 110.457 -177.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.439 ' HD2' ' OE1' ' A' ' 72' ' ' GLU . 13.5 Cg_endo -68.95 155.92 66.97 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.073 1.565 . . . . 0.0 110.377 178.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.53 ' CG1' HD13 ' A' ' 71' ' ' LEU . 8.9 p -61.3 169.69 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.349 -0.844 . . . . 0.0 110.616 -177.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.53 HD13 ' CG1' ' A' ' 70' ' ' VAL . 2.2 mp 59.45 16.02 4.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.629 -0.67 . . . . 0.0 110.277 -177.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.439 ' OE1' ' HD2' ' A' ' 69' ' ' PRO . 11.1 tt0 -137.2 85.15 22.61 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.206 -0.933 . . . . 0.0 109.472 173.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.403 ' HG3' ' HG3' ' A' ' 87' ' ' LYS . 75.8 Cg_exo -43.75 145.27 1.95 Allowed 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 124.051 1.553 . . . . 0.0 110.712 -174.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 62.6 m -132.67 139.62 47.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.47 -0.769 . . . . 0.0 110.078 -178.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.437 ' HA3' HG13 ' A' ' 85' ' ' ILE . . . 141.72 -175.88 22.26 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.234 -1.547 . . . . 0.0 109.234 -178.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.469 ' HD3' ' CD2' ' A' ' 21' ' ' LEU . 43.5 Cg_endo -79.47 132.91 26.58 Favored 'Cis proline' 0 C--N 1.314 -1.275 0 C-N-CA 121.834 -2.152 . . . . 0.0 110.367 -0.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.454 ' HG ' ' N ' ' A' ' 78' ' ' HIS . 43.7 tp -96.51 156.86 16.16 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.283 -0.885 . . . . 0.0 110.877 -174.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.454 ' N ' ' HG ' ' A' ' 77' ' ' LEU . 12.6 t60 -78.0 126.03 30.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.454 -0.779 . . . . 0.0 110.402 178.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.43 HG23 ' CE1' ' A' ' 84' ' ' HIS . 11.6 t -139.95 158.98 43.2 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.178 -0.951 . . . . 0.0 109.882 176.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -60.89 -25.74 66.93 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.16 -0.962 . . . . 0.0 110.864 -176.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -81.01 -9.94 59.78 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.007 -1.058 . . . . 0.0 110.639 -178.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 139.4 -128.43 3.99 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 108.653 -1.779 . . . . 0.0 108.653 -174.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.575 ' CZ ' ' HB2' ' A' ' 14' ' ' GLU . 91.6 m-85 -115.88 134.58 54.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.95 -1.323 . . . . 0.0 109.827 173.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.471 ' CD2' ' HG ' ' A' ' 10' ' ' LEU . 31.3 m170 -114.34 125.51 53.96 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.18 -0.95 . . . . 0.0 110.564 177.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.549 ' CG2' ' HB ' ' A' ' 9' ' ' ILE . 6.7 tt -114.1 122.23 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.904 -1.122 . . . . 0.0 109.264 170.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 85.3 mt -117.43 129.96 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.167 -0.958 . . . . 0.0 111.07 -170.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.563 ' HE3' ' CG ' ' A' ' 30' ' ' PHE . 12.1 ttmm -94.87 125.65 39.67 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.126 -0.984 . . . . 0.0 109.341 170.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.452 HG11 HG23 ' A' ' 65' ' ' VAL . 62.4 t -104.75 131.96 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.294 -0.879 . . . . 0.0 110.221 -174.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.493 ' O ' ' HB2' ' A' ' 90' ' ' TYR . 48.4 mt -133.74 154.07 51.24 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.493 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 2.2 m-85 64.19 -58.58 0.22 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.682 -0.637 . . . . 0.0 111.059 176.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.483 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 3.2 ttm180 . . . . . 0 N--CA 1.493 1.72 0 O-C-N 121.077 -1.014 . . . . 0.0 110.544 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.0 p . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 121.267 0.556 . . . . 0.0 110.58 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.43 ' C ' ' HG3' ' A' ' 51' ' ' GLU . . . -132.53 156.66 46.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.189 -0.944 . . . . 0.0 110.194 178.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.423 ' HB1' ' O ' ' A' ' 89' ' ' LEU . . . -92.07 125.33 36.71 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.153 -0.967 . . . . 0.0 109.285 175.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.553 ' CB ' ' CZ ' ' A' ' 52' ' ' PHE . . . -137.16 130.2 30.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.804 -1.185 . . . . 0.0 112.081 -169.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.495 ' O ' ' CD2' ' A' ' 8' ' ' HIS . 85.0 mt -103.46 140.72 37.1 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.282 -0.886 . . . . 0.0 108.994 168.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.567 ' NE2' ' CE1' ' A' ' 61' ' ' PHE . 35.5 m170 -134.41 148.53 50.66 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.681 -1.262 . . . . 0.0 111.539 -176.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.547 ' HB ' ' CG2' ' A' ' 85' ' ' ILE . 97.0 mt -136.33 130.88 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.297 -0.877 . . . . 0.0 109.862 169.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.504 HD21 ' N ' ' A' ' 11' ' ' VAL . 0.4 OUTLIER -99.25 123.65 43.7 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.383 -0.823 . . . . 0.0 109.667 177.153 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.515 ' CG1' HD21 ' A' ' 16' ' ' LEU . 2.6 t -115.86 129.78 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.183 -0.948 . . . . 0.0 110.028 177.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -69.25 -40.03 78.11 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.326 -0.859 . . . . 0.0 110.59 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -114.93 139.49 49.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.064 -1.022 . . . . 0.0 110.652 -177.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.502 ' HB2' ' CZ ' ' A' ' 83' ' ' TYR . 86.3 tt0 -59.94 -42.41 93.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.428 -0.795 . . . . 0.0 110.032 177.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -56.68 -42.84 79.75 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.325 -0.859 . . . . 0.0 110.2 179.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.515 HD21 ' CG1' ' A' ' 11' ' ' VAL . 7.4 tt -68.09 -42.4 80.41 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.052 -1.03 . . . . 0.0 109.875 179.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.464 ' O ' ' HB3' ' A' ' 20' ' ' LEU . . . -59.97 -46.53 89.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.133 -0.98 . . . . 0.0 109.714 174.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' A' ' 14' ' ' GLU . 25.5 mt -60.04 -39.97 87.77 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.889 . . . . 0.0 109.97 175.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.465 ' O ' ' HG3' ' A' ' 23' ' ' GLN . 48.1 t0 -59.97 -40.63 89.76 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.181 -0.949 . . . . 0.0 109.298 174.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.464 ' HB3' ' O ' ' A' ' 17' ' ' ALA . 2.6 tp -63.28 -39.88 95.83 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.445 -0.784 . . . . 0.0 109.325 173.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.54 HD11 ' CD1' ' A' ' 85' ' ' ILE . 3.4 mp -59.29 -42.78 92.08 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.53 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -60.26 -40.06 88.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.393 -0.817 . . . . 0.0 109.92 174.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.465 ' HG3' ' O ' ' A' ' 19' ' ' ASP . 27.1 mt-30 -61.83 -40.31 94.85 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.45 -0.781 . . . . 0.0 110.818 -177.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.526 ' O ' ' N ' ' A' ' 28' ' ' ALA . 96.9 mt -66.24 -40.02 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.104 -0.997 . . . . 0.0 109.843 -178.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -64.02 -53.73 45.46 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.084 -1.01 . . . . 0.0 109.802 176.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -60.49 -43.47 96.99 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.316 -0.865 . . . . 0.0 110.808 177.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.558 ' O ' ' CB ' ' A' ' 28' ' ' ALA . . . -106.37 -59.78 0.6 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 -175.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.558 ' CB ' ' O ' ' A' ' 27' ' ' GLY . . . 83.23 89.89 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 O-C-N 122.07 -0.665 . . . . 0.0 109.861 -175.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -176.92 78.79 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.395 -0.816 . . . . 0.0 109.904 -174.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.537 ' CD2' ' HE3' ' A' ' 87' ' ' LYS . 5.4 m-85 -60.06 -40.56 89.9 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.271 -0.893 . . . . 0.0 110.79 -175.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.63 -51.42 56.12 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.77 -1.205 . . . . 0.0 110.116 -176.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -66.21 -40.01 90.03 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.07 -1.253 . . . . 0.0 110.446 -175.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 67.3 mt -65.92 -39.98 91.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.226 -0.921 . . . . 0.0 110.113 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.543 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -59.29 -50.09 75.34 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.239 -0.913 . . . . 0.0 110.348 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.5 tttp -59.99 -48.25 82.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.913 . . . . 0.0 110.577 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.9 tttt -60.06 -49.54 77.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.208 -0.932 . . . . 0.0 110.987 -175.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -81.88 -40.54 22.24 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.934 -1.104 . . . . 0.0 111.637 -172.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.465 ' O ' ' C ' ' A' ' 39' ' ' ILE . 23.7 t -60.06 -49.99 75.49 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.91 -1.119 . . . . 0.0 111.074 -172.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.465 ' C ' ' O ' ' A' ' 38' ' ' SER . 83.7 mt 33.39 48.59 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 CA-C-O 121.195 0.521 . . . . 0.0 111.142 -177.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.442 ' SG ' ' OG ' ' A' ' 38' ' ' SER . 15.3 p -139.98 176.06 2.79 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.132 -0.98 . . . . 0.0 110.407 -177.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.474 ' O ' ' CB ' ' A' ' 42' ' ' SER . 3.0 Cg_exo -68.87 66.26 1.28 Allowed 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.874 1.46 . . . . 0.0 109.849 -178.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 45' ' ' ARG . 0.1 OUTLIER 165.44 -41.95 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.779 -0.576 . . . . 0.0 109.69 179.594 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.465 ' HA3' ' OG ' ' A' ' 38' ' ' SER . . . -41.77 -37.36 1.99 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -178.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -60.31 -40.01 89.04 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.019 -1.283 . . . . 0.0 110.133 175.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.545 ' N ' ' O ' ' A' ' 42' ' ' SER . 11.3 tpp180 -102.4 -43.2 5.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.526 -0.734 . . . . 0.0 110.596 -176.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -55.15 -35.33 59.69 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.926 -1.269 . . . . 0.0 109.926 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.463 ' O ' HD21 ' A' ' 7' ' ' LEU . . . -67.99 -5.96 42.79 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 176.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -169.84 64.71 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.285 -1.126 . . . . 0.0 109.176 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.539 ' CD2' ' HG3' ' A' ' 45' ' ' ARG . 5.0 mt -69.99 -27.63 64.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.539 -0.726 . . . . 0.0 110.07 -178.011 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 101.06 -143.42 16.17 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 -176.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.43 ' HG3' ' C ' ' A' ' 4' ' ' ALA . 72.2 tt0 -111.8 133.14 54.21 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.206 -1.173 . . . . 0.0 110.253 -179.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.553 ' CZ ' ' CB ' ' A' ' 6' ' ' ALA . 4.7 p90 -145.56 166.43 25.74 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.322 -0.861 . . . . 0.0 109.985 -178.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 . . . . . 0 N--CA 1.495 1.824 0 O-C-N 121.036 -1.04 . . . . 0.0 110.215 179.559 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.426 ' O ' ' C ' ' A' ' 60' ' ' ALA . 14.5 Cg_endo . . . . . 0 N--CA 1.485 0.972 0 N-CA-C 110.025 -0.798 . . . . 0.0 110.025 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 59' ' ' PRO . . . -39.81 -33.32 0.19 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.606 -0.684 . . . . 0.0 110.845 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.583 ' CD1' HG22 ' A' ' 86' ' ' ILE . 65.1 t80 -60.01 -44.03 94.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.043 -1.036 . . . . 0.0 110.358 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -60.73 -39.92 90.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.179 -0.95 . . . . 0.0 110.163 -179.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.408 ' HD3' ' HA ' ' A' ' 63' ' ' LYS . 75.6 mmtt -58.97 -45.89 89.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.182 -0.949 . . . . 0.0 110.378 -178.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.518 HG12 ' N ' ' A' ' 65' ' ' VAL . 8.5 p -73.39 -39.98 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.059 -1.025 . . . . 0.0 110.53 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.518 ' N ' HG12 ' A' ' 64' ' ' VAL . 9.6 t -55.75 -30.67 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.625 -1.297 . . . . 0.0 109.568 171.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -96.15 -0.36 50.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.37 -0.831 . . . . 0.0 109.844 176.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.421 ' CB ' ' HA ' ' A' ' 64' ' ' VAL . 6.9 t -96.44 -64.66 1.03 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.362 -0.836 . . . . 0.0 109.525 174.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.453 ' SG ' ' OG1' ' A' ' 74' ' ' THR . 91.1 m -89.57 130.73 42.33 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.326 -0.859 . . . . 0.0 110.016 175.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.548 ' O ' ' O ' ' A' ' 70' ' ' VAL . 25.2 Cg_endo -67.64 79.28 0.49 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.849 1.447 . . . . 0.0 110.79 -177.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.554 ' O ' ' N ' ' A' ' 72' ' ' GLU . 1.8 m 37.17 177.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.445 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 177.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.524 ' O ' ' CD2' ' A' ' 71' ' ' LEU . 0.0 OUTLIER 24.39 40.92 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.485 0 CA-C-O 121.636 0.731 . . . . 0.0 112.632 -170.72 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.554 ' N ' ' O ' ' A' ' 70' ' ' VAL . 3.4 tp10 -138.05 81.96 25.96 Favored Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 121.285 -0.885 . . . . 0.0 109.589 174.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -43.68 129.49 7.09 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 124.045 1.55 . . . . 0.0 110.204 -176.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.499 ' HB ' ' CG2' ' A' ' 64' ' ' VAL . 57.1 m -127.96 135.7 50.29 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.348 -0.845 . . . . 0.0 110.196 -175.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.441 ' HA3' HG13 ' A' ' 85' ' ' ILE . . . 133.6 -176.55 19.62 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 -178.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.531 ' HD3' ' CD1' ' A' ' 21' ' ' LEU . 43.3 Cg_endo -72.19 152.9 97.61 Favored 'Cis proline' 0 C--N 1.314 -1.276 0 C-N-CA 121.713 -2.203 . . . . 0.0 110.199 0.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.0 tp -131.38 154.51 48.54 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.129 -0.982 . . . . 0.0 110.329 -175.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 -76.64 130.92 38.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.244 -0.91 . . . . 0.0 110.761 -177.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.572 HG21 ' CE1' ' A' ' 84' ' ' HIS . 10.3 t -142.08 173.65 11.32 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.452 -0.78 . . . . 0.0 109.823 175.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -59.99 -27.72 67.1 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.158 -0.963 . . . . 0.0 110.517 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -96.39 9.97 39.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.999 -1.063 . . . . 0.0 110.902 -172.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 119.6 -124.65 6.04 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 -176.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.502 ' CZ ' ' HB2' ' A' ' 14' ' ' GLU . 87.1 m-85 -114.07 139.02 49.64 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.128 -1.219 . . . . 0.0 110.253 176.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.572 ' CE1' HG21 ' A' ' 79' ' ' THR . 21.9 m170 -121.7 121.63 37.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.35 -0.844 . . . . 0.0 110.377 177.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.547 ' CG2' ' HB ' ' A' ' 9' ' ' ILE . 6.1 tt -109.94 136.84 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.761 -1.212 . . . . 0.0 109.434 168.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.583 HG22 ' CD1' ' A' ' 61' ' ' PHE . 26.1 mt -133.48 131.67 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.076 -1.015 . . . . 0.0 111.223 -169.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.537 ' HE3' ' CD2' ' A' ' 30' ' ' PHE . 12.1 ttmm -105.25 128.03 53.23 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.237 -0.914 . . . . 0.0 109.411 170.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.424 ' CG2' HG21 ' A' ' 65' ' ' VAL . 60.8 t -108.77 139.3 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.204 -0.935 . . . . 0.0 110.363 -174.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.527 ' O ' ' CB ' ' A' ' 90' ' ' TYR . 81.6 mt -140.38 126.26 19.45 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.197 -0.94 . . . . 0.0 110.055 -177.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.527 ' CB ' ' O ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER 80.71 -57.97 0.3 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.415 -0.803 . . . . 0.0 111.53 171.985 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.546 ' HB2' ' CG1' ' A' ' 70' ' ' VAL . 47.5 ttp180 . . . . . 0 N--CA 1.493 1.692 0 O-C-N 120.863 -1.148 . . . . 0.0 110.631 -179.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 52' ' ' PHE . 72.6 m . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 120.834 0.35 . . . . 0.0 110.095 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.577 ' O ' ' CD1' ' A' ' 52' ' ' PHE . . . -153.4 157.77 40.45 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.914 -1.116 . . . . 0.0 110.786 -177.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.458 ' HB3' ' HB2' ' A' ' 90' ' ' TYR . . . -104.14 139.46 39.18 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.149 -0.969 . . . . 0.0 109.429 172.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.529 ' HB2' ' NE2' ' A' ' 8' ' ' HIS . . . -149.83 130.79 14.3 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.694 -1.254 . . . . 0.0 111.457 -177.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.538 ' CD1' ' HE3' ' A' ' 87' ' ' LYS . 17.4 mt -100.75 146.17 27.58 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.454 -0.779 . . . . 0.0 109.746 172.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.53 ' ND1' HG12 ' A' ' 86' ' ' ILE . 8.0 m-70 -134.5 150.1 50.76 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.121 -0.987 . . . . 0.0 110.826 -175.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.548 ' HB ' ' CG2' ' A' ' 85' ' ' ILE . 89.8 mt -128.78 129.88 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.063 -1.023 . . . . 0.0 109.671 167.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.524 ' HG ' ' CD2' ' A' ' 84' ' ' HIS . 0.5 OUTLIER -106.5 119.33 39.01 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.497 -0.752 . . . . 0.0 110.1 -177.523 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.512 ' CG1' ' HB3' ' A' ' 16' ' ' LEU . 3.1 t -114.97 131.05 68.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.227 -0.921 . . . . 0.0 110.045 176.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 49.0 tttt -69.95 -40.01 75.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.083 -1.011 . . . . 0.0 110.614 -178.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -109.04 137.25 47.24 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.107 -0.995 . . . . 0.0 110.839 -176.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.561 ' HB2' ' CZ ' ' A' ' 83' ' ' TYR . 86.5 tt0 -59.99 -42.01 93.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.443 -0.785 . . . . 0.0 110.121 178.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -56.37 -41.16 75.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.322 -0.861 . . . . 0.0 110.212 178.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.512 ' HB3' ' CG1' ' A' ' 11' ' ' VAL . 4.7 tt -67.95 -39.91 83.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.014 -1.054 . . . . 0.0 109.076 175.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.438 ' O ' HD11 ' A' ' 21' ' ' LEU . . . -59.93 -40.63 89.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.303 -0.873 . . . . 0.0 110.095 175.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.03 -42.05 93.56 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.022 -1.049 . . . . 0.0 109.571 175.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -59.99 -38.99 84.22 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.275 -0.891 . . . . 0.0 109.706 173.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.537 ' HG ' ' N ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -60.82 -50.38 73.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.313 -0.867 . . . . 0.0 109.885 178.822 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.537 ' N ' ' HG ' ' A' ' 20' ' ' LEU . 1.4 mt -60.02 -49.26 78.38 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.339 -0.851 . . . . 0.0 110.181 -178.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -60.48 -40.08 89.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.454 -0.779 . . . . 0.0 109.999 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 70.0 tp60 -59.99 -41.31 91.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.365 -0.834 . . . . 0.0 110.529 -175.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.528 ' O ' ' N ' ' A' ' 28' ' ' ALA . 63.1 mt -63.65 -47.92 89.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.2 -0.938 . . . . 0.0 110.21 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -62.11 -45.08 95.08 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.903 -1.123 . . . . 0.0 109.659 177.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -59.97 -60.8 3.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.376 -0.827 . . . . 0.0 110.178 177.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.553 ' O ' ' CB ' ' A' ' 28' ' ' ALA . . . -105.83 -45.8 1.26 Allowed Glycine 0 N--CA 1.486 1.992 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -175.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.592 ' O ' ' CB ' ' A' ' 29' ' ' ASP . . . 80.16 158.69 0.16 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.811 -0.817 . . . . 0.0 110.462 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.592 ' CB ' ' O ' ' A' ' 28' ' ' ALA . 96.7 m-20 118.26 81.24 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.038 0 C-N-CA 125.053 1.341 . . . . 0.0 109.634 -175.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.451 ' CZ ' HD12 ' A' ' 24' ' ' ILE . 2.1 m-85 -60.02 -45.04 94.1 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.207 -0.933 . . . . 0.0 110.999 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.39 -54.64 25.38 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.765 -1.207 . . . . 0.0 110.141 -174.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -65.94 -39.95 90.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.048 -1.266 . . . . 0.0 110.306 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 46.8 mt -63.65 -39.97 95.68 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.134 -0.979 . . . . 0.0 109.643 176.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.531 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -55.18 -50.64 68.83 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.266 -0.896 . . . . 0.0 110.091 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -59.96 -51.97 67.39 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.055 -1.028 . . . . 0.0 110.677 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -60.96 -50.07 74.87 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.21 -0.931 . . . . 0.0 111.175 -176.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -70.43 -39.97 74.07 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.123 -0.986 . . . . 0.0 110.867 -177.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.531 ' O ' ' CG2' ' A' ' 39' ' ' ILE . 20.7 t -60.08 -46.35 89.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.138 -0.976 . . . . 0.0 110.349 -175.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.531 ' CG2' ' O ' ' A' ' 38' ' ' SER . 16.0 tt 37.99 29.87 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.7 -0.625 . . . . 0.0 110.58 178.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.476 ' HB2' ' HD2' ' A' ' 41' ' ' PRO . 15.2 p -129.67 165.11 35.37 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.35 -0.844 . . . . 0.0 110.193 -176.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.476 ' HD2' ' HB2' ' A' ' 40' ' ' CYS . 1.1 Cg_endo -47.76 -28.43 9.61 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.802 1.422 . . . . 0.0 110.562 178.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.523 ' O ' ' CA ' ' A' ' 46' ' ' GLY . 0.2 OUTLIER -99.77 18.43 18.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.99 -1.069 . . . . 0.0 110.148 177.526 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 40' ' ' CYS . . . -75.44 -55.01 5.27 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.549 -1.82 . . . . 0.0 108.549 171.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -61.12 -40.03 92.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.457 -1.025 . . . . 0.0 110.749 177.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.402 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 12.8 tpt180 -104.53 -41.26 5.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.089 -1.007 . . . . 0.0 110.795 -174.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.523 ' CA ' ' O ' ' A' ' 42' ' ' SER . . . -69.95 -31.88 69.8 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.55 0.9 59.47 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 177.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.527 ' HA ' ' CD2' ' A' ' 7' ' ' LEU . 47.8 t0 -170.38 76.17 0.08 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.296 -1.12 . . . . 0.0 109.065 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 19.2 mt -82.63 -14.96 53.81 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.602 -0.686 . . . . 0.0 110.193 -174.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.01 -137.96 14.29 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 177.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 3.4 mt-10 -108.79 158.59 17.5 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.453 -1.028 . . . . 0.0 110.421 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' A' ' 52' ' ' PHE . 0.0 OUTLIER -139.96 177.83 7.69 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.389 -0.82 . . . . 0.0 109.407 -175.583 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.616 -0.677 . . . . 0.0 109.849 179.356 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo . . . . . 0 N--CA 1.485 1.021 0 N-CA-C 110.88 -0.469 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -45.28 -44.63 11.54 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.219 -0.925 . . . . 0.0 110.578 -174.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -59.99 -41.68 92.57 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.185 -0.947 . . . . 0.0 110.118 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.457 ' O ' HG11 ' A' ' 65' ' ' VAL . 57.4 t0 -71.78 -38.4 70.3 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.317 -0.864 . . . . 0.0 110.298 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.521 ' O ' ' N ' ' A' ' 67' ' ' SER . 87.6 tttt -55.06 -49.96 70.31 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.24 -0.912 . . . . 0.0 110.216 -175.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.481 ' HA ' ' HB3' ' A' ' 67' ' ' SER . 2.5 p -69.81 -47.1 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.129 -0.982 . . . . 0.0 111.814 -174.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.457 HG11 ' O ' ' A' ' 62' ' ' ASP . 3.0 p -57.4 -27.12 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.319 -1.488 . . . . 0.0 109.055 173.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -92.97 -11.19 33.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.407 -0.808 . . . . 0.0 109.846 175.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 63' ' ' LYS . 9.4 t -91.62 -44.74 8.87 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.318 -0.864 . . . . 0.0 109.756 176.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.46 ' HB3' ' HB3' ' A' ' 72' ' ' GLU . 66.1 m -137.14 149.98 67.82 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.306 -0.871 . . . . 0.0 110.382 178.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.464 ' O ' ' HB2' ' A' ' 72' ' ' GLU . 52.1 Cg_endo -77.71 -179.48 5.48 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.054 1.555 . . . . 0.0 110.932 -178.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.525 ' CG2' HD13 ' A' ' 71' ' ' LEU . 7.2 p -60.04 157.65 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.424 -0.797 . . . . 0.0 110.06 177.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.525 HD13 ' CG2' ' A' ' 70' ' ' VAL . 4.4 mp 60.01 40.03 19.22 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.419 -0.8 . . . . 0.0 110.234 -175.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -150.46 104.42 3.1 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.299 -0.875 . . . . 0.0 110.258 178.72 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -67.15 135.09 36.04 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.89 1.469 . . . . 0.0 110.273 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.458 ' OG1' ' SG ' ' A' ' 68' ' ' CYS . 87.2 m -140.13 147.21 39.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.164 -0.96 . . . . 0.0 110.488 -178.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.466 ' HA3' HG13 ' A' ' 85' ' ' ILE . . . 125.72 -168.88 17.72 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.486 ' CD ' HD12 ' A' ' 21' ' ' LEU . 43.0 Cg_endo -72.32 139.23 59.09 Favored 'Cis proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.847 -2.147 . . . . 0.0 110.732 -0.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.447 ' CD1' ' HB ' ' A' ' 64' ' ' VAL . 88.7 mt -92.99 169.37 10.48 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.3 -0.875 . . . . 0.0 110.633 -176.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 14.3 t60 -100.24 119.57 38.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.144 -0.972 . . . . 0.0 110.381 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.516 HG21 ' ND1' ' A' ' 84' ' ' HIS . 14.7 t -141.56 166.38 24.91 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.155 -0.965 . . . . 0.0 109.815 176.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.415 ' CG ' ' N ' ' A' ' 81' ' ' PHE . 15.8 pt20 -59.93 -34.75 73.66 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.121 -0.987 . . . . 0.0 110.397 -176.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.415 ' N ' ' CG ' ' A' ' 80' ' ' GLN . 94.4 m-85 -60.04 -27.26 66.78 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.271 -0.893 . . . . 0.0 110.208 178.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 141.63 -132.37 5.24 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -178.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.561 ' CZ ' ' HB2' ' A' ' 14' ' ' GLU . 81.3 m-85 -96.66 120.99 37.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -1.139 . . . . 0.0 109.876 175.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.524 ' CD2' ' HG ' ' A' ' 10' ' ' LEU . 0.6 OUTLIER -113.29 113.64 25.55 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.566 -0.709 . . . . 0.0 110.9 -176.453 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.548 ' CG2' ' HB ' ' A' ' 9' ' ' ILE . 12.2 tt -109.82 133.9 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 120.616 -1.302 . . . . 0.0 109.579 170.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.53 HG12 ' ND1' ' A' ' 8' ' ' HIS . 85.9 mt -138.24 141.93 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.044 -1.035 . . . . 0.0 110.67 -172.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.538 ' HE3' ' CD1' ' A' ' 7' ' ' LEU . 20.1 pttp -119.53 142.06 48.67 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.048 -1.033 . . . . 0.0 109.511 171.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 62.5 t -107.9 129.97 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.913 -1.117 . . . . 0.0 111.302 -168.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' A' ' 91' ' ' ARG . 89.5 mt -114.26 -170.97 1.83 Allowed 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.305 -0.872 . . . . 0.0 109.204 172.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.458 ' HB2' ' HB3' ' A' ' 5' ' ' ALA . 71.0 m-85 32.85 -86.46 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.735 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.533 ' N ' ' O ' ' A' ' 89' ' ' LEU . 29.7 ttp85 . . . . . 0 N--CA 1.493 1.683 0 O-C-N 120.696 -1.253 . . . . 0.0 110.617 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.433 HG22 ' N ' ' A' ' 53' ' ' ARG . 28.1 p . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.192 0.52 . . . . 0.0 110.087 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -129.88 160.12 34.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.254 -0.904 . . . . 0.0 109.656 178.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.495 ' CB ' ' CD1' ' A' ' 90' ' ' TYR . . . -95.52 127.39 41.51 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.121 -0.987 . . . . 0.0 109.551 179.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.525 ' HB1' ' NE2' ' A' ' 8' ' ' HIS . . . -134.51 131.07 37.57 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.699 -1.25 . . . . 0.0 111.56 -170.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.517 ' C ' ' CD2' ' A' ' 8' ' ' HIS . 39.9 mt -102.28 147.31 26.82 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.078 -1.014 . . . . 0.0 109.33 170.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.526 ' ND1' HG12 ' A' ' 86' ' ' ILE . 31.4 m-70 -143.52 134.02 24.84 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.803 -1.185 . . . . 0.0 111.407 -175.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.573 HG13 ' CZ ' ' A' ' 30' ' ' PHE . 95.3 mt -119.99 125.69 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.776 -1.202 . . . . 0.0 109.763 165.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.574 ' HG ' ' CD2' ' A' ' 84' ' ' HIS . 0.2 OUTLIER -102.79 121.4 42.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.603 -0.686 . . . . 0.0 109.689 179.553 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.518 ' N ' HD23 ' A' ' 10' ' ' LEU . 2.2 t -109.31 125.48 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.134 -0.979 . . . . 0.0 110.394 178.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -67.58 -39.97 84.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.445 -0.784 . . . . 0.0 110.446 175.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -108.11 136.84 47.11 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.217 -0.927 . . . . 0.0 110.966 -174.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -60.07 -40.84 90.93 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.4 -0.812 . . . . 0.0 110.115 173.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -58.86 -40.23 83.71 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.209 -0.932 . . . . 0.0 110.459 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.468 ' CD2' HG11 ' A' ' 11' ' ' VAL . 3.7 tt -68.31 -38.19 81.33 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.045 -1.034 . . . . 0.0 109.054 175.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.76 -44.48 90.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.361 -0.837 . . . . 0.0 110.114 175.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.99 -42.72 94.84 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.221 -0.924 . . . . 0.0 109.611 176.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.437 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 65.1 t0 -59.94 -40.63 89.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.312 -0.867 . . . . 0.0 109.674 173.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.492 HD21 ' N ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -63.91 -55.32 23.55 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 121.587 0.708 . . . . 0.0 110.035 -179.786 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.529 ' CD1' ' HG3' ' A' ' 76' ' ' PRO . 0.4 OUTLIER -54.89 -40.07 69.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.564 -0.71 . . . . 0.0 109.779 179.5 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -60.58 -49.11 78.86 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.586 -0.696 . . . . 0.0 110.74 -176.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.466 ' HB3' HD23 ' A' ' 33' ' ' LEU . 87.7 mm-40 -61.55 -40.04 93.25 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.116 -0.99 . . . . 0.0 110.375 -175.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.56 ' CG1' ' CD1' ' A' ' 33' ' ' LEU . 96.9 mt -59.97 -49.95 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.263 -0.898 . . . . 0.0 110.019 -177.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -62.18 -48.31 80.63 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.883 -1.136 . . . . 0.0 109.75 176.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.11 -55.79 29.54 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.341 -0.849 . . . . 0.0 110.28 178.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.537 ' O ' ' CB ' ' A' ' 28' ' ' ALA . . . -105.28 -48.57 1.05 Allowed Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -174.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.537 ' CB ' ' O ' ' A' ' 27' ' ' GLY . . . 81.81 96.03 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.173 0 O-C-N 122.151 -0.617 . . . . 0.0 110.228 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.43 ' HB3' ' HB2' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -176.0 84.61 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.466 -0.771 . . . . 0.0 109.935 -178.218 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.574 ' CG ' ' HE3' ' A' ' 87' ' ' LYS . 45.8 t80 -60.03 -48.5 81.45 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.314 -0.866 . . . . 0.0 110.573 -175.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.05 -47.84 89.03 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -176.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.43 ' HB2' ' HB3' ' A' ' 29' ' ' ASP . 36.6 mmtm -65.77 -40.16 91.75 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.055 -1.262 . . . . 0.0 110.561 -176.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.56 ' CD1' ' CG1' ' A' ' 24' ' ' ILE . 84.0 mt -66.76 -40.03 88.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.089 -1.007 . . . . 0.0 110.334 179.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.522 ' O ' ' CB ' ' A' ' 38' ' ' SER . . . -59.93 -47.35 86.16 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.121 -0.987 . . . . 0.0 109.992 179.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 66.8 tttt -60.01 -46.57 89.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.16 -0.963 . . . . 0.0 110.456 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.514 ' O ' ' CG2' ' A' ' 39' ' ' ILE . 55.7 mttt -70.03 -59.6 2.81 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.138 -0.976 . . . . 0.0 110.993 -176.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.445 ' HB3' HD23 ' A' ' 16' ' ' LEU . 80.9 m-70 -71.73 -40.18 69.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.095 -1.003 . . . . 0.0 111.129 -172.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.527 ' O ' ' CG1' ' A' ' 39' ' ' ILE . 8.6 t -60.17 -49.25 78.37 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.135 -0.978 . . . . 0.0 110.509 -175.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.527 ' CG1' ' O ' ' A' ' 38' ' ' SER . 36.4 pt 37.95 32.72 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-O 121.452 0.644 . . . . 0.0 110.465 -177.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.459 ' SG ' ' OG ' ' A' ' 38' ' ' SER . 14.9 p -125.93 166.21 22.7 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.393 -0.817 . . . . 0.0 109.658 178.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -51.7 -22.93 14.25 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.823 1.433 . . . . 0.0 110.425 -178.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.7 OUTLIER -101.63 12.99 36.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -0.908 . . . . 0.0 110.636 -179.025 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.08 -56.43 4.41 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 174.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 16.3 tttp -60.01 -40.0 87.73 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.343 -1.093 . . . . 0.0 110.368 177.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.466 ' HD2' HD23 ' A' ' 49' ' ' LEU . 8.7 tpp85 -98.86 -43.65 6.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 0.0 110.58 -175.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -60.0 -35.97 88.85 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.29 -4.21 35.68 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 110.016 -1.233 . . . . 0.0 110.016 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.432 ' HA ' ' CD2' ' A' ' 7' ' ' LEU . 9.7 t0 -171.32 69.37 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.016 -1.285 . . . . 0.0 109.449 178.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.466 HD23 ' HD2' ' A' ' 45' ' ' ARG . 4.8 mt -70.03 -29.91 67.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.508 -0.745 . . . . 0.0 110.75 -176.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 112.23 -152.57 17.76 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -111.91 136.96 50.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.358 -1.084 . . . . 0.0 110.079 -178.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.423 ' CZ ' ' HB2' ' A' ' 6' ' ' ALA . 0.1 OUTLIER -160.18 168.17 26.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.198 -0.939 . . . . 0.0 110.243 -174.764 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.433 ' N ' HG22 ' A' ' 3' ' ' THR . 48.7 ptt85 . . . . . 0 N--CA 1.493 1.702 0 O-C-N 120.997 -1.064 . . . . 0.0 110.546 -176.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.483 ' O ' ' N ' ' A' ' 61' ' ' PHE . 5.7 Cg_endo . . . . . 0 N--CA 1.485 0.98 0 N-CA-C 110.484 -0.622 . . . . 0.0 110.484 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 59' ' ' PRO . . . -37.5 -29.22 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.647 -0.658 . . . . 0.0 110.863 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.483 ' N ' ' O ' ' A' ' 59' ' ' PRO . 32.0 t80 -60.03 -43.9 94.99 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.999 -1.063 . . . . 0.0 110.309 178.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 59' ' ' PRO . 7.7 t70 -60.04 -40.03 87.96 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.213 -0.929 . . . . 0.0 109.459 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.459 ' O ' ' HB2' ' A' ' 67' ' ' SER . 12.4 tptp -57.63 -49.95 74.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.391 -0.818 . . . . 0.0 110.876 177.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.534 ' CG2' ' N ' ' A' ' 65' ' ' VAL . 1.3 m -70.36 -48.64 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 120.929 -1.107 . . . . 0.0 110.832 -172.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.534 ' N ' ' CG2' ' A' ' 64' ' ' VAL . 13.2 p -57.01 -24.64 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.431 -1.418 . . . . 0.0 109.318 172.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.459 ' O ' ' CD1' ' A' ' 66' ' ' PHE . 17.2 t80 -96.57 -0.06 49.3 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.402 -0.811 . . . . 0.0 109.737 175.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 63' ' ' LYS . 33.0 t -97.93 -49.13 4.9 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.431 -0.793 . . . . 0.0 110.006 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.465 ' HB2' ' OG1' ' A' ' 74' ' ' THR . 95.1 m -117.69 147.04 40.12 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.353 -0.842 . . . . 0.0 109.985 179.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -57.14 146.43 81.33 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.015 1.534 . . . . 0.0 110.471 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.518 HG22 ' N ' ' A' ' 71' ' ' LEU . 4.8 p -60.77 173.94 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.26 -0.9 . . . . 0.0 109.976 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.518 ' N ' HG22 ' A' ' 70' ' ' VAL . 2.3 mp 59.61 20.11 8.69 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.335 -0.853 . . . . 0.0 109.642 -175.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -139.21 87.3 13.91 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.5 -0.75 . . . . 0.0 109.668 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 87' ' ' LYS . 52.9 Cg_exo -45.3 115.22 0.87 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.052 1.554 . . . . 0.0 110.337 -176.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.465 ' OG1' ' HB2' ' A' ' 68' ' ' CYS . 54.9 m -108.61 122.91 48.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.255 -0.903 . . . . 0.0 110.405 -176.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 150.91 179.86 27.01 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.529 ' HG3' ' CD1' ' A' ' 21' ' ' LEU . 42.6 Cg_endo -72.15 170.14 68.28 Favored 'Cis proline' 0 C--N 1.315 -1.219 0 C-N-CA 121.674 -2.219 . . . . 0.0 110.588 -0.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.2 mt -139.17 160.55 39.54 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.355 -0.841 . . . . 0.0 110.284 -175.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -84.98 124.48 31.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.238 -0.914 . . . . 0.0 110.239 -179.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.518 HG23 ' CE1' ' A' ' 84' ' ' HIS . 8.8 t -137.63 158.17 44.94 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.105 -0.997 . . . . 0.0 109.895 175.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -59.99 -23.78 63.91 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -0.903 . . . . 0.0 110.225 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -78.88 -10.08 59.69 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.226 -0.921 . . . . 0.0 110.583 -178.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.44 ' O ' HG21 ' A' ' 79' ' ' THR . . . 130.45 -137.36 9.44 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 -175.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.409 ' O ' HD23 ' A' ' 10' ' ' LEU . 0.2 OUTLIER -95.37 136.9 35.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.164 -1.198 . . . . 0.0 110.015 175.211 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.574 ' CD2' ' HG ' ' A' ' 10' ' ' LEU . 3.9 m170 -127.99 114.79 17.56 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.472 -0.767 . . . . 0.0 110.835 -177.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.534 ' CG2' ' HB ' ' A' ' 9' ' ' ILE . 3.6 tt -111.12 130.96 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.09 -1.007 . . . . 0.0 109.515 171.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.526 HG12 ' ND1' ' A' ' 8' ' ' HIS . 78.4 mt -135.37 132.12 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.026 -1.046 . . . . 0.0 111.142 -169.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.574 ' HE3' ' CG ' ' A' ' 30' ' ' PHE . 23.1 mttt -99.27 140.45 33.43 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.876 -1.14 . . . . 0.0 109.985 171.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.481 HG11 ' CB ' ' A' ' 70' ' ' VAL . 37.5 t -109.95 129.97 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.367 -0.833 . . . . 0.0 110.078 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.554 ' O ' ' N ' ' A' ' 91' ' ' ARG . 88.1 mt -139.09 -164.59 1.69 Allowed 'General case' 0 C--N 1.307 -1.271 0 O-C-N 121.19 -0.944 . . . . 0.0 109.557 -178.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.495 ' CD1' ' CB ' ' A' ' 5' ' ' ALA . 44.2 m-85 34.68 -85.98 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.122 0 O-C-N 122.078 -0.389 . . . . 0.0 111.71 -178.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.554 ' N ' ' O ' ' A' ' 89' ' ' LEU . 36.1 ttp180 . . . . . 0 N--CA 1.498 1.945 0 O-C-N 120.873 -1.142 . . . . 0.0 110.893 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.513 ' CG2' ' HG2' ' A' ' 51' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.365 0.602 . . . . 0.0 110.81 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.433 ' C ' ' HG3' ' A' ' 51' ' ' GLU . . . -119.88 146.59 45.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.43 -0.794 . . . . 0.0 109.515 174.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 89' ' ' LEU . . . -92.57 125.69 37.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.039 -1.038 . . . . 0.0 109.461 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.58 ' HB3' ' CE2' ' A' ' 52' ' ' PHE . . . -136.33 135.1 38.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.833 -1.167 . . . . 0.0 111.556 -170.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.532 ' CD2' ' HA ' ' A' ' 48' ' ' ASP . 72.2 mt -109.11 143.89 37.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.207 -0.933 . . . . 0.0 108.877 168.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.501 ' CD2' HG12 ' A' ' 86' ' ' ILE . 45.7 m170 -130.89 129.5 42.33 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.723 -1.236 . . . . 0.0 111.365 -176.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.542 ' HB ' ' CG2' ' A' ' 85' ' ' ILE . 59.1 mt -109.99 129.96 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.106 -0.996 . . . . 0.0 109.229 168.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.578 HD21 ' CD2' ' A' ' 84' ' ' HIS . 1.8 tm? -107.55 120.04 41.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.144 -0.972 . . . . 0.0 110.135 178.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.527 HG12 ' CD2' ' A' ' 16' ' ' LEU . 2.6 t -99.66 132.46 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.526 -0.734 . . . . 0.0 110.001 -179.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -64.28 -39.98 95.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.395 -0.815 . . . . 0.0 110.673 -178.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -136.36 153.93 50.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.067 -1.021 . . . . 0.0 110.707 -176.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.432 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 86.1 tt0 -59.75 -40.09 86.98 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.397 -0.814 . . . . 0.0 110.462 -177.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 29.9 tptt -51.57 -45.54 63.14 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.275 -0.89 . . . . 0.0 110.09 -177.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.527 ' CD2' HG12 ' A' ' 11' ' ' VAL . 7.4 tt -67.8 -39.92 83.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.111 -0.993 . . . . 0.0 109.409 175.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.475 ' O ' ' CD1' ' A' ' 21' ' ' LEU . . . -57.12 -42.7 81.34 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.392 -0.818 . . . . 0.0 109.71 176.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.09 -46.94 87.91 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.231 -0.918 . . . . 0.0 109.634 173.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -60.1 -40.02 88.21 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.422 -0.799 . . . . 0.0 110.184 177.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.543 ' CD1' ' CD2' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -63.15 -52.31 62.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.105 -0.997 . . . . 0.0 109.469 178.716 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.539 ' N ' ' HG ' ' A' ' 20' ' ' LEU . 0.6 OUTLIER -56.55 -46.67 80.56 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.326 -0.859 . . . . 0.0 109.766 -177.689 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -60.04 -39.97 87.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.117 -0.989 . . . . 0.0 109.547 171.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.482 ' HB3' ' O ' ' A' ' 20' ' ' LEU . 61.5 tt0 -60.51 -39.97 89.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.435 -0.79 . . . . 0.0 111.047 -177.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.542 ' O ' ' CA ' ' A' ' 28' ' ' ALA . 18.9 mm -61.26 -39.99 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.796 -1.19 . . . . 0.0 109.724 -176.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -65.17 -56.48 12.65 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.676 -1.265 . . . . 0.0 110.14 177.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -60.11 -50.81 72.23 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.25 -0.906 . . . . 0.0 110.83 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 28' ' ' ALA . . . -105.64 -19.64 10.21 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -168.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.542 ' CA ' ' O ' ' A' ' 24' ' ' ILE . . . 34.18 94.48 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.821 -0.811 . . . . 0.0 111.474 -178.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -177.3 76.41 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.61 -0.681 . . . . 0.0 109.41 -178.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.531 ' HB3' ' CE ' ' A' ' 87' ' ' LYS . 2.5 m-85 -60.06 -43.2 95.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.876 . . . . 0.0 110.807 -173.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.4 -47.5 90.38 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -178.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.49 ' O ' ' HG2' ' A' ' 35' ' ' LYS . 83.6 tttt -63.72 -40.03 95.76 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.19 -1.182 . . . . 0.0 110.23 -178.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.543 ' CD2' ' CD1' ' A' ' 20' ' ' LEU . 40.3 tp -64.1 -40.04 95.35 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.866 -1.146 . . . . 0.0 110.162 178.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.504 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -59.24 -52.83 64.01 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.162 -0.961 . . . . 0.0 110.366 -177.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 55.8 pttt -62.84 -41.21 99.25 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.817 -1.177 . . . . 0.0 110.425 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.467 ' N ' ' CG ' ' A' ' 35' ' ' LYS . 88.3 tttt -62.48 -48.32 80.09 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.197 -0.94 . . . . 0.0 111.446 -174.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.406 ' O ' HG12 ' A' ' 39' ' ' ILE . 41.1 m170 -102.89 -17.64 15.42 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.814 -1.179 . . . . 0.0 111.513 -169.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.527 ' O ' ' CG1' ' A' ' 39' ' ' ILE . 33.7 t -59.96 -44.2 94.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.813 -1.179 . . . . 0.0 110.651 -174.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.527 ' CG1' ' O ' ' A' ' 38' ' ' SER . 45.2 pt 36.69 30.05 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.696 -0.628 . . . . 0.0 110.636 -178.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.499 ' N ' ' O ' ' A' ' 38' ' ' SER . 43.2 t -125.46 144.57 48.26 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.423 -0.798 . . . . 0.0 109.853 -176.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.471 ' HD2' ' SG ' ' A' ' 40' ' ' CYS . 51.6 Cg_exo -49.31 -21.44 4.64 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 123.673 1.354 . . . . 0.0 110.491 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.51 ' O ' ' CA ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -101.27 16.98 23.77 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.212 -0.93 . . . . 0.0 110.184 176.801 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 40' ' ' CYS . . . -79.61 -56.52 3.34 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 173.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -60.04 -39.93 87.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.349 -1.089 . . . . 0.0 110.392 176.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -97.15 -39.79 9.12 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.069 -1.02 . . . . 0.0 110.619 -176.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.51 ' CA ' ' O ' ' A' ' 42' ' ' SER . . . -76.79 -18.27 79.05 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.74 0.09 62.37 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.276 -1.529 . . . . 0.0 109.276 173.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.532 ' HA ' ' CD2' ' A' ' 7' ' ' LEU . 33.9 t0 -172.51 73.13 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.299 -1.118 . . . . 0.0 108.966 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.464 ' HG ' ' HA2' ' A' ' 46' ' ' GLY . 5.5 mt -80.09 -13.26 59.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.419 -0.801 . . . . 0.0 109.899 -175.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.08 -148.04 20.61 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -178.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.513 ' HG2' ' CG2' ' A' ' 3' ' ' THR . 80.5 tt0 -110.92 131.8 54.75 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.336 -1.096 . . . . 0.0 110.173 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.58 ' CE2' ' HB3' ' A' ' 6' ' ' ALA . 3.8 p90 -139.52 158.17 44.59 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.389 -0.819 . . . . 0.0 110.266 -178.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 30.7 ptt-85 . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.354 -0.841 . . . . 0.0 110.043 -178.565 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.497 ' O ' ' N ' ' A' ' 62' ' ' ASP . 10.3 Cg_endo . . . . . 0 N--CA 1.487 1.101 0 N-CA-C 110.389 -0.658 . . . . 0.0 110.389 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 59' ' ' PRO . . . -38.35 -33.1 0.09 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.711 -0.618 . . . . 0.0 110.498 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.483 ' CE1' ' NE2' ' A' ' 8' ' ' HIS . 68.3 t80 -60.05 -41.13 91.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.296 -0.878 . . . . 0.0 110.638 177.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' A' ' 59' ' ' PRO . 52.9 t0 -60.09 -39.94 87.87 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.26 -0.9 . . . . 0.0 110.104 -178.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.415 ' O ' ' HB2' ' A' ' 67' ' ' SER . 79.8 mttt -59.62 -40.06 86.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.874 . . . . 0.0 110.79 -176.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.528 HG21 ' CD1' ' A' ' 86' ' ' ILE . 0.9 OUTLIER -85.22 -48.0 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 120.996 -1.065 . . . . 0.0 111.125 -174.515 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.521 ' N ' ' CG2' ' A' ' 64' ' ' VAL . 7.5 p -54.6 -26.31 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.674 -1.266 . . . . 0.0 109.554 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -96.27 12.41 31.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.252 -0.905 . . . . 0.0 109.764 174.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.464 ' HB3' ' O ' ' A' ' 64' ' ' VAL . 44.4 t -101.27 -41.0 6.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.418 -0.801 . . . . 0.0 110.605 -177.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.514 ' CB ' ' OE1' ' A' ' 72' ' ' GLU . 59.7 m -126.23 154.22 74.49 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.15 -0.969 . . . . 0.0 110.727 -175.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.569 ' O ' ' O ' ' A' ' 70' ' ' VAL . 9.2 Cg_exo -68.05 67.1 0.96 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 124.036 1.545 . . . . 0.0 110.498 177.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.569 ' O ' ' O ' ' A' ' 69' ' ' PRO . 13.4 p 27.68 -169.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 C-N-CA 123.119 0.568 . . . . 0.0 111.891 176.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.495 HD12 ' CG1' ' A' ' 70' ' ' VAL . 4.7 mp 38.65 30.39 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 O-C-N 119.803 -1.811 . . . . 0.0 111.132 -168.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.514 ' OE1' ' CB ' ' A' ' 68' ' ' CYS . 2.0 tm-20 -147.64 94.4 4.42 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.19 -0.944 . . . . 0.0 110.241 -178.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -48.32 107.75 0.15 Allowed 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.908 1.478 . . . . 0.0 110.012 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 98.5 m -96.31 131.78 42.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.914 . . . . 0.0 110.388 -177.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 140.83 -163.2 26.62 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.494 ' CD ' HD13 ' A' ' 21' ' ' LEU . 44.0 Cg_endo -71.08 141.79 70.62 Favored 'Cis proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.872 -2.137 . . . . 0.0 110.647 1.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.523 HD21 ' CG1' ' A' ' 64' ' ' VAL . 42.9 tp -97.04 156.02 16.54 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.343 -0.848 . . . . 0.0 110.694 -177.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.443 ' N ' ' HG ' ' A' ' 77' ' ' LEU . 6.0 t60 -75.38 127.09 32.35 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.154 -0.966 . . . . 0.0 110.349 178.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.5 t -141.22 160.03 40.96 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.221 -0.925 . . . . 0.0 110.255 178.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -59.67 -26.61 65.7 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.186 -0.946 . . . . 0.0 110.521 -177.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.4 ' O ' HD23 ' A' ' 10' ' ' LEU . 97.0 m-85 -97.0 17.48 16.86 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.145 -0.972 . . . . 0.0 110.731 -176.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 121.09 -129.95 8.01 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 -178.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.488 ' HB3' ' HB2' ' A' ' 76' ' ' PRO . 84.5 m-85 -121.97 129.93 52.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.129 -1.218 . . . . 0.0 110.077 178.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.578 ' CD2' HD21 ' A' ' 10' ' ' LEU . 44.6 m170 -101.29 125.28 47.91 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.188 -0.945 . . . . 0.0 110.726 176.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.542 ' CG2' ' HB ' ' A' ' 9' ' ' ILE . 3.8 tt -109.33 128.61 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.709 -1.245 . . . . 0.0 109.078 167.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.528 ' CD1' HG21 ' A' ' 64' ' ' VAL . 96.7 mt -116.22 123.63 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.018 -1.051 . . . . 0.0 111.28 -167.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.531 ' CE ' ' HB3' ' A' ' 30' ' ' PHE . 27.6 mttt -83.77 130.05 34.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.23 -0.919 . . . . 0.0 109.036 170.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.532 ' CG1' HG23 ' A' ' 70' ' ' VAL . 29.2 t -109.33 129.44 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.163 -0.961 . . . . 0.0 109.973 -179.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.515 ' O ' ' HB2' ' A' ' 90' ' ' TYR . 91.6 mt -134.0 117.31 16.54 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.296 -0.878 . . . . 0.0 109.838 -178.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.515 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 50.8 m-85 70.75 -2.04 2.4 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.498 -0.751 . . . . 0.0 111.556 177.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 90' ' ' TYR . 22.3 ptt180 . . . . . 0 N--CA 1.496 1.837 0 O-C-N 121.249 -0.907 . . . . 0.0 110.264 174.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.113 0.482 . . . . 0.0 110.09 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 54' ' ' GLN . 93.5 mttt -69.99 -60.01 2.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.104 -0.997 . . . . 0.0 110.534 -177.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 27.3 m -105.22 139.01 40.51 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.409 -0.807 . . . . 0.0 110.722 -173.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' A' ' 51' ' ' GLU . . . -143.26 159.02 43.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.075 -1.015 . . . . 0.0 110.039 177.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 50' ' ' GLY . . . -94.62 123.71 38.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.268 -0.895 . . . . 0.0 109.145 174.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.581 ' HB1' ' CE1' ' A' ' 61' ' ' PHE . . . -137.24 134.99 36.81 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.709 -1.244 . . . . 0.0 111.884 -169.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.529 ' CD2' ' HA ' ' A' ' 48' ' ' ASP . 33.8 mt -109.32 137.07 47.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.39 -0.819 . . . . 0.0 109.371 170.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.626 ' NE2' ' CE1' ' A' ' 61' ' ' PHE . 22.2 m170 -130.87 132.38 45.12 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.932 -1.105 . . . . 0.0 111.0 -176.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.554 ' HB ' ' CG2' ' A' ' 85' ' ' ILE . 84.4 mt -118.64 129.89 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.947 -1.095 . . . . 0.0 109.567 169.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.565 HD22 ' CD2' ' A' ' 84' ' ' HIS . 2.7 tm? -110.0 120.41 42.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.361 -0.837 . . . . 0.0 109.896 178.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.1 t -103.94 128.97 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.179 -0.951 . . . . 0.0 110.053 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -68.5 -39.96 81.05 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.464 -0.773 . . . . 0.0 110.96 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -119.79 140.54 50.59 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.018 -1.051 . . . . 0.0 110.595 -175.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.443 ' HG2' ' CZ ' ' A' ' 83' ' ' TYR . 93.3 mt-10 -59.97 -39.99 87.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.527 -0.733 . . . . 0.0 110.939 -175.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.1 -41.86 68.75 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.024 -1.048 . . . . 0.0 110.343 -175.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.409 ' C ' HD21 ' A' ' 16' ' ' LEU . 8.1 tt -67.84 -38.56 83.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.124 -0.985 . . . . 0.0 109.648 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.441 ' O ' HD22 ' A' ' 20' ' ' LEU . . . -58.66 -45.82 88.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.294 -0.879 . . . . 0.0 110.314 178.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.5 tp -60.06 -46.25 90.16 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.121 -0.987 . . . . 0.0 109.766 175.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 23' ' ' GLN . 47.9 t0 -59.97 -40.0 87.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.332 -0.855 . . . . 0.0 109.929 178.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.544 ' CD2' HD12 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -62.37 -53.54 53.45 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.357 -0.839 . . . . 0.0 109.471 177.675 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.544 HD12 ' CD2' ' A' ' 20' ' ' LEU . 0.3 OUTLIER -54.57 -48.55 71.93 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.475 -0.766 . . . . 0.0 109.557 -176.717 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -65.1 -40.51 94.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.435 -0.791 . . . . 0.0 109.987 174.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.443 ' NE2' ' CD2' ' A' ' 33' ' ' LEU . 62.7 tt0 -61.54 -40.03 93.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.44 -0.787 . . . . 0.0 110.297 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.523 HG12 ' CD1' ' A' ' 33' ' ' LEU . 92.4 mt -67.07 -39.99 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.278 -0.889 . . . . 0.0 110.111 178.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -64.53 -54.54 30.65 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.948 -1.095 . . . . 0.0 110.226 176.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -60.01 -43.44 95.23 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.216 -0.927 . . . . 0.0 110.967 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.563 ' O ' ' CB ' ' A' ' 28' ' ' ALA . . . -105.55 -59.43 0.64 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -177.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.563 ' CB ' ' O ' ' A' ' 27' ' ' GLY . . . 83.92 104.65 0.05 Allowed 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 121.554 0.692 . . . . 0.0 110.053 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.427 ' CG ' ' O ' ' A' ' 28' ' ' ALA . 3.8 m-20 -175.08 70.48 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.582 -0.698 . . . . 0.0 109.501 -176.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -60.01 -44.24 94.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.925 . . . . 0.0 110.781 -174.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.59 -54.03 31.5 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 119.813 -1.184 . . . . 0.0 110.272 -177.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -66.7 -40.08 88.31 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.991 -1.299 . . . . 0.0 110.861 -175.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.523 ' CD1' HG12 ' A' ' 24' ' ' ILE . 64.5 mt -61.59 -42.94 99.58 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.91 -1.119 . . . . 0.0 110.266 178.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.524 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -59.98 -49.25 78.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 0.0 110.381 178.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -59.98 -47.19 86.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.103 -0.998 . . . . 0.0 110.653 -174.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -67.38 -50.08 61.22 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.971 -1.08 . . . . 0.0 110.998 -177.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 55.3 m170 -69.98 -39.92 75.64 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.047 -1.033 . . . . 0.0 111.103 -173.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.531 ' O ' ' CG2' ' A' ' 39' ' ' ILE . 22.9 t -60.08 -42.06 93.78 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.001 -1.062 . . . . 0.0 110.338 -174.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.531 ' CG2' ' O ' ' A' ' 38' ' ' SER . 21.3 tt 38.02 31.57 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.624 -0.673 . . . . 0.0 110.877 177.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.458 ' SG ' ' OG ' ' A' ' 38' ' ' SER . 15.5 p -120.25 166.15 16.07 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.253 -0.904 . . . . 0.0 110.206 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -53.05 -23.12 20.85 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.968 1.51 . . . . 0.0 110.273 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -107.58 21.27 17.71 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.276 -0.89 . . . . 0.0 109.836 177.006 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.4 -51.37 27.07 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 174.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 48.9 mttp -63.03 -40.03 96.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.442 -1.034 . . . . 0.0 110.849 176.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.466 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 11.9 tpt180 -102.59 -44.6 5.29 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.928 -1.108 . . . . 0.0 110.642 -172.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -63.75 -33.38 87.08 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.224 -1.551 . . . . 0.0 109.224 175.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.36 0.11 55.72 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 175.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.529 ' HA ' ' CD2' ' A' ' 7' ' ' LEU . 49.7 t0 -170.82 71.96 0.05 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.24 -1.153 . . . . 0.0 108.916 178.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 11.0 mt -76.15 -6.94 53.54 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.622 -0.674 . . . . 0.0 109.814 -177.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 5' ' ' ALA . . . 70.39 -139.06 29.97 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -174.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 4.8 mt-10 -101.59 132.1 47.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.397 -1.061 . . . . 0.0 110.643 178.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.52 ' CE2' ' HB2' ' A' ' 6' ' ' ALA . 5.3 p90 -145.38 160.64 41.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.678 -0.639 . . . . 0.0 109.333 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.502 ' HB2' ' NE2' ' A' ' 56' ' ' GLN . 95.0 mtt180 -66.8 156.57 35.2 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.039 -1.038 . . . . 0.0 110.526 -175.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.524 ' N ' ' O ' ' A' ' 2' ' ' LYS . 14.3 pt20 -60.72 -11.1 6.46 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.008 -1.058 . . . . 0.0 110.883 -176.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -124.07 63.21 0.56 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -177.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.502 ' NE2' ' HB2' ' A' ' 53' ' ' ARG . 3.5 mm-40 -113.77 -60.1 1.93 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.025 -1.28 . . . . 0.0 109.257 177.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.45 ' HE3' HD22 ' A' ' 49' ' ' LEU . 37.0 ttm -103.61 -77.75 0.56 Allowed 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.529 -0.869 . . . . 0.0 111.206 -167.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.47 HG23 ' HD2' ' A' ' 59' ' ' PRO . 14.4 p -122.0 130.61 24.65 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.034 -1.041 . . . . 0.0 110.304 -176.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.47 ' HD2' HG23 ' A' ' 58' ' ' VAL . 9.5 Cg_endo -57.17 -49.5 13.91 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.882 1.464 . . . . 0.0 110.407 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 59' ' ' PRO . . . -41.23 -35.29 0.59 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.455 -0.778 . . . . 0.0 110.212 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.626 ' CE1' ' NE2' ' A' ' 8' ' ' HIS . 90.4 t80 -60.08 -41.34 92.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.288 -0.883 . . . . 0.0 110.72 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.427 ' O ' HG12 ' A' ' 65' ' ' VAL . 53.0 t0 -60.01 -41.54 92.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.023 -1.048 . . . . 0.0 109.96 -178.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.441 ' O ' ' HB2' ' A' ' 67' ' ' SER . 62.7 tttm -55.09 -58.56 7.15 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.338 -0.851 . . . . 0.0 110.777 178.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 61' ' ' PHE . 2.9 p -70.0 -42.5 79.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.04 -1.038 . . . . 0.0 111.319 -170.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.427 HG12 ' O ' ' A' ' 62' ' ' ASP . 3.6 p -57.79 -28.26 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.388 -1.445 . . . . 0.0 109.584 174.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -92.33 -10.76 37.12 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.049 -1.032 . . . . 0.0 109.873 173.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.463 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 4.8 t -93.43 -66.21 0.94 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.409 -0.807 . . . . 0.0 109.715 175.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.42 ' SG ' ' O ' ' A' ' 64' ' ' VAL . 24.1 p -76.01 155.97 84.38 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.37 -0.831 . . . . 0.0 110.245 177.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.452 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 53.7 Cg_endo -79.27 148.11 20.99 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.993 1.523 . . . . 0.0 110.223 175.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.52 HG23 ' N ' ' A' ' 71' ' ' LEU . 6.3 p -54.63 168.4 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.146 -0.971 . . . . 0.0 109.887 177.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.52 ' N ' HG23 ' A' ' 70' ' ' VAL . 1.3 mp 58.24 22.25 9.03 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.34 -0.85 . . . . 0.0 110.188 -176.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.452 ' HB3' ' O ' ' A' ' 69' ' ' PRO . 1.4 tp10 -130.77 94.3 29.16 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.254 -0.904 . . . . 0.0 110.251 -179.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -51.07 109.6 0.33 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.927 1.488 . . . . 0.0 109.809 177.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 94.3 m -115.65 130.02 56.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.208 -0.932 . . . . 0.0 110.069 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 140.77 -171.53 24.03 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -176.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.52 ' HG3' ' CD1' ' A' ' 21' ' ' LEU . 41.5 Cg_endo -69.88 138.66 50.6 Favored 'Cis proline' 0 C--N 1.312 -1.373 0 C-N-CA 121.749 -2.188 . . . . 0.0 110.89 -0.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.42 ' HB2' ' O ' ' A' ' 84' ' ' HIS . 95.2 mt -92.94 172.89 8.04 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.52 -0.738 . . . . 0.0 110.484 -176.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -99.18 126.58 44.99 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.064 -1.023 . . . . 0.0 110.67 177.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.578 HG23 ' CE1' ' A' ' 84' ' ' HIS . 8.8 t -146.29 165.1 30.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.272 -0.893 . . . . 0.0 109.817 175.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -59.65 -40.0 86.26 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.104 -0.998 . . . . 0.0 110.769 -175.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -66.38 -15.37 63.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.135 -0.978 . . . . 0.0 110.331 -177.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.441 ' CA ' HD21 ' A' ' 10' ' ' LEU . . . 141.17 -135.69 7.05 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.036 -1.625 . . . . 0.0 109.036 -178.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.443 ' CZ ' ' HG2' ' A' ' 14' ' ' GLU . 4.3 m-85 -97.1 125.12 41.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.135 -1.215 . . . . 0.0 110.131 176.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.578 ' CE1' HG23 ' A' ' 79' ' ' THR . 7.4 m170 -102.73 115.97 31.65 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.607 -0.683 . . . . 0.0 110.345 177.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.554 ' CG2' ' HB ' ' A' ' 9' ' ' ILE . 4.4 tt -104.66 128.38 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.512 -1.367 . . . . 0.0 109.392 168.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.448 HG23 ' CE1' ' A' ' 61' ' ' PHE . 53.0 mt -118.96 125.72 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.369 -0.832 . . . . 0.0 111.051 -172.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.492 ' HB3' ' HB2' ' A' ' 7' ' ' LEU . 18.8 tttm -99.97 125.8 46.04 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.334 -0.854 . . . . 0.0 109.215 171.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.514 ' CG1' ' HA ' ' A' ' 70' ' ' VAL . 21.3 t -101.43 136.49 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.177 -0.952 . . . . 0.0 110.121 -175.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 91' ' ' ARG . 88.9 mt -140.04 147.04 39.76 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.241 -0.912 . . . . 0.0 109.227 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.495 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 98.0 m-85 62.66 -55.35 0.16 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.598 -0.689 . . . . 0.0 111.732 174.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.504 ' N ' ' O ' ' A' ' 89' ' ' LEU . 68.5 ttp85 60.06 20.03 9.21 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.93 -1.106 . . . . 0.0 110.859 -178.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.431 ' OXT' ' OE2' ' A' ' 51' ' ' GLU . 10.1 t-20 . . . . . 0 N--CA 1.491 1.599 0 O-C-N 120.86 -1.15 . . . . 0.0 110.122 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.376 0.608 . . . . 0.0 110.035 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -67.62 -39.15 84.72 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.267 -0.896 . . . . 0.0 110.333 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 92' ' ' ASN . 81.8 p -127.82 155.15 44.55 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.245 -0.91 . . . . 0.0 110.601 -176.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.452 ' HB2' ' CD ' ' A' ' 91' ' ' ARG . . . -140.52 150.53 43.83 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.422 -0.799 . . . . 0.0 110.265 -178.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . . . -95.66 137.84 34.16 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.122 -0.986 . . . . 0.0 109.71 177.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -148.54 130.88 15.62 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.92 -1.112 . . . . 0.0 111.517 -173.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.512 ' C ' ' CD2' ' A' ' 8' ' ' HIS . 78.1 mt -105.21 147.54 27.91 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.202 -0.936 . . . . 0.0 109.144 169.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.512 ' CD2' ' C ' ' A' ' 7' ' ' LEU . 35.1 m-70 -138.34 125.26 21.19 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.749 -1.219 . . . . 0.0 111.303 -177.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.576 HG13 ' CE1' ' A' ' 30' ' ' PHE . 81.5 mt -110.04 129.97 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.016 -1.052 . . . . 0.0 109.857 169.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.428 ' CD1' ' C ' ' A' ' 10' ' ' LEU . 1.0 OUTLIER -110.38 119.97 40.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -0.894 . . . . 0.0 110.365 178.435 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.525 ' CG1' HD22 ' A' ' 16' ' ' LEU . 2.9 t -104.03 135.29 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.421 -0.8 . . . . 0.0 109.954 177.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -67.51 -37.12 82.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.273 -0.892 . . . . 0.0 110.769 -176.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -129.75 149.73 51.37 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.013 -1.054 . . . . 0.0 110.871 -175.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.467 ' HB2' ' CZ ' ' A' ' 83' ' ' TYR . 89.0 tt0 -59.97 -42.8 94.94 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.384 -0.822 . . . . 0.0 111.049 -178.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -55.08 -42.35 72.7 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.022 -1.049 . . . . 0.0 110.293 -177.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.525 HD22 ' CG1' ' A' ' 11' ' ' VAL . 3.6 tt -67.97 -39.83 83.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.211 -0.931 . . . . 0.0 109.341 177.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.442 ' N ' HG12 ' A' ' 11' ' ' VAL . . . -57.99 -46.8 84.62 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.32 -0.863 . . . . 0.0 109.737 175.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.434 ' CD1' ' HG2' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -59.99 -42.62 94.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.153 -0.967 . . . . 0.0 109.6 173.925 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -60.44 -45.44 93.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.414 -0.803 . . . . 0.0 109.904 175.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.462 HD23 HG22 ' A' ' 11' ' ' VAL . 7.9 tp -64.01 -44.23 93.25 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.406 -0.809 . . . . 0.0 109.972 176.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.549 ' CD2' ' HD3' ' A' ' 76' ' ' PRO . 3.6 mp -58.95 -46.15 88.74 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.547 -0.721 . . . . 0.0 110.008 -175.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -62.71 -40.05 95.95 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.627 -0.671 . . . . 0.0 110.109 177.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 72.9 tp60 -60.05 -39.9 87.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 0.0 109.939 -178.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.515 ' CG1' ' CD1' ' A' ' 33' ' ' LEU . 96.7 mt -65.06 -46.84 90.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.274 -0.891 . . . . 0.0 110.122 177.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 64.3 mttt -60.78 -44.17 97.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.136 -0.978 . . . . 0.0 109.557 175.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -59.12 -64.58 0.89 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.348 -0.845 . . . . 0.0 110.343 176.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.553 ' O ' ' CB ' ' A' ' 28' ' ' ALA . . . -105.24 -40.02 2.16 Favored Glycine 0 N--CA 1.483 1.79 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 -171.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.553 ' CB ' ' O ' ' A' ' 27' ' ' GLY . . . 77.46 105.49 0.07 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.716 -0.873 . . . . 0.0 109.942 -177.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -175.37 73.17 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.346 -0.846 . . . . 0.0 109.867 -177.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.576 ' CE1' HG13 ' A' ' 9' ' ' ILE . 23.6 t80 -59.95 -42.76 94.75 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.56 -0.712 . . . . 0.0 110.511 -175.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.82 -49.99 60.63 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -176.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.459 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 74.1 mttt -65.44 -39.95 92.69 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.973 -1.31 . . . . 0.0 110.049 -177.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.515 ' CD1' ' CG1' ' A' ' 24' ' ' ILE . 84.9 mt -64.95 -39.94 94.26 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.206 -0.934 . . . . 0.0 110.027 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.523 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -57.4 -50.2 73.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.218 -0.926 . . . . 0.0 110.034 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.437 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 21.4 mmtp -59.98 -43.4 95.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.276 -0.89 . . . . 0.0 110.745 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 32' ' ' LYS . 99.7 mttt -70.0 -43.16 71.96 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.09 -1.006 . . . . 0.0 111.424 -172.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 32.1 m80 -93.33 -36.0 12.76 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.97 -1.081 . . . . 0.0 110.912 -174.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.524 ' O ' ' CG2' ' A' ' 39' ' ' ILE . 31.6 t -60.03 -52.95 63.19 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.088 -1.007 . . . . 0.0 110.606 -174.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.524 ' CG2' ' O ' ' A' ' 38' ' ' SER . 13.6 tt 38.46 39.28 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.589 -0.695 . . . . 0.0 110.711 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.498 ' SG ' ' N ' ' A' ' 43' ' ' GLY . 12.8 p -127.88 163.61 42.23 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.214 -0.929 . . . . 0.0 109.841 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.46 ' HD2' ' HB2' ' A' ' 40' ' ' CYS . 5.7 Cg_endo -52.34 -27.87 32.68 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.722 1.38 . . . . 0.0 110.188 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.526 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.7 OUTLIER -101.03 14.59 31.47 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.893 . . . . 0.0 109.767 174.675 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.498 ' N ' ' SG ' ' A' ' 40' ' ' CYS . . . -77.08 -55.0 4.55 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 176.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.448 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 28.5 ttpt -60.03 -40.01 87.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.481 -1.011 . . . . 0.0 110.226 177.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.447 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 3.3 tpp180 -98.31 -44.27 6.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.097 -1.002 . . . . 0.0 110.615 -176.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -60.66 -33.74 83.51 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.38 -3.04 37.22 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 176.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.468 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 38.5 p-10 -167.93 62.45 0.07 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.267 -1.137 . . . . 0.0 109.279 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.461 ' HG ' ' HA2' ' A' ' 46' ' ' GLY . 6.2 mt -70.03 -29.09 66.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.637 -0.664 . . . . 0.0 110.317 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.81 -119.32 6.2 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -177.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.438 ' HG3' ' C ' ' A' ' 4' ' ' ALA . 82.5 tt0 -133.02 130.03 38.91 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.209 -1.171 . . . . 0.0 110.475 -175.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -127.05 -178.82 4.56 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.107 -0.995 . . . . 0.0 109.941 175.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.452 ' CG ' ' NE2' ' A' ' 56' ' ' GLN . 26.6 mmt85 -63.6 -138.6 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.995 -1.066 . . . . 0.0 110.183 -173.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -61.43 -19.96 62.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.14 -0.975 . . . . 0.0 111.25 -174.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 140.76 89.6 0.16 Allowed Glycine 0 N--CA 1.496 2.652 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 -173.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.452 ' NE2' ' CG ' ' A' ' 53' ' ' ARG . 2.4 mt-30 -114.72 -43.69 3.12 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 119.951 -1.911 . . . . 0.0 110.745 -165.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.454 ' SD ' HD12 ' A' ' 49' ' ' LEU . 56.3 ttp -60.17 -40.06 88.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.153 -0.967 . . . . 0.0 110.948 -172.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.472 HG22 ' HD2' ' A' ' 59' ' ' PRO . 12.3 p -145.65 133.12 10.27 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.074 -1.016 . . . . 0.0 110.423 -174.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.5 ' O ' ' N ' ' A' ' 62' ' ' ASP . 14.4 Cg_endo -61.03 -51.53 4.52 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.968 1.51 . . . . 0.0 110.559 178.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 59' ' ' PRO . . . -41.17 -34.32 0.45 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.357 -0.839 . . . . 0.0 110.218 -178.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.633 ' CZ ' ' CG2' ' A' ' 65' ' ' VAL . 63.8 t80 -60.05 -39.75 87.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.274 -0.892 . . . . 0.0 110.388 177.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.5 ' N ' ' O ' ' A' ' 59' ' ' PRO . 8.0 t70 -60.0 -48.88 79.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.135 -0.978 . . . . 0.0 110.187 -176.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 67' ' ' SER . 38.8 tptt -59.91 -50.03 75.37 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.149 -0.969 . . . . 0.0 110.206 178.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.461 ' HA ' ' HB3' ' A' ' 67' ' ' SER . 7.5 p -77.43 -41.19 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.103 -0.998 . . . . 0.0 111.554 -174.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.633 ' CG2' ' CZ ' ' A' ' 61' ' ' PHE . 1.9 p -56.32 -27.15 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.357 -1.464 . . . . 0.0 109.305 174.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -94.61 -7.58 40.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.493 -0.754 . . . . 0.0 109.859 176.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.461 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 8.9 t -93.95 -62.04 1.42 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.502 -0.749 . . . . 0.0 109.925 178.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.471 ' HB3' ' OG1' ' A' ' 74' ' ' THR . 27.4 p -71.11 156.51 91.83 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.278 -0.889 . . . . 0.0 110.418 177.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.518 ' O ' ' N ' ' A' ' 71' ' ' LEU . 43.6 Cg_endo -82.22 79.22 3.16 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.998 1.525 . . . . 0.0 110.785 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.544 ' O ' ' CD1' ' A' ' 71' ' ' LEU . 10.9 p 20.19 47.19 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.345 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 177.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.544 ' CD1' ' O ' ' A' ' 70' ' ' VAL . 0.3 OUTLIER -167.17 -40.25 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.453 -0.779 . . . . 0.0 111.068 178.263 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.444 ' HG3' ' HD2' ' A' ' 69' ' ' PRO . 23.5 mm-40 -70.03 130.93 89.34 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 120.836 -1.165 . . . . 0.0 110.732 -173.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -67.48 95.49 0.39 Allowed 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.76 1.4 . . . . 0.0 109.271 172.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.471 ' OG1' ' HB3' ' A' ' 68' ' ' CYS . 21.1 m -94.42 139.77 30.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.154 -0.966 . . . . 0.0 110.451 -172.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.49 -170.36 22.36 Favored Glycine 0 N--CA 1.485 1.919 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.549 ' HD3' ' CD2' ' A' ' 21' ' ' LEU . 42.9 Cg_endo -74.66 124.17 9.71 Favored 'Cis proline' 0 C--N 1.311 -1.437 0 C-N-CA 121.933 -2.111 . . . . 0.0 110.28 0.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.454 ' HG ' ' N ' ' A' ' 78' ' ' HIS . 39.7 tp -94.01 160.3 14.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.278 -0.889 . . . . 0.0 110.123 -174.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.454 ' N ' ' HG ' ' A' ' 77' ' ' LEU . 47.1 t-80 -78.77 123.91 27.66 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.029 -1.044 . . . . 0.0 110.579 -178.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.579 HG23 ' CE1' ' A' ' 84' ' ' HIS . 7.0 t -133.75 164.79 26.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.265 -0.897 . . . . 0.0 109.505 172.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.04 -29.85 68.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.121 -0.987 . . . . 0.0 110.29 -177.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -83.01 -4.91 58.83 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.143 -0.973 . . . . 0.0 110.745 -176.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.473 ' O ' HG21 ' A' ' 79' ' ' THR . . . 133.35 -139.29 10.81 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 -177.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.474 ' HB3' ' HB2' ' A' ' 76' ' ' PRO . 95.8 m-85 -101.98 121.47 42.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.043 -1.269 . . . . 0.0 110.264 178.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.579 ' CE1' HG23 ' A' ' 79' ' ' THR . 34.3 m170 -103.55 128.79 50.73 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.09 -1.006 . . . . 0.0 110.895 178.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.537 HG22 ' CE2' ' A' ' 30' ' ' PHE . 4.5 tt -113.18 119.98 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.963 -1.086 . . . . 0.0 108.947 167.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.453 HD12 HG11 ' A' ' 64' ' ' VAL . 85.5 mt -114.84 131.75 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.919 -1.113 . . . . 0.0 111.322 -168.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.457 ' HB3' ' HB2' ' A' ' 7' ' ' LEU . 26.5 ttmt -100.01 124.12 45.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.345 -0.847 . . . . 0.0 109.614 173.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.521 ' CG1' ' HA ' ' A' ' 70' ' ' VAL . 57.7 t -113.85 131.5 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.15 -0.969 . . . . 0.0 110.438 -172.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.509 ' O ' ' N ' ' A' ' 91' ' ' ARG . 57.2 mt -138.04 170.76 15.47 Favored 'General case' 0 C--N 1.309 -1.154 0 O-C-N 121.186 -0.946 . . . . 0.0 109.867 -177.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.447 ' O ' ' HB2' ' A' ' 91' ' ' ARG . 45.9 m-85 54.07 -76.93 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.752 -0.593 . . . . 0.0 112.069 171.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.526 ' HG3' ' CG2' ' A' ' 70' ' ' VAL . 19.1 mmm180 55.58 40.03 31.03 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.799 -1.188 . . . . 0.0 110.794 -172.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 91' ' ' ARG . 7.6 t-20 . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.041 -1.037 . . . . 0.0 110.254 176.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.465 ' O ' ' O ' ' A' ' 92' ' ' ASN . . . . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.216 0.532 . . . . 0.0 110.432 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.462 ' O ' ' ND2' ' A' ' 92' ' ' ASN . 22.1 ttpt -59.99 -40.07 87.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.213 -0.929 . . . . 0.0 110.175 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.45 ' O ' ' O ' ' A' ' 91' ' ' ARG . 69.6 p -133.34 169.99 16.12 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.477 -0.764 . . . . 0.0 110.005 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 51' ' ' GLU . . . -112.99 128.59 56.54 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -0.93 . . . . 0.0 109.952 178.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 89' ' ' LEU . . . -91.49 126.25 36.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.41 -0.806 . . . . 0.0 109.213 176.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.579 ' CB ' ' NE2' ' A' ' 8' ' ' HIS . . . -135.23 126.09 27.46 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 118.915 -1.114 . . . . 0.0 111.486 -170.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.462 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 58.3 mt -102.68 137.91 40.28 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.144 -0.973 . . . . 0.0 109.132 169.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.579 ' NE2' ' CB ' ' A' ' 6' ' ' ALA . 38.1 m-70 -131.09 131.07 43.94 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.905 -1.122 . . . . 0.0 111.088 -176.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.483 ' HB ' ' CG2' ' A' ' 85' ' ' ILE . 71.3 mt -114.37 124.98 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.98 -1.075 . . . . 0.0 109.456 168.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.59 ' HG ' ' CD2' ' A' ' 84' ' ' HIS . 0.3 OUTLIER -97.67 101.27 12.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.323 -0.86 . . . . 0.0 109.505 179.496 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.539 ' O ' ' CB ' ' A' ' 12' ' ' LYS . 3.6 t -67.63 -50.96 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.202 -0.936 . . . . 0.0 110.514 -175.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.539 ' CB ' ' O ' ' A' ' 11' ' ' VAL . 28.8 tttt 80.61 -17.26 0.59 Allowed 'General case' 0 N--CA 1.503 2.21 0 O-C-N 122.027 -0.42 . . . . 0.0 110.942 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -138.45 135.03 34.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.805 -1.185 . . . . 0.0 110.582 177.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -59.97 -45.23 93.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.458 -0.776 . . . . 0.0 110.285 177.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.7 mttm -59.83 -40.48 88.62 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.237 -0.914 . . . . 0.0 109.938 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.462 ' HB3' HG13 ' A' ' 11' ' ' VAL . 5.0 tt -67.87 -39.75 83.68 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.376 -0.827 . . . . 0.0 109.577 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.472 ' N ' HG11 ' A' ' 11' ' ' VAL . . . -59.5 -43.93 93.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.233 -0.917 . . . . 0.0 109.775 175.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.486 ' O ' HD11 ' A' ' 21' ' ' LEU . 0.1 OUTLIER -60.0 -40.87 90.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.352 -0.842 . . . . 0.0 110.056 175.495 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -60.83 -49.73 76.3 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.993 -1.067 . . . . 0.0 110.147 176.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.593 ' CD1' ' N ' ' A' ' 21' ' ' LEU . 0.4 OUTLIER -69.13 -50.34 48.83 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.135 -0.978 . . . . 0.0 110.915 -175.667 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.609 ' CD1' ' N ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -58.87 -29.63 67.13 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 120.742 -1.224 . . . . 0.0 108.961 -173.055 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.609 ' N ' ' CD1' ' A' ' 21' ' ' LEU . 87.9 tt0 -64.65 -39.93 94.54 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.36 -0.838 . . . . 0.0 109.931 170.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.402 ' HB3' ' O ' ' A' ' 20' ' ' LEU . 68.4 tp60 -60.05 -45.11 93.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.356 -0.84 . . . . 0.0 111.351 -173.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.519 ' O ' ' N ' ' A' ' 28' ' ' ALA . 27.6 mt -61.07 -47.96 91.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.041 -1.037 . . . . 0.0 110.592 -173.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.8 mttp -60.28 -49.01 79.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.943 -1.098 . . . . 0.0 110.256 177.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -60.01 -58.39 8.73 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.099 -1.001 . . . . 0.0 110.287 176.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.558 ' O ' ' CB ' ' A' ' 28' ' ' ALA . . . -105.6 -46.76 1.18 Allowed Glycine 0 N--CA 1.484 1.849 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 -172.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.613 ' O ' ' CB ' ' A' ' 29' ' ' ASP . . . 79.71 170.33 0.17 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.795 -0.826 . . . . 0.0 110.078 -176.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.613 ' CB ' ' O ' ' A' ' 28' ' ' ALA . 87.4 m-20 109.48 85.91 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.911 0 C-N-CA 124.656 1.182 . . . . 0.0 109.662 -174.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.512 ' CZ ' ' CB ' ' A' ' 73' ' ' PRO . 6.5 m-85 -60.02 -49.61 77.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.239 -0.913 . . . . 0.0 110.447 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.37 -46.28 94.19 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -177.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 33.1 tttp -62.84 -40.0 96.09 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.112 -1.228 . . . . 0.0 110.152 -177.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.452 HD23 HD11 ' A' ' 24' ' ' ILE . 47.3 tp -62.92 -40.03 96.34 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.213 -0.929 . . . . 0.0 110.337 177.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.483 ' O ' ' CB ' ' A' ' 38' ' ' SER . . . -59.66 -49.97 75.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.073 -1.017 . . . . 0.0 110.269 -178.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 46.8 tttm -60.05 -47.49 85.64 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.935 -1.103 . . . . 0.0 110.615 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -60.66 -42.28 96.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.134 -0.979 . . . . 0.0 111.03 -173.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 10.3 m80 -104.01 -4.38 23.4 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.928 -1.107 . . . . 0.0 111.022 -174.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.526 ' O ' ' CG2' ' A' ' 39' ' ' ILE . 1.2 t -60.04 -46.07 90.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.072 -1.017 . . . . 0.0 110.645 -177.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.526 ' CG2' ' O ' ' A' ' 38' ' ' SER . 16.0 tt 38.86 29.75 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.621 -0.674 . . . . 0.0 110.494 -177.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.449 ' N ' ' O ' ' A' ' 38' ' ' SER . 13.4 t -131.7 135.63 27.13 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.358 -0.839 . . . . 0.0 110.032 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -51.6 -31.09 38.8 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.907 1.477 . . . . 0.0 110.776 -176.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 46' ' ' GLY . 0.3 OUTLIER -99.94 11.74 38.54 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.154 -0.966 . . . . 0.0 110.318 -179.695 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.47 ' HA3' ' OG ' ' A' ' 38' ' ' SER . . . -104.92 -62.87 0.65 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -60.07 -39.98 87.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.139 -1.212 . . . . 0.0 109.823 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -102.41 -33.33 9.59 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.444 -0.785 . . . . 0.0 110.029 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.474 ' O ' ' HG ' ' A' ' 49' ' ' LEU . . . -99.51 -4.78 55.96 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 -177.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.477 ' O ' HD13 ' A' ' 49' ' ' LEU . . . -51.31 -50.43 40.72 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.601 -1.799 . . . . 0.0 108.601 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -71.91 106.76 4.35 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.197 -1.178 . . . . 0.0 109.644 170.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.477 HD13 ' O ' ' A' ' 47' ' ' GLY . 0.8 OUTLIER -108.98 1.1 20.4 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.11 -0.994 . . . . 0.0 110.166 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.79 -134.09 25.52 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 13.7 mt-10 -121.47 138.47 54.27 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.298 -1.119 . . . . 0.0 111.234 -176.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.513 ' HB2' ' NE2' ' A' ' 56' ' ' GLN . 0.7 OUTLIER -121.72 173.1 7.67 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.399 -0.813 . . . . 0.0 109.555 173.548 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.535 ' O ' ' CB ' ' A' ' 54' ' ' GLN . 9.6 ptp85 -124.01 144.09 50.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.057 -1.027 . . . . 0.0 110.021 -178.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.535 ' CB ' ' O ' ' A' ' 53' ' ' ARG . 43.4 mt-30 83.5 -41.89 0.09 Allowed 'General case' 0 N--CA 1.503 2.175 0 CA-C-O 121.337 0.589 . . . . 0.0 109.615 -174.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.548 ' O ' ' N ' ' A' ' 57' ' ' MET . . . 133.53 -55.07 0.75 Allowed Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 -178.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.53 ' O ' ' C ' ' A' ' 57' ' ' MET . 1.1 pt20 35.25 -89.24 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 122.218 -0.578 . . . . 0.0 111.111 174.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.548 ' N ' ' O ' ' A' ' 55' ' ' GLY . 5.5 tpt -1.22 -71.74 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 176.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.529 ' CG1' ' HB2' ' A' ' 61' ' ' PHE . 12.6 p -155.46 133.18 6.67 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.303 -0.873 . . . . 0.0 110.074 -179.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.469 ' HD2' HG21 ' A' ' 58' ' ' VAL . 3.0 Cg_endo -50.35 -53.6 6.84 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.849 1.447 . . . . 0.0 110.41 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 59' ' ' PRO . . . -43.14 -36.12 1.58 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.233 -0.917 . . . . 0.0 110.441 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.529 ' HB2' ' CG1' ' A' ' 58' ' ' VAL . 71.9 t80 -59.99 -40.02 87.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.188 -0.945 . . . . 0.0 110.656 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.458 ' O ' HG11 ' A' ' 65' ' ' VAL . 29.4 t0 -59.97 -49.97 75.59 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.136 -0.977 . . . . 0.0 110.331 -177.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.462 ' O ' ' HB2' ' A' ' 67' ' ' SER . 33.9 tttt -60.0 -50.03 75.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.07 -1.019 . . . . 0.0 110.541 177.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.53 ' CG2' ' HB ' ' A' ' 74' ' ' THR . 14.6 p -72.27 -44.93 63.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.025 -1.047 . . . . 0.0 111.082 -173.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.504 ' N ' HG12 ' A' ' 64' ' ' VAL . 1.9 p -55.58 -28.44 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.458 -1.402 . . . . 0.0 109.162 173.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -93.43 -10.63 34.45 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.328 -0.858 . . . . 0.0 109.897 175.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.479 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 7.4 t -93.84 -57.27 2.6 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.381 -0.825 . . . . 0.0 109.963 175.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.506 ' CB ' ' OG1' ' A' ' 74' ' ' THR . 84.6 m -111.63 122.88 36.12 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.292 -0.88 . . . . 0.0 110.012 177.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -61.73 -179.65 0.41 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.797 1.42 . . . . 0.0 110.643 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.526 ' CG1' ' HB2' ' A' ' 91' ' ' ARG . 31.4 m -61.87 161.43 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.357 -0.839 . . . . 0.0 110.924 -175.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 70' ' ' VAL . 5.5 mp 58.55 23.58 10.99 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.584 -0.698 . . . . 0.0 110.367 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -129.76 72.2 81.99 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.304 -0.872 . . . . 0.0 109.545 175.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.512 ' CB ' ' CZ ' ' A' ' 30' ' ' PHE . 65.1 Cg_exo -44.55 122.07 3.7 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.025 1.54 . . . . 0.0 110.071 -177.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.53 ' HB ' ' CG2' ' A' ' 64' ' ' VAL . 94.7 m -119.99 130.06 54.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.215 -0.928 . . . . 0.0 110.264 -175.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.442 ' HA3' HG13 ' A' ' 85' ' ' ILE . . . 137.33 -171.44 23.16 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 178.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.459 ' HG3' ' HB1' ' A' ' 17' ' ' ALA . 40.5 Cg_endo -68.24 153.89 88.57 Favored 'Cis proline' 0 C--N 1.313 -1.3 0 C-N-CA 121.695 -2.21 . . . . 0.0 110.297 1.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.498 ' HG ' ' N ' ' A' ' 78' ' ' HIS . 25.0 tp -132.94 157.68 44.52 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.986 -1.071 . . . . 0.0 110.576 -171.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.498 ' N ' ' HG ' ' A' ' 77' ' ' LEU . 44.8 m80 -62.91 132.73 53.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.305 -0.872 . . . . 0.0 110.685 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.53 ' CG2' ' O ' ' A' ' 82' ' ' GLY . 5.0 t -148.25 159.17 44.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.269 -0.895 . . . . 0.0 109.809 173.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.02 -26.93 66.47 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.209 -0.932 . . . . 0.0 110.118 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -88.59 -1.54 58.11 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.355 -0.841 . . . . 0.0 110.675 -176.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.53 ' O ' ' CG2' ' A' ' 79' ' ' THR . . . 129.66 -123.67 4.18 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -177.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.442 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 96.0 m-85 -114.18 122.49 46.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.193 -1.18 . . . . 0.0 110.189 178.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.59 ' CD2' ' HG ' ' A' ' 10' ' ' LEU . 41.3 m170 -109.33 120.43 42.49 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.321 -0.862 . . . . 0.0 110.823 177.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.483 ' CG2' ' HB ' ' A' ' 9' ' ' ILE . 7.7 tt -103.19 116.81 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.474 -1.391 . . . . 0.0 109.077 165.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.456 HG23 ' CE1' ' A' ' 8' ' ' HIS . 85.5 mt -114.63 130.01 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.923 -1.111 . . . . 0.0 111.007 -170.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.462 ' HB3' ' HB2' ' A' ' 7' ' ' LEU . 22.9 tttm -100.16 120.7 40.28 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.427 -0.795 . . . . 0.0 109.232 174.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 90.9 t -101.17 139.23 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.085 -1.01 . . . . 0.0 110.609 -173.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.557 ' O ' ' CB ' ' A' ' 90' ' ' TYR . 84.8 mt -138.29 120.63 15.91 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 121.329 -0.857 . . . . 0.0 109.707 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.557 ' CB ' ' O ' ' A' ' 89' ' ' LEU . 2.5 m-85 82.33 -24.68 0.17 Allowed 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.586 -0.697 . . . . 0.0 111.217 175.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.526 ' HB2' ' CG1' ' A' ' 70' ' ' VAL . 35.1 ttm180 55.99 164.8 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.866 -1.146 . . . . 0.0 110.371 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.465 ' O ' ' O ' ' A' ' 1' ' ' ALA . 4.0 t-20 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.971 176.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.536 ' CB ' ' HB3' ' A' ' 92' ' ' ASN . . . . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.209 0.528 . . . . 0.0 110.365 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 53' ' ' ARG . 72.1 mmtt -67.98 -36.68 80.45 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.318 -0.864 . . . . 0.0 109.966 176.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 35.4 p -128.72 162.36 27.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.334 -0.853 . . . . 0.0 110.238 -178.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.458 ' CB ' ' HG2' ' A' ' 91' ' ' ARG . . . -146.86 165.14 30.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.351 -0.843 . . . . 0.0 109.824 176.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -99.21 134.12 42.51 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.197 -0.94 . . . . 0.0 109.639 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.516 ' HB1' ' CE1' ' A' ' 52' ' ' PHE . . . -135.92 128.01 29.75 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.708 -1.245 . . . . 0.0 111.828 -171.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.527 ' CD2' ' HA ' ' A' ' 48' ' ' ASP . 75.5 mt -108.82 141.09 41.35 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.188 -0.945 . . . . 0.0 109.201 168.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.57 ' CE1' HG23 ' A' ' 86' ' ' ILE . 26.3 m-70 -135.37 125.82 26.71 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.787 -1.195 . . . . 0.0 111.081 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.553 ' HB ' ' CG2' ' A' ' 85' ' ' ILE . 87.6 mt -110.14 130.05 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.91 -1.119 . . . . 0.0 110.211 170.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.525 ' HG ' ' CD2' ' A' ' 84' ' ' HIS . 0.7 OUTLIER -105.08 120.01 40.45 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.457 -0.777 . . . . 0.0 109.942 178.408 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.473 HG13 ' CD2' ' A' ' 16' ' ' LEU . 2.0 t -108.29 129.67 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.229 -0.919 . . . . 0.0 109.631 178.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -68.4 -39.46 81.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.258 -0.901 . . . . 0.0 110.558 -176.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -120.7 141.4 50.45 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.16 -0.962 . . . . 0.0 110.79 -177.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.582 ' HB2' ' CZ ' ' A' ' 83' ' ' TYR . 83.5 tt0 -60.0 -40.06 87.92 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.476 -0.765 . . . . 0.0 110.877 -178.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -55.88 -41.79 74.96 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.082 -1.011 . . . . 0.0 110.41 -174.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.473 ' CD2' HG13 ' A' ' 11' ' ' VAL . 1.4 tp -68.28 -40.01 81.96 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.214 -0.929 . . . . 0.0 109.563 177.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.72 -42.3 92.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.422 -0.799 . . . . 0.0 110.097 177.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.5 tp -60.06 -42.71 95.08 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.158 -0.964 . . . . 0.0 109.352 173.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.459 ' HB3' ' O ' ' A' ' 16' ' ' LEU . 56.1 t0 -59.99 -40.01 87.71 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -0.888 . . . . 0.0 109.387 174.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.512 HD13 ' CD1' ' A' ' 24' ' ' ILE . 0.6 OUTLIER -62.36 -43.28 99.2 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.494 -0.754 . . . . 0.0 109.463 175.68 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.523 ' CD2' ' HD3' ' A' ' 76' ' ' PRO . 4.0 mp -59.99 -49.61 77.0 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.765 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.439 ' HA ' ' OE1' ' A' ' 22' ' ' GLU . 51.7 tp10 -61.13 -40.0 92.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.287 -0.883 . . . . 0.0 109.85 173.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -61.14 -41.68 97.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.435 -0.791 . . . . 0.0 110.559 -176.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.527 ' O ' ' N ' ' A' ' 28' ' ' ALA . 33.0 mt -67.49 -40.08 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.007 -1.058 . . . . 0.0 110.281 176.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 21' ' ' LEU . 30.3 mttm -62.9 -53.93 46.5 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.099 -1.001 . . . . 0.0 109.987 -177.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -60.75 -50.78 72.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.194 -0.941 . . . . 0.0 110.048 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.554 ' O ' ' CB ' ' A' ' 28' ' ' ALA . . . -105.97 -54.56 0.71 Allowed Glycine 0 N--CA 1.487 2.043 0 N-CA-C 110.014 -1.235 . . . . 0.0 110.014 -173.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.614 ' O ' ' CB ' ' A' ' 29' ' ' ASP . . . 79.83 172.24 0.15 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.869 -0.783 . . . . 0.0 109.922 -176.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.614 ' CB ' ' O ' ' A' ' 28' ' ' ALA . 95.9 m-20 114.73 78.09 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.013 0 C-N-CA 124.859 1.264 . . . . 0.0 109.618 -175.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -60.03 -49.96 75.61 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.269 -0.895 . . . . 0.0 110.778 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.7 -49.91 65.35 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -175.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.46 ' HB2' ' HB3' ' A' ' 29' ' ' ASP . 94.6 mttt -64.59 -39.8 94.39 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.995 -1.297 . . . . 0.0 110.218 -175.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.49 ' HG ' ' CD2' ' A' ' 37' ' ' HIS . 9.8 tt -65.32 -40.04 93.23 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.176 -0.952 . . . . 0.0 110.127 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.541 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -59.81 -50.21 74.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.186 -0.946 . . . . 0.0 110.165 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.5 tttt -59.99 -50.0 75.44 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.382 -0.824 . . . . 0.0 110.717 -178.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.47 ' O ' HG12 ' A' ' 39' ' ' ILE . 88.8 tttt -65.93 -47.28 75.22 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.181 -0.949 . . . . 0.0 111.202 -174.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.49 ' CD2' ' HG ' ' A' ' 33' ' ' LEU . 67.2 m-70 -80.78 -50.01 10.4 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.874 -1.141 . . . . 0.0 111.674 -171.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.465 ' O ' ' C ' ' A' ' 39' ' ' ILE . 53.9 m -60.54 -40.07 90.19 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.915 -1.116 . . . . 0.0 110.765 -173.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.527 ' CG2' ' O ' ' A' ' 39' ' ' ILE . 31.9 mm 32.04 46.18 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 CA-C-O 121.5 0.667 . . . . 0.0 110.985 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.5 ' SG ' ' N ' ' A' ' 43' ' ' GLY . 17.0 p -133.79 170.14 12.1 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.348 -0.845 . . . . 0.0 109.945 -177.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.453 ' HD2' ' HB2' ' A' ' 40' ' ' CYS . 52.6 Cg_exo -49.96 -30.39 24.01 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.851 1.448 . . . . 0.0 109.982 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.481 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 6.1 p -108.84 27.29 9.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.22 -0.925 . . . . 0.0 109.61 173.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.5 ' N ' ' SG ' ' A' ' 40' ' ' CYS . . . -103.16 -67.16 0.75 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 108.607 -1.797 . . . . 0.0 108.607 176.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -59.99 -40.09 87.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -1.178 . . . . 0.0 109.961 172.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.451 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 13.7 tpt180 -99.8 -41.2 7.36 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.331 -0.856 . . . . 0.0 110.554 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.488 ' HA2' ' HG ' ' A' ' 49' ' ' LEU . . . -76.6 -22.81 71.71 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.32 -4.32 56.16 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 175.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.527 ' HA ' ' CD2' ' A' ' 7' ' ' LEU . 38.3 t0 -173.83 70.31 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.249 -1.148 . . . . 0.0 109.27 178.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.488 ' HG ' ' HA2' ' A' ' 46' ' ' GLY . 7.3 mt -70.08 -29.2 66.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.61 -0.681 . . . . 0.0 110.077 -176.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 111.78 -143.33 17.36 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -113.17 136.12 53.07 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.383 -1.069 . . . . 0.0 110.455 -177.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.628 ' CD1' ' NE2' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -148.6 168.44 22.78 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.305 -0.872 . . . . 0.0 109.707 175.373 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.486 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 75.1 ttt180 -50.43 -84.19 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.737 -1.227 . . . . 0.0 110.546 -172.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.468 ' HG2' ' HG2' ' A' ' 53' ' ' ARG . 10.9 pt20 -177.35 133.4 0.17 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.995 -1.066 . . . . 0.0 110.507 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.92 -9.99 75.39 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 174.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.628 ' NE2' ' CD1' ' A' ' 52' ' ' PHE . 0.5 OUTLIER -60.01 -36.57 77.52 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.05 -1.265 . . . . 0.0 111.157 -173.662 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.476 ' SD ' ' CG ' ' A' ' 8' ' ' HIS . 27.7 ttt -83.51 -42.09 17.25 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.591 -1.318 . . . . 0.0 110.852 -167.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.478 HG22 ' HD2' ' A' ' 59' ' ' PRO . 7.3 p -173.04 133.85 0.67 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.271 -0.893 . . . . 0.0 109.799 -173.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.478 ' HD2' HG22 ' A' ' 58' ' ' VAL . 2.8 Cg_endo -49.37 -53.38 7.13 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 O-C-N 123.793 1.417 . . . . 0.0 110.247 -178.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -43.95 -37.85 3.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.293 -0.879 . . . . 0.0 110.544 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.471 ' HB3' ' O ' ' A' ' 58' ' ' VAL . 37.7 t80 -59.9 -40.26 88.16 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.074 -1.016 . . . . 0.0 110.386 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.427 ' O ' HG13 ' A' ' 65' ' ' VAL . 32.9 t0 -59.97 -46.05 90.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.103 -0.998 . . . . 0.0 109.932 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -59.96 -49.99 75.51 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.293 -0.879 . . . . 0.0 110.623 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.511 HG13 ' N ' ' A' ' 65' ' ' VAL . 8.9 p -73.2 -45.4 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.03 -1.044 . . . . 0.0 111.144 -174.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.511 ' N ' HG13 ' A' ' 64' ' ' VAL . 5.5 p -57.46 -24.24 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.359 -1.463 . . . . 0.0 109.156 172.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -97.29 -1.5 44.54 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.365 -0.834 . . . . 0.0 109.904 175.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.466 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 22.8 t -96.58 -67.42 0.85 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.449 -0.782 . . . . 0.0 109.573 174.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 73.4 m -92.48 128.54 44.12 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.29 -0.881 . . . . 0.0 110.063 175.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -50.62 165.81 0.38 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.815 1.429 . . . . 0.0 110.353 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.506 HG13 ' CB ' ' A' ' 91' ' ' ARG . 31.4 m -59.8 169.1 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.265 -0.897 . . . . 0.0 110.726 -178.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' A' ' 70' ' ' VAL . 5.4 mp 59.94 26.17 15.4 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.699 -0.626 . . . . 0.0 110.583 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.06 90.96 37.6 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.085 -1.01 . . . . 0.0 110.17 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -52.22 110.64 0.47 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.771 1.406 . . . . 0.0 109.55 176.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 94.2 m -119.92 129.97 54.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.08 -1.012 . . . . 0.0 110.536 -173.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.499 ' HA2' ' CD2' ' A' ' 77' ' ' LEU . . . 148.41 -169.95 28.98 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.523 ' HD3' ' CD2' ' A' ' 21' ' ' LEU . 44.1 Cg_endo -75.6 139.16 59.51 Favored 'Cis proline' 0 C--N 1.313 -1.292 0 C-N-CA 121.854 -2.144 . . . . 0.0 110.481 1.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.499 ' CD2' ' HA2' ' A' ' 75' ' ' GLY . 1.1 mm? -98.15 174.83 6.33 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.241 -0.912 . . . . 0.0 110.699 -177.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.443 ' CD2' ' CE2' ' A' ' 83' ' ' TYR . 53.3 m170 -109.66 127.54 54.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.283 -0.885 . . . . 0.0 110.887 -176.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.575 HG23 ' CG ' ' A' ' 84' ' ' HIS . 11.1 t -140.42 168.77 19.02 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.457 -0.777 . . . . 0.0 109.775 174.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -59.95 -40.12 87.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.097 -1.002 . . . . 0.0 110.484 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -64.25 -16.69 62.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.086 -1.009 . . . . 0.0 110.583 -177.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.44 ' O ' HG22 ' A' ' 79' ' ' THR . . . 140.67 -143.62 13.68 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 -177.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.582 ' CZ ' ' HB2' ' A' ' 14' ' ' GLU . 68.9 m-85 -97.16 122.65 40.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.136 -1.214 . . . . 0.0 110.181 178.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.575 ' CG ' HG23 ' A' ' 79' ' ' THR . 24.7 m170 -105.79 120.07 40.77 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.46 -0.775 . . . . 0.0 110.603 178.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.553 ' CG2' ' HB ' ' A' ' 9' ' ' ILE . 6.5 tt -109.71 121.64 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.683 -1.261 . . . . 0.0 109.248 167.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.57 HG23 ' CE1' ' A' ' 8' ' ' HIS . 88.2 mt -115.53 130.04 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.108 -0.995 . . . . 0.0 111.289 -170.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.479 ' HB3' ' HB2' ' A' ' 7' ' ' LEU . 20.7 tttm -102.96 132.02 49.5 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.438 -0.789 . . . . 0.0 108.913 171.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.473 HG21 ' HA ' ' A' ' 70' ' ' VAL . 20.0 m -119.78 138.58 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.026 -1.046 . . . . 0.0 110.546 -176.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.534 ' O ' ' N ' ' A' ' 91' ' ' ARG . 58.5 mt -140.02 -167.34 2.28 Favored 'General case' 0 C--N 1.309 -1.186 0 O-C-N 121.291 -0.881 . . . . 0.0 109.901 -173.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.44 ' C ' ' O ' ' A' ' 89' ' ' LEU . 53.5 m-85 30.41 -85.63 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.865 -177.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.534 ' N ' ' O ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER 54.44 50.23 16.63 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.697 -1.252 . . . . 0.0 109.837 -175.262 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.536 ' HB3' ' CB ' ' A' ' 1' ' ' ALA . 4.6 t-20 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 118.074 -0.965 . . . . 0.0 110.332 -178.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.224 0.535 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 66.5 mmtt -60.21 -39.97 88.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.183 -0.948 . . . . 0.0 110.026 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.412 HG21 ' HG2' ' A' ' 53' ' ' ARG . 67.9 p -124.39 150.57 45.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.272 -0.892 . . . . 0.0 110.089 178.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.435 ' C ' ' HG3' ' A' ' 51' ' ' GLU . . . -130.71 154.78 47.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.054 -1.029 . . . . 0.0 110.463 -178.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.606 ' CB ' ' CD1' ' A' ' 90' ' ' TYR . . . -98.07 136.59 38.1 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.226 -0.921 . . . . 0.0 109.757 177.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.564 ' CB ' ' NE2' ' A' ' 8' ' ' HIS . . . -147.58 123.12 10.43 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.719 -1.238 . . . . 0.0 112.098 -172.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.601 ' N ' ' CD1' ' A' ' 7' ' ' LEU . 4.0 mp -96.17 147.0 24.2 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.024 -1.048 . . . . 0.0 108.995 167.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.564 ' NE2' ' CB ' ' A' ' 6' ' ' ALA . 37.5 m-70 -136.35 137.02 40.17 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.773 -1.204 . . . . 0.0 111.287 -175.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.544 ' HB ' ' CG2' ' A' ' 85' ' ' ILE . 79.3 mt -118.93 129.9 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.127 -0.983 . . . . 0.0 109.799 168.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.532 ' HG ' ' CD2' ' A' ' 84' ' ' HIS . 0.4 OUTLIER -102.16 118.08 36.14 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.509 -0.745 . . . . 0.0 110.262 -179.115 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.529 ' CG1' HD21 ' A' ' 16' ' ' LEU . 2.2 t -108.09 127.74 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.323 -0.861 . . . . 0.0 109.891 177.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -69.95 -39.95 75.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.352 -0.842 . . . . 0.0 110.296 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -120.03 140.36 51.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.216 -0.928 . . . . 0.0 110.496 -175.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -59.89 -39.95 87.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.382 -0.823 . . . . 0.0 110.617 -176.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -52.16 -41.48 62.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.086 -1.009 . . . . 0.0 110.254 -175.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.529 HD21 ' CG1' ' A' ' 11' ' ' VAL . 7.9 tt -67.73 -44.08 78.46 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.029 -1.045 . . . . 0.0 109.912 177.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.521 ' CB ' ' HG3' ' A' ' 76' ' ' PRO . . . -59.91 -45.93 90.98 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.249 -0.907 . . . . 0.0 109.936 177.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.495 ' O ' HD11 ' A' ' 21' ' ' LEU . 10.1 tp -60.99 -39.18 88.68 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.932 -1.105 . . . . 0.0 109.405 170.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.424 ' HB3' ' O ' ' A' ' 16' ' ' LEU . 48.6 t0 -62.25 -49.79 74.29 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 120.999 -1.063 . . . . 0.0 110.312 176.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.591 ' CD1' ' N ' ' A' ' 21' ' ' LEU . 0.7 OUTLIER -69.94 -47.2 63.31 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.019 -1.051 . . . . 0.0 110.788 -175.574 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.615 ' CD1' ' N ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -59.96 -29.29 68.32 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.012 -1.055 . . . . 0.0 108.864 -173.185 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.615 ' N ' ' CD1' ' A' ' 21' ' ' LEU . 85.7 tt0 -61.87 -42.66 99.33 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.407 -0.808 . . . . 0.0 110.137 173.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.79 -39.99 95.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.298 -0.876 . . . . 0.0 110.574 -176.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.55 HD12 ' CE2' ' A' ' 30' ' ' PHE . 97.6 mt -61.89 -45.44 98.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -0.86 . . . . 0.0 109.824 -178.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 36.7 mttm -61.06 -46.26 91.4 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.228 -0.92 . . . . 0.0 109.716 176.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -59.95 -61.34 2.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.382 -0.824 . . . . 0.0 110.485 177.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.543 ' O ' ' CB ' ' A' ' 28' ' ' ALA . . . -104.87 -39.58 2.3 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -172.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.543 ' CB ' ' O ' ' A' ' 27' ' ' GLY . . . 81.19 102.56 0.06 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.953 -0.734 . . . . 0.0 110.142 -178.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -175.74 67.05 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.421 -0.799 . . . . 0.0 110.128 -177.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.577 ' CG ' ' HD3' ' A' ' 87' ' ' LYS . 2.0 m-85 -59.98 -44.15 94.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -0.923 . . . . 0.0 110.838 -178.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.4 -43.63 98.48 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -177.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -65.09 -40.2 94.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.175 -1.191 . . . . 0.0 110.345 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.552 HD23 ' CD2' ' A' ' 37' ' ' HIS . 88.9 mt -66.33 -39.93 89.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.112 -0.992 . . . . 0.0 110.491 178.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.467 ' HB3' HG12 ' A' ' 9' ' ' ILE . . . -60.0 -46.42 89.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.107 -0.996 . . . . 0.0 110.027 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -60.0 -50.21 74.61 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.363 -0.835 . . . . 0.0 110.785 -177.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.465 ' O ' HG13 ' A' ' 39' ' ' ILE . 51.3 mttt -75.91 -47.89 23.5 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.023 -1.048 . . . . 0.0 111.249 -174.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.552 ' CD2' HD23 ' A' ' 33' ' ' LEU . 60.9 m-70 -71.78 -40.04 69.51 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.932 -1.105 . . . . 0.0 111.198 -174.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.515 ' OG ' ' CA ' ' A' ' 43' ' ' GLY . 16.5 t -61.02 -50.04 74.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.035 -1.041 . . . . 0.0 111.045 -172.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.484 ' C ' ' O ' ' A' ' 38' ' ' SER . 96.3 mt 31.98 49.06 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 CA-C-O 121.318 0.58 . . . . 0.0 111.037 -177.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.501 ' SG ' ' N ' ' A' ' 43' ' ' GLY . 16.4 p -143.3 161.94 45.14 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.402 -0.811 . . . . 0.0 110.229 -176.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.459 ' HD2' ' HB2' ' A' ' 40' ' ' CYS . 6.1 Cg_endo -53.0 -26.12 30.79 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.947 1.498 . . . . 0.0 110.779 -178.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.535 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -109.05 19.77 19.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.074 -1.016 . . . . 0.0 110.087 177.816 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.515 ' CA ' ' OG ' ' A' ' 38' ' ' SER . . . -77.81 -53.13 5.09 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 108.583 -1.807 . . . . 0.0 108.583 172.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 61.8 mttt -60.21 -40.05 88.76 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.301 -1.117 . . . . 0.0 110.354 176.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.428 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 9.5 tpp180 -94.99 -41.22 9.26 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.982 -1.074 . . . . 0.0 110.262 -177.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -67.04 -28.09 73.67 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 178.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.86 -4.46 54.53 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 177.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.439 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 51.4 t0 -173.95 70.96 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.266 -1.138 . . . . 0.0 109.135 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.506 ' CD1' ' CD2' ' A' ' 8' ' ' HIS . 7.5 mt -69.94 -27.73 64.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.445 -0.784 . . . . 0.0 110.66 -174.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.56 -145.28 16.14 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 -176.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.435 ' HG3' ' C ' ' A' ' 4' ' ' ALA . 59.5 tt0 -113.14 132.14 55.57 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.161 -1.199 . . . . 0.0 110.544 -177.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.483 ' CE2' ' HB3' ' A' ' 6' ' ' ALA . 1.9 p90 -136.83 161.95 34.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.34 -0.85 . . . . 0.0 109.768 177.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.511 ' O ' ' N ' ' A' ' 55' ' ' GLY . 82.8 mtp180 -69.25 57.2 0.11 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.942 -1.099 . . . . 0.0 111.155 -173.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.48 ' C ' ' O ' ' A' ' 53' ' ' ARG . 15.9 pt20 27.48 39.32 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.19 0 CA-C-O 121.037 0.446 . . . . 0.0 112.09 174.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . -175.7 53.77 0.12 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.476 ' NE2' ' HB2' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -155.72 -62.48 0.11 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.261 -1.141 . . . . 0.0 110.304 178.931 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 29.7 tpp -59.93 -41.11 91.08 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.164 -0.96 . . . . 0.0 110.818 -175.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.458 HG22 ' HD2' ' A' ' 59' ' ' PRO . 11.0 p -162.45 131.48 3.07 Favored Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.138 -0.976 . . . . 0.0 110.352 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.458 ' HD2' HG22 ' A' ' 58' ' ' VAL . 13.0 Cg_endo -60.41 -49.63 8.7 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.904 1.476 . . . . 0.0 110.245 178.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.412 ' O ' ' HB3' ' A' ' 63' ' ' LYS . . . -41.17 -34.29 0.45 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.48 -0.762 . . . . 0.0 110.399 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.47 ' O ' HG11 ' A' ' 64' ' ' VAL . 68.5 t80 -60.0 -39.99 87.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.114 -0.991 . . . . 0.0 110.005 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -59.92 -39.97 87.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.309 -0.87 . . . . 0.0 109.511 179.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 60' ' ' ALA . 87.7 tttt -57.49 -40.56 78.88 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.466 -0.771 . . . . 0.0 110.379 176.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.523 HG13 ' N ' ' A' ' 65' ' ' VAL . 14.3 p -91.77 -41.9 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.974 -1.079 . . . . 0.0 111.52 -173.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.523 ' N ' HG13 ' A' ' 64' ' ' VAL . 2.5 p -52.65 -27.16 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.53 -1.356 . . . . 0.0 109.805 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -99.83 5.66 45.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.172 -0.955 . . . . 0.0 109.88 176.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.465 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 37.5 t -99.61 -80.06 0.48 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.382 -0.824 . . . . 0.0 110.181 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 84.3 m -78.51 156.95 77.98 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.153 -0.967 . . . . 0.0 110.352 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.539 ' O ' ' O ' ' A' ' 70' ' ' VAL . 38.6 Cg_endo -79.07 69.78 7.78 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.069 1.562 . . . . 0.0 110.585 179.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.539 ' O ' ' O ' ' A' ' 69' ' ' PRO . 8.4 p 29.4 -174.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 178.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.533 ' CD1' HG13 ' A' ' 70' ' ' VAL . 0.0 OUTLIER 23.6 41.67 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.607 0 O-C-N 120.821 -1.174 . . . . 0.0 113.364 -164.139 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' A' ' 70' ' ' VAL . 9.7 tt0 -134.04 100.86 12.84 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.766 -1.209 . . . . 0.0 109.91 171.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.515 ' HB3' ' CZ ' ' A' ' 30' ' ' PHE . 50.9 Cg_exo -47.42 103.84 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.908 1.478 . . . . 0.0 110.38 -176.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.458 ' HB ' HG22 ' A' ' 64' ' ' VAL . 50.6 m -98.99 134.2 42.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.322 -0.861 . . . . 0.0 110.504 -177.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.458 ' HA3' HG13 ' A' ' 85' ' ' ILE . . . 135.78 -172.65 22.17 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 176.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.521 ' HG3' ' CB ' ' A' ' 17' ' ' ALA . 43.5 Cg_endo -70.13 127.95 12.11 Favored 'Cis proline' 0 N--CA 1.49 1.277 0 C-N-CA 121.798 -2.167 . . . . 0.0 110.292 2.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 62.3 tp -95.37 155.91 16.54 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.252 -0.905 . . . . 0.0 110.763 -174.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -71.41 123.97 23.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.335 -0.853 . . . . 0.0 110.514 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.582 HG22 ' CE1' ' A' ' 84' ' ' HIS . 12.9 t -140.12 156.11 46.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.205 -0.934 . . . . 0.0 109.727 174.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -60.12 -32.07 70.66 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.118 -0.989 . . . . 0.0 110.927 -175.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -75.68 -8.79 57.69 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.015 -1.053 . . . . 0.0 110.365 -178.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.504 ' O ' ' CG2' ' A' ' 79' ' ' THR . . . 138.34 -132.88 6.0 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 -175.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -107.86 125.78 51.88 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.092 -1.24 . . . . 0.0 110.1 175.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.582 ' CE1' HG22 ' A' ' 79' ' ' THR . 45.6 m170 -106.96 124.18 49.25 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.143 -0.973 . . . . 0.0 110.367 175.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.544 ' CG2' ' HB ' ' A' ' 9' ' ' ILE . 9.9 tt -108.54 125.47 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 118.719 -1.192 . . . . 0.0 109.398 168.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 86.0 mt -120.08 130.67 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.016 -1.052 . . . . 0.0 111.785 -167.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.577 ' HD3' ' CG ' ' A' ' 30' ' ' PHE . 13.5 mtmm -93.06 126.83 38.35 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.1 -1.0 . . . . 0.0 109.12 168.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.514 ' CG1' HG21 ' A' ' 70' ' ' VAL . 59.3 t -109.93 130.07 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.029 -1.044 . . . . 0.0 110.458 -175.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 91' ' ' ARG . 87.7 mt -139.71 -155.25 0.57 Allowed 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.272 -0.893 . . . . 0.0 110.109 -178.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.606 ' CD1' ' CB ' ' A' ' 5' ' ' ALA . 16.9 m-85 32.82 -89.0 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 O-C-N 122.104 -0.372 . . . . 0.0 111.268 -178.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.524 ' N ' ' O ' ' A' ' 89' ' ' LEU . 13.5 tpt180 59.55 46.82 11.58 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.878 -1.139 . . . . 0.0 110.62 177.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.6 p30 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.322 179.114 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.115 0.483 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 53' ' ' ARG . 24.6 mttm -59.98 -52.29 66.02 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.236 -0.915 . . . . 0.0 109.896 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 67.6 m -133.77 135.38 43.86 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.779 177.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.508 ' HA ' ' HA ' ' A' ' 91' ' ' ARG . . . -150.42 158.48 44.2 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.816 -1.178 . . . . 0.0 111.247 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.459 ' CA ' ' HG3' ' A' ' 51' ' ' GLU . . . -101.25 136.96 40.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.491 -0.755 . . . . 0.0 109.45 176.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.516 ' HB2' ' NE2' ' A' ' 8' ' ' HIS . . . -150.19 129.74 13.07 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.981 -1.075 . . . . 0.0 111.224 -177.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.497 ' CD2' ' HA ' ' A' ' 48' ' ' ASP . 72.6 mt -99.5 135.09 41.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.253 -0.904 . . . . 0.0 109.168 169.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.57 ' CD2' HG12 ' A' ' 86' ' ' ILE . 40.8 m170 -130.34 129.39 43.1 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.025 -1.047 . . . . 0.0 110.827 -176.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.538 ' HB ' ' CG2' ' A' ' 85' ' ' ILE . 84.6 mt -114.45 129.8 69.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.179 -0.951 . . . . 0.0 109.547 169.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.49 ' CD1' ' C ' ' A' ' 10' ' ' LEU . 1.8 tm? -106.8 114.92 29.31 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.291 -0.88 . . . . 0.0 110.138 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.523 ' CG1' ' HB3' ' A' ' 16' ' ' LEU . 2.3 t -101.3 128.97 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.312 -0.868 . . . . 0.0 109.925 177.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -67.33 -40.04 85.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.306 -0.871 . . . . 0.0 110.705 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -109.02 138.99 44.5 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.06 -1.025 . . . . 0.0 111.159 -174.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -60.09 -41.24 92.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.556 -0.715 . . . . 0.0 110.182 176.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -56.06 -43.76 78.22 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.257 -0.902 . . . . 0.0 109.848 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.523 ' HB3' ' CG1' ' A' ' 11' ' ' VAL . 3.2 tt -67.84 -36.02 79.6 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.342 -0.849 . . . . 0.0 109.5 177.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.454 ' HA ' ' HB3' ' A' ' 20' ' ' LEU . . . -57.52 -44.33 84.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.945 -1.097 . . . . 0.0 109.603 172.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.502 ' O ' HD13 ' A' ' 21' ' ' LEU . 0.1 OUTLIER -60.04 -39.95 87.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.204 -0.935 . . . . 0.0 109.901 173.159 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 16' ' ' LEU . 60.4 t0 -61.06 -40.83 95.16 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.677 -1.264 . . . . 0.0 109.101 171.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.55 ' C ' ' CD1' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -64.17 -80.69 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.551 -0.718 . . . . 0.0 110.445 179.826 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.54 HD12 ' N ' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -49.99 -20.01 0.84 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.21 -1.556 . . . . 0.0 110.497 -164.719 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.54 ' N ' HD12 ' A' ' 21' ' ' LEU . 50.2 tp10 -64.49 -39.99 94.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.682 -1.262 . . . . 0.0 110.189 173.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.42 ' N ' ' O ' ' A' ' 20' ' ' LEU . 85.4 mm-40 -60.44 -41.74 94.68 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.284 -0.885 . . . . 0.0 111.221 -172.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.52 ' O ' ' N ' ' A' ' 28' ' ' ALA . 1.7 mp -64.3 -43.67 97.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.016 -1.053 . . . . 0.0 110.768 -173.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -61.84 -50.05 73.82 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 120.775 -1.203 . . . . 0.0 110.164 178.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -63.26 -57.3 10.89 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.128 -0.983 . . . . 0.0 110.521 176.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.571 ' O ' ' CB ' ' A' ' 28' ' ' ALA . . . -104.53 -39.98 2.29 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -172.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.571 ' CB ' ' O ' ' A' ' 27' ' ' GLY . . . 82.99 -153.52 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.23 0 O-C-N 122.109 -0.642 . . . . 0.0 110.476 -179.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.486 ' HB2' ' O ' ' A' ' 28' ' ' ALA . 2.7 m-20 61.38 75.66 0.4 Allowed 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 122.082 0.944 . . . . 0.0 110.558 175.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.517 ' CZ ' HG13 ' A' ' 9' ' ' ILE . 62.8 t80 -59.97 -48.15 82.9 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.82 -0.55 . . . . 0.0 110.931 -178.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.0 -41.51 97.95 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -175.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.432 ' HD2' ' CG ' ' A' ' 29' ' ' ASP . 82.0 mttt -66.34 -39.94 89.54 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.042 -1.269 . . . . 0.0 110.194 -178.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.576 ' O ' ' CD2' ' A' ' 37' ' ' HIS . 49.1 mt -64.91 -40.07 94.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.066 -1.021 . . . . 0.0 110.206 178.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.486 ' O ' ' CB ' ' A' ' 38' ' ' SER . . . -59.57 -47.11 86.86 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.076 -1.015 . . . . 0.0 109.862 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -59.93 -40.9 90.46 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.032 -1.042 . . . . 0.0 110.431 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.8 mtpt -73.02 -52.08 15.76 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.013 -1.054 . . . . 0.0 111.764 -175.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.576 ' CD2' ' O ' ' A' ' 33' ' ' LEU . 7.4 p80 -106.01 -17.43 14.34 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.406 -1.434 . . . . 0.0 112.111 -167.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.525 ' O ' ' CG2' ' A' ' 39' ' ' ILE . 64.9 p -60.02 -50.06 75.22 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.621 -1.3 . . . . 0.0 110.301 -173.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.525 ' CG2' ' O ' ' A' ' 38' ' ' SER . 17.3 tt 38.34 31.2 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.692 -0.63 . . . . 0.0 110.466 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.51 ' SG ' ' N ' ' A' ' 43' ' ' GLY . 20.4 p -125.61 169.04 12.17 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.316 -0.865 . . . . 0.0 110.307 -176.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.456 ' HD2' ' HB2' ' A' ' 40' ' ' CYS . 41.0 Cg_exo -51.76 -34.61 55.1 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.893 1.47 . . . . 0.0 110.729 -175.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.535 ' O ' ' CA ' ' A' ' 46' ' ' GLY . 1.2 p -107.01 16.59 24.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.154 -0.966 . . . . 0.0 109.891 177.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.51 ' N ' ' SG ' ' A' ' 40' ' ' CYS . . . -79.98 -60.0 2.5 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 108.681 -1.768 . . . . 0.0 108.681 176.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -59.94 -40.37 88.73 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.424 -1.045 . . . . 0.0 110.488 176.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.442 ' HG3' HD22 ' A' ' 49' ' ' LEU . 17.0 tpt180 -104.95 -44.38 4.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.097 -1.002 . . . . 0.0 110.93 -175.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.535 ' CA ' ' O ' ' A' ' 42' ' ' SER . . . -62.37 -29.1 72.25 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.79 0.48 44.22 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 177.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.497 ' HA ' ' CD2' ' A' ' 7' ' ' LEU . 40.6 t0 -169.65 76.25 0.09 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.132 -1.217 . . . . 0.0 109.101 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.442 HD22 ' HG3' ' A' ' 45' ' ' ARG . 10.6 mt -91.28 -6.19 53.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.573 -0.704 . . . . 0.0 110.196 -175.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.95 -131.26 28.13 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 -173.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.477 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 54.8 mp0 -116.63 145.95 43.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.101 -1.235 . . . . 0.0 110.546 177.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.577 ' CE1' ' HG2' ' A' ' 57' ' ' MET . 0.3 OUTLIER -130.19 164.14 25.15 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.321 -0.862 . . . . 0.0 110.552 176.14 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 2' ' ' LYS . 87.7 mtt180 -108.7 -169.03 1.42 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.528 -0.732 . . . . 0.0 110.434 -175.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -61.22 -14.68 27.43 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.314 -0.866 . . . . 0.0 110.253 178.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.462 ' O ' ' OE1' ' A' ' 56' ' ' GLN . . . -87.77 25.65 8.31 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.044 -1.223 . . . . 0.0 110.044 -174.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.506 ' HG3' ' HB2' ' A' ' 52' ' ' PHE . 0.0 OUTLIER -167.52 -93.94 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.918 -1.343 . . . . 0.0 110.363 173.187 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.577 ' HG2' ' CE1' ' A' ' 52' ' ' PHE . 17.3 mtm 40.14 -166.66 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.397 -0.815 . . . . 0.0 110.709 -176.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.526 HG13 ' CB ' ' A' ' 61' ' ' PHE . 5.6 p -149.95 132.24 7.94 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.159 -0.963 . . . . 0.0 109.9 -177.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.474 ' HD2' HG23 ' A' ' 58' ' ' VAL . 9.1 Cg_exo -39.05 -49.17 2.87 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.917 1.483 . . . . 0.0 110.845 -175.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.55 -39.35 79.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -0.893 . . . . 0.0 110.216 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.526 ' CB ' HG13 ' A' ' 58' ' ' VAL . 59.5 t80 -59.92 -41.69 92.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.284 -0.885 . . . . 0.0 110.451 178.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -60.02 -47.24 86.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.232 -0.918 . . . . 0.0 109.878 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.459 ' O ' ' HB2' ' A' ' 67' ' ' SER . 96.9 mttt -59.88 -44.23 94.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.285 -0.885 . . . . 0.0 110.419 178.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.511 ' CG1' ' N ' ' A' ' 65' ' ' VAL . 6.2 p -83.57 -44.96 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.12 -0.987 . . . . 0.0 111.221 -172.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.511 ' N ' ' CG1' ' A' ' 64' ' ' VAL . 5.0 p -55.43 -24.3 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.206 -1.558 . . . . 0.0 109.142 172.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -92.86 -15.2 26.71 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.332 -0.855 . . . . 0.0 109.661 175.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.462 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 9.4 t -93.18 -47.61 6.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.378 -0.826 . . . . 0.0 109.936 175.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.514 ' CB ' ' OG1' ' A' ' 74' ' ' THR . 29.3 p -102.98 136.92 19.16 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.352 -0.843 . . . . 0.0 109.965 175.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -66.55 171.61 10.44 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.796 1.419 . . . . 0.0 110.261 178.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.473 ' CG1' ' HD3' ' A' ' 91' ' ' ARG . 12.7 m -57.69 171.41 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.372 -0.83 . . . . 0.0 110.422 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.461 HD12 HG21 ' A' ' 70' ' ' VAL . 4.3 mp 38.85 39.71 0.37 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.583 -0.698 . . . . 0.0 110.764 -177.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -137.78 83.98 23.04 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.162 -0.961 . . . . 0.0 110.01 177.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -50.08 124.87 13.55 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.027 1.541 . . . . 0.0 109.981 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.514 ' OG1' ' CB ' ' A' ' 68' ' ' CYS . 96.5 m -135.22 138.09 43.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.293 -0.879 . . . . 0.0 110.21 -177.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.455 ' HA3' HG13 ' A' ' 85' ' ' ILE . . . 147.92 -172.72 28.18 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -178.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -70.49 173.29 47.84 Favored 'Cis proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.77 -2.179 . . . . 0.0 110.59 -0.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.45 HD12 HG21 ' A' ' 64' ' ' VAL . 25.2 mt -133.57 175.33 9.52 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.243 -0.911 . . . . 0.0 110.224 -178.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -95.97 119.53 34.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.059 -1.026 . . . . 0.0 110.753 -175.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.418 HG22 ' O ' ' A' ' 82' ' ' GLY . 15.2 t -140.94 163.41 33.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.42 -0.8 . . . . 0.0 109.779 176.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -59.99 -39.99 87.64 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.979 -1.075 . . . . 0.0 110.437 -178.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -60.06 -18.38 46.23 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.222 -0.923 . . . . 0.0 110.451 179.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.418 ' O ' HG22 ' A' ' 79' ' ' THR . . . 134.1 -130.56 5.64 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 -177.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -93.06 121.06 34.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.085 -1.244 . . . . 0.0 110.245 177.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.415 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 1.0 OUTLIER -102.64 116.16 32.03 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.432 -0.793 . . . . 0.0 110.502 177.17 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.538 ' CG2' ' HB ' ' A' ' 9' ' ' ILE . 7.8 tt -108.62 126.28 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.86 -1.15 . . . . 0.0 109.427 170.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.57 HG12 ' CD2' ' A' ' 8' ' ' HIS . 89.5 mt -120.1 129.94 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.119 -0.988 . . . . 0.0 111.735 -167.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.476 ' HB3' ' HB2' ' A' ' 7' ' ' LEU . 27.8 tttt -101.08 129.84 47.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.225 -0.922 . . . . 0.0 109.165 169.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 18.0 t -100.82 139.98 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.075 -1.016 . . . . 0.0 110.414 -175.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' A' ' 91' ' ' ARG . 88.7 mt -141.68 170.15 16.27 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.434 ' C ' ' O ' ' A' ' 89' ' ' LEU . 77.8 m-85 33.37 -87.28 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 O-C-N 122.212 -0.305 . . . . 0.0 111.665 -178.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.533 ' N ' ' O ' ' A' ' 89' ' ' LEU . 1.8 ttp180 59.98 -159.9 0.3 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.7 -1.25 . . . . 0.0 109.502 -176.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.073 -1.017 . . . . 0.0 110.206 -179.532 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.465 ' CB ' ' HG2' ' A' ' 91' ' ' ARG . . . . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.105 0.479 . . . . 0.0 110.311 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.529 ' O ' ' CB ' ' A' ' 53' ' ' ARG . 88.1 tttt -59.96 -40.04 87.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.192 -0.942 . . . . 0.0 109.824 177.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.464 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 11.5 p -150.23 165.01 34.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.433 -0.792 . . . . 0.0 109.336 176.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.475 ' O ' ' HA ' ' A' ' 51' ' ' GLU . . . -127.8 150.56 49.77 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.86 -1.15 . . . . 0.0 109.954 176.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' ' 50' ' ' GLY . . . -89.71 121.63 32.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.32 -0.862 . . . . 0.0 109.62 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.552 ' HB3' ' CZ ' ' A' ' 52' ' ' PHE . . . -131.81 131.9 43.28 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 118.992 -1.083 . . . . 0.0 111.651 -169.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.469 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 85.7 mt -99.96 134.01 43.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.288 -0.882 . . . . 0.0 108.991 169.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.555 ' CD2' HG12 ' A' ' 86' ' ' ILE . 49.7 m170 -128.51 129.67 46.38 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.833 -1.167 . . . . 0.0 111.116 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.544 ' HB ' ' CG2' ' A' ' 85' ' ' ILE . 80.0 mt -116.69 128.65 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.07 -1.019 . . . . 0.0 109.718 169.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.472 HD22 ' N ' ' A' ' 11' ' ' VAL . 2.4 tm? -106.58 120.32 41.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.274 -0.891 . . . . 0.0 109.911 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.517 HG12 ' CD2' ' A' ' 16' ' ' LEU . 2.3 t -106.77 125.45 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.312 -0.867 . . . . 0.0 110.282 -178.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -70.03 -37.86 75.71 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.373 -0.829 . . . . 0.0 110.499 175.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -106.48 136.8 45.6 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.086 -1.009 . . . . 0.0 111.061 -173.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.568 ' HG2' ' CZ ' ' A' ' 83' ' ' TYR . 97.1 mt-10 -59.99 -39.99 87.62 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.356 -0.84 . . . . 0.0 110.294 175.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -56.24 -44.51 79.69 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -0.913 . . . . 0.0 110.035 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.517 ' CD2' HG12 ' A' ' 11' ' ' VAL . 7.9 tt -68.56 -39.93 80.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.296 -0.877 . . . . 0.0 109.935 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.521 ' O ' ' CD1' ' A' ' 21' ' ' LEU . . . -58.2 -41.85 84.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.178 -0.951 . . . . 0.0 109.384 176.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.407 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -60.04 -45.36 93.08 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.075 -1.016 . . . . 0.0 109.365 171.257 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.435 ' HB3' ' O ' ' A' ' 16' ' ' LEU . 55.1 t0 -60.03 -42.49 94.5 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.417 -0.802 . . . . 0.0 110.11 176.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.527 ' HG ' ' N ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -64.49 -47.05 80.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.237 -0.915 . . . . 0.0 109.523 178.09 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.527 ' N ' ' HG ' ' A' ' 20' ' ' LEU . 0.4 OUTLIER -56.53 -47.41 79.46 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.496 -0.753 . . . . 0.0 109.797 -178.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 18' ' ' LEU . 99.0 mt-10 -61.2 -39.65 91.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.55 -0.719 . . . . 0.0 110.141 177.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 50.4 tp60 -59.94 -47.19 86.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.281 -0.887 . . . . 0.0 110.817 -172.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.573 HG21 ' CE2' ' A' ' 30' ' ' PHE . 2.3 mt -66.48 -43.54 90.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.055 -1.028 . . . . 0.0 110.888 -176.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -61.3 -44.26 97.51 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.702 -1.249 . . . . 0.0 109.983 -178.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -60.8 -65.33 0.71 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.149 -0.969 . . . . 0.0 110.491 175.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.578 ' O ' ' CB ' ' A' ' 28' ' ' ALA . . . -105.86 -34.84 3.15 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -172.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.578 ' CB ' ' O ' ' A' ' 27' ' ' GLY . . . 87.09 -147.05 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.338 0 O-C-N 122.373 -0.486 . . . . 0.0 110.328 -178.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.535 ' CB ' ' O ' ' A' ' 28' ' ' ALA . 0.5 OUTLIER 75.91 65.35 0.06 Allowed 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.308 0.575 . . . . 0.0 110.523 176.324 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.573 ' CE2' HG21 ' A' ' 24' ' ' ILE . 7.2 m-85 -60.03 -41.91 93.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.355 -0.841 . . . . 0.0 110.572 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.23 -53.82 33.93 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.176 -1.169 . . . . 0.0 110.176 -176.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.422 ' HD2' ' CG ' ' A' ' 29' ' ' ASP . 97.9 mttt -66.5 -39.98 89.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.011 -1.288 . . . . 0.0 110.555 -174.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.402 HD13 ' O ' ' A' ' 28' ' ' ALA . 88.7 mt -63.81 -40.06 95.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.097 -1.002 . . . . 0.0 109.915 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.452 ' HB2' HG12 ' A' ' 9' ' ' ILE . . . -59.98 -47.71 84.7 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.403 -0.811 . . . . 0.0 110.323 177.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -60.09 -43.14 95.74 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.271 -0.893 . . . . 0.0 110.654 -176.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 49.2 tttt -69.31 -53.79 17.88 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.037 -1.039 . . . . 0.0 110.98 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -70.39 -40.03 74.17 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.054 -1.029 . . . . 0.0 111.535 -172.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.526 ' O ' ' CG2' ' A' ' 39' ' ' ILE . 21.0 t -60.0 -43.55 95.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.882 -1.136 . . . . 0.0 110.187 -174.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.526 ' CG2' ' O ' ' A' ' 38' ' ' SER . 16.8 tt 38.26 32.04 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.655 -0.653 . . . . 0.0 110.747 176.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.489 ' SG ' ' N ' ' A' ' 43' ' ' GLY . 16.3 p -127.42 166.38 23.42 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.055 -1.028 . . . . 0.0 110.379 -176.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -51.99 -35.69 61.91 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.993 1.522 . . . . 0.0 110.56 -178.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.53 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -97.64 18.75 14.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.983 -1.073 . . . . 0.0 109.743 174.544 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.489 ' N ' ' SG ' ' A' ' 40' ' ' CYS . . . -77.2 -54.26 4.83 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 108.303 -1.919 . . . . 0.0 108.303 172.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -60.86 -39.98 91.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.527 -0.984 . . . . 0.0 110.657 176.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.476 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 11.7 tpp180 -97.95 -45.21 6.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.177 -0.952 . . . . 0.0 110.154 -177.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -68.3 -30.3 73.48 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 178.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.41 -1.37 57.35 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 176.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -171.89 68.29 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.3 -1.118 . . . . 0.0 108.85 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 7.2 mt -70.03 -28.1 65.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.54 -0.725 . . . . 0.0 110.347 -174.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 5' ' ' ALA . . . 98.92 -144.18 17.05 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.351 -1.499 . . . . 0.0 109.351 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.475 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 3.5 mt-10 -99.54 130.78 45.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.528 -0.983 . . . . 0.0 110.571 -178.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.552 ' CZ ' ' HB3' ' A' ' 6' ' ' ALA . 3.3 p90 -149.02 168.41 23.2 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.241 -0.912 . . . . 0.0 110.875 178.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.529 ' CB ' ' O ' ' A' ' 2' ' ' LYS . 32.2 ttt85 -163.06 -65.18 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 173.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -68.88 136.7 53.04 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.488 -0.757 . . . . 0.0 109.655 169.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.486 ' C ' ' NE2' ' A' ' 56' ' ' GLN . . . 84.67 21.12 56.92 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 178.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.533 ' HG3' ' CD1' ' A' ' 52' ' ' PHE . 40.3 mm-40 -124.22 -64.05 1.15 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.048 -1.266 . . . . 0.0 109.763 177.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.558 ' O ' ' CG1' ' A' ' 58' ' ' VAL . 52.6 ttm 45.6 -107.13 0.13 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.78 -0.575 . . . . 0.0 110.874 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.558 ' CG1' ' O ' ' A' ' 57' ' ' MET . 7.2 p 45.41 127.51 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.551 0 CA-C-O 121.817 0.817 . . . . 0.0 113.079 -178.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.519 ' O ' ' N ' ' A' ' 62' ' ' ASP . 6.5 Cg_endo -51.69 -52.33 9.23 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 121.382 1.388 . . . . 0.0 110.997 -175.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 59' ' ' PRO . . . -42.01 -33.76 0.61 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.284 -0.885 . . . . 0.0 110.019 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.458 ' HB2' HG13 ' A' ' 58' ' ' VAL . 44.0 t80 -62.48 -39.75 94.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.334 -0.854 . . . . 0.0 110.028 177.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 59' ' ' PRO . 51.5 t0 -60.04 -40.0 87.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.34 -0.85 . . . . 0.0 110.536 -177.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 67' ' ' SER . 49.4 mttm -58.15 -48.49 80.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.093 -1.004 . . . . 0.0 111.434 -174.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.472 ' HA ' ' HB3' ' A' ' 67' ' ' SER . 2.4 p -94.73 -37.64 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.725 -1.235 . . . . 0.0 111.561 -173.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.2 p -54.82 -26.18 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.532 -1.355 . . . . 0.0 109.788 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.485 ' CD2' ' O ' ' A' ' 66' ' ' PHE . 50.7 t80 -100.68 0.05 38.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.315 -0.866 . . . . 0.0 110.127 176.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.476 ' HB2' ' O ' ' A' ' 63' ' ' LYS . 41.2 t -94.03 -74.58 0.53 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.263 -0.898 . . . . 0.0 110.37 -176.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.482 ' O ' ' N ' ' A' ' 70' ' ' VAL . 94.5 m -100.27 142.8 25.3 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.244 -0.91 . . . . 0.0 110.388 -178.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.501 ' O ' HD12 ' A' ' 71' ' ' LEU . 35.4 Cg_exo -56.47 81.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.053 1.554 . . . . 0.0 110.222 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.55 ' HA ' ' CG1' ' A' ' 88' ' ' VAL . 16.8 m 13.41 65.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.391 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.538 ' CD1' ' O ' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -166.95 -47.41 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.456 -0.778 . . . . 0.0 110.315 177.583 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -83.34 148.05 54.76 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.229 -0.92 . . . . 0.0 110.434 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -70.52 141.32 41.88 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.105 1.582 . . . . 0.0 110.622 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.445 ' HB ' ' CG2' ' A' ' 64' ' ' VAL . 94.5 m -138.01 137.8 38.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.25 -0.906 . . . . 0.0 110.189 178.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 140.89 -167.11 25.75 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.464 ' HD3' ' CD2' ' A' ' 21' ' ' LEU . 43.1 Cg_endo -72.1 140.6 66.84 Favored 'Cis proline' 0 C--N 1.315 -1.231 0 C-N-CA 121.783 -2.174 . . . . 0.0 110.586 1.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.464 HD13 HD13 ' A' ' 86' ' ' ILE . 96.2 mt -90.89 170.39 10.12 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.39 -0.819 . . . . 0.0 109.998 -177.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -106.82 123.67 48.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.857 -1.152 . . . . 0.0 110.898 -177.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.1 t -138.59 164.77 28.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.371 -0.83 . . . . 0.0 109.338 173.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -56.74 -39.76 74.53 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.941 -1.099 . . . . 0.0 110.253 -175.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -60.05 -26.98 66.56 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.183 -0.948 . . . . 0.0 110.535 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 149.26 -137.76 6.47 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -176.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.568 ' CZ ' ' HG2' ' A' ' 14' ' ' GLU . 66.3 m-85 -98.64 124.86 43.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.992 -1.299 . . . . 0.0 110.367 177.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.456 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 1.9 m170 -101.7 114.17 27.99 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.475 -0.766 . . . . 0.0 110.309 174.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.544 ' CG2' ' HB ' ' A' ' 9' ' ' ILE . 3.1 tt -102.05 118.84 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 120.761 -1.212 . . . . 0.0 109.408 170.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.555 HG12 ' CD2' ' A' ' 8' ' ' HIS . 96.1 mt -112.07 129.98 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.462 -0.774 . . . . 0.0 111.017 -172.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.469 ' HB3' ' HB2' ' A' ' 7' ' ' LEU . 10.5 ttmm -105.17 127.08 52.74 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.868 -1.145 . . . . 0.0 109.31 168.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.55 ' CG1' ' HA ' ' A' ' 70' ' ' VAL . 26.8 t -110.29 139.97 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.208 -0.933 . . . . 0.0 110.335 -173.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.529 ' CD2' ' O ' ' A' ' 88' ' ' VAL . 81.1 mt -148.9 177.15 9.81 Favored 'General case' 0 C--N 1.308 -1.203 0 O-C-N 121.336 -0.852 . . . . 0.0 109.402 -177.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.472 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER 67.49 -61.01 0.37 Allowed 'General case' 0 C--N 1.293 -1.859 0 O-C-N 121.422 -0.799 . . . . 0.0 111.389 167.23 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.472 ' HD2' HG23 ' A' ' 70' ' ' VAL . 61.7 ttt-85 54.85 40.08 31.79 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.04 -1.038 . . . . 0.0 110.567 -174.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.095 -1.003 . . . . 0.0 110.308 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.276 0.56 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.8 tttt -59.9 -40.0 87.31 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.235 -0.916 . . . . 0.0 110.052 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.454 ' O ' ' N ' ' A' ' 92' ' ' ASN . 67.4 p -139.69 156.53 46.76 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.366 -0.834 . . . . 0.0 110.262 177.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' A' ' 91' ' ' ARG . . . -138.56 143.44 39.42 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.192 -0.942 . . . . 0.0 110.264 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -94.53 130.32 40.98 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.315 -0.866 . . . . 0.0 109.145 173.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.579 ' HB2' ' CZ ' ' A' ' 52' ' ' PHE . . . -146.8 134.91 21.57 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.845 -1.159 . . . . 0.0 111.534 -171.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.503 ' C ' ' CD2' ' A' ' 8' ' ' HIS . 88.6 mt -107.35 149.88 27.34 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.298 -0.876 . . . . 0.0 109.581 173.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.64 ' CD2' ' CD1' ' A' ' 49' ' ' LEU . 21.2 m-70 -136.39 143.4 43.97 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.795 -1.19 . . . . 0.0 111.634 -176.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.527 HG12 ' CB ' ' A' ' 34' ' ' ALA . 91.1 mt -130.96 130.77 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.005 -1.059 . . . . 0.0 109.575 166.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.576 ' HG ' ' CD2' ' A' ' 84' ' ' HIS . 0.3 OUTLIER -104.72 119.96 40.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.428 -0.795 . . . . 0.0 110.053 179.782 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.451 HG23 HD21 ' A' ' 20' ' ' LEU . 2.5 t -105.04 126.6 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.17 -0.956 . . . . 0.0 110.266 178.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 26.2 mmtm -69.19 -40.01 78.33 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.479 -0.763 . . . . 0.0 110.32 177.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -109.32 140.54 42.86 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.217 -0.927 . . . . 0.0 110.918 -173.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -60.13 -47.46 85.81 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.409 -0.807 . . . . 0.0 110.36 175.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -59.35 -40.71 87.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.276 -0.89 . . . . 0.0 110.335 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.442 HD23 HG12 ' A' ' 11' ' ' VAL . 2.5 tt -67.84 -39.98 83.8 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.312 -0.867 . . . . 0.0 109.627 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.447 ' O ' ' CD1' ' A' ' 21' ' ' LEU . . . -59.02 -43.76 91.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -0.923 . . . . 0.0 109.815 175.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.487 ' HA ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -59.93 -43.1 95.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.192 -0.943 . . . . 0.0 109.942 175.299 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -60.01 -41.63 92.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.402 -0.811 . . . . 0.0 110.162 178.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.522 ' CD1' HD11 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -64.18 -46.09 85.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.161 -0.962 . . . . 0.0 109.825 178.666 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.543 ' CD1' ' CD ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -58.21 -50.03 75.0 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.329 -0.857 . . . . 0.0 110.428 -178.05 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -60.01 -36.93 78.27 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.213 -0.93 . . . . 0.0 110.261 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 52.8 tp60 -59.99 -40.01 87.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.189 -0.944 . . . . 0.0 110.374 -175.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.561 HD12 ' CZ ' ' A' ' 30' ' ' PHE . 3.9 mt -63.73 -41.96 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.112 -0.993 . . . . 0.0 110.715 -178.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -59.96 -45.69 91.86 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.824 -1.172 . . . . 0.0 109.565 176.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -59.78 -67.37 0.39 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.169 -0.957 . . . . 0.0 110.375 173.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.568 ' O ' ' CB ' ' A' ' 28' ' ' ALA . . . -106.54 -35.03 2.94 Favored Glycine 0 N--CA 1.487 2.067 0 C-N-CA 120.057 -1.068 . . . . 0.0 110.617 -170.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.568 ' CB ' ' O ' ' A' ' 27' ' ' GLY . . . 85.37 -156.91 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.402 0 O-C-N 122.001 -0.705 . . . . 0.0 110.196 -174.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.552 ' CB ' ' O ' ' A' ' 28' ' ' ALA . 0.7 OUTLIER 78.7 71.59 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 CA-C-O 121.487 0.66 . . . . 0.0 110.563 176.865 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.561 ' CZ ' HD12 ' A' ' 24' ' ' ILE . 1.7 m-85 -62.43 -42.21 99.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.203 -0.935 . . . . 0.0 110.664 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.29 -44.4 97.54 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 -176.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.6 mmtt -63.79 -39.96 95.51 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.162 -1.199 . . . . 0.0 110.082 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.559 ' CD1' HG13 ' A' ' 24' ' ' ILE . 85.9 mt -62.55 -39.92 95.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.107 -0.995 . . . . 0.0 110.355 176.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.527 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -58.17 -48.65 79.62 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.095 -1.003 . . . . 0.0 110.186 -178.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -59.24 -49.08 79.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.281 -0.887 . . . . 0.0 110.159 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -70.0 -43.04 72.22 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.297 -0.877 . . . . 0.0 111.473 -176.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -80.07 -49.99 10.98 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.031 -1.043 . . . . 0.0 111.217 -173.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.531 ' O ' ' CG2' ' A' ' 39' ' ' ILE . 54.1 m -60.12 -39.91 87.89 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.053 -1.029 . . . . 0.0 111.064 -172.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.531 ' CG2' ' O ' ' A' ' 38' ' ' SER . 10.9 tp 39.02 28.95 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.528 -0.733 . . . . 0.0 110.375 -178.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.469 ' N ' ' O ' ' A' ' 38' ' ' SER . 17.5 p -122.8 160.16 50.29 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.328 -0.857 . . . . 0.0 109.823 -178.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -52.68 -20.68 12.99 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.84 1.442 . . . . 0.0 110.42 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.525 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -106.58 16.41 24.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.181 -0.949 . . . . 0.0 110.205 176.885 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.49 -51.41 5.61 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.611 -1.796 . . . . 0.0 108.611 172.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.468 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 48.5 tttp -60.02 -39.99 87.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.423 -1.045 . . . . 0.0 110.259 177.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.473 ' HA ' ' OD1' ' A' ' 48' ' ' ASP . 20.7 tpt180 -96.68 -42.05 8.21 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.369 -0.832 . . . . 0.0 110.479 -177.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -63.25 -28.98 73.12 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.94 0.16 53.13 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 176.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.473 ' OD1' ' HA ' ' A' ' 45' ' ' ARG . 43.8 p-10 -170.15 62.75 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.249 -1.147 . . . . 0.0 109.183 -177.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.64 ' CD1' ' CD2' ' A' ' 8' ' ' HIS . 10.3 mt -69.98 -29.23 66.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.398 -0.814 . . . . 0.0 110.749 -175.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.21 -145.06 17.49 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -178.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -112.27 136.38 51.77 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.19 -1.182 . . . . 0.0 110.217 -178.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.579 ' CZ ' ' HB2' ' A' ' 6' ' ' ALA . 0.1 OUTLIER -133.79 -166.1 1.73 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.299 -0.876 . . . . 0.0 109.705 174.411 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.464 ' O ' ' HB3' ' A' ' 54' ' ' GLN . 95.9 mtt-85 -65.0 -40.31 94.74 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.845 -1.159 . . . . 0.0 109.865 -178.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.507 ' O ' ' CE2' ' A' ' 61' ' ' PHE . 14.1 pt20 -178.1 30.14 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.474 -0.766 . . . . 0.0 110.302 177.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.48 ' O ' ' CB ' ' A' ' 56' ' ' GLN . . . 117.81 -69.58 0.31 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.528 ' NE2' ' HB2' ' A' ' 52' ' ' PHE . 12.8 mt-30 68.93 -56.27 0.53 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.407 -1.054 . . . . 0.0 109.949 175.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.412 ' HE2' HD12 ' A' ' 49' ' ' LEU . 59.2 ttp -55.11 -43.44 74.05 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.75 -0.594 . . . . 0.0 110.941 -176.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.464 HG23 ' HD2' ' A' ' 59' ' ' PRO . 15.0 p -141.92 132.24 12.76 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.142 -0.974 . . . . 0.0 110.286 -175.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.464 ' HD2' HG23 ' A' ' 58' ' ' VAL . 12.4 Cg_endo -60.92 -49.67 7.83 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.879 1.462 . . . . 0.0 110.408 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -44.8 -29.43 0.79 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.24 -0.912 . . . . 0.0 110.574 -179.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.507 ' CE2' ' O ' ' A' ' 54' ' ' GLN . 59.4 t80 -60.01 -44.29 94.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.082 -1.011 . . . . 0.0 110.177 178.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -59.93 -42.0 93.02 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.05 -1.031 . . . . 0.0 109.549 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.493 ' O ' ' N ' ' A' ' 67' ' ' SER . 93.4 mttt -60.02 -47.42 85.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.512 -0.743 . . . . 0.0 111.011 -178.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.503 HG11 ' N ' ' A' ' 65' ' ' VAL . 10.3 p -73.02 -46.57 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 120.872 -1.143 . . . . 0.0 110.98 -175.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.503 ' N ' HG11 ' A' ' 64' ' ' VAL . 9.8 p -60.2 -22.05 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.208 -1.558 . . . . 0.0 109.662 170.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -90.41 -13.62 34.59 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.85 -1.156 . . . . 0.0 109.366 171.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.493 ' N ' ' O ' ' A' ' 63' ' ' LYS . 12.4 t -87.5 -61.85 1.63 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.464 -0.773 . . . . 0.0 108.917 172.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.474 ' O ' ' O ' ' A' ' 65' ' ' VAL . 31.3 p -82.5 133.31 50.09 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 120.876 -1.14 . . . . 0.0 109.087 167.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.507 ' O ' ' NH1' ' A' ' 91' ' ' ARG . 41.3 Cg_exo -52.28 -68.66 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.713 1.375 . . . . 0.0 110.671 -174.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.536 HG21 ' CD1' ' A' ' 71' ' ' LEU . 7.6 p -179.01 162.16 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -177.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.536 ' CD1' HG21 ' A' ' 70' ' ' VAL . 3.3 mp 42.76 32.96 0.43 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.897 -1.127 . . . . 0.0 109.946 -170.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.487 ' CG ' ' O ' ' A' ' 70' ' ' VAL . 8.4 mm-40 -130.9 79.98 70.49 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.667 -0.646 . . . . 0.0 109.918 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -47.07 126.64 11.63 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 123.859 1.452 . . . . 0.0 110.012 -178.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.401 ' OG1' ' HB3' ' A' ' 68' ' ' CYS . 70.7 m -135.38 139.37 44.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.182 -0.949 . . . . 0.0 110.432 -176.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.94 -170.82 25.13 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.543 ' CD ' ' CD1' ' A' ' 21' ' ' LEU . 42.0 Cg_endo -69.53 136.46 38.39 Favored 'Cis proline' 0 C--N 1.314 -1.262 0 C-N-CA 121.767 -2.18 . . . . 0.0 110.455 0.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.453 HD11 ' HB ' ' A' ' 64' ' ' VAL . 1.0 OUTLIER -95.29 142.69 27.4 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.221 -0.924 . . . . 0.0 110.433 -175.017 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -64.75 130.06 42.12 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.107 -0.995 . . . . 0.0 110.633 -176.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.574 HG22 ' CE1' ' A' ' 84' ' ' HIS . 9.5 t -144.66 160.24 41.51 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.283 -0.886 . . . . 0.0 110.375 178.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.568 ' HG3' ' CD2' ' A' ' 81' ' ' PHE . 20.1 pt20 -63.06 -16.22 59.19 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.263 -0.898 . . . . 0.0 110.879 -177.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.568 ' CD2' ' HG3' ' A' ' 80' ' ' GLN . 98.4 m-85 -95.01 6.27 49.56 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.003 -1.061 . . . . 0.0 110.457 -178.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 126.39 -115.4 2.26 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 -175.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.44 ' HB3' ' HB2' ' A' ' 76' ' ' PRO . 69.2 m-85 -140.41 126.97 20.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.09 -1.241 . . . . 0.0 110.287 175.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.576 ' CD2' ' HG ' ' A' ' 10' ' ' LEU . 42.1 m170 -103.31 127.57 50.61 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.522 -0.736 . . . . 0.0 110.676 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.522 ' CG2' ' HB ' ' A' ' 9' ' ' ILE . 8.4 tt -109.15 129.59 63.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 120.605 -1.309 . . . . 0.0 109.065 166.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.54 HG22 ' CE1' ' A' ' 8' ' ' HIS . 72.2 mt -130.18 135.1 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.015 -1.053 . . . . 0.0 110.701 -169.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 6' ' ' ALA . 12.5 mtpt -97.91 139.16 34.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.45 -0.781 . . . . 0.0 109.58 176.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 28.0 t -109.74 137.47 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.473 -0.767 . . . . 0.0 110.146 -178.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.526 ' HB3' ' CD2' ' A' ' 90' ' ' TYR . 92.3 mt -144.34 135.79 25.64 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.064 -1.022 . . . . 0.0 109.551 178.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.526 ' CD2' ' HB3' ' A' ' 89' ' ' LEU . 70.9 m-85 65.31 -63.42 0.2 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.332 -0.855 . . . . 0.0 111.076 177.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.507 ' NH1' ' O ' ' A' ' 69' ' ' PRO . 33.7 ttp180 49.95 38.65 16.8 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.049 -1.032 . . . . 0.0 110.214 -175.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.454 ' N ' ' O ' ' A' ' 3' ' ' THR . 7.1 t-20 . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 117.965 -1.017 . . . . 0.0 110.229 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.265 0.555 . . . . 0.0 110.243 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -66.43 -39.97 89.24 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.887 0.851 . . . . 0.0 109.807 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.6 t -159.49 155.46 26.5 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.972 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.54 ' O ' ' CD1' ' A' ' 52' ' ' PHE . . . -151.45 154.81 37.31 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.107 -0.995 . . . . 0.0 110.623 -174.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.418 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -101.32 140.0 36.22 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.009 -1.057 . . . . 0.0 109.14 171.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.515 ' HB2' ' NE2' ' A' ' 8' ' ' HIS . . . -159.04 154.55 25.9 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.859 -1.151 . . . . 0.0 111.29 -178.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 82.2 mt -109.91 149.99 29.09 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.434 -0.791 . . . . 0.0 109.142 172.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.581 ' CD2' ' CD1' ' A' ' 49' ' ' LEU . 46.5 m-70 -137.2 133.55 35.29 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.789 -1.194 . . . . 0.0 111.383 -177.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.536 ' HB ' ' CG2' ' A' ' 85' ' ' ILE . 87.3 mt -120.01 120.99 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.113 -0.992 . . . . 0.0 109.605 168.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.516 HD21 ' CD2' ' A' ' 84' ' ' HIS . 2.7 tm? -104.07 120.08 40.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.477 -0.765 . . . . 0.0 109.817 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.529 ' CG1' HD21 ' A' ' 16' ' ' LEU . 2.4 t -103.81 130.08 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.29 -0.881 . . . . 0.0 110.346 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -65.93 -40.08 91.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.459 -0.776 . . . . 0.0 110.551 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -119.54 140.02 51.2 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.126 -0.984 . . . . 0.0 110.531 -175.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.464 ' HB2' ' CE1' ' A' ' 83' ' ' TYR . 86.8 tt0 -59.91 -39.99 87.32 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.372 -0.83 . . . . 0.0 110.352 -178.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.6 mttt -52.46 -47.42 66.48 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.188 -0.945 . . . . 0.0 110.069 -176.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.529 HD21 ' CG1' ' A' ' 11' ' ' VAL . 8.4 tt -68.71 -37.07 79.22 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.104 -0.997 . . . . 0.0 109.546 176.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.507 ' N ' HG12 ' A' ' 11' ' ' VAL . . . -56.94 -49.29 76.1 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.042 -1.036 . . . . 0.0 109.522 176.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.471 ' HA ' HD12 ' A' ' 21' ' ' LEU . 0.9 OUTLIER -58.31 -40.44 82.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.15 -0.969 . . . . 0.0 109.579 174.573 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.475 ' HB3' ' O ' ' A' ' 16' ' ' LEU . 51.5 t0 -60.0 -39.98 87.66 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.096 -1.002 . . . . 0.0 109.671 174.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.547 ' HG ' ' N ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -62.91 -44.27 96.55 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.16 -0.963 . . . . 0.0 109.668 178.125 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.547 ' N ' ' HG ' ' A' ' 20' ' ' LEU . 1.3 mt -59.9 -50.14 74.93 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.381 -0.824 . . . . 0.0 110.07 -178.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -62.87 -39.92 95.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.314 -0.867 . . . . 0.0 110.247 177.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.462 ' O ' ' N ' ' A' ' 27' ' ' GLY . 64.9 tp60 -60.07 -40.95 91.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.305 -0.872 . . . . 0.0 110.311 -177.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.517 ' O ' ' N ' ' A' ' 28' ' ' ALA . 85.5 mt -67.32 -40.35 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.179 -0.95 . . . . 0.0 109.795 177.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -63.85 -59.96 3.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.139 -0.976 . . . . 0.0 109.598 176.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -60.32 -52.37 65.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.438 -0.789 . . . . 0.0 110.866 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 28' ' ' ALA . . . -106.18 -13.0 24.21 Favored Glycine 0 N--CA 1.487 2.041 0 C-N-CA 119.647 -1.263 . . . . 0.0 110.597 -166.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 24' ' ' ILE . . . 34.1 95.37 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.751 -0.853 . . . . 0.0 111.459 -177.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -171.68 86.35 0.09 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.466 -0.771 . . . . 0.0 109.827 -176.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.471 ' CG ' ' HE3' ' A' ' 87' ' ' LYS . 3.9 m-85 -69.8 -40.12 76.18 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.325 -0.859 . . . . 0.0 110.764 -176.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.36 -52.08 53.81 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -63.73 -41.1 98.12 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.185 -1.185 . . . . 0.0 110.513 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.523 HD22 ' CD1' ' A' ' 20' ' ' LEU . 33.0 tp -61.74 -50.06 73.91 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.074 -1.016 . . . . 0.0 110.716 -175.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.521 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -59.95 -47.88 83.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.198 -0.939 . . . . 0.0 110.383 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 50.3 mttm -60.02 -49.78 76.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.212 -0.93 . . . . 0.0 110.592 -176.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.445 ' O ' HG13 ' A' ' 39' ' ' ILE . 57.2 tptt -69.72 -52.5 24.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.156 -0.965 . . . . 0.0 111.235 -175.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -83.21 -40.28 19.85 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.913 -1.117 . . . . 0.0 111.583 -170.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.47 ' O ' ' C ' ' A' ' 39' ' ' ILE . 18.4 t -60.01 -45.2 93.54 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.973 -1.08 . . . . 0.0 110.443 -176.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.47 ' C ' ' O ' ' A' ' 38' ' ' SER . 80.2 mt 34.14 45.76 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 CA-C-O 121.322 0.582 . . . . 0.0 110.769 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.512 ' SG ' ' N ' ' A' ' 43' ' ' GLY . 17.2 p -133.91 160.04 70.09 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.254 -0.904 . . . . 0.0 110.093 -177.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.41 ' HD2' ' HB2' ' A' ' 40' ' ' CYS . 6.7 Cg_endo -54.02 -23.8 29.88 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.962 1.506 . . . . 0.0 110.522 -177.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.511 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -109.12 20.54 18.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.085 -1.009 . . . . 0.0 110.084 176.902 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.512 ' N ' ' SG ' ' A' ' 40' ' ' CYS . . . -79.11 -59.65 2.7 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 176.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -60.02 -33.91 72.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.41 -1.053 . . . . 0.0 110.39 176.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.448 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 16.0 tpt180 -91.57 -39.73 11.74 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.109 -0.994 . . . . 0.0 110.158 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -70.75 -29.02 69.9 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 177.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.97 0.54 58.06 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 173.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -168.76 63.34 0.06 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.291 -1.123 . . . . 0.0 109.134 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.581 ' CD1' ' CD2' ' A' ' 8' ' ' HIS . 12.7 mt -70.12 -28.89 65.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.599 -0.688 . . . . 0.0 110.155 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.27 -136.02 12.69 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.231 -1.547 . . . . 0.0 109.231 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -113.66 148.16 36.82 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.382 -1.069 . . . . 0.0 110.171 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.54 ' CD1' ' O ' ' A' ' 4' ' ' ALA . 0.0 OUTLIER -131.45 160.41 35.23 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.205 -0.934 . . . . 0.0 109.879 -172.382 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.543 ' O ' ' N ' ' A' ' 55' ' ' GLY . 36.5 ptt-85 -154.54 176.87 11.85 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.297 -0.877 . . . . 0.0 110.468 -173.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.495 ' O ' ' O ' ' A' ' 55' ' ' GLY . 87.2 mt-30 27.18 -84.16 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.274 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . -55.13 -117.7 0.01 OUTLIER Glycine 0 N--CA 1.495 2.614 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -175.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.483 ' OE1' ' HB3' ' A' ' 52' ' ' PHE . 44.3 mm-40 65.99 -65.4 0.18 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.137 -1.214 . . . . 0.0 109.944 -176.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.523 ' N ' ' O ' ' A' ' 55' ' ' GLY . 37.5 ttp 65.29 -56.47 0.31 Allowed 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.861 172.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.469 ' N ' ' O ' ' A' ' 56' ' ' GLN . 2.0 p -42.94 137.95 2.45 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 120.821 -1.175 . . . . 0.0 110.426 -169.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.443 ' HD2' HG23 ' A' ' 58' ' ' VAL . 32.9 Cg_endo -70.28 -55.01 0.17 Allowed 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.126 1.593 . . . . 0.0 111.059 -173.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 59' ' ' PRO . . . -42.67 -34.64 0.93 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.116 -0.99 . . . . 0.0 110.469 -174.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.434 ' CE2' ' CE1' ' A' ' 52' ' ' PHE . 56.1 t80 -60.0 -44.07 94.79 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.233 -0.917 . . . . 0.0 110.092 -179.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.522 ' OD1' ' CD1' ' A' ' 66' ' ' PHE . 56.5 t0 -68.31 -45.26 73.48 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.295 -0.878 . . . . 0.0 110.553 -178.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' A' ' 67' ' ' SER . 11.3 tptt -56.36 -50.15 72.37 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.031 -1.043 . . . . 0.0 110.269 -176.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.461 ' HA ' ' HB3' ' A' ' 67' ' ' SER . 5.8 p -69.5 -46.73 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.089 -1.007 . . . . 0.0 111.443 -173.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.508 HG11 ' CD1' ' A' ' 66' ' ' PHE . 6.8 p -58.15 -26.14 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.297 -1.502 . . . . 0.0 109.468 173.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.522 ' CD1' ' OD1' ' A' ' 62' ' ' ASP . 17.4 m-85 -96.2 -1.78 47.59 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.21 -0.931 . . . . 0.0 110.148 174.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' ' 63' ' ' LYS . 9.4 t -97.41 -59.03 1.87 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.348 -0.845 . . . . 0.0 109.67 173.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.458 ' HB3' ' OG1' ' A' ' 74' ' ' THR . 23.0 p -107.08 147.72 35.66 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.4 -0.813 . . . . 0.0 110.146 177.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -71.68 171.27 16.74 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 124.046 1.551 . . . . 0.0 110.682 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.531 HG21 ' N ' ' A' ' 71' ' ' LEU . 7.1 p -58.7 158.6 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.465 -0.772 . . . . 0.0 110.145 178.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.531 ' N ' HG21 ' A' ' 70' ' ' VAL . 3.2 mp 56.75 39.55 29.59 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.195 -0.941 . . . . 0.0 110.0 -175.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.419 ' C ' ' OE1' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -148.36 93.63 4.34 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.366 -0.834 . . . . 0.0 110.115 -179.907 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -63.15 130.52 29.13 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.981 1.516 . . . . 0.0 110.164 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.458 ' OG1' ' HB3' ' A' ' 68' ' ' CYS . 33.3 m -135.88 140.49 44.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.288 -0.882 . . . . 0.0 110.415 -178.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 149.16 -169.83 29.51 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.219 -1.553 . . . . 0.0 109.219 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.528 ' HD3' ' CD2' ' A' ' 21' ' ' LEU . 46.7 Cg_endo -76.03 136.36 44.24 Favored 'Cis proline' 0 C--N 1.313 -1.329 0 C-N-CA 121.825 -2.156 . . . . 0.0 110.663 -1.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 41.2 mt -93.36 -173.22 3.16 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.319 -0.863 . . . . 0.0 109.962 178.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -111.74 121.22 44.49 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.997 -1.064 . . . . 0.0 111.306 -173.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.45 HG21 ' CG ' ' A' ' 84' ' ' HIS . 9.8 t -138.06 164.28 29.48 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.274 -0.891 . . . . 0.0 109.438 170.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -54.92 -36.53 65.33 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.141 -0.975 . . . . 0.0 110.618 -175.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -63.13 -30.37 71.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.062 -1.024 . . . . 0.0 110.78 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 152.07 -135.58 5.06 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -177.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.464 ' O ' HD22 ' A' ' 10' ' ' LEU . 39.0 m-85 -93.98 131.12 39.76 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.35 -1.088 . . . . 0.0 109.96 177.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.516 ' CD2' HD21 ' A' ' 10' ' ' LEU . 0.1 OUTLIER -111.93 113.25 25.45 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.432 -0.792 . . . . 0.0 110.999 -178.863 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.536 ' CG2' ' HB ' ' A' ' 9' ' ' ILE . 4.5 tt -110.03 132.46 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.881 -1.137 . . . . 0.0 109.117 169.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.542 HG22 ' CE1' ' A' ' 8' ' ' HIS . 89.1 mt -135.98 140.12 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.598 -1.314 . . . . 0.0 111.899 -168.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.471 ' HE3' ' CG ' ' A' ' 30' ' ' PHE . 15.1 mttm -92.65 142.26 27.56 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.387 -0.821 . . . . 0.0 110.038 170.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.484 ' CG1' ' HD3' ' A' ' 91' ' ' ARG . 59.7 t -109.72 133.69 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.768 -0.582 . . . . 0.0 109.983 178.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.493 ' O ' ' HB2' ' A' ' 90' ' ' TYR . 81.0 mt -141.89 129.09 20.99 Favored 'General case' 0 C--N 1.308 -1.2 0 O-C-N 121.005 -1.059 . . . . 0.0 109.947 -176.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.493 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 42.2 m-85 65.29 -55.29 0.32 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.228 -0.92 . . . . 0.0 111.587 173.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.517 ' NE ' ' HB ' ' A' ' 70' ' ' VAL . 84.6 mtm180 56.27 40.23 29.98 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.037 -1.04 . . . . 0.0 110.894 -177.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 91' ' ' ARG . 3.6 t-20 . . . . . 0 N--CA 1.492 1.649 0 O-C-N 120.967 -1.083 . . . . 0.0 110.272 177.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 91' ' ' ARG . . . . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.196 0.522 . . . . 0.0 110.24 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 58.0 mmtt -61.8 -40.14 94.17 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.298 -0.876 . . . . 0.0 110.251 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.53 HG21 ' CB ' ' A' ' 53' ' ' ARG . 14.8 p -143.16 162.77 34.71 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.391 -0.818 . . . . 0.0 109.596 -178.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.433 ' C ' ' HG3' ' A' ' 51' ' ' GLU . . . -149.96 153.61 36.88 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.839 -1.163 . . . . 0.0 111.029 -178.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.446 ' HB1' ' HB2' ' A' ' 90' ' ' TYR . . . -96.69 131.46 43.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.424 -0.798 . . . . 0.0 109.253 174.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.576 ' CB ' ' NE2' ' A' ' 8' ' ' HIS . . . -147.41 122.73 10.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.834 -1.166 . . . . 0.0 111.688 -172.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.593 ' N ' ' CD1' ' A' ' 7' ' ' LEU . 3.5 mp -97.07 141.16 30.55 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.173 -0.954 . . . . 0.0 109.283 170.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.576 ' NE2' ' CB ' ' A' ' 6' ' ' ALA . 25.8 m-70 -134.54 128.17 32.78 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.887 -1.133 . . . . 0.0 110.947 -175.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.532 ' HB ' ' CG2' ' A' ' 85' ' ' ILE . 76.4 mt -109.96 129.96 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 120.882 -1.136 . . . . 0.0 110.136 168.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.583 ' HG ' ' CD2' ' A' ' 84' ' ' HIS . 0.3 OUTLIER -101.68 118.61 37.3 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.552 -0.717 . . . . 0.0 109.711 178.648 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.479 HG11 ' O ' ' A' ' 13' ' ' GLU . 2.0 t -101.48 127.21 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.243 -0.911 . . . . 0.0 110.125 -177.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.1 mttp -69.28 -40.01 78.0 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.308 -0.87 . . . . 0.0 110.313 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.479 ' O ' HG11 ' A' ' 11' ' ' VAL . 14.5 pt-20 -132.52 152.21 51.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.295 -0.878 . . . . 0.0 110.26 -178.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.508 ' HG3' ' CZ ' ' A' ' 83' ' ' TYR . 95.2 mt-10 -59.04 -39.9 83.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.29 -0.881 . . . . 0.0 110.409 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -51.31 -44.62 61.97 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.191 -0.943 . . . . 0.0 110.34 -176.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.475 HD23 HG12 ' A' ' 11' ' ' VAL . 9.7 tt -68.89 -40.0 79.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.044 -1.035 . . . . 0.0 109.715 177.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.461 ' O ' HD13 ' A' ' 21' ' ' LEU . . . -59.87 -44.43 94.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.307 -0.871 . . . . 0.0 110.14 177.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.85 -45.8 89.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.218 -0.926 . . . . 0.0 109.819 178.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 23' ' ' GLN . 53.1 t0 -60.03 -42.2 93.86 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.345 -0.847 . . . . 0.0 110.187 177.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.522 ' CD1' HD13 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -66.47 -43.56 85.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.147 -0.97 . . . . 0.0 110.047 -179.711 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.521 ' N ' ' HG ' ' A' ' 20' ' ' LEU . 0.3 OUTLIER -55.26 -59.93 4.1 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.38 -0.825 . . . . 0.0 110.072 -177.869 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -63.9 -40.0 95.48 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.394 -0.816 . . . . 0.0 110.707 177.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.569 ' NE2' ' CD2' ' A' ' 33' ' ' LEU . 62.2 tt0 -60.11 -29.49 68.64 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.118 -0.989 . . . . 0.0 110.185 -176.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.533 ' O ' ' CA ' ' A' ' 28' ' ' ALA . 91.6 mt -68.2 -40.01 82.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 120.687 -1.258 . . . . 0.0 109.606 173.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.4 tttp -66.69 -60.09 3.01 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.097 -1.002 . . . . 0.0 110.696 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.55 ' OD1' ' N ' ' A' ' 27' ' ' GLY . 47.3 p30 -62.16 -33.68 74.96 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.105 -0.997 . . . . 0.0 110.501 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.575 ' O ' ' CB ' ' A' ' 28' ' ' ALA . . . -106.23 -65.3 0.63 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.575 ' CB ' ' O ' ' A' ' 27' ' ' GLY . . . 85.58 95.51 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.254 0 CA-C-O 121.624 0.725 . . . . 0.0 110.615 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -177.1 80.01 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.61 -0.681 . . . . 0.0 109.651 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.558 ' CG ' ' HE2' ' A' ' 87' ' ' LYS . 5.5 m-85 -60.1 -47.77 84.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.876 . . . . 0.0 110.903 -174.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.05 -50.33 68.8 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 119.715 -1.231 . . . . 0.0 110.045 -176.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -66.6 -40.04 88.66 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.131 -1.217 . . . . 0.0 110.78 -175.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.569 ' CD2' ' NE2' ' A' ' 23' ' ' GLN . 83.8 mt -66.3 -40.19 89.84 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.164 -0.96 . . . . 0.0 110.562 -178.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.515 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -60.06 -50.03 75.34 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.049 -1.032 . . . . 0.0 110.198 177.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -60.02 -49.95 75.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.229 -0.919 . . . . 0.0 111.158 -177.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.0 tttp -70.08 -45.17 67.6 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.005 -1.06 . . . . 0.0 111.165 -172.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -81.61 -32.02 32.19 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.101 -1.0 . . . . 0.0 110.832 -174.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.49 ' CB ' ' O ' ' A' ' 34' ' ' ALA . 27.5 t -60.19 -44.92 94.71 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.121 -0.987 . . . . 0.0 111.31 -173.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.41 ' C ' ' O ' ' A' ' 38' ' ' SER . 73.6 mt 44.69 25.93 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 120.904 -1.122 . . . . 0.0 109.762 -173.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.456 ' SG ' ' HD2' ' A' ' 41' ' ' PRO . 35.8 t -117.43 143.27 31.76 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.391 -0.818 . . . . 0.0 109.943 -178.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.456 ' HD2' ' SG ' ' A' ' 40' ' ' CYS . 52.7 Cg_exo -49.21 -20.92 3.85 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.849 1.447 . . . . 0.0 110.655 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.514 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -109.12 19.92 18.94 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.182 -0.949 . . . . 0.0 109.81 176.877 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' A' ' 47' ' ' GLY . . . -75.05 -59.46 3.65 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 174.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -60.05 -39.97 87.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.389 -1.066 . . . . 0.0 110.573 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -94.14 -42.3 9.06 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.924 -1.11 . . . . 0.0 110.413 -176.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -70.6 -24.52 76.8 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 174.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 43' ' ' GLY . . . -74.4 -1.0 59.76 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 173.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.444 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 49.0 t0 -173.06 70.29 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.352 -1.087 . . . . 0.0 109.122 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.465 ' HG ' ' HA2' ' A' ' 46' ' ' GLY . 11.9 mt -72.47 -6.59 44.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.633 -0.667 . . . . 0.0 110.156 -176.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.55 -121.9 6.2 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -176.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.433 ' HG3' ' C ' ' A' ' 4' ' ' ALA . 71.3 tt0 -126.92 140.21 52.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.231 -1.158 . . . . 0.0 110.412 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.574 ' CE2' ' HB1' ' A' ' 6' ' ' ALA . 2.4 p90 -142.63 169.16 18.09 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.302 -0.874 . . . . 0.0 110.263 178.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.53 ' CB ' HG21 ' A' ' 3' ' ' THR . 34.3 ptt180 -155.05 145.0 21.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.979 -1.076 . . . . 0.0 111.628 -172.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.461 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 15.9 pt20 24.98 47.09 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 170.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 56' ' ' GLN . . . 179.97 47.06 0.08 OUTLIER Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.204 -1.474 . . . . 0.0 110.393 174.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.471 ' OE1' ' O ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER 173.54 -113.56 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.159 -1.2 . . . . 0.0 109.76 178.975 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.497 ' HE2' ' CD2' ' A' ' 61' ' ' PHE . 95.9 mtp 55.89 -174.48 0.05 Allowed 'General case' 0 N--CA 1.485 1.292 0 O-C-N 120.91 -1.119 . . . . 0.0 111.458 173.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.525 ' CG1' ' HB2' ' A' ' 61' ' ' PHE . 4.2 p -151.55 134.78 9.07 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.694 -0.629 . . . . 0.0 109.462 -176.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.494 ' HD2' HG22 ' A' ' 58' ' ' VAL . 49.1 Cg_exo -36.45 -49.3 1.31 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.8 1.421 . . . . 0.0 111.363 -174.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.98 -39.25 85.06 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.034 -1.041 . . . . 0.0 110.334 -178.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.525 ' HB2' ' CG1' ' A' ' 58' ' ' VAL . 66.4 t80 -59.95 -37.85 80.74 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.321 -0.862 . . . . 0.0 110.344 -178.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.452 ' O ' HG11 ' A' ' 65' ' ' VAL . 55.2 t0 -59.96 -48.6 81.02 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.061 -1.025 . . . . 0.0 110.102 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 67' ' ' SER . 24.3 tptm -60.09 -51.13 70.93 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.048 -1.033 . . . . 0.0 110.46 178.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.504 ' CG1' ' HA ' ' A' ' 61' ' ' PHE . 8.8 p -70.26 -46.99 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.049 -1.032 . . . . 0.0 111.173 -174.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.452 HG11 ' O ' ' A' ' 62' ' ' ASP . 3.8 p -53.95 -28.87 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.59 -1.319 . . . . 0.0 109.268 174.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -95.62 -10.56 29.12 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.223 -0.923 . . . . 0.0 110.252 175.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.483 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 7.7 t -91.08 -69.23 0.74 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.246 -0.909 . . . . 0.0 109.951 176.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.446 ' SG ' ' OG1' ' A' ' 74' ' ' THR . 83.7 m -91.19 127.48 51.17 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.214 -0.929 . . . . 0.0 109.83 176.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.469 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 24.5 Cg_exo -58.69 160.95 16.05 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.797 1.42 . . . . 0.0 109.949 178.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.521 HG22 ' CD1' ' A' ' 71' ' ' LEU . 7.1 p -58.71 173.48 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.081 -1.012 . . . . 0.0 109.912 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.521 ' CD1' HG22 ' A' ' 70' ' ' VAL . 2.8 mp 58.7 19.7 7.07 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.298 -0.877 . . . . 0.0 109.964 -174.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.469 ' HB3' ' O ' ' A' ' 69' ' ' PRO . 4.1 tt0 -140.07 80.97 19.32 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.28 -0.888 . . . . 0.0 109.937 177.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.427 ' HG3' ' HG3' ' A' ' 87' ' ' LYS . 53.0 Cg_exo -48.88 131.88 25.81 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.948 1.499 . . . . 0.0 109.972 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.487 ' HB ' ' CG2' ' A' ' 64' ' ' VAL . 92.5 m -133.08 139.01 46.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.185 -0.947 . . . . 0.0 110.407 -176.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.457 ' HA3' HG13 ' A' ' 85' ' ' ILE . . . 145.71 -173.52 26.04 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.486 ' CD ' HD21 ' A' ' 21' ' ' LEU . 43.7 Cg_endo -75.24 137.59 51.01 Favored 'Cis proline' 0 C--N 1.314 -1.276 0 C-N-CA 121.791 -2.171 . . . . 0.0 110.538 -1.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 59.3 tp -96.53 156.35 16.38 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.243 -0.911 . . . . 0.0 110.45 -176.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -85.12 123.24 30.41 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.154 -0.966 . . . . 0.0 111.06 -175.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.579 HG21 ' CE1' ' A' ' 84' ' ' HIS . 10.3 t -141.53 164.93 28.89 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.269 -0.894 . . . . 0.0 109.806 173.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.501 ' CG ' ' CD2' ' A' ' 81' ' ' PHE . 20.1 pt20 -59.93 -31.62 70.02 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.044 -1.035 . . . . 0.0 111.016 -175.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.501 ' CD2' ' CG ' ' A' ' 80' ' ' GLN . 97.9 m-85 -75.91 -8.02 55.94 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.027 -1.045 . . . . 0.0 110.531 -176.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.464 ' O ' HG22 ' A' ' 79' ' ' THR . . . 137.47 -143.58 14.77 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 -175.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.508 ' CZ ' ' HG3' ' A' ' 14' ' ' GLU . 96.1 m-85 -107.32 122.35 46.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.899 -1.353 . . . . 0.0 109.89 174.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.583 ' CD2' ' HG ' ' A' ' 10' ' ' LEU . 60.9 m170 -99.17 121.74 41.43 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.131 -0.981 . . . . 0.0 110.363 175.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.532 ' CG2' ' HB ' ' A' ' 9' ' ' ILE . 6.1 tt -107.68 121.66 60.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 C-N-CA 118.599 -1.24 . . . . 0.0 109.569 168.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.417 HD11 HG12 ' A' ' 64' ' ' VAL . 83.4 mt -114.1 130.02 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.241 -0.912 . . . . 0.0 111.081 -169.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.558 ' HE2' ' CG ' ' A' ' 30' ' ' PHE . 21.4 ttmm -98.04 126.58 43.54 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.106 -0.996 . . . . 0.0 109.258 169.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.457 ' O ' HD22 ' A' ' 89' ' ' LEU . 61.9 t -106.54 134.93 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.296 -0.877 . . . . 0.0 110.204 -175.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.514 ' O ' ' N ' ' A' ' 91' ' ' ARG . 92.7 mt -140.13 161.31 37.95 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.348 -0.845 . . . . 0.0 109.131 -178.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.498 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 25.6 m-85 62.45 -61.45 0.12 Allowed 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.03 0.443 . . . . 0.0 111.04 177.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.514 ' N ' ' O ' ' A' ' 89' ' ' LEU . 14.1 tpt180 54.93 39.93 31.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.001 -1.062 . . . . 0.0 110.209 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.168 -179.485 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.559 ' CB ' ' CB ' ' A' ' 92' ' ' ASN . . . . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.237 0.542 . . . . 0.0 110.174 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.522 ' O ' ' CD ' ' A' ' 53' ' ' ARG . 27.9 mtpt -90.03 -79.92 0.33 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.133 -0.98 . . . . 0.0 110.768 -177.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.531 ' CB ' ' HG2' ' A' ' 51' ' ' GLU . 27.3 p -137.21 152.52 49.96 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.234 -0.916 . . . . 0.0 110.375 -175.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 91' ' ' ARG . . . -109.95 151.24 27.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.097 -1.002 . . . . 0.0 109.886 175.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.473 ' HB2' ' O ' ' A' ' 89' ' ' LEU . . . -90.76 122.69 33.71 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.699 -0.8 . . . . 0.0 109.651 -178.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.58 ' HB1' ' CZ ' ' A' ' 52' ' ' PHE . . . -130.84 119.7 22.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.102 -0.999 . . . . 0.0 111.325 -172.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.545 ' HB2' ' CG ' ' A' ' 87' ' ' LYS . 83.2 mt -106.5 151.28 25.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.288 -0.882 . . . . 0.0 108.839 169.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.499 ' CD2' ' O ' ' A' ' 46' ' ' GLY . 0.3 OUTLIER -168.66 170.53 9.38 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 118.287 -1.365 . . . . 0.0 112.158 -178.716 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.444 ' HB ' ' CG2' ' A' ' 85' ' ' ILE . 87.0 mt -139.97 138.81 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.876 -0.515 . . . . 0.0 109.65 178.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.578 ' HG ' ' CD2' ' A' ' 84' ' ' HIS . 0.5 OUTLIER -100.42 120.08 39.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.364 -0.835 . . . . 0.0 110.218 -178.731 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.505 ' N ' HD22 ' A' ' 10' ' ' LEU . 2.4 t -112.74 128.44 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.204 -0.935 . . . . 0.0 109.964 178.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -69.43 -40.04 77.48 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.371 -0.831 . . . . 0.0 110.618 -178.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -130.43 155.81 45.79 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.023 -1.048 . . . . 0.0 110.728 -176.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.513 ' HG3' ' CZ ' ' A' ' 83' ' ' TYR . 95.7 mt-10 -60.09 -40.0 88.09 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.478 -0.764 . . . . 0.0 110.744 -178.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -55.4 -43.33 75.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.144 -0.973 . . . . 0.0 110.068 -175.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.448 ' HB3' ' CG1' ' A' ' 11' ' ' VAL . 5.9 tt -69.89 -41.01 75.32 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.086 -1.009 . . . . 0.0 109.378 174.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.47 ' O ' HD11 ' A' ' 21' ' ' LEU . . . -60.05 -41.32 92.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.407 -0.808 . . . . 0.0 110.098 175.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.408 ' HA ' HD13 ' A' ' 21' ' ' LEU . 0.2 OUTLIER -60.02 -42.27 94.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.329 -0.857 . . . . 0.0 109.474 178.051 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.461 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 47.8 t0 -59.94 -43.56 94.9 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.243 -0.91 . . . . 0.0 110.037 174.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.541 ' HG ' ' N ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -63.02 -46.78 85.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.113 -0.992 . . . . 0.0 109.79 179.996 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.541 ' N ' ' HG ' ' A' ' 20' ' ' LEU . 0.9 OUTLIER -59.83 -49.94 75.74 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.395 -0.816 . . . . 0.0 110.185 -178.58 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -60.77 -43.13 98.43 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.326 -0.859 . . . . 0.0 110.637 -177.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 19' ' ' ASP . 96.5 mm-40 -60.59 -42.59 97.05 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.184 -0.948 . . . . 0.0 110.606 -177.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.505 ' O ' ' N ' ' A' ' 28' ' ' ALA . 88.1 mt -64.84 -44.09 96.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.15 -0.969 . . . . 0.0 109.937 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -61.08 -47.14 87.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.175 -0.953 . . . . 0.0 109.665 175.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -59.81 -60.93 3.05 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.43 -0.794 . . . . 0.0 110.331 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.563 ' O ' ' CB ' ' A' ' 28' ' ' ALA . . . -105.21 -41.64 1.89 Allowed Glycine 0 N--CA 1.485 1.93 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -173.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.563 ' CB ' ' O ' ' A' ' 27' ' ' GLY . . . 80.19 99.4 0.06 Allowed 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.837 -0.802 . . . . 0.0 110.075 -177.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.426 ' CG ' ' HD2' ' A' ' 32' ' ' LYS . 1.8 m-20 -175.7 82.82 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.273 -0.892 . . . . 0.0 110.177 -176.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.563 ' CG ' ' HE3' ' A' ' 87' ' ' LYS . 9.9 m-85 -65.87 -45.58 81.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.151 -0.968 . . . . 0.0 110.752 -178.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.09 -49.26 80.51 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -177.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.426 ' HD2' ' CG ' ' A' ' 29' ' ' ASP . 60.7 mttm -64.96 -40.0 94.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -1.169 . . . . 0.0 110.049 -177.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.517 ' CD2' HD11 ' A' ' 20' ' ' LEU . 63.2 tp -61.81 -40.24 94.55 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.226 -0.921 . . . . 0.0 110.352 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.518 ' O ' ' CB ' ' A' ' 38' ' ' SER . . . -60.03 -49.95 75.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.067 -1.021 . . . . 0.0 110.135 177.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -59.97 -43.63 94.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.774 -1.204 . . . . 0.0 110.689 -176.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -69.95 -43.03 72.41 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.897 -1.127 . . . . 0.0 111.662 -175.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.508 ' CD2' HD11 ' A' ' 33' ' ' LEU . 83.8 m-70 -105.77 -28.29 10.76 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.686 -1.259 . . . . 0.0 111.691 -169.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.52 ' O ' ' CG1' ' A' ' 39' ' ' ILE . 54.3 p -60.01 -44.29 94.65 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.724 -1.235 . . . . 0.0 110.763 -171.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.52 ' CG1' ' O ' ' A' ' 38' ' ' SER . 46.5 pt 36.31 31.63 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.614 -0.679 . . . . 0.0 110.918 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.479 ' N ' ' O ' ' A' ' 38' ' ' SER . 38.2 t -125.83 144.23 47.77 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.125 -0.984 . . . . 0.0 110.247 -175.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.464 ' HD2' ' SG ' ' A' ' 40' ' ' CYS . 58.1 Cg_exo -44.7 -24.85 1.28 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.819 1.431 . . . . 0.0 110.753 178.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.484 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 0.2 OUTLIER -109.88 19.79 18.7 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.142 -0.974 . . . . 0.0 110.196 178.566 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 40' ' ' CYS . . . -95.63 -57.72 1.17 Allowed Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 175.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -59.93 -39.99 87.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.34 -1.094 . . . . 0.0 109.872 175.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 20.9 tpt180 -101.39 -37.15 8.59 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.328 -0.857 . . . . 0.0 110.58 -177.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.499 ' O ' ' CD2' ' A' ' 8' ' ' HIS . . . -82.88 -9.02 85.03 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -177.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.36 1.52 56.35 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 173.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.439 ' HA ' ' CD2' ' A' ' 7' ' ' LEU . 38.7 t0 -165.76 67.25 0.12 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.35 -1.088 . . . . 0.0 108.475 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.441 ' HG ' ' HA2' ' A' ' 46' ' ' GLY . 7.0 mt -69.99 -27.41 64.68 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.794 -0.566 . . . . 0.0 110.146 -175.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.34 -146.96 16.64 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.531 ' HG2' ' CB ' ' A' ' 3' ' ' THR . 49.9 tt0 -110.75 128.58 55.79 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.26 -1.141 . . . . 0.0 110.011 -178.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.58 ' CZ ' ' HB1' ' A' ' 6' ' ' ALA . 3.5 p90 -144.88 -178.02 5.82 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.178 -0.951 . . . . 0.0 110.584 -176.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.528 ' HB2' ' HA ' ' A' ' 3' ' ' THR . 51.8 ttt-85 -171.29 -46.86 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.93 -1.106 . . . . 0.0 110.23 173.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -60.04 -49.03 79.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.262 -0.899 . . . . 0.0 110.885 -168.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 57' ' ' MET . . . -87.15 -104.51 0.84 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 178.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.537 ' NE2' ' CG ' ' A' ' 52' ' ' PHE . 3.0 mm100 64.94 -69.32 0.1 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.369 -1.077 . . . . 0.0 109.547 172.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.536 ' N ' ' O ' ' A' ' 55' ' ' GLY . 30.5 ttp 62.91 -58.92 0.15 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.781 -0.574 . . . . 0.0 112.236 170.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.492 ' N ' ' O ' ' A' ' 56' ' ' GLN . 1.9 p -41.37 132.96 2.08 Favored Pre-proline 0 N--CA 1.498 1.931 0 O-C-N 120.907 -1.12 . . . . 0.0 110.605 -168.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.477 ' O ' ' N ' ' A' ' 62' ' ' ASP . 29.0 Cg_endo -67.59 -50.52 0.89 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.08 1.568 . . . . 0.0 110.709 -174.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 59' ' ' PRO . . . -41.77 -37.39 1.22 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.381 -0.824 . . . . 0.0 110.029 -177.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.542 ' CE2' HG22 ' A' ' 65' ' ' VAL . 67.7 t80 -59.97 -43.66 94.95 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.308 -0.87 . . . . 0.0 110.056 177.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.477 ' N ' ' O ' ' A' ' 59' ' ' PRO . 54.0 t0 -60.0 -43.75 94.99 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.295 -0.878 . . . . 0.0 110.284 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 67' ' ' SER . 34.3 mttt -58.23 -50.02 75.05 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.163 -0.961 . . . . 0.0 109.735 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.508 HG11 ' N ' ' A' ' 65' ' ' VAL . 7.5 p -69.5 -41.32 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.451 -0.781 . . . . 0.0 110.763 -177.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.542 HG22 ' CE2' ' A' ' 61' ' ' PHE . 11.4 t -55.54 -31.85 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.727 -1.233 . . . . 0.0 108.929 171.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.408 ' HB2' ' O ' ' A' ' 62' ' ' ASP . 24.6 m-85 -102.37 10.32 39.16 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.621 -0.674 . . . . 0.0 110.258 177.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.501 ' N ' ' O ' ' A' ' 63' ' ' LYS . 8.1 t -103.27 -58.29 1.9 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.151 -0.968 . . . . 0.0 109.898 173.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.448 ' SG ' ' OG1' ' A' ' 74' ' ' THR . 29.8 m -115.39 145.34 34.14 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.309 -0.869 . . . . 0.0 110.303 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.519 ' O ' ' N ' ' A' ' 71' ' ' LEU . 13.5 Cg_exo -64.98 76.52 0.21 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.807 1.425 . . . . 0.0 110.582 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.534 ' CG1' ' HG3' ' A' ' 91' ' ' ARG . 8.2 m 21.29 45.89 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.337 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 176.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.531 ' CD1' ' O ' ' A' ' 70' ' ' VAL . 0.3 OUTLIER -166.55 46.86 0.07 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.45 -0.781 . . . . 0.0 110.057 178.259 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -170.66 123.97 0.6 Allowed Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.348 -0.845 . . . . 0.0 110.148 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -55.63 119.07 5.96 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.746 1.392 . . . . 0.0 110.196 178.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.448 ' OG1' ' SG ' ' A' ' 68' ' ' CYS . 74.9 m -126.61 128.35 46.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.197 -0.939 . . . . 0.0 110.219 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.455 ' HA3' HG13 ' A' ' 85' ' ' ILE . . . 145.85 -177.81 23.99 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.519 ' HD3' ' CD2' ' A' ' 21' ' ' LEU . 42.4 Cg_endo -71.02 161.61 89.44 Favored 'Cis proline' 0 C--N 1.313 -1.313 0 C-N-CA 121.754 -2.186 . . . . 0.0 110.463 -0.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.527 ' CD2' ' N ' ' A' ' 78' ' ' HIS . 8.0 tt -134.92 155.26 51.02 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.274 -0.891 . . . . 0.0 110.158 -175.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.527 ' N ' ' CD2' ' A' ' 77' ' ' LEU . 42.0 m80 -73.42 129.37 37.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.168 -0.958 . . . . 0.0 110.768 -176.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.576 HG22 ' CE1' ' A' ' 84' ' ' HIS . 9.0 t -144.2 163.42 33.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.367 -0.833 . . . . 0.0 109.848 175.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -60.0 -24.34 64.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.194 -0.941 . . . . 0.0 110.185 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.578 ' HB2' ' CE1' ' A' ' 84' ' ' HIS . 97.8 m-85 -86.68 -0.68 56.73 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.196 -0.94 . . . . 0.0 110.926 -175.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.458 ' O ' HG23 ' A' ' 79' ' ' THR . . . 123.64 -137.72 11.07 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 -174.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.513 ' CZ ' ' HG3' ' A' ' 14' ' ' GLU . 59.2 m-85 -100.16 130.04 46.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.1 -1.235 . . . . 0.0 109.948 173.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.578 ' CD2' ' HG ' ' A' ' 10' ' ' LEU . 19.3 m170 -116.86 124.12 48.73 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.23 -0.918 . . . . 0.0 110.537 178.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.455 HG13 ' HA3' ' A' ' 75' ' ' GLY . 8.5 tt -110.07 130.06 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.925 -1.11 . . . . 0.0 109.596 170.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.476 HG12 ' HB2' ' A' ' 8' ' ' HIS . 20.5 mt -138.45 137.84 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.996 -1.065 . . . . 0.0 110.824 -172.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.563 ' HE3' ' CG ' ' A' ' 30' ' ' PHE . 15.8 ptpt -111.16 135.08 52.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.772 -1.205 . . . . 0.0 109.313 168.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.486 ' HB ' ' HA ' ' A' ' 70' ' ' VAL . 37.6 t -110.49 144.17 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.253 -0.905 . . . . 0.0 110.345 -171.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.554 ' O ' ' CB ' ' A' ' 90' ' ' TYR . 63.2 mt -140.09 129.52 24.06 Favored 'General case' 0 C--N 1.31 -1.126 0 O-C-N 121.027 -1.046 . . . . 0.0 110.21 -175.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.554 ' CB ' ' O ' ' A' ' 89' ' ' LEU . 14.5 t80 81.27 -24.99 0.17 Allowed 'General case' 0 N--CA 1.507 2.391 0 O-C-N 121.4 -0.813 . . . . 0.0 111.833 169.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.534 ' HG3' ' CG1' ' A' ' 70' ' ' VAL . 7.0 ttm-85 59.74 -160.13 0.29 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.867 -1.146 . . . . 0.0 109.771 -175.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.559 ' CB ' ' CB ' ' A' ' 1' ' ' ALA . 25.7 m120 . . . . . 0 N--CA 1.489 1.519 0 O-C-N 120.953 -1.092 . . . . 0.0 110.335 177.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.199 0.523 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.411 ' C ' HG22 ' A' ' 3' ' ' THR . 59.4 tttm -59.95 -40.9 90.59 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.214 -0.928 . . . . 0.0 110.132 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.505 ' O ' ' N ' ' A' ' 92' ' ' ASN . 46.0 p -132.79 144.19 50.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.397 -0.815 . . . . 0.0 110.038 177.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.451 ' HB1' ' HE1' ' A' ' 57' ' ' MET . . . -134.59 142.26 46.88 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.166 -0.959 . . . . 0.0 110.241 178.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.456 ' HB2' ' HB2' ' A' ' 89' ' ' LEU . . . -93.44 119.97 33.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.242 -0.911 . . . . 0.0 108.952 175.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.573 ' HB1' ' CZ ' ' A' ' 52' ' ' PHE . . . -134.32 119.3 18.51 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.637 -1.289 . . . . 0.0 111.505 -168.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.6 ' N ' ' CD1' ' A' ' 7' ' ' LEU . 4.2 mp -96.63 146.98 24.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.177 -0.952 . . . . 0.0 109.288 171.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.43 ' CE1' HG22 ' A' ' 86' ' ' ILE . 56.2 m-70 -137.85 126.39 23.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.05 -1.031 . . . . 0.0 110.624 -176.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.57 ' HB ' ' CG2' ' A' ' 85' ' ' ILE . 68.8 mt -103.18 125.6 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 120.868 -1.145 . . . . 0.0 109.714 169.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.494 ' CD1' ' C ' ' A' ' 10' ' ' LEU . 2.7 tm? -103.43 119.98 39.94 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.605 -0.685 . . . . 0.0 109.684 177.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.495 HG13 ' CD2' ' A' ' 16' ' ' LEU . 3.0 t -111.84 132.34 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.319 -0.863 . . . . 0.0 110.286 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -65.99 -40.01 90.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.377 -0.827 . . . . 0.0 110.399 179.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -119.78 139.24 52.63 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.139 -0.976 . . . . 0.0 110.822 -173.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -60.04 -47.22 86.76 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.556 -0.715 . . . . 0.0 111.282 -177.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.3 mttp -53.31 -36.54 61.36 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.14 -0.975 . . . . 0.0 110.185 -173.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.495 ' CD2' HG13 ' A' ' 11' ' ' VAL . 8.4 tt -65.26 -40.07 93.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.254 -0.904 . . . . 0.0 109.419 176.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.458 ' O ' HD11 ' A' ' 21' ' ' LEU . . . -58.97 -46.46 88.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.384 -0.823 . . . . 0.0 109.994 176.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.98 -44.62 94.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.235 -0.916 . . . . 0.0 109.874 177.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -59.97 -43.41 95.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.147 -0.971 . . . . 0.0 109.754 175.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.468 ' O ' HG12 ' A' ' 24' ' ' ILE . 2.6 tp -64.14 -45.55 88.0 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.43 -0.793 . . . . 0.0 109.948 177.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.529 ' CD2' ' HD3' ' A' ' 76' ' ' PRO . 1.9 mp -57.99 -49.58 76.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.38 -0.825 . . . . 0.0 109.866 -174.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -61.03 -37.0 81.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.274 -0.891 . . . . 0.0 109.689 172.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.455 ' HB3' ' O ' ' A' ' 20' ' ' LEU . 60.5 tt0 -59.96 -34.79 73.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.456 -0.777 . . . . 0.0 110.443 -174.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.521 ' O ' ' N ' ' A' ' 28' ' ' ALA . 45.4 mm -59.92 -49.57 83.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.092 -1.005 . . . . 0.0 109.325 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -60.68 -46.43 90.4 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.097 -1.002 . . . . 0.0 109.789 178.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -60.08 -53.25 60.04 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.291 -0.88 . . . . 0.0 110.327 177.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.539 ' O ' ' CB ' ' A' ' 28' ' ' ALA . . . -104.48 -54.71 0.77 Allowed Glycine 0 N--CA 1.486 1.992 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -173.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.539 ' CB ' ' O ' ' A' ' 27' ' ' GLY . . . 79.19 95.03 0.06 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.862 -0.787 . . . . 0.0 110.58 178.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.466 ' OD2' ' HD2' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -177.6 80.42 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.422 -0.799 . . . . 0.0 109.751 -178.814 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.577 ' CG ' ' HD2' ' A' ' 87' ' ' LYS . 11.9 m-85 -60.09 -49.97 75.56 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.319 -0.863 . . . . 0.0 111.187 -174.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.08 -50.13 58.94 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.722 -1.228 . . . . 0.0 110.126 -174.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.466 ' HD2' ' OD2' ' A' ' 29' ' ' ASP . 32.3 mttm -66.57 -40.01 88.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.086 -1.244 . . . . 0.0 110.383 -175.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.486 ' CD1' HD13 ' A' ' 24' ' ' ILE . 67.7 mt -66.44 -40.01 89.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.062 -1.024 . . . . 0.0 110.477 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.534 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -59.22 -51.91 67.94 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.087 -1.008 . . . . 0.0 110.082 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -60.14 -45.84 91.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.327 -0.858 . . . . 0.0 110.722 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -68.32 -47.38 67.7 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.11 -0.994 . . . . 0.0 110.848 -175.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.464 ' CE1' HD22 ' A' ' 33' ' ' LEU . 35.4 m170 -74.79 -45.18 45.31 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.148 -0.97 . . . . 0.0 110.765 -175.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.517 ' O ' ' N ' ' A' ' 40' ' ' CYS . 25.4 t -60.39 -46.27 90.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.203 -0.935 . . . . 0.0 110.133 -179.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.472 HG23 ' O ' ' A' ' 38' ' ' SER . 13.3 tt 36.02 30.04 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-O 121.445 0.64 . . . . 0.0 110.774 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.517 ' N ' ' O ' ' A' ' 38' ' ' SER . 14.2 p -121.56 171.63 5.91 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.286 -0.884 . . . . 0.0 110.024 -178.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.471 ' HD2' ' HB2' ' A' ' 40' ' ' CYS . 43.7 Cg_exo -48.94 -31.35 20.0 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.647 1.341 . . . . 0.0 110.352 -177.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.6 OUTLIER -101.65 15.11 29.96 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.306 -0.871 . . . . 0.0 110.028 177.788 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.29 -58.86 3.78 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.754 -1.738 . . . . 0.0 108.754 174.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.1 tptt -59.91 -40.08 87.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -1.114 . . . . 0.0 110.551 177.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.459 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 11.1 tpt180 -98.29 -41.1 8.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.085 -1.009 . . . . 0.0 110.567 -175.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -70.24 -30.33 69.58 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -178.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.48 -5.56 50.57 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.417 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 25.1 t0 -172.67 72.16 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.332 -1.099 . . . . 0.0 108.586 179.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 6.8 mt -70.03 -27.1 64.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.456 -0.777 . . . . 0.0 110.177 -173.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 113.58 -154.71 16.78 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.441 ' HG3' ' C ' ' A' ' 4' ' ' ALA . 84.6 tt0 -106.55 129.83 54.43 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.291 -1.123 . . . . 0.0 109.845 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.573 ' CZ ' ' HB1' ' A' ' 6' ' ' ALA . 0.1 OUTLIER -131.57 173.47 11.08 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.051 -1.031 . . . . 0.0 110.704 178.044 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.524 ' HG2' ' NE2' ' A' ' 56' ' ' GLN . 20.6 ptt180 -112.52 176.5 4.99 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.323 -0.861 . . . . 0.0 110.229 179.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -61.06 -11.2 7.69 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.205 -0.935 . . . . 0.0 111.27 -173.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.443 ' C ' ' HG2' ' A' ' 56' ' ' GLN . . . -84.54 42.41 3.11 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 177.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.524 ' NE2' ' HG2' ' A' ' 53' ' ' ARG . 2.0 pt20 -178.08 -32.96 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.196 -1.179 . . . . 0.0 110.298 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.469 ' HG3' ' O ' ' A' ' 53' ' ' ARG . 62.6 mtt -47.23 142.28 3.99 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.074 -1.016 . . . . 0.0 110.97 -169.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.527 HG13 ' CB ' ' A' ' 61' ' ' PHE . 7.5 p -71.6 130.97 86.61 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.515 -0.741 . . . . 0.0 110.098 177.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.474 ' HD2' HG21 ' A' ' 58' ' ' VAL . 3.1 Cg_exo -43.95 -44.77 11.9 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 121.627 1.551 . . . . 0.0 111.286 -174.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.09 -38.45 79.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.009 -1.057 . . . . 0.0 109.938 -178.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.527 ' CB ' HG13 ' A' ' 58' ' ' VAL . 63.2 t80 -59.99 -38.79 83.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.268 -0.895 . . . . 0.0 110.282 174.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.415 ' O ' HG11 ' A' ' 65' ' ' VAL . 48.8 t0 -60.03 -43.75 95.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.204 -0.935 . . . . 0.0 110.117 -176.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 67' ' ' SER . 23.6 tttm -60.07 -47.03 87.58 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.216 -0.927 . . . . 0.0 110.417 177.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.514 HG13 ' N ' ' A' ' 65' ' ' VAL . 13.1 p -79.25 -44.47 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.024 -1.047 . . . . 0.0 111.347 -173.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.514 ' N ' HG13 ' A' ' 64' ' ' VAL . 4.4 p -53.56 -25.8 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.361 -1.462 . . . . 0.0 109.008 173.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -94.97 -13.22 25.5 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.513 -0.742 . . . . 0.0 109.939 176.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.466 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 8.0 t -93.38 -61.65 1.52 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.354 -0.841 . . . . 0.0 110.053 177.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.458 ' SG ' ' OG1' ' A' ' 74' ' ' THR . 78.6 m -99.98 132.01 23.47 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.38 -0.825 . . . . 0.0 110.272 178.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.471 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 12.1 Cg_endo -61.31 159.93 29.08 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.861 1.453 . . . . 0.0 110.082 178.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.522 HG22 ' CD1' ' A' ' 71' ' ' LEU . 8.1 p -60.46 177.41 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.198 -0.939 . . . . 0.0 109.891 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.522 ' CD1' HG22 ' A' ' 70' ' ' VAL . 4.7 mp 45.48 40.02 5.25 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.639 -1.288 . . . . 0.0 109.981 -168.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.471 ' HB3' ' O ' ' A' ' 69' ' ' PRO . 0.4 OUTLIER -150.57 89.65 4.4 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.384 -0.822 . . . . 0.0 109.729 175.497 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -59.26 126.55 21.19 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.827 1.435 . . . . 0.0 109.782 -177.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.458 ' OG1' ' SG ' ' A' ' 68' ' ' CYS . 53.3 m -130.7 136.72 49.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.095 -1.003 . . . . 0.0 110.453 -177.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.475 ' HA3' HG13 ' A' ' 85' ' ' ILE . . . 152.27 -171.38 31.54 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -178.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.529 ' HD3' ' CD2' ' A' ' 21' ' ' LEU . 41.7 Cg_endo -84.77 134.03 19.45 Favored 'Cis proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.209 -1.996 . . . . 0.0 110.42 3.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 74.8 mt -93.0 -178.52 4.82 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.254 -0.904 . . . . 0.0 110.735 -172.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -102.66 125.37 49.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.072 -1.018 . . . . 0.0 110.712 -176.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.539 HG23 ' CE1' ' A' ' 84' ' ' HIS . 12.5 t -140.05 162.43 35.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.428 -0.795 . . . . 0.0 109.813 176.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -60.05 -39.95 87.72 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.101 -0.999 . . . . 0.0 110.364 -178.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.406 ' C ' HD23 ' A' ' 10' ' ' LEU . 96.8 m-85 -70.31 -5.56 28.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.208 -0.933 . . . . 0.0 110.61 -177.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.443 ' O ' HG21 ' A' ' 79' ' ' THR . . . 134.43 -137.47 9.3 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.423 ' O ' ' HA ' ' A' ' 10' ' ' LEU . 75.1 m-85 -96.1 130.67 43.07 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.165 -1.197 . . . . 0.0 110.241 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.539 ' CE1' HG23 ' A' ' 79' ' ' THR . 6.0 m170 -107.89 112.43 25.04 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.674 -0.641 . . . . 0.0 110.643 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.57 ' CG2' ' HB ' ' A' ' 9' ' ' ILE . 2.5 tt -104.86 120.32 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.527 -1.358 . . . . 0.0 109.076 167.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.458 HD11 HG12 ' A' ' 64' ' ' VAL . 88.2 mt -110.02 130.02 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.936 -1.103 . . . . 0.0 111.298 -169.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.577 ' HD2' ' CG ' ' A' ' 30' ' ' PHE . 63.0 tttm -101.71 126.41 48.56 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 172.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.488 HG11 ' HA ' ' A' ' 70' ' ' VAL . 24.5 t -103.42 136.46 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.13 -0.981 . . . . 0.0 110.297 -176.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.525 ' O ' ' HB2' ' A' ' 90' ' ' TYR . 58.0 mt -130.58 119.91 23.22 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.416 -0.802 . . . . 0.0 109.349 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.525 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 44.3 m-85 72.55 -58.9 0.58 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.648 -0.658 . . . . 0.0 110.856 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.416 ' CB ' ' HB ' ' A' ' 70' ' ' VAL . 67.1 ttp85 57.11 39.91 28.73 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.234 -0.916 . . . . 0.0 110.622 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.505 ' N ' ' O ' ' A' ' 3' ' ' THR . 24.3 t-20 . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.202 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.461 ' O ' ' OD1' ' A' ' 92' ' ' ASN . . . . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.221 0.534 . . . . 0.0 110.286 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.8 tttp -63.36 -40.06 96.24 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.213 -0.929 . . . . 0.0 110.285 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 91' ' ' ARG . 35.6 p -135.77 162.29 33.2 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.352 -0.843 . . . . 0.0 109.817 178.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.477 ' O ' ' HA ' ' A' ' 51' ' ' GLU . . . -109.88 131.24 55.24 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.173 -0.955 . . . . 0.0 110.549 -175.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' A' ' 50' ' ' GLY . . . -99.32 122.05 41.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.405 -0.809 . . . . 0.0 109.64 177.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.518 ' CB ' ' NE2' ' A' ' 8' ' ' HIS . . . -140.05 132.03 27.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.856 -1.153 . . . . 0.0 111.212 -175.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.489 ' CD1' ' HD2' ' A' ' 87' ' ' LYS . 86.7 mt -98.32 139.78 33.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.138 -0.976 . . . . 0.0 108.806 168.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.518 ' NE2' ' CB ' ' A' ' 6' ' ' ALA . 34.7 m-70 -135.17 117.97 16.15 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.805 -1.185 . . . . 0.0 110.754 -177.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.532 HG12 ' CB ' ' A' ' 34' ' ' ALA . 92.6 mt -105.17 126.62 60.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.35 -0.844 . . . . 0.0 109.869 172.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.577 ' HG ' ' CD2' ' A' ' 84' ' ' HIS . 0.3 OUTLIER -101.8 117.94 35.89 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.561 -0.712 . . . . 0.0 109.898 -179.757 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.522 ' CG1' HD23 ' A' ' 16' ' ' LEU . 2.2 t -108.23 125.3 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.229 -0.919 . . . . 0.0 109.747 177.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.2 mmtp -68.48 -39.39 81.38 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.44 -0.788 . . . . 0.0 110.17 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -111.43 138.11 48.35 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.186 -0.946 . . . . 0.0 110.699 -178.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.576 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 88.8 tt0 -59.97 -42.12 93.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.366 -0.833 . . . . 0.0 109.939 177.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -56.94 -40.53 76.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.395 -0.816 . . . . 0.0 110.139 -178.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.522 HD23 ' CG1' ' A' ' 11' ' ' VAL . 5.5 tt -68.82 -40.04 79.72 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.025 -1.047 . . . . 0.0 109.301 174.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.481 ' O ' ' CD1' ' A' ' 21' ' ' LEU . . . -59.95 -40.72 89.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.386 -0.821 . . . . 0.0 110.021 175.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.465 ' HA ' HD12 ' A' ' 21' ' ' LEU . 0.2 OUTLIER -59.94 -41.67 92.37 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.15 -0.969 . . . . 0.0 109.695 175.973 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -60.03 -44.75 94.42 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.32 -0.863 . . . . 0.0 110.246 176.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.524 ' HG ' ' N ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -64.11 -43.74 94.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.075 -1.015 . . . . 0.0 109.544 178.51 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.524 ' N ' ' HG ' ' A' ' 20' ' ' LEU . 0.3 OUTLIER -56.19 -49.92 72.67 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.499 -0.75 . . . . 0.0 109.697 -179.588 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -61.7 -40.01 93.51 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.391 -0.818 . . . . 0.0 110.134 175.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.46 ' O ' ' N ' ' A' ' 27' ' ' GLY . 70.0 tp60 -60.1 -39.9 87.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.271 -0.893 . . . . 0.0 110.945 -174.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.518 ' O ' ' N ' ' A' ' 28' ' ' ALA . 96.7 mt -62.76 -40.55 89.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.104 -0.997 . . . . 0.0 110.289 -176.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -65.42 -58.75 5.09 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.964 -1.085 . . . . 0.0 110.067 175.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -60.05 -39.96 87.78 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.34 -0.85 . . . . 0.0 110.799 178.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.548 ' O ' ' CB ' ' A' ' 28' ' ' ALA . . . -104.0 -63.03 0.68 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -176.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.548 ' CB ' ' O ' ' A' ' 27' ' ' GLY . . . 81.79 93.04 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.175 0 O-C-N 122.06 -0.671 . . . . 0.0 110.508 178.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 179.74 78.32 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.423 -0.798 . . . . 0.0 109.952 -178.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.495 ' CZ ' HG23 ' A' ' 85' ' ' ILE . 17.1 t80 -61.12 -39.98 92.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.318 -0.864 . . . . 0.0 110.72 -174.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.44 ' O ' ' HG3' ' A' ' 35' ' ' LYS . . . -66.01 -53.65 29.04 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -176.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.435 ' HE3' ' HE3' ' A' ' 36' ' ' LYS . 82.5 tttt -64.8 -41.55 95.72 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.111 -1.229 . . . . 0.0 110.523 -178.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 85.7 mt -65.89 -40.04 91.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.238 -0.914 . . . . 0.0 109.931 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.532 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -60.25 -48.87 79.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.365 -0.835 . . . . 0.0 110.347 178.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.44 ' HG3' ' O ' ' A' ' 31' ' ' GLY . 72.4 mttt -59.99 -46.34 89.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 0.0 110.391 -175.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.435 ' HE3' ' HE3' ' A' ' 32' ' ' LYS . 41.5 mttt -69.41 -50.82 42.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.094 -1.004 . . . . 0.0 111.074 -176.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 53.9 m170 -70.05 -39.97 75.4 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.124 -0.985 . . . . 0.0 111.073 -173.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.527 ' O ' ' CG2' ' A' ' 39' ' ' ILE . 14.5 t -59.99 -45.6 92.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.037 -1.04 . . . . 0.0 110.313 -175.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.527 ' CG2' ' O ' ' A' ' 38' ' ' SER . 20.4 tt 38.73 34.18 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.589 -0.695 . . . . 0.0 110.603 178.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.489 ' HB2' ' HD2' ' A' ' 41' ' ' PRO . 15.0 p -127.36 165.68 27.91 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.288 -0.883 . . . . 0.0 109.764 -178.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.489 ' HD2' ' HB2' ' A' ' 40' ' ' CYS . 2.0 Cg_endo -49.2 -33.24 27.29 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.626 1.329 . . . . 0.0 110.172 179.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.2 OUTLIER -92.8 8.69 38.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.145 -0.972 . . . . 0.0 110.308 176.834 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 40' ' ' CYS . . . -56.17 -54.45 35.5 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.591 -1.804 . . . . 0.0 108.591 177.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -61.22 -39.97 92.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.355 -1.085 . . . . 0.0 110.658 175.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.468 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -94.16 -68.91 0.78 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.124 -0.985 . . . . 0.0 110.353 -173.589 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -52.82 -38.12 53.44 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.95 -5.52 52.87 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 176.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.472 ' HA ' ' CD2' ' A' ' 7' ' ' LEU . 50.2 t0 -172.34 71.12 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.35 -1.088 . . . . 0.0 108.856 178.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 7.0 mt -69.85 -25.26 63.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.544 -0.722 . . . . 0.0 109.911 -174.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 5' ' ' ALA . . . 82.79 -137.69 17.04 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.074 -1.611 . . . . 0.0 109.074 -178.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.477 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 1.8 mt-10 -102.27 129.65 48.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.443 -1.033 . . . . 0.0 110.635 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.488 ' CZ ' ' HB3' ' A' ' 6' ' ' ALA . 1.5 p90 -134.62 159.2 41.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.544 -0.722 . . . . 0.0 109.799 178.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.51 ' O ' ' N ' ' A' ' 55' ' ' GLY . 78.1 mtm180 -116.62 143.83 45.13 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.839 -1.163 . . . . 0.0 111.352 -170.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.505 ' O ' ' N ' ' A' ' 56' ' ' GLN . 89.5 mt-30 31.35 -88.71 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 176.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . -64.81 61.76 0.07 OUTLIER Glycine 0 N--CA 1.495 2.62 0 O-C-N 120.965 -1.084 . . . . 0.0 110.63 -169.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.505 ' N ' ' O ' ' A' ' 54' ' ' GLN . 55.9 mm-40 -132.67 3.96 3.87 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.951 -1.323 . . . . 0.0 110.616 178.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.446 ' HG2' ' CE2' ' A' ' 61' ' ' PHE . 75.4 mtm -91.78 -175.99 4.32 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.266 -1.521 . . . . 0.0 112.086 -162.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.529 ' CG1' ' HB2' ' A' ' 61' ' ' PHE . 1.6 p -171.29 137.58 1.08 Allowed Pre-proline 0 N--CA 1.488 1.445 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -174.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.484 ' HD2' HG23 ' A' ' 58' ' ' VAL . 14.7 Cg_exo -32.88 -52.1 0.4 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 121.754 1.636 . . . . 0.0 111.185 -172.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.468 ' CA ' HD22 ' A' ' 77' ' ' LEU . . . -61.81 -42.69 99.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.091 -1.006 . . . . 0.0 110.553 178.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.529 ' HB2' ' CG1' ' A' ' 58' ' ' VAL . 60.9 t80 -60.06 -40.17 88.55 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.141 -0.975 . . . . 0.0 110.647 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 66' ' ' PHE . 54.8 t0 -63.34 -42.85 98.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.012 -1.055 . . . . 0.0 109.69 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.473 ' O ' ' OG ' ' A' ' 67' ' ' SER . 59.0 mttm -57.7 -55.77 30.61 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.285 -0.885 . . . . 0.0 110.266 178.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.493 ' HA ' ' HB2' ' A' ' 67' ' ' SER . 2.7 p -70.0 -43.83 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.016 -1.052 . . . . 0.0 111.775 -172.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.443 HG13 ' O ' ' A' ' 62' ' ' ASP . 4.8 p -55.26 -27.11 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.223 -1.548 . . . . 0.0 108.94 174.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.447 ' HB2' ' O ' ' A' ' 62' ' ' ASP . 0.1 OUTLIER -94.97 -8.7 36.21 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.261 -0.899 . . . . 0.0 110.582 175.468 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.493 ' HB2' ' HA ' ' A' ' 64' ' ' VAL . 24.1 m -93.19 -41.89 9.66 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.003 -1.06 . . . . 0.0 110.042 176.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 88.2 m -120.71 150.58 52.87 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.166 -0.959 . . . . 0.0 110.205 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -73.41 156.34 50.29 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.977 1.514 . . . . 0.0 109.955 178.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.525 HG23 ' CD1' ' A' ' 71' ' ' LEU . 7.2 p -58.03 172.63 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.171 -0.956 . . . . 0.0 109.855 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.525 ' CD1' HG23 ' A' ' 70' ' ' VAL . 3.6 mp 57.44 39.78 27.8 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.413 -0.804 . . . . 0.0 110.077 -174.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -155.84 117.28 2.28 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.116 -0.99 . . . . 0.0 110.394 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 87' ' ' LYS . 30.6 Cg_endo -68.98 132.74 25.25 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.828 1.436 . . . . 0.0 110.182 179.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.438 ' HB ' HG22 ' A' ' 64' ' ' VAL . 87.0 m -139.58 147.15 40.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.157 -0.965 . . . . 0.0 110.295 -178.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.453 ' HA3' HG13 ' A' ' 85' ' ' ILE . . . 134.44 -176.11 20.07 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -178.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.52 ' CD ' HD11 ' A' ' 21' ' ' LEU . 44.1 Cg_endo -74.57 135.97 42.86 Favored 'Cis proline' 0 C--N 1.314 -1.271 0 C-N-CA 121.79 -2.171 . . . . 0.0 110.557 -0.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.468 HD22 ' CA ' ' A' ' 60' ' ' ALA . 59.8 tp -94.94 155.08 16.91 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.26 -0.9 . . . . 0.0 110.435 -178.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -77.89 119.74 21.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -0.891 . . . . 0.0 110.459 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.58 HG23 ' CE1' ' A' ' 84' ' ' HIS . 10.8 t -134.21 165.57 24.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.214 -0.929 . . . . 0.0 109.55 173.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -59.97 -39.58 86.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.113 -0.992 . . . . 0.0 110.047 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -66.75 -11.55 55.15 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.226 -0.921 . . . . 0.0 110.717 -177.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.468 ' O ' HG21 ' A' ' 79' ' ' THR . . . 132.32 -139.75 11.22 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 -176.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.576 ' CE2' ' HB2' ' A' ' 14' ' ' GLU . 75.5 m-85 -102.64 122.14 43.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.108 -1.23 . . . . 0.0 110.291 178.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.58 ' CE1' HG23 ' A' ' 79' ' ' THR . 41.2 m170 -104.98 122.64 46.27 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.196 -0.94 . . . . 0.0 110.422 175.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.527 ' CG2' ' HB ' ' A' ' 9' ' ' ILE . 3.5 tt -103.52 119.23 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 118.376 -1.329 . . . . 0.0 109.361 167.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.449 ' CG2' ' CE1' ' A' ' 8' ' ' HIS . 85.5 mt -114.77 130.02 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.095 -1.003 . . . . 0.0 110.707 -170.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.489 ' HD2' ' CD1' ' A' ' 7' ' ' LEU . 34.9 ttmt -96.96 126.08 41.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.135 -0.978 . . . . 0.0 109.164 171.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.479 HG11 HG22 ' A' ' 70' ' ' VAL . 48.5 t -107.61 123.19 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.382 -0.824 . . . . 0.0 109.959 -175.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.545 ' O ' ' CB ' ' A' ' 90' ' ' TYR . 60.1 mt -134.36 113.04 11.5 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.522 -0.736 . . . . 0.0 109.317 -176.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.545 ' CB ' ' O ' ' A' ' 89' ' ' LEU . 2.9 m-85 81.91 -43.37 0.16 Allowed 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.718 -0.614 . . . . 0.0 110.444 -178.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.472 ' O ' ' O ' ' A' ' 3' ' ' THR . 4.4 ttm180 59.9 -159.52 0.3 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.082 -1.011 . . . . 0.0 109.983 -178.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.461 ' OD1' ' O ' ' A' ' 1' ' ' ALA . 52.7 t-20 . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.048 -1.033 . . . . 0.0 110.319 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.245 0.545 . . . . 0.0 110.253 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.454 ' O ' ' OG1' ' A' ' 3' ' ' THR . 40.8 mttt -123.64 145.33 49.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.25 -0.906 . . . . 0.0 110.133 179.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.454 ' OG1' ' O ' ' A' ' 2' ' ' LYS . 19.3 p 47.4 -164.76 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.213 -0.93 . . . . 0.0 109.516 -176.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -140.16 142.81 35.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.913 -1.117 . . . . 0.0 110.732 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.424 ' HB2' ' HB2' ' A' ' 89' ' ' LEU . . . -97.24 126.98 42.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.267 -0.895 . . . . 0.0 108.907 171.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.582 ' CB ' ' NE2' ' A' ' 8' ' ' HIS . . . -136.67 130.82 32.72 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.661 -1.274 . . . . 0.0 112.112 -168.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.511 ' C ' ' CD2' ' A' ' 8' ' ' HIS . 75.2 mt -103.48 144.42 31.42 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.263 -0.898 . . . . 0.0 109.411 167.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.582 ' NE2' ' CB ' ' A' ' 6' ' ' ALA . 10.0 m-70 -136.28 142.59 43.95 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.797 -1.19 . . . . 0.0 111.121 -175.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.549 ' HB ' ' CG2' ' A' ' 85' ' ' ILE . 96.7 mt -129.14 131.9 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.133 -0.98 . . . . 0.0 109.953 170.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.471 ' HG ' ' CD2' ' A' ' 84' ' ' HIS . 0.3 OUTLIER -103.27 121.9 43.66 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.507 -0.746 . . . . 0.0 110.068 179.382 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.53 ' CG1' HD21 ' A' ' 16' ' ' LEU . 2.7 t -110.25 133.15 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.088 -1.008 . . . . 0.0 110.142 178.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.2 mttt -68.33 -40.02 81.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.238 -0.914 . . . . 0.0 110.646 -178.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -120.14 142.0 49.34 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.152 -0.968 . . . . 0.0 110.977 -176.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.575 ' HB2' ' CZ ' ' A' ' 83' ' ' TYR . 88.6 tt0 -59.99 -42.99 95.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.447 -0.783 . . . . 0.0 110.172 178.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -57.47 -40.06 77.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.682 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.53 HD21 ' CG1' ' A' ' 11' ' ' VAL . 5.5 tt -67.99 -40.28 83.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.2 -0.938 . . . . 0.0 109.704 177.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.45 ' N ' HG12 ' A' ' 11' ' ' VAL . . . -59.94 -44.1 94.59 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -0.933 . . . . 0.0 110.061 175.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.01 -43.24 95.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.303 -0.873 . . . . 0.0 109.707 175.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -59.99 -41.46 92.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.312 -0.867 . . . . 0.0 109.586 174.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.0 tp -63.08 -45.47 91.99 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.573 0.702 . . . . 0.0 109.88 176.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.532 HD11 ' CD1' ' A' ' 85' ' ' ILE . 2.4 mp -59.96 -44.98 94.1 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.659 -0.651 . . . . 0.0 110.376 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.5 tp10 -60.59 -40.07 90.4 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.421 -0.8 . . . . 0.0 110.411 -178.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -60.39 -41.14 93.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.277 -0.89 . . . . 0.0 110.133 -177.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.533 ' CG1' HD13 ' A' ' 33' ' ' LEU . 24.8 mt -67.14 -43.09 88.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.36 -0.837 . . . . 0.0 110.801 -178.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -60.2 -47.97 83.73 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.869 -1.145 . . . . 0.0 110.395 -175.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.7 -62.55 1.79 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.004 -1.06 . . . . 0.0 110.345 176.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.565 ' O ' ' CB ' ' A' ' 28' ' ' ALA . . . -105.76 -39.23 2.22 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -172.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.618 ' O ' ' CB ' ' A' ' 29' ' ' ASP . . . 81.47 -176.79 0.05 Allowed 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.811 -0.817 . . . . 0.0 109.623 -173.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.618 ' CB ' ' O ' ' A' ' 28' ' ' ALA . 95.9 m-20 115.11 71.84 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.954 0 C-N-CA 124.822 1.249 . . . . 0.0 109.623 -175.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.563 ' CG ' ' HE3' ' A' ' 87' ' ' LYS . 7.6 m-85 -63.42 -39.77 95.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.266 -0.897 . . . . 0.0 110.32 176.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.64 -55.75 28.16 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 -177.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.2 mttp -66.52 -40.62 89.27 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.923 -1.339 . . . . 0.0 110.912 -176.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.533 HD13 ' CG1' ' A' ' 24' ' ' ILE . 34.9 mt -66.59 -40.06 88.7 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.045 -1.035 . . . . 0.0 110.19 -179.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.526 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -59.98 -46.2 90.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.096 -1.003 . . . . 0.0 110.029 177.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -60.06 -48.89 79.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.273 -0.892 . . . . 0.0 110.44 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -64.11 -46.57 83.62 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.181 -0.949 . . . . 0.0 110.941 -174.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 57.1 m-70 -73.95 -44.93 53.27 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.917 -1.114 . . . . 0.0 111.334 -175.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.533 ' O ' ' CG2' ' A' ' 39' ' ' ILE . 6.7 t -59.97 -48.16 82.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.977 -1.077 . . . . 0.0 110.707 -172.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.533 ' CG2' ' O ' ' A' ' 38' ' ' SER . 20.1 tt 38.33 32.24 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.588 -0.695 . . . . 0.0 110.837 179.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.487 ' SG ' ' N ' ' A' ' 43' ' ' GLY . 18.7 p -128.71 164.2 40.0 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.143 -0.973 . . . . 0.0 110.366 -176.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' A' ' 40' ' ' CYS . 1.7 Cg_endo -50.66 -29.11 24.43 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.951 1.501 . . . . 0.0 110.454 178.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.485 ' O ' ' CA ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -100.57 17.93 20.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.065 -1.022 . . . . 0.0 109.65 175.4 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.487 ' N ' ' SG ' ' A' ' 40' ' ' CYS . . . -79.51 -57.85 3.03 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 175.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.467 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 86.8 tttt -59.99 -39.53 86.03 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.383 -1.069 . . . . 0.0 110.04 177.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.0 tpt180 -95.71 -42.36 8.42 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.089 -1.007 . . . . 0.0 110.767 -177.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.485 ' CA ' ' O ' ' A' ' 42' ' ' SER . . . -70.13 -25.63 75.36 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.86 -1.04 58.12 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 175.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' A' ' 44' ' ' LYS . 45.7 p-10 -171.01 66.85 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.326 -1.102 . . . . 0.0 108.755 -178.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.535 ' CD1' ' CD2' ' A' ' 8' ' ' HIS . 7.5 mt -69.96 -26.27 64.03 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.51 -0.744 . . . . 0.0 109.924 -175.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.03 -145.48 17.8 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 -178.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -109.95 137.57 47.55 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.226 -1.161 . . . . 0.0 110.383 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.526 ' CE2' ' HB3' ' A' ' 6' ' ' ALA . 3.4 p90 -148.09 163.01 38.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.434 -0.791 . . . . 0.0 110.1 -178.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.514 ' O ' ' NE2' ' A' ' 56' ' ' GLN . 96.4 mtt180 -75.58 158.59 32.26 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.24 -0.913 . . . . 0.0 109.354 176.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -62.31 123.99 19.7 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.084 -1.01 . . . . 0.0 109.368 176.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 105.74 66.0 0.66 Allowed Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -174.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.514 ' NE2' ' O ' ' A' ' 53' ' ' ARG . 21.7 mm-40 -128.89 -63.7 0.95 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.881 -1.364 . . . . 0.0 109.571 176.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 45.0 ttm -115.33 -62.92 1.53 Allowed 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.376 -0.929 . . . . 0.0 111.209 -166.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.486 ' CG1' ' HB2' ' A' ' 61' ' ' PHE . 10.8 p -123.21 133.13 24.34 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.181 -0.949 . . . . 0.0 110.528 -173.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.473 ' HD2' HG21 ' A' ' 58' ' ' VAL . 14.2 Cg_endo -60.42 -52.93 3.32 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.869 1.458 . . . . 0.0 110.205 176.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 59' ' ' PRO . . . -39.76 -28.98 0.05 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.585 -0.697 . . . . 0.0 110.628 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.486 ' HB2' ' CG1' ' A' ' 58' ' ' VAL . 62.5 t80 -60.03 -44.56 94.55 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.161 -0.962 . . . . 0.0 110.204 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.465 ' O ' HG12 ' A' ' 65' ' ' VAL . 47.8 t0 -59.93 -40.05 87.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.156 -0.965 . . . . 0.0 109.723 176.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 67' ' ' SER . 79.9 tttt -58.55 -41.92 86.72 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.387 -0.821 . . . . 0.0 110.348 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.5 ' CG2' ' N ' ' A' ' 65' ' ' VAL . 0.9 OUTLIER -77.69 -46.43 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.122 -0.986 . . . . 0.0 110.667 -177.153 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.5 ' N ' ' CG2' ' A' ' 64' ' ' VAL . 0.3 OUTLIER -56.14 -25.12 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.502 -1.374 . . . . 0.0 109.201 172.776 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -95.21 -5.17 44.46 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.493 -0.754 . . . . 0.0 109.917 175.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.469 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 29.7 t -96.32 -44.54 7.19 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.418 -0.801 . . . . 0.0 110.14 178.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 56.5 m -131.68 152.38 80.29 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.353 -0.842 . . . . 0.0 110.457 -177.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.439 ' HD2' ' OE1' ' A' ' 72' ' ' GLU . 13.5 Cg_endo -68.95 155.92 66.97 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.073 1.565 . . . . 0.0 110.377 178.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.53 ' CG1' HD13 ' A' ' 71' ' ' LEU . 8.9 p -61.3 169.69 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.349 -0.844 . . . . 0.0 110.616 -177.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.53 HD13 ' CG1' ' A' ' 70' ' ' VAL . 2.2 mp 59.45 16.02 4.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.629 -0.67 . . . . 0.0 110.277 -177.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.439 ' OE1' ' HD2' ' A' ' 69' ' ' PRO . 11.1 tt0 -137.2 85.15 22.61 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.206 -0.933 . . . . 0.0 109.472 173.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.403 ' HG3' ' HG3' ' A' ' 87' ' ' LYS . 75.8 Cg_exo -43.75 145.27 1.95 Allowed 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 124.051 1.553 . . . . 0.0 110.712 -174.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 62.6 m -132.67 139.62 47.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.47 -0.769 . . . . 0.0 110.078 -178.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.437 ' HA3' HG13 ' A' ' 85' ' ' ILE . . . 141.72 -175.88 22.26 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.234 -1.547 . . . . 0.0 109.234 -178.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.469 ' HD3' ' CD2' ' A' ' 21' ' ' LEU . 43.5 Cg_endo -79.47 132.91 26.58 Favored 'Cis proline' 0 C--N 1.314 -1.275 0 C-N-CA 121.834 -2.152 . . . . 0.0 110.367 -0.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.454 ' HG ' ' N ' ' A' ' 78' ' ' HIS . 43.7 tp -96.51 156.86 16.16 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.283 -0.885 . . . . 0.0 110.877 -174.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.454 ' N ' ' HG ' ' A' ' 77' ' ' LEU . 12.6 t60 -78.0 126.03 30.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.454 -0.779 . . . . 0.0 110.402 178.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.43 HG23 ' CE1' ' A' ' 84' ' ' HIS . 11.6 t -139.95 158.98 43.2 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.178 -0.951 . . . . 0.0 109.882 176.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -60.89 -25.74 66.93 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.16 -0.962 . . . . 0.0 110.864 -176.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -81.01 -9.94 59.78 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.007 -1.058 . . . . 0.0 110.639 -178.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 139.4 -128.43 3.99 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 108.653 -1.779 . . . . 0.0 108.653 -174.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.575 ' CZ ' ' HB2' ' A' ' 14' ' ' GLU . 91.6 m-85 -115.88 134.58 54.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.95 -1.323 . . . . 0.0 109.827 173.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.471 ' CD2' ' HG ' ' A' ' 10' ' ' LEU . 31.3 m170 -114.34 125.51 53.96 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.18 -0.95 . . . . 0.0 110.564 177.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.549 ' CG2' ' HB ' ' A' ' 9' ' ' ILE . 6.7 tt -114.1 122.23 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.904 -1.122 . . . . 0.0 109.264 170.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 85.3 mt -117.43 129.96 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.167 -0.958 . . . . 0.0 111.07 -170.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.563 ' HE3' ' CG ' ' A' ' 30' ' ' PHE . 12.1 ttmm -94.87 125.65 39.67 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.126 -0.984 . . . . 0.0 109.341 170.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.452 HG11 HG23 ' A' ' 65' ' ' VAL . 62.4 t -104.75 131.96 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.294 -0.879 . . . . 0.0 110.221 -174.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.493 ' O ' ' HB2' ' A' ' 90' ' ' TYR . 48.4 mt -133.74 154.07 51.24 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.493 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 2.2 m-85 64.19 -58.58 0.22 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.682 -0.637 . . . . 0.0 111.059 176.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.483 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 3.2 ttm180 60.44 178.75 0.1 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.077 -1.014 . . . . 0.0 110.544 -179.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 48.5 t30 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 118.045 -0.979 . . . . 0.0 110.187 -179.413 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.519 ' CB ' ' O ' ' A' ' 91' ' ' ARG . . . . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.197 0.523 . . . . 0.0 110.09 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 53' ' ' ARG . 15.5 ttpp -59.97 -40.03 87.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.223 -0.923 . . . . 0.0 110.325 -177.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.0 p -140.99 150.95 43.73 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.301 -0.874 . . . . 0.0 110.58 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.43 ' C ' ' HG3' ' A' ' 51' ' ' GLU . . . -132.53 156.66 46.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.189 -0.944 . . . . 0.0 110.194 178.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.423 ' HB1' ' O ' ' A' ' 89' ' ' LEU . . . -92.07 125.33 36.71 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.153 -0.967 . . . . 0.0 109.285 175.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.553 ' CB ' ' CZ ' ' A' ' 52' ' ' PHE . . . -137.16 130.2 30.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.804 -1.185 . . . . 0.0 112.081 -169.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.495 ' O ' ' CD2' ' A' ' 8' ' ' HIS . 85.0 mt -103.46 140.72 37.1 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.282 -0.886 . . . . 0.0 108.994 168.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.567 ' NE2' ' CE1' ' A' ' 61' ' ' PHE . 35.5 m170 -134.41 148.53 50.66 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.681 -1.262 . . . . 0.0 111.539 -176.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.547 ' HB ' ' CG2' ' A' ' 85' ' ' ILE . 97.0 mt -136.33 130.88 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.297 -0.877 . . . . 0.0 109.862 169.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.504 HD21 ' N ' ' A' ' 11' ' ' VAL . 0.4 OUTLIER -99.25 123.65 43.7 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.383 -0.823 . . . . 0.0 109.667 177.153 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.515 ' CG1' HD21 ' A' ' 16' ' ' LEU . 2.6 t -115.86 129.78 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.183 -0.948 . . . . 0.0 110.028 177.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -69.25 -40.03 78.11 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.326 -0.859 . . . . 0.0 110.59 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -114.93 139.49 49.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.064 -1.022 . . . . 0.0 110.652 -177.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.502 ' HB2' ' CZ ' ' A' ' 83' ' ' TYR . 86.3 tt0 -59.94 -42.41 93.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.428 -0.795 . . . . 0.0 110.032 177.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -56.68 -42.84 79.75 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.325 -0.859 . . . . 0.0 110.2 179.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.515 HD21 ' CG1' ' A' ' 11' ' ' VAL . 7.4 tt -68.09 -42.4 80.41 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.052 -1.03 . . . . 0.0 109.875 179.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.464 ' O ' ' HB3' ' A' ' 20' ' ' LEU . . . -59.97 -46.53 89.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.133 -0.98 . . . . 0.0 109.714 174.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' A' ' 14' ' ' GLU . 25.5 mt -60.04 -39.97 87.77 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.889 . . . . 0.0 109.97 175.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.465 ' O ' ' HG3' ' A' ' 23' ' ' GLN . 48.1 t0 -59.97 -40.63 89.76 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.181 -0.949 . . . . 0.0 109.298 174.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.464 ' HB3' ' O ' ' A' ' 17' ' ' ALA . 2.6 tp -63.28 -39.88 95.83 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.445 -0.784 . . . . 0.0 109.325 173.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.54 HD11 ' CD1' ' A' ' 85' ' ' ILE . 3.4 mp -59.29 -42.78 92.08 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.53 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -60.26 -40.06 88.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.393 -0.817 . . . . 0.0 109.92 174.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.465 ' HG3' ' O ' ' A' ' 19' ' ' ASP . 27.1 mt-30 -61.83 -40.31 94.85 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.45 -0.781 . . . . 0.0 110.818 -177.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.526 ' O ' ' N ' ' A' ' 28' ' ' ALA . 96.9 mt -66.24 -40.02 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.104 -0.997 . . . . 0.0 109.843 -178.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -64.02 -53.73 45.46 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.084 -1.01 . . . . 0.0 109.802 176.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -60.49 -43.47 96.99 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.316 -0.865 . . . . 0.0 110.808 177.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.558 ' O ' ' CB ' ' A' ' 28' ' ' ALA . . . -106.37 -59.78 0.6 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 -175.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.558 ' CB ' ' O ' ' A' ' 27' ' ' GLY . . . 83.23 89.89 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 O-C-N 122.07 -0.665 . . . . 0.0 109.861 -175.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -176.92 78.79 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.395 -0.816 . . . . 0.0 109.904 -174.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.537 ' CD2' ' HE3' ' A' ' 87' ' ' LYS . 5.4 m-85 -60.06 -40.56 89.9 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.271 -0.893 . . . . 0.0 110.79 -175.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.63 -51.42 56.12 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.77 -1.205 . . . . 0.0 110.116 -176.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -66.21 -40.01 90.03 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.07 -1.253 . . . . 0.0 110.446 -175.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 67.3 mt -65.92 -39.98 91.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.226 -0.921 . . . . 0.0 110.113 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.543 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -59.29 -50.09 75.34 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.239 -0.913 . . . . 0.0 110.348 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.5 tttp -59.99 -48.25 82.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.913 . . . . 0.0 110.577 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.9 tttt -60.06 -49.54 77.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.208 -0.932 . . . . 0.0 110.987 -175.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -81.88 -40.54 22.24 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.934 -1.104 . . . . 0.0 111.637 -172.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.465 ' O ' ' C ' ' A' ' 39' ' ' ILE . 23.7 t -60.06 -49.99 75.49 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.91 -1.119 . . . . 0.0 111.074 -172.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.465 ' C ' ' O ' ' A' ' 38' ' ' SER . 83.7 mt 33.39 48.59 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 CA-C-O 121.195 0.521 . . . . 0.0 111.142 -177.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.442 ' SG ' ' OG ' ' A' ' 38' ' ' SER . 15.3 p -139.98 176.06 2.79 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.132 -0.98 . . . . 0.0 110.407 -177.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.474 ' O ' ' CB ' ' A' ' 42' ' ' SER . 3.0 Cg_exo -68.87 66.26 1.28 Allowed 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.874 1.46 . . . . 0.0 109.849 -178.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 45' ' ' ARG . 0.1 OUTLIER 165.44 -41.95 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.779 -0.576 . . . . 0.0 109.69 179.594 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.465 ' HA3' ' OG ' ' A' ' 38' ' ' SER . . . -41.77 -37.36 1.99 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -178.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -60.31 -40.01 89.04 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.019 -1.283 . . . . 0.0 110.133 175.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.545 ' N ' ' O ' ' A' ' 42' ' ' SER . 11.3 tpp180 -102.4 -43.2 5.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.526 -0.734 . . . . 0.0 110.596 -176.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -55.15 -35.33 59.69 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.926 -1.269 . . . . 0.0 109.926 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.463 ' O ' HD21 ' A' ' 7' ' ' LEU . . . -67.99 -5.96 42.79 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 176.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -169.84 64.71 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.285 -1.126 . . . . 0.0 109.176 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.539 ' CD2' ' HG3' ' A' ' 45' ' ' ARG . 5.0 mt -69.99 -27.63 64.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.539 -0.726 . . . . 0.0 110.07 -178.011 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 101.06 -143.42 16.17 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 -176.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.43 ' HG3' ' C ' ' A' ' 4' ' ' ALA . 72.2 tt0 -111.8 133.14 54.21 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.206 -1.173 . . . . 0.0 110.253 -179.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.553 ' CZ ' ' CB ' ' A' ' 6' ' ' ALA . 4.7 p90 -145.56 166.43 25.74 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.322 -0.861 . . . . 0.0 109.985 -178.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.545 ' O ' ' N ' ' A' ' 55' ' ' GLY . 87.6 mtt180 -68.75 144.34 54.4 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.036 -1.04 . . . . 0.0 110.215 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.459 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 15.4 pt20 -63.44 64.06 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.572 -0.705 . . . . 0.0 110.76 -177.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . 165.08 61.96 0.02 OUTLIER Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 -179.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.47 ' HG3' ' HB2' ' A' ' 52' ' ' PHE . 3.1 mm-40 -117.94 -62.42 1.55 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.071 -1.252 . . . . 0.0 109.193 177.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.429 ' HE3' ' CG1' ' A' ' 58' ' ' VAL . 56.3 ttp -93.89 -51.41 4.89 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.706 -170.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.469 HG21 ' HD2' ' A' ' 59' ' ' PRO . 13.3 p -143.26 132.8 11.77 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.358 -0.839 . . . . 0.0 110.164 -174.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.469 ' HD2' HG21 ' A' ' 58' ' ' VAL . 14.5 Cg_endo -61.9 -48.57 8.36 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.902 1.475 . . . . 0.0 110.025 178.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 59' ' ' PRO . . . -39.81 -33.32 0.19 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.606 -0.684 . . . . 0.0 110.845 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.583 ' CD1' HG22 ' A' ' 86' ' ' ILE . 65.1 t80 -60.01 -44.03 94.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.043 -1.036 . . . . 0.0 110.358 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -60.73 -39.92 90.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.179 -0.95 . . . . 0.0 110.163 -179.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.408 ' HD3' ' HA ' ' A' ' 63' ' ' LYS . 75.6 mmtt -58.97 -45.89 89.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.182 -0.949 . . . . 0.0 110.378 -178.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.518 HG12 ' N ' ' A' ' 65' ' ' VAL . 8.5 p -73.39 -39.98 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.059 -1.025 . . . . 0.0 110.53 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.518 ' N ' HG12 ' A' ' 64' ' ' VAL . 9.6 t -55.75 -30.67 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.625 -1.297 . . . . 0.0 109.568 171.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -96.15 -0.36 50.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.37 -0.831 . . . . 0.0 109.844 176.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.421 ' CB ' ' HA ' ' A' ' 64' ' ' VAL . 6.9 t -96.44 -64.66 1.03 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.362 -0.836 . . . . 0.0 109.525 174.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.453 ' SG ' ' OG1' ' A' ' 74' ' ' THR . 91.1 m -89.57 130.73 42.33 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.326 -0.859 . . . . 0.0 110.016 175.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.548 ' O ' ' O ' ' A' ' 70' ' ' VAL . 25.2 Cg_endo -67.64 79.28 0.49 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.849 1.447 . . . . 0.0 110.79 -177.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.554 ' O ' ' N ' ' A' ' 72' ' ' GLU . 1.8 m 37.17 177.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.445 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 177.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.524 ' O ' ' CD2' ' A' ' 71' ' ' LEU . 0.0 OUTLIER 24.39 40.92 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.485 0 CA-C-O 121.636 0.731 . . . . 0.0 112.632 -170.72 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.554 ' N ' ' O ' ' A' ' 70' ' ' VAL . 3.4 tp10 -138.05 81.96 25.96 Favored Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 121.285 -0.885 . . . . 0.0 109.589 174.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -43.68 129.49 7.09 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 124.045 1.55 . . . . 0.0 110.204 -176.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.499 ' HB ' ' CG2' ' A' ' 64' ' ' VAL . 57.1 m -127.96 135.7 50.29 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.348 -0.845 . . . . 0.0 110.196 -175.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.441 ' HA3' HG13 ' A' ' 85' ' ' ILE . . . 133.6 -176.55 19.62 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 -178.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.531 ' HD3' ' CD1' ' A' ' 21' ' ' LEU . 43.3 Cg_endo -72.19 152.9 97.61 Favored 'Cis proline' 0 C--N 1.314 -1.276 0 C-N-CA 121.713 -2.203 . . . . 0.0 110.199 0.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.0 tp -131.38 154.51 48.54 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.129 -0.982 . . . . 0.0 110.329 -175.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 -76.64 130.92 38.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.244 -0.91 . . . . 0.0 110.761 -177.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.572 HG21 ' CE1' ' A' ' 84' ' ' HIS . 10.3 t -142.08 173.65 11.32 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.452 -0.78 . . . . 0.0 109.823 175.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -59.99 -27.72 67.1 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.158 -0.963 . . . . 0.0 110.517 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -96.39 9.97 39.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.999 -1.063 . . . . 0.0 110.902 -172.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 119.6 -124.65 6.04 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 -176.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.502 ' CZ ' ' HB2' ' A' ' 14' ' ' GLU . 87.1 m-85 -114.07 139.02 49.64 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.128 -1.219 . . . . 0.0 110.253 176.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.572 ' CE1' HG21 ' A' ' 79' ' ' THR . 21.9 m170 -121.7 121.63 37.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.35 -0.844 . . . . 0.0 110.377 177.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.547 ' CG2' ' HB ' ' A' ' 9' ' ' ILE . 6.1 tt -109.94 136.84 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.761 -1.212 . . . . 0.0 109.434 168.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.583 HG22 ' CD1' ' A' ' 61' ' ' PHE . 26.1 mt -133.48 131.67 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.076 -1.015 . . . . 0.0 111.223 -169.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.537 ' HE3' ' CD2' ' A' ' 30' ' ' PHE . 12.1 ttmm -105.25 128.03 53.23 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.237 -0.914 . . . . 0.0 109.411 170.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.424 ' CG2' HG21 ' A' ' 65' ' ' VAL . 60.8 t -108.77 139.3 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.204 -0.935 . . . . 0.0 110.363 -174.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.527 ' O ' ' CB ' ' A' ' 90' ' ' TYR . 81.6 mt -140.38 126.26 19.45 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.197 -0.94 . . . . 0.0 110.055 -177.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.527 ' CB ' ' O ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER 80.71 -57.97 0.3 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.415 -0.803 . . . . 0.0 111.53 171.985 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.546 ' HB2' ' CG1' ' A' ' 70' ' ' VAL . 47.5 ttp180 55.63 39.97 30.95 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.863 -1.148 . . . . 0.0 110.631 -179.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.466 ' ND2' ' HA ' ' A' ' 1' ' ' ALA . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 118.076 -0.964 . . . . 0.0 110.123 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.276 0.56 . . . . 0.0 110.39 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -61.35 -33.03 72.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.169 -0.957 . . . . 0.0 110.377 178.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 52' ' ' PHE . 72.6 m -132.46 150.02 52.23 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.147 -0.971 . . . . 0.0 110.095 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.577 ' O ' ' CD1' ' A' ' 52' ' ' PHE . . . -153.4 157.77 40.45 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.914 -1.116 . . . . 0.0 110.786 -177.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.458 ' HB3' ' HB2' ' A' ' 90' ' ' TYR . . . -104.14 139.46 39.18 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.149 -0.969 . . . . 0.0 109.429 172.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.529 ' HB2' ' NE2' ' A' ' 8' ' ' HIS . . . -149.83 130.79 14.3 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.694 -1.254 . . . . 0.0 111.457 -177.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.538 ' CD1' ' HE3' ' A' ' 87' ' ' LYS . 17.4 mt -100.75 146.17 27.58 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.454 -0.779 . . . . 0.0 109.746 172.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.53 ' ND1' HG12 ' A' ' 86' ' ' ILE . 8.0 m-70 -134.5 150.1 50.76 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.121 -0.987 . . . . 0.0 110.826 -175.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.548 ' HB ' ' CG2' ' A' ' 85' ' ' ILE . 89.8 mt -128.78 129.88 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.063 -1.023 . . . . 0.0 109.671 167.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.524 ' HG ' ' CD2' ' A' ' 84' ' ' HIS . 0.5 OUTLIER -106.5 119.33 39.01 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.497 -0.752 . . . . 0.0 110.1 -177.523 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.512 ' CG1' ' HB3' ' A' ' 16' ' ' LEU . 3.1 t -114.97 131.05 68.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.227 -0.921 . . . . 0.0 110.045 176.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 49.0 tttt -69.95 -40.01 75.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.083 -1.011 . . . . 0.0 110.614 -178.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -109.04 137.25 47.24 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.107 -0.995 . . . . 0.0 110.839 -176.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.561 ' HB2' ' CZ ' ' A' ' 83' ' ' TYR . 86.5 tt0 -59.99 -42.01 93.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.443 -0.785 . . . . 0.0 110.121 178.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -56.37 -41.16 75.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.322 -0.861 . . . . 0.0 110.212 178.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.512 ' HB3' ' CG1' ' A' ' 11' ' ' VAL . 4.7 tt -67.95 -39.91 83.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.014 -1.054 . . . . 0.0 109.076 175.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.438 ' O ' HD11 ' A' ' 21' ' ' LEU . . . -59.93 -40.63 89.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.303 -0.873 . . . . 0.0 110.095 175.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.03 -42.05 93.56 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.022 -1.049 . . . . 0.0 109.571 175.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -59.99 -38.99 84.22 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.275 -0.891 . . . . 0.0 109.706 173.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.537 ' HG ' ' N ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -60.82 -50.38 73.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.313 -0.867 . . . . 0.0 109.885 178.822 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.537 ' N ' ' HG ' ' A' ' 20' ' ' LEU . 1.4 mt -60.02 -49.26 78.38 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.339 -0.851 . . . . 0.0 110.181 -178.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -60.48 -40.08 89.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.454 -0.779 . . . . 0.0 109.999 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 70.0 tp60 -59.99 -41.31 91.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.365 -0.834 . . . . 0.0 110.529 -175.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.528 ' O ' ' N ' ' A' ' 28' ' ' ALA . 63.1 mt -63.65 -47.92 89.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.2 -0.938 . . . . 0.0 110.21 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -62.11 -45.08 95.08 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.903 -1.123 . . . . 0.0 109.659 177.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -59.97 -60.8 3.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.376 -0.827 . . . . 0.0 110.178 177.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.553 ' O ' ' CB ' ' A' ' 28' ' ' ALA . . . -105.83 -45.8 1.26 Allowed Glycine 0 N--CA 1.486 1.992 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -175.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.592 ' O ' ' CB ' ' A' ' 29' ' ' ASP . . . 80.16 158.69 0.16 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.811 -0.817 . . . . 0.0 110.462 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.592 ' CB ' ' O ' ' A' ' 28' ' ' ALA . 96.7 m-20 118.26 81.24 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.038 0 C-N-CA 125.053 1.341 . . . . 0.0 109.634 -175.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.451 ' CZ ' HD12 ' A' ' 24' ' ' ILE . 2.1 m-85 -60.02 -45.04 94.1 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.207 -0.933 . . . . 0.0 110.999 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.39 -54.64 25.38 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.765 -1.207 . . . . 0.0 110.141 -174.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -65.94 -39.95 90.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.048 -1.266 . . . . 0.0 110.306 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 46.8 mt -63.65 -39.97 95.68 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.134 -0.979 . . . . 0.0 109.643 176.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.531 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -55.18 -50.64 68.83 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.266 -0.896 . . . . 0.0 110.091 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -59.96 -51.97 67.39 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.055 -1.028 . . . . 0.0 110.677 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -60.96 -50.07 74.87 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.21 -0.931 . . . . 0.0 111.175 -176.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -70.43 -39.97 74.07 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.123 -0.986 . . . . 0.0 110.867 -177.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.531 ' O ' ' CG2' ' A' ' 39' ' ' ILE . 20.7 t -60.08 -46.35 89.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.138 -0.976 . . . . 0.0 110.349 -175.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.531 ' CG2' ' O ' ' A' ' 38' ' ' SER . 16.0 tt 37.99 29.87 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.7 -0.625 . . . . 0.0 110.58 178.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.476 ' HB2' ' HD2' ' A' ' 41' ' ' PRO . 15.2 p -129.67 165.11 35.37 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.35 -0.844 . . . . 0.0 110.193 -176.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.476 ' HD2' ' HB2' ' A' ' 40' ' ' CYS . 1.1 Cg_endo -47.76 -28.43 9.61 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.802 1.422 . . . . 0.0 110.562 178.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.523 ' O ' ' CA ' ' A' ' 46' ' ' GLY . 0.2 OUTLIER -99.77 18.43 18.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.99 -1.069 . . . . 0.0 110.148 177.526 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 40' ' ' CYS . . . -75.44 -55.01 5.27 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.549 -1.82 . . . . 0.0 108.549 171.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -61.12 -40.03 92.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.457 -1.025 . . . . 0.0 110.749 177.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.402 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 12.8 tpt180 -104.53 -41.26 5.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.089 -1.007 . . . . 0.0 110.795 -174.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.523 ' CA ' ' O ' ' A' ' 42' ' ' SER . . . -69.95 -31.88 69.8 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.55 0.9 59.47 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 177.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.527 ' HA ' ' CD2' ' A' ' 7' ' ' LEU . 47.8 t0 -170.38 76.17 0.08 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.296 -1.12 . . . . 0.0 109.065 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 19.2 mt -82.63 -14.96 53.81 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.602 -0.686 . . . . 0.0 110.193 -174.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.01 -137.96 14.29 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 177.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 3.4 mt-10 -108.79 158.59 17.5 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.453 -1.028 . . . . 0.0 110.421 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' A' ' 52' ' ' PHE . 0.0 OUTLIER -139.96 177.83 7.69 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.389 -0.82 . . . . 0.0 109.407 -175.583 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.539 ' O ' ' N ' ' A' ' 55' ' ' GLY . 29.8 ptt180 -167.32 -175.88 3.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.616 -0.677 . . . . 0.0 109.849 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.481 ' O ' ' O ' ' A' ' 55' ' ' GLY . 96.7 mt-30 32.08 -87.47 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 O-C-N 122.006 -0.434 . . . . 0.0 112.135 178.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . -53.23 -111.51 0.01 OUTLIER Glycine 0 N--CA 1.496 2.695 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 -174.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.522 ' OE1' ' CB ' ' A' ' 52' ' ' PHE . 51.0 mm-40 60.0 22.91 12.04 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.788 -1.419 . . . . 0.0 109.667 -178.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.443 ' O ' ' C ' ' A' ' 58' ' ' VAL . 54.5 ttm -60.02 -45.86 91.4 Favored 'General case' 0 C--N 1.289 -2.049 0 O-C-N 120.8 -1.188 . . . . 0.0 111.539 -160.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.484 HG22 ' HD2' ' A' ' 59' ' ' PRO . 1.4 p -39.35 132.75 1.26 Allowed Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.575 -0.703 . . . . 0.0 110.307 -174.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.484 ' HD2' HG22 ' A' ' 58' ' ' VAL . 10.1 Cg_endo -56.77 -52.81 6.07 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.005 1.529 . . . . 0.0 110.88 -171.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -45.28 -44.63 11.54 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.219 -0.925 . . . . 0.0 110.578 -174.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -59.99 -41.68 92.57 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.185 -0.947 . . . . 0.0 110.118 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.457 ' O ' HG11 ' A' ' 65' ' ' VAL . 57.4 t0 -71.78 -38.4 70.3 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.317 -0.864 . . . . 0.0 110.298 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.521 ' O ' ' N ' ' A' ' 67' ' ' SER . 87.6 tttt -55.06 -49.96 70.31 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.24 -0.912 . . . . 0.0 110.216 -175.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.481 ' HA ' ' HB3' ' A' ' 67' ' ' SER . 2.5 p -69.81 -47.1 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.129 -0.982 . . . . 0.0 111.814 -174.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.457 HG11 ' O ' ' A' ' 62' ' ' ASP . 3.0 p -57.4 -27.12 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.319 -1.488 . . . . 0.0 109.055 173.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -92.97 -11.19 33.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.407 -0.808 . . . . 0.0 109.846 175.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 63' ' ' LYS . 9.4 t -91.62 -44.74 8.87 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.318 -0.864 . . . . 0.0 109.756 176.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.46 ' HB3' ' HB3' ' A' ' 72' ' ' GLU . 66.1 m -137.14 149.98 67.82 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.306 -0.871 . . . . 0.0 110.382 178.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.464 ' O ' ' HB2' ' A' ' 72' ' ' GLU . 52.1 Cg_endo -77.71 -179.48 5.48 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.054 1.555 . . . . 0.0 110.932 -178.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.525 ' CG2' HD13 ' A' ' 71' ' ' LEU . 7.2 p -60.04 157.65 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.424 -0.797 . . . . 0.0 110.06 177.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.525 HD13 ' CG2' ' A' ' 70' ' ' VAL . 4.4 mp 60.01 40.03 19.22 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.419 -0.8 . . . . 0.0 110.234 -175.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -150.46 104.42 3.1 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.299 -0.875 . . . . 0.0 110.258 178.72 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -67.15 135.09 36.04 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.89 1.469 . . . . 0.0 110.273 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.458 ' OG1' ' SG ' ' A' ' 68' ' ' CYS . 87.2 m -140.13 147.21 39.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.164 -0.96 . . . . 0.0 110.488 -178.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.466 ' HA3' HG13 ' A' ' 85' ' ' ILE . . . 125.72 -168.88 17.72 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.486 ' CD ' HD12 ' A' ' 21' ' ' LEU . 43.0 Cg_endo -72.32 139.23 59.09 Favored 'Cis proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.847 -2.147 . . . . 0.0 110.732 -0.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.447 ' CD1' ' HB ' ' A' ' 64' ' ' VAL . 88.7 mt -92.99 169.37 10.48 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.3 -0.875 . . . . 0.0 110.633 -176.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 14.3 t60 -100.24 119.57 38.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.144 -0.972 . . . . 0.0 110.381 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.516 HG21 ' ND1' ' A' ' 84' ' ' HIS . 14.7 t -141.56 166.38 24.91 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.155 -0.965 . . . . 0.0 109.815 176.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.415 ' CG ' ' N ' ' A' ' 81' ' ' PHE . 15.8 pt20 -59.93 -34.75 73.66 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.121 -0.987 . . . . 0.0 110.397 -176.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.415 ' N ' ' CG ' ' A' ' 80' ' ' GLN . 94.4 m-85 -60.04 -27.26 66.78 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.271 -0.893 . . . . 0.0 110.208 178.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 141.63 -132.37 5.24 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -178.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.561 ' CZ ' ' HB2' ' A' ' 14' ' ' GLU . 81.3 m-85 -96.66 120.99 37.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -1.139 . . . . 0.0 109.876 175.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.524 ' CD2' ' HG ' ' A' ' 10' ' ' LEU . 0.6 OUTLIER -113.29 113.64 25.55 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.566 -0.709 . . . . 0.0 110.9 -176.453 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.548 ' CG2' ' HB ' ' A' ' 9' ' ' ILE . 12.2 tt -109.82 133.9 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 120.616 -1.302 . . . . 0.0 109.579 170.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.53 HG12 ' ND1' ' A' ' 8' ' ' HIS . 85.9 mt -138.24 141.93 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.044 -1.035 . . . . 0.0 110.67 -172.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.538 ' HE3' ' CD1' ' A' ' 7' ' ' LEU . 20.1 pttp -119.53 142.06 48.67 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.048 -1.033 . . . . 0.0 109.511 171.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 62.5 t -107.9 129.97 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.913 -1.117 . . . . 0.0 111.302 -168.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' A' ' 91' ' ' ARG . 89.5 mt -114.26 -170.97 1.83 Allowed 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.305 -0.872 . . . . 0.0 109.204 172.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.458 ' HB2' ' HB3' ' A' ' 5' ' ' ALA . 71.0 m-85 32.85 -86.46 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.735 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.533 ' N ' ' O ' ' A' ' 89' ' ' LEU . 29.7 ttp85 60.82 48.63 6.75 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.696 -1.253 . . . . 0.0 110.617 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.444 ' ND2' ' C ' ' A' ' 92' ' ' ASN . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.945 176.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.48 ' HA ' ' CB ' ' A' ' 92' ' ' ASN . . . . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.235 0.541 . . . . 0.0 110.16 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.424 ' O ' HG21 ' A' ' 3' ' ' THR . 32.0 mtpt -60.01 -41.93 93.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.222 -0.924 . . . . 0.0 109.174 177.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.433 HG22 ' N ' ' A' ' 53' ' ' ARG . 28.1 p -139.98 156.64 46.55 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.192 0.52 . . . . 0.0 110.087 175.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -129.88 160.12 34.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.254 -0.904 . . . . 0.0 109.656 178.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.495 ' CB ' ' CD1' ' A' ' 90' ' ' TYR . . . -95.52 127.39 41.51 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.121 -0.987 . . . . 0.0 109.551 179.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.525 ' HB1' ' NE2' ' A' ' 8' ' ' HIS . . . -134.51 131.07 37.57 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.699 -1.25 . . . . 0.0 111.56 -170.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.517 ' C ' ' CD2' ' A' ' 8' ' ' HIS . 39.9 mt -102.28 147.31 26.82 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.078 -1.014 . . . . 0.0 109.33 170.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.526 ' ND1' HG12 ' A' ' 86' ' ' ILE . 31.4 m-70 -143.52 134.02 24.84 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.803 -1.185 . . . . 0.0 111.407 -175.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.573 HG13 ' CZ ' ' A' ' 30' ' ' PHE . 95.3 mt -119.99 125.69 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.776 -1.202 . . . . 0.0 109.763 165.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.574 ' HG ' ' CD2' ' A' ' 84' ' ' HIS . 0.2 OUTLIER -102.79 121.4 42.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.603 -0.686 . . . . 0.0 109.689 179.553 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.518 ' N ' HD23 ' A' ' 10' ' ' LEU . 2.2 t -109.31 125.48 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.134 -0.979 . . . . 0.0 110.394 178.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -67.58 -39.97 84.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.445 -0.784 . . . . 0.0 110.446 175.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -108.11 136.84 47.11 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.217 -0.927 . . . . 0.0 110.966 -174.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -60.07 -40.84 90.93 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.4 -0.812 . . . . 0.0 110.115 173.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -58.86 -40.23 83.71 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.209 -0.932 . . . . 0.0 110.459 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.468 ' CD2' HG11 ' A' ' 11' ' ' VAL . 3.7 tt -68.31 -38.19 81.33 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.045 -1.034 . . . . 0.0 109.054 175.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.76 -44.48 90.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.361 -0.837 . . . . 0.0 110.114 175.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.99 -42.72 94.84 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.221 -0.924 . . . . 0.0 109.611 176.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.437 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 65.1 t0 -59.94 -40.63 89.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.312 -0.867 . . . . 0.0 109.674 173.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.492 HD21 ' N ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -63.91 -55.32 23.55 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 121.587 0.708 . . . . 0.0 110.035 -179.786 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.529 ' CD1' ' HG3' ' A' ' 76' ' ' PRO . 0.4 OUTLIER -54.89 -40.07 69.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.564 -0.71 . . . . 0.0 109.779 179.5 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -60.58 -49.11 78.86 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.586 -0.696 . . . . 0.0 110.74 -176.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.466 ' HB3' HD23 ' A' ' 33' ' ' LEU . 87.7 mm-40 -61.55 -40.04 93.25 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.116 -0.99 . . . . 0.0 110.375 -175.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.56 ' CG1' ' CD1' ' A' ' 33' ' ' LEU . 96.9 mt -59.97 -49.95 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.263 -0.898 . . . . 0.0 110.019 -177.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -62.18 -48.31 80.63 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.883 -1.136 . . . . 0.0 109.75 176.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.11 -55.79 29.54 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.341 -0.849 . . . . 0.0 110.28 178.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.537 ' O ' ' CB ' ' A' ' 28' ' ' ALA . . . -105.28 -48.57 1.05 Allowed Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -174.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.537 ' CB ' ' O ' ' A' ' 27' ' ' GLY . . . 81.81 96.03 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.173 0 O-C-N 122.151 -0.617 . . . . 0.0 110.228 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.43 ' HB3' ' HB2' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -176.0 84.61 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.466 -0.771 . . . . 0.0 109.935 -178.218 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.574 ' CG ' ' HE3' ' A' ' 87' ' ' LYS . 45.8 t80 -60.03 -48.5 81.45 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.314 -0.866 . . . . 0.0 110.573 -175.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.05 -47.84 89.03 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -176.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.43 ' HB2' ' HB3' ' A' ' 29' ' ' ASP . 36.6 mmtm -65.77 -40.16 91.75 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.055 -1.262 . . . . 0.0 110.561 -176.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.56 ' CD1' ' CG1' ' A' ' 24' ' ' ILE . 84.0 mt -66.76 -40.03 88.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.089 -1.007 . . . . 0.0 110.334 179.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.522 ' O ' ' CB ' ' A' ' 38' ' ' SER . . . -59.93 -47.35 86.16 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.121 -0.987 . . . . 0.0 109.992 179.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 66.8 tttt -60.01 -46.57 89.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.16 -0.963 . . . . 0.0 110.456 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.514 ' O ' ' CG2' ' A' ' 39' ' ' ILE . 55.7 mttt -70.03 -59.6 2.81 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.138 -0.976 . . . . 0.0 110.993 -176.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.445 ' HB3' HD23 ' A' ' 16' ' ' LEU . 80.9 m-70 -71.73 -40.18 69.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.095 -1.003 . . . . 0.0 111.129 -172.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.527 ' O ' ' CG1' ' A' ' 39' ' ' ILE . 8.6 t -60.17 -49.25 78.37 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.135 -0.978 . . . . 0.0 110.509 -175.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.527 ' CG1' ' O ' ' A' ' 38' ' ' SER . 36.4 pt 37.95 32.72 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-O 121.452 0.644 . . . . 0.0 110.465 -177.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.459 ' SG ' ' OG ' ' A' ' 38' ' ' SER . 14.9 p -125.93 166.21 22.7 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.393 -0.817 . . . . 0.0 109.658 178.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -51.7 -22.93 14.25 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.823 1.433 . . . . 0.0 110.425 -178.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.7 OUTLIER -101.63 12.99 36.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -0.908 . . . . 0.0 110.636 -179.025 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.08 -56.43 4.41 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 174.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 16.3 tttp -60.01 -40.0 87.73 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.343 -1.093 . . . . 0.0 110.368 177.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.466 ' HD2' HD23 ' A' ' 49' ' ' LEU . 8.7 tpp85 -98.86 -43.65 6.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 0.0 110.58 -175.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -60.0 -35.97 88.85 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.29 -4.21 35.68 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 110.016 -1.233 . . . . 0.0 110.016 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.432 ' HA ' ' CD2' ' A' ' 7' ' ' LEU . 9.7 t0 -171.32 69.37 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.016 -1.285 . . . . 0.0 109.449 178.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.466 HD23 ' HD2' ' A' ' 45' ' ' ARG . 4.8 mt -70.03 -29.91 67.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.508 -0.745 . . . . 0.0 110.75 -176.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 112.23 -152.57 17.76 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -111.91 136.96 50.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.358 -1.084 . . . . 0.0 110.079 -178.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.48 ' HB2' ' HG3' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -160.18 168.17 26.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.198 -0.939 . . . . 0.0 110.243 -174.764 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.516 ' HG2' ' NE2' ' A' ' 56' ' ' GLN . 48.7 ptt85 -94.52 -174.16 3.24 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.997 -1.064 . . . . 0.0 110.546 -176.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -63.51 -37.51 87.6 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.143 -0.973 . . . . 0.0 110.99 -176.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.437 ' HA3' ' NH2' ' A' ' 53' ' ' ARG . . . -85.67 61.45 4.56 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -173.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.516 ' NE2' ' HG2' ' A' ' 53' ' ' ARG . 5.0 mm-40 -134.83 -53.26 0.81 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.956 -1.32 . . . . 0.0 109.466 178.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 9.7 ttm -119.4 -150.73 0.46 Allowed 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.959 -162.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.472 ' O ' ' HB3' ' A' ' 61' ' ' PHE . 2.8 p -68.18 133.46 91.57 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.485 -0.759 . . . . 0.0 110.032 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.483 ' O ' ' N ' ' A' ' 61' ' ' PHE . 5.7 Cg_endo -52.68 -55.16 4.03 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.012 1.533 . . . . 0.0 110.484 -177.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 59' ' ' PRO . . . -37.5 -29.22 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.647 -0.658 . . . . 0.0 110.863 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.483 ' N ' ' O ' ' A' ' 59' ' ' PRO . 32.0 t80 -60.03 -43.9 94.99 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.999 -1.063 . . . . 0.0 110.309 178.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 59' ' ' PRO . 7.7 t70 -60.04 -40.03 87.96 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.213 -0.929 . . . . 0.0 109.459 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.459 ' O ' ' HB2' ' A' ' 67' ' ' SER . 12.4 tptp -57.63 -49.95 74.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.391 -0.818 . . . . 0.0 110.876 177.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.534 ' CG2' ' N ' ' A' ' 65' ' ' VAL . 1.3 m -70.36 -48.64 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 120.929 -1.107 . . . . 0.0 110.832 -172.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.534 ' N ' ' CG2' ' A' ' 64' ' ' VAL . 13.2 p -57.01 -24.64 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.431 -1.418 . . . . 0.0 109.318 172.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.459 ' O ' ' CD1' ' A' ' 66' ' ' PHE . 17.2 t80 -96.57 -0.06 49.3 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.402 -0.811 . . . . 0.0 109.737 175.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 63' ' ' LYS . 33.0 t -97.93 -49.13 4.9 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.431 -0.793 . . . . 0.0 110.006 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.465 ' HB2' ' OG1' ' A' ' 74' ' ' THR . 95.1 m -117.69 147.04 40.12 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.353 -0.842 . . . . 0.0 109.985 179.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -57.14 146.43 81.33 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.015 1.534 . . . . 0.0 110.471 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.518 HG22 ' N ' ' A' ' 71' ' ' LEU . 4.8 p -60.77 173.94 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.26 -0.9 . . . . 0.0 109.976 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.518 ' N ' HG22 ' A' ' 70' ' ' VAL . 2.3 mp 59.61 20.11 8.69 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.335 -0.853 . . . . 0.0 109.642 -175.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -139.21 87.3 13.91 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.5 -0.75 . . . . 0.0 109.668 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 87' ' ' LYS . 52.9 Cg_exo -45.3 115.22 0.87 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.052 1.554 . . . . 0.0 110.337 -176.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.465 ' OG1' ' HB2' ' A' ' 68' ' ' CYS . 54.9 m -108.61 122.91 48.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.255 -0.903 . . . . 0.0 110.405 -176.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 150.91 179.86 27.01 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.529 ' HG3' ' CD1' ' A' ' 21' ' ' LEU . 42.6 Cg_endo -72.15 170.14 68.28 Favored 'Cis proline' 0 C--N 1.315 -1.219 0 C-N-CA 121.674 -2.219 . . . . 0.0 110.588 -0.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.2 mt -139.17 160.55 39.54 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.355 -0.841 . . . . 0.0 110.284 -175.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -84.98 124.48 31.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.238 -0.914 . . . . 0.0 110.239 -179.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.518 HG23 ' CE1' ' A' ' 84' ' ' HIS . 8.8 t -137.63 158.17 44.94 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.105 -0.997 . . . . 0.0 109.895 175.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -59.99 -23.78 63.91 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -0.903 . . . . 0.0 110.225 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -78.88 -10.08 59.69 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.226 -0.921 . . . . 0.0 110.583 -178.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.44 ' O ' HG21 ' A' ' 79' ' ' THR . . . 130.45 -137.36 9.44 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 -175.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.409 ' O ' HD23 ' A' ' 10' ' ' LEU . 0.2 OUTLIER -95.37 136.9 35.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.164 -1.198 . . . . 0.0 110.015 175.211 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.574 ' CD2' ' HG ' ' A' ' 10' ' ' LEU . 3.9 m170 -127.99 114.79 17.56 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.472 -0.767 . . . . 0.0 110.835 -177.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.534 ' CG2' ' HB ' ' A' ' 9' ' ' ILE . 3.6 tt -111.12 130.96 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.09 -1.007 . . . . 0.0 109.515 171.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.526 HG12 ' ND1' ' A' ' 8' ' ' HIS . 78.4 mt -135.37 132.12 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.026 -1.046 . . . . 0.0 111.142 -169.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.574 ' HE3' ' CG ' ' A' ' 30' ' ' PHE . 23.1 mttt -99.27 140.45 33.43 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.876 -1.14 . . . . 0.0 109.985 171.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.481 HG11 ' CB ' ' A' ' 70' ' ' VAL . 37.5 t -109.95 129.97 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.367 -0.833 . . . . 0.0 110.078 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.554 ' O ' ' N ' ' A' ' 91' ' ' ARG . 88.1 mt -139.09 -164.59 1.69 Allowed 'General case' 0 C--N 1.307 -1.271 0 O-C-N 121.19 -0.944 . . . . 0.0 109.557 -178.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.495 ' CD1' ' CB ' ' A' ' 5' ' ' ALA . 44.2 m-85 34.68 -85.98 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.122 0 O-C-N 122.078 -0.389 . . . . 0.0 111.71 -178.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.554 ' N ' ' O ' ' A' ' 89' ' ' LEU . 36.1 ttp180 61.0 51.07 4.68 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.873 -1.142 . . . . 0.0 110.893 -178.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.48 ' CB ' ' HA ' ' A' ' 1' ' ' ALA . 23.7 t-20 . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 118.083 -0.961 . . . . 0.0 110.311 176.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.487 ' HB3' ' CB ' ' A' ' 92' ' ' ASN . . . . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.219 0.533 . . . . 0.0 110.222 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.512 ' N ' ' OXT' ' A' ' 92' ' ' ASN . 31.7 mmtm -124.38 144.63 49.93 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.259 -0.901 . . . . 0.0 110.635 178.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.513 ' CG2' ' HG2' ' A' ' 51' ' ' GLU . 0.2 OUTLIER 58.48 123.98 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.493 -0.755 . . . . 0.0 110.81 175.014 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.433 ' C ' ' HG3' ' A' ' 51' ' ' GLU . . . -119.88 146.59 45.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.43 -0.794 . . . . 0.0 109.515 174.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 89' ' ' LEU . . . -92.57 125.69 37.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.039 -1.038 . . . . 0.0 109.461 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.58 ' HB3' ' CE2' ' A' ' 52' ' ' PHE . . . -136.33 135.1 38.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.833 -1.167 . . . . 0.0 111.556 -170.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.532 ' CD2' ' HA ' ' A' ' 48' ' ' ASP . 72.2 mt -109.11 143.89 37.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.207 -0.933 . . . . 0.0 108.877 168.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.501 ' CD2' HG12 ' A' ' 86' ' ' ILE . 45.7 m170 -130.89 129.5 42.33 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.723 -1.236 . . . . 0.0 111.365 -176.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.542 ' HB ' ' CG2' ' A' ' 85' ' ' ILE . 59.1 mt -109.99 129.96 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.106 -0.996 . . . . 0.0 109.229 168.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.578 HD21 ' CD2' ' A' ' 84' ' ' HIS . 1.8 tm? -107.55 120.04 41.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.144 -0.972 . . . . 0.0 110.135 178.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.527 HG12 ' CD2' ' A' ' 16' ' ' LEU . 2.6 t -99.66 132.46 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.526 -0.734 . . . . 0.0 110.001 -179.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -64.28 -39.98 95.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.395 -0.815 . . . . 0.0 110.673 -178.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -136.36 153.93 50.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.067 -1.021 . . . . 0.0 110.707 -176.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.432 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 86.1 tt0 -59.75 -40.09 86.98 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.397 -0.814 . . . . 0.0 110.462 -177.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 29.9 tptt -51.57 -45.54 63.14 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.275 -0.89 . . . . 0.0 110.09 -177.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.527 ' CD2' HG12 ' A' ' 11' ' ' VAL . 7.4 tt -67.8 -39.92 83.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.111 -0.993 . . . . 0.0 109.409 175.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.475 ' O ' ' CD1' ' A' ' 21' ' ' LEU . . . -57.12 -42.7 81.34 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.392 -0.818 . . . . 0.0 109.71 176.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.09 -46.94 87.91 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.231 -0.918 . . . . 0.0 109.634 173.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -60.1 -40.02 88.21 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.422 -0.799 . . . . 0.0 110.184 177.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.543 ' CD1' ' CD2' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -63.15 -52.31 62.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.105 -0.997 . . . . 0.0 109.469 178.716 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.539 ' N ' ' HG ' ' A' ' 20' ' ' LEU . 0.6 OUTLIER -56.55 -46.67 80.56 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.326 -0.859 . . . . 0.0 109.766 -177.689 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -60.04 -39.97 87.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.117 -0.989 . . . . 0.0 109.547 171.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.482 ' HB3' ' O ' ' A' ' 20' ' ' LEU . 61.5 tt0 -60.51 -39.97 89.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.435 -0.79 . . . . 0.0 111.047 -177.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.542 ' O ' ' CA ' ' A' ' 28' ' ' ALA . 18.9 mm -61.26 -39.99 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.796 -1.19 . . . . 0.0 109.724 -176.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -65.17 -56.48 12.65 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.676 -1.265 . . . . 0.0 110.14 177.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -60.11 -50.81 72.23 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.25 -0.906 . . . . 0.0 110.83 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 28' ' ' ALA . . . -105.64 -19.64 10.21 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -168.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.542 ' CA ' ' O ' ' A' ' 24' ' ' ILE . . . 34.18 94.48 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.821 -0.811 . . . . 0.0 111.474 -178.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -177.3 76.41 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.61 -0.681 . . . . 0.0 109.41 -178.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.531 ' HB3' ' CE ' ' A' ' 87' ' ' LYS . 2.5 m-85 -60.06 -43.2 95.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.876 . . . . 0.0 110.807 -173.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.4 -47.5 90.38 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -178.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.49 ' O ' ' HG2' ' A' ' 35' ' ' LYS . 83.6 tttt -63.72 -40.03 95.76 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.19 -1.182 . . . . 0.0 110.23 -178.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.543 ' CD2' ' CD1' ' A' ' 20' ' ' LEU . 40.3 tp -64.1 -40.04 95.35 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.866 -1.146 . . . . 0.0 110.162 178.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.504 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -59.24 -52.83 64.01 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.162 -0.961 . . . . 0.0 110.366 -177.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 55.8 pttt -62.84 -41.21 99.25 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.817 -1.177 . . . . 0.0 110.425 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.467 ' N ' ' CG ' ' A' ' 35' ' ' LYS . 88.3 tttt -62.48 -48.32 80.09 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.197 -0.94 . . . . 0.0 111.446 -174.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.406 ' O ' HG12 ' A' ' 39' ' ' ILE . 41.1 m170 -102.89 -17.64 15.42 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.814 -1.179 . . . . 0.0 111.513 -169.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.527 ' O ' ' CG1' ' A' ' 39' ' ' ILE . 33.7 t -59.96 -44.2 94.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.813 -1.179 . . . . 0.0 110.651 -174.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.527 ' CG1' ' O ' ' A' ' 38' ' ' SER . 45.2 pt 36.69 30.05 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.696 -0.628 . . . . 0.0 110.636 -178.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.499 ' N ' ' O ' ' A' ' 38' ' ' SER . 43.2 t -125.46 144.57 48.26 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.423 -0.798 . . . . 0.0 109.853 -176.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.471 ' HD2' ' SG ' ' A' ' 40' ' ' CYS . 51.6 Cg_exo -49.31 -21.44 4.64 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 123.673 1.354 . . . . 0.0 110.491 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.51 ' O ' ' CA ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -101.27 16.98 23.77 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.212 -0.93 . . . . 0.0 110.184 176.801 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 40' ' ' CYS . . . -79.61 -56.52 3.34 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 173.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -60.04 -39.93 87.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.349 -1.089 . . . . 0.0 110.392 176.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -97.15 -39.79 9.12 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.069 -1.02 . . . . 0.0 110.619 -176.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.51 ' CA ' ' O ' ' A' ' 42' ' ' SER . . . -76.79 -18.27 79.05 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.74 0.09 62.37 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.276 -1.529 . . . . 0.0 109.276 173.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.532 ' HA ' ' CD2' ' A' ' 7' ' ' LEU . 33.9 t0 -172.51 73.13 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.299 -1.118 . . . . 0.0 108.966 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.464 ' HG ' ' HA2' ' A' ' 46' ' ' GLY . 5.5 mt -80.09 -13.26 59.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.419 -0.801 . . . . 0.0 109.899 -175.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.08 -148.04 20.61 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -178.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.513 ' HG2' ' CG2' ' A' ' 3' ' ' THR . 80.5 tt0 -110.92 131.8 54.75 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.336 -1.096 . . . . 0.0 110.173 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.58 ' CE2' ' HB3' ' A' ' 6' ' ' ALA . 3.8 p90 -139.52 158.17 44.59 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.389 -0.819 . . . . 0.0 110.266 -178.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.521 ' O ' ' CG ' ' A' ' 56' ' ' GLN . 30.7 ptt-85 -89.81 -178.32 5.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.354 -0.841 . . . . 0.0 110.043 -178.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -60.71 136.67 58.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.146 -0.971 . . . . 0.0 109.848 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 91.79 63.98 1.15 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.58 ' HG3' ' CD1' ' A' ' 52' ' ' PHE . 33.1 mm-40 -129.47 -64.43 0.89 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.795 -1.415 . . . . 0.0 110.114 176.162 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 28.9 tpp -116.62 -63.44 1.45 Allowed 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 118.935 -1.106 . . . . 0.0 111.57 -163.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.477 HG23 ' HD2' ' A' ' 59' ' ' PRO . 12.9 p -151.16 135.09 9.4 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 120.921 -1.112 . . . . 0.0 110.577 -169.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.497 ' O ' ' N ' ' A' ' 62' ' ' ASP . 10.3 Cg_endo -55.07 -53.01 6.6 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.971 1.511 . . . . 0.0 110.389 177.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 59' ' ' PRO . . . -38.35 -33.1 0.09 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.711 -0.618 . . . . 0.0 110.498 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.483 ' CE1' ' NE2' ' A' ' 8' ' ' HIS . 68.3 t80 -60.05 -41.13 91.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.296 -0.878 . . . . 0.0 110.638 177.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' A' ' 59' ' ' PRO . 52.9 t0 -60.09 -39.94 87.87 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.26 -0.9 . . . . 0.0 110.104 -178.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.415 ' O ' ' HB2' ' A' ' 67' ' ' SER . 79.8 mttt -59.62 -40.06 86.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.874 . . . . 0.0 110.79 -176.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.528 HG21 ' CD1' ' A' ' 86' ' ' ILE . 0.9 OUTLIER -85.22 -48.0 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 120.996 -1.065 . . . . 0.0 111.125 -174.515 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.521 ' N ' ' CG2' ' A' ' 64' ' ' VAL . 7.5 p -54.6 -26.31 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.674 -1.266 . . . . 0.0 109.554 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -96.27 12.41 31.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.252 -0.905 . . . . 0.0 109.764 174.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.464 ' HB3' ' O ' ' A' ' 64' ' ' VAL . 44.4 t -101.27 -41.0 6.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.418 -0.801 . . . . 0.0 110.605 -177.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.514 ' CB ' ' OE1' ' A' ' 72' ' ' GLU . 59.7 m -126.23 154.22 74.49 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.15 -0.969 . . . . 0.0 110.727 -175.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.569 ' O ' ' O ' ' A' ' 70' ' ' VAL . 9.2 Cg_exo -68.05 67.1 0.96 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 124.036 1.545 . . . . 0.0 110.498 177.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.569 ' O ' ' O ' ' A' ' 69' ' ' PRO . 13.4 p 27.68 -169.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 C-N-CA 123.119 0.568 . . . . 0.0 111.891 176.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.495 HD12 ' CG1' ' A' ' 70' ' ' VAL . 4.7 mp 38.65 30.39 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 O-C-N 119.803 -1.811 . . . . 0.0 111.132 -168.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.514 ' OE1' ' CB ' ' A' ' 68' ' ' CYS . 2.0 tm-20 -147.64 94.4 4.42 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.19 -0.944 . . . . 0.0 110.241 -178.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -48.32 107.75 0.15 Allowed 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.908 1.478 . . . . 0.0 110.012 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 98.5 m -96.31 131.78 42.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.914 . . . . 0.0 110.388 -177.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 140.83 -163.2 26.62 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.494 ' CD ' HD13 ' A' ' 21' ' ' LEU . 44.0 Cg_endo -71.08 141.79 70.62 Favored 'Cis proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.872 -2.137 . . . . 0.0 110.647 1.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.523 HD21 ' CG1' ' A' ' 64' ' ' VAL . 42.9 tp -97.04 156.02 16.54 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.343 -0.848 . . . . 0.0 110.694 -177.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.443 ' N ' ' HG ' ' A' ' 77' ' ' LEU . 6.0 t60 -75.38 127.09 32.35 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.154 -0.966 . . . . 0.0 110.349 178.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.5 t -141.22 160.03 40.96 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.221 -0.925 . . . . 0.0 110.255 178.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -59.67 -26.61 65.7 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.186 -0.946 . . . . 0.0 110.521 -177.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.4 ' O ' HD23 ' A' ' 10' ' ' LEU . 97.0 m-85 -97.0 17.48 16.86 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.145 -0.972 . . . . 0.0 110.731 -176.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 121.09 -129.95 8.01 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 -178.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.488 ' HB3' ' HB2' ' A' ' 76' ' ' PRO . 84.5 m-85 -121.97 129.93 52.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.129 -1.218 . . . . 0.0 110.077 178.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.578 ' CD2' HD21 ' A' ' 10' ' ' LEU . 44.6 m170 -101.29 125.28 47.91 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.188 -0.945 . . . . 0.0 110.726 176.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.542 ' CG2' ' HB ' ' A' ' 9' ' ' ILE . 3.8 tt -109.33 128.61 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.709 -1.245 . . . . 0.0 109.078 167.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.528 ' CD1' HG21 ' A' ' 64' ' ' VAL . 96.7 mt -116.22 123.63 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.018 -1.051 . . . . 0.0 111.28 -167.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.531 ' CE ' ' HB3' ' A' ' 30' ' ' PHE . 27.6 mttt -83.77 130.05 34.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.23 -0.919 . . . . 0.0 109.036 170.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.532 ' CG1' HG23 ' A' ' 70' ' ' VAL . 29.2 t -109.33 129.44 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.163 -0.961 . . . . 0.0 109.973 -179.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.515 ' O ' ' HB2' ' A' ' 90' ' ' TYR . 91.6 mt -134.0 117.31 16.54 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.296 -0.878 . . . . 0.0 109.838 -178.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.515 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 50.8 m-85 70.75 -2.04 2.4 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.498 -0.751 . . . . 0.0 111.556 177.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 90' ' ' TYR . 22.3 ptt180 40.37 -163.14 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.249 -0.907 . . . . 0.0 110.264 174.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.512 ' OXT' ' N ' ' A' ' 2' ' ' LYS . 91.4 m-20 . . . . . 0 N--CA 1.49 1.566 0 O-C-N 120.79 -1.193 . . . . 0.0 110.142 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 27.3 m . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.225 0.536 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.488 ' O ' ' HA ' ' A' ' 51' ' ' GLU . . . -143.26 159.02 43.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.075 -1.015 . . . . 0.0 110.039 177.202 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.506 ' HA ' ' O ' ' A' ' 50' ' ' GLY . . . -94.62 123.71 38.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.268 -0.895 . . . . 0.0 109.145 174.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.728 ' HB1' ' NE2' ' A' ' 8' ' ' HIS . . . -137.24 134.99 36.81 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.709 -1.244 . . . . 0.0 111.884 -169.166 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.524 ' CD2' ' HA ' ' A' ' 48' ' ' ASP . 33.8 mt -109.32 137.07 47.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.39 -0.819 . . . . 0.0 109.371 170.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.728 ' NE2' ' HB1' ' A' ' 6' ' ' ALA . 22.2 m170 -130.87 132.38 45.12 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.932 -1.105 . . . . 0.0 111.0 -176.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.683 ' HB ' HG22 ' A' ' 85' ' ' ILE . 84.4 mt -118.64 129.89 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.947 -1.095 . . . . 0.0 109.567 169.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.769 HD13 ' C ' ' A' ' 10' ' ' LEU . 2.7 tm? -110.0 120.41 42.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.361 -0.837 . . . . 0.0 109.896 178.098 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.758 HG13 HD22 ' A' ' 16' ' ' LEU . 3.1 t -103.94 128.97 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.179 -0.951 . . . . 0.0 110.053 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -68.5 -39.96 81.05 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.464 -0.773 . . . . 0.0 110.96 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -119.79 140.54 50.59 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.018 -1.051 . . . . 0.0 110.595 -175.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.458 ' HG2' ' CZ ' ' A' ' 83' ' ' TYR . 93.3 mt-10 -59.97 -39.99 87.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.527 -0.733 . . . . 0.0 110.939 -175.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.1 -41.86 68.75 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.024 -1.048 . . . . 0.0 110.343 -175.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.758 HD22 HG13 ' A' ' 11' ' ' VAL . 8.1 tt -67.84 -38.56 83.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.124 -0.985 . . . . 0.0 109.648 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.863 ' O ' HD12 ' A' ' 21' ' ' LEU . . . -58.66 -45.82 88.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.294 -0.879 . . . . 0.0 110.314 178.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.5 tp -60.06 -46.25 90.16 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.121 -0.987 . . . . 0.0 109.766 175.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.421 ' O ' ' HB2' ' A' ' 23' ' ' GLN . 47.9 t0 -59.97 -40.0 87.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.332 -0.855 . . . . 0.0 109.929 178.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.631 HD23 ' N ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -62.37 -53.54 53.45 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.357 -0.839 . . . . 0.0 109.471 177.675 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.892 HD11 ' HG3' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -54.57 -48.55 71.93 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.475 -0.766 . . . . 0.0 109.557 -176.717 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -65.1 -40.51 94.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.435 -0.791 . . . . 0.0 109.987 174.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.478 ' NE2' HD21 ' A' ' 33' ' ' LEU . 62.7 tt0 -61.54 -40.03 93.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.44 -0.787 . . . . 0.0 110.297 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.548 HG12 ' CD1' ' A' ' 33' ' ' LEU . 92.4 mt -67.07 -39.99 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.278 -0.889 . . . . 0.0 110.111 178.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -64.53 -54.54 30.65 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.948 -1.095 . . . . 0.0 110.226 176.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -60.01 -43.44 95.23 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.216 -0.927 . . . . 0.0 110.967 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.735 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -105.55 -59.43 0.64 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -177.295 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.735 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 83.92 104.65 0.05 Allowed 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 121.554 0.692 . . . . 0.0 110.053 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.427 ' CG ' ' O ' ' A' ' 28' ' ' ALA . 3.8 m-20 -175.08 70.48 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.582 -0.698 . . . . 0.0 109.501 -176.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -60.01 -44.24 94.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.925 . . . . 0.0 110.781 -174.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.59 -54.03 31.5 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 119.813 -1.184 . . . . 0.0 110.272 -177.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -66.7 -40.08 88.31 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.991 -1.299 . . . . 0.0 110.861 -175.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.548 ' CD1' HG12 ' A' ' 24' ' ' ILE . 64.5 mt -61.59 -42.94 99.58 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.91 -1.119 . . . . 0.0 110.266 178.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.535 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -59.98 -49.25 78.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 0.0 110.381 178.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -59.98 -47.19 86.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.103 -0.998 . . . . 0.0 110.653 -174.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -67.38 -50.08 61.22 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.971 -1.08 . . . . 0.0 110.998 -177.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 55.3 m170 -69.98 -39.92 75.64 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.047 -1.033 . . . . 0.0 111.103 -173.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.638 ' O ' HG22 ' A' ' 39' ' ' ILE . 22.9 t -60.08 -42.06 93.78 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.001 -1.062 . . . . 0.0 110.338 -174.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.638 HG22 ' O ' ' A' ' 38' ' ' SER . 21.3 tt 38.02 31.57 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.624 -0.673 . . . . 0.0 110.877 177.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.43 ' N ' ' O ' ' A' ' 38' ' ' SER . 15.5 p -120.25 166.15 16.07 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.253 -0.904 . . . . 0.0 110.206 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -53.05 -23.12 20.85 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.968 1.51 . . . . 0.0 110.273 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -107.58 21.27 17.71 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.276 -0.89 . . . . 0.0 109.836 177.006 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.4 -51.37 27.07 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 174.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 48.9 mttp -63.03 -40.03 96.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.442 -1.034 . . . . 0.0 110.849 176.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.652 ' HE ' HD23 ' A' ' 49' ' ' LEU . 11.9 tpt180 -102.59 -44.6 5.29 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.928 -1.108 . . . . 0.0 110.642 -172.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -63.75 -33.38 87.08 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.224 -1.551 . . . . 0.0 109.224 175.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.482 ' O ' HD22 ' A' ' 7' ' ' LEU . . . -74.36 0.11 55.72 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 175.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.524 ' HA ' ' CD2' ' A' ' 7' ' ' LEU . 49.7 t0 -170.82 71.96 0.05 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.24 -1.153 . . . . 0.0 108.916 178.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.652 HD23 ' HE ' ' A' ' 45' ' ' ARG . 11.0 mt -76.15 -6.94 53.54 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.622 -0.674 . . . . 0.0 109.814 -177.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 5' ' ' ALA . . . 70.39 -139.06 29.97 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -174.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.491 ' HG3' ' HB2' ' A' ' 5' ' ' ALA . 4.8 mt-10 -101.59 132.1 47.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.397 -1.061 . . . . 0.0 110.643 178.027 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.717 ' CE2' ' HB3' ' A' ' 6' ' ' ALA . 5.3 p90 -145.38 160.64 41.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.678 -0.639 . . . . 0.0 109.333 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 . . . . . 0 N--CA 1.493 1.71 0 O-C-N 121.039 -1.038 . . . . 0.0 110.526 -175.235 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.429 ' O ' ' C ' ' A' ' 60' ' ' ALA . 9.5 Cg_endo . . . . . 0 N--CA 1.485 1.004 0 N-CA-C 110.407 -0.651 . . . . 0.0 110.407 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 59' ' ' PRO . . . -41.23 -35.29 0.59 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.455 -0.778 . . . . 0.0 110.212 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.585 ' CE1' ' NE2' ' A' ' 8' ' ' HIS . 90.4 t80 -60.08 -41.34 92.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.288 -0.883 . . . . 0.0 110.72 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.466 ' O ' HG12 ' A' ' 65' ' ' VAL . 53.0 t0 -60.01 -41.54 92.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.023 -1.048 . . . . 0.0 109.96 -178.163 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 67' ' ' SER . 62.7 tttm -55.09 -58.56 7.15 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.338 -0.851 . . . . 0.0 110.777 178.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.616 HG11 ' CD1' ' A' ' 86' ' ' ILE . 2.9 p -70.0 -42.5 79.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.04 -1.038 . . . . 0.0 111.319 -170.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.466 HG12 ' O ' ' A' ' 62' ' ' ASP . 3.6 p -57.79 -28.26 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.388 -1.445 . . . . 0.0 109.584 174.064 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -92.33 -10.76 37.12 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.049 -1.032 . . . . 0.0 109.873 173.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.534 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 4.8 t -93.43 -66.21 0.94 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.409 -0.807 . . . . 0.0 109.715 175.277 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.534 ' SG ' HG22 ' A' ' 64' ' ' VAL . 24.1 p -76.01 155.97 84.38 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.37 -0.831 . . . . 0.0 110.245 177.243 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.478 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 53.7 Cg_endo -79.27 148.11 20.99 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.993 1.523 . . . . 0.0 110.223 175.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.75 HG13 HD12 ' A' ' 71' ' ' LEU . 6.3 p -54.63 168.4 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.146 -0.971 . . . . 0.0 109.887 177.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.75 HD12 HG13 ' A' ' 70' ' ' VAL . 1.3 mp 58.24 22.25 9.03 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.34 -0.85 . . . . 0.0 110.188 -176.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.478 ' HB3' ' O ' ' A' ' 69' ' ' PRO . 1.4 tp10 -130.77 94.3 29.16 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.254 -0.904 . . . . 0.0 110.251 -179.202 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -51.07 109.6 0.33 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.927 1.488 . . . . 0.0 109.809 177.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 94.3 m -115.65 130.02 56.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.208 -0.932 . . . . 0.0 110.069 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 140.77 -171.53 24.03 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -176.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.892 ' HG3' HD11 ' A' ' 21' ' ' LEU . 41.5 Cg_endo -69.88 138.66 50.6 Favored 'Cis proline' 0 C--N 1.312 -1.373 0 C-N-CA 121.749 -2.188 . . . . 0.0 110.89 -0.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.771 HD12 HD12 ' A' ' 86' ' ' ILE . 95.2 mt -92.94 172.89 8.04 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.52 -0.738 . . . . 0.0 110.484 -176.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -99.18 126.58 44.99 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.064 -1.023 . . . . 0.0 110.67 177.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.899 HG21 ' CG ' ' A' ' 84' ' ' HIS . 8.8 t -146.29 165.1 30.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.272 -0.893 . . . . 0.0 109.817 175.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -59.65 -40.0 86.26 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.104 -0.998 . . . . 0.0 110.769 -175.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -66.38 -15.37 63.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.135 -0.978 . . . . 0.0 110.331 -177.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.426 ' CA ' HD21 ' A' ' 10' ' ' LEU . . . 141.17 -135.69 7.05 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.036 -1.625 . . . . 0.0 109.036 -178.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.473 ' O ' ' HA ' ' A' ' 10' ' ' LEU . 4.3 m-85 -97.1 125.12 41.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.135 -1.215 . . . . 0.0 110.131 176.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.899 ' CG ' HG21 ' A' ' 79' ' ' THR . 1.0 OUTLIER -102.73 115.97 31.65 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.607 -0.683 . . . . 0.0 110.345 177.484 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.683 HG22 ' HB ' ' A' ' 9' ' ' ILE . 4.4 tt -104.66 128.38 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.512 -1.367 . . . . 0.0 109.392 168.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.771 HD12 HD12 ' A' ' 77' ' ' LEU . 53.0 mt -118.96 125.72 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.369 -0.832 . . . . 0.0 111.051 -172.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.518 ' HB3' ' HB2' ' A' ' 7' ' ' LEU . 18.8 tttm -99.97 125.8 46.04 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.334 -0.854 . . . . 0.0 109.215 171.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.596 ' O ' HD23 ' A' ' 89' ' ' LEU . 21.3 t -101.43 136.49 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.177 -0.952 . . . . 0.0 110.121 -175.247 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.596 HD23 ' O ' ' A' ' 88' ' ' VAL . 88.9 mt -140.04 147.04 39.76 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.241 -0.912 . . . . 0.0 109.227 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.494 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 98.0 m-85 62.66 -55.35 0.16 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.598 -0.689 . . . . 0.0 111.732 174.12 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.504 ' N ' ' O ' ' A' ' 89' ' ' LEU . 68.5 ttp85 . . . . . 0 N--CA 1.493 1.719 0 O-C-N 120.93 -1.106 . . . . 0.0 110.859 -178.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.528 HG22 ' HD3' ' A' ' 53' ' ' ARG . 81.8 p . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 121.307 0.575 . . . . 0.0 110.601 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.614 ' HB2' ' HD2' ' A' ' 91' ' ' ARG . . . -140.52 150.53 43.83 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.422 -0.799 . . . . 0.0 110.265 -178.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.401 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -95.66 137.84 34.16 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.122 -0.986 . . . . 0.0 109.71 177.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.642 ' HB1' ' NE2' ' A' ' 8' ' ' HIS . . . -148.54 130.88 15.62 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.92 -1.112 . . . . 0.0 111.517 -173.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.564 HD12 ' HD2' ' A' ' 87' ' ' LYS . 78.1 mt -105.21 147.54 27.91 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.202 -0.936 . . . . 0.0 109.144 169.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.642 ' NE2' ' HB1' ' A' ' 6' ' ' ALA . 35.1 m-70 -138.34 125.26 21.19 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.749 -1.219 . . . . 0.0 111.303 -177.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.693 ' HB ' HG22 ' A' ' 85' ' ' ILE . 81.5 mt -110.04 129.97 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.016 -1.052 . . . . 0.0 109.857 169.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.768 ' O ' HD13 ' A' ' 10' ' ' LEU . 1.0 OUTLIER -110.38 119.97 40.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -0.894 . . . . 0.0 110.365 178.435 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.804 HG13 HD22 ' A' ' 16' ' ' LEU . 2.9 t -104.03 135.29 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.421 -0.8 . . . . 0.0 109.954 177.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -67.51 -37.12 82.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.273 -0.892 . . . . 0.0 110.769 -176.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.412 ' HG3' ' HB2' ' A' ' 16' ' ' LEU . 18.1 pt-20 -129.75 149.73 51.37 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.013 -1.054 . . . . 0.0 110.871 -175.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.468 ' HB2' ' CZ ' ' A' ' 83' ' ' TYR . 89.0 tt0 -59.97 -42.8 94.94 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.384 -0.822 . . . . 0.0 111.049 -178.026 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -55.08 -42.35 72.7 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.022 -1.049 . . . . 0.0 110.293 -177.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.804 HD22 HG13 ' A' ' 11' ' ' VAL . 3.6 tt -67.97 -39.83 83.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.211 -0.931 . . . . 0.0 109.341 177.182 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.513 ' N ' HG11 ' A' ' 11' ' ' VAL . . . -57.99 -46.8 84.62 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.32 -0.863 . . . . 0.0 109.737 175.12 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.458 ' CD1' ' HG2' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -59.99 -42.62 94.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.153 -0.967 . . . . 0.0 109.6 173.925 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -60.44 -45.44 93.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.414 -0.803 . . . . 0.0 109.904 175.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.417 ' CD1' ' HB3' ' A' ' 33' ' ' LEU . 7.9 tp -64.01 -44.23 93.25 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.406 -0.809 . . . . 0.0 109.972 176.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.892 HD21 ' HD3' ' A' ' 76' ' ' PRO . 3.6 mp -58.95 -46.15 88.74 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.547 -0.721 . . . . 0.0 110.008 -175.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -62.71 -40.05 95.95 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.627 -0.671 . . . . 0.0 110.109 177.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.616 ' HG2' HD21 ' A' ' 33' ' ' LEU . 72.9 tp60 -60.05 -39.9 87.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 0.0 109.939 -178.026 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.518 HG13 HD13 ' A' ' 33' ' ' LEU . 96.7 mt -65.06 -46.84 90.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.274 -0.891 . . . . 0.0 110.122 177.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 64.3 mttt -60.78 -44.17 97.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.136 -0.978 . . . . 0.0 109.557 175.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -59.12 -64.58 0.89 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.348 -0.845 . . . . 0.0 110.343 176.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.742 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -105.24 -40.02 2.16 Favored Glycine 0 N--CA 1.483 1.79 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 -171.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.742 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 77.46 105.49 0.07 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.716 -0.873 . . . . 0.0 109.942 -177.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -175.37 73.17 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.346 -0.846 . . . . 0.0 109.867 -177.534 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.579 ' CE1' HG13 ' A' ' 9' ' ' ILE . 23.6 t80 -59.95 -42.76 94.75 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.56 -0.712 . . . . 0.0 110.511 -175.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.82 -49.99 60.63 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -176.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.449 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 74.1 mttt -65.44 -39.95 92.69 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.973 -1.31 . . . . 0.0 110.049 -177.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.616 HD21 ' HG2' ' A' ' 23' ' ' GLN . 84.9 mt -64.95 -39.94 94.26 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.206 -0.934 . . . . 0.0 110.027 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.602 ' HB2' HG12 ' A' ' 9' ' ' ILE . . . -57.4 -50.2 73.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.218 -0.926 . . . . 0.0 110.034 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.473 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 21.4 mmtp -59.98 -43.4 95.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.276 -0.89 . . . . 0.0 110.745 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 32' ' ' LYS . 99.7 mttt -70.0 -43.16 71.96 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.09 -1.006 . . . . 0.0 111.424 -172.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.579 ' ND1' HD21 ' A' ' 16' ' ' LEU . 81.7 m-70 -93.33 -36.0 12.76 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.97 -1.081 . . . . 0.0 110.912 -174.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.647 ' O ' HG22 ' A' ' 39' ' ' ILE . 31.6 t -60.03 -52.95 63.19 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.088 -1.007 . . . . 0.0 110.606 -174.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.647 HG22 ' O ' ' A' ' 38' ' ' SER . 13.6 tt 38.46 39.28 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.589 -0.695 . . . . 0.0 110.711 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.498 ' SG ' ' N ' ' A' ' 43' ' ' GLY . 12.8 p -127.88 163.61 42.23 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.214 -0.929 . . . . 0.0 109.841 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.46 ' HD2' ' HB2' ' A' ' 40' ' ' CYS . 5.7 Cg_endo -52.34 -27.87 32.68 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.722 1.38 . . . . 0.0 110.188 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.526 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.7 OUTLIER -101.03 14.59 31.47 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.893 . . . . 0.0 109.767 174.675 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.498 ' N ' ' SG ' ' A' ' 40' ' ' CYS . . . -77.08 -55.0 4.55 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 176.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.473 ' HA ' ' HE2' ' A' ' 35' ' ' LYS . 28.5 ttpt -60.03 -40.01 87.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.481 -1.011 . . . . 0.0 110.226 177.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.456 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 3.3 tpp180 -98.31 -44.27 6.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.097 -1.002 . . . . 0.0 110.615 -176.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -60.66 -33.74 83.51 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.38 -3.04 37.22 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 176.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.468 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 38.5 p-10 -167.93 62.45 0.07 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.267 -1.137 . . . . 0.0 109.279 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 6.2 mt -70.03 -29.09 66.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.637 -0.664 . . . . 0.0 110.317 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.81 -119.32 6.2 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -177.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.46 ' HG3' ' C ' ' A' ' 4' ' ' ALA . 82.5 tt0 -133.02 130.03 38.91 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.209 -1.171 . . . . 0.0 110.475 -175.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.469 ' CE2' ' HB3' ' A' ' 6' ' ' ALA . 1.5 p90 -127.05 -178.82 4.56 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.107 -0.995 . . . . 0.0 109.941 175.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.528 ' HD3' HG22 ' A' ' 3' ' ' THR . 26.6 mmt85 . . . . . 0 N--CA 1.492 1.656 0 O-C-N 120.995 -1.066 . . . . 0.0 110.183 -173.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.473 ' O ' ' N ' ' A' ' 62' ' ' ASP . 14.4 Cg_endo . . . . . 0 N--CA 1.487 1.124 0 N-CA-C 110.559 -0.593 . . . . 0.0 110.559 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.618 ' O ' HG12 ' A' ' 64' ' ' VAL . . . -41.17 -34.32 0.45 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.357 -0.839 . . . . 0.0 110.218 -178.534 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.871 ' CZ ' HG21 ' A' ' 65' ' ' VAL . 63.8 t80 -60.05 -39.75 87.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.274 -0.892 . . . . 0.0 110.388 177.119 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.473 ' N ' ' O ' ' A' ' 59' ' ' PRO . 8.0 t70 -60.0 -48.88 79.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.135 -0.978 . . . . 0.0 110.187 -176.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 67' ' ' SER . 38.8 tptt -59.91 -50.03 75.37 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.149 -0.969 . . . . 0.0 110.206 178.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.837 HG11 HD12 ' A' ' 86' ' ' ILE . 7.5 p -77.43 -41.19 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.103 -0.998 . . . . 0.0 111.554 -174.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.871 HG21 ' CZ ' ' A' ' 61' ' ' PHE . 1.9 p -56.32 -27.15 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.357 -1.464 . . . . 0.0 109.305 174.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -94.61 -7.58 40.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.493 -0.754 . . . . 0.0 109.859 176.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.522 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 8.9 t -93.95 -62.04 1.42 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.502 -0.749 . . . . 0.0 109.925 178.338 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.491 ' HB3' ' OG1' ' A' ' 74' ' ' THR . 27.4 p -71.11 156.51 91.83 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.278 -0.889 . . . . 0.0 110.418 177.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.518 ' O ' ' N ' ' A' ' 71' ' ' LEU . 43.6 Cg_endo -82.22 79.22 3.16 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.998 1.525 . . . . 0.0 110.785 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.058 HG13 HD12 ' A' ' 71' ' ' LEU . 10.9 p 20.19 47.19 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.345 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 177.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.058 HD12 HG13 ' A' ' 70' ' ' VAL . 0.3 OUTLIER -167.17 -40.25 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.453 -0.779 . . . . 0.0 111.068 178.263 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.474 ' HG3' ' HD2' ' A' ' 69' ' ' PRO . 23.5 mm-40 -70.03 130.93 89.34 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 120.836 -1.165 . . . . 0.0 110.732 -173.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -67.48 95.49 0.39 Allowed 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.76 1.4 . . . . 0.0 109.271 172.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.726 HG21 HG23 ' A' ' 64' ' ' VAL . 21.1 m -94.42 139.77 30.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.154 -0.966 . . . . 0.0 110.451 -172.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.49 -170.36 22.36 Favored Glycine 0 N--CA 1.485 1.919 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.892 ' HD3' HD21 ' A' ' 21' ' ' LEU . 42.9 Cg_endo -74.66 124.17 9.71 Favored 'Cis proline' 0 C--N 1.311 -1.437 0 C-N-CA 121.933 -2.111 . . . . 0.0 110.28 0.062 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.461 ' HG ' ' N ' ' A' ' 78' ' ' HIS . 39.7 tp -94.01 160.3 14.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.278 -0.889 . . . . 0.0 110.123 -174.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.461 ' N ' ' HG ' ' A' ' 77' ' ' LEU . 47.1 t-80 -78.77 123.91 27.66 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.029 -1.044 . . . . 0.0 110.579 -178.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.939 HG21 ' CE1' ' A' ' 84' ' ' HIS . 7.0 t -133.75 164.79 26.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.265 -0.897 . . . . 0.0 109.505 172.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.04 -29.85 68.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.121 -0.987 . . . . 0.0 110.29 -177.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.429 ' H ' HG23 ' A' ' 79' ' ' THR . 98.6 m-85 -83.01 -4.91 58.83 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.143 -0.973 . . . . 0.0 110.745 -176.549 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.667 ' O ' HG22 ' A' ' 79' ' ' THR . . . 133.35 -139.29 10.81 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 -177.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.507 ' HB3' ' HB2' ' A' ' 76' ' ' PRO . 95.8 m-85 -101.98 121.47 42.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.043 -1.269 . . . . 0.0 110.264 178.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.939 ' CE1' HG21 ' A' ' 79' ' ' THR . 34.3 m170 -103.55 128.79 50.73 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.09 -1.006 . . . . 0.0 110.895 178.221 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.693 HG22 ' HB ' ' A' ' 9' ' ' ILE . 4.5 tt -113.18 119.98 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.963 -1.086 . . . . 0.0 108.947 167.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.837 HD12 HG11 ' A' ' 64' ' ' VAL . 85.5 mt -114.84 131.75 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.919 -1.113 . . . . 0.0 111.322 -168.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.564 ' HD2' HD12 ' A' ' 7' ' ' LEU . 26.5 ttmt -100.01 124.12 45.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.345 -0.847 . . . . 0.0 109.614 173.193 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.652 HG12 ' HA ' ' A' ' 70' ' ' VAL . 57.7 t -113.85 131.5 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.15 -0.969 . . . . 0.0 110.438 -172.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.509 ' O ' ' N ' ' A' ' 91' ' ' ARG . 57.2 mt -138.04 170.76 15.47 Favored 'General case' 0 C--N 1.309 -1.154 0 O-C-N 121.186 -0.946 . . . . 0.0 109.867 -177.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.449 ' O ' ' HB2' ' A' ' 91' ' ' ARG . 45.9 m-85 54.07 -76.93 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.752 -0.593 . . . . 0.0 112.069 171.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.64 ' CG ' HG23 ' A' ' 70' ' ' VAL . 19.1 mmm180 . . . . . 0 N--CA 1.496 1.874 0 O-C-N 120.799 -1.188 . . . . 0.0 110.794 -172.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.45 ' O ' ' O ' ' A' ' 91' ' ' ARG . 69.6 p . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.246 0.546 . . . . 0.0 110.005 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' A' ' 51' ' ' GLU . . . -112.99 128.59 56.54 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -0.93 . . . . 0.0 109.952 178.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.594 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -91.49 126.25 36.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.41 -0.806 . . . . 0.0 109.213 176.016 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.814 ' HB1' ' NE2' ' A' ' 8' ' ' HIS . . . -135.23 126.09 27.46 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 118.915 -1.114 . . . . 0.0 111.486 -170.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.483 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 58.3 mt -102.68 137.91 40.28 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.144 -0.973 . . . . 0.0 109.132 169.125 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.814 ' NE2' ' HB1' ' A' ' 6' ' ' ALA . 38.1 m-70 -131.09 131.07 43.94 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.905 -1.122 . . . . 0.0 111.088 -176.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.736 ' HB ' HG22 ' A' ' 85' ' ' ILE . 71.3 mt -114.37 124.98 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.98 -1.075 . . . . 0.0 109.456 168.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.604 ' HG ' ' CD2' ' A' ' 84' ' ' HIS . 0.3 OUTLIER -97.67 101.27 12.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.323 -0.86 . . . . 0.0 109.505 179.496 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.661 HG11 ' HB2' ' A' ' 17' ' ' ALA . 3.6 t -67.63 -50.96 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.202 -0.936 . . . . 0.0 110.514 -175.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.539 ' CB ' ' O ' ' A' ' 11' ' ' VAL . 28.8 tttt 80.61 -17.26 0.59 Allowed 'General case' 0 N--CA 1.503 2.21 0 O-C-N 122.027 -0.42 . . . . 0.0 110.942 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -138.45 135.03 34.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.805 -1.185 . . . . 0.0 110.582 177.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -59.97 -45.23 93.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.458 -0.776 . . . . 0.0 110.285 177.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.7 mttm -59.83 -40.48 88.62 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.237 -0.914 . . . . 0.0 109.938 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.647 HD23 HG13 ' A' ' 11' ' ' VAL . 5.0 tt -67.87 -39.75 83.68 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.376 -0.827 . . . . 0.0 109.577 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.863 ' HB1' ' HG3' ' A' ' 76' ' ' PRO . . . -59.5 -43.93 93.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.233 -0.917 . . . . 0.0 109.775 175.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.589 ' HA ' HD12 ' A' ' 21' ' ' LEU . 0.1 OUTLIER -60.0 -40.87 90.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.352 -0.842 . . . . 0.0 110.056 175.495 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -60.83 -49.73 76.3 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.993 -1.067 . . . . 0.0 110.147 176.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 1.034 HD13 HD21 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -69.13 -50.34 48.83 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.135 -0.978 . . . . 0.0 110.915 -175.667 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 1.116 HD13 ' N ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -58.87 -29.63 67.13 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 120.742 -1.224 . . . . 0.0 108.961 -173.055 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 1.116 ' N ' HD13 ' A' ' 21' ' ' LEU . 87.9 tt0 -64.65 -39.93 94.54 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.36 -0.838 . . . . 0.0 109.931 170.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.415 ' HB3' ' O ' ' A' ' 20' ' ' LEU . 68.4 tp60 -60.05 -45.11 93.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.356 -0.84 . . . . 0.0 111.351 -173.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.557 HD11 ' CD2' ' A' ' 33' ' ' LEU . 27.6 mt -61.07 -47.96 91.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.041 -1.037 . . . . 0.0 110.592 -173.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.8 mttp -60.28 -49.01 79.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.943 -1.098 . . . . 0.0 110.256 177.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -60.01 -58.39 8.73 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.099 -1.001 . . . . 0.0 110.287 176.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.749 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -105.6 -46.76 1.18 Allowed Glycine 0 N--CA 1.484 1.849 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 -172.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.749 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 79.71 170.33 0.17 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.795 -0.826 . . . . 0.0 110.078 -176.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.613 ' CB ' ' O ' ' A' ' 28' ' ' ALA . 87.4 m-20 109.48 85.91 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.911 0 C-N-CA 124.656 1.182 . . . . 0.0 109.662 -174.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.512 ' CZ ' ' CB ' ' A' ' 73' ' ' PRO . 6.5 m-85 -60.02 -49.61 77.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.239 -0.913 . . . . 0.0 110.447 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.37 -46.28 94.19 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -177.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.437 ' HB3' ' HB3' ' A' ' 29' ' ' ASP . 33.1 tttp -62.84 -40.0 96.09 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.112 -1.228 . . . . 0.0 110.152 -177.186 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.034 HD21 HD13 ' A' ' 20' ' ' LEU . 47.3 tp -62.92 -40.03 96.34 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.213 -0.929 . . . . 0.0 110.337 177.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.487 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -59.66 -49.97 75.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.073 -1.017 . . . . 0.0 110.269 -178.312 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 46.8 tttm -60.05 -47.49 85.64 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.935 -1.103 . . . . 0.0 110.615 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -60.66 -42.28 96.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.134 -0.979 . . . . 0.0 111.03 -173.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 10.3 m80 -104.01 -4.38 23.4 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.928 -1.107 . . . . 0.0 111.022 -174.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.66 ' O ' HG22 ' A' ' 39' ' ' ILE . 1.2 t -60.04 -46.07 90.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.072 -1.017 . . . . 0.0 110.645 -177.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.66 HG22 ' O ' ' A' ' 38' ' ' SER . 16.0 tt 38.86 29.75 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.621 -0.674 . . . . 0.0 110.494 -177.17 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.453 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 13.4 t -131.7 135.63 27.13 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.358 -0.839 . . . . 0.0 110.032 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 40' ' ' CYS . 46.1 Cg_exo -51.6 -31.09 38.8 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.907 1.477 . . . . 0.0 110.776 -176.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 46' ' ' GLY . 0.3 OUTLIER -99.94 11.74 38.54 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.154 -0.966 . . . . 0.0 110.318 -179.695 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.464 ' HA3' ' OG ' ' A' ' 38' ' ' SER . . . -104.92 -62.87 0.65 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -60.07 -39.98 87.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.139 -1.212 . . . . 0.0 109.823 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -102.41 -33.33 9.59 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.444 -0.785 . . . . 0.0 110.029 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.478 ' O ' ' HG ' ' A' ' 49' ' ' LEU . . . -99.51 -4.78 55.96 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 -177.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.676 ' O ' HD12 ' A' ' 49' ' ' LEU . . . -51.31 -50.43 40.72 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.601 -1.799 . . . . 0.0 108.601 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -71.91 106.76 4.35 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.197 -1.178 . . . . 0.0 109.644 170.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.676 HD12 ' O ' ' A' ' 47' ' ' GLY . 0.8 OUTLIER -108.98 1.1 20.4 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.11 -0.994 . . . . 0.0 110.166 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.79 -134.09 25.52 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.507 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 13.7 mt-10 -121.47 138.47 54.27 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.298 -1.119 . . . . 0.0 111.234 -176.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.446 ' CE1' ' HB3' ' A' ' 4' ' ' ALA . 0.7 OUTLIER -121.72 173.1 7.67 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.399 -0.813 . . . . 0.0 109.555 173.548 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 9.6 ptp85 . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.057 -1.027 . . . . 0.0 110.021 -178.751 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 60' ' ' ALA . 3.0 Cg_endo . . . . . 0 N--CA 1.483 0.86 0 N-CA-C 110.41 -0.65 . . . . 0.0 110.41 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.416 ' O ' HG12 ' A' ' 64' ' ' VAL . . . -43.14 -36.12 1.58 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.233 -0.917 . . . . 0.0 110.441 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.516 ' HA ' ' CG1' ' A' ' 64' ' ' VAL . 71.9 t80 -59.99 -40.02 87.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.188 -0.945 . . . . 0.0 110.656 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.519 ' O ' HG12 ' A' ' 65' ' ' VAL . 29.4 t0 -59.97 -49.97 75.59 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.136 -0.977 . . . . 0.0 110.331 -177.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.475 ' O ' ' HB2' ' A' ' 67' ' ' SER . 33.9 tttt -60.0 -50.03 75.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.07 -1.019 . . . . 0.0 110.541 177.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.657 HG23 HG21 ' A' ' 74' ' ' THR . 14.6 p -72.27 -44.93 63.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.025 -1.047 . . . . 0.0 111.082 -173.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.586 ' N ' HG13 ' A' ' 64' ' ' VAL . 1.9 p -55.58 -28.44 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.458 -1.402 . . . . 0.0 109.162 173.011 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -93.43 -10.63 34.45 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.328 -0.858 . . . . 0.0 109.897 175.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.55 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 7.4 t -93.84 -57.27 2.6 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.381 -0.825 . . . . 0.0 109.963 175.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.597 ' CB ' ' HG1' ' A' ' 74' ' ' THR . 84.6 m -111.63 122.88 36.12 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.292 -0.88 . . . . 0.0 110.012 177.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.402 ' HB3' ' NH2' ' A' ' 91' ' ' ARG . 12.2 Cg_endo -61.73 -179.65 0.41 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.797 1.42 . . . . 0.0 110.643 -177.023 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.649 HG12 HG12 ' A' ' 88' ' ' VAL . 31.4 m -61.87 161.43 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.357 -0.839 . . . . 0.0 110.924 -175.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.523 HD12 ' HB ' ' A' ' 70' ' ' VAL . 5.5 mp 58.55 23.58 10.99 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.584 -0.698 . . . . 0.0 110.367 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -129.76 72.2 81.99 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.304 -0.872 . . . . 0.0 109.545 175.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.512 ' CB ' ' CZ ' ' A' ' 30' ' ' PHE . 65.1 Cg_exo -44.55 122.07 3.7 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.025 1.54 . . . . 0.0 110.071 -177.207 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.657 HG21 HG23 ' A' ' 64' ' ' VAL . 94.7 m -119.99 130.06 54.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.215 -0.928 . . . . 0.0 110.264 -175.262 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.424 ' HA3' HG13 ' A' ' 85' ' ' ILE . . . 137.33 -171.44 23.16 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 178.324 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.863 ' HG3' ' HB1' ' A' ' 17' ' ' ALA . 40.5 Cg_endo -68.24 153.89 88.57 Favored 'Cis proline' 0 C--N 1.313 -1.3 0 C-N-CA 121.695 -2.21 . . . . 0.0 110.297 1.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.501 ' HG ' ' N ' ' A' ' 78' ' ' HIS . 25.0 tp -132.94 157.68 44.52 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.986 -1.071 . . . . 0.0 110.576 -171.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.501 ' N ' ' HG ' ' A' ' 77' ' ' LEU . 44.8 m80 -62.91 132.73 53.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.305 -0.872 . . . . 0.0 110.685 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.69 HG22 ' O ' ' A' ' 82' ' ' GLY . 5.0 t -148.25 159.17 44.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.269 -0.895 . . . . 0.0 109.809 173.074 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.02 -26.93 66.47 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.209 -0.932 . . . . 0.0 110.118 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -88.59 -1.54 58.11 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.355 -0.841 . . . . 0.0 110.675 -176.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.69 ' O ' HG22 ' A' ' 79' ' ' THR . . . 129.66 -123.67 4.18 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -177.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.478 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 96.0 m-85 -114.18 122.49 46.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.193 -1.18 . . . . 0.0 110.189 178.027 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.667 ' CG ' HG21 ' A' ' 79' ' ' THR . 41.3 m170 -109.33 120.43 42.49 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.321 -0.862 . . . . 0.0 110.823 177.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.736 HG22 ' HB ' ' A' ' 9' ' ' ILE . 7.7 tt -103.19 116.81 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.474 -1.391 . . . . 0.0 109.077 165.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.512 HG21 ' HD1' ' A' ' 61' ' ' PHE . 85.5 mt -114.63 130.01 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.923 -1.111 . . . . 0.0 111.007 -170.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.483 ' HB3' ' HB2' ' A' ' 7' ' ' LEU . 22.9 tttm -100.16 120.7 40.28 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.427 -0.795 . . . . 0.0 109.232 174.18 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.649 HG12 HG12 ' A' ' 70' ' ' VAL . 90.9 t -101.17 139.23 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.085 -1.01 . . . . 0.0 110.609 -173.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.621 HD23 ' O ' ' A' ' 88' ' ' VAL . 84.8 mt -138.29 120.63 15.91 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 121.329 -0.857 . . . . 0.0 109.707 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.557 ' CB ' ' O ' ' A' ' 89' ' ' LEU . 2.5 m-85 82.33 -24.68 0.17 Allowed 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.586 -0.697 . . . . 0.0 111.217 175.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.539 ' HB2' ' CG1' ' A' ' 70' ' ' VAL . 35.1 ttm180 . . . . . 0 N--CA 1.493 1.72 0 O-C-N 120.866 -1.146 . . . . 0.0 110.371 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.499 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 35.4 p . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.204 0.525 . . . . 0.0 110.238 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.774 ' HB2' ' HG2' ' A' ' 91' ' ' ARG . . . -146.86 165.14 30.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.351 -0.843 . . . . 0.0 109.824 176.173 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.66 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -99.21 134.12 42.51 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.197 -0.94 . . . . 0.0 109.639 178.069 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.697 ' HB1' ' NE2' ' A' ' 8' ' ' HIS . . . -135.92 128.01 29.75 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.708 -1.245 . . . . 0.0 111.828 -171.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.542 HD12 ' HD3' ' A' ' 87' ' ' LYS . 75.5 mt -108.82 141.09 41.35 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.188 -0.945 . . . . 0.0 109.201 168.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.697 ' NE2' ' HB1' ' A' ' 6' ' ' ALA . 26.3 m-70 -135.37 125.82 26.71 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.787 -1.195 . . . . 0.0 111.081 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.568 ' HB ' ' CG2' ' A' ' 85' ' ' ILE . 87.6 mt -110.14 130.05 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.91 -1.119 . . . . 0.0 110.211 170.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.622 HD23 ' N ' ' A' ' 11' ' ' VAL . 0.7 OUTLIER -105.08 120.01 40.45 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.457 -0.777 . . . . 0.0 109.942 178.408 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.908 HG13 HD23 ' A' ' 16' ' ' LEU . 2.0 t -108.29 129.67 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.229 -0.919 . . . . 0.0 109.631 178.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -68.4 -39.46 81.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.258 -0.901 . . . . 0.0 110.558 -176.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -120.7 141.4 50.45 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.16 -0.962 . . . . 0.0 110.79 -177.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.585 ' HB2' ' CZ ' ' A' ' 83' ' ' TYR . 83.5 tt0 -60.0 -40.06 87.92 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.476 -0.765 . . . . 0.0 110.877 -178.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -55.88 -41.79 74.96 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.082 -1.011 . . . . 0.0 110.41 -174.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.908 HD23 HG13 ' A' ' 11' ' ' VAL . 1.4 tp -68.28 -40.01 81.96 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.214 -0.929 . . . . 0.0 109.563 177.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.401 ' HA ' ' HB3' ' A' ' 20' ' ' LEU . . . -59.72 -42.3 92.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.422 -0.799 . . . . 0.0 110.097 177.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.5 tp -60.06 -42.71 95.08 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.158 -0.964 . . . . 0.0 109.352 173.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.461 ' HB3' ' O ' ' A' ' 16' ' ' LEU . 56.1 t0 -59.99 -40.01 87.71 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -0.888 . . . . 0.0 109.387 174.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.741 HD13 HD21 ' A' ' 33' ' ' LEU . 0.6 OUTLIER -62.36 -43.28 99.2 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.494 -0.754 . . . . 0.0 109.463 175.68 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.787 HD21 ' HD3' ' A' ' 76' ' ' PRO . 4.0 mp -59.99 -49.61 77.0 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.765 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.421 ' HA ' ' OE1' ' A' ' 22' ' ' GLU . 51.7 tp10 -61.13 -40.0 92.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.287 -0.883 . . . . 0.0 109.85 173.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -61.14 -41.68 97.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.435 -0.791 . . . . 0.0 110.559 -176.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.717 HD11 HD11 ' A' ' 20' ' ' LEU . 33.0 mt -67.49 -40.08 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.007 -1.058 . . . . 0.0 110.281 176.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.402 ' HG3' ' O ' ' A' ' 21' ' ' LEU . 30.3 mttm -62.9 -53.93 46.5 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.099 -1.001 . . . . 0.0 109.987 -177.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -60.75 -50.78 72.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.194 -0.941 . . . . 0.0 110.048 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.757 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -105.97 -54.56 0.71 Allowed Glycine 0 N--CA 1.487 2.043 0 N-CA-C 110.014 -1.235 . . . . 0.0 110.014 -173.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.757 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 79.83 172.24 0.15 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.869 -0.783 . . . . 0.0 109.922 -176.103 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.614 ' CB ' ' O ' ' A' ' 28' ' ' ALA . 95.9 m-20 114.73 78.09 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.013 0 C-N-CA 124.859 1.264 . . . . 0.0 109.618 -175.338 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -60.03 -49.96 75.61 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.269 -0.895 . . . . 0.0 110.778 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.7 -49.91 65.35 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -175.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.491 ' HB2' ' HB3' ' A' ' 29' ' ' ASP . 94.6 mttt -64.59 -39.8 94.39 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.995 -1.297 . . . . 0.0 110.218 -175.338 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.741 HD21 HD13 ' A' ' 20' ' ' LEU . 9.8 tt -65.32 -40.04 93.23 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.176 -0.952 . . . . 0.0 110.127 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.564 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -59.81 -50.21 74.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.186 -0.946 . . . . 0.0 110.165 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.5 tttt -59.99 -50.0 75.44 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.382 -0.824 . . . . 0.0 110.717 -178.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.493 ' O ' HG12 ' A' ' 39' ' ' ILE . 88.8 tttt -65.93 -47.28 75.22 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.181 -0.949 . . . . 0.0 111.202 -174.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 73.9 m80 -80.78 -50.01 10.4 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.874 -1.141 . . . . 0.0 111.674 -171.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.465 ' O ' ' C ' ' A' ' 39' ' ' ILE . 53.9 m -60.54 -40.07 90.19 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.915 -1.116 . . . . 0.0 110.765 -173.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.797 ' O ' HG22 ' A' ' 39' ' ' ILE . 31.9 mm 32.04 46.18 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 CA-C-O 121.5 0.667 . . . . 0.0 110.985 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.5 ' SG ' ' N ' ' A' ' 43' ' ' GLY . 17.0 p -133.79 170.14 12.1 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.348 -0.845 . . . . 0.0 109.945 -177.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.464 ' HD2' ' HB2' ' A' ' 40' ' ' CYS . 52.6 Cg_exo -49.96 -30.39 24.01 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.851 1.448 . . . . 0.0 109.982 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.473 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 6.1 p -108.84 27.29 9.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.22 -0.925 . . . . 0.0 109.61 173.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.5 ' N ' ' SG ' ' A' ' 40' ' ' CYS . . . -103.16 -67.16 0.75 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 108.607 -1.797 . . . . 0.0 108.607 176.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -59.99 -40.09 87.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -1.178 . . . . 0.0 109.961 172.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.463 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 13.7 tpt180 -99.8 -41.2 7.36 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.331 -0.856 . . . . 0.0 110.554 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.473 ' HA3' ' O ' ' A' ' 42' ' ' SER . . . -76.6 -22.81 71.71 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.32 -4.32 56.16 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 175.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.525 ' HA ' ' CD2' ' A' ' 7' ' ' LEU . 38.3 t0 -173.83 70.31 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.249 -1.148 . . . . 0.0 109.27 178.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.471 ' HG ' ' HA2' ' A' ' 46' ' ' GLY . 7.3 mt -70.08 -29.2 66.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.61 -0.681 . . . . 0.0 110.077 -176.258 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 111.78 -143.33 17.36 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -113.17 136.12 53.07 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.383 -1.069 . . . . 0.0 110.455 -177.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.691 ' CZ ' ' HB3' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -148.6 168.44 22.78 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.305 -0.872 . . . . 0.0 109.707 175.373 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.499 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 75.1 ttt180 . . . . . 0 N--CA 1.493 1.691 0 O-C-N 120.737 -1.227 . . . . 0.0 110.546 -172.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo . . . . . 0 N--CA 1.482 0.81 0 N-CA-C 110.247 -0.713 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -43.95 -37.85 3.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.293 -0.879 . . . . 0.0 110.544 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.649 ' HD1' HG21 ' A' ' 86' ' ' ILE . 37.7 t80 -59.9 -40.26 88.16 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.074 -1.016 . . . . 0.0 110.386 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.43 ' O ' HG12 ' A' ' 65' ' ' VAL . 32.9 t0 -59.97 -46.05 90.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.103 -0.998 . . . . 0.0 109.932 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -59.96 -49.99 75.51 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.293 -0.879 . . . . 0.0 110.623 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.725 HG11 HD12 ' A' ' 86' ' ' ILE . 8.9 p -73.2 -45.4 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.03 -1.044 . . . . 0.0 111.144 -174.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.549 ' N ' HG13 ' A' ' 64' ' ' VAL . 5.5 p -57.46 -24.24 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.359 -1.463 . . . . 0.0 109.156 172.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -97.29 -1.5 44.54 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.365 -0.834 . . . . 0.0 109.904 175.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.531 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 22.8 t -96.58 -67.42 0.85 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.449 -0.782 . . . . 0.0 109.573 174.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 73.4 m -92.48 128.54 44.12 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.29 -0.881 . . . . 0.0 110.063 175.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -50.62 165.81 0.38 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.815 1.429 . . . . 0.0 110.353 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.504 HG11 ' CB ' ' A' ' 91' ' ' ARG . 31.4 m -59.8 169.1 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.265 -0.897 . . . . 0.0 110.726 -178.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 70' ' ' VAL . 5.4 mp 59.94 26.17 15.4 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.699 -0.626 . . . . 0.0 110.583 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.06 90.96 37.6 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.085 -1.01 . . . . 0.0 110.17 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -52.22 110.64 0.47 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.771 1.406 . . . . 0.0 109.55 176.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 94.2 m -119.92 129.97 54.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.08 -1.012 . . . . 0.0 110.536 -173.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.512 ' HA2' ' CD2' ' A' ' 77' ' ' LEU . . . 148.41 -169.95 28.98 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.787 ' HD3' HD21 ' A' ' 21' ' ' LEU . 44.1 Cg_endo -75.6 139.16 59.51 Favored 'Cis proline' 0 C--N 1.313 -1.292 0 C-N-CA 121.854 -2.144 . . . . 0.0 110.481 1.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.512 ' CD2' ' HA2' ' A' ' 75' ' ' GLY . 1.1 mm? -98.15 174.83 6.33 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.241 -0.912 . . . . 0.0 110.699 -177.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.477 ' CE1' ' HE2' ' A' ' 83' ' ' TYR . 7.0 m-70 -109.66 127.54 54.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.283 -0.885 . . . . 0.0 110.887 -176.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.998 HG21 ' CE1' ' A' ' 84' ' ' HIS . 11.1 t -140.42 168.77 19.02 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.457 -0.777 . . . . 0.0 109.775 174.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -59.95 -40.12 87.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.097 -1.002 . . . . 0.0 110.484 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -64.25 -16.69 62.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.086 -1.009 . . . . 0.0 110.583 -177.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.472 ' O ' HG22 ' A' ' 79' ' ' THR . . . 140.67 -143.62 13.68 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 -177.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.585 ' CZ ' ' HB2' ' A' ' 14' ' ' GLU . 68.9 m-85 -97.16 122.65 40.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.136 -1.214 . . . . 0.0 110.181 178.094 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.998 ' CE1' HG21 ' A' ' 79' ' ' THR . 24.7 m170 -105.79 120.07 40.77 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.46 -0.775 . . . . 0.0 110.603 178.199 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.568 ' CG2' ' HB ' ' A' ' 9' ' ' ILE . 6.5 tt -109.71 121.64 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.683 -1.261 . . . . 0.0 109.248 167.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.725 HD12 HG11 ' A' ' 64' ' ' VAL . 88.2 mt -115.53 130.04 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.108 -0.995 . . . . 0.0 111.289 -170.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.542 ' HD3' HD12 ' A' ' 7' ' ' LEU . 20.7 tttm -102.96 132.02 49.5 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.438 -0.789 . . . . 0.0 108.913 171.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.595 ' O ' HD23 ' A' ' 89' ' ' LEU . 20.0 m -119.78 138.58 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.026 -1.046 . . . . 0.0 110.546 -176.047 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.66 ' HB2' ' HB3' ' A' ' 5' ' ' ALA . 58.5 mt -140.02 -167.34 2.28 Favored 'General case' 0 C--N 1.309 -1.186 0 O-C-N 121.291 -0.881 . . . . 0.0 109.901 -173.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.44 ' C ' ' O ' ' A' ' 89' ' ' LEU . 53.5 m-85 30.41 -85.63 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.865 -177.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.774 ' HG2' ' HB2' ' A' ' 4' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 O-C-N 120.697 -1.252 . . . . 0.0 109.837 -175.262 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.557 HG22 ' HG2' ' A' ' 53' ' ' ARG . 67.9 p . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.214 0.53 . . . . 0.0 110.089 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.459 ' C ' ' HG3' ' A' ' 51' ' ' GLU . . . -130.71 154.78 47.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.054 -1.029 . . . . 0.0 110.463 -178.132 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.606 ' CB ' ' CD1' ' A' ' 90' ' ' TYR . . . -98.07 136.59 38.1 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.226 -0.921 . . . . 0.0 109.757 177.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.7 ' HB1' ' NE2' ' A' ' 8' ' ' HIS . . . -147.58 123.12 10.43 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.719 -1.238 . . . . 0.0 112.098 -172.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.601 ' N ' ' CD1' ' A' ' 7' ' ' LEU . 4.0 mp -96.17 147.0 24.2 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.024 -1.048 . . . . 0.0 108.995 167.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.894 ' CD2' HD12 ' A' ' 49' ' ' LEU . 37.5 m-70 -136.35 137.02 40.17 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.773 -1.204 . . . . 0.0 111.287 -175.165 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.719 ' HB ' HG22 ' A' ' 85' ' ' ILE . 79.3 mt -118.93 129.9 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.127 -0.983 . . . . 0.0 109.799 168.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.542 ' HG ' ' CD2' ' A' ' 84' ' ' HIS . 0.4 OUTLIER -102.16 118.08 36.14 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.509 -0.745 . . . . 0.0 110.262 -179.115 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.946 HG13 HD22 ' A' ' 16' ' ' LEU . 2.2 t -108.09 127.74 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.323 -0.861 . . . . 0.0 109.891 177.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -69.95 -39.95 75.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.352 -0.842 . . . . 0.0 110.296 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -120.03 140.36 51.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.216 -0.928 . . . . 0.0 110.496 -175.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -59.89 -39.95 87.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.382 -0.823 . . . . 0.0 110.617 -176.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -52.16 -41.48 62.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.086 -1.009 . . . . 0.0 110.254 -175.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.946 HD22 HG13 ' A' ' 11' ' ' VAL . 7.9 tt -67.73 -44.08 78.46 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.029 -1.045 . . . . 0.0 109.912 177.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.941 ' HB1' ' HG3' ' A' ' 76' ' ' PRO . . . -59.91 -45.93 90.98 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.249 -0.907 . . . . 0.0 109.936 177.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.601 ' HA ' HD12 ' A' ' 21' ' ' LEU . 10.1 tp -60.99 -39.18 88.68 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.932 -1.105 . . . . 0.0 109.405 170.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.432 ' HB3' ' O ' ' A' ' 16' ' ' LEU . 48.6 t0 -62.25 -49.79 74.29 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 120.999 -1.063 . . . . 0.0 110.312 176.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.83 HD12 ' N ' ' A' ' 21' ' ' LEU . 0.7 OUTLIER -69.94 -47.2 63.31 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.019 -1.051 . . . . 0.0 110.788 -175.574 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 1.141 HD13 ' N ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -59.96 -29.29 68.32 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.012 -1.055 . . . . 0.0 108.864 -173.185 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 1.141 ' N ' HD13 ' A' ' 21' ' ' LEU . 85.7 tt0 -61.87 -42.66 99.33 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.407 -0.808 . . . . 0.0 110.137 173.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.79 -39.99 95.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.298 -0.876 . . . . 0.0 110.574 -176.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.862 HD13 ' CE2' ' A' ' 30' ' ' PHE . 97.6 mt -61.89 -45.44 98.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -0.86 . . . . 0.0 109.824 -178.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.566 ' HE3' HD21 ' A' ' 21' ' ' LEU . 36.7 mttm -61.06 -46.26 91.4 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.228 -0.92 . . . . 0.0 109.716 176.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -59.95 -61.34 2.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.382 -0.824 . . . . 0.0 110.485 177.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.755 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -104.87 -39.58 2.3 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -172.071 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.755 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 81.19 102.56 0.06 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.953 -0.734 . . . . 0.0 110.142 -178.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -175.74 67.05 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.421 -0.799 . . . . 0.0 110.128 -177.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.862 ' CE2' HD13 ' A' ' 24' ' ' ILE . 2.0 m-85 -59.98 -44.15 94.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -0.923 . . . . 0.0 110.838 -178.209 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.4 -43.63 98.48 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -177.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -65.09 -40.2 94.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.175 -1.191 . . . . 0.0 110.345 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.566 ' CD1' HG13 ' A' ' 24' ' ' ILE . 88.9 mt -66.33 -39.93 89.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.112 -0.992 . . . . 0.0 110.491 178.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 38' ' ' SER . . . -60.0 -46.42 89.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.107 -0.996 . . . . 0.0 110.027 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -60.0 -50.21 74.61 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.363 -0.835 . . . . 0.0 110.785 -177.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.472 ' O ' HG13 ' A' ' 39' ' ' ILE . 51.3 mttt -75.91 -47.89 23.5 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.023 -1.048 . . . . 0.0 111.249 -174.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 60.9 m-70 -71.78 -40.04 69.51 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.932 -1.105 . . . . 0.0 111.198 -174.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.515 ' OG ' ' CA ' ' A' ' 43' ' ' GLY . 16.5 t -61.02 -50.04 74.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.035 -1.041 . . . . 0.0 111.045 -172.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.741 ' O ' HG22 ' A' ' 39' ' ' ILE . 96.3 mt 31.98 49.06 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 CA-C-O 121.318 0.58 . . . . 0.0 111.037 -177.231 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.501 ' SG ' ' N ' ' A' ' 43' ' ' GLY . 16.4 p -143.3 161.94 45.14 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.402 -0.811 . . . . 0.0 110.229 -176.369 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.457 ' HD2' ' HB2' ' A' ' 40' ' ' CYS . 6.1 Cg_endo -53.0 -26.12 30.79 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.947 1.498 . . . . 0.0 110.779 -178.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.532 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -109.05 19.77 19.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.074 -1.016 . . . . 0.0 110.087 177.816 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.515 ' CA ' ' OG ' ' A' ' 38' ' ' SER . . . -77.81 -53.13 5.09 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 108.583 -1.807 . . . . 0.0 108.583 172.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 61.8 mttt -60.21 -40.05 88.76 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.301 -1.117 . . . . 0.0 110.354 176.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.437 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 9.5 tpp180 -94.99 -41.22 9.26 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.982 -1.074 . . . . 0.0 110.262 -177.096 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -67.04 -28.09 73.67 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 178.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.86 -4.46 54.53 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 177.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.423 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 51.4 t0 -173.95 70.96 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.266 -1.138 . . . . 0.0 109.135 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.894 HD12 ' CD2' ' A' ' 8' ' ' HIS . 7.5 mt -69.94 -27.73 64.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.445 -0.784 . . . . 0.0 110.66 -174.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.56 -145.28 16.14 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 -176.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.459 ' HG3' ' C ' ' A' ' 4' ' ' ALA . 59.5 tt0 -113.14 132.14 55.57 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.161 -1.199 . . . . 0.0 110.544 -177.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 6' ' ' ALA . 1.9 p90 -136.83 161.95 34.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.34 -0.85 . . . . 0.0 109.768 177.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.557 ' HG2' HG22 ' A' ' 3' ' ' THR . 82.8 mtp180 . . . . . 0 N--CA 1.497 1.894 0 O-C-N 120.942 -1.099 . . . . 0.0 111.155 -173.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.41 ' O ' ' C ' ' A' ' 60' ' ' ALA . 13.0 Cg_endo . . . . . 0 N--CA 1.484 0.934 0 N-CA-C 110.245 -0.714 . . . . 0.0 110.245 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.426 ' O ' ' HB3' ' A' ' 63' ' ' LYS . . . -41.17 -34.29 0.45 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.48 -0.762 . . . . 0.0 110.399 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.505 ' O ' HG12 ' A' ' 64' ' ' VAL . 68.5 t80 -60.0 -39.99 87.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.114 -0.991 . . . . 0.0 110.005 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -59.92 -39.97 87.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.309 -0.87 . . . . 0.0 109.511 179.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.723 ' HD3' HD21 ' A' ' 77' ' ' LEU . 87.7 tttt -57.49 -40.56 78.88 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.466 -0.771 . . . . 0.0 110.379 176.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.76 HG23 HG21 ' A' ' 74' ' ' THR . 14.3 p -91.77 -41.9 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.974 -1.079 . . . . 0.0 111.52 -173.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.526 HG22 ' CZ ' ' A' ' 91' ' ' ARG . 2.5 p -52.65 -27.16 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.53 -1.356 . . . . 0.0 109.805 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -99.83 5.66 45.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.172 -0.955 . . . . 0.0 109.88 176.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.523 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 37.5 t -99.61 -80.06 0.48 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.382 -0.824 . . . . 0.0 110.181 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 84.3 m -78.51 156.95 77.98 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.153 -0.967 . . . . 0.0 110.352 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.539 ' O ' ' O ' ' A' ' 70' ' ' VAL . 38.6 Cg_endo -79.07 69.78 7.78 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.069 1.562 . . . . 0.0 110.585 179.279 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.016 ' C ' HD13 ' A' ' 71' ' ' LEU . 8.4 p 29.4 -174.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 178.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.016 HD13 ' C ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER 23.6 41.67 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.607 0 O-C-N 120.821 -1.174 . . . . 0.0 113.364 -164.139 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' A' ' 70' ' ' VAL . 9.7 tt0 -134.04 100.86 12.84 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.766 -1.209 . . . . 0.0 109.91 171.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.544 ' HB3' ' CZ ' ' A' ' 30' ' ' PHE . 50.9 Cg_exo -47.42 103.84 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.908 1.478 . . . . 0.0 110.38 -176.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.76 HG21 HG23 ' A' ' 64' ' ' VAL . 50.6 m -98.99 134.2 42.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.322 -0.861 . . . . 0.0 110.504 -177.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.447 ' HA3' HG13 ' A' ' 85' ' ' ILE . . . 135.78 -172.65 22.17 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 176.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.941 ' HG3' ' HB1' ' A' ' 17' ' ' ALA . 43.5 Cg_endo -70.13 127.95 12.11 Favored 'Cis proline' 0 N--CA 1.49 1.277 0 C-N-CA 121.798 -2.167 . . . . 0.0 110.292 2.067 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.723 HD21 ' HD3' ' A' ' 63' ' ' LYS . 62.3 tp -95.37 155.91 16.54 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.252 -0.905 . . . . 0.0 110.763 -174.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -71.41 123.97 23.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.335 -0.853 . . . . 0.0 110.514 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.811 HG21 ' CG ' ' A' ' 84' ' ' HIS . 12.9 t -140.12 156.11 46.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.205 -0.934 . . . . 0.0 109.727 174.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -60.12 -32.07 70.66 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.118 -0.989 . . . . 0.0 110.927 -175.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -75.68 -8.79 57.69 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.015 -1.053 . . . . 0.0 110.365 -178.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.725 ' O ' HG22 ' A' ' 79' ' ' THR . . . 138.34 -132.88 6.0 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 -175.043 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -107.86 125.78 51.88 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.092 -1.24 . . . . 0.0 110.1 175.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.811 ' CG ' HG21 ' A' ' 79' ' ' THR . 45.6 m170 -106.96 124.18 49.25 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.143 -0.973 . . . . 0.0 110.367 175.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.719 HG22 ' HB ' ' A' ' 9' ' ' ILE . 9.9 tt -108.54 125.47 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 118.719 -1.192 . . . . 0.0 109.398 168.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 86.0 mt -120.08 130.67 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.016 -1.052 . . . . 0.0 111.785 -167.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.598 ' HD3' ' CG ' ' A' ' 30' ' ' PHE . 13.5 mtmm -93.06 126.83 38.35 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.1 -1.0 . . . . 0.0 109.12 168.076 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.938 HG12 HG23 ' A' ' 70' ' ' VAL . 59.3 t -109.93 130.07 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.029 -1.044 . . . . 0.0 110.458 -175.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.597 HD23 ' O ' ' A' ' 88' ' ' VAL . 87.7 mt -139.71 -155.25 0.57 Allowed 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.272 -0.893 . . . . 0.0 110.109 -178.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.606 ' CD1' ' CB ' ' A' ' 5' ' ' ALA . 16.9 m-85 32.82 -89.0 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 O-C-N 122.104 -0.372 . . . . 0.0 111.268 -178.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.526 ' CZ ' HG22 ' A' ' 65' ' ' VAL . 13.5 tpt180 . . . . . 0 N--CA 1.493 1.678 0 O-C-N 120.878 -1.139 . . . . 0.0 110.62 177.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 67.6 m . . . . . 0 N--CA 1.493 1.71 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' A' ' 51' ' ' GLU . . . -150.42 158.48 44.2 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.816 -1.178 . . . . 0.0 111.247 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.619 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -101.25 136.96 40.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.491 -0.755 . . . . 0.0 109.45 176.15 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.709 ' HB1' ' NE2' ' A' ' 8' ' ' HIS . . . -150.19 129.74 13.07 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.981 -1.075 . . . . 0.0 111.224 -177.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.526 HD12 ' HD3' ' A' ' 87' ' ' LYS . 72.6 mt -99.5 135.09 41.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.253 -0.904 . . . . 0.0 109.168 169.34 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.709 ' NE2' ' HB1' ' A' ' 6' ' ' ALA . 40.8 m170 -130.34 129.39 43.1 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.025 -1.047 . . . . 0.0 110.827 -176.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.55 ' HB ' ' CG2' ' A' ' 85' ' ' ILE . 84.6 mt -114.45 129.8 69.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.179 -0.951 . . . . 0.0 109.547 169.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.797 ' O ' HD13 ' A' ' 10' ' ' LEU . 1.8 tm? -106.8 114.92 29.31 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.291 -0.88 . . . . 0.0 110.138 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.807 HG13 HD22 ' A' ' 16' ' ' LEU . 2.3 t -101.3 128.97 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.312 -0.868 . . . . 0.0 109.925 177.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -67.33 -40.04 85.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.306 -0.871 . . . . 0.0 110.705 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -109.02 138.99 44.5 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.06 -1.025 . . . . 0.0 111.159 -174.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.495 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 87.9 tt0 -60.09 -41.24 92.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.556 -0.715 . . . . 0.0 110.182 176.183 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -56.06 -43.76 78.22 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.257 -0.902 . . . . 0.0 109.848 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.807 HD22 HG13 ' A' ' 11' ' ' VAL . 3.2 tt -67.84 -36.02 79.6 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.342 -0.849 . . . . 0.0 109.5 177.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.529 ' HA ' ' HB3' ' A' ' 20' ' ' LEU . . . -57.52 -44.33 84.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.945 -1.097 . . . . 0.0 109.603 172.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.717 ' HA ' HD11 ' A' ' 21' ' ' LEU . 0.1 OUTLIER -60.04 -39.95 87.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.204 -0.935 . . . . 0.0 109.901 173.159 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.476 ' HB3' ' O ' ' A' ' 16' ' ' LEU . 60.4 t0 -61.06 -40.83 95.16 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.677 -1.264 . . . . 0.0 109.101 171.056 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.842 ' C ' HD12 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -64.17 -80.69 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.551 -0.718 . . . . 0.0 110.445 179.826 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.808 HD12 ' H ' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -49.99 -20.01 0.84 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.21 -1.556 . . . . 0.0 110.497 -164.719 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.808 ' H ' HD12 ' A' ' 21' ' ' LEU . 50.2 tp10 -64.49 -39.99 94.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.682 -1.262 . . . . 0.0 110.189 173.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.44 ' HG2' ' O ' ' A' ' 19' ' ' ASP . 85.4 mm-40 -60.44 -41.74 94.68 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.284 -0.885 . . . . 0.0 111.221 -172.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.608 HG13 HD12 ' A' ' 33' ' ' LEU . 1.7 mp -64.3 -43.67 97.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.016 -1.053 . . . . 0.0 110.768 -173.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -61.84 -50.05 73.82 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 120.775 -1.203 . . . . 0.0 110.164 178.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -63.26 -57.3 10.89 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.128 -0.983 . . . . 0.0 110.521 176.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.748 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -104.53 -39.98 2.29 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -172.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.748 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 82.99 -153.52 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.23 0 O-C-N 122.109 -0.642 . . . . 0.0 110.476 -179.227 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.486 ' HB2' ' O ' ' A' ' 28' ' ' ALA . 2.7 m-20 61.38 75.66 0.4 Allowed 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 122.082 0.944 . . . . 0.0 110.558 175.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.506 ' CZ ' HG13 ' A' ' 9' ' ' ILE . 62.8 t80 -59.97 -48.15 82.9 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.82 -0.55 . . . . 0.0 110.931 -178.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.0 -41.51 97.95 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -175.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.437 ' HD2' ' CG ' ' A' ' 29' ' ' ASP . 82.0 mttt -66.34 -39.94 89.54 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.042 -1.269 . . . . 0.0 110.194 -178.321 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.608 HD12 HG13 ' A' ' 24' ' ' ILE . 49.1 mt -64.91 -40.07 94.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.066 -1.021 . . . . 0.0 110.206 178.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.486 ' O ' ' CB ' ' A' ' 38' ' ' SER . . . -59.57 -47.11 86.86 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.076 -1.015 . . . . 0.0 109.862 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -59.93 -40.9 90.46 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.032 -1.042 . . . . 0.0 110.431 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.8 mtpt -73.02 -52.08 15.76 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.013 -1.054 . . . . 0.0 111.764 -175.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.576 ' CD2' ' O ' ' A' ' 33' ' ' LEU . 7.4 p80 -106.01 -17.43 14.34 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.406 -1.434 . . . . 0.0 112.111 -167.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.668 ' O ' HG22 ' A' ' 39' ' ' ILE . 64.9 p -60.02 -50.06 75.22 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.621 -1.3 . . . . 0.0 110.301 -173.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.668 HG22 ' O ' ' A' ' 38' ' ' SER . 17.3 tt 38.34 31.2 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.692 -0.63 . . . . 0.0 110.466 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.51 ' SG ' ' N ' ' A' ' 43' ' ' GLY . 20.4 p -125.61 169.04 12.17 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.316 -0.865 . . . . 0.0 110.307 -176.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.469 ' HD2' ' HB2' ' A' ' 40' ' ' CYS . 41.0 Cg_exo -51.76 -34.61 55.1 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.893 1.47 . . . . 0.0 110.729 -175.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.535 ' O ' ' CA ' ' A' ' 46' ' ' GLY . 1.2 p -107.01 16.59 24.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.154 -0.966 . . . . 0.0 109.891 177.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.51 ' N ' ' SG ' ' A' ' 40' ' ' CYS . . . -79.98 -60.0 2.5 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 108.681 -1.768 . . . . 0.0 108.681 176.137 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -59.94 -40.37 88.73 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.424 -1.045 . . . . 0.0 110.488 176.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.556 ' NE ' HD23 ' A' ' 49' ' ' LEU . 17.0 tpt180 -104.95 -44.38 4.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.097 -1.002 . . . . 0.0 110.93 -175.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.535 ' CA ' ' O ' ' A' ' 42' ' ' SER . . . -62.37 -29.1 72.25 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.79 0.48 44.22 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 177.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.502 ' HA ' ' CD2' ' A' ' 7' ' ' LEU . 40.6 t0 -169.65 76.25 0.09 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.132 -1.217 . . . . 0.0 109.101 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.556 HD23 ' NE ' ' A' ' 45' ' ' ARG . 10.6 mt -91.28 -6.19 53.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.573 -0.704 . . . . 0.0 110.196 -175.109 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.95 -131.26 28.13 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 -173.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 54.8 mp0 -116.63 145.95 43.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.101 -1.235 . . . . 0.0 110.546 177.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.636 ' CE2' ' HB3' ' A' ' 6' ' ' ALA . 0.3 OUTLIER -130.19 164.14 25.15 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.321 -0.862 . . . . 0.0 110.552 176.14 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 87.7 mtt180 . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.528 -0.732 . . . . 0.0 110.434 -175.307 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo . . . . . 0 N--CA 1.48 0.724 0 N-CA-C 110.845 -0.483 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.55 -39.35 79.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -0.893 . . . . 0.0 110.216 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.506 ' HA ' HG12 ' A' ' 64' ' ' VAL . 59.5 t80 -59.92 -41.69 92.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.284 -0.885 . . . . 0.0 110.451 178.164 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -60.02 -47.24 86.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.232 -0.918 . . . . 0.0 109.878 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 67' ' ' SER . 96.9 mttt -59.88 -44.23 94.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.285 -0.885 . . . . 0.0 110.419 178.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.611 HG22 ' SG ' ' A' ' 68' ' ' CYS . 6.2 p -83.57 -44.96 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.12 -0.987 . . . . 0.0 111.221 -172.126 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.565 ' N ' HG13 ' A' ' 64' ' ' VAL . 5.0 p -55.43 -24.3 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.206 -1.558 . . . . 0.0 109.142 172.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -92.86 -15.2 26.71 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.332 -0.855 . . . . 0.0 109.661 175.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.525 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 9.4 t -93.18 -47.61 6.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.378 -0.826 . . . . 0.0 109.936 175.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.611 ' SG ' HG22 ' A' ' 64' ' ' VAL . 29.3 p -102.98 136.92 19.16 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.352 -0.843 . . . . 0.0 109.965 175.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.42 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 10.1 Cg_exo -66.55 171.61 10.44 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.796 1.419 . . . . 0.0 110.261 178.027 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.753 ' HB ' HD12 ' A' ' 71' ' ' LEU . 12.7 m -57.69 171.41 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.372 -0.83 . . . . 0.0 110.422 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.753 HD12 ' HB ' ' A' ' 70' ' ' VAL . 4.3 mp 38.85 39.71 0.37 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.583 -0.698 . . . . 0.0 110.764 -177.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.42 ' HB3' ' O ' ' A' ' 69' ' ' PRO . 20.0 tp10 -137.78 83.98 23.04 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.162 -0.961 . . . . 0.0 110.01 177.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -50.08 124.87 13.55 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.027 1.541 . . . . 0.0 109.981 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.514 ' OG1' ' CB ' ' A' ' 68' ' ' CYS . 96.5 m -135.22 138.09 43.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.293 -0.879 . . . . 0.0 110.21 -177.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.441 ' HA3' HG13 ' A' ' 85' ' ' ILE . . . 147.92 -172.72 28.18 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -178.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.506 ' HG3' ' HB1' ' A' ' 17' ' ' ALA . 44.6 Cg_endo -70.49 173.29 47.84 Favored 'Cis proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.77 -2.179 . . . . 0.0 110.59 -0.22 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.544 HD11 ' CG2' ' A' ' 64' ' ' VAL . 25.2 mt -133.57 175.33 9.52 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.243 -0.911 . . . . 0.0 110.224 -178.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -95.97 119.53 34.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.059 -1.026 . . . . 0.0 110.753 -175.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.824 HG21 ' CG ' ' A' ' 84' ' ' HIS . 15.2 t -140.94 163.41 33.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.42 -0.8 . . . . 0.0 109.779 176.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -59.99 -39.99 87.64 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.979 -1.075 . . . . 0.0 110.437 -178.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -60.06 -18.38 46.23 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.222 -0.923 . . . . 0.0 110.451 179.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.541 ' O ' HG22 ' A' ' 79' ' ' THR . . . 134.1 -130.56 5.64 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 -177.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.438 ' O ' ' HA ' ' A' ' 10' ' ' LEU . 3.6 m-85 -93.06 121.06 34.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.085 -1.244 . . . . 0.0 110.245 177.138 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.824 ' CG ' HG21 ' A' ' 79' ' ' THR . 0.1 OUTLIER -102.64 116.16 32.03 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.432 -0.793 . . . . 0.0 110.502 177.17 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.55 ' CG2' ' HB ' ' A' ' 9' ' ' ILE . 7.8 tt -108.62 126.28 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.86 -1.15 . . . . 0.0 109.427 170.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.578 HG12 ' CD2' ' A' ' 8' ' ' HIS . 89.5 mt -120.1 129.94 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.119 -0.988 . . . . 0.0 111.735 -167.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.526 ' HD3' HD12 ' A' ' 7' ' ' LEU . 27.8 tttt -101.08 129.84 47.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.225 -0.922 . . . . 0.0 109.165 169.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 18.0 t -100.82 139.98 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.075 -1.016 . . . . 0.0 110.414 -175.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.619 ' HB2' ' HB3' ' A' ' 5' ' ' ALA . 88.7 mt -141.68 170.15 16.27 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.434 ' C ' ' O ' ' A' ' 89' ' ' LEU . 77.8 m-85 33.37 -87.28 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 O-C-N 122.212 -0.305 . . . . 0.0 111.665 -178.337 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.533 ' N ' ' O ' ' A' ' 89' ' ' LEU . 1.8 ttp180 . . . . . 0 N--CA 1.492 1.671 0 O-C-N 120.7 -1.25 . . . . 0.0 109.502 -176.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.476 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 11.5 p . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.521 ' O ' ' HA ' ' A' ' 51' ' ' GLU . . . -127.8 150.56 49.77 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.86 -1.15 . . . . 0.0 109.954 176.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.505 ' HB3' ' HB2' ' A' ' 90' ' ' TYR . . . -89.71 121.63 32.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.32 -0.862 . . . . 0.0 109.62 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.628 ' HB3' ' CE2' ' A' ' 52' ' ' PHE . . . -131.81 131.9 43.28 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 118.992 -1.083 . . . . 0.0 111.651 -169.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.562 HD12 ' HD2' ' A' ' 87' ' ' LYS . 85.7 mt -99.96 134.01 43.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.288 -0.882 . . . . 0.0 108.991 169.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.569 ' NE2' ' HB1' ' A' ' 6' ' ' ALA . 49.7 m170 -128.51 129.67 46.38 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.833 -1.167 . . . . 0.0 111.116 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.59 ' HB ' HG22 ' A' ' 85' ' ' ILE . 80.0 mt -116.69 128.65 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.07 -1.019 . . . . 0.0 109.718 169.018 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.593 HD13 ' C ' ' A' ' 10' ' ' LEU . 2.4 tm? -106.58 120.32 41.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.274 -0.891 . . . . 0.0 109.911 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 1.059 HG13 HD22 ' A' ' 16' ' ' LEU . 2.3 t -106.77 125.45 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.312 -0.867 . . . . 0.0 110.282 -178.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -70.03 -37.86 75.71 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.373 -0.829 . . . . 0.0 110.499 175.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -106.48 136.8 45.6 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.086 -1.009 . . . . 0.0 111.061 -173.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.589 ' HG2' ' CZ ' ' A' ' 83' ' ' TYR . 97.1 mt-10 -59.99 -39.99 87.62 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.356 -0.84 . . . . 0.0 110.294 175.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -56.24 -44.51 79.69 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -0.913 . . . . 0.0 110.035 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 1.059 HD22 HG13 ' A' ' 11' ' ' VAL . 7.9 tt -68.56 -39.93 80.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.296 -0.877 . . . . 0.0 109.935 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.05 ' O ' HD12 ' A' ' 21' ' ' LEU . . . -58.2 -41.85 84.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.178 -0.951 . . . . 0.0 109.384 176.255 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.04 -45.36 93.08 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.075 -1.016 . . . . 0.0 109.365 171.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.439 ' HB3' ' O ' ' A' ' 16' ' ' LEU . 55.1 t0 -60.03 -42.49 94.5 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.417 -0.802 . . . . 0.0 110.11 176.53 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.701 ' C ' HD12 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -64.49 -47.05 80.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.237 -0.915 . . . . 0.0 109.523 178.09 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 1.05 HD12 ' O ' ' A' ' 17' ' ' ALA . 0.4 OUTLIER -56.53 -47.41 79.46 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.496 -0.753 . . . . 0.0 109.797 -178.955 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -61.2 -39.65 91.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.55 -0.719 . . . . 0.0 110.141 177.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.5 ' HG2' HD22 ' A' ' 33' ' ' LEU . 50.4 tp60 -59.94 -47.19 86.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.281 -0.887 . . . . 0.0 110.817 -172.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.761 HG21 ' CE2' ' A' ' 30' ' ' PHE . 2.3 mt -66.48 -43.54 90.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.055 -1.028 . . . . 0.0 110.888 -176.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -61.3 -44.26 97.51 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.702 -1.249 . . . . 0.0 109.983 -178.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -60.8 -65.33 0.71 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.149 -0.969 . . . . 0.0 110.491 175.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.759 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -105.86 -34.84 3.15 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -172.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.759 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 87.09 -147.05 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.338 0 O-C-N 122.373 -0.486 . . . . 0.0 110.328 -178.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.535 ' CB ' ' O ' ' A' ' 28' ' ' ALA . 0.5 OUTLIER 75.91 65.35 0.06 Allowed 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.308 0.575 . . . . 0.0 110.523 176.324 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.761 ' CE2' HG21 ' A' ' 24' ' ' ILE . 7.2 m-85 -60.03 -41.91 93.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.355 -0.841 . . . . 0.0 110.572 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.23 -53.82 33.93 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.176 -1.169 . . . . 0.0 110.176 -176.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.429 ' HD2' ' CG ' ' A' ' 29' ' ' ASP . 97.9 mttt -66.5 -39.98 89.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.011 -1.288 . . . . 0.0 110.555 -174.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.514 HD11 ' O ' ' A' ' 28' ' ' ALA . 88.7 mt -63.81 -40.06 95.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.097 -1.002 . . . . 0.0 109.915 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.414 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -59.98 -47.71 84.7 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.403 -0.811 . . . . 0.0 110.323 177.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -60.09 -43.14 95.74 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.271 -0.893 . . . . 0.0 110.654 -176.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 49.2 tttt -69.31 -53.79 17.88 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.037 -1.039 . . . . 0.0 110.98 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -70.39 -40.03 74.17 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.054 -1.029 . . . . 0.0 111.535 -172.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.673 ' O ' HG22 ' A' ' 39' ' ' ILE . 21.0 t -60.0 -43.55 95.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.882 -1.136 . . . . 0.0 110.187 -174.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.673 HG22 ' O ' ' A' ' 38' ' ' SER . 16.8 tt 38.26 32.04 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.655 -0.653 . . . . 0.0 110.747 176.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.489 ' SG ' ' N ' ' A' ' 43' ' ' GLY . 16.3 p -127.42 166.38 23.42 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.055 -1.028 . . . . 0.0 110.379 -176.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -51.99 -35.69 61.91 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.993 1.522 . . . . 0.0 110.56 -178.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.53 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -97.64 18.75 14.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.983 -1.073 . . . . 0.0 109.743 174.544 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.489 ' N ' ' SG ' ' A' ' 40' ' ' CYS . . . -77.2 -54.26 4.83 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 108.303 -1.919 . . . . 0.0 108.303 172.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -60.86 -39.98 91.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.527 -0.984 . . . . 0.0 110.657 176.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.485 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 11.7 tpp180 -97.95 -45.21 6.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.177 -0.952 . . . . 0.0 110.154 -177.005 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -68.3 -30.3 73.48 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 178.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.41 -1.37 57.35 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 176.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -171.89 68.29 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.3 -1.118 . . . . 0.0 108.85 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 7.2 mt -70.03 -28.1 65.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.54 -0.725 . . . . 0.0 110.347 -174.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 5' ' ' ALA . . . 98.92 -144.18 17.05 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.351 -1.499 . . . . 0.0 109.351 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.521 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 3.5 mt-10 -99.54 130.78 45.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.528 -0.983 . . . . 0.0 110.571 -178.042 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.628 ' CE2' ' HB3' ' A' ' 6' ' ' ALA . 3.3 p90 -149.02 168.41 23.2 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.241 -0.912 . . . . 0.0 110.875 178.23 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.476 ' HB2' ' HA ' ' A' ' 3' ' ' THR . 32.2 ttt85 . . . . . 0 N--CA 1.494 1.727 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 173.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.519 ' O ' ' N ' ' A' ' 62' ' ' ASP . 6.5 Cg_endo . . . . . 0 N--CA 1.486 1.07 0 N-CA-C 110.997 -0.424 . . . . 0.0 110.997 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 59' ' ' PRO . . . -42.01 -33.76 0.61 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.284 -0.885 . . . . 0.0 110.019 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -62.48 -39.75 94.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.334 -0.854 . . . . 0.0 110.028 177.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 59' ' ' PRO . 51.5 t0 -60.04 -40.0 87.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.34 -0.85 . . . . 0.0 110.536 -177.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 67' ' ' SER . 49.4 mttm -58.15 -48.49 80.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.093 -1.004 . . . . 0.0 111.434 -174.203 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.539 ' HA ' ' HB3' ' A' ' 67' ' ' SER . 2.4 p -94.73 -37.64 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.725 -1.235 . . . . 0.0 111.561 -173.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.2 p -54.82 -26.18 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.532 -1.355 . . . . 0.0 109.788 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.485 ' CD2' ' O ' ' A' ' 66' ' ' PHE . 50.7 t80 -100.68 0.05 38.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.315 -0.866 . . . . 0.0 110.127 176.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.539 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 41.2 t -94.03 -74.58 0.53 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.263 -0.898 . . . . 0.0 110.37 -176.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.482 ' O ' ' N ' ' A' ' 70' ' ' VAL . 94.5 m -100.27 142.8 25.3 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.244 -0.91 . . . . 0.0 110.388 -178.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.495 ' O ' ' C ' ' A' ' 70' ' ' VAL . 35.4 Cg_exo -56.47 81.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.053 1.554 . . . . 0.0 110.222 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.824 ' O ' HD12 ' A' ' 71' ' ' LEU . 16.8 m 13.41 65.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.391 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.824 HD12 ' O ' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -166.95 -47.41 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.456 -0.778 . . . . 0.0 110.315 177.583 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -83.34 148.05 54.76 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.229 -0.92 . . . . 0.0 110.434 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -70.52 141.32 41.88 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.105 1.582 . . . . 0.0 110.622 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.455 ' HB ' ' CG2' ' A' ' 64' ' ' VAL . 94.5 m -138.01 137.8 38.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.25 -0.906 . . . . 0.0 110.189 178.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 140.89 -167.11 25.75 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.756 ' HD3' HD21 ' A' ' 21' ' ' LEU . 43.1 Cg_endo -72.1 140.6 66.84 Favored 'Cis proline' 0 C--N 1.315 -1.231 0 C-N-CA 121.783 -2.174 . . . . 0.0 110.586 1.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.519 HD11 ' HB ' ' A' ' 64' ' ' VAL . 96.2 mt -90.89 170.39 10.12 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.39 -0.819 . . . . 0.0 109.998 -177.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -106.82 123.67 48.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.857 -1.152 . . . . 0.0 110.898 -177.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.1 t -138.59 164.77 28.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.371 -0.83 . . . . 0.0 109.338 173.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -56.74 -39.76 74.53 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.941 -1.099 . . . . 0.0 110.253 -175.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -60.05 -26.98 66.56 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.183 -0.948 . . . . 0.0 110.535 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 149.26 -137.76 6.47 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -176.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.589 ' CZ ' ' HG2' ' A' ' 14' ' ' GLU . 66.3 m-85 -98.64 124.86 43.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.992 -1.299 . . . . 0.0 110.367 177.125 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.438 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 1.9 m170 -101.7 114.17 27.99 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.475 -0.766 . . . . 0.0 110.309 174.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.59 HG22 ' HB ' ' A' ' 9' ' ' ILE . 3.1 tt -102.05 118.84 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 120.761 -1.212 . . . . 0.0 109.408 170.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.561 HG12 ' CD2' ' A' ' 8' ' ' HIS . 96.1 mt -112.07 129.98 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.462 -0.774 . . . . 0.0 111.017 -172.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.562 ' HD2' HD12 ' A' ' 7' ' ' LEU . 10.5 ttmm -105.17 127.08 52.74 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.868 -1.145 . . . . 0.0 109.31 168.063 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.771 ' O ' HD23 ' A' ' 89' ' ' LEU . 26.8 t -110.29 139.97 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.208 -0.933 . . . . 0.0 110.335 -173.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.771 HD23 ' O ' ' A' ' 88' ' ' VAL . 81.1 mt -148.9 177.15 9.81 Favored 'General case' 0 C--N 1.308 -1.203 0 O-C-N 121.336 -0.852 . . . . 0.0 109.402 -177.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.505 ' HB2' ' HB3' ' A' ' 5' ' ' ALA . 0.3 OUTLIER 67.49 -61.01 0.37 Allowed 'General case' 0 C--N 1.293 -1.859 0 O-C-N 121.422 -0.799 . . . . 0.0 111.389 167.23 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.76 ' HD2' HG21 ' A' ' 70' ' ' VAL . 61.7 ttt-85 . . . . . 0 N--CA 1.495 1.784 0 O-C-N 121.04 -1.038 . . . . 0.0 110.567 -174.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 67.4 p . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 121.117 0.484 . . . . 0.0 110.262 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 91' ' ' ARG . . . -138.56 143.44 39.42 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.192 -0.942 . . . . 0.0 110.264 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.609 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -94.53 130.32 40.98 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.315 -0.866 . . . . 0.0 109.145 173.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.748 ' HB3' ' CZ ' ' A' ' 52' ' ' PHE . . . -146.8 134.91 21.57 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.845 -1.159 . . . . 0.0 111.534 -171.126 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.646 HD12 ' HD3' ' A' ' 87' ' ' LYS . 88.6 mt -107.35 149.88 27.34 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.298 -0.876 . . . . 0.0 109.581 173.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.665 ' ND1' HD12 ' A' ' 49' ' ' LEU . 25.1 m80 -136.39 143.4 43.97 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.795 -1.19 . . . . 0.0 111.634 -176.205 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.618 HG12 ' HB2' ' A' ' 34' ' ' ALA . 91.1 mt -130.96 130.77 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.005 -1.059 . . . . 0.0 109.575 166.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.589 ' HG ' ' CD2' ' A' ' 84' ' ' HIS . 0.3 OUTLIER -104.72 119.96 40.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.428 -0.795 . . . . 0.0 110.053 179.782 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.749 HG11 ' N ' ' A' ' 17' ' ' ALA . 2.5 t -105.04 126.6 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.17 -0.956 . . . . 0.0 110.266 178.259 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 26.2 mmtm -69.19 -40.01 78.33 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.479 -0.763 . . . . 0.0 110.32 177.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -109.32 140.54 42.86 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.217 -0.927 . . . . 0.0 110.918 -173.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -60.13 -47.46 85.81 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.409 -0.807 . . . . 0.0 110.36 175.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -59.35 -40.71 87.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.276 -0.89 . . . . 0.0 110.335 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.42 ' CD2' HG13 ' A' ' 11' ' ' VAL . 2.5 tt -67.84 -39.98 83.8 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.312 -0.867 . . . . 0.0 109.627 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.995 ' O ' HD12 ' A' ' 21' ' ' LEU . . . -59.02 -43.76 91.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -0.923 . . . . 0.0 109.815 175.168 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.93 -43.1 95.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.192 -0.943 . . . . 0.0 109.942 175.299 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -60.01 -41.63 92.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.402 -0.811 . . . . 0.0 110.162 178.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.707 ' C ' HD12 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -64.18 -46.09 85.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.161 -0.962 . . . . 0.0 109.825 178.666 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.995 HD12 ' O ' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -58.21 -50.03 75.0 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.329 -0.857 . . . . 0.0 110.428 -178.05 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -60.01 -36.93 78.27 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.213 -0.93 . . . . 0.0 110.261 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.485 ' HG2' HD21 ' A' ' 33' ' ' LEU . 52.8 tp60 -59.99 -40.01 87.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.189 -0.944 . . . . 0.0 110.374 -175.034 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.823 HG21 ' HE1' ' A' ' 30' ' ' PHE . 3.9 mt -63.73 -41.96 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.112 -0.993 . . . . 0.0 110.715 -178.016 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -59.96 -45.69 91.86 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.824 -1.172 . . . . 0.0 109.565 176.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -59.78 -67.37 0.39 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.169 -0.957 . . . . 0.0 110.375 173.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.747 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -106.54 -35.03 2.94 Favored Glycine 0 N--CA 1.487 2.067 0 C-N-CA 120.057 -1.068 . . . . 0.0 110.617 -170.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.747 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 85.37 -156.91 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.402 0 O-C-N 122.001 -0.705 . . . . 0.0 110.196 -174.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.552 ' CB ' ' O ' ' A' ' 28' ' ' ALA . 0.7 OUTLIER 78.7 71.59 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 CA-C-O 121.487 0.66 . . . . 0.0 110.563 176.865 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.823 ' HE1' HG21 ' A' ' 24' ' ' ILE . 1.7 m-85 -62.43 -42.21 99.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.203 -0.935 . . . . 0.0 110.664 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.29 -44.4 97.54 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 -176.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.6 mmtt -63.79 -39.96 95.51 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.162 -1.199 . . . . 0.0 110.082 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.58 ' CD1' HG13 ' A' ' 24' ' ' ILE . 85.9 mt -62.55 -39.92 95.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.107 -0.995 . . . . 0.0 110.355 176.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.618 ' HB2' HG12 ' A' ' 9' ' ' ILE . . . -58.17 -48.65 79.62 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.095 -1.003 . . . . 0.0 110.186 -178.117 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -59.24 -49.08 79.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.281 -0.887 . . . . 0.0 110.159 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -70.0 -43.04 72.22 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.297 -0.877 . . . . 0.0 111.473 -176.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -80.07 -49.99 10.98 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.031 -1.043 . . . . 0.0 111.217 -173.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.649 ' O ' HG22 ' A' ' 39' ' ' ILE . 54.1 m -60.12 -39.91 87.89 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.053 -1.029 . . . . 0.0 111.064 -172.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.649 HG22 ' O ' ' A' ' 38' ' ' SER . 10.9 tp 39.02 28.95 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.528 -0.733 . . . . 0.0 110.375 -178.301 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.469 ' N ' ' O ' ' A' ' 38' ' ' SER . 17.5 p -122.8 160.16 50.29 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.328 -0.857 . . . . 0.0 109.823 -178.447 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -52.68 -20.68 12.99 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.84 1.442 . . . . 0.0 110.42 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.525 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -106.58 16.41 24.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.181 -0.949 . . . . 0.0 110.205 176.885 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.49 -51.41 5.61 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.611 -1.796 . . . . 0.0 108.611 172.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.468 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 48.5 tttp -60.02 -39.99 87.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.423 -1.045 . . . . 0.0 110.259 177.451 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.535 ' HA ' ' OD1' ' A' ' 48' ' ' ASP . 20.7 tpt180 -96.68 -42.05 8.21 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.369 -0.832 . . . . 0.0 110.479 -177.033 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -63.25 -28.98 73.12 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.94 0.16 53.13 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 176.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.535 ' OD1' ' HA ' ' A' ' 45' ' ' ARG . 43.8 p-10 -170.15 62.75 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.249 -1.147 . . . . 0.0 109.183 -177.066 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.665 HD12 ' ND1' ' A' ' 8' ' ' HIS . 10.3 mt -69.98 -29.23 66.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.398 -0.814 . . . . 0.0 110.749 -175.102 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.21 -145.06 17.49 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -178.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.406 ' HG3' ' C ' ' A' ' 4' ' ' ALA . 32.9 tt0 -112.27 136.38 51.77 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.19 -1.182 . . . . 0.0 110.217 -178.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.748 ' CZ ' ' HB3' ' A' ' 6' ' ' ALA . 0.1 OUTLIER -133.79 -166.1 1.73 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.299 -0.876 . . . . 0.0 109.705 174.411 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 . . . . . 0 N--CA 1.494 1.772 0 O-C-N 120.845 -1.159 . . . . 0.0 109.865 -178.576 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo . . . . . 0 N--CA 1.485 1.004 0 N-CA-C 110.408 -0.651 . . . . 0.0 110.408 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -44.8 -29.43 0.79 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.24 -0.912 . . . . 0.0 110.574 -179.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.8 ' CD1' HG21 ' A' ' 86' ' ' ILE . 59.4 t80 -60.01 -44.29 94.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.082 -1.011 . . . . 0.0 110.177 178.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -59.93 -42.0 93.02 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.05 -1.031 . . . . 0.0 109.549 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.493 ' O ' ' N ' ' A' ' 67' ' ' SER . 93.4 mttt -60.02 -47.42 85.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.512 -0.743 . . . . 0.0 111.011 -178.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.556 ' HB ' HD13 ' A' ' 77' ' ' LEU . 10.3 p -73.02 -46.57 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 120.872 -1.143 . . . . 0.0 110.98 -175.12 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.552 ' N ' HG13 ' A' ' 64' ' ' VAL . 9.8 p -60.2 -22.05 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.208 -1.558 . . . . 0.0 109.662 170.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -90.41 -13.62 34.59 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.85 -1.156 . . . . 0.0 109.366 171.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.511 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 12.4 t -87.5 -61.85 1.63 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.464 -0.773 . . . . 0.0 108.917 172.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.511 ' N ' ' O ' ' A' ' 64' ' ' VAL . 31.3 p -82.5 133.31 50.09 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 120.876 -1.14 . . . . 0.0 109.087 167.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.507 ' O ' ' NH1' ' A' ' 91' ' ' ARG . 41.3 Cg_exo -52.28 -68.66 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.713 1.375 . . . . 0.0 110.671 -174.119 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.005 HG22 HD12 ' A' ' 71' ' ' LEU . 7.6 p -179.01 162.16 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -177.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.005 HD12 HG22 ' A' ' 70' ' ' VAL . 3.3 mp 42.76 32.96 0.43 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.897 -1.127 . . . . 0.0 109.946 -170.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.487 ' CG ' ' O ' ' A' ' 70' ' ' VAL . 8.4 mm-40 -130.9 79.98 70.49 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.667 -0.646 . . . . 0.0 109.918 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -47.07 126.64 11.63 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 123.859 1.452 . . . . 0.0 110.012 -178.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.416 ' OG1' ' HB3' ' A' ' 68' ' ' CYS . 70.7 m -135.38 139.37 44.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.182 -0.949 . . . . 0.0 110.432 -176.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.94 -170.82 25.13 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.971 ' CD ' HD11 ' A' ' 21' ' ' LEU . 42.0 Cg_endo -69.53 136.46 38.39 Favored 'Cis proline' 0 C--N 1.314 -1.262 0 C-N-CA 121.767 -2.18 . . . . 0.0 110.455 0.164 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.556 HD13 ' HB ' ' A' ' 64' ' ' VAL . 1.0 OUTLIER -95.29 142.69 27.4 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.221 -0.924 . . . . 0.0 110.433 -175.017 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -64.75 130.06 42.12 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.107 -0.995 . . . . 0.0 110.633 -176.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.505 HG21 ' CE1' ' A' ' 84' ' ' HIS . 9.5 t -144.66 160.24 41.51 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.283 -0.886 . . . . 0.0 110.375 178.202 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.591 ' HG3' ' CD2' ' A' ' 81' ' ' PHE . 20.1 pt20 -63.06 -16.22 59.19 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.263 -0.898 . . . . 0.0 110.879 -177.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.591 ' CD2' ' HG3' ' A' ' 80' ' ' GLN . 98.4 m-85 -95.01 6.27 49.56 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.003 -1.061 . . . . 0.0 110.457 -178.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 126.39 -115.4 2.26 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 -175.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.469 ' HB3' ' HB2' ' A' ' 76' ' ' PRO . 69.2 m-85 -140.41 126.97 20.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.09 -1.241 . . . . 0.0 110.287 175.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.589 ' CD2' ' HG ' ' A' ' 10' ' ' LEU . 42.1 m170 -103.31 127.57 50.61 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.522 -0.736 . . . . 0.0 110.676 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.582 HG22 ' HB ' ' A' ' 9' ' ' ILE . 8.4 tt -109.15 129.59 63.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 120.605 -1.309 . . . . 0.0 109.065 166.308 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.8 HG21 ' CD1' ' A' ' 61' ' ' PHE . 72.2 mt -130.18 135.1 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.015 -1.053 . . . . 0.0 110.701 -169.076 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.646 ' HD3' HD12 ' A' ' 7' ' ' LEU . 12.5 mtpt -97.91 139.16 34.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.45 -0.781 . . . . 0.0 109.58 176.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.547 HG11 ' HA ' ' A' ' 70' ' ' VAL . 28.0 t -109.74 137.47 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.473 -0.767 . . . . 0.0 110.146 -178.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.609 ' HB2' ' HB3' ' A' ' 5' ' ' ALA . 92.3 mt -144.34 135.79 25.64 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.064 -1.022 . . . . 0.0 109.551 178.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.543 ' CD2' ' HB3' ' A' ' 89' ' ' LEU . 70.9 m-85 65.31 -63.42 0.2 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.332 -0.855 . . . . 0.0 111.076 177.174 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.507 ' NH1' ' O ' ' A' ' 69' ' ' PRO . 33.7 ttp180 . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.049 -1.032 . . . . 0.0 110.214 -175.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.494 1.774 0 CA-C-O 121.029 0.442 . . . . 0.0 109.972 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.54 ' O ' ' CD1' ' A' ' 52' ' ' PHE . . . -151.45 154.81 37.31 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.107 -0.995 . . . . 0.0 110.623 -174.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.529 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -101.32 140.0 36.22 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.009 -1.057 . . . . 0.0 109.14 171.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.727 ' HB3' ' CZ ' ' A' ' 52' ' ' PHE . . . -159.04 154.55 25.9 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.859 -1.151 . . . . 0.0 111.29 -178.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.803 HD12 ' HD2' ' A' ' 87' ' ' LYS . 82.2 mt -109.91 149.99 29.09 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.434 -0.791 . . . . 0.0 109.142 172.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.875 ' CD2' HD12 ' A' ' 49' ' ' LEU . 46.5 m-70 -137.2 133.55 35.29 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.789 -1.194 . . . . 0.0 111.383 -177.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.69 ' HB ' HG22 ' A' ' 85' ' ' ILE . 87.3 mt -120.01 120.99 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.113 -0.992 . . . . 0.0 109.605 168.295 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.782 HD13 ' C ' ' A' ' 10' ' ' LEU . 2.7 tm? -104.07 120.08 40.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.477 -0.765 . . . . 0.0 109.817 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.862 HG13 HD22 ' A' ' 16' ' ' LEU . 2.4 t -103.81 130.08 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.29 -0.881 . . . . 0.0 110.346 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -65.93 -40.08 91.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.459 -0.776 . . . . 0.0 110.551 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -119.54 140.02 51.2 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.126 -0.984 . . . . 0.0 110.531 -175.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.453 ' HB2' ' CE1' ' A' ' 83' ' ' TYR . 86.8 tt0 -59.91 -39.99 87.32 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.372 -0.83 . . . . 0.0 110.352 -178.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.6 mttt -52.46 -47.42 66.48 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.188 -0.945 . . . . 0.0 110.069 -176.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.862 HD22 HG13 ' A' ' 11' ' ' VAL . 8.4 tt -68.71 -37.07 79.22 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.104 -0.997 . . . . 0.0 109.546 176.115 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.665 ' HA ' HD23 ' A' ' 20' ' ' LEU . . . -56.94 -49.29 76.1 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.042 -1.036 . . . . 0.0 109.522 176.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.448 ' HA ' HD12 ' A' ' 21' ' ' LEU . 0.9 OUTLIER -58.31 -40.44 82.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.15 -0.969 . . . . 0.0 109.579 174.573 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.48 ' HB3' ' O ' ' A' ' 16' ' ' LEU . 51.5 t0 -60.0 -39.98 87.66 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.096 -1.002 . . . . 0.0 109.671 174.055 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 1.011 HD13 HD21 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -62.91 -44.27 96.55 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.16 -0.963 . . . . 0.0 109.668 178.125 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.841 HD21 ' HD3' ' A' ' 76' ' ' PRO . 1.3 mt -59.9 -50.14 74.93 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.381 -0.824 . . . . 0.0 110.07 -178.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -62.87 -39.92 95.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.314 -0.867 . . . . 0.0 110.247 177.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.451 ' O ' ' N ' ' A' ' 27' ' ' GLY . 64.9 tp60 -60.07 -40.95 91.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.305 -0.872 . . . . 0.0 110.311 -177.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.517 ' O ' ' N ' ' A' ' 28' ' ' ALA . 85.5 mt -67.32 -40.35 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.179 -0.95 . . . . 0.0 109.795 177.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -63.85 -59.96 3.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.139 -0.976 . . . . 0.0 109.598 176.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -60.32 -52.37 65.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.438 -0.789 . . . . 0.0 110.866 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 28' ' ' ALA . . . -106.18 -13.0 24.21 Favored Glycine 0 N--CA 1.487 2.041 0 C-N-CA 119.647 -1.263 . . . . 0.0 110.597 -166.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 24' ' ' ILE . . . 34.1 95.37 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.751 -0.853 . . . . 0.0 111.459 -177.119 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -171.68 86.35 0.09 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.466 -0.771 . . . . 0.0 109.827 -176.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.503 ' CG ' ' HE3' ' A' ' 87' ' ' LYS . 3.9 m-85 -69.8 -40.12 76.18 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.325 -0.859 . . . . 0.0 110.764 -176.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.36 -52.08 53.81 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -63.73 -41.1 98.12 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.185 -1.185 . . . . 0.0 110.513 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.011 HD21 HD13 ' A' ' 20' ' ' LEU . 33.0 tp -61.74 -50.06 73.91 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.074 -1.016 . . . . 0.0 110.716 -175.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.667 ' HB2' HG12 ' A' ' 9' ' ' ILE . . . -59.95 -47.88 83.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.198 -0.939 . . . . 0.0 110.383 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 50.3 mttm -60.02 -49.78 76.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.212 -0.93 . . . . 0.0 110.592 -176.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.456 ' O ' HG13 ' A' ' 39' ' ' ILE . 57.2 tptt -69.72 -52.5 24.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.156 -0.965 . . . . 0.0 111.235 -175.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.694 ' HB3' HD21 ' A' ' 16' ' ' LEU . 86.9 m-70 -83.21 -40.28 19.85 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.913 -1.117 . . . . 0.0 111.583 -170.145 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.483 ' HB3' ' O ' ' A' ' 34' ' ' ALA . 18.4 t -60.01 -45.2 93.54 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.973 -1.08 . . . . 0.0 110.443 -176.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.623 ' O ' HG22 ' A' ' 39' ' ' ILE . 80.2 mt 34.14 45.76 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 CA-C-O 121.322 0.582 . . . . 0.0 110.769 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.512 ' SG ' ' N ' ' A' ' 43' ' ' GLY . 17.2 p -133.91 160.04 70.09 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.254 -0.904 . . . . 0.0 110.093 -177.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.404 ' HD2' ' HB2' ' A' ' 40' ' ' CYS . 6.7 Cg_endo -54.02 -23.8 29.88 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.962 1.506 . . . . 0.0 110.522 -177.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.511 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -109.12 20.54 18.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.085 -1.009 . . . . 0.0 110.084 176.902 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.512 ' N ' ' SG ' ' A' ' 40' ' ' CYS . . . -79.11 -59.65 2.7 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 176.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -60.02 -33.91 72.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.41 -1.053 . . . . 0.0 110.39 176.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.458 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 16.0 tpt180 -91.57 -39.73 11.74 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.109 -0.994 . . . . 0.0 110.158 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -70.75 -29.02 69.9 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 177.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.97 0.54 58.06 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 173.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -168.76 63.34 0.06 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.291 -1.123 . . . . 0.0 109.134 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.875 HD12 ' CD2' ' A' ' 8' ' ' HIS . 12.7 mt -70.12 -28.89 65.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.599 -0.688 . . . . 0.0 110.155 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.27 -136.02 12.69 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.231 -1.547 . . . . 0.0 109.231 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -113.66 148.16 36.82 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.382 -1.069 . . . . 0.0 110.171 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.727 ' CZ ' ' HB3' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -131.45 160.41 35.23 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.205 -0.934 . . . . 0.0 109.879 -172.382 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 36.5 ptt-85 . . . . . 0 N--CA 1.494 1.756 0 O-C-N 121.297 -0.877 . . . . 0.0 110.468 -173.802 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 60' ' ' ALA . 32.9 Cg_endo . . . . . 0 N--CA 1.484 0.916 0 N-CA-C 111.059 -0.4 . . . . 0.0 111.059 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.5 ' O ' HG12 ' A' ' 64' ' ' VAL . . . -42.67 -34.64 0.93 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.116 -0.99 . . . . 0.0 110.469 -174.494 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.434 ' CE2' ' CE1' ' A' ' 52' ' ' PHE . 56.1 t80 -60.0 -44.07 94.79 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.233 -0.917 . . . . 0.0 110.092 -179.4 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.522 ' OD1' ' CD1' ' A' ' 66' ' ' PHE . 56.5 t0 -68.31 -45.26 73.48 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.295 -0.878 . . . . 0.0 110.553 -178.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' A' ' 67' ' ' SER . 11.3 tptt -56.36 -50.15 72.37 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.031 -1.043 . . . . 0.0 110.269 -176.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.522 ' HA ' ' HB3' ' A' ' 67' ' ' SER . 5.8 p -69.5 -46.73 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.089 -1.007 . . . . 0.0 111.443 -173.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.51 ' N ' HG13 ' A' ' 64' ' ' VAL . 6.8 p -58.15 -26.14 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.297 -1.502 . . . . 0.0 109.468 173.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.522 ' CD1' ' OD1' ' A' ' 62' ' ' ASP . 17.4 m-85 -96.2 -1.78 47.59 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.21 -0.931 . . . . 0.0 110.148 174.072 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.522 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 9.4 t -97.41 -59.03 1.87 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.348 -0.845 . . . . 0.0 109.67 173.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.536 ' CB ' ' HG1' ' A' ' 74' ' ' THR . 23.0 p -107.08 147.72 35.66 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.4 -0.813 . . . . 0.0 110.146 177.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -71.68 171.27 16.74 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 124.046 1.551 . . . . 0.0 110.682 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.066 HG22 HD12 ' A' ' 71' ' ' LEU . 7.1 p -58.7 158.6 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.465 -0.772 . . . . 0.0 110.145 178.289 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.066 HD12 HG22 ' A' ' 70' ' ' VAL . 3.2 mp 56.75 39.55 29.59 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.195 -0.941 . . . . 0.0 110.0 -175.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.419 ' C ' ' OE1' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -148.36 93.63 4.34 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.366 -0.834 . . . . 0.0 110.115 -179.907 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -63.15 130.52 29.13 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.981 1.516 . . . . 0.0 110.164 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.536 ' HG1' ' CB ' ' A' ' 68' ' ' CYS . 33.3 m -135.88 140.49 44.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.288 -0.882 . . . . 0.0 110.415 -178.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 149.16 -169.83 29.51 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.219 -1.553 . . . . 0.0 109.219 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.841 ' HD3' HD21 ' A' ' 21' ' ' LEU . 46.7 Cg_endo -76.03 136.36 44.24 Favored 'Cis proline' 0 C--N 1.313 -1.329 0 C-N-CA 121.825 -2.156 . . . . 0.0 110.663 -1.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 41.2 mt -93.36 -173.22 3.16 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.319 -0.863 . . . . 0.0 109.962 178.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -111.74 121.22 44.49 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.997 -1.064 . . . . 0.0 111.306 -173.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.482 HG21 ' CD2' ' A' ' 84' ' ' HIS . 9.8 t -138.06 164.28 29.48 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.274 -0.891 . . . . 0.0 109.438 170.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -54.92 -36.53 65.33 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.141 -0.975 . . . . 0.0 110.618 -175.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -63.13 -30.37 71.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.062 -1.024 . . . . 0.0 110.78 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 152.07 -135.58 5.06 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -177.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 10' ' ' LEU . 39.0 m-85 -93.98 131.12 39.76 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.35 -1.088 . . . . 0.0 109.96 177.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.482 ' CD2' HG21 ' A' ' 79' ' ' THR . 0.0 OUTLIER -111.93 113.25 25.45 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.432 -0.792 . . . . 0.0 110.999 -178.863 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.713 HD13 HD11 ' A' ' 20' ' ' LEU . 4.5 tt -110.03 132.46 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.881 -1.137 . . . . 0.0 109.117 169.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.514 HG12 ' ND1' ' A' ' 8' ' ' HIS . 89.1 mt -135.98 140.12 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.598 -1.314 . . . . 0.0 111.899 -168.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.803 ' HD2' HD12 ' A' ' 7' ' ' LEU . 15.1 mttm -92.65 142.26 27.56 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.387 -0.821 . . . . 0.0 110.038 170.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.474 ' CG1' ' HD3' ' A' ' 91' ' ' ARG . 59.7 t -109.72 133.69 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.768 -0.582 . . . . 0.0 109.983 178.095 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.529 ' HB2' ' HB3' ' A' ' 5' ' ' ALA . 81.0 mt -141.89 129.09 20.99 Favored 'General case' 0 C--N 1.308 -1.2 0 O-C-N 121.005 -1.059 . . . . 0.0 109.947 -176.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.488 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 42.2 m-85 65.29 -55.29 0.32 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.228 -0.92 . . . . 0.0 111.587 173.197 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.527 ' NE ' ' HB ' ' A' ' 70' ' ' VAL . 84.6 mtm180 . . . . . 0 N--CA 1.495 1.792 0 O-C-N 121.037 -1.04 . . . . 0.0 110.894 -177.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.664 HG22 ' CB ' ' A' ' 53' ' ' ARG . 14.8 p . . . . . 0 N--CA 1.493 1.696 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.454 ' C ' ' HG3' ' A' ' 51' ' ' GLU . . . -149.96 153.61 36.88 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.839 -1.163 . . . . 0.0 111.029 -178.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.441 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -96.69 131.46 43.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.424 -0.798 . . . . 0.0 109.253 174.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.671 ' HB3' ' CZ ' ' A' ' 52' ' ' PHE . . . -147.41 122.73 10.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.834 -1.166 . . . . 0.0 111.688 -172.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.593 ' N ' ' CD1' ' A' ' 7' ' ' LEU . 3.5 mp -97.07 141.16 30.55 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.173 -0.954 . . . . 0.0 109.283 170.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.73 ' CD2' HD12 ' A' ' 49' ' ' LEU . 25.8 m-70 -134.54 128.17 32.78 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.887 -1.133 . . . . 0.0 110.947 -175.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.548 ' HB ' ' CG2' ' A' ' 85' ' ' ILE . 76.4 mt -109.96 129.96 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 120.882 -1.136 . . . . 0.0 110.136 168.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.597 ' HG ' ' CD2' ' A' ' 84' ' ' HIS . 0.3 OUTLIER -101.68 118.61 37.3 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.552 -0.717 . . . . 0.0 109.711 178.648 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.828 HG13 HD22 ' A' ' 16' ' ' LEU . 2.0 t -101.48 127.21 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.243 -0.911 . . . . 0.0 110.125 -177.095 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.1 mttp -69.28 -40.01 78.0 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.308 -0.87 . . . . 0.0 110.313 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -132.52 152.21 51.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.295 -0.878 . . . . 0.0 110.26 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.527 ' HG3' ' CZ ' ' A' ' 83' ' ' TYR . 95.2 mt-10 -59.04 -39.9 83.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.29 -0.881 . . . . 0.0 110.409 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -51.31 -44.62 61.97 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.191 -0.943 . . . . 0.0 110.34 -176.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.828 HD22 HG13 ' A' ' 11' ' ' VAL . 9.7 tt -68.89 -40.0 79.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.044 -1.035 . . . . 0.0 109.715 177.002 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.954 ' O ' HD12 ' A' ' 21' ' ' LEU . . . -59.87 -44.43 94.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.307 -0.871 . . . . 0.0 110.14 177.32 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.85 -45.8 89.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.218 -0.926 . . . . 0.0 109.819 178.006 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.49 ' O ' ' HB2' ' A' ' 23' ' ' GLN . 53.1 t0 -60.03 -42.2 93.86 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.345 -0.847 . . . . 0.0 110.187 177.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.727 ' C ' HD12 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -66.47 -43.56 85.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.147 -0.97 . . . . 0.0 110.047 -179.711 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.954 HD12 ' O ' ' A' ' 17' ' ' ALA . 0.3 OUTLIER -55.26 -59.93 4.1 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.38 -0.825 . . . . 0.0 110.072 -177.869 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -63.9 -40.0 95.48 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.394 -0.816 . . . . 0.0 110.707 177.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.574 ' HA ' ' OD1' ' A' ' 26' ' ' ASN . 7.4 tt0 -60.11 -29.49 68.64 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.118 -0.989 . . . . 0.0 110.185 -176.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.533 ' O ' ' CA ' ' A' ' 28' ' ' ALA . 91.6 mt -68.2 -40.01 82.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 120.687 -1.258 . . . . 0.0 109.606 173.362 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.4 tttp -66.69 -60.09 3.01 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.097 -1.002 . . . . 0.0 110.696 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.574 ' OD1' ' HA ' ' A' ' 23' ' ' GLN . 47.3 p30 -62.16 -33.68 74.96 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.105 -0.997 . . . . 0.0 110.501 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.758 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -106.23 -65.3 0.63 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.758 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 85.58 95.51 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.254 0 CA-C-O 121.624 0.725 . . . . 0.0 110.615 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -177.1 80.01 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.61 -0.681 . . . . 0.0 109.651 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.588 ' CG ' ' HE2' ' A' ' 87' ' ' LYS . 5.5 m-85 -60.1 -47.77 84.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.876 . . . . 0.0 110.903 -174.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.05 -50.33 68.8 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 119.715 -1.231 . . . . 0.0 110.045 -176.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -66.6 -40.04 88.66 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.131 -1.217 . . . . 0.0 110.78 -175.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.417 ' CD2' ' OE1' ' A' ' 23' ' ' GLN . 83.8 mt -66.3 -40.19 89.84 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.164 -0.96 . . . . 0.0 110.562 -178.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.529 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -60.06 -50.03 75.34 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.049 -1.032 . . . . 0.0 110.198 177.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -60.02 -49.95 75.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.229 -0.919 . . . . 0.0 111.158 -177.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.0 tttp -70.08 -45.17 67.6 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.005 -1.06 . . . . 0.0 111.165 -172.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -81.61 -32.02 32.19 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.101 -1.0 . . . . 0.0 110.832 -174.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.49 ' CB ' ' O ' ' A' ' 34' ' ' ALA . 27.5 t -60.19 -44.92 94.71 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.121 -0.987 . . . . 0.0 111.31 -173.116 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.627 ' O ' HG22 ' A' ' 39' ' ' ILE . 73.6 mt 44.69 25.93 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 120.904 -1.122 . . . . 0.0 109.762 -173.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.462 ' SG ' ' HD2' ' A' ' 41' ' ' PRO . 35.8 t -117.43 143.27 31.76 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.391 -0.818 . . . . 0.0 109.943 -178.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.462 ' HD2' ' SG ' ' A' ' 40' ' ' CYS . 52.7 Cg_exo -49.21 -20.92 3.85 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.849 1.447 . . . . 0.0 110.655 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.514 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -109.12 19.92 18.94 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.182 -0.949 . . . . 0.0 109.81 176.877 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' A' ' 47' ' ' GLY . . . -75.05 -59.46 3.65 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 174.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -60.05 -39.97 87.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.389 -1.066 . . . . 0.0 110.573 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -94.14 -42.3 9.06 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.924 -1.11 . . . . 0.0 110.413 -176.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -70.6 -24.52 76.8 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 174.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 43' ' ' GLY . . . -74.4 -1.0 59.76 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 173.279 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.436 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 49.0 t0 -173.06 70.29 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.352 -1.087 . . . . 0.0 109.122 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.73 HD12 ' CD2' ' A' ' 8' ' ' HIS . 11.9 mt -72.47 -6.59 44.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.633 -0.667 . . . . 0.0 110.156 -176.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 5' ' ' ALA . . . 76.55 -121.9 6.2 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -176.057 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.454 ' HG3' ' C ' ' A' ' 4' ' ' ALA . 71.3 tt0 -126.92 140.21 52.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.231 -1.158 . . . . 0.0 110.412 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.671 ' CZ ' ' HB3' ' A' ' 6' ' ' ALA . 2.4 p90 -142.63 169.16 18.09 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.302 -0.874 . . . . 0.0 110.263 178.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.664 ' CB ' HG22 ' A' ' 3' ' ' THR . 34.3 ptt180 . . . . . 0 N--CA 1.491 1.591 0 O-C-N 120.979 -1.076 . . . . 0.0 111.628 -172.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo . . . . . 0 C--O 1.215 -0.662 0 CA-C-O 121.009 0.337 . . . . 0.0 111.363 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.806 ' HB1' HD23 ' A' ' 77' ' ' LEU . . . -59.98 -39.25 85.06 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.034 -1.041 . . . . 0.0 110.334 -178.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.633 ' CD1' HG21 ' A' ' 86' ' ' ILE . 66.4 t80 -59.95 -37.85 80.74 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.321 -0.862 . . . . 0.0 110.344 -178.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.516 ' O ' HG12 ' A' ' 65' ' ' VAL . 55.2 t0 -59.96 -48.6 81.02 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.061 -1.025 . . . . 0.0 110.102 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.493 ' O ' ' HB2' ' A' ' 67' ' ' SER . 24.3 tptm -60.09 -51.13 70.93 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.048 -1.033 . . . . 0.0 110.46 178.02 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.687 HG11 HD12 ' A' ' 86' ' ' ILE . 8.8 p -70.26 -46.99 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.049 -1.032 . . . . 0.0 111.173 -174.207 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.578 ' N ' HG13 ' A' ' 64' ' ' VAL . 3.8 p -53.95 -28.87 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.59 -1.319 . . . . 0.0 109.268 174.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -95.62 -10.56 29.12 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.223 -0.923 . . . . 0.0 110.252 175.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.55 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 7.7 t -91.08 -69.23 0.74 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.246 -0.909 . . . . 0.0 109.951 176.308 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.486 ' CB ' ' HG1' ' A' ' 74' ' ' THR . 83.7 m -91.19 127.48 51.17 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.214 -0.929 . . . . 0.0 109.83 176.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.492 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 24.5 Cg_exo -58.69 160.95 16.05 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.797 1.42 . . . . 0.0 109.949 178.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.828 HG22 HD12 ' A' ' 71' ' ' LEU . 7.1 p -58.71 173.48 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.081 -1.012 . . . . 0.0 109.912 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.828 HD12 HG22 ' A' ' 70' ' ' VAL . 2.8 mp 58.7 19.7 7.07 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.298 -0.877 . . . . 0.0 109.964 -174.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.492 ' HB3' ' O ' ' A' ' 69' ' ' PRO . 4.1 tt0 -140.07 80.97 19.32 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.28 -0.888 . . . . 0.0 109.937 177.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.433 ' HG3' ' HG3' ' A' ' 87' ' ' LYS . 53.0 Cg_exo -48.88 131.88 25.81 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.948 1.499 . . . . 0.0 109.972 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.494 ' HB ' ' CG2' ' A' ' 64' ' ' VAL . 92.5 m -133.08 139.01 46.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.185 -0.947 . . . . 0.0 110.407 -176.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.441 ' HA3' HG13 ' A' ' 85' ' ' ILE . . . 145.71 -173.52 26.04 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.746 ' CD ' HD11 ' A' ' 21' ' ' LEU . 43.7 Cg_endo -75.24 137.59 51.01 Favored 'Cis proline' 0 C--N 1.314 -1.276 0 C-N-CA 121.791 -2.171 . . . . 0.0 110.538 -1.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.806 HD23 ' HB1' ' A' ' 60' ' ' ALA . 59.3 tp -96.53 156.35 16.38 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.243 -0.911 . . . . 0.0 110.45 -176.162 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -85.12 123.24 30.41 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.154 -0.966 . . . . 0.0 111.06 -175.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . 1.037 HG21 ' CE1' ' A' ' 84' ' ' HIS . 10.3 t -141.53 164.93 28.89 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.269 -0.894 . . . . 0.0 109.806 173.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.501 ' CG ' ' CD2' ' A' ' 81' ' ' PHE . 20.1 pt20 -59.93 -31.62 70.02 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.044 -1.035 . . . . 0.0 111.016 -175.273 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.501 ' CD2' ' CG ' ' A' ' 80' ' ' GLN . 97.9 m-85 -75.91 -8.02 55.94 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.027 -1.045 . . . . 0.0 110.531 -176.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.441 ' O ' HG22 ' A' ' 79' ' ' THR . . . 137.47 -143.58 14.77 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 -175.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.527 ' CZ ' ' HG3' ' A' ' 14' ' ' GLU . 96.1 m-85 -107.32 122.35 46.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.899 -1.353 . . . . 0.0 109.89 174.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 1.037 ' CE1' HG21 ' A' ' 79' ' ' THR . 60.9 m170 -99.17 121.74 41.43 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.131 -0.981 . . . . 0.0 110.363 175.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.548 ' CG2' ' HB ' ' A' ' 9' ' ' ILE . 6.1 tt -107.68 121.66 60.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 C-N-CA 118.599 -1.24 . . . . 0.0 109.569 168.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.687 HD12 HG11 ' A' ' 64' ' ' VAL . 83.4 mt -114.1 130.02 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.241 -0.912 . . . . 0.0 111.081 -169.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.588 ' HE2' ' CG ' ' A' ' 30' ' ' PHE . 21.4 ttmm -98.04 126.58 43.54 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.106 -0.996 . . . . 0.0 109.258 169.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.522 HG12 HG23 ' A' ' 70' ' ' VAL . 61.9 t -106.54 134.93 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.296 -0.877 . . . . 0.0 110.204 -175.106 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.514 ' O ' ' N ' ' A' ' 91' ' ' ARG . 92.7 mt -140.13 161.31 37.95 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.348 -0.845 . . . . 0.0 109.131 -178.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.509 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 25.6 m-85 62.45 -61.45 0.12 Allowed 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.03 0.443 . . . . 0.0 111.04 177.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.514 ' N ' ' O ' ' A' ' 89' ' ' LEU . 14.1 tpt180 . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.001 -1.062 . . . . 0.0 110.209 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.562 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 27.3 p . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 121.08 0.467 . . . . 0.0 110.375 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.511 ' O ' ' HA ' ' A' ' 51' ' ' GLU . . . -109.95 151.24 27.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.097 -1.002 . . . . 0.0 109.886 175.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.65 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -90.76 122.69 33.71 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.699 -0.8 . . . . 0.0 109.651 -178.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.537 ' HB3' ' CE2' ' A' ' 52' ' ' PHE . . . -130.84 119.7 22.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.102 -0.999 . . . . 0.0 111.325 -172.403 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.613 HD12 ' HD2' ' A' ' 87' ' ' LYS . 83.2 mt -106.5 151.28 25.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.288 -0.882 . . . . 0.0 108.839 169.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.523 ' HB2' HG12 ' A' ' 86' ' ' ILE . 0.3 OUTLIER -168.66 170.53 9.38 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 118.287 -1.365 . . . . 0.0 112.158 -178.716 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.452 ' HB ' ' CG2' ' A' ' 85' ' ' ILE . 87.0 mt -139.97 138.81 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.876 -0.515 . . . . 0.0 109.65 178.042 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.588 ' HG ' ' CD2' ' A' ' 84' ' ' HIS . 0.5 OUTLIER -100.42 120.08 39.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.364 -0.835 . . . . 0.0 110.218 -178.731 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.969 HG13 HD22 ' A' ' 16' ' ' LEU . 2.4 t -112.74 128.44 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.204 -0.935 . . . . 0.0 109.964 178.343 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -69.43 -40.04 77.48 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.371 -0.831 . . . . 0.0 110.618 -178.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -130.43 155.81 45.79 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.023 -1.048 . . . . 0.0 110.728 -176.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.531 ' HG3' ' CZ ' ' A' ' 83' ' ' TYR . 95.7 mt-10 -60.09 -40.0 88.09 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.478 -0.764 . . . . 0.0 110.744 -178.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -55.4 -43.33 75.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.144 -0.973 . . . . 0.0 110.068 -175.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.969 HD22 HG13 ' A' ' 11' ' ' VAL . 5.9 tt -69.89 -41.01 75.32 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.086 -1.009 . . . . 0.0 109.378 174.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.933 ' O ' HD12 ' A' ' 21' ' ' LEU . . . -60.05 -41.32 92.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.407 -0.808 . . . . 0.0 110.098 175.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.463 HD12 ' O ' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -60.02 -42.27 94.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.329 -0.857 . . . . 0.0 109.474 178.051 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.477 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 47.8 t0 -59.94 -43.56 94.9 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.243 -0.91 . . . . 0.0 110.037 174.188 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.716 HD11 HD13 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -63.02 -46.78 85.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.113 -0.992 . . . . 0.0 109.79 179.996 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.933 HD12 ' O ' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -59.83 -49.94 75.74 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.395 -0.816 . . . . 0.0 110.185 -178.58 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -60.77 -43.13 98.43 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.326 -0.859 . . . . 0.0 110.637 -177.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.477 ' HG2' ' O ' ' A' ' 19' ' ' ASP . 96.5 mm-40 -60.59 -42.59 97.05 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.184 -0.948 . . . . 0.0 110.606 -177.008 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.505 ' O ' ' N ' ' A' ' 28' ' ' ALA . 88.1 mt -64.84 -44.09 96.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.15 -0.969 . . . . 0.0 109.937 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -61.08 -47.14 87.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.175 -0.953 . . . . 0.0 109.665 175.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -59.81 -60.93 3.05 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.43 -0.794 . . . . 0.0 110.331 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.755 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -105.21 -41.64 1.89 Allowed Glycine 0 N--CA 1.485 1.93 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -173.324 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.755 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 80.19 99.4 0.06 Allowed 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.837 -0.802 . . . . 0.0 110.075 -177.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.434 ' HB3' ' HB2' ' A' ' 32' ' ' LYS . 1.8 m-20 -175.7 82.82 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.273 -0.892 . . . . 0.0 110.177 -176.139 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.585 ' CG ' ' HE3' ' A' ' 87' ' ' LYS . 9.9 m-85 -65.87 -45.58 81.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.151 -0.968 . . . . 0.0 110.752 -178.317 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.09 -49.26 80.51 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -177.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.434 ' HB2' ' HB3' ' A' ' 29' ' ' ASP . 60.7 mttm -64.96 -40.0 94.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -1.169 . . . . 0.0 110.049 -177.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.572 HD21 ' HB2' ' A' ' 20' ' ' LEU . 63.2 tp -61.81 -40.24 94.55 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.226 -0.921 . . . . 0.0 110.352 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.518 ' O ' ' CB ' ' A' ' 38' ' ' SER . . . -60.03 -49.95 75.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.067 -1.021 . . . . 0.0 110.135 177.429 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -59.97 -43.63 94.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.774 -1.204 . . . . 0.0 110.689 -176.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.405 ' NZ ' ' HB3' ' A' ' 32' ' ' LYS . 43.5 mttp -69.95 -43.03 72.41 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.897 -1.127 . . . . 0.0 111.662 -175.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.452 ' O ' HG12 ' A' ' 39' ' ' ILE . 80.9 m80 -105.77 -28.29 10.76 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.686 -1.259 . . . . 0.0 111.691 -169.088 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.52 ' O ' ' CG1' ' A' ' 39' ' ' ILE . 54.3 p -60.01 -44.29 94.65 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.724 -1.235 . . . . 0.0 110.763 -171.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.52 ' CG1' ' O ' ' A' ' 38' ' ' SER . 46.5 pt 36.31 31.63 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.614 -0.679 . . . . 0.0 110.918 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.479 ' N ' ' O ' ' A' ' 38' ' ' SER . 38.2 t -125.83 144.23 47.77 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.125 -0.984 . . . . 0.0 110.247 -175.171 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.465 ' HD2' ' SG ' ' A' ' 40' ' ' CYS . 58.1 Cg_exo -44.7 -24.85 1.28 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.819 1.431 . . . . 0.0 110.753 178.388 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.475 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 0.2 OUTLIER -109.88 19.79 18.7 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.142 -0.974 . . . . 0.0 110.196 178.566 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -95.63 -57.72 1.17 Allowed Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 175.213 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -59.93 -39.99 87.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.34 -1.094 . . . . 0.0 109.872 175.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 20.9 tpt180 -101.39 -37.15 8.59 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.328 -0.857 . . . . 0.0 110.58 -177.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.499 ' O ' ' CD2' ' A' ' 8' ' ' HIS . . . -82.88 -9.02 85.03 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -177.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.36 1.52 56.35 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 173.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.444 ' HA ' ' CD2' ' A' ' 7' ' ' LEU . 38.7 t0 -165.76 67.25 0.12 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.35 -1.088 . . . . 0.0 108.475 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.44 ' HG ' ' HA2' ' A' ' 46' ' ' GLY . 7.0 mt -69.99 -27.41 64.68 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.794 -0.566 . . . . 0.0 110.146 -175.171 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.34 -146.96 16.64 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.534 ' HG2' ' CB ' ' A' ' 3' ' ' THR . 49.9 tt0 -110.75 128.58 55.79 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.26 -1.141 . . . . 0.0 110.011 -178.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.537 ' CE2' ' HB3' ' A' ' 6' ' ' ALA . 3.5 p90 -144.88 -178.02 5.82 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.178 -0.951 . . . . 0.0 110.584 -176.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.562 ' HB2' ' HA ' ' A' ' 3' ' ' THR . 51.8 ttt-85 . . . . . 0 N--CA 1.495 1.789 0 O-C-N 120.93 -1.106 . . . . 0.0 110.23 173.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.477 ' O ' ' N ' ' A' ' 62' ' ' ASP . 29.0 Cg_endo . . . . . 0 N--CA 1.486 1.071 0 N-CA-C 110.709 -0.535 . . . . 0.0 110.709 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 59' ' ' PRO . . . -41.77 -37.39 1.22 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.381 -0.824 . . . . 0.0 110.029 -177.401 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.565 ' CE2' HG21 ' A' ' 65' ' ' VAL . 67.7 t80 -59.97 -43.66 94.95 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.308 -0.87 . . . . 0.0 110.056 177.021 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.477 ' N ' ' O ' ' A' ' 59' ' ' PRO . 54.0 t0 -60.0 -43.75 94.99 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.295 -0.878 . . . . 0.0 110.284 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 67' ' ' SER . 34.3 mttt -58.23 -50.02 75.05 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.163 -0.961 . . . . 0.0 109.735 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.537 ' HA ' ' HB3' ' A' ' 67' ' ' SER . 7.5 p -69.5 -41.32 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.451 -0.781 . . . . 0.0 110.763 -177.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.565 HG21 ' CE2' ' A' ' 61' ' ' PHE . 11.4 t -55.54 -31.85 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.727 -1.233 . . . . 0.0 108.929 171.04 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -102.37 10.32 39.16 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.621 -0.674 . . . . 0.0 110.258 177.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.537 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 8.1 t -103.27 -58.29 1.9 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.151 -0.968 . . . . 0.0 109.898 173.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.469 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 29.8 m -115.39 145.34 34.14 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.309 -0.869 . . . . 0.0 110.303 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.519 ' O ' ' N ' ' A' ' 71' ' ' LEU . 13.5 Cg_exo -64.98 76.52 0.21 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.807 1.425 . . . . 0.0 110.582 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.082 HG11 ' HG3' ' A' ' 91' ' ' ARG . 8.2 m 21.29 45.89 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.337 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 176.598 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.008 HD12 HG23 ' A' ' 70' ' ' VAL . 0.3 OUTLIER -166.55 46.86 0.07 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.45 -0.781 . . . . 0.0 110.057 178.259 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -170.66 123.97 0.6 Allowed Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.348 -0.845 . . . . 0.0 110.148 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -55.63 119.07 5.96 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.746 1.392 . . . . 0.0 110.196 178.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.424 ' OG1' ' SG ' ' A' ' 68' ' ' CYS . 74.9 m -126.61 128.35 46.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.197 -0.939 . . . . 0.0 110.219 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.44 ' HA3' HG13 ' A' ' 85' ' ' ILE . . . 145.85 -177.81 23.99 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.906 ' CD ' HD21 ' A' ' 21' ' ' LEU . 42.4 Cg_endo -71.02 161.61 89.44 Favored 'Cis proline' 0 C--N 1.313 -1.313 0 C-N-CA 121.754 -2.186 . . . . 0.0 110.463 -0.276 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.993 HD23 ' N ' ' A' ' 78' ' ' HIS . 8.0 tt -134.92 155.26 51.02 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.274 -0.891 . . . . 0.0 110.158 -175.397 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.993 ' N ' HD23 ' A' ' 77' ' ' LEU . 42.0 m80 -73.42 129.37 37.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.168 -0.958 . . . . 0.0 110.768 -176.364 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.776 HG21 ' CG ' ' A' ' 84' ' ' HIS . 9.0 t -144.2 163.42 33.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.367 -0.833 . . . . 0.0 109.848 175.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -60.0 -24.34 64.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.194 -0.941 . . . . 0.0 110.185 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.593 ' HB2' ' CE1' ' A' ' 84' ' ' HIS . 97.8 m-85 -86.68 -0.68 56.73 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.196 -0.94 . . . . 0.0 110.926 -175.178 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.695 ' O ' HG22 ' A' ' 79' ' ' THR . . . 123.64 -137.72 11.07 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 -174.186 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.531 ' CZ ' ' HG3' ' A' ' 14' ' ' GLU . 59.2 m-85 -100.16 130.04 46.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.1 -1.235 . . . . 0.0 109.948 173.604 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.776 ' CG ' HG21 ' A' ' 79' ' ' THR . 19.3 m170 -116.86 124.12 48.73 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.23 -0.918 . . . . 0.0 110.537 178.325 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.716 HD13 HD11 ' A' ' 20' ' ' LEU . 8.5 tt -110.07 130.06 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.925 -1.11 . . . . 0.0 109.596 170.468 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.523 HG12 ' HB2' ' A' ' 8' ' ' HIS . 20.5 mt -138.45 137.84 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.996 -1.065 . . . . 0.0 110.824 -172.289 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.613 ' HD2' HD12 ' A' ' 7' ' ' LEU . 15.8 ptpt -111.16 135.08 52.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.772 -1.205 . . . . 0.0 109.313 168.256 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.812 ' O ' HD23 ' A' ' 89' ' ' LEU . 37.6 t -110.49 144.17 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.253 -0.905 . . . . 0.0 110.345 -171.101 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.812 HD23 ' O ' ' A' ' 88' ' ' VAL . 63.2 mt -140.09 129.52 24.06 Favored 'General case' 0 C--N 1.31 -1.126 0 O-C-N 121.027 -1.046 . . . . 0.0 110.21 -175.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.554 ' CB ' ' O ' ' A' ' 89' ' ' LEU . 14.5 t80 81.27 -24.99 0.17 Allowed 'General case' 0 N--CA 1.507 2.391 0 O-C-N 121.4 -0.813 . . . . 0.0 111.833 169.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 1.082 ' HG3' HG11 ' A' ' 70' ' ' VAL . 7.0 ttm-85 . . . . . 0 N--CA 1.491 1.598 0 O-C-N 120.867 -1.146 . . . . 0.0 109.771 -175.383 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 46.0 p . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.227 0.537 . . . . 0.0 110.038 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.462 ' C ' ' HG3' ' A' ' 51' ' ' GLU . . . -134.59 142.26 46.88 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.166 -0.959 . . . . 0.0 110.241 178.43 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.683 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -93.44 119.97 33.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.242 -0.911 . . . . 0.0 108.952 175.447 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.693 ' HB3' ' CZ ' ' A' ' 52' ' ' PHE . . . -134.32 119.3 18.51 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.637 -1.289 . . . . 0.0 111.505 -168.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.6 ' N ' ' CD1' ' A' ' 7' ' ' LEU . 4.2 mp -96.63 146.98 24.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.177 -0.952 . . . . 0.0 109.288 171.063 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.616 ' NE2' ' HB1' ' A' ' 6' ' ' ALA . 56.2 m-70 -137.85 126.39 23.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.05 -1.031 . . . . 0.0 110.624 -176.656 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.774 ' HB ' HG22 ' A' ' 85' ' ' ILE . 68.8 mt -103.18 125.6 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 120.868 -1.145 . . . . 0.0 109.714 169.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.777 HD13 ' C ' ' A' ' 10' ' ' LEU . 2.7 tm? -103.43 119.98 39.94 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.605 -0.685 . . . . 0.0 109.684 177.115 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.942 HG13 HD22 ' A' ' 16' ' ' LEU . 3.0 t -111.84 132.34 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.319 -0.863 . . . . 0.0 110.286 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -65.99 -40.01 90.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.377 -0.827 . . . . 0.0 110.399 179.02 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -119.78 139.24 52.63 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.139 -0.976 . . . . 0.0 110.822 -173.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.455 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 88.4 tt0 -60.04 -47.22 86.76 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.556 -0.715 . . . . 0.0 111.282 -177.285 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.3 mttp -53.31 -36.54 61.36 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.14 -0.975 . . . . 0.0 110.185 -173.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.942 HD22 HG13 ' A' ' 11' ' ' VAL . 8.4 tt -65.26 -40.07 93.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.254 -0.904 . . . . 0.0 109.419 176.263 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.768 ' HB1' ' HG3' ' A' ' 76' ' ' PRO . . . -58.97 -46.46 88.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.384 -0.823 . . . . 0.0 109.994 176.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.98 -44.62 94.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.235 -0.916 . . . . 0.0 109.874 177.098 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -59.97 -43.41 95.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.147 -0.971 . . . . 0.0 109.754 175.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.478 ' O ' HG12 ' A' ' 24' ' ' ILE . 2.6 tp -64.14 -45.55 88.0 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.43 -0.793 . . . . 0.0 109.948 177.234 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.67 HD11 ' CD1' ' A' ' 85' ' ' ILE . 1.9 mp -57.99 -49.58 76.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.38 -0.825 . . . . 0.0 109.866 -174.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -61.03 -37.0 81.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.274 -0.891 . . . . 0.0 109.689 172.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.464 ' HB3' ' O ' ' A' ' 20' ' ' LEU . 7.4 tt0 -59.96 -34.79 73.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.456 -0.777 . . . . 0.0 110.443 -174.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.533 HD13 ' CD1' ' A' ' 33' ' ' LEU . 45.4 mm -59.92 -49.57 83.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.092 -1.005 . . . . 0.0 109.325 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -60.68 -46.43 90.4 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.097 -1.002 . . . . 0.0 109.789 178.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -60.08 -53.25 60.04 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.291 -0.88 . . . . 0.0 110.327 177.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.758 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -104.48 -54.71 0.77 Allowed Glycine 0 N--CA 1.486 1.992 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -173.188 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.758 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 79.19 95.03 0.06 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.862 -0.787 . . . . 0.0 110.58 178.009 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.485 ' OD2' ' HD2' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -177.6 80.42 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.422 -0.799 . . . . 0.0 109.751 -178.814 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.578 ' CG ' ' HD2' ' A' ' 87' ' ' LYS . 11.9 m-85 -60.09 -49.97 75.56 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.319 -0.863 . . . . 0.0 111.187 -174.098 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.08 -50.13 58.94 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.722 -1.228 . . . . 0.0 110.126 -174.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.485 ' HD2' ' OD2' ' A' ' 29' ' ' ASP . 32.3 mttm -66.57 -40.01 88.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.086 -1.244 . . . . 0.0 110.383 -175.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.533 ' CD1' HD13 ' A' ' 24' ' ' ILE . 67.7 mt -66.44 -40.01 89.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.062 -1.024 . . . . 0.0 110.477 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.554 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -59.22 -51.91 67.94 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.087 -1.008 . . . . 0.0 110.082 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -60.14 -45.84 91.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.327 -0.858 . . . . 0.0 110.722 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -68.32 -47.38 67.7 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.11 -0.994 . . . . 0.0 110.848 -175.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -74.79 -45.18 45.31 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.148 -0.97 . . . . 0.0 110.765 -175.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.563 ' O ' HG22 ' A' ' 39' ' ' ILE . 25.4 t -60.39 -46.27 90.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.203 -0.935 . . . . 0.0 110.133 -179.035 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.563 HG22 ' O ' ' A' ' 38' ' ' SER . 13.3 tt 36.02 30.04 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-O 121.445 0.64 . . . . 0.0 110.774 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.517 ' N ' ' O ' ' A' ' 38' ' ' SER . 14.2 p -121.56 171.63 5.91 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.286 -0.884 . . . . 0.0 110.024 -178.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.485 ' HD2' ' HB2' ' A' ' 40' ' ' CYS . 43.7 Cg_exo -48.94 -31.35 20.0 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.647 1.341 . . . . 0.0 110.352 -177.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.6 OUTLIER -101.65 15.11 29.96 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.306 -0.871 . . . . 0.0 110.028 177.788 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.29 -58.86 3.78 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.754 -1.738 . . . . 0.0 108.754 174.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.1 tptt -59.91 -40.08 87.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -1.114 . . . . 0.0 110.551 177.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.469 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 11.1 tpt180 -98.29 -41.1 8.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.085 -1.009 . . . . 0.0 110.567 -175.597 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -70.24 -30.33 69.58 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -178.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.48 -5.56 50.57 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.417 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 25.1 t0 -172.67 72.16 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.332 -1.099 . . . . 0.0 108.586 179.059 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.542 HD12 ' CD2' ' A' ' 8' ' ' HIS . 6.8 mt -70.03 -27.1 64.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.456 -0.777 . . . . 0.0 110.177 -173.236 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 113.58 -154.71 16.78 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.462 ' HG3' ' C ' ' A' ' 4' ' ' ALA . 84.6 tt0 -106.55 129.83 54.43 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.291 -1.123 . . . . 0.0 109.845 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.693 ' CZ ' ' HB3' ' A' ' 6' ' ' ALA . 0.1 OUTLIER -131.57 173.47 11.08 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.051 -1.031 . . . . 0.0 110.704 178.044 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 20.6 ptt180 . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.323 -0.861 . . . . 0.0 110.229 179.308 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.485 0.975 0 CA-C-O 121.049 0.354 . . . . 0.0 111.286 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.09 -38.45 79.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.009 -1.057 . . . . 0.0 109.938 -178.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.539 ' HD2' HG21 ' A' ' 86' ' ' ILE . 63.2 t80 -59.99 -38.79 83.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.268 -0.895 . . . . 0.0 110.282 174.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.44 ' O ' HG12 ' A' ' 65' ' ' VAL . 48.8 t0 -60.03 -43.75 95.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.204 -0.935 . . . . 0.0 110.117 -176.252 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 67' ' ' SER . 23.6 tttm -60.07 -47.03 87.58 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.216 -0.927 . . . . 0.0 110.417 177.447 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.658 HG11 HD12 ' A' ' 86' ' ' ILE . 13.1 p -79.25 -44.47 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.024 -1.047 . . . . 0.0 111.347 -173.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.548 ' N ' HG13 ' A' ' 64' ' ' VAL . 4.4 p -53.56 -25.8 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.361 -1.462 . . . . 0.0 109.008 173.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -94.97 -13.22 25.5 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.513 -0.742 . . . . 0.0 109.939 176.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.526 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 8.0 t -93.38 -61.65 1.52 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.354 -0.841 . . . . 0.0 110.053 177.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 78.6 m -99.98 132.01 23.47 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.38 -0.825 . . . . 0.0 110.272 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.498 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 12.1 Cg_endo -61.31 159.93 29.08 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.861 1.453 . . . . 0.0 110.082 178.393 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.981 HG23 HG12 ' A' ' 88' ' ' VAL . 8.1 p -60.46 177.41 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.198 -0.939 . . . . 0.0 109.891 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.833 HD12 HG13 ' A' ' 70' ' ' VAL . 4.7 mp 45.48 40.02 5.25 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.639 -1.288 . . . . 0.0 109.981 -168.532 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.498 ' HB3' ' O ' ' A' ' 69' ' ' PRO . 0.4 OUTLIER -150.57 89.65 4.4 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.384 -0.822 . . . . 0.0 109.729 175.497 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -59.26 126.55 21.19 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.827 1.435 . . . . 0.0 109.782 -177.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.433 HG21 HG23 ' A' ' 64' ' ' VAL . 53.3 m -130.7 136.72 49.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.095 -1.003 . . . . 0.0 110.453 -177.016 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.459 ' HA3' HG13 ' A' ' 85' ' ' ILE . . . 152.27 -171.38 31.54 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -178.54 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.768 ' HG3' ' HB1' ' A' ' 17' ' ' ALA . 41.7 Cg_endo -84.77 134.03 19.45 Favored 'Cis proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.209 -1.996 . . . . 0.0 110.42 3.441 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 74.8 mt -93.0 -178.52 4.82 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.254 -0.904 . . . . 0.0 110.735 -172.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -102.66 125.37 49.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.072 -1.018 . . . . 0.0 110.712 -176.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.768 HG21 ' CE1' ' A' ' 84' ' ' HIS . 12.5 t -140.05 162.43 35.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.428 -0.795 . . . . 0.0 109.813 176.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -60.05 -39.95 87.72 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.101 -0.999 . . . . 0.0 110.364 -178.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -70.31 -5.56 28.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.208 -0.933 . . . . 0.0 110.61 -177.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.65 ' O ' HG22 ' A' ' 79' ' ' THR . . . 134.43 -137.47 9.3 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.46 ' O ' ' HA ' ' A' ' 10' ' ' LEU . 75.1 m-85 -96.1 130.67 43.07 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.165 -1.197 . . . . 0.0 110.241 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.768 ' CE1' HG21 ' A' ' 79' ' ' THR . 1.1 m-70 -107.89 112.43 25.04 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.674 -0.641 . . . . 0.0 110.643 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.774 HG22 ' HB ' ' A' ' 9' ' ' ILE . 2.5 tt -104.86 120.32 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.527 -1.358 . . . . 0.0 109.076 167.234 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.658 HD12 HG11 ' A' ' 64' ' ' VAL . 88.2 mt -110.02 130.02 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.936 -1.103 . . . . 0.0 111.298 -169.609 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.813 ' NZ ' HD21 ' A' ' 89' ' ' LEU . 63.0 tttm -101.71 126.41 48.56 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 172.407 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.981 HG12 HG23 ' A' ' 70' ' ' VAL . 24.5 t -103.42 136.46 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.13 -0.981 . . . . 0.0 110.297 -176.335 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.813 HD21 ' NZ ' ' A' ' 87' ' ' LYS . 58.0 mt -130.58 119.91 23.22 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.416 -0.802 . . . . 0.0 109.349 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.528 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 44.3 m-85 72.55 -58.9 0.58 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.648 -0.658 . . . . 0.0 110.856 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.443 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 67.1 ttp85 . . . . . 0 N--CA 1.494 1.728 0 O-C-N 121.234 -0.916 . . . . 0.0 110.622 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 91' ' ' ARG . 35.6 p . . . . . 0 N--CA 1.494 1.735 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.523 ' HB3' ' CE1' ' A' ' 52' ' ' PHE . . . -109.88 131.24 55.24 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.173 -0.955 . . . . 0.0 110.549 -175.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.563 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -99.32 122.05 41.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.405 -0.809 . . . . 0.0 109.64 177.518 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.86 ' HB1' ' NE2' ' A' ' 8' ' ' HIS . . . -140.05 132.03 27.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.856 -1.153 . . . . 0.0 111.212 -175.242 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.984 HD12 ' HD2' ' A' ' 87' ' ' LYS . 86.7 mt -98.32 139.78 33.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.138 -0.976 . . . . 0.0 108.806 168.281 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.86 ' NE2' ' HB1' ' A' ' 6' ' ' ALA . 34.7 m-70 -135.17 117.97 16.15 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.805 -1.185 . . . . 0.0 110.754 -177.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.761 ' HB ' HG22 ' A' ' 85' ' ' ILE . 92.6 mt -105.17 126.62 60.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.35 -0.844 . . . . 0.0 109.869 172.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.591 ' HG ' ' CD2' ' A' ' 84' ' ' HIS . 0.3 OUTLIER -101.8 117.94 35.89 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.561 -0.712 . . . . 0.0 109.898 -179.757 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.731 HG13 HD22 ' A' ' 16' ' ' LEU . 2.2 t -108.23 125.3 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.229 -0.919 . . . . 0.0 109.747 177.011 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.2 mmtp -68.48 -39.39 81.38 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.44 -0.788 . . . . 0.0 110.17 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -111.43 138.11 48.35 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.186 -0.946 . . . . 0.0 110.699 -178.078 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.66 ' HG2' HD12 ' A' ' 18' ' ' LEU . 88.8 tt0 -59.97 -42.12 93.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.366 -0.833 . . . . 0.0 109.939 177.138 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -56.94 -40.53 76.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.395 -0.816 . . . . 0.0 110.139 -178.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.731 HD22 HG13 ' A' ' 11' ' ' VAL . 5.5 tt -68.82 -40.04 79.72 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.025 -1.047 . . . . 0.0 109.301 174.444 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.997 ' O ' HD12 ' A' ' 21' ' ' LEU . . . -59.95 -40.72 89.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.386 -0.821 . . . . 0.0 110.021 175.236 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.66 HD12 ' HG2' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -59.94 -41.67 92.37 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.15 -0.969 . . . . 0.0 109.695 175.973 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -60.03 -44.75 94.42 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.32 -0.863 . . . . 0.0 110.246 176.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.71 ' C ' HD12 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -64.11 -43.74 94.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.075 -1.015 . . . . 0.0 109.544 178.51 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.997 HD12 ' O ' ' A' ' 17' ' ' ALA . 0.3 OUTLIER -56.19 -49.92 72.67 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.499 -0.75 . . . . 0.0 109.697 -179.588 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -61.7 -40.01 93.51 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.391 -0.818 . . . . 0.0 110.134 175.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.419 ' O ' ' N ' ' A' ' 27' ' ' GLY . 70.0 tp60 -60.1 -39.9 87.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.271 -0.893 . . . . 0.0 110.945 -174.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.518 ' O ' ' N ' ' A' ' 28' ' ' ALA . 96.7 mt -62.76 -40.55 89.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.104 -0.997 . . . . 0.0 110.289 -176.231 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -65.42 -58.75 5.09 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.964 -1.085 . . . . 0.0 110.067 175.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -60.05 -39.96 87.78 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.34 -0.85 . . . . 0.0 110.799 178.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.732 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -104.0 -63.03 0.68 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -176.487 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.732 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 81.79 93.04 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.175 0 O-C-N 122.06 -0.671 . . . . 0.0 110.508 178.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 179.74 78.32 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.423 -0.798 . . . . 0.0 109.952 -178.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.525 ' CZ ' HG23 ' A' ' 85' ' ' ILE . 17.1 t80 -61.12 -39.98 92.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.318 -0.864 . . . . 0.0 110.72 -174.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.435 ' O ' ' HG3' ' A' ' 35' ' ' LYS . . . -66.01 -53.65 29.04 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -176.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.463 ' HE3' ' HE3' ' A' ' 36' ' ' LYS . 82.5 tttt -64.8 -41.55 95.72 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.111 -1.229 . . . . 0.0 110.523 -178.456 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 85.7 mt -65.89 -40.04 91.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.238 -0.914 . . . . 0.0 109.931 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.548 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -60.25 -48.87 79.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.365 -0.835 . . . . 0.0 110.347 178.25 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.435 ' HG3' ' O ' ' A' ' 31' ' ' GLY . 72.4 mttt -59.99 -46.34 89.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 0.0 110.391 -175.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.463 ' HE3' ' HE3' ' A' ' 32' ' ' LYS . 41.5 mttt -69.41 -50.82 42.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.094 -1.004 . . . . 0.0 111.074 -176.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 53.9 m170 -70.05 -39.97 75.4 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.124 -0.985 . . . . 0.0 111.073 -173.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.655 ' O ' HG22 ' A' ' 39' ' ' ILE . 14.5 t -59.99 -45.6 92.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.037 -1.04 . . . . 0.0 110.313 -175.007 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.655 HG22 ' O ' ' A' ' 38' ' ' SER . 20.4 tt 38.73 34.18 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.589 -0.695 . . . . 0.0 110.603 178.338 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.483 ' HB2' ' HD2' ' A' ' 41' ' ' PRO . 15.0 p -127.36 165.68 27.91 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.288 -0.883 . . . . 0.0 109.764 -178.007 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' A' ' 40' ' ' CYS . 2.0 Cg_endo -49.2 -33.24 27.29 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.626 1.329 . . . . 0.0 110.172 179.388 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.2 OUTLIER -92.8 8.69 38.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.145 -0.972 . . . . 0.0 110.308 176.834 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.422 ' HA2' ' OG ' ' A' ' 38' ' ' SER . . . -56.17 -54.45 35.5 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.591 -1.804 . . . . 0.0 108.591 177.483 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -61.22 -39.97 92.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.355 -1.085 . . . . 0.0 110.658 175.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.541 ' HG3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -94.16 -68.91 0.78 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.124 -0.985 . . . . 0.0 110.353 -173.589 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -52.82 -38.12 53.44 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.95 -5.52 52.87 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 176.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.482 ' HA ' ' CD2' ' A' ' 7' ' ' LEU . 50.2 t0 -172.34 71.12 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.35 -1.088 . . . . 0.0 108.856 178.2 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.541 HD23 ' HG3' ' A' ' 45' ' ' ARG . 7.0 mt -69.85 -25.26 63.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.544 -0.722 . . . . 0.0 109.911 -174.179 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' A' ' 5' ' ' ALA . . . 82.79 -137.69 17.04 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.074 -1.611 . . . . 0.0 109.074 -178.535 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.516 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 1.8 mt-10 -102.27 129.65 48.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.443 -1.033 . . . . 0.0 110.635 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.655 ' CE2' ' HB3' ' A' ' 6' ' ' ALA . 1.5 p90 -134.62 159.2 41.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.544 -0.722 . . . . 0.0 109.799 178.002 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.448 ' HG2' HG22 ' A' ' 3' ' ' THR . 78.1 mtm180 . . . . . 0 N--CA 1.492 1.671 0 O-C-N 120.839 -1.163 . . . . 0.0 111.352 -170.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo . . . . . 0 C--O 1.215 -0.66 0 CA-C-O 121.052 0.355 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.562 ' HB2' ' HB ' ' A' ' 79' ' ' THR . . . -61.81 -42.69 99.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.091 -1.006 . . . . 0.0 110.553 178.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -60.06 -40.17 88.55 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.141 -0.975 . . . . 0.0 110.647 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.492 ' O ' HG12 ' A' ' 65' ' ' VAL . 54.8 t0 -63.34 -42.85 98.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.012 -1.055 . . . . 0.0 109.69 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -57.7 -55.77 30.61 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.285 -0.885 . . . . 0.0 110.266 178.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.626 HG11 HD12 ' A' ' 86' ' ' ILE . 2.7 p -70.0 -43.83 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.016 -1.052 . . . . 0.0 111.775 -172.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.492 HG12 ' O ' ' A' ' 62' ' ' ASP . 4.8 p -55.26 -27.11 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.223 -1.548 . . . . 0.0 108.94 174.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.452 ' HB2' ' O ' ' A' ' 62' ' ' ASP . 0.1 OUTLIER -94.97 -8.7 36.21 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.261 -0.899 . . . . 0.0 110.582 175.468 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.524 ' HB2' ' HA ' ' A' ' 64' ' ' VAL . 24.1 m -93.19 -41.89 9.66 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.003 -1.06 . . . . 0.0 110.042 176.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 88.2 m -120.71 150.58 52.87 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.166 -0.959 . . . . 0.0 110.205 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -73.41 156.34 50.29 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.977 1.514 . . . . 0.0 109.955 178.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.981 HG22 HD12 ' A' ' 71' ' ' LEU . 7.2 p -58.03 172.63 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.171 -0.956 . . . . 0.0 109.855 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.981 HD12 HG22 ' A' ' 70' ' ' VAL . 3.6 mp 57.44 39.78 27.8 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.413 -0.804 . . . . 0.0 110.077 -174.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -155.84 117.28 2.28 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.116 -0.99 . . . . 0.0 110.394 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 87' ' ' LYS . 30.6 Cg_endo -68.98 132.74 25.25 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.828 1.436 . . . . 0.0 110.182 179.156 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.522 HG21 HG23 ' A' ' 64' ' ' VAL . 87.0 m -139.58 147.15 40.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.157 -0.965 . . . . 0.0 110.295 -178.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.469 ' HA3' ' HA ' ' A' ' 85' ' ' ILE . . . 134.44 -176.11 20.07 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -178.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.853 ' CD ' HD11 ' A' ' 21' ' ' LEU . 44.1 Cg_endo -74.57 135.97 42.86 Favored 'Cis proline' 0 C--N 1.314 -1.271 0 C-N-CA 121.79 -2.171 . . . . 0.0 110.557 -0.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.462 HD23 ' HB1' ' A' ' 60' ' ' ALA . 59.8 tp -94.94 155.08 16.91 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.26 -0.9 . . . . 0.0 110.435 -178.112 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 -77.89 119.74 21.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -0.891 . . . . 0.0 110.459 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.674 HG22 ' O ' ' A' ' 82' ' ' GLY . 10.8 t -134.21 165.57 24.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.214 -0.929 . . . . 0.0 109.55 173.461 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -59.97 -39.58 86.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.113 -0.992 . . . . 0.0 110.047 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -66.75 -11.55 55.15 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.226 -0.921 . . . . 0.0 110.717 -177.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.674 ' O ' HG22 ' A' ' 79' ' ' THR . . . 132.32 -139.75 11.22 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 -176.275 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.576 ' CE2' ' HB2' ' A' ' 14' ' ' GLU . 75.5 m-85 -102.64 122.14 43.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.108 -1.23 . . . . 0.0 110.291 178.193 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.626 ' CE1' HG21 ' A' ' 79' ' ' THR . 41.2 m170 -104.98 122.64 46.27 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.196 -0.94 . . . . 0.0 110.422 175.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.761 HG22 ' HB ' ' A' ' 9' ' ' ILE . 3.5 tt -103.52 119.23 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 118.376 -1.329 . . . . 0.0 109.361 167.275 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.724 HG23 ' CE1' ' A' ' 8' ' ' HIS . 85.5 mt -114.77 130.02 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.095 -1.003 . . . . 0.0 110.707 -170.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.984 ' HD2' HD12 ' A' ' 7' ' ' LEU . 34.9 ttmt -96.96 126.08 41.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.135 -0.978 . . . . 0.0 109.164 171.09 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.565 HG12 HG23 ' A' ' 70' ' ' VAL . 48.5 t -107.61 123.19 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.382 -0.824 . . . . 0.0 109.959 -175.06 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.563 ' HB2' ' HB3' ' A' ' 5' ' ' ALA . 60.1 mt -134.36 113.04 11.5 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.522 -0.736 . . . . 0.0 109.317 -176.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.545 ' CB ' ' O ' ' A' ' 89' ' ' LEU . 2.9 m-85 81.91 -43.37 0.16 Allowed 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.718 -0.614 . . . . 0.0 110.444 -178.114 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.472 ' O ' ' O ' ' A' ' 3' ' ' THR . 4.4 ttm180 . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.082 -1.011 . . . . 0.0 109.983 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.511 HG22 ' HG2' ' A' ' 53' ' ' ARG . 19.3 p . . . . . 0 N--CA 1.494 1.732 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -140.16 142.81 35.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.913 -1.117 . . . . 0.0 110.732 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.431 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -97.24 126.98 42.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.267 -0.895 . . . . 0.0 108.907 171.542 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.582 ' CB ' ' NE2' ' A' ' 8' ' ' HIS . . . -136.67 130.82 32.72 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.661 -1.274 . . . . 0.0 112.112 -168.476 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.511 ' C ' ' CD2' ' A' ' 8' ' ' HIS . 75.2 mt -103.48 144.42 31.42 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.263 -0.898 . . . . 0.0 109.411 167.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.977 ' CD2' HD12 ' A' ' 49' ' ' LEU . 10.0 m-70 -136.28 142.59 43.95 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.797 -1.19 . . . . 0.0 111.121 -175.505 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.565 ' HB ' ' CG2' ' A' ' 85' ' ' ILE . 96.7 mt -129.14 131.9 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.133 -0.98 . . . . 0.0 109.953 170.432 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.552 HD23 ' N ' ' A' ' 11' ' ' VAL . 0.3 OUTLIER -103.27 121.9 43.66 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.507 -0.746 . . . . 0.0 110.068 179.382 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.725 HG13 HD22 ' A' ' 16' ' ' LEU . 2.7 t -110.25 133.15 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.088 -1.008 . . . . 0.0 110.142 178.165 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.2 mttt -68.33 -40.02 81.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.238 -0.914 . . . . 0.0 110.646 -178.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -120.14 142.0 49.34 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.152 -0.968 . . . . 0.0 110.977 -176.077 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.583 ' HB2' ' CZ ' ' A' ' 83' ' ' TYR . 88.6 tt0 -59.99 -42.99 95.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.447 -0.783 . . . . 0.0 110.172 178.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -57.47 -40.06 77.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.682 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.725 HD22 HG13 ' A' ' 11' ' ' VAL . 5.5 tt -67.99 -40.28 83.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.2 -0.938 . . . . 0.0 109.704 177.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.6 ' N ' HG11 ' A' ' 11' ' ' VAL . . . -59.94 -44.1 94.59 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -0.933 . . . . 0.0 110.061 175.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.408 ' CD1' ' HG2' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -60.01 -43.24 95.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.303 -0.873 . . . . 0.0 109.707 175.829 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -59.99 -41.46 92.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.312 -0.867 . . . . 0.0 109.586 174.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.0 tp -63.08 -45.47 91.99 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.573 0.702 . . . . 0.0 109.88 176.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.676 HD11 ' CD1' ' A' ' 85' ' ' ILE . 2.4 mp -59.96 -44.98 94.1 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.659 -0.651 . . . . 0.0 110.376 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.5 tp10 -60.59 -40.07 90.4 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.421 -0.8 . . . . 0.0 110.411 -178.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -60.39 -41.14 93.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.277 -0.89 . . . . 0.0 110.133 -177.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.81 HG13 HD13 ' A' ' 33' ' ' LEU . 24.8 mt -67.14 -43.09 88.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.36 -0.837 . . . . 0.0 110.801 -178.518 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -60.2 -47.97 83.73 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.869 -1.145 . . . . 0.0 110.395 -175.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -59.7 -62.55 1.79 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.004 -1.06 . . . . 0.0 110.345 176.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.743 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -105.76 -39.23 2.22 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -172.621 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.743 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 81.47 -176.79 0.05 Allowed 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.811 -0.817 . . . . 0.0 109.623 -173.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.618 ' CB ' ' O ' ' A' ' 28' ' ' ALA . 95.9 m-20 115.11 71.84 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.954 0 C-N-CA 124.822 1.249 . . . . 0.0 109.623 -175.175 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.594 ' CG ' ' HE3' ' A' ' 87' ' ' LYS . 7.6 m-85 -63.42 -39.77 95.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.266 -0.897 . . . . 0.0 110.32 176.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.64 -55.75 28.16 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 -177.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.2 mttp -66.52 -40.62 89.27 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.923 -1.339 . . . . 0.0 110.912 -176.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.81 HD13 HG13 ' A' ' 24' ' ' ILE . 34.9 mt -66.59 -40.06 88.7 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.045 -1.035 . . . . 0.0 110.19 -179.126 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.546 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -59.98 -46.2 90.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.096 -1.003 . . . . 0.0 110.029 177.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -60.06 -48.89 79.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.273 -0.892 . . . . 0.0 110.44 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -64.11 -46.57 83.62 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.181 -0.949 . . . . 0.0 110.941 -174.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.4 ' CE1' HD21 ' A' ' 16' ' ' LEU . 57.1 m-70 -73.95 -44.93 53.27 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.917 -1.114 . . . . 0.0 111.334 -175.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.655 ' O ' HG22 ' A' ' 39' ' ' ILE . 6.7 t -59.97 -48.16 82.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.977 -1.077 . . . . 0.0 110.707 -172.386 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.655 HG22 ' O ' ' A' ' 38' ' ' SER . 20.1 tt 38.33 32.24 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.588 -0.695 . . . . 0.0 110.837 179.217 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.487 ' SG ' ' N ' ' A' ' 43' ' ' GLY . 18.7 p -128.71 164.2 40.0 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.143 -0.973 . . . . 0.0 110.366 -176.354 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.472 ' HD2' ' HB2' ' A' ' 40' ' ' CYS . 1.7 Cg_endo -50.66 -29.11 24.43 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.951 1.501 . . . . 0.0 110.454 178.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.485 ' O ' ' CA ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -100.57 17.93 20.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.065 -1.022 . . . . 0.0 109.65 175.4 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.488 ' HA2' ' OG ' ' A' ' 38' ' ' SER . . . -79.51 -57.85 3.03 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 175.026 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.467 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 86.8 tttt -59.99 -39.53 86.03 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.383 -1.069 . . . . 0.0 110.04 177.192 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.0 tpt180 -95.71 -42.36 8.42 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.089 -1.007 . . . . 0.0 110.767 -177.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.485 ' CA ' ' O ' ' A' ' 42' ' ' SER . . . -70.13 -25.63 75.36 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.86 -1.04 58.12 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 175.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' A' ' 44' ' ' LYS . 45.7 p-10 -171.01 66.85 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.326 -1.102 . . . . 0.0 108.755 -178.464 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.977 HD12 ' CD2' ' A' ' 8' ' ' HIS . 7.5 mt -69.96 -26.27 64.03 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.51 -0.744 . . . . 0.0 109.924 -175.372 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.03 -145.48 17.8 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 -178.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -109.95 137.57 47.55 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.226 -1.161 . . . . 0.0 110.383 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.565 ' CE2' ' HB3' ' A' ' 6' ' ' ALA . 3.4 p90 -148.09 163.01 38.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.434 -0.791 . . . . 0.0 110.1 -178.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.511 ' HG2' HG22 ' A' ' 3' ' ' THR . 96.4 mtt180 . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.24 -0.913 . . . . 0.0 109.354 176.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.447 ' O ' ' N ' ' A' ' 61' ' ' PHE . 14.2 Cg_endo . . . . . 0 N--CA 1.485 0.982 0 N-CA-C 110.205 -0.729 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.732 ' O ' HG13 ' A' ' 64' ' ' VAL . . . -39.76 -28.98 0.05 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.585 -0.697 . . . . 0.0 110.628 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.489 ' O ' HG22 ' A' ' 64' ' ' VAL . 62.5 t80 -60.03 -44.56 94.55 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.161 -0.962 . . . . 0.0 110.204 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.466 ' O ' HG12 ' A' ' 65' ' ' VAL . 47.8 t0 -59.93 -40.05 87.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.156 -0.965 . . . . 0.0 109.723 176.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.885 ' HD3' HD21 ' A' ' 77' ' ' LEU . 79.9 tttt -58.55 -41.92 86.72 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.387 -0.821 . . . . 0.0 110.348 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.732 HG13 ' O ' ' A' ' 60' ' ' ALA . 0.9 OUTLIER -77.69 -46.43 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.122 -0.986 . . . . 0.0 110.667 -177.153 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.5 ' N ' ' CG2' ' A' ' 64' ' ' VAL . 0.3 OUTLIER -56.14 -25.12 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.502 -1.374 . . . . 0.0 109.201 172.776 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -95.21 -5.17 44.46 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.493 -0.754 . . . . 0.0 109.917 175.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.532 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 29.7 t -96.32 -44.54 7.19 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.418 -0.801 . . . . 0.0 110.14 178.471 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 56.5 m -131.68 152.38 80.29 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.353 -0.842 . . . . 0.0 110.457 -177.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.437 ' HD2' ' OE1' ' A' ' 72' ' ' GLU . 13.5 Cg_endo -68.95 155.92 66.97 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.073 1.565 . . . . 0.0 110.377 178.232 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.888 HG22 HD12 ' A' ' 71' ' ' LEU . 8.9 p -61.3 169.69 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.349 -0.844 . . . . 0.0 110.616 -177.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.888 HD12 HG22 ' A' ' 70' ' ' VAL . 2.2 mp 59.45 16.02 4.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.629 -0.67 . . . . 0.0 110.277 -177.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.437 ' OE1' ' HD2' ' A' ' 69' ' ' PRO . 11.1 tt0 -137.2 85.15 22.61 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.206 -0.933 . . . . 0.0 109.472 173.044 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -43.75 145.27 1.95 Allowed 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 124.051 1.553 . . . . 0.0 110.712 -174.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 62.6 m -132.67 139.62 47.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.47 -0.769 . . . . 0.0 110.078 -178.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.42 ' HA3' HG13 ' A' ' 85' ' ' ILE . . . 141.72 -175.88 22.26 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.234 -1.547 . . . . 0.0 109.234 -178.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.549 ' HD3' HD21 ' A' ' 21' ' ' LEU . 43.5 Cg_endo -79.47 132.91 26.58 Favored 'Cis proline' 0 C--N 1.314 -1.275 0 C-N-CA 121.834 -2.152 . . . . 0.0 110.367 -0.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.885 HD21 ' HD3' ' A' ' 63' ' ' LYS . 43.7 tp -96.51 156.86 16.16 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.283 -0.885 . . . . 0.0 110.877 -174.357 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.461 ' N ' ' HG ' ' A' ' 77' ' ' LEU . 36.1 t-80 -78.0 126.03 30.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.454 -0.779 . . . . 0.0 110.402 178.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.575 HG21 ' CG ' ' A' ' 84' ' ' HIS . 11.6 t -139.95 158.98 43.2 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.178 -0.951 . . . . 0.0 109.882 176.528 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -60.89 -25.74 66.93 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.16 -0.962 . . . . 0.0 110.864 -176.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -81.01 -9.94 59.78 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.007 -1.058 . . . . 0.0 110.639 -178.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.502 ' O ' HG22 ' A' ' 79' ' ' THR . . . 139.4 -128.43 3.99 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 108.653 -1.779 . . . . 0.0 108.653 -174.126 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.583 ' CZ ' ' HB2' ' A' ' 14' ' ' GLU . 91.6 m-85 -115.88 134.58 54.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.95 -1.323 . . . . 0.0 109.827 173.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.575 ' CG ' HG21 ' A' ' 79' ' ' THR . 31.3 m170 -114.34 125.51 53.96 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.18 -0.95 . . . . 0.0 110.564 177.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.676 ' CD1' HD11 ' A' ' 21' ' ' LEU . 6.7 tt -114.1 122.23 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.904 -1.122 . . . . 0.0 109.264 170.365 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.72 HD12 HG11 ' A' ' 64' ' ' VAL . 85.3 mt -117.43 129.96 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.167 -0.958 . . . . 0.0 111.07 -170.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.594 ' HE3' ' CG ' ' A' ' 30' ' ' PHE . 12.1 ttmm -94.87 125.65 39.67 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.126 -0.984 . . . . 0.0 109.341 170.008 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.613 HG12 HG23 ' A' ' 70' ' ' VAL . 62.4 t -104.75 131.96 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.294 -0.879 . . . . 0.0 110.221 -174.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.522 ' O ' ' N ' ' A' ' 91' ' ' ARG . 48.4 mt -133.74 154.07 51.24 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.507 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 2.2 m-85 64.19 -58.58 0.22 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.682 -0.637 . . . . 0.0 111.059 176.345 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.522 ' N ' ' O ' ' A' ' 89' ' ' LEU . 3.2 ttm180 . . . . . 0 N--CA 1.493 1.72 0 O-C-N 121.077 -1.014 . . . . 0.0 110.544 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.0 p . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 121.267 0.556 . . . . 0.0 110.58 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.448 ' C ' ' HG3' ' A' ' 51' ' ' GLU . . . -132.53 156.66 46.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.189 -0.944 . . . . 0.0 110.194 178.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.522 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -92.07 125.33 36.71 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.153 -0.967 . . . . 0.0 109.285 175.37 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.797 ' HB3' ' CE2' ' A' ' 52' ' ' PHE . . . -137.16 130.2 30.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.804 -1.185 . . . . 0.0 112.081 -169.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.74 HD12 ' HD2' ' A' ' 87' ' ' LYS . 85.0 mt -103.46 140.72 37.1 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.282 -0.886 . . . . 0.0 108.994 168.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.621 ' NE2' ' HB1' ' A' ' 6' ' ' ALA . 35.5 m170 -134.41 148.53 50.66 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.681 -1.262 . . . . 0.0 111.539 -176.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.68 ' HB ' HG22 ' A' ' 85' ' ' ILE . 97.0 mt -136.33 130.88 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.297 -0.877 . . . . 0.0 109.862 169.4 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.62 HD23 ' N ' ' A' ' 11' ' ' VAL . 0.4 OUTLIER -99.25 123.65 43.7 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.383 -0.823 . . . . 0.0 109.667 177.153 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.666 HG11 ' N ' ' A' ' 17' ' ' ALA . 2.6 t -115.86 129.78 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.183 -0.948 . . . . 0.0 110.028 177.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -69.25 -40.03 78.11 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.326 -0.859 . . . . 0.0 110.59 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -114.93 139.49 49.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.064 -1.022 . . . . 0.0 110.652 -177.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.507 ' HB2' ' CZ ' ' A' ' 83' ' ' TYR . 86.3 tt0 -59.94 -42.41 93.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.428 -0.795 . . . . 0.0 110.032 177.096 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -56.68 -42.84 79.75 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.325 -0.859 . . . . 0.0 110.2 179.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.615 HD22 HG13 ' A' ' 11' ' ' VAL . 7.4 tt -68.09 -42.4 80.41 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.052 -1.03 . . . . 0.0 109.875 179.186 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.666 ' N ' HG11 ' A' ' 11' ' ' VAL . . . -59.97 -46.53 89.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.133 -0.98 . . . . 0.0 109.714 174.202 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.789 HD23 HD22 ' A' ' 21' ' ' LEU . 25.5 mt -60.04 -39.97 87.77 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.889 . . . . 0.0 109.97 175.186 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.464 ' HB3' ' O ' ' A' ' 16' ' ' LEU . 48.1 t0 -59.97 -40.63 89.76 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.181 -0.949 . . . . 0.0 109.298 174.122 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.459 ' HB3' ' O ' ' A' ' 17' ' ' ALA . 2.6 tp -63.28 -39.88 95.83 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.445 -0.784 . . . . 0.0 109.325 173.311 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.789 HD22 HD23 ' A' ' 18' ' ' LEU . 3.4 mp -59.29 -42.78 92.08 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.53 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -60.26 -40.06 88.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.393 -0.817 . . . . 0.0 109.92 174.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.466 ' OE1' HD22 ' A' ' 33' ' ' LEU . 96.7 mt-30 -61.83 -40.31 94.85 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.45 -0.781 . . . . 0.0 110.818 -177.275 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.526 ' O ' ' N ' ' A' ' 28' ' ' ALA . 96.9 mt -66.24 -40.02 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.104 -0.997 . . . . 0.0 109.843 -178.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -64.02 -53.73 45.46 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.084 -1.01 . . . . 0.0 109.802 176.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -60.49 -43.47 96.99 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.316 -0.865 . . . . 0.0 110.808 177.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.747 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -106.37 -59.78 0.6 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 -175.227 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.747 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 83.23 89.89 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 O-C-N 122.07 -0.665 . . . . 0.0 109.861 -175.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -176.92 78.79 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.395 -0.816 . . . . 0.0 109.904 -174.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.565 ' CD2' ' HE3' ' A' ' 87' ' ' LYS . 5.4 m-85 -60.06 -40.56 89.9 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.271 -0.893 . . . . 0.0 110.79 -175.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.63 -51.42 56.12 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.77 -1.205 . . . . 0.0 110.116 -176.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -66.21 -40.01 90.03 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.07 -1.253 . . . . 0.0 110.446 -175.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.466 HD22 ' OE1' ' A' ' 23' ' ' GLN . 67.3 mt -65.92 -39.98 91.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.226 -0.921 . . . . 0.0 110.113 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.563 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -59.29 -50.09 75.34 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.239 -0.913 . . . . 0.0 110.348 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.5 tttp -59.99 -48.25 82.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.913 . . . . 0.0 110.577 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.9 tttt -60.06 -49.54 77.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.208 -0.932 . . . . 0.0 110.987 -175.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -81.88 -40.54 22.24 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.934 -1.104 . . . . 0.0 111.637 -172.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.485 ' OG ' ' HA3' ' A' ' 43' ' ' GLY . 23.7 t -60.06 -49.99 75.49 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.91 -1.119 . . . . 0.0 111.074 -172.332 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.637 ' O ' HG22 ' A' ' 39' ' ' ILE . 83.7 mt 33.39 48.59 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 CA-C-O 121.195 0.521 . . . . 0.0 111.142 -177.147 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.42 ' HB2' ' CD ' ' A' ' 41' ' ' PRO . 15.3 p -139.98 176.06 2.79 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.132 -0.98 . . . . 0.0 110.407 -177.362 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.474 ' O ' ' CB ' ' A' ' 42' ' ' SER . 3.0 Cg_exo -68.87 66.26 1.28 Allowed 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.874 1.46 . . . . 0.0 109.849 -178.088 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 45' ' ' ARG . 0.1 OUTLIER 165.44 -41.95 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.779 -0.576 . . . . 0.0 109.69 179.594 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.485 ' HA3' ' OG ' ' A' ' 38' ' ' SER . . . -41.77 -37.36 1.99 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -178.017 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -60.31 -40.01 89.04 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.019 -1.283 . . . . 0.0 110.133 175.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.552 ' HG3' ' CD2' ' A' ' 49' ' ' LEU . 11.3 tpp180 -102.4 -43.2 5.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.526 -0.734 . . . . 0.0 110.596 -176.422 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.544 ' HA2' HD11 ' A' ' 49' ' ' LEU . . . -55.15 -35.33 59.69 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.926 -1.269 . . . . 0.0 109.926 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.49 ' O ' HD22 ' A' ' 7' ' ' LEU . . . -67.99 -5.96 42.79 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 176.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -169.84 64.71 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.285 -1.126 . . . . 0.0 109.176 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.552 ' CD2' ' HG3' ' A' ' 45' ' ' ARG . 5.0 mt -69.99 -27.63 64.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.539 -0.726 . . . . 0.0 110.07 -178.011 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 101.06 -143.42 16.17 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 -176.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.448 ' HG3' ' C ' ' A' ' 4' ' ' ALA . 72.2 tt0 -111.8 133.14 54.21 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.206 -1.173 . . . . 0.0 110.253 -179.003 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.797 ' CE2' ' HB3' ' A' ' 6' ' ' ALA . 4.7 p90 -145.56 166.43 25.74 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.322 -0.861 . . . . 0.0 109.985 -178.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 . . . . . 0 N--CA 1.495 1.824 0 O-C-N 121.036 -1.04 . . . . 0.0 110.215 179.559 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.426 ' O ' ' C ' ' A' ' 60' ' ' ALA . 14.5 Cg_endo . . . . . 0 N--CA 1.485 0.972 0 N-CA-C 110.025 -0.798 . . . . 0.0 110.025 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 59' ' ' PRO . . . -39.81 -33.32 0.19 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.606 -0.684 . . . . 0.0 110.845 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.655 ' CE2' HG21 ' A' ' 65' ' ' VAL . 65.1 t80 -60.01 -44.03 94.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.043 -1.036 . . . . 0.0 110.358 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -60.73 -39.92 90.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.179 -0.95 . . . . 0.0 110.163 -179.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.416 ' O ' ' HB2' ' A' ' 67' ' ' SER . 75.6 mmtt -58.97 -45.89 89.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.182 -0.949 . . . . 0.0 110.378 -178.293 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.709 HG23 HG21 ' A' ' 74' ' ' THR . 8.5 p -73.39 -39.98 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.059 -1.025 . . . . 0.0 110.53 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.655 HG21 ' CE2' ' A' ' 61' ' ' PHE . 9.6 t -55.75 -30.67 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.625 -1.297 . . . . 0.0 109.568 171.294 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -96.15 -0.36 50.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.37 -0.831 . . . . 0.0 109.844 176.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.454 ' CB ' ' HA ' ' A' ' 64' ' ' VAL . 6.9 t -96.44 -64.66 1.03 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.362 -0.836 . . . . 0.0 109.525 174.573 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.411 ' SG ' ' OG1' ' A' ' 74' ' ' THR . 91.1 m -89.57 130.73 42.33 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.326 -0.859 . . . . 0.0 110.016 175.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.548 ' O ' ' O ' ' A' ' 70' ' ' VAL . 25.2 Cg_endo -67.64 79.28 0.49 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.849 1.447 . . . . 0.0 110.79 -177.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.017 ' C ' HD13 ' A' ' 71' ' ' LEU . 1.8 m 37.17 177.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.445 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 177.04 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.017 HD13 ' C ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER 24.39 40.92 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.485 0 CA-C-O 121.636 0.731 . . . . 0.0 112.632 -170.72 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.554 ' N ' ' O ' ' A' ' 70' ' ' VAL . 3.4 tp10 -138.05 81.96 25.96 Favored Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 121.285 -0.885 . . . . 0.0 109.589 174.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -43.68 129.49 7.09 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 124.045 1.55 . . . . 0.0 110.204 -176.166 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.709 HG21 HG23 ' A' ' 64' ' ' VAL . 57.1 m -127.96 135.7 50.29 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.348 -0.845 . . . . 0.0 110.196 -175.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.421 ' HA3' HG13 ' A' ' 85' ' ' ILE . . . 133.6 -176.55 19.62 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 -178.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.605 ' CD ' HD21 ' A' ' 21' ' ' LEU . 43.3 Cg_endo -72.19 152.9 97.61 Favored 'Cis proline' 0 C--N 1.314 -1.276 0 C-N-CA 121.713 -2.203 . . . . 0.0 110.199 0.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.0 tp -131.38 154.51 48.54 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.129 -0.982 . . . . 0.0 110.329 -175.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 -76.64 130.92 38.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.244 -0.91 . . . . 0.0 110.761 -177.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.63 HG21 ' CG ' ' A' ' 84' ' ' HIS . 10.3 t -142.08 173.65 11.32 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.452 -0.78 . . . . 0.0 109.823 175.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -59.99 -27.72 67.1 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.158 -0.963 . . . . 0.0 110.517 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -96.39 9.97 39.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.999 -1.063 . . . . 0.0 110.902 -172.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.401 ' O ' HG22 ' A' ' 79' ' ' THR . . . 119.6 -124.65 6.04 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 -176.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.507 ' CZ ' ' HB2' ' A' ' 14' ' ' GLU . 87.1 m-85 -114.07 139.02 49.64 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.128 -1.219 . . . . 0.0 110.253 176.566 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.63 ' CG ' HG21 ' A' ' 79' ' ' THR . 21.9 m170 -121.7 121.63 37.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.35 -0.844 . . . . 0.0 110.377 177.339 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.68 HG22 ' HB ' ' A' ' 9' ' ' ILE . 6.1 tt -109.94 136.84 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.761 -1.212 . . . . 0.0 109.434 168.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.554 HG12 ' CD2' ' A' ' 8' ' ' HIS . 26.1 mt -133.48 131.67 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.076 -1.015 . . . . 0.0 111.223 -169.514 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.74 ' HD2' HD12 ' A' ' 7' ' ' LEU . 12.1 ttmm -105.25 128.03 53.23 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.237 -0.914 . . . . 0.0 109.411 170.144 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.771 HG12 HG12 ' A' ' 70' ' ' VAL . 60.8 t -108.77 139.3 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.204 -0.935 . . . . 0.0 110.363 -174.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.527 ' O ' ' CB ' ' A' ' 90' ' ' TYR . 81.6 mt -140.38 126.26 19.45 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.197 -0.94 . . . . 0.0 110.055 -177.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.527 ' CB ' ' O ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER 80.71 -57.97 0.3 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.415 -0.803 . . . . 0.0 111.53 171.985 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.657 ' HB2' HG11 ' A' ' 70' ' ' VAL . 47.5 ttp180 . . . . . 0 N--CA 1.493 1.692 0 O-C-N 120.863 -1.148 . . . . 0.0 110.631 -179.01 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 52' ' ' PHE . 72.6 m . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 120.834 0.35 . . . . 0.0 110.095 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.577 ' O ' ' CD1' ' A' ' 52' ' ' PHE . . . -153.4 157.77 40.45 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.914 -1.116 . . . . 0.0 110.786 -177.704 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.489 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -104.14 139.46 39.18 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.149 -0.969 . . . . 0.0 109.429 172.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.821 ' HB3' ' CZ ' ' A' ' 52' ' ' PHE . . . -149.83 130.79 14.3 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.694 -1.254 . . . . 0.0 111.457 -177.61 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.915 HD12 ' HE3' ' A' ' 87' ' ' LYS . 17.4 mt -100.75 146.17 27.58 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.454 -0.779 . . . . 0.0 109.746 172.406 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.678 ' CD2' HD12 ' A' ' 49' ' ' LEU . 8.0 m-70 -134.5 150.1 50.76 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.121 -0.987 . . . . 0.0 110.826 -175.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.561 ' HB ' ' CG2' ' A' ' 85' ' ' ILE . 89.8 mt -128.78 129.88 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.063 -1.023 . . . . 0.0 109.671 167.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.535 ' HG ' ' CD2' ' A' ' 84' ' ' HIS . 0.5 OUTLIER -106.5 119.33 39.01 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.497 -0.752 . . . . 0.0 110.1 -177.523 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.952 HG13 HD22 ' A' ' 16' ' ' LEU . 3.1 t -114.97 131.05 68.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.227 -0.921 . . . . 0.0 110.045 176.251 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 49.0 tttt -69.95 -40.01 75.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.083 -1.011 . . . . 0.0 110.614 -178.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -109.04 137.25 47.24 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.107 -0.995 . . . . 0.0 110.839 -176.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.555 ' HB2' ' CZ ' ' A' ' 83' ' ' TYR . 86.5 tt0 -59.99 -42.01 93.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.443 -0.785 . . . . 0.0 110.121 178.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -56.37 -41.16 75.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.322 -0.861 . . . . 0.0 110.212 178.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.952 HD22 HG13 ' A' ' 11' ' ' VAL . 4.7 tt -67.95 -39.91 83.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.014 -1.054 . . . . 0.0 109.076 175.279 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.674 ' O ' HD12 ' A' ' 21' ' ' LEU . . . -59.93 -40.63 89.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.303 -0.873 . . . . 0.0 110.095 175.482 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.03 -42.05 93.56 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.022 -1.049 . . . . 0.0 109.571 175.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -59.99 -38.99 84.22 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.275 -0.891 . . . . 0.0 109.706 173.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.711 ' C ' HD12 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -60.82 -50.38 73.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.313 -0.867 . . . . 0.0 109.885 178.822 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.797 HD21 ' HD3' ' A' ' 76' ' ' PRO . 1.4 mt -60.02 -49.26 78.38 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.339 -0.851 . . . . 0.0 110.181 -178.505 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -60.48 -40.08 89.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.454 -0.779 . . . . 0.0 109.999 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 70.0 tp60 -59.99 -41.31 91.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.365 -0.834 . . . . 0.0 110.529 -175.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.528 ' O ' ' N ' ' A' ' 28' ' ' ALA . 63.1 mt -63.65 -47.92 89.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.2 -0.938 . . . . 0.0 110.21 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -62.11 -45.08 95.08 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.903 -1.123 . . . . 0.0 109.659 177.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -59.97 -60.8 3.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.376 -0.827 . . . . 0.0 110.178 177.052 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.745 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -105.83 -45.8 1.26 Allowed Glycine 0 N--CA 1.486 1.992 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -175.355 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.745 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 80.16 158.69 0.16 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.811 -0.817 . . . . 0.0 110.462 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.592 ' CB ' ' O ' ' A' ' 28' ' ' ALA . 96.7 m-20 118.26 81.24 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.038 0 C-N-CA 125.053 1.341 . . . . 0.0 109.634 -175.262 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.439 ' CZ ' HD13 ' A' ' 24' ' ' ILE . 2.1 m-85 -60.02 -45.04 94.1 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.207 -0.933 . . . . 0.0 110.999 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.39 -54.64 25.38 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.765 -1.207 . . . . 0.0 110.141 -174.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -65.94 -39.95 90.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.048 -1.266 . . . . 0.0 110.306 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 46.8 mt -63.65 -39.97 95.68 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.134 -0.979 . . . . 0.0 109.643 176.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.546 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -55.18 -50.64 68.83 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.266 -0.896 . . . . 0.0 110.091 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -59.96 -51.97 67.39 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.055 -1.028 . . . . 0.0 110.677 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -60.96 -50.07 74.87 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.21 -0.931 . . . . 0.0 111.175 -176.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -70.43 -39.97 74.07 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.123 -0.986 . . . . 0.0 110.867 -177.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.658 ' O ' HG22 ' A' ' 39' ' ' ILE . 20.7 t -60.08 -46.35 89.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.138 -0.976 . . . . 0.0 110.349 -175.007 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.658 HG22 ' O ' ' A' ' 38' ' ' SER . 16.0 tt 37.99 29.87 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.7 -0.625 . . . . 0.0 110.58 178.095 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.47 ' N ' ' O ' ' A' ' 38' ' ' SER . 15.2 p -129.67 165.11 35.37 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.35 -0.844 . . . . 0.0 110.193 -176.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.47 ' HD2' ' HB2' ' A' ' 40' ' ' CYS . 1.1 Cg_endo -47.76 -28.43 9.61 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.802 1.422 . . . . 0.0 110.562 178.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.523 ' O ' ' CA ' ' A' ' 46' ' ' GLY . 0.2 OUTLIER -99.77 18.43 18.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.99 -1.069 . . . . 0.0 110.148 177.526 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.44 -55.01 5.27 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.549 -1.82 . . . . 0.0 108.549 171.139 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -61.12 -40.03 92.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.457 -1.025 . . . . 0.0 110.749 177.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.412 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 12.8 tpt180 -104.53 -41.26 5.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.089 -1.007 . . . . 0.0 110.795 -174.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.523 ' CA ' ' O ' ' A' ' 42' ' ' SER . . . -69.95 -31.88 69.8 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.55 0.9 59.47 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 177.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.521 ' HA ' ' CD2' ' A' ' 7' ' ' LEU . 47.8 t0 -170.38 76.17 0.08 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.296 -1.12 . . . . 0.0 109.065 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.678 HD12 ' CD2' ' A' ' 8' ' ' HIS . 19.2 mt -82.63 -14.96 53.81 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.602 -0.686 . . . . 0.0 110.193 -174.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.01 -137.96 14.29 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 177.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.499 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 3.4 mt-10 -108.79 158.59 17.5 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.453 -1.028 . . . . 0.0 110.421 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.821 ' CZ ' ' HB3' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -139.96 177.83 7.69 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.389 -0.82 . . . . 0.0 109.407 -175.583 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.616 -0.677 . . . . 0.0 109.849 179.356 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo . . . . . 0 N--CA 1.485 1.021 0 N-CA-C 110.88 -0.469 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -45.28 -44.63 11.54 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.219 -0.925 . . . . 0.0 110.578 -174.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -59.99 -41.68 92.57 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.185 -0.947 . . . . 0.0 110.118 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.516 ' O ' HG12 ' A' ' 65' ' ' VAL . 57.4 t0 -71.78 -38.4 70.3 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.317 -0.864 . . . . 0.0 110.298 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.521 ' O ' ' N ' ' A' ' 67' ' ' SER . 87.6 tttt -55.06 -49.96 70.31 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.24 -0.912 . . . . 0.0 110.216 -175.566 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.667 ' HB ' HD11 ' A' ' 77' ' ' LEU . 2.5 p -69.81 -47.1 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.129 -0.982 . . . . 0.0 111.814 -174.144 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.516 HG12 ' O ' ' A' ' 62' ' ' ASP . 3.0 p -57.4 -27.12 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.319 -1.488 . . . . 0.0 109.055 173.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -92.97 -11.19 33.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.407 -0.808 . . . . 0.0 109.846 175.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.544 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 9.4 t -91.62 -44.74 8.87 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.318 -0.864 . . . . 0.0 109.756 176.373 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.503 ' HB3' ' HB3' ' A' ' 72' ' ' GLU . 66.1 m -137.14 149.98 67.82 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.306 -0.871 . . . . 0.0 110.382 178.523 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.485 ' O ' ' HB2' ' A' ' 72' ' ' GLU . 52.1 Cg_endo -77.71 -179.48 5.48 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.054 1.555 . . . . 0.0 110.932 -178.461 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.938 HG22 ' CD1' ' A' ' 71' ' ' LEU . 7.2 p -60.04 157.65 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.424 -0.797 . . . . 0.0 110.06 177.768 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.938 ' CD1' HG22 ' A' ' 70' ' ' VAL . 4.4 mp 60.01 40.03 19.22 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.419 -0.8 . . . . 0.0 110.234 -175.657 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.503 ' HB3' ' HB3' ' A' ' 68' ' ' CYS . 0.0 OUTLIER -150.46 104.42 3.1 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.299 -0.875 . . . . 0.0 110.258 178.72 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 72' ' ' GLU . 26.0 Cg_endo -67.15 135.09 36.04 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.89 1.469 . . . . 0.0 110.273 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.636 ' HB ' HG23 ' A' ' 64' ' ' VAL . 87.2 m -140.13 147.21 39.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.164 -0.96 . . . . 0.0 110.488 -178.201 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.447 ' HA3' HG13 ' A' ' 85' ' ' ILE . . . 125.72 -168.88 17.72 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.797 ' HD3' HD21 ' A' ' 21' ' ' LEU . 43.0 Cg_endo -72.32 139.23 59.09 Favored 'Cis proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.847 -2.147 . . . . 0.0 110.732 -0.407 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.667 HD11 ' HB ' ' A' ' 64' ' ' VAL . 88.7 mt -92.99 169.37 10.48 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.3 -0.875 . . . . 0.0 110.633 -176.506 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 14.3 t60 -100.24 119.57 38.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.144 -0.972 . . . . 0.0 110.381 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.637 HG21 ' ND1' ' A' ' 84' ' ' HIS . 14.7 t -141.56 166.38 24.91 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.155 -0.965 . . . . 0.0 109.815 176.201 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.415 ' CG ' ' N ' ' A' ' 81' ' ' PHE . 15.8 pt20 -59.93 -34.75 73.66 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.121 -0.987 . . . . 0.0 110.397 -176.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.415 ' N ' ' CG ' ' A' ' 80' ' ' GLN . 94.4 m-85 -60.04 -27.26 66.78 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.271 -0.893 . . . . 0.0 110.208 178.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 141.63 -132.37 5.24 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -178.527 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.555 ' CZ ' ' HB2' ' A' ' 14' ' ' GLU . 81.3 m-85 -96.66 120.99 37.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -1.139 . . . . 0.0 109.876 175.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.637 ' ND1' HG21 ' A' ' 79' ' ' THR . 0.6 OUTLIER -113.29 113.64 25.55 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.566 -0.709 . . . . 0.0 110.9 -176.453 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.561 ' CG2' ' HB ' ' A' ' 9' ' ' ILE . 12.2 tt -109.82 133.9 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 120.616 -1.302 . . . . 0.0 109.579 170.073 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.528 HG12 ' ND1' ' A' ' 8' ' ' HIS . 85.9 mt -138.24 141.93 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.044 -1.035 . . . . 0.0 110.67 -172.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.915 ' HE3' HD12 ' A' ' 7' ' ' LEU . 20.1 pttp -119.53 142.06 48.67 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.048 -1.033 . . . . 0.0 109.511 171.156 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 62.5 t -107.9 129.97 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.913 -1.117 . . . . 0.0 111.302 -168.101 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' A' ' 91' ' ' ARG . 89.5 mt -114.26 -170.97 1.83 Allowed 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.305 -0.872 . . . . 0.0 109.204 172.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.435 ' C ' ' O ' ' A' ' 89' ' ' LEU . 71.0 m-85 32.85 -86.46 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.735 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.533 ' N ' ' O ' ' A' ' 89' ' ' LEU . 29.7 ttp85 . . . . . 0 N--CA 1.493 1.683 0 O-C-N 120.696 -1.253 . . . . 0.0 110.617 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.579 HG22 ' HB3' ' A' ' 53' ' ' ARG . 28.1 p . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.192 0.52 . . . . 0.0 110.087 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.404 ' C ' ' HG3' ' A' ' 51' ' ' GLU . . . -129.88 160.12 34.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.254 -0.904 . . . . 0.0 109.656 178.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.555 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -95.52 127.39 41.51 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.121 -0.987 . . . . 0.0 109.551 179.091 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.823 ' HB3' ' HZ ' ' A' ' 52' ' ' PHE . . . -134.51 131.07 37.57 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.699 -1.25 . . . . 0.0 111.56 -170.68 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.517 ' C ' ' CD2' ' A' ' 8' ' ' HIS . 39.9 mt -102.28 147.31 26.82 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.078 -1.014 . . . . 0.0 109.33 170.036 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.672 ' NE2' ' HB1' ' A' ' 6' ' ' ALA . 31.4 m-70 -143.52 134.02 24.84 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.803 -1.185 . . . . 0.0 111.407 -175.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.564 HG13 ' CZ ' ' A' ' 30' ' ' PHE . 95.3 mt -119.99 125.69 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.776 -1.202 . . . . 0.0 109.763 165.036 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.592 ' HG ' ' CD2' ' A' ' 84' ' ' HIS . 0.2 OUTLIER -102.79 121.4 42.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.603 -0.686 . . . . 0.0 109.689 179.553 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.823 HG13 HD22 ' A' ' 16' ' ' LEU . 2.2 t -109.31 125.48 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.134 -0.979 . . . . 0.0 110.394 178.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -67.58 -39.97 84.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.445 -0.784 . . . . 0.0 110.446 175.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -108.11 136.84 47.11 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.217 -0.927 . . . . 0.0 110.966 -174.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.451 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 97.1 mt-10 -60.07 -40.84 90.93 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.4 -0.812 . . . . 0.0 110.115 173.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -58.86 -40.23 83.71 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.209 -0.932 . . . . 0.0 110.459 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.823 HD22 HG13 ' A' ' 11' ' ' VAL . 3.7 tt -68.31 -38.19 81.33 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.045 -1.034 . . . . 0.0 109.054 175.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.739 ' O ' HD12 ' A' ' 21' ' ' LEU . . . -58.76 -44.48 90.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.361 -0.837 . . . . 0.0 110.114 175.373 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.99 -42.72 94.84 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.221 -0.924 . . . . 0.0 109.611 176.514 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.456 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 65.1 t0 -59.94 -40.63 89.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.312 -0.867 . . . . 0.0 109.674 173.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.841 HD23 ' N ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -63.91 -55.32 23.55 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 121.587 0.708 . . . . 0.0 110.035 -179.786 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 1.08 HD11 ' HG3' ' A' ' 76' ' ' PRO . 0.4 OUTLIER -54.89 -40.07 69.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.564 -0.71 . . . . 0.0 109.779 179.5 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -60.58 -49.11 78.86 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.586 -0.696 . . . . 0.0 110.74 -176.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 19' ' ' ASP . 87.7 mm-40 -61.55 -40.04 93.25 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.116 -0.99 . . . . 0.0 110.375 -175.208 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.604 HG12 HD12 ' A' ' 33' ' ' LEU . 96.9 mt -59.97 -49.95 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.263 -0.898 . . . . 0.0 110.019 -177.267 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -62.18 -48.31 80.63 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.883 -1.136 . . . . 0.0 109.75 176.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.11 -55.79 29.54 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.341 -0.849 . . . . 0.0 110.28 178.48 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.747 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -105.28 -48.57 1.05 Allowed Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -174.393 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.747 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 81.81 96.03 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.173 0 O-C-N 122.151 -0.617 . . . . 0.0 110.228 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.44 ' HB3' ' HB2' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -176.0 84.61 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.466 -0.771 . . . . 0.0 109.935 -178.218 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.593 ' CG ' ' HE3' ' A' ' 87' ' ' LYS . 45.8 t80 -60.03 -48.5 81.45 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.314 -0.866 . . . . 0.0 110.573 -175.344 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.05 -47.84 89.03 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -176.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.44 ' HB2' ' HB3' ' A' ' 29' ' ' ASP . 36.6 mmtm -65.77 -40.16 91.75 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.055 -1.262 . . . . 0.0 110.561 -176.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.604 HD12 HG12 ' A' ' 24' ' ' ILE . 84.0 mt -66.76 -40.03 88.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.089 -1.007 . . . . 0.0 110.334 179.162 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.522 ' O ' ' CB ' ' A' ' 38' ' ' SER . . . -59.93 -47.35 86.16 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.121 -0.987 . . . . 0.0 109.992 179.327 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 66.8 tttt -60.01 -46.57 89.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.16 -0.963 . . . . 0.0 110.456 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.608 ' O ' HG23 ' A' ' 39' ' ' ILE . 55.7 mttt -70.03 -59.6 2.81 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.138 -0.976 . . . . 0.0 110.993 -176.742 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.453 ' HB3' HD21 ' A' ' 16' ' ' LEU . 79.9 m80 -71.73 -40.18 69.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.095 -1.003 . . . . 0.0 111.129 -172.101 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.527 ' O ' ' CG1' ' A' ' 39' ' ' ILE . 8.6 t -60.17 -49.25 78.37 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.135 -0.978 . . . . 0.0 110.509 -175.531 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.608 HG23 ' O ' ' A' ' 36' ' ' LYS . 36.4 pt 37.95 32.72 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-O 121.452 0.644 . . . . 0.0 110.465 -177.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.455 ' SG ' ' OG ' ' A' ' 38' ' ' SER . 14.9 p -125.93 166.21 22.7 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.393 -0.817 . . . . 0.0 109.658 178.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -51.7 -22.93 14.25 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.823 1.433 . . . . 0.0 110.425 -178.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.7 OUTLIER -101.63 12.99 36.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -0.908 . . . . 0.0 110.636 -179.025 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.08 -56.43 4.41 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 174.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 16.3 tttp -60.01 -40.0 87.73 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.343 -1.093 . . . . 0.0 110.368 177.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.473 ' HD2' HD23 ' A' ' 49' ' ' LEU . 8.7 tpp85 -98.86 -43.65 6.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 0.0 110.58 -175.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -60.0 -35.97 88.85 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.29 -4.21 35.68 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 110.016 -1.233 . . . . 0.0 110.016 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.427 ' HA ' ' CD2' ' A' ' 7' ' ' LEU . 9.7 t0 -171.32 69.37 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.016 -1.285 . . . . 0.0 109.449 178.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.473 HD23 ' HD2' ' A' ' 45' ' ' ARG . 4.8 mt -70.03 -29.91 67.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.508 -0.745 . . . . 0.0 110.75 -176.208 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 112.23 -152.57 17.76 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.404 ' HG3' ' C ' ' A' ' 4' ' ' ALA . 79.1 tt0 -111.91 136.96 50.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.358 -1.084 . . . . 0.0 110.079 -178.092 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.823 ' HZ ' ' HB3' ' A' ' 6' ' ' ALA . 0.1 OUTLIER -160.18 168.17 26.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.198 -0.939 . . . . 0.0 110.243 -174.764 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.579 ' HB3' HG22 ' A' ' 3' ' ' THR . 48.7 ptt85 . . . . . 0 N--CA 1.493 1.702 0 O-C-N 120.997 -1.064 . . . . 0.0 110.546 -176.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.483 ' O ' ' N ' ' A' ' 61' ' ' PHE . 5.7 Cg_endo . . . . . 0 N--CA 1.485 0.98 0 N-CA-C 110.484 -0.622 . . . . 0.0 110.484 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.674 ' O ' HG13 ' A' ' 64' ' ' VAL . . . -37.5 -29.22 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.647 -0.658 . . . . 0.0 110.863 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.483 ' N ' ' O ' ' A' ' 59' ' ' PRO . 32.0 t80 -60.03 -43.9 94.99 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.999 -1.063 . . . . 0.0 110.309 178.188 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 59' ' ' PRO . 7.7 t70 -60.04 -40.03 87.96 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.213 -0.929 . . . . 0.0 109.459 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 67' ' ' SER . 12.4 tptp -57.63 -49.95 74.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.391 -0.818 . . . . 0.0 110.876 177.143 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.674 HG13 ' O ' ' A' ' 60' ' ' ALA . 1.3 m -70.36 -48.64 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 120.929 -1.107 . . . . 0.0 110.832 -172.401 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.534 ' N ' ' CG2' ' A' ' 64' ' ' VAL . 13.2 p -57.01 -24.64 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.431 -1.418 . . . . 0.0 109.318 172.102 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.459 ' O ' ' CD1' ' A' ' 66' ' ' PHE . 17.2 t80 -96.57 -0.06 49.3 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.402 -0.811 . . . . 0.0 109.737 175.513 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.505 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 33.0 t -97.93 -49.13 4.9 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.431 -0.793 . . . . 0.0 110.006 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.481 ' HB2' ' OG1' ' A' ' 74' ' ' THR . 95.1 m -117.69 147.04 40.12 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.353 -0.842 . . . . 0.0 109.985 179.651 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.41 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 39.6 Cg_exo -57.14 146.43 81.33 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.015 1.534 . . . . 0.0 110.471 179.118 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.924 HG22 HD12 ' A' ' 71' ' ' LEU . 4.8 p -60.77 173.94 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.26 -0.9 . . . . 0.0 109.976 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.924 HD12 HG22 ' A' ' 70' ' ' VAL . 2.3 mp 59.61 20.11 8.69 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.335 -0.853 . . . . 0.0 109.642 -175.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.41 ' HB3' ' O ' ' A' ' 69' ' ' PRO . 1.0 OUTLIER -139.21 87.3 13.91 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.5 -0.75 . . . . 0.0 109.668 179.001 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.431 ' HG3' ' HD3' ' A' ' 87' ' ' LYS . 52.9 Cg_exo -45.3 115.22 0.87 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.052 1.554 . . . . 0.0 110.337 -176.563 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.481 ' OG1' ' HB2' ' A' ' 68' ' ' CYS . 54.9 m -108.61 122.91 48.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.255 -0.903 . . . . 0.0 110.405 -176.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 150.91 179.86 27.01 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 1.08 ' HG3' HD11 ' A' ' 21' ' ' LEU . 42.6 Cg_endo -72.15 170.14 68.28 Favored 'Cis proline' 0 C--N 1.315 -1.219 0 C-N-CA 121.674 -2.219 . . . . 0.0 110.588 -0.353 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.2 mt -139.17 160.55 39.54 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.355 -0.841 . . . . 0.0 110.284 -175.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -84.98 124.48 31.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.238 -0.914 . . . . 0.0 110.239 -179.182 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.816 HG21 ' CG ' ' A' ' 84' ' ' HIS . 8.8 t -137.63 158.17 44.94 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.105 -0.997 . . . . 0.0 109.895 175.36 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -59.99 -23.78 63.91 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -0.903 . . . . 0.0 110.225 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -78.88 -10.08 59.69 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.226 -0.921 . . . . 0.0 110.583 -178.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.572 ' O ' HG22 ' A' ' 79' ' ' THR . . . 130.45 -137.36 9.44 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 -175.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.4 ' O ' HD23 ' A' ' 10' ' ' LEU . 0.2 OUTLIER -95.37 136.9 35.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.164 -1.198 . . . . 0.0 110.015 175.211 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.816 ' CG ' HG21 ' A' ' 79' ' ' THR . 3.9 m170 -127.99 114.79 17.56 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.472 -0.767 . . . . 0.0 110.835 -177.397 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.549 ' CG2' ' HB ' ' A' ' 9' ' ' ILE . 3.6 tt -111.12 130.96 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.09 -1.007 . . . . 0.0 109.515 171.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.574 HG23 ' CE1' ' A' ' 8' ' ' HIS . 78.4 mt -135.37 132.12 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.026 -1.046 . . . . 0.0 111.142 -169.25 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.593 ' HE3' ' CG ' ' A' ' 30' ' ' PHE . 23.1 mttt -99.27 140.45 33.43 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.876 -1.14 . . . . 0.0 109.985 171.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.777 HG12 HG23 ' A' ' 70' ' ' VAL . 37.5 t -109.95 129.97 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.367 -0.833 . . . . 0.0 110.078 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.555 ' HB2' ' HB3' ' A' ' 5' ' ' ALA . 88.1 mt -139.09 -164.59 1.69 Allowed 'General case' 0 C--N 1.307 -1.271 0 O-C-N 121.19 -0.944 . . . . 0.0 109.557 -178.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.495 ' CD1' ' CB ' ' A' ' 5' ' ' ALA . 44.2 m-85 34.68 -85.98 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.122 0 O-C-N 122.078 -0.389 . . . . 0.0 111.71 -178.509 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.554 ' N ' ' O ' ' A' ' 89' ' ' LEU . 36.1 ttp180 . . . . . 0 N--CA 1.498 1.945 0 O-C-N 120.873 -1.142 . . . . 0.0 110.893 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.751 HG22 ' HG2' ' A' ' 51' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.365 0.602 . . . . 0.0 110.81 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.447 ' C ' ' HG3' ' A' ' 51' ' ' GLU . . . -119.88 146.59 45.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.43 -0.794 . . . . 0.0 109.515 174.29 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.571 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -92.57 125.69 37.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.039 -1.038 . . . . 0.0 109.461 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.542 ' HB3' ' CE2' ' A' ' 52' ' ' PHE . . . -136.33 135.1 38.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.833 -1.167 . . . . 0.0 111.556 -170.477 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.731 HD12 ' HD2' ' A' ' 87' ' ' LYS . 72.2 mt -109.11 143.89 37.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.207 -0.933 . . . . 0.0 108.877 168.356 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.702 ' HE2' ' HE1' ' A' ' 61' ' ' PHE . 45.7 m170 -130.89 129.5 42.33 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.723 -1.236 . . . . 0.0 111.365 -176.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.732 ' HB ' HG22 ' A' ' 85' ' ' ILE . 59.1 mt -109.99 129.96 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.106 -0.996 . . . . 0.0 109.229 168.434 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.745 HD13 ' C ' ' A' ' 10' ' ' LEU . 1.8 tm? -107.55 120.04 41.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.144 -0.972 . . . . 0.0 110.135 178.456 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 1.096 HG13 HD22 ' A' ' 16' ' ' LEU . 2.6 t -99.66 132.46 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.526 -0.734 . . . . 0.0 110.001 -179.449 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -64.28 -39.98 95.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.395 -0.815 . . . . 0.0 110.673 -178.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -136.36 153.93 50.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.067 -1.021 . . . . 0.0 110.707 -176.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.444 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 86.1 tt0 -59.75 -40.09 86.98 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.397 -0.814 . . . . 0.0 110.462 -177.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 29.9 tptt -51.57 -45.54 63.14 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.275 -0.89 . . . . 0.0 110.09 -177.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 1.096 HD22 HG13 ' A' ' 11' ' ' VAL . 7.4 tt -67.8 -39.92 83.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.111 -0.993 . . . . 0.0 109.409 175.246 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.002 ' O ' HD12 ' A' ' 21' ' ' LEU . . . -57.12 -42.7 81.34 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.392 -0.818 . . . . 0.0 109.71 176.329 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.425 HD12 ' HG2' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -60.09 -46.94 87.91 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.231 -0.918 . . . . 0.0 109.634 173.239 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -60.1 -40.02 88.21 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.422 -0.799 . . . . 0.0 110.184 177.445 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 1.018 HD13 ' CD2' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -63.15 -52.31 62.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.105 -0.997 . . . . 0.0 109.469 178.716 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 1.002 HD12 ' O ' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -56.55 -46.67 80.56 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.326 -0.859 . . . . 0.0 109.766 -177.689 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -60.04 -39.97 87.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.117 -0.989 . . . . 0.0 109.547 171.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.493 ' HB3' ' O ' ' A' ' 20' ' ' LEU . 61.5 tt0 -60.51 -39.97 89.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.435 -0.79 . . . . 0.0 111.047 -177.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.542 ' O ' ' CA ' ' A' ' 28' ' ' ALA . 18.9 mm -61.26 -39.99 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.796 -1.19 . . . . 0.0 109.724 -176.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -65.17 -56.48 12.65 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.676 -1.265 . . . . 0.0 110.14 177.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -60.11 -50.81 72.23 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.25 -0.906 . . . . 0.0 110.83 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 28' ' ' ALA . . . -105.64 -19.64 10.21 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -168.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.542 ' CA ' ' O ' ' A' ' 24' ' ' ILE . . . 34.18 94.48 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.821 -0.811 . . . . 0.0 111.474 -178.705 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -177.3 76.41 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.61 -0.681 . . . . 0.0 109.41 -178.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.539 ' HB3' ' CE ' ' A' ' 87' ' ' LYS . 2.5 m-85 -60.06 -43.2 95.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.876 . . . . 0.0 110.807 -173.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.4 -47.5 90.38 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -178.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' A' ' 35' ' ' LYS . 83.6 tttt -63.72 -40.03 95.76 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.19 -1.182 . . . . 0.0 110.23 -178.088 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.018 ' CD2' HD13 ' A' ' 20' ' ' LEU . 40.3 tp -64.1 -40.04 95.35 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.866 -1.146 . . . . 0.0 110.162 178.355 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.542 ' HB2' HG12 ' A' ' 9' ' ' ILE . . . -59.24 -52.83 64.01 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.162 -0.961 . . . . 0.0 110.366 -177.478 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 55.8 pttt -62.84 -41.21 99.25 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.817 -1.177 . . . . 0.0 110.425 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.467 ' N ' ' CG ' ' A' ' 35' ' ' LYS . 88.3 tttt -62.48 -48.32 80.09 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.197 -0.94 . . . . 0.0 111.446 -174.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.413 ' O ' HG12 ' A' ' 39' ' ' ILE . 41.1 m170 -102.89 -17.64 15.42 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.814 -1.179 . . . . 0.0 111.513 -169.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.527 ' O ' ' CG1' ' A' ' 39' ' ' ILE . 33.7 t -59.96 -44.2 94.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.813 -1.179 . . . . 0.0 110.651 -174.164 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.527 ' CG1' ' O ' ' A' ' 38' ' ' SER . 45.2 pt 36.69 30.05 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.696 -0.628 . . . . 0.0 110.636 -178.467 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.499 ' N ' ' O ' ' A' ' 38' ' ' SER . 43.2 t -125.46 144.57 48.26 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.423 -0.798 . . . . 0.0 109.853 -176.374 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.473 ' HD2' ' SG ' ' A' ' 40' ' ' CYS . 51.6 Cg_exo -49.31 -21.44 4.64 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 123.673 1.354 . . . . 0.0 110.491 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.51 ' O ' ' CA ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -101.27 16.98 23.77 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.212 -0.93 . . . . 0.0 110.184 176.801 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.411 ' CA ' ' OG ' ' A' ' 38' ' ' SER . . . -79.61 -56.52 3.34 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 173.294 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -60.04 -39.93 87.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.349 -1.089 . . . . 0.0 110.392 176.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -97.15 -39.79 9.12 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.069 -1.02 . . . . 0.0 110.619 -176.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.51 ' CA ' ' O ' ' A' ' 42' ' ' SER . . . -76.79 -18.27 79.05 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.74 0.09 62.37 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.276 -1.529 . . . . 0.0 109.276 173.258 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.528 ' HA ' ' CD2' ' A' ' 7' ' ' LEU . 33.9 t0 -172.51 73.13 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.299 -1.118 . . . . 0.0 108.966 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.452 ' HG ' ' HA2' ' A' ' 46' ' ' GLY . 5.5 mt -80.09 -13.26 59.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.419 -0.801 . . . . 0.0 109.899 -175.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.08 -148.04 20.61 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -178.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.751 ' HG2' HG22 ' A' ' 3' ' ' THR . 80.5 tt0 -110.92 131.8 54.75 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.336 -1.096 . . . . 0.0 110.173 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.542 ' CE2' ' HB3' ' A' ' 6' ' ' ALA . 3.8 p90 -139.52 158.17 44.59 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.389 -0.819 . . . . 0.0 110.266 -178.496 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 30.7 ptt-85 . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.354 -0.841 . . . . 0.0 110.043 -178.565 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.497 ' O ' ' N ' ' A' ' 62' ' ' ASP . 10.3 Cg_endo . . . . . 0 N--CA 1.487 1.101 0 N-CA-C 110.389 -0.658 . . . . 0.0 110.389 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.643 ' HB1' HD23 ' A' ' 77' ' ' LEU . . . -38.35 -33.1 0.09 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.711 -0.618 . . . . 0.0 110.498 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.702 ' HE1' ' HE2' ' A' ' 8' ' ' HIS . 68.3 t80 -60.05 -41.13 91.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.296 -0.878 . . . . 0.0 110.638 177.534 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' A' ' 59' ' ' PRO . 52.9 t0 -60.09 -39.94 87.87 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.26 -0.9 . . . . 0.0 110.104 -178.009 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.43 ' O ' ' HB2' ' A' ' 67' ' ' SER . 79.8 mttt -59.62 -40.06 86.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.874 . . . . 0.0 110.79 -176.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.843 HG21 HD12 ' A' ' 86' ' ' ILE . 0.9 OUTLIER -85.22 -48.0 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 120.996 -1.065 . . . . 0.0 111.125 -174.515 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.58 HG12 ' O ' ' A' ' 61' ' ' PHE . 7.5 p -54.6 -26.31 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.674 -1.266 . . . . 0.0 109.554 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -96.27 12.41 31.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.252 -0.905 . . . . 0.0 109.764 174.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.48 ' HB3' ' O ' ' A' ' 64' ' ' VAL . 44.4 t -101.27 -41.0 6.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.418 -0.801 . . . . 0.0 110.605 -177.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.514 ' CB ' ' OE1' ' A' ' 72' ' ' GLU . 59.7 m -126.23 154.22 74.49 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.15 -0.969 . . . . 0.0 110.727 -175.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.569 ' O ' ' O ' ' A' ' 70' ' ' VAL . 9.2 Cg_exo -68.05 67.1 0.96 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 124.036 1.545 . . . . 0.0 110.498 177.552 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.017 HG23 HG12 ' A' ' 88' ' ' VAL . 13.4 p 27.68 -169.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 C-N-CA 123.119 0.568 . . . . 0.0 111.891 176.051 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.003 HD12 HG13 ' A' ' 70' ' ' VAL . 4.7 mp 38.65 30.39 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 O-C-N 119.803 -1.811 . . . . 0.0 111.132 -168.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.514 ' OE1' ' CB ' ' A' ' 68' ' ' CYS . 2.0 tm-20 -147.64 94.4 4.42 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.19 -0.944 . . . . 0.0 110.241 -178.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -48.32 107.75 0.15 Allowed 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.908 1.478 . . . . 0.0 110.012 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 98.5 m -96.31 131.78 42.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.914 . . . . 0.0 110.388 -177.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 140.83 -163.2 26.62 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.827 ' CD ' HD11 ' A' ' 21' ' ' LEU . 44.0 Cg_endo -71.08 141.79 70.62 Favored 'Cis proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.872 -2.137 . . . . 0.0 110.647 1.109 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.643 HD23 ' HB1' ' A' ' 60' ' ' ALA . 42.9 tp -97.04 156.02 16.54 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.343 -0.848 . . . . 0.0 110.694 -177.088 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.449 ' N ' ' HG ' ' A' ' 77' ' ' LEU . 18.1 t-80 -75.38 127.09 32.35 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.154 -0.966 . . . . 0.0 110.349 178.147 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.7 HG22 ' O ' ' A' ' 82' ' ' GLY . 13.5 t -141.22 160.03 40.96 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.221 -0.925 . . . . 0.0 110.255 178.141 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -59.67 -26.61 65.7 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.186 -0.946 . . . . 0.0 110.521 -177.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.425 ' O ' HD21 ' A' ' 10' ' ' LEU . 97.0 m-85 -97.0 17.48 16.86 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.145 -0.972 . . . . 0.0 110.731 -176.29 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.7 ' O ' HG22 ' A' ' 79' ' ' THR . . . 121.09 -129.95 8.01 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 -178.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.528 ' HB3' ' HB2' ' A' ' 76' ' ' PRO . 84.5 m-85 -121.97 129.93 52.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.129 -1.218 . . . . 0.0 110.077 178.628 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.421 ' ND1' HD23 ' A' ' 10' ' ' LEU . 5.7 m-70 -101.29 125.28 47.91 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.188 -0.945 . . . . 0.0 110.726 176.53 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.732 HG22 ' HB ' ' A' ' 9' ' ' ILE . 3.8 tt -109.33 128.61 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.709 -1.245 . . . . 0.0 109.078 167.065 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.843 HD12 HG21 ' A' ' 64' ' ' VAL . 96.7 mt -116.22 123.63 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.018 -1.051 . . . . 0.0 111.28 -167.376 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.731 ' HD2' HD12 ' A' ' 7' ' ' LEU . 27.6 mttt -83.77 130.05 34.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.23 -0.919 . . . . 0.0 109.036 170.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 1.017 HG12 HG23 ' A' ' 70' ' ' VAL . 29.2 t -109.33 129.44 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.163 -0.961 . . . . 0.0 109.973 -179.089 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.571 ' HB2' ' HB3' ' A' ' 5' ' ' ALA . 91.6 mt -134.0 117.31 16.54 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.296 -0.878 . . . . 0.0 109.838 -178.415 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.524 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 50.8 m-85 70.75 -2.04 2.4 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.498 -0.751 . . . . 0.0 111.556 177.148 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.524 ' HG2' ' O ' ' A' ' 90' ' ' TYR . 22.3 ptt180 . . . . . 0 N--CA 1.496 1.837 0 O-C-N 121.249 -0.907 . . . . 0.0 110.264 174.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.113 0.482 . . . . 0.0 110.09 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 54' ' ' GLN . 93.5 mttt -69.99 -60.01 2.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.104 -0.997 . . . . 0.0 110.534 -177.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 27.3 m -105.22 139.01 40.51 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.409 -0.807 . . . . 0.0 110.722 -173.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.488 ' O ' ' HA ' ' A' ' 51' ' ' GLU . . . -143.26 159.02 43.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.075 -1.015 . . . . 0.0 110.039 177.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.506 ' HA ' ' O ' ' A' ' 50' ' ' GLY . . . -94.62 123.71 38.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.268 -0.895 . . . . 0.0 109.145 174.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.728 ' HB1' ' NE2' ' A' ' 8' ' ' HIS . . . -137.24 134.99 36.81 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.709 -1.244 . . . . 0.0 111.884 -169.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.524 ' CD2' ' HA ' ' A' ' 48' ' ' ASP . 33.8 mt -109.32 137.07 47.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.39 -0.819 . . . . 0.0 109.371 170.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.728 ' NE2' ' HB1' ' A' ' 6' ' ' ALA . 22.2 m170 -130.87 132.38 45.12 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.932 -1.105 . . . . 0.0 111.0 -176.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.683 ' HB ' HG22 ' A' ' 85' ' ' ILE . 84.4 mt -118.64 129.89 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.947 -1.095 . . . . 0.0 109.567 169.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.769 HD13 ' C ' ' A' ' 10' ' ' LEU . 2.7 tm? -110.0 120.41 42.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.361 -0.837 . . . . 0.0 109.896 178.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.758 HG13 HD22 ' A' ' 16' ' ' LEU . 3.1 t -103.94 128.97 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.179 -0.951 . . . . 0.0 110.053 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -68.5 -39.96 81.05 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.464 -0.773 . . . . 0.0 110.96 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -119.79 140.54 50.59 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.018 -1.051 . . . . 0.0 110.595 -175.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.458 ' HG2' ' CZ ' ' A' ' 83' ' ' TYR . 93.3 mt-10 -59.97 -39.99 87.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.527 -0.733 . . . . 0.0 110.939 -175.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.1 -41.86 68.75 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.024 -1.048 . . . . 0.0 110.343 -175.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.758 HD22 HG13 ' A' ' 11' ' ' VAL . 8.1 tt -67.84 -38.56 83.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.124 -0.985 . . . . 0.0 109.648 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.863 ' O ' HD12 ' A' ' 21' ' ' LEU . . . -58.66 -45.82 88.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.294 -0.879 . . . . 0.0 110.314 178.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.5 tp -60.06 -46.25 90.16 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.121 -0.987 . . . . 0.0 109.766 175.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.421 ' O ' ' HB2' ' A' ' 23' ' ' GLN . 47.9 t0 -59.97 -40.0 87.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.332 -0.855 . . . . 0.0 109.929 178.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.631 HD23 ' N ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -62.37 -53.54 53.45 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.357 -0.839 . . . . 0.0 109.471 177.675 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.892 HD11 ' HG3' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -54.57 -48.55 71.93 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.475 -0.766 . . . . 0.0 109.557 -176.717 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -65.1 -40.51 94.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.435 -0.791 . . . . 0.0 109.987 174.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.478 ' NE2' HD21 ' A' ' 33' ' ' LEU . 62.7 tt0 -61.54 -40.03 93.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.44 -0.787 . . . . 0.0 110.297 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.548 HG12 ' CD1' ' A' ' 33' ' ' LEU . 92.4 mt -67.07 -39.99 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.278 -0.889 . . . . 0.0 110.111 178.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -64.53 -54.54 30.65 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.948 -1.095 . . . . 0.0 110.226 176.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -60.01 -43.44 95.23 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.216 -0.927 . . . . 0.0 110.967 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.735 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -105.55 -59.43 0.64 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -177.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.735 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 83.92 104.65 0.05 Allowed 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 121.554 0.692 . . . . 0.0 110.053 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.427 ' CG ' ' O ' ' A' ' 28' ' ' ALA . 3.8 m-20 -175.08 70.48 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.582 -0.698 . . . . 0.0 109.501 -176.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -60.01 -44.24 94.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.925 . . . . 0.0 110.781 -174.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.59 -54.03 31.5 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 119.813 -1.184 . . . . 0.0 110.272 -177.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -66.7 -40.08 88.31 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.991 -1.299 . . . . 0.0 110.861 -175.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.548 ' CD1' HG12 ' A' ' 24' ' ' ILE . 64.5 mt -61.59 -42.94 99.58 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.91 -1.119 . . . . 0.0 110.266 178.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.535 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -59.98 -49.25 78.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 0.0 110.381 178.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -59.98 -47.19 86.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.103 -0.998 . . . . 0.0 110.653 -174.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -67.38 -50.08 61.22 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.971 -1.08 . . . . 0.0 110.998 -177.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 55.3 m170 -69.98 -39.92 75.64 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.047 -1.033 . . . . 0.0 111.103 -173.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.638 ' O ' HG22 ' A' ' 39' ' ' ILE . 22.9 t -60.08 -42.06 93.78 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.001 -1.062 . . . . 0.0 110.338 -174.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.638 HG22 ' O ' ' A' ' 38' ' ' SER . 21.3 tt 38.02 31.57 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.624 -0.673 . . . . 0.0 110.877 177.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.43 ' N ' ' O ' ' A' ' 38' ' ' SER . 15.5 p -120.25 166.15 16.07 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.253 -0.904 . . . . 0.0 110.206 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -53.05 -23.12 20.85 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.968 1.51 . . . . 0.0 110.273 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -107.58 21.27 17.71 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.276 -0.89 . . . . 0.0 109.836 177.006 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.4 -51.37 27.07 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 174.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 48.9 mttp -63.03 -40.03 96.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.442 -1.034 . . . . 0.0 110.849 176.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.652 ' HE ' HD23 ' A' ' 49' ' ' LEU . 11.9 tpt180 -102.59 -44.6 5.29 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.928 -1.108 . . . . 0.0 110.642 -172.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -63.75 -33.38 87.08 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.224 -1.551 . . . . 0.0 109.224 175.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.482 ' O ' HD22 ' A' ' 7' ' ' LEU . . . -74.36 0.11 55.72 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 175.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.524 ' HA ' ' CD2' ' A' ' 7' ' ' LEU . 49.7 t0 -170.82 71.96 0.05 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.24 -1.153 . . . . 0.0 108.916 178.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.652 HD23 ' HE ' ' A' ' 45' ' ' ARG . 11.0 mt -76.15 -6.94 53.54 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.622 -0.674 . . . . 0.0 109.814 -177.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 5' ' ' ALA . . . 70.39 -139.06 29.97 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -174.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.491 ' HG3' ' HB2' ' A' ' 5' ' ' ALA . 4.8 mt-10 -101.59 132.1 47.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.397 -1.061 . . . . 0.0 110.643 178.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.717 ' CE2' ' HB3' ' A' ' 6' ' ' ALA . 5.3 p90 -145.38 160.64 41.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.678 -0.639 . . . . 0.0 109.333 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.517 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 95.0 mtt180 -66.8 156.57 35.2 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.039 -1.038 . . . . 0.0 110.526 -175.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.534 ' N ' ' O ' ' A' ' 2' ' ' LYS . 14.3 pt20 -60.72 -11.1 6.46 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.008 -1.058 . . . . 0.0 110.883 -176.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -124.07 63.21 0.56 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -177.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.517 ' HG2' ' O ' ' A' ' 53' ' ' ARG . 3.5 mm-40 -113.77 -60.1 1.93 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.025 -1.28 . . . . 0.0 109.257 177.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 37.0 ttm -103.61 -77.75 0.56 Allowed 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.529 -0.869 . . . . 0.0 111.206 -167.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.504 HG13 ' O ' ' A' ' 58' ' ' VAL . 14.4 p -122.0 130.61 24.65 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.034 -1.041 . . . . 0.0 110.304 -176.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.429 ' O ' ' C ' ' A' ' 60' ' ' ALA . 9.5 Cg_endo -57.17 -49.5 13.91 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.882 1.464 . . . . 0.0 110.407 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 59' ' ' PRO . . . -41.23 -35.29 0.59 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.455 -0.778 . . . . 0.0 110.212 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.585 ' CE1' ' NE2' ' A' ' 8' ' ' HIS . 90.4 t80 -60.08 -41.34 92.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.288 -0.883 . . . . 0.0 110.72 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.466 ' O ' HG12 ' A' ' 65' ' ' VAL . 53.0 t0 -60.01 -41.54 92.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.023 -1.048 . . . . 0.0 109.96 -178.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 67' ' ' SER . 62.7 tttm -55.09 -58.56 7.15 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.338 -0.851 . . . . 0.0 110.777 178.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.616 HG11 ' CD1' ' A' ' 86' ' ' ILE . 2.9 p -70.0 -42.5 79.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.04 -1.038 . . . . 0.0 111.319 -170.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.466 HG12 ' O ' ' A' ' 62' ' ' ASP . 3.6 p -57.79 -28.26 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.388 -1.445 . . . . 0.0 109.584 174.064 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -92.33 -10.76 37.12 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.049 -1.032 . . . . 0.0 109.873 173.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.534 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 4.8 t -93.43 -66.21 0.94 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.409 -0.807 . . . . 0.0 109.715 175.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.534 ' SG ' HG22 ' A' ' 64' ' ' VAL . 24.1 p -76.01 155.97 84.38 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.37 -0.831 . . . . 0.0 110.245 177.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.478 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 53.7 Cg_endo -79.27 148.11 20.99 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.993 1.523 . . . . 0.0 110.223 175.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.75 HG13 HD12 ' A' ' 71' ' ' LEU . 6.3 p -54.63 168.4 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.146 -0.971 . . . . 0.0 109.887 177.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.75 HD12 HG13 ' A' ' 70' ' ' VAL . 1.3 mp 58.24 22.25 9.03 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.34 -0.85 . . . . 0.0 110.188 -176.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.478 ' HB3' ' O ' ' A' ' 69' ' ' PRO . 1.4 tp10 -130.77 94.3 29.16 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.254 -0.904 . . . . 0.0 110.251 -179.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -51.07 109.6 0.33 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.927 1.488 . . . . 0.0 109.809 177.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 94.3 m -115.65 130.02 56.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.208 -0.932 . . . . 0.0 110.069 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 140.77 -171.53 24.03 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -176.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.892 ' HG3' HD11 ' A' ' 21' ' ' LEU . 41.5 Cg_endo -69.88 138.66 50.6 Favored 'Cis proline' 0 C--N 1.312 -1.373 0 C-N-CA 121.749 -2.188 . . . . 0.0 110.89 -0.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.771 HD12 HD12 ' A' ' 86' ' ' ILE . 95.2 mt -92.94 172.89 8.04 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.52 -0.738 . . . . 0.0 110.484 -176.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -99.18 126.58 44.99 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.064 -1.023 . . . . 0.0 110.67 177.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.899 HG21 ' CG ' ' A' ' 84' ' ' HIS . 8.8 t -146.29 165.1 30.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.272 -0.893 . . . . 0.0 109.817 175.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -59.65 -40.0 86.26 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.104 -0.998 . . . . 0.0 110.769 -175.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -66.38 -15.37 63.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.135 -0.978 . . . . 0.0 110.331 -177.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.426 ' CA ' HD21 ' A' ' 10' ' ' LEU . . . 141.17 -135.69 7.05 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.036 -1.625 . . . . 0.0 109.036 -178.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.473 ' O ' ' HA ' ' A' ' 10' ' ' LEU . 4.3 m-85 -97.1 125.12 41.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.135 -1.215 . . . . 0.0 110.131 176.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.899 ' CG ' HG21 ' A' ' 79' ' ' THR . 1.0 OUTLIER -102.73 115.97 31.65 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.607 -0.683 . . . . 0.0 110.345 177.484 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.683 HG22 ' HB ' ' A' ' 9' ' ' ILE . 4.4 tt -104.66 128.38 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.512 -1.367 . . . . 0.0 109.392 168.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.771 HD12 HD12 ' A' ' 77' ' ' LEU . 53.0 mt -118.96 125.72 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.369 -0.832 . . . . 0.0 111.051 -172.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.518 ' HB3' ' HB2' ' A' ' 7' ' ' LEU . 18.8 tttm -99.97 125.8 46.04 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.334 -0.854 . . . . 0.0 109.215 171.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.596 ' O ' HD23 ' A' ' 89' ' ' LEU . 21.3 t -101.43 136.49 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.177 -0.952 . . . . 0.0 110.121 -175.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.596 HD23 ' O ' ' A' ' 88' ' ' VAL . 88.9 mt -140.04 147.04 39.76 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.241 -0.912 . . . . 0.0 109.227 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.494 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 98.0 m-85 62.66 -55.35 0.16 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.598 -0.689 . . . . 0.0 111.732 174.12 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.504 ' N ' ' O ' ' A' ' 89' ' ' LEU . 68.5 ttp85 60.06 20.03 9.21 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.93 -1.106 . . . . 0.0 110.859 -178.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.431 ' OXT' ' OE2' ' A' ' 51' ' ' GLU . 10.1 t-20 . . . . . 0 N--CA 1.491 1.599 0 O-C-N 120.86 -1.15 . . . . 0.0 110.122 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.376 0.608 . . . . 0.0 110.035 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -67.62 -39.15 84.72 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.267 -0.896 . . . . 0.0 110.333 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.528 HG22 ' HD3' ' A' ' 53' ' ' ARG . 81.8 p -127.82 155.15 44.55 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.245 -0.91 . . . . 0.0 110.601 -176.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.614 ' HB2' ' HD2' ' A' ' 91' ' ' ARG . . . -140.52 150.53 43.83 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.422 -0.799 . . . . 0.0 110.265 -178.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.401 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -95.66 137.84 34.16 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.122 -0.986 . . . . 0.0 109.71 177.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.642 ' HB1' ' NE2' ' A' ' 8' ' ' HIS . . . -148.54 130.88 15.62 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.92 -1.112 . . . . 0.0 111.517 -173.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.564 HD12 ' HD2' ' A' ' 87' ' ' LYS . 78.1 mt -105.21 147.54 27.91 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.202 -0.936 . . . . 0.0 109.144 169.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.642 ' NE2' ' HB1' ' A' ' 6' ' ' ALA . 35.1 m-70 -138.34 125.26 21.19 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.749 -1.219 . . . . 0.0 111.303 -177.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.693 ' HB ' HG22 ' A' ' 85' ' ' ILE . 81.5 mt -110.04 129.97 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.016 -1.052 . . . . 0.0 109.857 169.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.768 ' O ' HD13 ' A' ' 10' ' ' LEU . 1.0 OUTLIER -110.38 119.97 40.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -0.894 . . . . 0.0 110.365 178.435 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.804 HG13 HD22 ' A' ' 16' ' ' LEU . 2.9 t -104.03 135.29 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.421 -0.8 . . . . 0.0 109.954 177.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -67.51 -37.12 82.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.273 -0.892 . . . . 0.0 110.769 -176.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.412 ' HG3' ' HB2' ' A' ' 16' ' ' LEU . 18.1 pt-20 -129.75 149.73 51.37 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.013 -1.054 . . . . 0.0 110.871 -175.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.468 ' HB2' ' CZ ' ' A' ' 83' ' ' TYR . 89.0 tt0 -59.97 -42.8 94.94 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.384 -0.822 . . . . 0.0 111.049 -178.026 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -55.08 -42.35 72.7 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.022 -1.049 . . . . 0.0 110.293 -177.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.804 HD22 HG13 ' A' ' 11' ' ' VAL . 3.6 tt -67.97 -39.83 83.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.211 -0.931 . . . . 0.0 109.341 177.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.513 ' N ' HG11 ' A' ' 11' ' ' VAL . . . -57.99 -46.8 84.62 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.32 -0.863 . . . . 0.0 109.737 175.12 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.458 ' CD1' ' HG2' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -59.99 -42.62 94.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.153 -0.967 . . . . 0.0 109.6 173.925 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -60.44 -45.44 93.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.414 -0.803 . . . . 0.0 109.904 175.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.417 ' CD1' ' HB3' ' A' ' 33' ' ' LEU . 7.9 tp -64.01 -44.23 93.25 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.406 -0.809 . . . . 0.0 109.972 176.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.892 HD21 ' HD3' ' A' ' 76' ' ' PRO . 3.6 mp -58.95 -46.15 88.74 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.547 -0.721 . . . . 0.0 110.008 -175.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -62.71 -40.05 95.95 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.627 -0.671 . . . . 0.0 110.109 177.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.616 ' HG2' HD21 ' A' ' 33' ' ' LEU . 72.9 tp60 -60.05 -39.9 87.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 0.0 109.939 -178.026 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.518 HG13 HD13 ' A' ' 33' ' ' LEU . 96.7 mt -65.06 -46.84 90.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.274 -0.891 . . . . 0.0 110.122 177.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 64.3 mttt -60.78 -44.17 97.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.136 -0.978 . . . . 0.0 109.557 175.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -59.12 -64.58 0.89 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.348 -0.845 . . . . 0.0 110.343 176.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.742 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -105.24 -40.02 2.16 Favored Glycine 0 N--CA 1.483 1.79 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 -171.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.742 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 77.46 105.49 0.07 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.716 -0.873 . . . . 0.0 109.942 -177.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -175.37 73.17 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.346 -0.846 . . . . 0.0 109.867 -177.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.579 ' CE1' HG13 ' A' ' 9' ' ' ILE . 23.6 t80 -59.95 -42.76 94.75 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.56 -0.712 . . . . 0.0 110.511 -175.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.82 -49.99 60.63 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -176.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.449 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 74.1 mttt -65.44 -39.95 92.69 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.973 -1.31 . . . . 0.0 110.049 -177.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.616 HD21 ' HG2' ' A' ' 23' ' ' GLN . 84.9 mt -64.95 -39.94 94.26 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.206 -0.934 . . . . 0.0 110.027 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.602 ' HB2' HG12 ' A' ' 9' ' ' ILE . . . -57.4 -50.2 73.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.218 -0.926 . . . . 0.0 110.034 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.473 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 21.4 mmtp -59.98 -43.4 95.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.276 -0.89 . . . . 0.0 110.745 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 32' ' ' LYS . 99.7 mttt -70.0 -43.16 71.96 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.09 -1.006 . . . . 0.0 111.424 -172.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.579 ' ND1' HD21 ' A' ' 16' ' ' LEU . 81.7 m-70 -93.33 -36.0 12.76 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.97 -1.081 . . . . 0.0 110.912 -174.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.647 ' O ' HG22 ' A' ' 39' ' ' ILE . 31.6 t -60.03 -52.95 63.19 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.088 -1.007 . . . . 0.0 110.606 -174.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.647 HG22 ' O ' ' A' ' 38' ' ' SER . 13.6 tt 38.46 39.28 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.589 -0.695 . . . . 0.0 110.711 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.498 ' SG ' ' N ' ' A' ' 43' ' ' GLY . 12.8 p -127.88 163.61 42.23 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.214 -0.929 . . . . 0.0 109.841 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.46 ' HD2' ' HB2' ' A' ' 40' ' ' CYS . 5.7 Cg_endo -52.34 -27.87 32.68 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.722 1.38 . . . . 0.0 110.188 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.526 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.7 OUTLIER -101.03 14.59 31.47 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.893 . . . . 0.0 109.767 174.675 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.498 ' N ' ' SG ' ' A' ' 40' ' ' CYS . . . -77.08 -55.0 4.55 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 176.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.473 ' HA ' ' HE2' ' A' ' 35' ' ' LYS . 28.5 ttpt -60.03 -40.01 87.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.481 -1.011 . . . . 0.0 110.226 177.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.456 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 3.3 tpp180 -98.31 -44.27 6.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.097 -1.002 . . . . 0.0 110.615 -176.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -60.66 -33.74 83.51 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.38 -3.04 37.22 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 176.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.468 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 38.5 p-10 -167.93 62.45 0.07 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.267 -1.137 . . . . 0.0 109.279 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 6.2 mt -70.03 -29.09 66.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.637 -0.664 . . . . 0.0 110.317 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.81 -119.32 6.2 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -177.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.46 ' HG3' ' C ' ' A' ' 4' ' ' ALA . 82.5 tt0 -133.02 130.03 38.91 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.209 -1.171 . . . . 0.0 110.475 -175.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.469 ' CE2' ' HB3' ' A' ' 6' ' ' ALA . 1.5 p90 -127.05 -178.82 4.56 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.107 -0.995 . . . . 0.0 109.941 175.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.528 ' HD3' HG22 ' A' ' 3' ' ' THR . 26.6 mmt85 -63.6 -138.6 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.995 -1.066 . . . . 0.0 110.183 -173.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -61.43 -19.96 62.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.14 -0.975 . . . . 0.0 111.25 -174.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 140.76 89.6 0.16 Allowed Glycine 0 N--CA 1.496 2.652 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 -173.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.453 ' CD ' ' HB2' ' A' ' 53' ' ' ARG . 1.2 mt-30 -114.72 -43.69 3.12 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 119.951 -1.911 . . . . 0.0 110.745 -165.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.445 ' SD ' ' CD1' ' A' ' 49' ' ' LEU . 56.3 ttp -60.17 -40.06 88.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.153 -0.967 . . . . 0.0 110.948 -172.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.468 HG13 ' O ' ' A' ' 58' ' ' VAL . 12.3 p -145.65 133.12 10.27 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.074 -1.016 . . . . 0.0 110.423 -174.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.473 ' O ' ' N ' ' A' ' 62' ' ' ASP . 14.4 Cg_endo -61.03 -51.53 4.52 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.968 1.51 . . . . 0.0 110.559 178.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.618 ' O ' HG12 ' A' ' 64' ' ' VAL . . . -41.17 -34.32 0.45 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.357 -0.839 . . . . 0.0 110.218 -178.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.871 ' CZ ' HG21 ' A' ' 65' ' ' VAL . 63.8 t80 -60.05 -39.75 87.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.274 -0.892 . . . . 0.0 110.388 177.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.473 ' N ' ' O ' ' A' ' 59' ' ' PRO . 8.0 t70 -60.0 -48.88 79.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.135 -0.978 . . . . 0.0 110.187 -176.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 67' ' ' SER . 38.8 tptt -59.91 -50.03 75.37 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.149 -0.969 . . . . 0.0 110.206 178.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.837 HG11 HD12 ' A' ' 86' ' ' ILE . 7.5 p -77.43 -41.19 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.103 -0.998 . . . . 0.0 111.554 -174.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.871 HG21 ' CZ ' ' A' ' 61' ' ' PHE . 1.9 p -56.32 -27.15 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.357 -1.464 . . . . 0.0 109.305 174.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -94.61 -7.58 40.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.493 -0.754 . . . . 0.0 109.859 176.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.522 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 8.9 t -93.95 -62.04 1.42 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.502 -0.749 . . . . 0.0 109.925 178.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.491 ' HB3' ' OG1' ' A' ' 74' ' ' THR . 27.4 p -71.11 156.51 91.83 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.278 -0.889 . . . . 0.0 110.418 177.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.518 ' O ' ' N ' ' A' ' 71' ' ' LEU . 43.6 Cg_endo -82.22 79.22 3.16 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.998 1.525 . . . . 0.0 110.785 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.058 HG13 HD12 ' A' ' 71' ' ' LEU . 10.9 p 20.19 47.19 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.345 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 177.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.058 HD12 HG13 ' A' ' 70' ' ' VAL . 0.3 OUTLIER -167.17 -40.25 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.453 -0.779 . . . . 0.0 111.068 178.263 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.474 ' HG3' ' HD2' ' A' ' 69' ' ' PRO . 23.5 mm-40 -70.03 130.93 89.34 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 120.836 -1.165 . . . . 0.0 110.732 -173.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -67.48 95.49 0.39 Allowed 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.76 1.4 . . . . 0.0 109.271 172.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.726 HG21 HG23 ' A' ' 64' ' ' VAL . 21.1 m -94.42 139.77 30.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.154 -0.966 . . . . 0.0 110.451 -172.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.49 -170.36 22.36 Favored Glycine 0 N--CA 1.485 1.919 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.892 ' HD3' HD21 ' A' ' 21' ' ' LEU . 42.9 Cg_endo -74.66 124.17 9.71 Favored 'Cis proline' 0 C--N 1.311 -1.437 0 C-N-CA 121.933 -2.111 . . . . 0.0 110.28 0.062 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.461 ' HG ' ' N ' ' A' ' 78' ' ' HIS . 39.7 tp -94.01 160.3 14.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.278 -0.889 . . . . 0.0 110.123 -174.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.461 ' N ' ' HG ' ' A' ' 77' ' ' LEU . 47.1 t-80 -78.77 123.91 27.66 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.029 -1.044 . . . . 0.0 110.579 -178.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.939 HG21 ' CE1' ' A' ' 84' ' ' HIS . 7.0 t -133.75 164.79 26.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.265 -0.897 . . . . 0.0 109.505 172.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.04 -29.85 68.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.121 -0.987 . . . . 0.0 110.29 -177.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.429 ' H ' HG23 ' A' ' 79' ' ' THR . 98.6 m-85 -83.01 -4.91 58.83 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.143 -0.973 . . . . 0.0 110.745 -176.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.667 ' O ' HG22 ' A' ' 79' ' ' THR . . . 133.35 -139.29 10.81 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 -177.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.507 ' HB3' ' HB2' ' A' ' 76' ' ' PRO . 95.8 m-85 -101.98 121.47 42.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.043 -1.269 . . . . 0.0 110.264 178.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.939 ' CE1' HG21 ' A' ' 79' ' ' THR . 34.3 m170 -103.55 128.79 50.73 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.09 -1.006 . . . . 0.0 110.895 178.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.693 HG22 ' HB ' ' A' ' 9' ' ' ILE . 4.5 tt -113.18 119.98 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.963 -1.086 . . . . 0.0 108.947 167.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.837 HD12 HG11 ' A' ' 64' ' ' VAL . 85.5 mt -114.84 131.75 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.919 -1.113 . . . . 0.0 111.322 -168.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.564 ' HD2' HD12 ' A' ' 7' ' ' LEU . 26.5 ttmt -100.01 124.12 45.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.345 -0.847 . . . . 0.0 109.614 173.193 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.652 HG12 ' HA ' ' A' ' 70' ' ' VAL . 57.7 t -113.85 131.5 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.15 -0.969 . . . . 0.0 110.438 -172.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.509 ' O ' ' N ' ' A' ' 91' ' ' ARG . 57.2 mt -138.04 170.76 15.47 Favored 'General case' 0 C--N 1.309 -1.154 0 O-C-N 121.186 -0.946 . . . . 0.0 109.867 -177.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.449 ' O ' ' HB2' ' A' ' 91' ' ' ARG . 45.9 m-85 54.07 -76.93 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.752 -0.593 . . . . 0.0 112.069 171.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.64 ' CG ' HG23 ' A' ' 70' ' ' VAL . 19.1 mmm180 55.58 40.03 31.03 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.799 -1.188 . . . . 0.0 110.794 -172.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 91' ' ' ARG . 52.3 t30 . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.041 -1.037 . . . . 0.0 110.254 176.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.465 ' O ' ' O ' ' A' ' 92' ' ' ASN . . . . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.216 0.532 . . . . 0.0 110.432 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.462 ' O ' ' ND2' ' A' ' 92' ' ' ASN . 22.1 ttpt -59.99 -40.07 87.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.213 -0.929 . . . . 0.0 110.175 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.45 ' O ' ' O ' ' A' ' 91' ' ' ARG . 69.6 p -133.34 169.99 16.12 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.477 -0.764 . . . . 0.0 110.005 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' A' ' 51' ' ' GLU . . . -112.99 128.59 56.54 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -0.93 . . . . 0.0 109.952 178.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.594 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -91.49 126.25 36.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.41 -0.806 . . . . 0.0 109.213 176.016 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.814 ' HB1' ' NE2' ' A' ' 8' ' ' HIS . . . -135.23 126.09 27.46 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 118.915 -1.114 . . . . 0.0 111.486 -170.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.483 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 58.3 mt -102.68 137.91 40.28 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.144 -0.973 . . . . 0.0 109.132 169.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.814 ' NE2' ' HB1' ' A' ' 6' ' ' ALA . 38.1 m-70 -131.09 131.07 43.94 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.905 -1.122 . . . . 0.0 111.088 -176.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.736 ' HB ' HG22 ' A' ' 85' ' ' ILE . 71.3 mt -114.37 124.98 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.98 -1.075 . . . . 0.0 109.456 168.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.604 ' HG ' ' CD2' ' A' ' 84' ' ' HIS . 0.3 OUTLIER -97.67 101.27 12.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.323 -0.86 . . . . 0.0 109.505 179.496 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.661 HG11 ' HB2' ' A' ' 17' ' ' ALA . 3.6 t -67.63 -50.96 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.202 -0.936 . . . . 0.0 110.514 -175.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.539 ' CB ' ' O ' ' A' ' 11' ' ' VAL . 28.8 tttt 80.61 -17.26 0.59 Allowed 'General case' 0 N--CA 1.503 2.21 0 O-C-N 122.027 -0.42 . . . . 0.0 110.942 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -138.45 135.03 34.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.805 -1.185 . . . . 0.0 110.582 177.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -59.97 -45.23 93.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.458 -0.776 . . . . 0.0 110.285 177.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.7 mttm -59.83 -40.48 88.62 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.237 -0.914 . . . . 0.0 109.938 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.647 HD23 HG13 ' A' ' 11' ' ' VAL . 5.0 tt -67.87 -39.75 83.68 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.376 -0.827 . . . . 0.0 109.577 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.863 ' HB1' ' HG3' ' A' ' 76' ' ' PRO . . . -59.5 -43.93 93.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.233 -0.917 . . . . 0.0 109.775 175.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.589 ' HA ' HD12 ' A' ' 21' ' ' LEU . 0.1 OUTLIER -60.0 -40.87 90.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.352 -0.842 . . . . 0.0 110.056 175.495 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -60.83 -49.73 76.3 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.993 -1.067 . . . . 0.0 110.147 176.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 1.034 HD13 HD21 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -69.13 -50.34 48.83 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.135 -0.978 . . . . 0.0 110.915 -175.667 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 1.116 HD13 ' N ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -58.87 -29.63 67.13 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 120.742 -1.224 . . . . 0.0 108.961 -173.055 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 1.116 ' N ' HD13 ' A' ' 21' ' ' LEU . 87.9 tt0 -64.65 -39.93 94.54 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.36 -0.838 . . . . 0.0 109.931 170.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.415 ' HB3' ' O ' ' A' ' 20' ' ' LEU . 68.4 tp60 -60.05 -45.11 93.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.356 -0.84 . . . . 0.0 111.351 -173.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.557 HD11 ' CD2' ' A' ' 33' ' ' LEU . 27.6 mt -61.07 -47.96 91.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.041 -1.037 . . . . 0.0 110.592 -173.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.8 mttp -60.28 -49.01 79.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.943 -1.098 . . . . 0.0 110.256 177.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -60.01 -58.39 8.73 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.099 -1.001 . . . . 0.0 110.287 176.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.749 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -105.6 -46.76 1.18 Allowed Glycine 0 N--CA 1.484 1.849 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 -172.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.749 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 79.71 170.33 0.17 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.795 -0.826 . . . . 0.0 110.078 -176.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.613 ' CB ' ' O ' ' A' ' 28' ' ' ALA . 87.4 m-20 109.48 85.91 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.911 0 C-N-CA 124.656 1.182 . . . . 0.0 109.662 -174.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.512 ' CZ ' ' CB ' ' A' ' 73' ' ' PRO . 6.5 m-85 -60.02 -49.61 77.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.239 -0.913 . . . . 0.0 110.447 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.37 -46.28 94.19 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -177.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.437 ' HB3' ' HB3' ' A' ' 29' ' ' ASP . 33.1 tttp -62.84 -40.0 96.09 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.112 -1.228 . . . . 0.0 110.152 -177.186 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.034 HD21 HD13 ' A' ' 20' ' ' LEU . 47.3 tp -62.92 -40.03 96.34 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.213 -0.929 . . . . 0.0 110.337 177.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.487 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -59.66 -49.97 75.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.073 -1.017 . . . . 0.0 110.269 -178.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 46.8 tttm -60.05 -47.49 85.64 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.935 -1.103 . . . . 0.0 110.615 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -60.66 -42.28 96.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.134 -0.979 . . . . 0.0 111.03 -173.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 10.3 m80 -104.01 -4.38 23.4 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.928 -1.107 . . . . 0.0 111.022 -174.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.66 ' O ' HG22 ' A' ' 39' ' ' ILE . 1.2 t -60.04 -46.07 90.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.072 -1.017 . . . . 0.0 110.645 -177.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.66 HG22 ' O ' ' A' ' 38' ' ' SER . 16.0 tt 38.86 29.75 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.621 -0.674 . . . . 0.0 110.494 -177.17 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.453 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 13.4 t -131.7 135.63 27.13 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.358 -0.839 . . . . 0.0 110.032 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 40' ' ' CYS . 46.1 Cg_exo -51.6 -31.09 38.8 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.907 1.477 . . . . 0.0 110.776 -176.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 46' ' ' GLY . 0.3 OUTLIER -99.94 11.74 38.54 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.154 -0.966 . . . . 0.0 110.318 -179.695 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.464 ' HA3' ' OG ' ' A' ' 38' ' ' SER . . . -104.92 -62.87 0.65 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -60.07 -39.98 87.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.139 -1.212 . . . . 0.0 109.823 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -102.41 -33.33 9.59 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.444 -0.785 . . . . 0.0 110.029 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.478 ' O ' ' HG ' ' A' ' 49' ' ' LEU . . . -99.51 -4.78 55.96 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 -177.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.676 ' O ' HD12 ' A' ' 49' ' ' LEU . . . -51.31 -50.43 40.72 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.601 -1.799 . . . . 0.0 108.601 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -71.91 106.76 4.35 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.197 -1.178 . . . . 0.0 109.644 170.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.676 HD12 ' O ' ' A' ' 47' ' ' GLY . 0.8 OUTLIER -108.98 1.1 20.4 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.11 -0.994 . . . . 0.0 110.166 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.79 -134.09 25.52 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.507 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 13.7 mt-10 -121.47 138.47 54.27 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.298 -1.119 . . . . 0.0 111.234 -176.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.513 ' CD2' ' HB2' ' A' ' 57' ' ' MET . 0.7 OUTLIER -121.72 173.1 7.67 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.399 -0.813 . . . . 0.0 109.555 173.548 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.538 ' O ' ' HB2' ' A' ' 54' ' ' GLN . 9.6 ptp85 -124.01 144.09 50.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.057 -1.027 . . . . 0.0 110.021 -178.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.538 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 43.4 mt-30 83.5 -41.89 0.09 Allowed 'General case' 0 N--CA 1.503 2.175 0 CA-C-O 121.337 0.589 . . . . 0.0 109.615 -174.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.548 ' O ' ' N ' ' A' ' 57' ' ' MET . . . 133.53 -55.07 0.75 Allowed Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 -178.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.53 ' O ' ' C ' ' A' ' 57' ' ' MET . 0.7 OUTLIER 35.25 -89.24 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 122.218 -0.578 . . . . 0.0 111.111 174.344 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.784 ' HG3' HG12 ' A' ' 58' ' ' VAL . 5.5 tpt -1.22 -71.74 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 176.038 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.784 HG12 ' HG3' ' A' ' 57' ' ' MET . 12.6 p -155.46 133.18 6.67 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.303 -0.873 . . . . 0.0 110.074 -179.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 60' ' ' ALA . 3.0 Cg_endo -50.35 -53.6 6.84 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.849 1.447 . . . . 0.0 110.41 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.416 ' O ' HG12 ' A' ' 64' ' ' VAL . . . -43.14 -36.12 1.58 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.233 -0.917 . . . . 0.0 110.441 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.555 ' HB2' ' CG1' ' A' ' 58' ' ' VAL . 71.9 t80 -59.99 -40.02 87.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.188 -0.945 . . . . 0.0 110.656 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.519 ' O ' HG12 ' A' ' 65' ' ' VAL . 29.4 t0 -59.97 -49.97 75.59 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.136 -0.977 . . . . 0.0 110.331 -177.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.475 ' O ' ' HB2' ' A' ' 67' ' ' SER . 33.9 tttt -60.0 -50.03 75.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.07 -1.019 . . . . 0.0 110.541 177.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.657 HG23 HG21 ' A' ' 74' ' ' THR . 14.6 p -72.27 -44.93 63.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.025 -1.047 . . . . 0.0 111.082 -173.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.586 ' N ' HG13 ' A' ' 64' ' ' VAL . 1.9 p -55.58 -28.44 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.458 -1.402 . . . . 0.0 109.162 173.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -93.43 -10.63 34.45 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.328 -0.858 . . . . 0.0 109.897 175.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.55 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 7.4 t -93.84 -57.27 2.6 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.381 -0.825 . . . . 0.0 109.963 175.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.597 ' CB ' ' HG1' ' A' ' 74' ' ' THR . 84.6 m -111.63 122.88 36.12 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.292 -0.88 . . . . 0.0 110.012 177.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.402 ' HB3' ' NH2' ' A' ' 91' ' ' ARG . 12.2 Cg_endo -61.73 -179.65 0.41 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.797 1.42 . . . . 0.0 110.643 -177.023 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.649 HG12 HG12 ' A' ' 88' ' ' VAL . 31.4 m -61.87 161.43 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.357 -0.839 . . . . 0.0 110.924 -175.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.523 HD12 ' HB ' ' A' ' 70' ' ' VAL . 5.5 mp 58.55 23.58 10.99 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.584 -0.698 . . . . 0.0 110.367 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -129.76 72.2 81.99 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.304 -0.872 . . . . 0.0 109.545 175.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.512 ' CB ' ' CZ ' ' A' ' 30' ' ' PHE . 65.1 Cg_exo -44.55 122.07 3.7 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.025 1.54 . . . . 0.0 110.071 -177.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.657 HG21 HG23 ' A' ' 64' ' ' VAL . 94.7 m -119.99 130.06 54.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.215 -0.928 . . . . 0.0 110.264 -175.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.424 ' HA3' HG13 ' A' ' 85' ' ' ILE . . . 137.33 -171.44 23.16 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 178.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.863 ' HG3' ' HB1' ' A' ' 17' ' ' ALA . 40.5 Cg_endo -68.24 153.89 88.57 Favored 'Cis proline' 0 C--N 1.313 -1.3 0 C-N-CA 121.695 -2.21 . . . . 0.0 110.297 1.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.501 ' HG ' ' N ' ' A' ' 78' ' ' HIS . 25.0 tp -132.94 157.68 44.52 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.986 -1.071 . . . . 0.0 110.576 -171.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.501 ' N ' ' HG ' ' A' ' 77' ' ' LEU . 44.8 m80 -62.91 132.73 53.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.305 -0.872 . . . . 0.0 110.685 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.69 HG22 ' O ' ' A' ' 82' ' ' GLY . 5.0 t -148.25 159.17 44.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.269 -0.895 . . . . 0.0 109.809 173.074 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.02 -26.93 66.47 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.209 -0.932 . . . . 0.0 110.118 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -88.59 -1.54 58.11 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.355 -0.841 . . . . 0.0 110.675 -176.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.69 ' O ' HG22 ' A' ' 79' ' ' THR . . . 129.66 -123.67 4.18 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -177.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.478 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 96.0 m-85 -114.18 122.49 46.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.193 -1.18 . . . . 0.0 110.189 178.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.667 ' CG ' HG21 ' A' ' 79' ' ' THR . 41.3 m170 -109.33 120.43 42.49 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.321 -0.862 . . . . 0.0 110.823 177.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.736 HG22 ' HB ' ' A' ' 9' ' ' ILE . 7.7 tt -103.19 116.81 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.474 -1.391 . . . . 0.0 109.077 165.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.512 HG21 ' HD1' ' A' ' 61' ' ' PHE . 85.5 mt -114.63 130.01 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.923 -1.111 . . . . 0.0 111.007 -170.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.483 ' HB3' ' HB2' ' A' ' 7' ' ' LEU . 22.9 tttm -100.16 120.7 40.28 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.427 -0.795 . . . . 0.0 109.232 174.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.649 HG12 HG12 ' A' ' 70' ' ' VAL . 90.9 t -101.17 139.23 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.085 -1.01 . . . . 0.0 110.609 -173.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.621 HD23 ' O ' ' A' ' 88' ' ' VAL . 84.8 mt -138.29 120.63 15.91 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 121.329 -0.857 . . . . 0.0 109.707 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.557 ' CB ' ' O ' ' A' ' 89' ' ' LEU . 2.5 m-85 82.33 -24.68 0.17 Allowed 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.586 -0.697 . . . . 0.0 111.217 175.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.539 ' HB2' ' CG1' ' A' ' 70' ' ' VAL . 35.1 ttm180 55.99 164.8 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.866 -1.146 . . . . 0.0 110.371 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.465 ' O ' ' O ' ' A' ' 1' ' ' ALA . 4.0 t-20 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.971 176.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.564 ' CB ' ' HB3' ' A' ' 92' ' ' ASN . . . . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.209 0.528 . . . . 0.0 110.365 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 53' ' ' ARG . 72.1 mmtt -67.98 -36.68 80.45 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.318 -0.864 . . . . 0.0 109.966 176.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.499 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 35.4 p -128.72 162.36 27.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.334 -0.853 . . . . 0.0 110.238 -178.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.774 ' HB2' ' HG2' ' A' ' 91' ' ' ARG . . . -146.86 165.14 30.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.351 -0.843 . . . . 0.0 109.824 176.173 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.66 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -99.21 134.12 42.51 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.197 -0.94 . . . . 0.0 109.639 178.069 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.697 ' HB1' ' NE2' ' A' ' 8' ' ' HIS . . . -135.92 128.01 29.75 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.708 -1.245 . . . . 0.0 111.828 -171.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.542 HD12 ' HD3' ' A' ' 87' ' ' LYS . 75.5 mt -108.82 141.09 41.35 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.188 -0.945 . . . . 0.0 109.201 168.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.697 ' NE2' ' HB1' ' A' ' 6' ' ' ALA . 26.3 m-70 -135.37 125.82 26.71 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.787 -1.195 . . . . 0.0 111.081 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.568 ' HB ' ' CG2' ' A' ' 85' ' ' ILE . 87.6 mt -110.14 130.05 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.91 -1.119 . . . . 0.0 110.211 170.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.622 HD23 ' N ' ' A' ' 11' ' ' VAL . 0.7 OUTLIER -105.08 120.01 40.45 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.457 -0.777 . . . . 0.0 109.942 178.408 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.908 HG13 HD23 ' A' ' 16' ' ' LEU . 2.0 t -108.29 129.67 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.229 -0.919 . . . . 0.0 109.631 178.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -68.4 -39.46 81.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.258 -0.901 . . . . 0.0 110.558 -176.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -120.7 141.4 50.45 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.16 -0.962 . . . . 0.0 110.79 -177.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.585 ' HB2' ' CZ ' ' A' ' 83' ' ' TYR . 83.5 tt0 -60.0 -40.06 87.92 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.476 -0.765 . . . . 0.0 110.877 -178.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -55.88 -41.79 74.96 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.082 -1.011 . . . . 0.0 110.41 -174.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.908 HD23 HG13 ' A' ' 11' ' ' VAL . 1.4 tp -68.28 -40.01 81.96 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.214 -0.929 . . . . 0.0 109.563 177.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.401 ' HA ' ' HB3' ' A' ' 20' ' ' LEU . . . -59.72 -42.3 92.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.422 -0.799 . . . . 0.0 110.097 177.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.5 tp -60.06 -42.71 95.08 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.158 -0.964 . . . . 0.0 109.352 173.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.461 ' HB3' ' O ' ' A' ' 16' ' ' LEU . 56.1 t0 -59.99 -40.01 87.71 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -0.888 . . . . 0.0 109.387 174.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.741 HD13 HD21 ' A' ' 33' ' ' LEU . 0.6 OUTLIER -62.36 -43.28 99.2 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.494 -0.754 . . . . 0.0 109.463 175.68 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.787 HD21 ' HD3' ' A' ' 76' ' ' PRO . 4.0 mp -59.99 -49.61 77.0 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.765 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.421 ' HA ' ' OE1' ' A' ' 22' ' ' GLU . 51.7 tp10 -61.13 -40.0 92.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.287 -0.883 . . . . 0.0 109.85 173.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -61.14 -41.68 97.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.435 -0.791 . . . . 0.0 110.559 -176.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.717 HD11 HD11 ' A' ' 20' ' ' LEU . 33.0 mt -67.49 -40.08 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.007 -1.058 . . . . 0.0 110.281 176.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.402 ' HG3' ' O ' ' A' ' 21' ' ' LEU . 30.3 mttm -62.9 -53.93 46.5 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.099 -1.001 . . . . 0.0 109.987 -177.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -60.75 -50.78 72.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.194 -0.941 . . . . 0.0 110.048 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.757 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -105.97 -54.56 0.71 Allowed Glycine 0 N--CA 1.487 2.043 0 N-CA-C 110.014 -1.235 . . . . 0.0 110.014 -173.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.757 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 79.83 172.24 0.15 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.869 -0.783 . . . . 0.0 109.922 -176.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.614 ' CB ' ' O ' ' A' ' 28' ' ' ALA . 95.9 m-20 114.73 78.09 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.013 0 C-N-CA 124.859 1.264 . . . . 0.0 109.618 -175.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -60.03 -49.96 75.61 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.269 -0.895 . . . . 0.0 110.778 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.7 -49.91 65.35 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -175.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.491 ' HB2' ' HB3' ' A' ' 29' ' ' ASP . 94.6 mttt -64.59 -39.8 94.39 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.995 -1.297 . . . . 0.0 110.218 -175.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.741 HD21 HD13 ' A' ' 20' ' ' LEU . 9.8 tt -65.32 -40.04 93.23 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.176 -0.952 . . . . 0.0 110.127 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.564 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -59.81 -50.21 74.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.186 -0.946 . . . . 0.0 110.165 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.5 tttt -59.99 -50.0 75.44 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.382 -0.824 . . . . 0.0 110.717 -178.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.493 ' O ' HG12 ' A' ' 39' ' ' ILE . 88.8 tttt -65.93 -47.28 75.22 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.181 -0.949 . . . . 0.0 111.202 -174.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 73.9 m80 -80.78 -50.01 10.4 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.874 -1.141 . . . . 0.0 111.674 -171.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.465 ' O ' ' C ' ' A' ' 39' ' ' ILE . 53.9 m -60.54 -40.07 90.19 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.915 -1.116 . . . . 0.0 110.765 -173.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.797 ' O ' HG22 ' A' ' 39' ' ' ILE . 31.9 mm 32.04 46.18 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 CA-C-O 121.5 0.667 . . . . 0.0 110.985 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.5 ' SG ' ' N ' ' A' ' 43' ' ' GLY . 17.0 p -133.79 170.14 12.1 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.348 -0.845 . . . . 0.0 109.945 -177.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.464 ' HD2' ' HB2' ' A' ' 40' ' ' CYS . 52.6 Cg_exo -49.96 -30.39 24.01 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.851 1.448 . . . . 0.0 109.982 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.473 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 6.1 p -108.84 27.29 9.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.22 -0.925 . . . . 0.0 109.61 173.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.5 ' N ' ' SG ' ' A' ' 40' ' ' CYS . . . -103.16 -67.16 0.75 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 108.607 -1.797 . . . . 0.0 108.607 176.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -59.99 -40.09 87.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -1.178 . . . . 0.0 109.961 172.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.463 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 13.7 tpt180 -99.8 -41.2 7.36 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.331 -0.856 . . . . 0.0 110.554 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.473 ' HA3' ' O ' ' A' ' 42' ' ' SER . . . -76.6 -22.81 71.71 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.32 -4.32 56.16 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 175.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.525 ' HA ' ' CD2' ' A' ' 7' ' ' LEU . 38.3 t0 -173.83 70.31 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.249 -1.148 . . . . 0.0 109.27 178.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.471 ' HG ' ' HA2' ' A' ' 46' ' ' GLY . 7.3 mt -70.08 -29.2 66.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.61 -0.681 . . . . 0.0 110.077 -176.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 111.78 -143.33 17.36 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -113.17 136.12 53.07 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.383 -1.069 . . . . 0.0 110.455 -177.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.691 ' CZ ' ' HB3' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -148.6 168.44 22.78 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.305 -0.872 . . . . 0.0 109.707 175.373 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.503 ' HA ' ' O ' ' A' ' 2' ' ' LYS . 75.1 ttt180 -50.43 -84.19 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.737 -1.227 . . . . 0.0 110.546 -172.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.462 ' HG2' ' HG2' ' A' ' 53' ' ' ARG . 10.9 pt20 -177.35 133.4 0.17 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.995 -1.066 . . . . 0.0 110.507 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.92 -9.99 75.39 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 174.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.628 ' NE2' ' CD1' ' A' ' 52' ' ' PHE . 0.5 OUTLIER -60.01 -36.57 77.52 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.05 -1.265 . . . . 0.0 111.157 -173.662 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.478 ' HE1' ' HB2' ' A' ' 8' ' ' HIS . 27.7 ttt -83.51 -42.09 17.25 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.591 -1.318 . . . . 0.0 110.852 -167.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.493 ' O ' ' HB3' ' A' ' 61' ' ' PHE . 7.3 p -173.04 133.85 0.67 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.271 -0.893 . . . . 0.0 109.799 -173.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -49.37 -53.38 7.13 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 O-C-N 123.793 1.417 . . . . 0.0 110.247 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -43.95 -37.85 3.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.293 -0.879 . . . . 0.0 110.544 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.649 ' HD1' HG21 ' A' ' 86' ' ' ILE . 37.7 t80 -59.9 -40.26 88.16 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.074 -1.016 . . . . 0.0 110.386 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.43 ' O ' HG12 ' A' ' 65' ' ' VAL . 32.9 t0 -59.97 -46.05 90.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.103 -0.998 . . . . 0.0 109.932 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -59.96 -49.99 75.51 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.293 -0.879 . . . . 0.0 110.623 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.725 HG11 HD12 ' A' ' 86' ' ' ILE . 8.9 p -73.2 -45.4 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.03 -1.044 . . . . 0.0 111.144 -174.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.549 ' N ' HG13 ' A' ' 64' ' ' VAL . 5.5 p -57.46 -24.24 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.359 -1.463 . . . . 0.0 109.156 172.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -97.29 -1.5 44.54 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.365 -0.834 . . . . 0.0 109.904 175.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.531 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 22.8 t -96.58 -67.42 0.85 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.449 -0.782 . . . . 0.0 109.573 174.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 73.4 m -92.48 128.54 44.12 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.29 -0.881 . . . . 0.0 110.063 175.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -50.62 165.81 0.38 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.815 1.429 . . . . 0.0 110.353 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.504 HG11 ' CB ' ' A' ' 91' ' ' ARG . 31.4 m -59.8 169.1 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.265 -0.897 . . . . 0.0 110.726 -178.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 70' ' ' VAL . 5.4 mp 59.94 26.17 15.4 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.699 -0.626 . . . . 0.0 110.583 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.06 90.96 37.6 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.085 -1.01 . . . . 0.0 110.17 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -52.22 110.64 0.47 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.771 1.406 . . . . 0.0 109.55 176.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 94.2 m -119.92 129.97 54.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.08 -1.012 . . . . 0.0 110.536 -173.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.512 ' HA2' ' CD2' ' A' ' 77' ' ' LEU . . . 148.41 -169.95 28.98 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.787 ' HD3' HD21 ' A' ' 21' ' ' LEU . 44.1 Cg_endo -75.6 139.16 59.51 Favored 'Cis proline' 0 C--N 1.313 -1.292 0 C-N-CA 121.854 -2.144 . . . . 0.0 110.481 1.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.512 ' CD2' ' HA2' ' A' ' 75' ' ' GLY . 1.1 mm? -98.15 174.83 6.33 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.241 -0.912 . . . . 0.0 110.699 -177.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.477 ' CE1' ' HE2' ' A' ' 83' ' ' TYR . 7.0 m-70 -109.66 127.54 54.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.283 -0.885 . . . . 0.0 110.887 -176.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.998 HG21 ' CE1' ' A' ' 84' ' ' HIS . 11.1 t -140.42 168.77 19.02 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.457 -0.777 . . . . 0.0 109.775 174.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -59.95 -40.12 87.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.097 -1.002 . . . . 0.0 110.484 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -64.25 -16.69 62.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.086 -1.009 . . . . 0.0 110.583 -177.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.472 ' O ' HG22 ' A' ' 79' ' ' THR . . . 140.67 -143.62 13.68 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 -177.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.585 ' CZ ' ' HB2' ' A' ' 14' ' ' GLU . 68.9 m-85 -97.16 122.65 40.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.136 -1.214 . . . . 0.0 110.181 178.094 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.998 ' CE1' HG21 ' A' ' 79' ' ' THR . 24.7 m170 -105.79 120.07 40.77 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.46 -0.775 . . . . 0.0 110.603 178.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.568 ' CG2' ' HB ' ' A' ' 9' ' ' ILE . 6.5 tt -109.71 121.64 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.683 -1.261 . . . . 0.0 109.248 167.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.725 HD12 HG11 ' A' ' 64' ' ' VAL . 88.2 mt -115.53 130.04 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.108 -0.995 . . . . 0.0 111.289 -170.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.542 ' HD3' HD12 ' A' ' 7' ' ' LEU . 20.7 tttm -102.96 132.02 49.5 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.438 -0.789 . . . . 0.0 108.913 171.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.595 ' O ' HD23 ' A' ' 89' ' ' LEU . 20.0 m -119.78 138.58 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.026 -1.046 . . . . 0.0 110.546 -176.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.66 ' HB2' ' HB3' ' A' ' 5' ' ' ALA . 58.5 mt -140.02 -167.34 2.28 Favored 'General case' 0 C--N 1.309 -1.186 0 O-C-N 121.291 -0.881 . . . . 0.0 109.901 -173.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.44 ' C ' ' O ' ' A' ' 89' ' ' LEU . 53.5 m-85 30.41 -85.63 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.865 -177.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.774 ' HG2' ' HB2' ' A' ' 4' ' ' ALA . 0.0 OUTLIER 54.44 50.23 16.63 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.697 -1.252 . . . . 0.0 109.837 -175.262 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.564 ' HB3' ' CB ' ' A' ' 1' ' ' ALA . 4.6 t-20 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 118.074 -0.965 . . . . 0.0 110.332 -178.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.43 ' HA ' ' OXT' ' A' ' 92' ' ' ASN . . . . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.224 0.535 . . . . 0.0 110.248 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 66.5 mmtt -60.21 -39.97 88.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.183 -0.948 . . . . 0.0 110.026 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.557 HG22 ' HG2' ' A' ' 53' ' ' ARG . 67.9 p -124.39 150.57 45.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.272 -0.892 . . . . 0.0 110.089 178.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.459 ' C ' ' HG3' ' A' ' 51' ' ' GLU . . . -130.71 154.78 47.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.054 -1.029 . . . . 0.0 110.463 -178.132 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.606 ' CB ' ' CD1' ' A' ' 90' ' ' TYR . . . -98.07 136.59 38.1 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.226 -0.921 . . . . 0.0 109.757 177.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.7 ' HB1' ' NE2' ' A' ' 8' ' ' HIS . . . -147.58 123.12 10.43 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.719 -1.238 . . . . 0.0 112.098 -172.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.601 ' N ' ' CD1' ' A' ' 7' ' ' LEU . 4.0 mp -96.17 147.0 24.2 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.024 -1.048 . . . . 0.0 108.995 167.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.894 ' CD2' HD12 ' A' ' 49' ' ' LEU . 37.5 m-70 -136.35 137.02 40.17 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.773 -1.204 . . . . 0.0 111.287 -175.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.719 ' HB ' HG22 ' A' ' 85' ' ' ILE . 79.3 mt -118.93 129.9 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.127 -0.983 . . . . 0.0 109.799 168.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.542 ' HG ' ' CD2' ' A' ' 84' ' ' HIS . 0.4 OUTLIER -102.16 118.08 36.14 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.509 -0.745 . . . . 0.0 110.262 -179.115 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.946 HG13 HD22 ' A' ' 16' ' ' LEU . 2.2 t -108.09 127.74 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.323 -0.861 . . . . 0.0 109.891 177.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -69.95 -39.95 75.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.352 -0.842 . . . . 0.0 110.296 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -120.03 140.36 51.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.216 -0.928 . . . . 0.0 110.496 -175.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -59.89 -39.95 87.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.382 -0.823 . . . . 0.0 110.617 -176.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -52.16 -41.48 62.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.086 -1.009 . . . . 0.0 110.254 -175.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.946 HD22 HG13 ' A' ' 11' ' ' VAL . 7.9 tt -67.73 -44.08 78.46 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.029 -1.045 . . . . 0.0 109.912 177.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.941 ' HB1' ' HG3' ' A' ' 76' ' ' PRO . . . -59.91 -45.93 90.98 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.249 -0.907 . . . . 0.0 109.936 177.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.601 ' HA ' HD12 ' A' ' 21' ' ' LEU . 10.1 tp -60.99 -39.18 88.68 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.932 -1.105 . . . . 0.0 109.405 170.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.432 ' HB3' ' O ' ' A' ' 16' ' ' LEU . 48.6 t0 -62.25 -49.79 74.29 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 120.999 -1.063 . . . . 0.0 110.312 176.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.83 HD12 ' N ' ' A' ' 21' ' ' LEU . 0.7 OUTLIER -69.94 -47.2 63.31 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.019 -1.051 . . . . 0.0 110.788 -175.574 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 1.141 HD13 ' N ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -59.96 -29.29 68.32 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.012 -1.055 . . . . 0.0 108.864 -173.185 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 1.141 ' N ' HD13 ' A' ' 21' ' ' LEU . 85.7 tt0 -61.87 -42.66 99.33 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.407 -0.808 . . . . 0.0 110.137 173.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.79 -39.99 95.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.298 -0.876 . . . . 0.0 110.574 -176.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.862 HD13 ' CE2' ' A' ' 30' ' ' PHE . 97.6 mt -61.89 -45.44 98.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -0.86 . . . . 0.0 109.824 -178.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.566 ' HE3' HD21 ' A' ' 21' ' ' LEU . 36.7 mttm -61.06 -46.26 91.4 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.228 -0.92 . . . . 0.0 109.716 176.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -59.95 -61.34 2.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.382 -0.824 . . . . 0.0 110.485 177.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.755 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -104.87 -39.58 2.3 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -172.071 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.755 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 81.19 102.56 0.06 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.953 -0.734 . . . . 0.0 110.142 -178.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -175.74 67.05 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.421 -0.799 . . . . 0.0 110.128 -177.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.862 ' CE2' HD13 ' A' ' 24' ' ' ILE . 2.0 m-85 -59.98 -44.15 94.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -0.923 . . . . 0.0 110.838 -178.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.4 -43.63 98.48 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -177.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -65.09 -40.2 94.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.175 -1.191 . . . . 0.0 110.345 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.566 ' CD1' HG13 ' A' ' 24' ' ' ILE . 88.9 mt -66.33 -39.93 89.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.112 -0.992 . . . . 0.0 110.491 178.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 38' ' ' SER . . . -60.0 -46.42 89.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.107 -0.996 . . . . 0.0 110.027 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -60.0 -50.21 74.61 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.363 -0.835 . . . . 0.0 110.785 -177.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.472 ' O ' HG13 ' A' ' 39' ' ' ILE . 51.3 mttt -75.91 -47.89 23.5 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.023 -1.048 . . . . 0.0 111.249 -174.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 60.9 m-70 -71.78 -40.04 69.51 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.932 -1.105 . . . . 0.0 111.198 -174.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.515 ' OG ' ' CA ' ' A' ' 43' ' ' GLY . 16.5 t -61.02 -50.04 74.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.035 -1.041 . . . . 0.0 111.045 -172.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.741 ' O ' HG22 ' A' ' 39' ' ' ILE . 96.3 mt 31.98 49.06 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 CA-C-O 121.318 0.58 . . . . 0.0 111.037 -177.231 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.501 ' SG ' ' N ' ' A' ' 43' ' ' GLY . 16.4 p -143.3 161.94 45.14 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.402 -0.811 . . . . 0.0 110.229 -176.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.457 ' HD2' ' HB2' ' A' ' 40' ' ' CYS . 6.1 Cg_endo -53.0 -26.12 30.79 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.947 1.498 . . . . 0.0 110.779 -178.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.532 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -109.05 19.77 19.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.074 -1.016 . . . . 0.0 110.087 177.816 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.515 ' CA ' ' OG ' ' A' ' 38' ' ' SER . . . -77.81 -53.13 5.09 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 108.583 -1.807 . . . . 0.0 108.583 172.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 61.8 mttt -60.21 -40.05 88.76 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.301 -1.117 . . . . 0.0 110.354 176.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.437 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 9.5 tpp180 -94.99 -41.22 9.26 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.982 -1.074 . . . . 0.0 110.262 -177.096 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -67.04 -28.09 73.67 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 178.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.86 -4.46 54.53 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 177.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.423 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 51.4 t0 -173.95 70.96 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.266 -1.138 . . . . 0.0 109.135 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.894 HD12 ' CD2' ' A' ' 8' ' ' HIS . 7.5 mt -69.94 -27.73 64.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.445 -0.784 . . . . 0.0 110.66 -174.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.56 -145.28 16.14 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 -176.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.459 ' HG3' ' C ' ' A' ' 4' ' ' ALA . 59.5 tt0 -113.14 132.14 55.57 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.161 -1.199 . . . . 0.0 110.544 -177.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 6' ' ' ALA . 1.9 p90 -136.83 161.95 34.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.34 -0.85 . . . . 0.0 109.768 177.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.557 ' HG2' HG22 ' A' ' 3' ' ' THR . 82.8 mtp180 -69.25 57.2 0.11 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.942 -1.099 . . . . 0.0 111.155 -173.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.48 ' C ' ' O ' ' A' ' 53' ' ' ARG . 15.9 pt20 27.48 39.32 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.19 0 CA-C-O 121.037 0.446 . . . . 0.0 112.09 174.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . -175.7 53.77 0.12 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.475 ' OE1' ' HB2' ' A' ' 52' ' ' PHE . 0.0 OUTLIER -155.72 -62.48 0.11 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.261 -1.141 . . . . 0.0 110.304 178.931 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.78 ' HG2' HD13 ' A' ' 49' ' ' LEU . 29.7 tpp -59.93 -41.11 91.08 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.164 -0.96 . . . . 0.0 110.818 -175.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 58' ' ' VAL . 11.0 p -162.45 131.48 3.07 Favored Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.138 -0.976 . . . . 0.0 110.352 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.41 ' O ' ' C ' ' A' ' 60' ' ' ALA . 13.0 Cg_endo -60.41 -49.63 8.7 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.904 1.476 . . . . 0.0 110.245 178.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.426 ' O ' ' HB3' ' A' ' 63' ' ' LYS . . . -41.17 -34.29 0.45 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.48 -0.762 . . . . 0.0 110.399 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.505 ' O ' HG12 ' A' ' 64' ' ' VAL . 68.5 t80 -60.0 -39.99 87.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.114 -0.991 . . . . 0.0 110.005 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -59.92 -39.97 87.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.309 -0.87 . . . . 0.0 109.511 179.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.723 ' HD3' HD21 ' A' ' 77' ' ' LEU . 87.7 tttt -57.49 -40.56 78.88 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.466 -0.771 . . . . 0.0 110.379 176.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.76 HG23 HG21 ' A' ' 74' ' ' THR . 14.3 p -91.77 -41.9 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.974 -1.079 . . . . 0.0 111.52 -173.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.526 HG22 ' CZ ' ' A' ' 91' ' ' ARG . 2.5 p -52.65 -27.16 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.53 -1.356 . . . . 0.0 109.805 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -99.83 5.66 45.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.172 -0.955 . . . . 0.0 109.88 176.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.523 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 37.5 t -99.61 -80.06 0.48 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.382 -0.824 . . . . 0.0 110.181 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 84.3 m -78.51 156.95 77.98 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.153 -0.967 . . . . 0.0 110.352 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.539 ' O ' ' O ' ' A' ' 70' ' ' VAL . 38.6 Cg_endo -79.07 69.78 7.78 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.069 1.562 . . . . 0.0 110.585 179.279 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.016 ' C ' HD13 ' A' ' 71' ' ' LEU . 8.4 p 29.4 -174.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 178.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.016 HD13 ' C ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER 23.6 41.67 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.607 0 O-C-N 120.821 -1.174 . . . . 0.0 113.364 -164.139 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' A' ' 70' ' ' VAL . 9.7 tt0 -134.04 100.86 12.84 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.766 -1.209 . . . . 0.0 109.91 171.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.544 ' HB3' ' CZ ' ' A' ' 30' ' ' PHE . 50.9 Cg_exo -47.42 103.84 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.908 1.478 . . . . 0.0 110.38 -176.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.76 HG21 HG23 ' A' ' 64' ' ' VAL . 50.6 m -98.99 134.2 42.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.322 -0.861 . . . . 0.0 110.504 -177.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.447 ' HA3' HG13 ' A' ' 85' ' ' ILE . . . 135.78 -172.65 22.17 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 176.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.941 ' HG3' ' HB1' ' A' ' 17' ' ' ALA . 43.5 Cg_endo -70.13 127.95 12.11 Favored 'Cis proline' 0 N--CA 1.49 1.277 0 C-N-CA 121.798 -2.167 . . . . 0.0 110.292 2.067 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.723 HD21 ' HD3' ' A' ' 63' ' ' LYS . 62.3 tp -95.37 155.91 16.54 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.252 -0.905 . . . . 0.0 110.763 -174.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -71.41 123.97 23.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.335 -0.853 . . . . 0.0 110.514 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.811 HG21 ' CG ' ' A' ' 84' ' ' HIS . 12.9 t -140.12 156.11 46.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.205 -0.934 . . . . 0.0 109.727 174.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -60.12 -32.07 70.66 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.118 -0.989 . . . . 0.0 110.927 -175.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -75.68 -8.79 57.69 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.015 -1.053 . . . . 0.0 110.365 -178.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.725 ' O ' HG22 ' A' ' 79' ' ' THR . . . 138.34 -132.88 6.0 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 -175.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -107.86 125.78 51.88 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.092 -1.24 . . . . 0.0 110.1 175.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.811 ' CG ' HG21 ' A' ' 79' ' ' THR . 45.6 m170 -106.96 124.18 49.25 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.143 -0.973 . . . . 0.0 110.367 175.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.719 HG22 ' HB ' ' A' ' 9' ' ' ILE . 9.9 tt -108.54 125.47 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 118.719 -1.192 . . . . 0.0 109.398 168.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 86.0 mt -120.08 130.67 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.016 -1.052 . . . . 0.0 111.785 -167.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.598 ' HD3' ' CG ' ' A' ' 30' ' ' PHE . 13.5 mtmm -93.06 126.83 38.35 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.1 -1.0 . . . . 0.0 109.12 168.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.938 HG12 HG23 ' A' ' 70' ' ' VAL . 59.3 t -109.93 130.07 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.029 -1.044 . . . . 0.0 110.458 -175.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.597 HD23 ' O ' ' A' ' 88' ' ' VAL . 87.7 mt -139.71 -155.25 0.57 Allowed 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.272 -0.893 . . . . 0.0 110.109 -178.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.606 ' CD1' ' CB ' ' A' ' 5' ' ' ALA . 16.9 m-85 32.82 -89.0 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 O-C-N 122.104 -0.372 . . . . 0.0 111.268 -178.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.526 ' CZ ' HG22 ' A' ' 65' ' ' VAL . 13.5 tpt180 59.55 46.82 11.58 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.878 -1.139 . . . . 0.0 110.62 177.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.43 ' OXT' ' HA ' ' A' ' 1' ' ' ALA . 4.6 p30 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.322 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.115 0.483 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 53' ' ' ARG . 24.6 mttm -59.98 -52.29 66.02 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.236 -0.915 . . . . 0.0 109.896 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 67.6 m -133.77 135.38 43.86 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.779 177.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' A' ' 51' ' ' GLU . . . -150.42 158.48 44.2 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.816 -1.178 . . . . 0.0 111.247 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.619 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -101.25 136.96 40.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.491 -0.755 . . . . 0.0 109.45 176.15 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.709 ' HB1' ' NE2' ' A' ' 8' ' ' HIS . . . -150.19 129.74 13.07 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.981 -1.075 . . . . 0.0 111.224 -177.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.526 HD12 ' HD3' ' A' ' 87' ' ' LYS . 72.6 mt -99.5 135.09 41.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.253 -0.904 . . . . 0.0 109.168 169.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.709 ' NE2' ' HB1' ' A' ' 6' ' ' ALA . 40.8 m170 -130.34 129.39 43.1 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.025 -1.047 . . . . 0.0 110.827 -176.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.55 ' HB ' ' CG2' ' A' ' 85' ' ' ILE . 84.6 mt -114.45 129.8 69.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.179 -0.951 . . . . 0.0 109.547 169.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.797 ' O ' HD13 ' A' ' 10' ' ' LEU . 1.8 tm? -106.8 114.92 29.31 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.291 -0.88 . . . . 0.0 110.138 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.807 HG13 HD22 ' A' ' 16' ' ' LEU . 2.3 t -101.3 128.97 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.312 -0.868 . . . . 0.0 109.925 177.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -67.33 -40.04 85.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.306 -0.871 . . . . 0.0 110.705 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -109.02 138.99 44.5 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.06 -1.025 . . . . 0.0 111.159 -174.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.495 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 87.9 tt0 -60.09 -41.24 92.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.556 -0.715 . . . . 0.0 110.182 176.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -56.06 -43.76 78.22 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.257 -0.902 . . . . 0.0 109.848 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.807 HD22 HG13 ' A' ' 11' ' ' VAL . 3.2 tt -67.84 -36.02 79.6 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.342 -0.849 . . . . 0.0 109.5 177.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.529 ' HA ' ' HB3' ' A' ' 20' ' ' LEU . . . -57.52 -44.33 84.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.945 -1.097 . . . . 0.0 109.603 172.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.717 ' HA ' HD11 ' A' ' 21' ' ' LEU . 0.1 OUTLIER -60.04 -39.95 87.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.204 -0.935 . . . . 0.0 109.901 173.159 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.476 ' HB3' ' O ' ' A' ' 16' ' ' LEU . 60.4 t0 -61.06 -40.83 95.16 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.677 -1.264 . . . . 0.0 109.101 171.056 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.842 ' C ' HD12 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -64.17 -80.69 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.551 -0.718 . . . . 0.0 110.445 179.826 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.808 HD12 ' H ' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -49.99 -20.01 0.84 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.21 -1.556 . . . . 0.0 110.497 -164.719 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.808 ' H ' HD12 ' A' ' 21' ' ' LEU . 50.2 tp10 -64.49 -39.99 94.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.682 -1.262 . . . . 0.0 110.189 173.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.44 ' HG2' ' O ' ' A' ' 19' ' ' ASP . 85.4 mm-40 -60.44 -41.74 94.68 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.284 -0.885 . . . . 0.0 111.221 -172.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.608 HG13 HD12 ' A' ' 33' ' ' LEU . 1.7 mp -64.3 -43.67 97.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.016 -1.053 . . . . 0.0 110.768 -173.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -61.84 -50.05 73.82 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 120.775 -1.203 . . . . 0.0 110.164 178.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -63.26 -57.3 10.89 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.128 -0.983 . . . . 0.0 110.521 176.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.748 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -104.53 -39.98 2.29 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -172.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.748 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 82.99 -153.52 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.23 0 O-C-N 122.109 -0.642 . . . . 0.0 110.476 -179.227 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.486 ' HB2' ' O ' ' A' ' 28' ' ' ALA . 2.7 m-20 61.38 75.66 0.4 Allowed 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 122.082 0.944 . . . . 0.0 110.558 175.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.506 ' CZ ' HG13 ' A' ' 9' ' ' ILE . 62.8 t80 -59.97 -48.15 82.9 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.82 -0.55 . . . . 0.0 110.931 -178.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.0 -41.51 97.95 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -175.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.437 ' HD2' ' CG ' ' A' ' 29' ' ' ASP . 82.0 mttt -66.34 -39.94 89.54 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.042 -1.269 . . . . 0.0 110.194 -178.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.608 HD12 HG13 ' A' ' 24' ' ' ILE . 49.1 mt -64.91 -40.07 94.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.066 -1.021 . . . . 0.0 110.206 178.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.486 ' O ' ' CB ' ' A' ' 38' ' ' SER . . . -59.57 -47.11 86.86 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.076 -1.015 . . . . 0.0 109.862 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -59.93 -40.9 90.46 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.032 -1.042 . . . . 0.0 110.431 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.8 mtpt -73.02 -52.08 15.76 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.013 -1.054 . . . . 0.0 111.764 -175.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.576 ' CD2' ' O ' ' A' ' 33' ' ' LEU . 7.4 p80 -106.01 -17.43 14.34 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.406 -1.434 . . . . 0.0 112.111 -167.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.668 ' O ' HG22 ' A' ' 39' ' ' ILE . 64.9 p -60.02 -50.06 75.22 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.621 -1.3 . . . . 0.0 110.301 -173.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.668 HG22 ' O ' ' A' ' 38' ' ' SER . 17.3 tt 38.34 31.2 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.692 -0.63 . . . . 0.0 110.466 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.51 ' SG ' ' N ' ' A' ' 43' ' ' GLY . 20.4 p -125.61 169.04 12.17 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.316 -0.865 . . . . 0.0 110.307 -176.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.469 ' HD2' ' HB2' ' A' ' 40' ' ' CYS . 41.0 Cg_exo -51.76 -34.61 55.1 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.893 1.47 . . . . 0.0 110.729 -175.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.535 ' O ' ' CA ' ' A' ' 46' ' ' GLY . 1.2 p -107.01 16.59 24.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.154 -0.966 . . . . 0.0 109.891 177.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.51 ' N ' ' SG ' ' A' ' 40' ' ' CYS . . . -79.98 -60.0 2.5 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 108.681 -1.768 . . . . 0.0 108.681 176.137 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -59.94 -40.37 88.73 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.424 -1.045 . . . . 0.0 110.488 176.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.556 ' NE ' HD23 ' A' ' 49' ' ' LEU . 17.0 tpt180 -104.95 -44.38 4.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.097 -1.002 . . . . 0.0 110.93 -175.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.535 ' CA ' ' O ' ' A' ' 42' ' ' SER . . . -62.37 -29.1 72.25 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.79 0.48 44.22 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 177.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.502 ' HA ' ' CD2' ' A' ' 7' ' ' LEU . 40.6 t0 -169.65 76.25 0.09 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.132 -1.217 . . . . 0.0 109.101 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.556 HD23 ' NE ' ' A' ' 45' ' ' ARG . 10.6 mt -91.28 -6.19 53.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.573 -0.704 . . . . 0.0 110.196 -175.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.95 -131.26 28.13 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 -173.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 54.8 mp0 -116.63 145.95 43.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.101 -1.235 . . . . 0.0 110.546 177.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.636 ' CE2' ' HB3' ' A' ' 6' ' ' ALA . 0.3 OUTLIER -130.19 164.14 25.15 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.321 -0.862 . . . . 0.0 110.552 176.14 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 2' ' ' LYS . 87.7 mtt180 -108.7 -169.03 1.42 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.528 -0.732 . . . . 0.0 110.434 -175.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -61.22 -14.68 27.43 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.314 -0.866 . . . . 0.0 110.253 178.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.462 ' O ' ' OE1' ' A' ' 56' ' ' GLN . . . -87.77 25.65 8.31 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.044 -1.223 . . . . 0.0 110.044 -174.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.57 ' HG3' ' HB2' ' A' ' 52' ' ' PHE . 0.0 OUTLIER -167.52 -93.94 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.918 -1.343 . . . . 0.0 110.363 173.187 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.6 ' HG2' ' CE1' ' A' ' 52' ' ' PHE . 17.3 mtm 40.14 -166.66 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.397 -0.815 . . . . 0.0 110.709 -176.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.547 HG13 ' H ' ' A' ' 61' ' ' PHE . 5.6 p -149.95 132.24 7.94 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.159 -0.963 . . . . 0.0 109.9 -177.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -39.05 -49.17 2.87 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.917 1.483 . . . . 0.0 110.845 -175.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.55 -39.35 79.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -0.893 . . . . 0.0 110.216 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.547 ' H ' HG13 ' A' ' 58' ' ' VAL . 59.5 t80 -59.92 -41.69 92.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.284 -0.885 . . . . 0.0 110.451 178.164 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -60.02 -47.24 86.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.232 -0.918 . . . . 0.0 109.878 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 67' ' ' SER . 96.9 mttt -59.88 -44.23 94.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.285 -0.885 . . . . 0.0 110.419 178.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.611 HG22 ' SG ' ' A' ' 68' ' ' CYS . 6.2 p -83.57 -44.96 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.12 -0.987 . . . . 0.0 111.221 -172.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.565 ' N ' HG13 ' A' ' 64' ' ' VAL . 5.0 p -55.43 -24.3 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.206 -1.558 . . . . 0.0 109.142 172.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -92.86 -15.2 26.71 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.332 -0.855 . . . . 0.0 109.661 175.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.525 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 9.4 t -93.18 -47.61 6.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.378 -0.826 . . . . 0.0 109.936 175.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.611 ' SG ' HG22 ' A' ' 64' ' ' VAL . 29.3 p -102.98 136.92 19.16 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.352 -0.843 . . . . 0.0 109.965 175.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.42 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 10.1 Cg_exo -66.55 171.61 10.44 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.796 1.419 . . . . 0.0 110.261 178.027 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.753 ' HB ' HD12 ' A' ' 71' ' ' LEU . 12.7 m -57.69 171.41 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.372 -0.83 . . . . 0.0 110.422 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.753 HD12 ' HB ' ' A' ' 70' ' ' VAL . 4.3 mp 38.85 39.71 0.37 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.583 -0.698 . . . . 0.0 110.764 -177.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.42 ' HB3' ' O ' ' A' ' 69' ' ' PRO . 20.0 tp10 -137.78 83.98 23.04 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.162 -0.961 . . . . 0.0 110.01 177.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -50.08 124.87 13.55 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.027 1.541 . . . . 0.0 109.981 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.514 ' OG1' ' CB ' ' A' ' 68' ' ' CYS . 96.5 m -135.22 138.09 43.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.293 -0.879 . . . . 0.0 110.21 -177.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.441 ' HA3' HG13 ' A' ' 85' ' ' ILE . . . 147.92 -172.72 28.18 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -178.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.506 ' HG3' ' HB1' ' A' ' 17' ' ' ALA . 44.6 Cg_endo -70.49 173.29 47.84 Favored 'Cis proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.77 -2.179 . . . . 0.0 110.59 -0.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.544 HD11 ' CG2' ' A' ' 64' ' ' VAL . 25.2 mt -133.57 175.33 9.52 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.243 -0.911 . . . . 0.0 110.224 -178.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -95.97 119.53 34.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.059 -1.026 . . . . 0.0 110.753 -175.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.824 HG21 ' CG ' ' A' ' 84' ' ' HIS . 15.2 t -140.94 163.41 33.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.42 -0.8 . . . . 0.0 109.779 176.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -59.99 -39.99 87.64 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.979 -1.075 . . . . 0.0 110.437 -178.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -60.06 -18.38 46.23 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.222 -0.923 . . . . 0.0 110.451 179.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.541 ' O ' HG22 ' A' ' 79' ' ' THR . . . 134.1 -130.56 5.64 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 -177.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.438 ' O ' ' HA ' ' A' ' 10' ' ' LEU . 3.6 m-85 -93.06 121.06 34.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.085 -1.244 . . . . 0.0 110.245 177.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.824 ' CG ' HG21 ' A' ' 79' ' ' THR . 0.1 OUTLIER -102.64 116.16 32.03 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.432 -0.793 . . . . 0.0 110.502 177.17 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.55 ' CG2' ' HB ' ' A' ' 9' ' ' ILE . 7.8 tt -108.62 126.28 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.86 -1.15 . . . . 0.0 109.427 170.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.578 HG12 ' CD2' ' A' ' 8' ' ' HIS . 89.5 mt -120.1 129.94 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.119 -0.988 . . . . 0.0 111.735 -167.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.526 ' HD3' HD12 ' A' ' 7' ' ' LEU . 27.8 tttt -101.08 129.84 47.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.225 -0.922 . . . . 0.0 109.165 169.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 18.0 t -100.82 139.98 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.075 -1.016 . . . . 0.0 110.414 -175.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.619 ' HB2' ' HB3' ' A' ' 5' ' ' ALA . 88.7 mt -141.68 170.15 16.27 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.434 ' C ' ' O ' ' A' ' 89' ' ' LEU . 77.8 m-85 33.37 -87.28 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 O-C-N 122.212 -0.305 . . . . 0.0 111.665 -178.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.533 ' N ' ' O ' ' A' ' 89' ' ' LEU . 1.8 ttp180 59.98 -159.9 0.3 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.7 -1.25 . . . . 0.0 109.502 -176.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.073 -1.017 . . . . 0.0 110.206 -179.532 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.791 ' HB2' ' HG2' ' A' ' 91' ' ' ARG . . . . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.105 0.479 . . . . 0.0 110.311 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.529 ' O ' ' CB ' ' A' ' 53' ' ' ARG . 88.1 tttt -59.96 -40.04 87.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.192 -0.942 . . . . 0.0 109.824 177.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.476 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 11.5 p -150.23 165.01 34.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.433 -0.792 . . . . 0.0 109.336 176.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.521 ' O ' ' HA ' ' A' ' 51' ' ' GLU . . . -127.8 150.56 49.77 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.86 -1.15 . . . . 0.0 109.954 176.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.505 ' HB3' ' HB2' ' A' ' 90' ' ' TYR . . . -89.71 121.63 32.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.32 -0.862 . . . . 0.0 109.62 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.628 ' HB3' ' CE2' ' A' ' 52' ' ' PHE . . . -131.81 131.9 43.28 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 118.992 -1.083 . . . . 0.0 111.651 -169.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.562 HD12 ' HD2' ' A' ' 87' ' ' LYS . 85.7 mt -99.96 134.01 43.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.288 -0.882 . . . . 0.0 108.991 169.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.569 ' NE2' ' HB1' ' A' ' 6' ' ' ALA . 49.7 m170 -128.51 129.67 46.38 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.833 -1.167 . . . . 0.0 111.116 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.59 ' HB ' HG22 ' A' ' 85' ' ' ILE . 80.0 mt -116.69 128.65 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.07 -1.019 . . . . 0.0 109.718 169.018 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.593 HD13 ' C ' ' A' ' 10' ' ' LEU . 2.4 tm? -106.58 120.32 41.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.274 -0.891 . . . . 0.0 109.911 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 1.059 HG13 HD22 ' A' ' 16' ' ' LEU . 2.3 t -106.77 125.45 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.312 -0.867 . . . . 0.0 110.282 -178.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -70.03 -37.86 75.71 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.373 -0.829 . . . . 0.0 110.499 175.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -106.48 136.8 45.6 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.086 -1.009 . . . . 0.0 111.061 -173.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.589 ' HG2' ' CZ ' ' A' ' 83' ' ' TYR . 97.1 mt-10 -59.99 -39.99 87.62 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.356 -0.84 . . . . 0.0 110.294 175.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -56.24 -44.51 79.69 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -0.913 . . . . 0.0 110.035 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.059 HD22 HG13 ' A' ' 11' ' ' VAL . 7.9 tt -68.56 -39.93 80.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.296 -0.877 . . . . 0.0 109.935 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.05 ' O ' HD12 ' A' ' 21' ' ' LEU . . . -58.2 -41.85 84.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.178 -0.951 . . . . 0.0 109.384 176.255 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.04 -45.36 93.08 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.075 -1.016 . . . . 0.0 109.365 171.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.439 ' HB3' ' O ' ' A' ' 16' ' ' LEU . 55.1 t0 -60.03 -42.49 94.5 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.417 -0.802 . . . . 0.0 110.11 176.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.701 ' C ' HD12 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -64.49 -47.05 80.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.237 -0.915 . . . . 0.0 109.523 178.09 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 1.05 HD12 ' O ' ' A' ' 17' ' ' ALA . 0.4 OUTLIER -56.53 -47.41 79.46 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.496 -0.753 . . . . 0.0 109.797 -178.955 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -61.2 -39.65 91.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.55 -0.719 . . . . 0.0 110.141 177.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.5 ' HG2' HD22 ' A' ' 33' ' ' LEU . 50.4 tp60 -59.94 -47.19 86.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.281 -0.887 . . . . 0.0 110.817 -172.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.761 HG21 ' CE2' ' A' ' 30' ' ' PHE . 2.3 mt -66.48 -43.54 90.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.055 -1.028 . . . . 0.0 110.888 -176.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -61.3 -44.26 97.51 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.702 -1.249 . . . . 0.0 109.983 -178.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -60.8 -65.33 0.71 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.149 -0.969 . . . . 0.0 110.491 175.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.759 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -105.86 -34.84 3.15 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -172.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.759 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 87.09 -147.05 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.338 0 O-C-N 122.373 -0.486 . . . . 0.0 110.328 -178.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.535 ' CB ' ' O ' ' A' ' 28' ' ' ALA . 0.5 OUTLIER 75.91 65.35 0.06 Allowed 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.308 0.575 . . . . 0.0 110.523 176.324 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.761 ' CE2' HG21 ' A' ' 24' ' ' ILE . 7.2 m-85 -60.03 -41.91 93.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.355 -0.841 . . . . 0.0 110.572 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.23 -53.82 33.93 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.176 -1.169 . . . . 0.0 110.176 -176.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.429 ' HD2' ' CG ' ' A' ' 29' ' ' ASP . 97.9 mttt -66.5 -39.98 89.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.011 -1.288 . . . . 0.0 110.555 -174.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.514 HD11 ' O ' ' A' ' 28' ' ' ALA . 88.7 mt -63.81 -40.06 95.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.097 -1.002 . . . . 0.0 109.915 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.414 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -59.98 -47.71 84.7 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.403 -0.811 . . . . 0.0 110.323 177.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -60.09 -43.14 95.74 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.271 -0.893 . . . . 0.0 110.654 -176.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 49.2 tttt -69.31 -53.79 17.88 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.037 -1.039 . . . . 0.0 110.98 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -70.39 -40.03 74.17 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.054 -1.029 . . . . 0.0 111.535 -172.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.673 ' O ' HG22 ' A' ' 39' ' ' ILE . 21.0 t -60.0 -43.55 95.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.882 -1.136 . . . . 0.0 110.187 -174.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.673 HG22 ' O ' ' A' ' 38' ' ' SER . 16.8 tt 38.26 32.04 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.655 -0.653 . . . . 0.0 110.747 176.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.489 ' SG ' ' N ' ' A' ' 43' ' ' GLY . 16.3 p -127.42 166.38 23.42 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.055 -1.028 . . . . 0.0 110.379 -176.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -51.99 -35.69 61.91 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.993 1.522 . . . . 0.0 110.56 -178.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.53 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -97.64 18.75 14.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.983 -1.073 . . . . 0.0 109.743 174.544 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.489 ' N ' ' SG ' ' A' ' 40' ' ' CYS . . . -77.2 -54.26 4.83 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 108.303 -1.919 . . . . 0.0 108.303 172.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -60.86 -39.98 91.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.527 -0.984 . . . . 0.0 110.657 176.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.485 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 11.7 tpp180 -97.95 -45.21 6.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.177 -0.952 . . . . 0.0 110.154 -177.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -68.3 -30.3 73.48 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 178.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.41 -1.37 57.35 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 176.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -171.89 68.29 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.3 -1.118 . . . . 0.0 108.85 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 7.2 mt -70.03 -28.1 65.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.54 -0.725 . . . . 0.0 110.347 -174.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 5' ' ' ALA . . . 98.92 -144.18 17.05 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.351 -1.499 . . . . 0.0 109.351 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.521 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 3.5 mt-10 -99.54 130.78 45.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.528 -0.983 . . . . 0.0 110.571 -178.042 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.628 ' CE2' ' HB3' ' A' ' 6' ' ' ALA . 3.3 p90 -149.02 168.41 23.2 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.241 -0.912 . . . . 0.0 110.875 178.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.529 ' CB ' ' O ' ' A' ' 2' ' ' LYS . 32.2 ttt85 -163.06 -65.18 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 173.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -68.88 136.7 53.04 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.488 -0.757 . . . . 0.0 109.655 169.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.486 ' C ' ' NE2' ' A' ' 56' ' ' GLN . . . 84.67 21.12 56.92 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 178.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.536 ' HG3' ' CD1' ' A' ' 52' ' ' PHE . 40.3 mm-40 -124.22 -64.05 1.15 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.048 -1.266 . . . . 0.0 109.763 177.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.602 ' C ' HG12 ' A' ' 58' ' ' VAL . 52.6 ttm 45.6 -107.13 0.13 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.78 -0.575 . . . . 0.0 110.874 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.602 HG12 ' C ' ' A' ' 57' ' ' MET . 7.2 p 45.41 127.51 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.551 0 CA-C-O 121.817 0.817 . . . . 0.0 113.079 -178.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.519 ' O ' ' N ' ' A' ' 62' ' ' ASP . 6.5 Cg_endo -51.69 -52.33 9.23 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 121.382 1.388 . . . . 0.0 110.997 -175.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 59' ' ' PRO . . . -42.01 -33.76 0.61 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.284 -0.885 . . . . 0.0 110.019 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.47 ' HB2' HG13 ' A' ' 58' ' ' VAL . 44.0 t80 -62.48 -39.75 94.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.334 -0.854 . . . . 0.0 110.028 177.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 59' ' ' PRO . 51.5 t0 -60.04 -40.0 87.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.34 -0.85 . . . . 0.0 110.536 -177.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 67' ' ' SER . 49.4 mttm -58.15 -48.49 80.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.093 -1.004 . . . . 0.0 111.434 -174.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.539 ' HA ' ' HB3' ' A' ' 67' ' ' SER . 2.4 p -94.73 -37.64 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.725 -1.235 . . . . 0.0 111.561 -173.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.2 p -54.82 -26.18 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.532 -1.355 . . . . 0.0 109.788 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.485 ' CD2' ' O ' ' A' ' 66' ' ' PHE . 50.7 t80 -100.68 0.05 38.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.315 -0.866 . . . . 0.0 110.127 176.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.539 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 41.2 t -94.03 -74.58 0.53 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.263 -0.898 . . . . 0.0 110.37 -176.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.482 ' O ' ' N ' ' A' ' 70' ' ' VAL . 94.5 m -100.27 142.8 25.3 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.244 -0.91 . . . . 0.0 110.388 -178.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.495 ' O ' ' C ' ' A' ' 70' ' ' VAL . 35.4 Cg_exo -56.47 81.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.053 1.554 . . . . 0.0 110.222 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.824 ' O ' HD12 ' A' ' 71' ' ' LEU . 16.8 m 13.41 65.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.391 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.824 HD12 ' O ' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -166.95 -47.41 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.456 -0.778 . . . . 0.0 110.315 177.583 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -83.34 148.05 54.76 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.229 -0.92 . . . . 0.0 110.434 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -70.52 141.32 41.88 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.105 1.582 . . . . 0.0 110.622 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.455 ' HB ' ' CG2' ' A' ' 64' ' ' VAL . 94.5 m -138.01 137.8 38.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.25 -0.906 . . . . 0.0 110.189 178.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 140.89 -167.11 25.75 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.756 ' HD3' HD21 ' A' ' 21' ' ' LEU . 43.1 Cg_endo -72.1 140.6 66.84 Favored 'Cis proline' 0 C--N 1.315 -1.231 0 C-N-CA 121.783 -2.174 . . . . 0.0 110.586 1.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.519 HD11 ' HB ' ' A' ' 64' ' ' VAL . 96.2 mt -90.89 170.39 10.12 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.39 -0.819 . . . . 0.0 109.998 -177.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -106.82 123.67 48.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.857 -1.152 . . . . 0.0 110.898 -177.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.1 t -138.59 164.77 28.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.371 -0.83 . . . . 0.0 109.338 173.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -56.74 -39.76 74.53 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.941 -1.099 . . . . 0.0 110.253 -175.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -60.05 -26.98 66.56 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.183 -0.948 . . . . 0.0 110.535 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 149.26 -137.76 6.47 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -176.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.589 ' CZ ' ' HG2' ' A' ' 14' ' ' GLU . 66.3 m-85 -98.64 124.86 43.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.992 -1.299 . . . . 0.0 110.367 177.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.438 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 1.9 m170 -101.7 114.17 27.99 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.475 -0.766 . . . . 0.0 110.309 174.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.59 HG22 ' HB ' ' A' ' 9' ' ' ILE . 3.1 tt -102.05 118.84 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 120.761 -1.212 . . . . 0.0 109.408 170.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.561 HG12 ' CD2' ' A' ' 8' ' ' HIS . 96.1 mt -112.07 129.98 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.462 -0.774 . . . . 0.0 111.017 -172.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.562 ' HD2' HD12 ' A' ' 7' ' ' LEU . 10.5 ttmm -105.17 127.08 52.74 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.868 -1.145 . . . . 0.0 109.31 168.063 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.771 ' O ' HD23 ' A' ' 89' ' ' LEU . 26.8 t -110.29 139.97 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.208 -0.933 . . . . 0.0 110.335 -173.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.771 HD23 ' O ' ' A' ' 88' ' ' VAL . 81.1 mt -148.9 177.15 9.81 Favored 'General case' 0 C--N 1.308 -1.203 0 O-C-N 121.336 -0.852 . . . . 0.0 109.402 -177.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.505 ' HB2' ' HB3' ' A' ' 5' ' ' ALA . 0.3 OUTLIER 67.49 -61.01 0.37 Allowed 'General case' 0 C--N 1.293 -1.859 0 O-C-N 121.422 -0.799 . . . . 0.0 111.389 167.23 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.791 ' HG2' ' HB2' ' A' ' 1' ' ' ALA . 61.7 ttt-85 54.85 40.08 31.79 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.04 -1.038 . . . . 0.0 110.567 -174.09 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.095 -1.003 . . . . 0.0 110.308 -179.948 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.276 0.56 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.8 tttt -59.9 -40.0 87.31 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.235 -0.916 . . . . 0.0 110.052 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.454 ' O ' ' N ' ' A' ' 92' ' ' ASN . 67.4 p -139.69 156.53 46.76 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.366 -0.834 . . . . 0.0 110.262 177.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 91' ' ' ARG . . . -138.56 143.44 39.42 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.192 -0.942 . . . . 0.0 110.264 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.609 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -94.53 130.32 40.98 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.315 -0.866 . . . . 0.0 109.145 173.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.748 ' HB3' ' CZ ' ' A' ' 52' ' ' PHE . . . -146.8 134.91 21.57 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.845 -1.159 . . . . 0.0 111.534 -171.126 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.646 HD12 ' HD3' ' A' ' 87' ' ' LYS . 88.6 mt -107.35 149.88 27.34 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.298 -0.876 . . . . 0.0 109.581 173.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.665 ' ND1' HD12 ' A' ' 49' ' ' LEU . 25.1 m80 -136.39 143.4 43.97 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.795 -1.19 . . . . 0.0 111.634 -176.205 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.618 HG12 ' HB2' ' A' ' 34' ' ' ALA . 91.1 mt -130.96 130.77 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.005 -1.059 . . . . 0.0 109.575 166.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.589 ' HG ' ' CD2' ' A' ' 84' ' ' HIS . 0.3 OUTLIER -104.72 119.96 40.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.428 -0.795 . . . . 0.0 110.053 179.782 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.749 HG11 ' N ' ' A' ' 17' ' ' ALA . 2.5 t -105.04 126.6 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.17 -0.956 . . . . 0.0 110.266 178.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 26.2 mmtm -69.19 -40.01 78.33 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.479 -0.763 . . . . 0.0 110.32 177.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -109.32 140.54 42.86 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.217 -0.927 . . . . 0.0 110.918 -173.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -60.13 -47.46 85.81 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.409 -0.807 . . . . 0.0 110.36 175.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -59.35 -40.71 87.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.276 -0.89 . . . . 0.0 110.335 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.42 ' CD2' HG13 ' A' ' 11' ' ' VAL . 2.5 tt -67.84 -39.98 83.8 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.312 -0.867 . . . . 0.0 109.627 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.995 ' O ' HD12 ' A' ' 21' ' ' LEU . . . -59.02 -43.76 91.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -0.923 . . . . 0.0 109.815 175.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.93 -43.1 95.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.192 -0.943 . . . . 0.0 109.942 175.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -60.01 -41.63 92.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.402 -0.811 . . . . 0.0 110.162 178.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.707 ' C ' HD12 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -64.18 -46.09 85.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.161 -0.962 . . . . 0.0 109.825 178.666 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.995 HD12 ' O ' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -58.21 -50.03 75.0 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.329 -0.857 . . . . 0.0 110.428 -178.05 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -60.01 -36.93 78.27 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.213 -0.93 . . . . 0.0 110.261 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.485 ' HG2' HD21 ' A' ' 33' ' ' LEU . 52.8 tp60 -59.99 -40.01 87.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.189 -0.944 . . . . 0.0 110.374 -175.034 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.823 HG21 ' HE1' ' A' ' 30' ' ' PHE . 3.9 mt -63.73 -41.96 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.112 -0.993 . . . . 0.0 110.715 -178.016 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -59.96 -45.69 91.86 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.824 -1.172 . . . . 0.0 109.565 176.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -59.78 -67.37 0.39 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.169 -0.957 . . . . 0.0 110.375 173.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.747 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -106.54 -35.03 2.94 Favored Glycine 0 N--CA 1.487 2.067 0 C-N-CA 120.057 -1.068 . . . . 0.0 110.617 -170.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.747 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 85.37 -156.91 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.402 0 O-C-N 122.001 -0.705 . . . . 0.0 110.196 -174.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.552 ' CB ' ' O ' ' A' ' 28' ' ' ALA . 0.7 OUTLIER 78.7 71.59 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 CA-C-O 121.487 0.66 . . . . 0.0 110.563 176.865 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.823 ' HE1' HG21 ' A' ' 24' ' ' ILE . 1.7 m-85 -62.43 -42.21 99.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.203 -0.935 . . . . 0.0 110.664 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.29 -44.4 97.54 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 -176.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.6 mmtt -63.79 -39.96 95.51 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.162 -1.199 . . . . 0.0 110.082 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.58 ' CD1' HG13 ' A' ' 24' ' ' ILE . 85.9 mt -62.55 -39.92 95.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.107 -0.995 . . . . 0.0 110.355 176.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.618 ' HB2' HG12 ' A' ' 9' ' ' ILE . . . -58.17 -48.65 79.62 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.095 -1.003 . . . . 0.0 110.186 -178.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -59.24 -49.08 79.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.281 -0.887 . . . . 0.0 110.159 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -70.0 -43.04 72.22 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.297 -0.877 . . . . 0.0 111.473 -176.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -80.07 -49.99 10.98 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.031 -1.043 . . . . 0.0 111.217 -173.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.649 ' O ' HG22 ' A' ' 39' ' ' ILE . 54.1 m -60.12 -39.91 87.89 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.053 -1.029 . . . . 0.0 111.064 -172.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.649 HG22 ' O ' ' A' ' 38' ' ' SER . 10.9 tp 39.02 28.95 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.528 -0.733 . . . . 0.0 110.375 -178.301 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.469 ' N ' ' O ' ' A' ' 38' ' ' SER . 17.5 p -122.8 160.16 50.29 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.328 -0.857 . . . . 0.0 109.823 -178.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -52.68 -20.68 12.99 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.84 1.442 . . . . 0.0 110.42 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.525 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -106.58 16.41 24.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.181 -0.949 . . . . 0.0 110.205 176.885 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.49 -51.41 5.61 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.611 -1.796 . . . . 0.0 108.611 172.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.468 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 48.5 tttp -60.02 -39.99 87.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.423 -1.045 . . . . 0.0 110.259 177.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.535 ' HA ' ' OD1' ' A' ' 48' ' ' ASP . 20.7 tpt180 -96.68 -42.05 8.21 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.369 -0.832 . . . . 0.0 110.479 -177.033 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -63.25 -28.98 73.12 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.94 0.16 53.13 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 176.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.535 ' OD1' ' HA ' ' A' ' 45' ' ' ARG . 43.8 p-10 -170.15 62.75 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.249 -1.147 . . . . 0.0 109.183 -177.066 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.665 HD12 ' ND1' ' A' ' 8' ' ' HIS . 10.3 mt -69.98 -29.23 66.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.398 -0.814 . . . . 0.0 110.749 -175.102 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.21 -145.06 17.49 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -178.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.406 ' HG3' ' C ' ' A' ' 4' ' ' ALA . 32.9 tt0 -112.27 136.38 51.77 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.19 -1.182 . . . . 0.0 110.217 -178.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.748 ' CZ ' ' HB3' ' A' ' 6' ' ' ALA . 0.1 OUTLIER -133.79 -166.1 1.73 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.299 -0.876 . . . . 0.0 109.705 174.411 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.456 ' O ' ' HB3' ' A' ' 54' ' ' GLN . 95.9 mtt-85 -65.0 -40.31 94.74 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.845 -1.159 . . . . 0.0 109.865 -178.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.507 ' O ' ' CE2' ' A' ' 61' ' ' PHE . 14.1 pt20 -178.1 30.14 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.474 -0.766 . . . . 0.0 110.302 177.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.491 ' HA3' ' CD2' ' A' ' 61' ' ' PHE . . . 117.81 -69.58 0.31 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.48 ' CB ' ' O ' ' A' ' 55' ' ' GLY . 13.3 mt-30 68.93 -56.27 0.53 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.407 -1.054 . . . . 0.0 109.949 175.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.467 ' N ' ' O ' ' A' ' 55' ' ' GLY . 59.2 ttp -55.11 -43.44 74.05 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.75 -0.594 . . . . 0.0 110.941 -176.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.483 HG13 ' O ' ' A' ' 58' ' ' VAL . 15.0 p -141.92 132.24 12.76 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.142 -0.974 . . . . 0.0 110.286 -175.002 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -60.92 -49.67 7.83 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.879 1.462 . . . . 0.0 110.408 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -44.8 -29.43 0.79 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.24 -0.912 . . . . 0.0 110.574 -179.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.8 ' CD1' HG21 ' A' ' 86' ' ' ILE . 59.4 t80 -60.01 -44.29 94.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.082 -1.011 . . . . 0.0 110.177 178.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -59.93 -42.0 93.02 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.05 -1.031 . . . . 0.0 109.549 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.493 ' O ' ' N ' ' A' ' 67' ' ' SER . 93.4 mttt -60.02 -47.42 85.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.512 -0.743 . . . . 0.0 111.011 -178.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.556 ' HB ' HD13 ' A' ' 77' ' ' LEU . 10.3 p -73.02 -46.57 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 120.872 -1.143 . . . . 0.0 110.98 -175.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.552 ' N ' HG13 ' A' ' 64' ' ' VAL . 9.8 p -60.2 -22.05 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.208 -1.558 . . . . 0.0 109.662 170.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -90.41 -13.62 34.59 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.85 -1.156 . . . . 0.0 109.366 171.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.511 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 12.4 t -87.5 -61.85 1.63 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.464 -0.773 . . . . 0.0 108.917 172.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.511 ' N ' ' O ' ' A' ' 64' ' ' VAL . 31.3 p -82.5 133.31 50.09 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 120.876 -1.14 . . . . 0.0 109.087 167.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.507 ' O ' ' NH1' ' A' ' 91' ' ' ARG . 41.3 Cg_exo -52.28 -68.66 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.713 1.375 . . . . 0.0 110.671 -174.119 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.005 HG22 HD12 ' A' ' 71' ' ' LEU . 7.6 p -179.01 162.16 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -177.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.005 HD12 HG22 ' A' ' 70' ' ' VAL . 3.3 mp 42.76 32.96 0.43 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.897 -1.127 . . . . 0.0 109.946 -170.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.487 ' CG ' ' O ' ' A' ' 70' ' ' VAL . 8.4 mm-40 -130.9 79.98 70.49 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.667 -0.646 . . . . 0.0 109.918 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -47.07 126.64 11.63 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 123.859 1.452 . . . . 0.0 110.012 -178.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.416 ' OG1' ' HB3' ' A' ' 68' ' ' CYS . 70.7 m -135.38 139.37 44.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.182 -0.949 . . . . 0.0 110.432 -176.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.94 -170.82 25.13 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.971 ' CD ' HD11 ' A' ' 21' ' ' LEU . 42.0 Cg_endo -69.53 136.46 38.39 Favored 'Cis proline' 0 C--N 1.314 -1.262 0 C-N-CA 121.767 -2.18 . . . . 0.0 110.455 0.164 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.556 HD13 ' HB ' ' A' ' 64' ' ' VAL . 1.0 OUTLIER -95.29 142.69 27.4 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.221 -0.924 . . . . 0.0 110.433 -175.017 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -64.75 130.06 42.12 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.107 -0.995 . . . . 0.0 110.633 -176.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.505 HG21 ' CE1' ' A' ' 84' ' ' HIS . 9.5 t -144.66 160.24 41.51 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.283 -0.886 . . . . 0.0 110.375 178.202 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.591 ' HG3' ' CD2' ' A' ' 81' ' ' PHE . 20.1 pt20 -63.06 -16.22 59.19 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.263 -0.898 . . . . 0.0 110.879 -177.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.591 ' CD2' ' HG3' ' A' ' 80' ' ' GLN . 98.4 m-85 -95.01 6.27 49.56 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.003 -1.061 . . . . 0.0 110.457 -178.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 126.39 -115.4 2.26 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 -175.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.469 ' HB3' ' HB2' ' A' ' 76' ' ' PRO . 69.2 m-85 -140.41 126.97 20.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.09 -1.241 . . . . 0.0 110.287 175.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.589 ' CD2' ' HG ' ' A' ' 10' ' ' LEU . 42.1 m170 -103.31 127.57 50.61 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.522 -0.736 . . . . 0.0 110.676 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.582 HG22 ' HB ' ' A' ' 9' ' ' ILE . 8.4 tt -109.15 129.59 63.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 120.605 -1.309 . . . . 0.0 109.065 166.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.8 HG21 ' CD1' ' A' ' 61' ' ' PHE . 72.2 mt -130.18 135.1 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.015 -1.053 . . . . 0.0 110.701 -169.076 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.646 ' HD3' HD12 ' A' ' 7' ' ' LEU . 12.5 mtpt -97.91 139.16 34.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.45 -0.781 . . . . 0.0 109.58 176.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.547 HG11 ' HA ' ' A' ' 70' ' ' VAL . 28.0 t -109.74 137.47 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.473 -0.767 . . . . 0.0 110.146 -178.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.609 ' HB2' ' HB3' ' A' ' 5' ' ' ALA . 92.3 mt -144.34 135.79 25.64 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.064 -1.022 . . . . 0.0 109.551 178.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.543 ' CD2' ' HB3' ' A' ' 89' ' ' LEU . 70.9 m-85 65.31 -63.42 0.2 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.332 -0.855 . . . . 0.0 111.076 177.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.507 ' NH1' ' O ' ' A' ' 69' ' ' PRO . 33.7 ttp180 49.95 38.65 16.8 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.049 -1.032 . . . . 0.0 110.214 -175.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.454 ' N ' ' O ' ' A' ' 3' ' ' THR . 60.0 t30 . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 117.965 -1.017 . . . . 0.0 110.229 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.265 0.555 . . . . 0.0 110.243 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -66.43 -39.97 89.24 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.887 0.851 . . . . 0.0 109.807 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.6 t -159.49 155.46 26.5 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.972 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.54 ' O ' ' CD1' ' A' ' 52' ' ' PHE . . . -151.45 154.81 37.31 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.107 -0.995 . . . . 0.0 110.623 -174.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.529 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -101.32 140.0 36.22 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.009 -1.057 . . . . 0.0 109.14 171.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.727 ' HB3' ' CZ ' ' A' ' 52' ' ' PHE . . . -159.04 154.55 25.9 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.859 -1.151 . . . . 0.0 111.29 -178.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.803 HD12 ' HD2' ' A' ' 87' ' ' LYS . 82.2 mt -109.91 149.99 29.09 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.434 -0.791 . . . . 0.0 109.142 172.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.875 ' CD2' HD12 ' A' ' 49' ' ' LEU . 46.5 m-70 -137.2 133.55 35.29 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.789 -1.194 . . . . 0.0 111.383 -177.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.69 ' HB ' HG22 ' A' ' 85' ' ' ILE . 87.3 mt -120.01 120.99 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.113 -0.992 . . . . 0.0 109.605 168.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.782 HD13 ' C ' ' A' ' 10' ' ' LEU . 2.7 tm? -104.07 120.08 40.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.477 -0.765 . . . . 0.0 109.817 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.862 HG13 HD22 ' A' ' 16' ' ' LEU . 2.4 t -103.81 130.08 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.29 -0.881 . . . . 0.0 110.346 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -65.93 -40.08 91.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.459 -0.776 . . . . 0.0 110.551 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -119.54 140.02 51.2 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.126 -0.984 . . . . 0.0 110.531 -175.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.453 ' HB2' ' CE1' ' A' ' 83' ' ' TYR . 86.8 tt0 -59.91 -39.99 87.32 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.372 -0.83 . . . . 0.0 110.352 -178.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.6 mttt -52.46 -47.42 66.48 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.188 -0.945 . . . . 0.0 110.069 -176.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.862 HD22 HG13 ' A' ' 11' ' ' VAL . 8.4 tt -68.71 -37.07 79.22 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.104 -0.997 . . . . 0.0 109.546 176.115 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.665 ' HA ' HD23 ' A' ' 20' ' ' LEU . . . -56.94 -49.29 76.1 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.042 -1.036 . . . . 0.0 109.522 176.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.448 ' HA ' HD12 ' A' ' 21' ' ' LEU . 0.9 OUTLIER -58.31 -40.44 82.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.15 -0.969 . . . . 0.0 109.579 174.573 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.48 ' HB3' ' O ' ' A' ' 16' ' ' LEU . 51.5 t0 -60.0 -39.98 87.66 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.096 -1.002 . . . . 0.0 109.671 174.055 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 1.011 HD13 HD21 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -62.91 -44.27 96.55 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.16 -0.963 . . . . 0.0 109.668 178.125 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.841 HD21 ' HD3' ' A' ' 76' ' ' PRO . 1.3 mt -59.9 -50.14 74.93 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.381 -0.824 . . . . 0.0 110.07 -178.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -62.87 -39.92 95.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.314 -0.867 . . . . 0.0 110.247 177.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.451 ' O ' ' N ' ' A' ' 27' ' ' GLY . 64.9 tp60 -60.07 -40.95 91.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.305 -0.872 . . . . 0.0 110.311 -177.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.517 ' O ' ' N ' ' A' ' 28' ' ' ALA . 85.5 mt -67.32 -40.35 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.179 -0.95 . . . . 0.0 109.795 177.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -63.85 -59.96 3.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.139 -0.976 . . . . 0.0 109.598 176.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -60.32 -52.37 65.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.438 -0.789 . . . . 0.0 110.866 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 28' ' ' ALA . . . -106.18 -13.0 24.21 Favored Glycine 0 N--CA 1.487 2.041 0 C-N-CA 119.647 -1.263 . . . . 0.0 110.597 -166.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 24' ' ' ILE . . . 34.1 95.37 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.751 -0.853 . . . . 0.0 111.459 -177.119 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -171.68 86.35 0.09 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.466 -0.771 . . . . 0.0 109.827 -176.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.503 ' CG ' ' HE3' ' A' ' 87' ' ' LYS . 3.9 m-85 -69.8 -40.12 76.18 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.325 -0.859 . . . . 0.0 110.764 -176.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.36 -52.08 53.81 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -63.73 -41.1 98.12 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.185 -1.185 . . . . 0.0 110.513 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.011 HD21 HD13 ' A' ' 20' ' ' LEU . 33.0 tp -61.74 -50.06 73.91 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.074 -1.016 . . . . 0.0 110.716 -175.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.667 ' HB2' HG12 ' A' ' 9' ' ' ILE . . . -59.95 -47.88 83.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.198 -0.939 . . . . 0.0 110.383 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 50.3 mttm -60.02 -49.78 76.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.212 -0.93 . . . . 0.0 110.592 -176.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.456 ' O ' HG13 ' A' ' 39' ' ' ILE . 57.2 tptt -69.72 -52.5 24.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.156 -0.965 . . . . 0.0 111.235 -175.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.694 ' HB3' HD21 ' A' ' 16' ' ' LEU . 86.9 m-70 -83.21 -40.28 19.85 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.913 -1.117 . . . . 0.0 111.583 -170.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.483 ' HB3' ' O ' ' A' ' 34' ' ' ALA . 18.4 t -60.01 -45.2 93.54 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.973 -1.08 . . . . 0.0 110.443 -176.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.623 ' O ' HG22 ' A' ' 39' ' ' ILE . 80.2 mt 34.14 45.76 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 CA-C-O 121.322 0.582 . . . . 0.0 110.769 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.512 ' SG ' ' N ' ' A' ' 43' ' ' GLY . 17.2 p -133.91 160.04 70.09 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.254 -0.904 . . . . 0.0 110.093 -177.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.404 ' HD2' ' HB2' ' A' ' 40' ' ' CYS . 6.7 Cg_endo -54.02 -23.8 29.88 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.962 1.506 . . . . 0.0 110.522 -177.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.511 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -109.12 20.54 18.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.085 -1.009 . . . . 0.0 110.084 176.902 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.512 ' N ' ' SG ' ' A' ' 40' ' ' CYS . . . -79.11 -59.65 2.7 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 176.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -60.02 -33.91 72.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.41 -1.053 . . . . 0.0 110.39 176.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.458 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 16.0 tpt180 -91.57 -39.73 11.74 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.109 -0.994 . . . . 0.0 110.158 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -70.75 -29.02 69.9 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 177.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.97 0.54 58.06 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 173.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -168.76 63.34 0.06 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.291 -1.123 . . . . 0.0 109.134 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.875 HD12 ' CD2' ' A' ' 8' ' ' HIS . 12.7 mt -70.12 -28.89 65.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.599 -0.688 . . . . 0.0 110.155 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.27 -136.02 12.69 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.231 -1.547 . . . . 0.0 109.231 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -113.66 148.16 36.82 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.382 -1.069 . . . . 0.0 110.171 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.727 ' CZ ' ' HB3' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -131.45 160.41 35.23 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.205 -0.934 . . . . 0.0 109.879 -172.382 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.543 ' O ' ' N ' ' A' ' 55' ' ' GLY . 36.5 ptt-85 -154.54 176.87 11.85 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.297 -0.877 . . . . 0.0 110.468 -173.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.495 ' O ' ' O ' ' A' ' 55' ' ' GLY . 87.2 mt-30 27.18 -84.16 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.274 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . -55.13 -117.7 0.01 OUTLIER Glycine 0 N--CA 1.495 2.614 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -175.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.513 ' OE1' ' HB3' ' A' ' 52' ' ' PHE . 44.3 mm-40 65.99 -65.4 0.18 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.137 -1.214 . . . . 0.0 109.944 -176.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.523 ' N ' ' O ' ' A' ' 55' ' ' GLY . 37.5 ttp 65.29 -56.47 0.31 Allowed 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.861 172.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.554 HG23 ' HD2' ' A' ' 59' ' ' PRO . 2.0 p -42.94 137.95 2.45 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 120.821 -1.175 . . . . 0.0 110.426 -169.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.554 ' HD2' HG23 ' A' ' 58' ' ' VAL . 32.9 Cg_endo -70.28 -55.01 0.17 Allowed 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.126 1.593 . . . . 0.0 111.059 -173.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.5 ' O ' HG12 ' A' ' 64' ' ' VAL . . . -42.67 -34.64 0.93 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.116 -0.99 . . . . 0.0 110.469 -174.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.434 ' CE2' ' CE1' ' A' ' 52' ' ' PHE . 56.1 t80 -60.0 -44.07 94.79 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.233 -0.917 . . . . 0.0 110.092 -179.4 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.522 ' OD1' ' CD1' ' A' ' 66' ' ' PHE . 56.5 t0 -68.31 -45.26 73.48 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.295 -0.878 . . . . 0.0 110.553 -178.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' A' ' 67' ' ' SER . 11.3 tptt -56.36 -50.15 72.37 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.031 -1.043 . . . . 0.0 110.269 -176.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.522 ' HA ' ' HB3' ' A' ' 67' ' ' SER . 5.8 p -69.5 -46.73 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.089 -1.007 . . . . 0.0 111.443 -173.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.51 ' N ' HG13 ' A' ' 64' ' ' VAL . 6.8 p -58.15 -26.14 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.297 -1.502 . . . . 0.0 109.468 173.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.522 ' CD1' ' OD1' ' A' ' 62' ' ' ASP . 17.4 m-85 -96.2 -1.78 47.59 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.21 -0.931 . . . . 0.0 110.148 174.072 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.522 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 9.4 t -97.41 -59.03 1.87 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.348 -0.845 . . . . 0.0 109.67 173.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.536 ' CB ' ' HG1' ' A' ' 74' ' ' THR . 23.0 p -107.08 147.72 35.66 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.4 -0.813 . . . . 0.0 110.146 177.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -71.68 171.27 16.74 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 124.046 1.551 . . . . 0.0 110.682 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.066 HG22 HD12 ' A' ' 71' ' ' LEU . 7.1 p -58.7 158.6 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.465 -0.772 . . . . 0.0 110.145 178.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.066 HD12 HG22 ' A' ' 70' ' ' VAL . 3.2 mp 56.75 39.55 29.59 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.195 -0.941 . . . . 0.0 110.0 -175.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.419 ' C ' ' OE1' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -148.36 93.63 4.34 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.366 -0.834 . . . . 0.0 110.115 -179.907 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -63.15 130.52 29.13 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.981 1.516 . . . . 0.0 110.164 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.536 ' HG1' ' CB ' ' A' ' 68' ' ' CYS . 33.3 m -135.88 140.49 44.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.288 -0.882 . . . . 0.0 110.415 -178.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 149.16 -169.83 29.51 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.219 -1.553 . . . . 0.0 109.219 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.841 ' HD3' HD21 ' A' ' 21' ' ' LEU . 46.7 Cg_endo -76.03 136.36 44.24 Favored 'Cis proline' 0 C--N 1.313 -1.329 0 C-N-CA 121.825 -2.156 . . . . 0.0 110.663 -1.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 41.2 mt -93.36 -173.22 3.16 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.319 -0.863 . . . . 0.0 109.962 178.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -111.74 121.22 44.49 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.997 -1.064 . . . . 0.0 111.306 -173.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.482 HG21 ' CD2' ' A' ' 84' ' ' HIS . 9.8 t -138.06 164.28 29.48 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.274 -0.891 . . . . 0.0 109.438 170.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -54.92 -36.53 65.33 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.141 -0.975 . . . . 0.0 110.618 -175.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -63.13 -30.37 71.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.062 -1.024 . . . . 0.0 110.78 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 152.07 -135.58 5.06 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -177.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 10' ' ' LEU . 39.0 m-85 -93.98 131.12 39.76 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.35 -1.088 . . . . 0.0 109.96 177.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.482 ' CD2' HG21 ' A' ' 79' ' ' THR . 0.0 OUTLIER -111.93 113.25 25.45 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.432 -0.792 . . . . 0.0 110.999 -178.863 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.713 HD13 HD11 ' A' ' 20' ' ' LEU . 4.5 tt -110.03 132.46 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.881 -1.137 . . . . 0.0 109.117 169.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.514 HG12 ' ND1' ' A' ' 8' ' ' HIS . 89.1 mt -135.98 140.12 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.598 -1.314 . . . . 0.0 111.899 -168.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.803 ' HD2' HD12 ' A' ' 7' ' ' LEU . 15.1 mttm -92.65 142.26 27.56 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.387 -0.821 . . . . 0.0 110.038 170.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.474 ' CG1' ' HD3' ' A' ' 91' ' ' ARG . 59.7 t -109.72 133.69 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.768 -0.582 . . . . 0.0 109.983 178.095 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.529 ' HB2' ' HB3' ' A' ' 5' ' ' ALA . 81.0 mt -141.89 129.09 20.99 Favored 'General case' 0 C--N 1.308 -1.2 0 O-C-N 121.005 -1.059 . . . . 0.0 109.947 -176.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.488 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 42.2 m-85 65.29 -55.29 0.32 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.228 -0.92 . . . . 0.0 111.587 173.197 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.527 ' NE ' ' HB ' ' A' ' 70' ' ' VAL . 84.6 mtm180 56.27 40.23 29.98 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.037 -1.04 . . . . 0.0 110.894 -177.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 91' ' ' ARG . 53.2 t30 . . . . . 0 N--CA 1.492 1.649 0 O-C-N 120.967 -1.083 . . . . 0.0 110.272 177.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.196 0.522 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 58.0 mmtt -61.8 -40.14 94.17 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.298 -0.876 . . . . 0.0 110.251 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.664 HG22 ' CB ' ' A' ' 53' ' ' ARG . 14.8 p -143.16 162.77 34.71 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.391 -0.818 . . . . 0.0 109.596 -178.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.454 ' C ' ' HG3' ' A' ' 51' ' ' GLU . . . -149.96 153.61 36.88 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.839 -1.163 . . . . 0.0 111.029 -178.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.441 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -96.69 131.46 43.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.424 -0.798 . . . . 0.0 109.253 174.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.671 ' HB3' ' CZ ' ' A' ' 52' ' ' PHE . . . -147.41 122.73 10.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.834 -1.166 . . . . 0.0 111.688 -172.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.593 ' N ' ' CD1' ' A' ' 7' ' ' LEU . 3.5 mp -97.07 141.16 30.55 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.173 -0.954 . . . . 0.0 109.283 170.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.73 ' CD2' HD12 ' A' ' 49' ' ' LEU . 25.8 m-70 -134.54 128.17 32.78 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.887 -1.133 . . . . 0.0 110.947 -175.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.548 ' HB ' ' CG2' ' A' ' 85' ' ' ILE . 76.4 mt -109.96 129.96 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 120.882 -1.136 . . . . 0.0 110.136 168.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.597 ' HG ' ' CD2' ' A' ' 84' ' ' HIS . 0.3 OUTLIER -101.68 118.61 37.3 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.552 -0.717 . . . . 0.0 109.711 178.648 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.828 HG13 HD22 ' A' ' 16' ' ' LEU . 2.0 t -101.48 127.21 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.243 -0.911 . . . . 0.0 110.125 -177.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.1 mttp -69.28 -40.01 78.0 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.308 -0.87 . . . . 0.0 110.313 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -132.52 152.21 51.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.295 -0.878 . . . . 0.0 110.26 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.527 ' HG3' ' CZ ' ' A' ' 83' ' ' TYR . 95.2 mt-10 -59.04 -39.9 83.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.29 -0.881 . . . . 0.0 110.409 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -51.31 -44.62 61.97 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.191 -0.943 . . . . 0.0 110.34 -176.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.828 HD22 HG13 ' A' ' 11' ' ' VAL . 9.7 tt -68.89 -40.0 79.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.044 -1.035 . . . . 0.0 109.715 177.002 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.954 ' O ' HD12 ' A' ' 21' ' ' LEU . . . -59.87 -44.43 94.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.307 -0.871 . . . . 0.0 110.14 177.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.85 -45.8 89.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.218 -0.926 . . . . 0.0 109.819 178.006 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.49 ' O ' ' HB2' ' A' ' 23' ' ' GLN . 53.1 t0 -60.03 -42.2 93.86 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.345 -0.847 . . . . 0.0 110.187 177.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.727 ' C ' HD12 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -66.47 -43.56 85.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.147 -0.97 . . . . 0.0 110.047 -179.711 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.954 HD12 ' O ' ' A' ' 17' ' ' ALA . 0.3 OUTLIER -55.26 -59.93 4.1 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.38 -0.825 . . . . 0.0 110.072 -177.869 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -63.9 -40.0 95.48 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.394 -0.816 . . . . 0.0 110.707 177.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.574 ' HA ' ' OD1' ' A' ' 26' ' ' ASN . 7.4 tt0 -60.11 -29.49 68.64 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.118 -0.989 . . . . 0.0 110.185 -176.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.533 ' O ' ' CA ' ' A' ' 28' ' ' ALA . 91.6 mt -68.2 -40.01 82.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 120.687 -1.258 . . . . 0.0 109.606 173.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.4 tttp -66.69 -60.09 3.01 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.097 -1.002 . . . . 0.0 110.696 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.574 ' OD1' ' HA ' ' A' ' 23' ' ' GLN . 47.3 p30 -62.16 -33.68 74.96 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.105 -0.997 . . . . 0.0 110.501 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.758 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -106.23 -65.3 0.63 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.758 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 85.58 95.51 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.254 0 CA-C-O 121.624 0.725 . . . . 0.0 110.615 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -177.1 80.01 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.61 -0.681 . . . . 0.0 109.651 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.588 ' CG ' ' HE2' ' A' ' 87' ' ' LYS . 5.5 m-85 -60.1 -47.77 84.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.876 . . . . 0.0 110.903 -174.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.05 -50.33 68.8 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 119.715 -1.231 . . . . 0.0 110.045 -176.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -66.6 -40.04 88.66 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.131 -1.217 . . . . 0.0 110.78 -175.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.417 ' CD2' ' OE1' ' A' ' 23' ' ' GLN . 83.8 mt -66.3 -40.19 89.84 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.164 -0.96 . . . . 0.0 110.562 -178.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.529 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -60.06 -50.03 75.34 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.049 -1.032 . . . . 0.0 110.198 177.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -60.02 -49.95 75.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.229 -0.919 . . . . 0.0 111.158 -177.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.0 tttp -70.08 -45.17 67.6 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.005 -1.06 . . . . 0.0 111.165 -172.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -81.61 -32.02 32.19 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.101 -1.0 . . . . 0.0 110.832 -174.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.49 ' CB ' ' O ' ' A' ' 34' ' ' ALA . 27.5 t -60.19 -44.92 94.71 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.121 -0.987 . . . . 0.0 111.31 -173.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.627 ' O ' HG22 ' A' ' 39' ' ' ILE . 73.6 mt 44.69 25.93 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 120.904 -1.122 . . . . 0.0 109.762 -173.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.462 ' SG ' ' HD2' ' A' ' 41' ' ' PRO . 35.8 t -117.43 143.27 31.76 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.391 -0.818 . . . . 0.0 109.943 -178.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.462 ' HD2' ' SG ' ' A' ' 40' ' ' CYS . 52.7 Cg_exo -49.21 -20.92 3.85 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.849 1.447 . . . . 0.0 110.655 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.514 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -109.12 19.92 18.94 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.182 -0.949 . . . . 0.0 109.81 176.877 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' A' ' 47' ' ' GLY . . . -75.05 -59.46 3.65 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 174.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -60.05 -39.97 87.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.389 -1.066 . . . . 0.0 110.573 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -94.14 -42.3 9.06 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.924 -1.11 . . . . 0.0 110.413 -176.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -70.6 -24.52 76.8 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 174.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 43' ' ' GLY . . . -74.4 -1.0 59.76 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 173.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.436 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 49.0 t0 -173.06 70.29 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.352 -1.087 . . . . 0.0 109.122 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.73 HD12 ' CD2' ' A' ' 8' ' ' HIS . 11.9 mt -72.47 -6.59 44.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.633 -0.667 . . . . 0.0 110.156 -176.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 5' ' ' ALA . . . 76.55 -121.9 6.2 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -176.057 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.454 ' HG3' ' C ' ' A' ' 4' ' ' ALA . 71.3 tt0 -126.92 140.21 52.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.231 -1.158 . . . . 0.0 110.412 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.671 ' CZ ' ' HB3' ' A' ' 6' ' ' ALA . 2.4 p90 -142.63 169.16 18.09 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.302 -0.874 . . . . 0.0 110.263 178.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.664 ' CB ' HG22 ' A' ' 3' ' ' THR . 34.3 ptt180 -155.05 145.0 21.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.979 -1.076 . . . . 0.0 111.628 -172.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.459 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 15.9 pt20 24.98 47.09 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 170.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 56' ' ' GLN . . . 179.97 47.06 0.08 OUTLIER Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.204 -1.474 . . . . 0.0 110.393 174.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.471 ' OE1' ' O ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER 173.54 -113.56 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.159 -1.2 . . . . 0.0 109.76 178.975 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.461 ' HB2' ' O ' ' A' ' 56' ' ' GLN . 95.9 mtp 55.89 -174.48 0.05 Allowed 'General case' 0 N--CA 1.485 1.292 0 O-C-N 120.91 -1.119 . . . . 0.0 111.458 173.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.55 ' CG1' ' HB2' ' A' ' 61' ' ' PHE . 4.2 p -151.55 134.78 9.07 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.694 -0.629 . . . . 0.0 109.462 -176.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.4 ' C ' ' O ' ' A' ' 58' ' ' VAL . 49.1 Cg_exo -36.45 -49.3 1.31 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.8 1.421 . . . . 0.0 111.363 -174.079 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.806 ' HB1' HD23 ' A' ' 77' ' ' LEU . . . -59.98 -39.25 85.06 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.034 -1.041 . . . . 0.0 110.334 -178.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.633 ' CD1' HG21 ' A' ' 86' ' ' ILE . 66.4 t80 -59.95 -37.85 80.74 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.321 -0.862 . . . . 0.0 110.344 -178.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.516 ' O ' HG12 ' A' ' 65' ' ' VAL . 55.2 t0 -59.96 -48.6 81.02 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.061 -1.025 . . . . 0.0 110.102 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.493 ' O ' ' HB2' ' A' ' 67' ' ' SER . 24.3 tptm -60.09 -51.13 70.93 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.048 -1.033 . . . . 0.0 110.46 178.02 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.687 HG11 HD12 ' A' ' 86' ' ' ILE . 8.8 p -70.26 -46.99 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.049 -1.032 . . . . 0.0 111.173 -174.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.578 ' N ' HG13 ' A' ' 64' ' ' VAL . 3.8 p -53.95 -28.87 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.59 -1.319 . . . . 0.0 109.268 174.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -95.62 -10.56 29.12 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.223 -0.923 . . . . 0.0 110.252 175.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.55 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 7.7 t -91.08 -69.23 0.74 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.246 -0.909 . . . . 0.0 109.951 176.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.486 ' CB ' ' HG1' ' A' ' 74' ' ' THR . 83.7 m -91.19 127.48 51.17 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.214 -0.929 . . . . 0.0 109.83 176.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.492 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 24.5 Cg_exo -58.69 160.95 16.05 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.797 1.42 . . . . 0.0 109.949 178.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.828 HG22 HD12 ' A' ' 71' ' ' LEU . 7.1 p -58.71 173.48 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.081 -1.012 . . . . 0.0 109.912 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.828 HD12 HG22 ' A' ' 70' ' ' VAL . 2.8 mp 58.7 19.7 7.07 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.298 -0.877 . . . . 0.0 109.964 -174.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.492 ' HB3' ' O ' ' A' ' 69' ' ' PRO . 4.1 tt0 -140.07 80.97 19.32 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.28 -0.888 . . . . 0.0 109.937 177.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.433 ' HG3' ' HG3' ' A' ' 87' ' ' LYS . 53.0 Cg_exo -48.88 131.88 25.81 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.948 1.499 . . . . 0.0 109.972 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.494 ' HB ' ' CG2' ' A' ' 64' ' ' VAL . 92.5 m -133.08 139.01 46.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.185 -0.947 . . . . 0.0 110.407 -176.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.441 ' HA3' HG13 ' A' ' 85' ' ' ILE . . . 145.71 -173.52 26.04 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.746 ' CD ' HD11 ' A' ' 21' ' ' LEU . 43.7 Cg_endo -75.24 137.59 51.01 Favored 'Cis proline' 0 C--N 1.314 -1.276 0 C-N-CA 121.791 -2.171 . . . . 0.0 110.538 -1.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.806 HD23 ' HB1' ' A' ' 60' ' ' ALA . 59.3 tp -96.53 156.35 16.38 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.243 -0.911 . . . . 0.0 110.45 -176.162 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -85.12 123.24 30.41 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.154 -0.966 . . . . 0.0 111.06 -175.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . 1.037 HG21 ' CE1' ' A' ' 84' ' ' HIS . 10.3 t -141.53 164.93 28.89 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.269 -0.894 . . . . 0.0 109.806 173.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.501 ' CG ' ' CD2' ' A' ' 81' ' ' PHE . 20.1 pt20 -59.93 -31.62 70.02 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.044 -1.035 . . . . 0.0 111.016 -175.273 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.501 ' CD2' ' CG ' ' A' ' 80' ' ' GLN . 97.9 m-85 -75.91 -8.02 55.94 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.027 -1.045 . . . . 0.0 110.531 -176.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.441 ' O ' HG22 ' A' ' 79' ' ' THR . . . 137.47 -143.58 14.77 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 -175.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.527 ' CZ ' ' HG3' ' A' ' 14' ' ' GLU . 96.1 m-85 -107.32 122.35 46.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.899 -1.353 . . . . 0.0 109.89 174.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 1.037 ' CE1' HG21 ' A' ' 79' ' ' THR . 60.9 m170 -99.17 121.74 41.43 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.131 -0.981 . . . . 0.0 110.363 175.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.548 ' CG2' ' HB ' ' A' ' 9' ' ' ILE . 6.1 tt -107.68 121.66 60.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 C-N-CA 118.599 -1.24 . . . . 0.0 109.569 168.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.687 HD12 HG11 ' A' ' 64' ' ' VAL . 83.4 mt -114.1 130.02 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.241 -0.912 . . . . 0.0 111.081 -169.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.588 ' HE2' ' CG ' ' A' ' 30' ' ' PHE . 21.4 ttmm -98.04 126.58 43.54 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.106 -0.996 . . . . 0.0 109.258 169.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.522 HG12 HG23 ' A' ' 70' ' ' VAL . 61.9 t -106.54 134.93 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.296 -0.877 . . . . 0.0 110.204 -175.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.514 ' O ' ' N ' ' A' ' 91' ' ' ARG . 92.7 mt -140.13 161.31 37.95 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.348 -0.845 . . . . 0.0 109.131 -178.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.509 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 25.6 m-85 62.45 -61.45 0.12 Allowed 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.03 0.443 . . . . 0.0 111.04 177.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.514 ' N ' ' O ' ' A' ' 89' ' ' LEU . 14.1 tpt180 54.93 39.93 31.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.001 -1.062 . . . . 0.0 110.209 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 45.5 t30 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.168 -179.485 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 1.074 ' HB1' ' CB ' ' A' ' 92' ' ' ASN . . . . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.237 0.542 . . . . 0.0 110.174 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.522 ' O ' ' CD ' ' A' ' 53' ' ' ARG . 27.9 mtpt -90.03 -79.92 0.33 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.133 -0.98 . . . . 0.0 110.768 -177.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.562 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 27.3 p -137.21 152.52 49.96 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.234 -0.916 . . . . 0.0 110.375 -175.112 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.511 ' O ' ' HA ' ' A' ' 51' ' ' GLU . . . -109.95 151.24 27.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.097 -1.002 . . . . 0.0 109.886 175.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.65 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -90.76 122.69 33.71 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.699 -0.8 . . . . 0.0 109.651 -178.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.537 ' HB3' ' CE2' ' A' ' 52' ' ' PHE . . . -130.84 119.7 22.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.102 -0.999 . . . . 0.0 111.325 -172.403 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.613 HD12 ' HD2' ' A' ' 87' ' ' LYS . 83.2 mt -106.5 151.28 25.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.288 -0.882 . . . . 0.0 108.839 169.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.523 ' HB2' HG12 ' A' ' 86' ' ' ILE . 0.3 OUTLIER -168.66 170.53 9.38 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 118.287 -1.365 . . . . 0.0 112.158 -178.716 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.452 ' HB ' ' CG2' ' A' ' 85' ' ' ILE . 87.0 mt -139.97 138.81 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.876 -0.515 . . . . 0.0 109.65 178.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.588 ' HG ' ' CD2' ' A' ' 84' ' ' HIS . 0.5 OUTLIER -100.42 120.08 39.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.364 -0.835 . . . . 0.0 110.218 -178.731 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.969 HG13 HD22 ' A' ' 16' ' ' LEU . 2.4 t -112.74 128.44 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.204 -0.935 . . . . 0.0 109.964 178.343 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -69.43 -40.04 77.48 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.371 -0.831 . . . . 0.0 110.618 -178.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -130.43 155.81 45.79 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.023 -1.048 . . . . 0.0 110.728 -176.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.531 ' HG3' ' CZ ' ' A' ' 83' ' ' TYR . 95.7 mt-10 -60.09 -40.0 88.09 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.478 -0.764 . . . . 0.0 110.744 -178.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -55.4 -43.33 75.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.144 -0.973 . . . . 0.0 110.068 -175.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.969 HD22 HG13 ' A' ' 11' ' ' VAL . 5.9 tt -69.89 -41.01 75.32 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.086 -1.009 . . . . 0.0 109.378 174.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.933 ' O ' HD12 ' A' ' 21' ' ' LEU . . . -60.05 -41.32 92.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.407 -0.808 . . . . 0.0 110.098 175.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.463 HD12 ' O ' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -60.02 -42.27 94.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.329 -0.857 . . . . 0.0 109.474 178.051 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.477 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 47.8 t0 -59.94 -43.56 94.9 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.243 -0.91 . . . . 0.0 110.037 174.188 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.716 HD11 HD13 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -63.02 -46.78 85.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.113 -0.992 . . . . 0.0 109.79 179.996 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.933 HD12 ' O ' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -59.83 -49.94 75.74 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.395 -0.816 . . . . 0.0 110.185 -178.58 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -60.77 -43.13 98.43 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.326 -0.859 . . . . 0.0 110.637 -177.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.477 ' HG2' ' O ' ' A' ' 19' ' ' ASP . 96.5 mm-40 -60.59 -42.59 97.05 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.184 -0.948 . . . . 0.0 110.606 -177.008 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.505 ' O ' ' N ' ' A' ' 28' ' ' ALA . 88.1 mt -64.84 -44.09 96.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.15 -0.969 . . . . 0.0 109.937 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -61.08 -47.14 87.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.175 -0.953 . . . . 0.0 109.665 175.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -59.81 -60.93 3.05 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.43 -0.794 . . . . 0.0 110.331 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.755 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -105.21 -41.64 1.89 Allowed Glycine 0 N--CA 1.485 1.93 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -173.324 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.755 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 80.19 99.4 0.06 Allowed 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.837 -0.802 . . . . 0.0 110.075 -177.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.434 ' HB3' ' HB2' ' A' ' 32' ' ' LYS . 1.8 m-20 -175.7 82.82 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.273 -0.892 . . . . 0.0 110.177 -176.139 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.585 ' CG ' ' HE3' ' A' ' 87' ' ' LYS . 9.9 m-85 -65.87 -45.58 81.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.151 -0.968 . . . . 0.0 110.752 -178.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.09 -49.26 80.51 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -177.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.434 ' HB2' ' HB3' ' A' ' 29' ' ' ASP . 60.7 mttm -64.96 -40.0 94.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -1.169 . . . . 0.0 110.049 -177.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.572 HD21 ' HB2' ' A' ' 20' ' ' LEU . 63.2 tp -61.81 -40.24 94.55 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.226 -0.921 . . . . 0.0 110.352 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.518 ' O ' ' CB ' ' A' ' 38' ' ' SER . . . -60.03 -49.95 75.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.067 -1.021 . . . . 0.0 110.135 177.429 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -59.97 -43.63 94.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.774 -1.204 . . . . 0.0 110.689 -176.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.405 ' NZ ' ' HB3' ' A' ' 32' ' ' LYS . 43.5 mttp -69.95 -43.03 72.41 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.897 -1.127 . . . . 0.0 111.662 -175.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.452 ' O ' HG12 ' A' ' 39' ' ' ILE . 80.9 m80 -105.77 -28.29 10.76 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.686 -1.259 . . . . 0.0 111.691 -169.088 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.52 ' O ' ' CG1' ' A' ' 39' ' ' ILE . 54.3 p -60.01 -44.29 94.65 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.724 -1.235 . . . . 0.0 110.763 -171.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.52 ' CG1' ' O ' ' A' ' 38' ' ' SER . 46.5 pt 36.31 31.63 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.614 -0.679 . . . . 0.0 110.918 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.479 ' N ' ' O ' ' A' ' 38' ' ' SER . 38.2 t -125.83 144.23 47.77 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.125 -0.984 . . . . 0.0 110.247 -175.171 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.465 ' HD2' ' SG ' ' A' ' 40' ' ' CYS . 58.1 Cg_exo -44.7 -24.85 1.28 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.819 1.431 . . . . 0.0 110.753 178.388 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.475 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 0.2 OUTLIER -109.88 19.79 18.7 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.142 -0.974 . . . . 0.0 110.196 178.566 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -95.63 -57.72 1.17 Allowed Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 175.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -59.93 -39.99 87.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.34 -1.094 . . . . 0.0 109.872 175.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 20.9 tpt180 -101.39 -37.15 8.59 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.328 -0.857 . . . . 0.0 110.58 -177.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.499 ' O ' ' CD2' ' A' ' 8' ' ' HIS . . . -82.88 -9.02 85.03 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -177.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.36 1.52 56.35 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 173.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.444 ' HA ' ' CD2' ' A' ' 7' ' ' LEU . 38.7 t0 -165.76 67.25 0.12 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.35 -1.088 . . . . 0.0 108.475 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.44 ' HG ' ' HA2' ' A' ' 46' ' ' GLY . 7.0 mt -69.99 -27.41 64.68 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.794 -0.566 . . . . 0.0 110.146 -175.171 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.34 -146.96 16.64 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.534 ' HG2' ' CB ' ' A' ' 3' ' ' THR . 49.9 tt0 -110.75 128.58 55.79 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.26 -1.141 . . . . 0.0 110.011 -178.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.537 ' CE2' ' HB3' ' A' ' 6' ' ' ALA . 3.5 p90 -144.88 -178.02 5.82 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.178 -0.951 . . . . 0.0 110.584 -176.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.562 ' HB2' ' HA ' ' A' ' 3' ' ' THR . 51.8 ttt-85 -171.29 -46.86 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.93 -1.106 . . . . 0.0 110.23 173.448 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -60.04 -49.03 79.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.262 -0.899 . . . . 0.0 110.885 -168.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 57' ' ' MET . . . -87.15 -104.51 0.84 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 178.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.537 ' NE2' ' CG ' ' A' ' 52' ' ' PHE . 3.0 mm100 64.94 -69.32 0.1 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.369 -1.077 . . . . 0.0 109.547 172.121 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.536 ' N ' ' O ' ' A' ' 55' ' ' GLY . 30.5 ttp 62.91 -58.92 0.15 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.781 -0.574 . . . . 0.0 112.236 170.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.492 ' N ' ' O ' ' A' ' 56' ' ' GLN . 1.9 p -41.37 132.96 2.08 Favored Pre-proline 0 N--CA 1.498 1.931 0 O-C-N 120.907 -1.12 . . . . 0.0 110.605 -168.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.477 ' O ' ' N ' ' A' ' 62' ' ' ASP . 29.0 Cg_endo -67.59 -50.52 0.89 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.08 1.568 . . . . 0.0 110.709 -174.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 59' ' ' PRO . . . -41.77 -37.39 1.22 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.381 -0.824 . . . . 0.0 110.029 -177.401 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.565 ' CE2' HG21 ' A' ' 65' ' ' VAL . 67.7 t80 -59.97 -43.66 94.95 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.308 -0.87 . . . . 0.0 110.056 177.021 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.477 ' N ' ' O ' ' A' ' 59' ' ' PRO . 54.0 t0 -60.0 -43.75 94.99 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.295 -0.878 . . . . 0.0 110.284 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 67' ' ' SER . 34.3 mttt -58.23 -50.02 75.05 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.163 -0.961 . . . . 0.0 109.735 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.537 ' HA ' ' HB3' ' A' ' 67' ' ' SER . 7.5 p -69.5 -41.32 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.451 -0.781 . . . . 0.0 110.763 -177.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.565 HG21 ' CE2' ' A' ' 61' ' ' PHE . 11.4 t -55.54 -31.85 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.727 -1.233 . . . . 0.0 108.929 171.04 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -102.37 10.32 39.16 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.621 -0.674 . . . . 0.0 110.258 177.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.537 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 8.1 t -103.27 -58.29 1.9 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.151 -0.968 . . . . 0.0 109.898 173.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.469 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 29.8 m -115.39 145.34 34.14 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.309 -0.869 . . . . 0.0 110.303 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.519 ' O ' ' N ' ' A' ' 71' ' ' LEU . 13.5 Cg_exo -64.98 76.52 0.21 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.807 1.425 . . . . 0.0 110.582 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.082 HG11 ' HG3' ' A' ' 91' ' ' ARG . 8.2 m 21.29 45.89 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.337 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 176.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.008 HD12 HG23 ' A' ' 70' ' ' VAL . 0.3 OUTLIER -166.55 46.86 0.07 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.45 -0.781 . . . . 0.0 110.057 178.259 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -170.66 123.97 0.6 Allowed Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.348 -0.845 . . . . 0.0 110.148 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -55.63 119.07 5.96 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.746 1.392 . . . . 0.0 110.196 178.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.424 ' OG1' ' SG ' ' A' ' 68' ' ' CYS . 74.9 m -126.61 128.35 46.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.197 -0.939 . . . . 0.0 110.219 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.44 ' HA3' HG13 ' A' ' 85' ' ' ILE . . . 145.85 -177.81 23.99 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.906 ' CD ' HD21 ' A' ' 21' ' ' LEU . 42.4 Cg_endo -71.02 161.61 89.44 Favored 'Cis proline' 0 C--N 1.313 -1.313 0 C-N-CA 121.754 -2.186 . . . . 0.0 110.463 -0.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.993 HD23 ' N ' ' A' ' 78' ' ' HIS . 8.0 tt -134.92 155.26 51.02 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.274 -0.891 . . . . 0.0 110.158 -175.397 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.993 ' N ' HD23 ' A' ' 77' ' ' LEU . 42.0 m80 -73.42 129.37 37.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.168 -0.958 . . . . 0.0 110.768 -176.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.776 HG21 ' CG ' ' A' ' 84' ' ' HIS . 9.0 t -144.2 163.42 33.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.367 -0.833 . . . . 0.0 109.848 175.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -60.0 -24.34 64.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.194 -0.941 . . . . 0.0 110.185 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.593 ' HB2' ' CE1' ' A' ' 84' ' ' HIS . 97.8 m-85 -86.68 -0.68 56.73 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.196 -0.94 . . . . 0.0 110.926 -175.178 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.695 ' O ' HG22 ' A' ' 79' ' ' THR . . . 123.64 -137.72 11.07 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 -174.186 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.531 ' CZ ' ' HG3' ' A' ' 14' ' ' GLU . 59.2 m-85 -100.16 130.04 46.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.1 -1.235 . . . . 0.0 109.948 173.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.776 ' CG ' HG21 ' A' ' 79' ' ' THR . 19.3 m170 -116.86 124.12 48.73 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.23 -0.918 . . . . 0.0 110.537 178.325 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.716 HD13 HD11 ' A' ' 20' ' ' LEU . 8.5 tt -110.07 130.06 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.925 -1.11 . . . . 0.0 109.596 170.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.523 HG12 ' HB2' ' A' ' 8' ' ' HIS . 20.5 mt -138.45 137.84 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.996 -1.065 . . . . 0.0 110.824 -172.289 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.613 ' HD2' HD12 ' A' ' 7' ' ' LEU . 15.8 ptpt -111.16 135.08 52.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.772 -1.205 . . . . 0.0 109.313 168.256 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.812 ' O ' HD23 ' A' ' 89' ' ' LEU . 37.6 t -110.49 144.17 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.253 -0.905 . . . . 0.0 110.345 -171.101 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.812 HD23 ' O ' ' A' ' 88' ' ' VAL . 63.2 mt -140.09 129.52 24.06 Favored 'General case' 0 C--N 1.31 -1.126 0 O-C-N 121.027 -1.046 . . . . 0.0 110.21 -175.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.554 ' CB ' ' O ' ' A' ' 89' ' ' LEU . 14.5 t80 81.27 -24.99 0.17 Allowed 'General case' 0 N--CA 1.507 2.391 0 O-C-N 121.4 -0.813 . . . . 0.0 111.833 169.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 1.082 ' HG3' HG11 ' A' ' 70' ' ' VAL . 7.0 ttm-85 59.74 -160.13 0.29 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.867 -1.146 . . . . 0.0 109.771 -175.383 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 1.074 ' CB ' ' HB1' ' A' ' 1' ' ' ALA . 57.1 m-80 . . . . . 0 N--CA 1.489 1.519 0 O-C-N 120.953 -1.092 . . . . 0.0 110.335 177.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.199 0.523 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -59.95 -40.9 90.59 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.214 -0.928 . . . . 0.0 110.132 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.505 ' O ' ' N ' ' A' ' 92' ' ' ASN . 46.0 p -132.79 144.19 50.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.397 -0.815 . . . . 0.0 110.038 177.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.462 ' C ' ' HG3' ' A' ' 51' ' ' GLU . . . -134.59 142.26 46.88 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.166 -0.959 . . . . 0.0 110.241 178.43 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.683 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -93.44 119.97 33.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.242 -0.911 . . . . 0.0 108.952 175.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.693 ' HB3' ' CZ ' ' A' ' 52' ' ' PHE . . . -134.32 119.3 18.51 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.637 -1.289 . . . . 0.0 111.505 -168.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.6 ' N ' ' CD1' ' A' ' 7' ' ' LEU . 4.2 mp -96.63 146.98 24.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.177 -0.952 . . . . 0.0 109.288 171.063 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.616 ' NE2' ' HB1' ' A' ' 6' ' ' ALA . 56.2 m-70 -137.85 126.39 23.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.05 -1.031 . . . . 0.0 110.624 -176.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.774 ' HB ' HG22 ' A' ' 85' ' ' ILE . 68.8 mt -103.18 125.6 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 120.868 -1.145 . . . . 0.0 109.714 169.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.777 HD13 ' C ' ' A' ' 10' ' ' LEU . 2.7 tm? -103.43 119.98 39.94 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.605 -0.685 . . . . 0.0 109.684 177.115 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.942 HG13 HD22 ' A' ' 16' ' ' LEU . 3.0 t -111.84 132.34 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.319 -0.863 . . . . 0.0 110.286 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -65.99 -40.01 90.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.377 -0.827 . . . . 0.0 110.399 179.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -119.78 139.24 52.63 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.139 -0.976 . . . . 0.0 110.822 -173.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.455 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 88.4 tt0 -60.04 -47.22 86.76 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.556 -0.715 . . . . 0.0 111.282 -177.285 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.3 mttp -53.31 -36.54 61.36 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.14 -0.975 . . . . 0.0 110.185 -173.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.942 HD22 HG13 ' A' ' 11' ' ' VAL . 8.4 tt -65.26 -40.07 93.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.254 -0.904 . . . . 0.0 109.419 176.263 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.768 ' HB1' ' HG3' ' A' ' 76' ' ' PRO . . . -58.97 -46.46 88.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.384 -0.823 . . . . 0.0 109.994 176.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.98 -44.62 94.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.235 -0.916 . . . . 0.0 109.874 177.098 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -59.97 -43.41 95.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.147 -0.971 . . . . 0.0 109.754 175.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.478 ' O ' HG12 ' A' ' 24' ' ' ILE . 2.6 tp -64.14 -45.55 88.0 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.43 -0.793 . . . . 0.0 109.948 177.234 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.67 HD11 ' CD1' ' A' ' 85' ' ' ILE . 1.9 mp -57.99 -49.58 76.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.38 -0.825 . . . . 0.0 109.866 -174.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -61.03 -37.0 81.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.274 -0.891 . . . . 0.0 109.689 172.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.464 ' HB3' ' O ' ' A' ' 20' ' ' LEU . 7.4 tt0 -59.96 -34.79 73.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.456 -0.777 . . . . 0.0 110.443 -174.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.533 HD13 ' CD1' ' A' ' 33' ' ' LEU . 45.4 mm -59.92 -49.57 83.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.092 -1.005 . . . . 0.0 109.325 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -60.68 -46.43 90.4 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.097 -1.002 . . . . 0.0 109.789 178.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -60.08 -53.25 60.04 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.291 -0.88 . . . . 0.0 110.327 177.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.758 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -104.48 -54.71 0.77 Allowed Glycine 0 N--CA 1.486 1.992 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -173.188 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.758 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 79.19 95.03 0.06 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.862 -0.787 . . . . 0.0 110.58 178.009 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.485 ' OD2' ' HD2' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -177.6 80.42 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.422 -0.799 . . . . 0.0 109.751 -178.814 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.578 ' CG ' ' HD2' ' A' ' 87' ' ' LYS . 11.9 m-85 -60.09 -49.97 75.56 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.319 -0.863 . . . . 0.0 111.187 -174.098 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.08 -50.13 58.94 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.722 -1.228 . . . . 0.0 110.126 -174.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.485 ' HD2' ' OD2' ' A' ' 29' ' ' ASP . 32.3 mttm -66.57 -40.01 88.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.086 -1.244 . . . . 0.0 110.383 -175.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.533 ' CD1' HD13 ' A' ' 24' ' ' ILE . 67.7 mt -66.44 -40.01 89.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.062 -1.024 . . . . 0.0 110.477 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.554 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -59.22 -51.91 67.94 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.087 -1.008 . . . . 0.0 110.082 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -60.14 -45.84 91.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.327 -0.858 . . . . 0.0 110.722 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -68.32 -47.38 67.7 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.11 -0.994 . . . . 0.0 110.848 -175.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -74.79 -45.18 45.31 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.148 -0.97 . . . . 0.0 110.765 -175.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.563 ' O ' HG22 ' A' ' 39' ' ' ILE . 25.4 t -60.39 -46.27 90.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.203 -0.935 . . . . 0.0 110.133 -179.035 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.563 HG22 ' O ' ' A' ' 38' ' ' SER . 13.3 tt 36.02 30.04 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-O 121.445 0.64 . . . . 0.0 110.774 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.517 ' N ' ' O ' ' A' ' 38' ' ' SER . 14.2 p -121.56 171.63 5.91 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.286 -0.884 . . . . 0.0 110.024 -178.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.485 ' HD2' ' HB2' ' A' ' 40' ' ' CYS . 43.7 Cg_exo -48.94 -31.35 20.0 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.647 1.341 . . . . 0.0 110.352 -177.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.6 OUTLIER -101.65 15.11 29.96 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.306 -0.871 . . . . 0.0 110.028 177.788 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.29 -58.86 3.78 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.754 -1.738 . . . . 0.0 108.754 174.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.1 tptt -59.91 -40.08 87.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -1.114 . . . . 0.0 110.551 177.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.469 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 11.1 tpt180 -98.29 -41.1 8.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.085 -1.009 . . . . 0.0 110.567 -175.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -70.24 -30.33 69.58 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -178.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.48 -5.56 50.57 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.417 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 25.1 t0 -172.67 72.16 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.332 -1.099 . . . . 0.0 108.586 179.059 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.542 HD12 ' CD2' ' A' ' 8' ' ' HIS . 6.8 mt -70.03 -27.1 64.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.456 -0.777 . . . . 0.0 110.177 -173.236 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 113.58 -154.71 16.78 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.462 ' HG3' ' C ' ' A' ' 4' ' ' ALA . 84.6 tt0 -106.55 129.83 54.43 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.291 -1.123 . . . . 0.0 109.845 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.693 ' CZ ' ' HB3' ' A' ' 6' ' ' ALA . 0.1 OUTLIER -131.57 173.47 11.08 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.051 -1.031 . . . . 0.0 110.704 178.044 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.554 ' HG2' ' NE2' ' A' ' 56' ' ' GLN . 20.6 ptt180 -112.52 176.5 4.99 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.323 -0.861 . . . . 0.0 110.229 179.308 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -61.06 -11.2 7.69 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.205 -0.935 . . . . 0.0 111.27 -173.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.46 ' C ' ' HG2' ' A' ' 56' ' ' GLN . . . -84.54 42.41 3.11 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 177.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.554 ' NE2' ' HG2' ' A' ' 53' ' ' ARG . 2.0 pt20 -178.08 -32.96 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.196 -1.179 . . . . 0.0 110.298 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.476 ' HG3' ' O ' ' A' ' 53' ' ' ARG . 62.6 mtt -47.23 142.28 3.99 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.074 -1.016 . . . . 0.0 110.97 -169.401 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.487 HG13 ' H ' ' A' ' 61' ' ' PHE . 7.5 p -71.6 130.97 86.61 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.515 -0.741 . . . . 0.0 110.098 177.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -43.95 -44.77 11.9 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 121.627 1.551 . . . . 0.0 111.286 -174.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.09 -38.45 79.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.009 -1.057 . . . . 0.0 109.938 -178.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.539 ' HD2' HG21 ' A' ' 86' ' ' ILE . 63.2 t80 -59.99 -38.79 83.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.268 -0.895 . . . . 0.0 110.282 174.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.44 ' O ' HG12 ' A' ' 65' ' ' VAL . 48.8 t0 -60.03 -43.75 95.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.204 -0.935 . . . . 0.0 110.117 -176.252 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 67' ' ' SER . 23.6 tttm -60.07 -47.03 87.58 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.216 -0.927 . . . . 0.0 110.417 177.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.658 HG11 HD12 ' A' ' 86' ' ' ILE . 13.1 p -79.25 -44.47 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.024 -1.047 . . . . 0.0 111.347 -173.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.548 ' N ' HG13 ' A' ' 64' ' ' VAL . 4.4 p -53.56 -25.8 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.361 -1.462 . . . . 0.0 109.008 173.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -94.97 -13.22 25.5 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.513 -0.742 . . . . 0.0 109.939 176.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.526 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 8.0 t -93.38 -61.65 1.52 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.354 -0.841 . . . . 0.0 110.053 177.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 78.6 m -99.98 132.01 23.47 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.38 -0.825 . . . . 0.0 110.272 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.498 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 12.1 Cg_endo -61.31 159.93 29.08 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.861 1.453 . . . . 0.0 110.082 178.393 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.981 HG23 HG12 ' A' ' 88' ' ' VAL . 8.1 p -60.46 177.41 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.198 -0.939 . . . . 0.0 109.891 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.833 HD12 HG13 ' A' ' 70' ' ' VAL . 4.7 mp 45.48 40.02 5.25 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.639 -1.288 . . . . 0.0 109.981 -168.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.498 ' HB3' ' O ' ' A' ' 69' ' ' PRO . 0.4 OUTLIER -150.57 89.65 4.4 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.384 -0.822 . . . . 0.0 109.729 175.497 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -59.26 126.55 21.19 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.827 1.435 . . . . 0.0 109.782 -177.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.433 HG21 HG23 ' A' ' 64' ' ' VAL . 53.3 m -130.7 136.72 49.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.095 -1.003 . . . . 0.0 110.453 -177.016 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.459 ' HA3' HG13 ' A' ' 85' ' ' ILE . . . 152.27 -171.38 31.54 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -178.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.768 ' HG3' ' HB1' ' A' ' 17' ' ' ALA . 41.7 Cg_endo -84.77 134.03 19.45 Favored 'Cis proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.209 -1.996 . . . . 0.0 110.42 3.441 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 74.8 mt -93.0 -178.52 4.82 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.254 -0.904 . . . . 0.0 110.735 -172.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -102.66 125.37 49.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.072 -1.018 . . . . 0.0 110.712 -176.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.768 HG21 ' CE1' ' A' ' 84' ' ' HIS . 12.5 t -140.05 162.43 35.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.428 -0.795 . . . . 0.0 109.813 176.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -60.05 -39.95 87.72 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.101 -0.999 . . . . 0.0 110.364 -178.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -70.31 -5.56 28.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.208 -0.933 . . . . 0.0 110.61 -177.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.65 ' O ' HG22 ' A' ' 79' ' ' THR . . . 134.43 -137.47 9.3 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.46 ' O ' ' HA ' ' A' ' 10' ' ' LEU . 75.1 m-85 -96.1 130.67 43.07 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.165 -1.197 . . . . 0.0 110.241 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.768 ' CE1' HG21 ' A' ' 79' ' ' THR . 1.1 m-70 -107.89 112.43 25.04 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.674 -0.641 . . . . 0.0 110.643 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.774 HG22 ' HB ' ' A' ' 9' ' ' ILE . 2.5 tt -104.86 120.32 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.527 -1.358 . . . . 0.0 109.076 167.234 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.658 HD12 HG11 ' A' ' 64' ' ' VAL . 88.2 mt -110.02 130.02 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.936 -1.103 . . . . 0.0 111.298 -169.609 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.813 ' NZ ' HD21 ' A' ' 89' ' ' LEU . 63.0 tttm -101.71 126.41 48.56 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 172.407 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.981 HG12 HG23 ' A' ' 70' ' ' VAL . 24.5 t -103.42 136.46 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.13 -0.981 . . . . 0.0 110.297 -176.335 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.813 HD21 ' NZ ' ' A' ' 87' ' ' LYS . 58.0 mt -130.58 119.91 23.22 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.416 -0.802 . . . . 0.0 109.349 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.528 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 44.3 m-85 72.55 -58.9 0.58 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.648 -0.658 . . . . 0.0 110.856 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.443 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 67.1 ttp85 57.11 39.91 28.73 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.234 -0.916 . . . . 0.0 110.622 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.505 ' N ' ' O ' ' A' ' 3' ' ' THR . 24.3 t-20 . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.202 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.461 ' O ' ' OD1' ' A' ' 92' ' ' ASN . . . . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.221 0.534 . . . . 0.0 110.286 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.8 tttp -63.36 -40.06 96.24 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.213 -0.929 . . . . 0.0 110.285 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 91' ' ' ARG . 35.6 p -135.77 162.29 33.2 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.352 -0.843 . . . . 0.0 109.817 178.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.523 ' HB3' ' CE1' ' A' ' 52' ' ' PHE . . . -109.88 131.24 55.24 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.173 -0.955 . . . . 0.0 110.549 -175.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.563 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -99.32 122.05 41.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.405 -0.809 . . . . 0.0 109.64 177.518 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.86 ' HB1' ' NE2' ' A' ' 8' ' ' HIS . . . -140.05 132.03 27.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.856 -1.153 . . . . 0.0 111.212 -175.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.984 HD12 ' HD2' ' A' ' 87' ' ' LYS . 86.7 mt -98.32 139.78 33.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.138 -0.976 . . . . 0.0 108.806 168.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.86 ' NE2' ' HB1' ' A' ' 6' ' ' ALA . 34.7 m-70 -135.17 117.97 16.15 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.805 -1.185 . . . . 0.0 110.754 -177.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.761 ' HB ' HG22 ' A' ' 85' ' ' ILE . 92.6 mt -105.17 126.62 60.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.35 -0.844 . . . . 0.0 109.869 172.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.591 ' HG ' ' CD2' ' A' ' 84' ' ' HIS . 0.3 OUTLIER -101.8 117.94 35.89 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.561 -0.712 . . . . 0.0 109.898 -179.757 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.731 HG13 HD22 ' A' ' 16' ' ' LEU . 2.2 t -108.23 125.3 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.229 -0.919 . . . . 0.0 109.747 177.011 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.2 mmtp -68.48 -39.39 81.38 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.44 -0.788 . . . . 0.0 110.17 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -111.43 138.11 48.35 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.186 -0.946 . . . . 0.0 110.699 -178.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.66 ' HG2' HD12 ' A' ' 18' ' ' LEU . 88.8 tt0 -59.97 -42.12 93.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.366 -0.833 . . . . 0.0 109.939 177.138 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -56.94 -40.53 76.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.395 -0.816 . . . . 0.0 110.139 -178.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.731 HD22 HG13 ' A' ' 11' ' ' VAL . 5.5 tt -68.82 -40.04 79.72 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.025 -1.047 . . . . 0.0 109.301 174.444 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.997 ' O ' HD12 ' A' ' 21' ' ' LEU . . . -59.95 -40.72 89.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.386 -0.821 . . . . 0.0 110.021 175.236 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.66 HD12 ' HG2' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -59.94 -41.67 92.37 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.15 -0.969 . . . . 0.0 109.695 175.973 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -60.03 -44.75 94.42 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.32 -0.863 . . . . 0.0 110.246 176.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.71 ' C ' HD12 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -64.11 -43.74 94.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.075 -1.015 . . . . 0.0 109.544 178.51 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.997 HD12 ' O ' ' A' ' 17' ' ' ALA . 0.3 OUTLIER -56.19 -49.92 72.67 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.499 -0.75 . . . . 0.0 109.697 -179.588 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -61.7 -40.01 93.51 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.391 -0.818 . . . . 0.0 110.134 175.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.419 ' O ' ' N ' ' A' ' 27' ' ' GLY . 70.0 tp60 -60.1 -39.9 87.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.271 -0.893 . . . . 0.0 110.945 -174.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.518 ' O ' ' N ' ' A' ' 28' ' ' ALA . 96.7 mt -62.76 -40.55 89.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.104 -0.997 . . . . 0.0 110.289 -176.231 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -65.42 -58.75 5.09 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.964 -1.085 . . . . 0.0 110.067 175.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -60.05 -39.96 87.78 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.34 -0.85 . . . . 0.0 110.799 178.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.732 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -104.0 -63.03 0.68 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -176.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.732 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 81.79 93.04 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.175 0 O-C-N 122.06 -0.671 . . . . 0.0 110.508 178.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 179.74 78.32 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.423 -0.798 . . . . 0.0 109.952 -178.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.525 ' CZ ' HG23 ' A' ' 85' ' ' ILE . 17.1 t80 -61.12 -39.98 92.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.318 -0.864 . . . . 0.0 110.72 -174.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.435 ' O ' ' HG3' ' A' ' 35' ' ' LYS . . . -66.01 -53.65 29.04 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -176.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.463 ' HE3' ' HE3' ' A' ' 36' ' ' LYS . 82.5 tttt -64.8 -41.55 95.72 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.111 -1.229 . . . . 0.0 110.523 -178.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 85.7 mt -65.89 -40.04 91.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.238 -0.914 . . . . 0.0 109.931 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.548 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -60.25 -48.87 79.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.365 -0.835 . . . . 0.0 110.347 178.25 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.435 ' HG3' ' O ' ' A' ' 31' ' ' GLY . 72.4 mttt -59.99 -46.34 89.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 0.0 110.391 -175.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.463 ' HE3' ' HE3' ' A' ' 32' ' ' LYS . 41.5 mttt -69.41 -50.82 42.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.094 -1.004 . . . . 0.0 111.074 -176.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 53.9 m170 -70.05 -39.97 75.4 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.124 -0.985 . . . . 0.0 111.073 -173.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.655 ' O ' HG22 ' A' ' 39' ' ' ILE . 14.5 t -59.99 -45.6 92.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.037 -1.04 . . . . 0.0 110.313 -175.007 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.655 HG22 ' O ' ' A' ' 38' ' ' SER . 20.4 tt 38.73 34.18 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.589 -0.695 . . . . 0.0 110.603 178.338 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.483 ' HB2' ' HD2' ' A' ' 41' ' ' PRO . 15.0 p -127.36 165.68 27.91 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.288 -0.883 . . . . 0.0 109.764 -178.007 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' A' ' 40' ' ' CYS . 2.0 Cg_endo -49.2 -33.24 27.29 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.626 1.329 . . . . 0.0 110.172 179.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.2 OUTLIER -92.8 8.69 38.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.145 -0.972 . . . . 0.0 110.308 176.834 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.422 ' HA2' ' OG ' ' A' ' 38' ' ' SER . . . -56.17 -54.45 35.5 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.591 -1.804 . . . . 0.0 108.591 177.483 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -61.22 -39.97 92.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.355 -1.085 . . . . 0.0 110.658 175.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.541 ' HG3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -94.16 -68.91 0.78 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.124 -0.985 . . . . 0.0 110.353 -173.589 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -52.82 -38.12 53.44 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.95 -5.52 52.87 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 176.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.482 ' HA ' ' CD2' ' A' ' 7' ' ' LEU . 50.2 t0 -172.34 71.12 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.35 -1.088 . . . . 0.0 108.856 178.2 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.541 HD23 ' HG3' ' A' ' 45' ' ' ARG . 7.0 mt -69.85 -25.26 63.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.544 -0.722 . . . . 0.0 109.911 -174.179 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' A' ' 5' ' ' ALA . . . 82.79 -137.69 17.04 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.074 -1.611 . . . . 0.0 109.074 -178.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.516 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 1.8 mt-10 -102.27 129.65 48.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.443 -1.033 . . . . 0.0 110.635 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.655 ' CE2' ' HB3' ' A' ' 6' ' ' ALA . 1.5 p90 -134.62 159.2 41.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.544 -0.722 . . . . 0.0 109.799 178.002 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.51 ' O ' ' N ' ' A' ' 55' ' ' GLY . 78.1 mtm180 -116.62 143.83 45.13 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.839 -1.163 . . . . 0.0 111.352 -170.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.505 ' O ' ' N ' ' A' ' 56' ' ' GLN . 89.5 mt-30 31.35 -88.71 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 176.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . -64.81 61.76 0.07 OUTLIER Glycine 0 N--CA 1.495 2.62 0 O-C-N 120.965 -1.084 . . . . 0.0 110.63 -169.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.505 ' N ' ' O ' ' A' ' 54' ' ' GLN . 55.9 mm-40 -132.67 3.96 3.87 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.951 -1.323 . . . . 0.0 110.616 178.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.447 ' HG2' ' CE2' ' A' ' 61' ' ' PHE . 75.4 mtm -91.78 -175.99 4.32 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.266 -1.521 . . . . 0.0 112.086 -162.175 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.602 HG13 ' CB ' ' A' ' 61' ' ' PHE . 1.6 p -171.29 137.58 1.08 Allowed Pre-proline 0 N--CA 1.488 1.445 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -174.219 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.439 ' C ' ' O ' ' A' ' 58' ' ' VAL . 14.7 Cg_exo -32.88 -52.1 0.4 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 121.754 1.636 . . . . 0.0 111.185 -172.354 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.562 ' HB2' ' HB ' ' A' ' 79' ' ' THR . . . -61.81 -42.69 99.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.091 -1.006 . . . . 0.0 110.553 178.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.602 ' CB ' HG13 ' A' ' 58' ' ' VAL . 60.9 t80 -60.06 -40.17 88.55 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.141 -0.975 . . . . 0.0 110.647 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.492 ' O ' HG12 ' A' ' 65' ' ' VAL . 54.8 t0 -63.34 -42.85 98.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.012 -1.055 . . . . 0.0 109.69 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -57.7 -55.77 30.61 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.285 -0.885 . . . . 0.0 110.266 178.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.626 HG11 HD12 ' A' ' 86' ' ' ILE . 2.7 p -70.0 -43.83 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.016 -1.052 . . . . 0.0 111.775 -172.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.492 HG12 ' O ' ' A' ' 62' ' ' ASP . 4.8 p -55.26 -27.11 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.223 -1.548 . . . . 0.0 108.94 174.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.452 ' HB2' ' O ' ' A' ' 62' ' ' ASP . 0.1 OUTLIER -94.97 -8.7 36.21 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.261 -0.899 . . . . 0.0 110.582 175.468 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.524 ' HB2' ' HA ' ' A' ' 64' ' ' VAL . 24.1 m -93.19 -41.89 9.66 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.003 -1.06 . . . . 0.0 110.042 176.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 88.2 m -120.71 150.58 52.87 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.166 -0.959 . . . . 0.0 110.205 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -73.41 156.34 50.29 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.977 1.514 . . . . 0.0 109.955 178.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.981 HG22 HD12 ' A' ' 71' ' ' LEU . 7.2 p -58.03 172.63 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.171 -0.956 . . . . 0.0 109.855 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.981 HD12 HG22 ' A' ' 70' ' ' VAL . 3.6 mp 57.44 39.78 27.8 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.413 -0.804 . . . . 0.0 110.077 -174.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -155.84 117.28 2.28 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.116 -0.99 . . . . 0.0 110.394 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 87' ' ' LYS . 30.6 Cg_endo -68.98 132.74 25.25 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.828 1.436 . . . . 0.0 110.182 179.156 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.522 HG21 HG23 ' A' ' 64' ' ' VAL . 87.0 m -139.58 147.15 40.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.157 -0.965 . . . . 0.0 110.295 -178.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.469 ' HA3' ' HA ' ' A' ' 85' ' ' ILE . . . 134.44 -176.11 20.07 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -178.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.853 ' CD ' HD11 ' A' ' 21' ' ' LEU . 44.1 Cg_endo -74.57 135.97 42.86 Favored 'Cis proline' 0 C--N 1.314 -1.271 0 C-N-CA 121.79 -2.171 . . . . 0.0 110.557 -0.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.462 HD23 ' HB1' ' A' ' 60' ' ' ALA . 59.8 tp -94.94 155.08 16.91 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.26 -0.9 . . . . 0.0 110.435 -178.112 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 -77.89 119.74 21.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -0.891 . . . . 0.0 110.459 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.674 HG22 ' O ' ' A' ' 82' ' ' GLY . 10.8 t -134.21 165.57 24.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.214 -0.929 . . . . 0.0 109.55 173.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -59.97 -39.58 86.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.113 -0.992 . . . . 0.0 110.047 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -66.75 -11.55 55.15 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.226 -0.921 . . . . 0.0 110.717 -177.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.674 ' O ' HG22 ' A' ' 79' ' ' THR . . . 132.32 -139.75 11.22 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 -176.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.576 ' CE2' ' HB2' ' A' ' 14' ' ' GLU . 75.5 m-85 -102.64 122.14 43.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.108 -1.23 . . . . 0.0 110.291 178.193 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.626 ' CE1' HG21 ' A' ' 79' ' ' THR . 41.2 m170 -104.98 122.64 46.27 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.196 -0.94 . . . . 0.0 110.422 175.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.761 HG22 ' HB ' ' A' ' 9' ' ' ILE . 3.5 tt -103.52 119.23 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 118.376 -1.329 . . . . 0.0 109.361 167.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.724 HG23 ' CE1' ' A' ' 8' ' ' HIS . 85.5 mt -114.77 130.02 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.095 -1.003 . . . . 0.0 110.707 -170.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.984 ' HD2' HD12 ' A' ' 7' ' ' LEU . 34.9 ttmt -96.96 126.08 41.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.135 -0.978 . . . . 0.0 109.164 171.09 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.565 HG12 HG23 ' A' ' 70' ' ' VAL . 48.5 t -107.61 123.19 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.382 -0.824 . . . . 0.0 109.959 -175.06 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.563 ' HB2' ' HB3' ' A' ' 5' ' ' ALA . 60.1 mt -134.36 113.04 11.5 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.522 -0.736 . . . . 0.0 109.317 -176.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.545 ' CB ' ' O ' ' A' ' 89' ' ' LEU . 2.9 m-85 81.91 -43.37 0.16 Allowed 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.718 -0.614 . . . . 0.0 110.444 -178.114 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.472 ' O ' ' O ' ' A' ' 3' ' ' THR . 4.4 ttm180 59.9 -159.52 0.3 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.082 -1.011 . . . . 0.0 109.983 -178.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.461 ' OD1' ' O ' ' A' ' 1' ' ' ALA . 52.7 t-20 . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.048 -1.033 . . . . 0.0 110.319 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.245 0.545 . . . . 0.0 110.253 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 40.8 mttt -123.64 145.33 49.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.25 -0.906 . . . . 0.0 110.133 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.511 HG22 ' HG2' ' A' ' 53' ' ' ARG . 19.3 p 47.4 -164.76 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.213 -0.93 . . . . 0.0 109.516 -176.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -140.16 142.81 35.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.913 -1.117 . . . . 0.0 110.732 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.431 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -97.24 126.98 42.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.267 -0.895 . . . . 0.0 108.907 171.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.582 ' CB ' ' NE2' ' A' ' 8' ' ' HIS . . . -136.67 130.82 32.72 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.661 -1.274 . . . . 0.0 112.112 -168.476 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.511 ' C ' ' CD2' ' A' ' 8' ' ' HIS . 75.2 mt -103.48 144.42 31.42 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.263 -0.898 . . . . 0.0 109.411 167.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.977 ' CD2' HD12 ' A' ' 49' ' ' LEU . 10.0 m-70 -136.28 142.59 43.95 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.797 -1.19 . . . . 0.0 111.121 -175.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.565 ' HB ' ' CG2' ' A' ' 85' ' ' ILE . 96.7 mt -129.14 131.9 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.133 -0.98 . . . . 0.0 109.953 170.432 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.552 HD23 ' N ' ' A' ' 11' ' ' VAL . 0.3 OUTLIER -103.27 121.9 43.66 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.507 -0.746 . . . . 0.0 110.068 179.382 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.725 HG13 HD22 ' A' ' 16' ' ' LEU . 2.7 t -110.25 133.15 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.088 -1.008 . . . . 0.0 110.142 178.165 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.2 mttt -68.33 -40.02 81.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.238 -0.914 . . . . 0.0 110.646 -178.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -120.14 142.0 49.34 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.152 -0.968 . . . . 0.0 110.977 -176.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.583 ' HB2' ' CZ ' ' A' ' 83' ' ' TYR . 88.6 tt0 -59.99 -42.99 95.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.447 -0.783 . . . . 0.0 110.172 178.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -57.47 -40.06 77.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.682 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.725 HD22 HG13 ' A' ' 11' ' ' VAL . 5.5 tt -67.99 -40.28 83.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.2 -0.938 . . . . 0.0 109.704 177.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.6 ' N ' HG11 ' A' ' 11' ' ' VAL . . . -59.94 -44.1 94.59 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -0.933 . . . . 0.0 110.061 175.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.408 ' CD1' ' HG2' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -60.01 -43.24 95.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.303 -0.873 . . . . 0.0 109.707 175.829 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -59.99 -41.46 92.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.312 -0.867 . . . . 0.0 109.586 174.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.0 tp -63.08 -45.47 91.99 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.573 0.702 . . . . 0.0 109.88 176.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.676 HD11 ' CD1' ' A' ' 85' ' ' ILE . 2.4 mp -59.96 -44.98 94.1 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.659 -0.651 . . . . 0.0 110.376 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.5 tp10 -60.59 -40.07 90.4 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.421 -0.8 . . . . 0.0 110.411 -178.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -60.39 -41.14 93.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.277 -0.89 . . . . 0.0 110.133 -177.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.81 HG13 HD13 ' A' ' 33' ' ' LEU . 24.8 mt -67.14 -43.09 88.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.36 -0.837 . . . . 0.0 110.801 -178.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -60.2 -47.97 83.73 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.869 -1.145 . . . . 0.0 110.395 -175.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -59.7 -62.55 1.79 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.004 -1.06 . . . . 0.0 110.345 176.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.743 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -105.76 -39.23 2.22 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -172.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.743 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 81.47 -176.79 0.05 Allowed 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.811 -0.817 . . . . 0.0 109.623 -173.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.618 ' CB ' ' O ' ' A' ' 28' ' ' ALA . 95.9 m-20 115.11 71.84 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.954 0 C-N-CA 124.822 1.249 . . . . 0.0 109.623 -175.175 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.594 ' CG ' ' HE3' ' A' ' 87' ' ' LYS . 7.6 m-85 -63.42 -39.77 95.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.266 -0.897 . . . . 0.0 110.32 176.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.64 -55.75 28.16 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 -177.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.2 mttp -66.52 -40.62 89.27 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.923 -1.339 . . . . 0.0 110.912 -176.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.81 HD13 HG13 ' A' ' 24' ' ' ILE . 34.9 mt -66.59 -40.06 88.7 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.045 -1.035 . . . . 0.0 110.19 -179.126 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.546 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -59.98 -46.2 90.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.096 -1.003 . . . . 0.0 110.029 177.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -60.06 -48.89 79.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.273 -0.892 . . . . 0.0 110.44 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -64.11 -46.57 83.62 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.181 -0.949 . . . . 0.0 110.941 -174.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.4 ' CE1' HD21 ' A' ' 16' ' ' LEU . 57.1 m-70 -73.95 -44.93 53.27 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.917 -1.114 . . . . 0.0 111.334 -175.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.655 ' O ' HG22 ' A' ' 39' ' ' ILE . 6.7 t -59.97 -48.16 82.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.977 -1.077 . . . . 0.0 110.707 -172.386 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.655 HG22 ' O ' ' A' ' 38' ' ' SER . 20.1 tt 38.33 32.24 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.588 -0.695 . . . . 0.0 110.837 179.217 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.487 ' SG ' ' N ' ' A' ' 43' ' ' GLY . 18.7 p -128.71 164.2 40.0 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.143 -0.973 . . . . 0.0 110.366 -176.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.472 ' HD2' ' HB2' ' A' ' 40' ' ' CYS . 1.7 Cg_endo -50.66 -29.11 24.43 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.951 1.501 . . . . 0.0 110.454 178.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.485 ' O ' ' CA ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -100.57 17.93 20.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.065 -1.022 . . . . 0.0 109.65 175.4 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.488 ' HA2' ' OG ' ' A' ' 38' ' ' SER . . . -79.51 -57.85 3.03 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 175.026 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.467 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 86.8 tttt -59.99 -39.53 86.03 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.383 -1.069 . . . . 0.0 110.04 177.192 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.0 tpt180 -95.71 -42.36 8.42 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.089 -1.007 . . . . 0.0 110.767 -177.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.485 ' CA ' ' O ' ' A' ' 42' ' ' SER . . . -70.13 -25.63 75.36 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.86 -1.04 58.12 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 175.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' A' ' 44' ' ' LYS . 45.7 p-10 -171.01 66.85 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.326 -1.102 . . . . 0.0 108.755 -178.464 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.977 HD12 ' CD2' ' A' ' 8' ' ' HIS . 7.5 mt -69.96 -26.27 64.03 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.51 -0.744 . . . . 0.0 109.924 -175.372 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.03 -145.48 17.8 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 -178.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -109.95 137.57 47.55 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.226 -1.161 . . . . 0.0 110.383 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.608 ' HB2' ' NE2' ' A' ' 56' ' ' GLN . 3.4 p90 -148.09 163.01 38.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.434 -0.791 . . . . 0.0 110.1 -178.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.511 ' HG2' HG22 ' A' ' 3' ' ' THR . 96.4 mtt180 -75.58 158.59 32.26 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.24 -0.913 . . . . 0.0 109.354 176.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -62.31 123.99 19.7 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.084 -1.01 . . . . 0.0 109.368 176.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 105.74 66.0 0.66 Allowed Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -174.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.608 ' NE2' ' HB2' ' A' ' 52' ' ' PHE . 5.0 mm100 -128.89 -63.7 0.95 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.881 -1.364 . . . . 0.0 109.571 176.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 45.0 ttm -115.33 -62.92 1.53 Allowed 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.376 -0.929 . . . . 0.0 111.209 -166.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 58' ' ' VAL . 10.8 p -123.21 133.13 24.34 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.181 -0.949 . . . . 0.0 110.528 -173.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.447 ' O ' ' N ' ' A' ' 61' ' ' PHE . 14.2 Cg_endo -60.42 -52.93 3.32 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.869 1.458 . . . . 0.0 110.205 176.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.732 ' O ' HG13 ' A' ' 64' ' ' VAL . . . -39.76 -28.98 0.05 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.585 -0.697 . . . . 0.0 110.628 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.506 ' HB2' ' CG1' ' A' ' 58' ' ' VAL . 62.5 t80 -60.03 -44.56 94.55 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.161 -0.962 . . . . 0.0 110.204 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.466 ' O ' HG12 ' A' ' 65' ' ' VAL . 47.8 t0 -59.93 -40.05 87.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.156 -0.965 . . . . 0.0 109.723 176.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.885 ' HD3' HD21 ' A' ' 77' ' ' LEU . 79.9 tttt -58.55 -41.92 86.72 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.387 -0.821 . . . . 0.0 110.348 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.732 HG13 ' O ' ' A' ' 60' ' ' ALA . 0.9 OUTLIER -77.69 -46.43 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.122 -0.986 . . . . 0.0 110.667 -177.153 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.5 ' N ' ' CG2' ' A' ' 64' ' ' VAL . 0.3 OUTLIER -56.14 -25.12 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.502 -1.374 . . . . 0.0 109.201 172.776 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -95.21 -5.17 44.46 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.493 -0.754 . . . . 0.0 109.917 175.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.532 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 29.7 t -96.32 -44.54 7.19 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.418 -0.801 . . . . 0.0 110.14 178.471 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 56.5 m -131.68 152.38 80.29 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.353 -0.842 . . . . 0.0 110.457 -177.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.437 ' HD2' ' OE1' ' A' ' 72' ' ' GLU . 13.5 Cg_endo -68.95 155.92 66.97 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.073 1.565 . . . . 0.0 110.377 178.232 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.888 HG22 HD12 ' A' ' 71' ' ' LEU . 8.9 p -61.3 169.69 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.349 -0.844 . . . . 0.0 110.616 -177.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.888 HD12 HG22 ' A' ' 70' ' ' VAL . 2.2 mp 59.45 16.02 4.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.629 -0.67 . . . . 0.0 110.277 -177.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.437 ' OE1' ' HD2' ' A' ' 69' ' ' PRO . 11.1 tt0 -137.2 85.15 22.61 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.206 -0.933 . . . . 0.0 109.472 173.044 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -43.75 145.27 1.95 Allowed 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 124.051 1.553 . . . . 0.0 110.712 -174.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 62.6 m -132.67 139.62 47.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.47 -0.769 . . . . 0.0 110.078 -178.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.42 ' HA3' HG13 ' A' ' 85' ' ' ILE . . . 141.72 -175.88 22.26 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.234 -1.547 . . . . 0.0 109.234 -178.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.549 ' HD3' HD21 ' A' ' 21' ' ' LEU . 43.5 Cg_endo -79.47 132.91 26.58 Favored 'Cis proline' 0 C--N 1.314 -1.275 0 C-N-CA 121.834 -2.152 . . . . 0.0 110.367 -0.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.885 HD21 ' HD3' ' A' ' 63' ' ' LYS . 43.7 tp -96.51 156.86 16.16 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.283 -0.885 . . . . 0.0 110.877 -174.357 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.461 ' N ' ' HG ' ' A' ' 77' ' ' LEU . 36.1 t-80 -78.0 126.03 30.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.454 -0.779 . . . . 0.0 110.402 178.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.575 HG21 ' CG ' ' A' ' 84' ' ' HIS . 11.6 t -139.95 158.98 43.2 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.178 -0.951 . . . . 0.0 109.882 176.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -60.89 -25.74 66.93 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.16 -0.962 . . . . 0.0 110.864 -176.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -81.01 -9.94 59.78 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.007 -1.058 . . . . 0.0 110.639 -178.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.502 ' O ' HG22 ' A' ' 79' ' ' THR . . . 139.4 -128.43 3.99 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 108.653 -1.779 . . . . 0.0 108.653 -174.126 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.583 ' CZ ' ' HB2' ' A' ' 14' ' ' GLU . 91.6 m-85 -115.88 134.58 54.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.95 -1.323 . . . . 0.0 109.827 173.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.575 ' CG ' HG21 ' A' ' 79' ' ' THR . 31.3 m170 -114.34 125.51 53.96 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.18 -0.95 . . . . 0.0 110.564 177.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.676 ' CD1' HD11 ' A' ' 21' ' ' LEU . 6.7 tt -114.1 122.23 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.904 -1.122 . . . . 0.0 109.264 170.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.72 HD12 HG11 ' A' ' 64' ' ' VAL . 85.3 mt -117.43 129.96 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.167 -0.958 . . . . 0.0 111.07 -170.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.594 ' HE3' ' CG ' ' A' ' 30' ' ' PHE . 12.1 ttmm -94.87 125.65 39.67 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.126 -0.984 . . . . 0.0 109.341 170.008 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.613 HG12 HG23 ' A' ' 70' ' ' VAL . 62.4 t -104.75 131.96 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.294 -0.879 . . . . 0.0 110.221 -174.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.522 ' O ' ' N ' ' A' ' 91' ' ' ARG . 48.4 mt -133.74 154.07 51.24 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.507 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 2.2 m-85 64.19 -58.58 0.22 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.682 -0.637 . . . . 0.0 111.059 176.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.522 ' N ' ' O ' ' A' ' 89' ' ' LEU . 3.2 ttm180 60.44 178.75 0.1 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.077 -1.014 . . . . 0.0 110.544 -179.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 48.5 t30 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 118.045 -0.979 . . . . 0.0 110.187 -179.413 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.61 ' HB1' ' O ' ' A' ' 91' ' ' ARG . . . . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.197 0.523 . . . . 0.0 110.09 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 53' ' ' ARG . 15.5 ttpp -59.97 -40.03 87.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.223 -0.923 . . . . 0.0 110.325 -177.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.0 p -140.99 150.95 43.73 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.301 -0.874 . . . . 0.0 110.58 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.448 ' C ' ' HG3' ' A' ' 51' ' ' GLU . . . -132.53 156.66 46.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.189 -0.944 . . . . 0.0 110.194 178.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.522 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -92.07 125.33 36.71 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.153 -0.967 . . . . 0.0 109.285 175.37 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.797 ' HB3' ' CE2' ' A' ' 52' ' ' PHE . . . -137.16 130.2 30.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.804 -1.185 . . . . 0.0 112.081 -169.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.74 HD12 ' HD2' ' A' ' 87' ' ' LYS . 85.0 mt -103.46 140.72 37.1 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.282 -0.886 . . . . 0.0 108.994 168.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.621 ' NE2' ' HB1' ' A' ' 6' ' ' ALA . 35.5 m170 -134.41 148.53 50.66 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.681 -1.262 . . . . 0.0 111.539 -176.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.68 ' HB ' HG22 ' A' ' 85' ' ' ILE . 97.0 mt -136.33 130.88 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.297 -0.877 . . . . 0.0 109.862 169.4 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.62 HD23 ' N ' ' A' ' 11' ' ' VAL . 0.4 OUTLIER -99.25 123.65 43.7 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.383 -0.823 . . . . 0.0 109.667 177.153 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.666 HG11 ' N ' ' A' ' 17' ' ' ALA . 2.6 t -115.86 129.78 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.183 -0.948 . . . . 0.0 110.028 177.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -69.25 -40.03 78.11 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.326 -0.859 . . . . 0.0 110.59 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -114.93 139.49 49.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.064 -1.022 . . . . 0.0 110.652 -177.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.507 ' HB2' ' CZ ' ' A' ' 83' ' ' TYR . 86.3 tt0 -59.94 -42.41 93.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.428 -0.795 . . . . 0.0 110.032 177.096 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -56.68 -42.84 79.75 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.325 -0.859 . . . . 0.0 110.2 179.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.615 HD22 HG13 ' A' ' 11' ' ' VAL . 7.4 tt -68.09 -42.4 80.41 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.052 -1.03 . . . . 0.0 109.875 179.186 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.666 ' N ' HG11 ' A' ' 11' ' ' VAL . . . -59.97 -46.53 89.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.133 -0.98 . . . . 0.0 109.714 174.202 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.789 HD23 HD22 ' A' ' 21' ' ' LEU . 25.5 mt -60.04 -39.97 87.77 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.889 . . . . 0.0 109.97 175.186 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.464 ' HB3' ' O ' ' A' ' 16' ' ' LEU . 48.1 t0 -59.97 -40.63 89.76 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.181 -0.949 . . . . 0.0 109.298 174.122 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.459 ' HB3' ' O ' ' A' ' 17' ' ' ALA . 2.6 tp -63.28 -39.88 95.83 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.445 -0.784 . . . . 0.0 109.325 173.311 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.789 HD22 HD23 ' A' ' 18' ' ' LEU . 3.4 mp -59.29 -42.78 92.08 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.53 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -60.26 -40.06 88.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.393 -0.817 . . . . 0.0 109.92 174.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.466 ' OE1' HD22 ' A' ' 33' ' ' LEU . 96.7 mt-30 -61.83 -40.31 94.85 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.45 -0.781 . . . . 0.0 110.818 -177.275 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.526 ' O ' ' N ' ' A' ' 28' ' ' ALA . 96.9 mt -66.24 -40.02 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.104 -0.997 . . . . 0.0 109.843 -178.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -64.02 -53.73 45.46 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.084 -1.01 . . . . 0.0 109.802 176.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -60.49 -43.47 96.99 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.316 -0.865 . . . . 0.0 110.808 177.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.747 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -106.37 -59.78 0.6 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 -175.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.747 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 83.23 89.89 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 O-C-N 122.07 -0.665 . . . . 0.0 109.861 -175.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -176.92 78.79 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.395 -0.816 . . . . 0.0 109.904 -174.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.565 ' CD2' ' HE3' ' A' ' 87' ' ' LYS . 5.4 m-85 -60.06 -40.56 89.9 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.271 -0.893 . . . . 0.0 110.79 -175.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.63 -51.42 56.12 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.77 -1.205 . . . . 0.0 110.116 -176.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -66.21 -40.01 90.03 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.07 -1.253 . . . . 0.0 110.446 -175.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.466 HD22 ' OE1' ' A' ' 23' ' ' GLN . 67.3 mt -65.92 -39.98 91.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.226 -0.921 . . . . 0.0 110.113 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.563 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -59.29 -50.09 75.34 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.239 -0.913 . . . . 0.0 110.348 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.5 tttp -59.99 -48.25 82.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.913 . . . . 0.0 110.577 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.9 tttt -60.06 -49.54 77.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.208 -0.932 . . . . 0.0 110.987 -175.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -81.88 -40.54 22.24 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.934 -1.104 . . . . 0.0 111.637 -172.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.485 ' OG ' ' HA3' ' A' ' 43' ' ' GLY . 23.7 t -60.06 -49.99 75.49 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.91 -1.119 . . . . 0.0 111.074 -172.332 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.637 ' O ' HG22 ' A' ' 39' ' ' ILE . 83.7 mt 33.39 48.59 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 CA-C-O 121.195 0.521 . . . . 0.0 111.142 -177.147 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.42 ' HB2' ' CD ' ' A' ' 41' ' ' PRO . 15.3 p -139.98 176.06 2.79 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.132 -0.98 . . . . 0.0 110.407 -177.362 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.474 ' O ' ' CB ' ' A' ' 42' ' ' SER . 3.0 Cg_exo -68.87 66.26 1.28 Allowed 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.874 1.46 . . . . 0.0 109.849 -178.088 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 45' ' ' ARG . 0.1 OUTLIER 165.44 -41.95 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.779 -0.576 . . . . 0.0 109.69 179.594 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.485 ' HA3' ' OG ' ' A' ' 38' ' ' SER . . . -41.77 -37.36 1.99 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -178.017 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -60.31 -40.01 89.04 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.019 -1.283 . . . . 0.0 110.133 175.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.552 ' HG3' ' CD2' ' A' ' 49' ' ' LEU . 11.3 tpp180 -102.4 -43.2 5.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.526 -0.734 . . . . 0.0 110.596 -176.422 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.544 ' HA2' HD11 ' A' ' 49' ' ' LEU . . . -55.15 -35.33 59.69 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.926 -1.269 . . . . 0.0 109.926 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.49 ' O ' HD22 ' A' ' 7' ' ' LEU . . . -67.99 -5.96 42.79 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 176.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -169.84 64.71 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.285 -1.126 . . . . 0.0 109.176 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.552 ' CD2' ' HG3' ' A' ' 45' ' ' ARG . 5.0 mt -69.99 -27.63 64.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.539 -0.726 . . . . 0.0 110.07 -178.011 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 101.06 -143.42 16.17 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 -176.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.448 ' HG3' ' C ' ' A' ' 4' ' ' ALA . 72.2 tt0 -111.8 133.14 54.21 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.206 -1.173 . . . . 0.0 110.253 -179.003 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.797 ' CE2' ' HB3' ' A' ' 6' ' ' ALA . 4.7 p90 -145.56 166.43 25.74 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.322 -0.861 . . . . 0.0 109.985 -178.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.545 ' O ' ' N ' ' A' ' 55' ' ' GLY . 87.6 mtt180 -68.75 144.34 54.4 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.036 -1.04 . . . . 0.0 110.215 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.458 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 15.4 pt20 -63.44 64.06 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.572 -0.705 . . . . 0.0 110.76 -177.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . 165.08 61.96 0.02 OUTLIER Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 -179.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.486 ' OE1' ' HB2' ' A' ' 52' ' ' PHE . 3.1 mm-40 -117.94 -62.42 1.55 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.071 -1.252 . . . . 0.0 109.193 177.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 56.3 ttp -93.89 -51.41 4.89 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.706 -170.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.504 HG13 ' O ' ' A' ' 58' ' ' VAL . 13.3 p -143.26 132.8 11.77 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.358 -0.839 . . . . 0.0 110.164 -174.419 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.426 ' O ' ' C ' ' A' ' 60' ' ' ALA . 14.5 Cg_endo -61.9 -48.57 8.36 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.902 1.475 . . . . 0.0 110.025 178.132 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 59' ' ' PRO . . . -39.81 -33.32 0.19 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.606 -0.684 . . . . 0.0 110.845 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.655 ' CE2' HG21 ' A' ' 65' ' ' VAL . 65.1 t80 -60.01 -44.03 94.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.043 -1.036 . . . . 0.0 110.358 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -60.73 -39.92 90.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.179 -0.95 . . . . 0.0 110.163 -179.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.416 ' O ' ' HB2' ' A' ' 67' ' ' SER . 75.6 mmtt -58.97 -45.89 89.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.182 -0.949 . . . . 0.0 110.378 -178.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.709 HG23 HG21 ' A' ' 74' ' ' THR . 8.5 p -73.39 -39.98 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.059 -1.025 . . . . 0.0 110.53 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.655 HG21 ' CE2' ' A' ' 61' ' ' PHE . 9.6 t -55.75 -30.67 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.625 -1.297 . . . . 0.0 109.568 171.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -96.15 -0.36 50.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.37 -0.831 . . . . 0.0 109.844 176.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.454 ' CB ' ' HA ' ' A' ' 64' ' ' VAL . 6.9 t -96.44 -64.66 1.03 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.362 -0.836 . . . . 0.0 109.525 174.573 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.411 ' SG ' ' OG1' ' A' ' 74' ' ' THR . 91.1 m -89.57 130.73 42.33 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.326 -0.859 . . . . 0.0 110.016 175.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.548 ' O ' ' O ' ' A' ' 70' ' ' VAL . 25.2 Cg_endo -67.64 79.28 0.49 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.849 1.447 . . . . 0.0 110.79 -177.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.017 ' C ' HD13 ' A' ' 71' ' ' LEU . 1.8 m 37.17 177.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.445 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 177.04 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.017 HD13 ' C ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER 24.39 40.92 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.485 0 CA-C-O 121.636 0.731 . . . . 0.0 112.632 -170.72 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.554 ' N ' ' O ' ' A' ' 70' ' ' VAL . 3.4 tp10 -138.05 81.96 25.96 Favored Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 121.285 -0.885 . . . . 0.0 109.589 174.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -43.68 129.49 7.09 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 124.045 1.55 . . . . 0.0 110.204 -176.166 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.709 HG21 HG23 ' A' ' 64' ' ' VAL . 57.1 m -127.96 135.7 50.29 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.348 -0.845 . . . . 0.0 110.196 -175.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.421 ' HA3' HG13 ' A' ' 85' ' ' ILE . . . 133.6 -176.55 19.62 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 -178.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.605 ' CD ' HD21 ' A' ' 21' ' ' LEU . 43.3 Cg_endo -72.19 152.9 97.61 Favored 'Cis proline' 0 C--N 1.314 -1.276 0 C-N-CA 121.713 -2.203 . . . . 0.0 110.199 0.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.0 tp -131.38 154.51 48.54 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.129 -0.982 . . . . 0.0 110.329 -175.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 -76.64 130.92 38.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.244 -0.91 . . . . 0.0 110.761 -177.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.63 HG21 ' CG ' ' A' ' 84' ' ' HIS . 10.3 t -142.08 173.65 11.32 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.452 -0.78 . . . . 0.0 109.823 175.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -59.99 -27.72 67.1 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.158 -0.963 . . . . 0.0 110.517 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -96.39 9.97 39.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.999 -1.063 . . . . 0.0 110.902 -172.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.401 ' O ' HG22 ' A' ' 79' ' ' THR . . . 119.6 -124.65 6.04 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 -176.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.507 ' CZ ' ' HB2' ' A' ' 14' ' ' GLU . 87.1 m-85 -114.07 139.02 49.64 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.128 -1.219 . . . . 0.0 110.253 176.566 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.63 ' CG ' HG21 ' A' ' 79' ' ' THR . 21.9 m170 -121.7 121.63 37.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.35 -0.844 . . . . 0.0 110.377 177.339 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.68 HG22 ' HB ' ' A' ' 9' ' ' ILE . 6.1 tt -109.94 136.84 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.761 -1.212 . . . . 0.0 109.434 168.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.554 HG12 ' CD2' ' A' ' 8' ' ' HIS . 26.1 mt -133.48 131.67 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.076 -1.015 . . . . 0.0 111.223 -169.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.74 ' HD2' HD12 ' A' ' 7' ' ' LEU . 12.1 ttmm -105.25 128.03 53.23 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.237 -0.914 . . . . 0.0 109.411 170.144 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.771 HG12 HG12 ' A' ' 70' ' ' VAL . 60.8 t -108.77 139.3 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.204 -0.935 . . . . 0.0 110.363 -174.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.527 ' O ' ' CB ' ' A' ' 90' ' ' TYR . 81.6 mt -140.38 126.26 19.45 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.197 -0.94 . . . . 0.0 110.055 -177.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.527 ' CB ' ' O ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER 80.71 -57.97 0.3 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.415 -0.803 . . . . 0.0 111.53 171.985 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.657 ' HB2' HG11 ' A' ' 70' ' ' VAL . 47.5 ttp180 55.63 39.97 30.95 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.863 -1.148 . . . . 0.0 110.631 -179.01 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.432 ' CG ' ' O ' ' A' ' 91' ' ' ARG . 4.4 m-20 . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 118.076 -0.964 . . . . 0.0 110.123 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.276 0.56 . . . . 0.0 110.39 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -61.35 -33.03 72.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.169 -0.957 . . . . 0.0 110.377 178.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 52' ' ' PHE . 72.6 m -132.46 150.02 52.23 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.147 -0.971 . . . . 0.0 110.095 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.577 ' O ' ' CD1' ' A' ' 52' ' ' PHE . . . -153.4 157.77 40.45 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.914 -1.116 . . . . 0.0 110.786 -177.704 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.489 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -104.14 139.46 39.18 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.149 -0.969 . . . . 0.0 109.429 172.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.821 ' HB3' ' CZ ' ' A' ' 52' ' ' PHE . . . -149.83 130.79 14.3 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.694 -1.254 . . . . 0.0 111.457 -177.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.915 HD12 ' HE3' ' A' ' 87' ' ' LYS . 17.4 mt -100.75 146.17 27.58 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.454 -0.779 . . . . 0.0 109.746 172.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.678 ' CD2' HD12 ' A' ' 49' ' ' LEU . 8.0 m-70 -134.5 150.1 50.76 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.121 -0.987 . . . . 0.0 110.826 -175.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.561 ' HB ' ' CG2' ' A' ' 85' ' ' ILE . 89.8 mt -128.78 129.88 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.063 -1.023 . . . . 0.0 109.671 167.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.535 ' HG ' ' CD2' ' A' ' 84' ' ' HIS . 0.5 OUTLIER -106.5 119.33 39.01 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.497 -0.752 . . . . 0.0 110.1 -177.523 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.952 HG13 HD22 ' A' ' 16' ' ' LEU . 3.1 t -114.97 131.05 68.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.227 -0.921 . . . . 0.0 110.045 176.251 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 49.0 tttt -69.95 -40.01 75.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.083 -1.011 . . . . 0.0 110.614 -178.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -109.04 137.25 47.24 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.107 -0.995 . . . . 0.0 110.839 -176.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.555 ' HB2' ' CZ ' ' A' ' 83' ' ' TYR . 86.5 tt0 -59.99 -42.01 93.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.443 -0.785 . . . . 0.0 110.121 178.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -56.37 -41.16 75.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.322 -0.861 . . . . 0.0 110.212 178.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.952 HD22 HG13 ' A' ' 11' ' ' VAL . 4.7 tt -67.95 -39.91 83.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.014 -1.054 . . . . 0.0 109.076 175.279 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.674 ' O ' HD12 ' A' ' 21' ' ' LEU . . . -59.93 -40.63 89.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.303 -0.873 . . . . 0.0 110.095 175.482 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.03 -42.05 93.56 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.022 -1.049 . . . . 0.0 109.571 175.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -59.99 -38.99 84.22 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.275 -0.891 . . . . 0.0 109.706 173.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.711 ' C ' HD12 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -60.82 -50.38 73.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.313 -0.867 . . . . 0.0 109.885 178.822 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.797 HD21 ' HD3' ' A' ' 76' ' ' PRO . 1.4 mt -60.02 -49.26 78.38 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.339 -0.851 . . . . 0.0 110.181 -178.505 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -60.48 -40.08 89.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.454 -0.779 . . . . 0.0 109.999 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 70.0 tp60 -59.99 -41.31 91.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.365 -0.834 . . . . 0.0 110.529 -175.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.528 ' O ' ' N ' ' A' ' 28' ' ' ALA . 63.1 mt -63.65 -47.92 89.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.2 -0.938 . . . . 0.0 110.21 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -62.11 -45.08 95.08 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.903 -1.123 . . . . 0.0 109.659 177.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -59.97 -60.8 3.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.376 -0.827 . . . . 0.0 110.178 177.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.745 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -105.83 -45.8 1.26 Allowed Glycine 0 N--CA 1.486 1.992 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -175.355 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.745 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 80.16 158.69 0.16 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.811 -0.817 . . . . 0.0 110.462 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.592 ' CB ' ' O ' ' A' ' 28' ' ' ALA . 96.7 m-20 118.26 81.24 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.038 0 C-N-CA 125.053 1.341 . . . . 0.0 109.634 -175.262 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.439 ' CZ ' HD13 ' A' ' 24' ' ' ILE . 2.1 m-85 -60.02 -45.04 94.1 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.207 -0.933 . . . . 0.0 110.999 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.39 -54.64 25.38 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.765 -1.207 . . . . 0.0 110.141 -174.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -65.94 -39.95 90.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.048 -1.266 . . . . 0.0 110.306 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 46.8 mt -63.65 -39.97 95.68 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.134 -0.979 . . . . 0.0 109.643 176.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.546 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -55.18 -50.64 68.83 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.266 -0.896 . . . . 0.0 110.091 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -59.96 -51.97 67.39 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.055 -1.028 . . . . 0.0 110.677 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -60.96 -50.07 74.87 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.21 -0.931 . . . . 0.0 111.175 -176.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -70.43 -39.97 74.07 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.123 -0.986 . . . . 0.0 110.867 -177.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.658 ' O ' HG22 ' A' ' 39' ' ' ILE . 20.7 t -60.08 -46.35 89.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.138 -0.976 . . . . 0.0 110.349 -175.007 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.658 HG22 ' O ' ' A' ' 38' ' ' SER . 16.0 tt 37.99 29.87 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.7 -0.625 . . . . 0.0 110.58 178.095 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.47 ' N ' ' O ' ' A' ' 38' ' ' SER . 15.2 p -129.67 165.11 35.37 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.35 -0.844 . . . . 0.0 110.193 -176.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.47 ' HD2' ' HB2' ' A' ' 40' ' ' CYS . 1.1 Cg_endo -47.76 -28.43 9.61 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.802 1.422 . . . . 0.0 110.562 178.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.523 ' O ' ' CA ' ' A' ' 46' ' ' GLY . 0.2 OUTLIER -99.77 18.43 18.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.99 -1.069 . . . . 0.0 110.148 177.526 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.44 -55.01 5.27 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.549 -1.82 . . . . 0.0 108.549 171.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -61.12 -40.03 92.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.457 -1.025 . . . . 0.0 110.749 177.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.412 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 12.8 tpt180 -104.53 -41.26 5.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.089 -1.007 . . . . 0.0 110.795 -174.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.523 ' CA ' ' O ' ' A' ' 42' ' ' SER . . . -69.95 -31.88 69.8 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.55 0.9 59.47 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 177.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.521 ' HA ' ' CD2' ' A' ' 7' ' ' LEU . 47.8 t0 -170.38 76.17 0.08 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.296 -1.12 . . . . 0.0 109.065 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.678 HD12 ' CD2' ' A' ' 8' ' ' HIS . 19.2 mt -82.63 -14.96 53.81 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.602 -0.686 . . . . 0.0 110.193 -174.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.01 -137.96 14.29 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 177.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.499 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 3.4 mt-10 -108.79 158.59 17.5 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.453 -1.028 . . . . 0.0 110.421 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.821 ' CZ ' ' HB3' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -139.96 177.83 7.69 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.389 -0.82 . . . . 0.0 109.407 -175.583 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.539 ' O ' ' N ' ' A' ' 55' ' ' GLY . 29.8 ptt180 -167.32 -175.88 3.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.616 -0.677 . . . . 0.0 109.849 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.481 ' O ' ' O ' ' A' ' 55' ' ' GLY . 96.7 mt-30 32.08 -87.47 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 O-C-N 122.006 -0.434 . . . . 0.0 112.135 178.275 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . -53.23 -111.51 0.01 OUTLIER Glycine 0 N--CA 1.496 2.695 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 -174.555 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.522 ' OE1' ' CB ' ' A' ' 52' ' ' PHE . 51.0 mm-40 60.0 22.91 12.04 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.788 -1.419 . . . . 0.0 109.667 -178.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.443 ' O ' ' C ' ' A' ' 58' ' ' VAL . 54.5 ttm -60.02 -45.86 91.4 Favored 'General case' 0 C--N 1.289 -2.049 0 O-C-N 120.8 -1.188 . . . . 0.0 111.539 -160.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.443 ' C ' ' O ' ' A' ' 57' ' ' MET . 1.4 p -39.35 132.75 1.26 Allowed Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.575 -0.703 . . . . 0.0 110.307 -174.256 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -56.77 -52.81 6.07 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.005 1.529 . . . . 0.0 110.88 -171.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -45.28 -44.63 11.54 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.219 -0.925 . . . . 0.0 110.578 -174.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -59.99 -41.68 92.57 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.185 -0.947 . . . . 0.0 110.118 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.516 ' O ' HG12 ' A' ' 65' ' ' VAL . 57.4 t0 -71.78 -38.4 70.3 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.317 -0.864 . . . . 0.0 110.298 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.521 ' O ' ' N ' ' A' ' 67' ' ' SER . 87.6 tttt -55.06 -49.96 70.31 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.24 -0.912 . . . . 0.0 110.216 -175.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.667 ' HB ' HD11 ' A' ' 77' ' ' LEU . 2.5 p -69.81 -47.1 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.129 -0.982 . . . . 0.0 111.814 -174.144 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.516 HG12 ' O ' ' A' ' 62' ' ' ASP . 3.0 p -57.4 -27.12 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.319 -1.488 . . . . 0.0 109.055 173.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -92.97 -11.19 33.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.407 -0.808 . . . . 0.0 109.846 175.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.544 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 9.4 t -91.62 -44.74 8.87 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.318 -0.864 . . . . 0.0 109.756 176.373 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.503 ' HB3' ' HB3' ' A' ' 72' ' ' GLU . 66.1 m -137.14 149.98 67.82 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.306 -0.871 . . . . 0.0 110.382 178.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.485 ' O ' ' HB2' ' A' ' 72' ' ' GLU . 52.1 Cg_endo -77.71 -179.48 5.48 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.054 1.555 . . . . 0.0 110.932 -178.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.938 HG22 ' CD1' ' A' ' 71' ' ' LEU . 7.2 p -60.04 157.65 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.424 -0.797 . . . . 0.0 110.06 177.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.938 ' CD1' HG22 ' A' ' 70' ' ' VAL . 4.4 mp 60.01 40.03 19.22 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.419 -0.8 . . . . 0.0 110.234 -175.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.503 ' HB3' ' HB3' ' A' ' 68' ' ' CYS . 0.0 OUTLIER -150.46 104.42 3.1 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.299 -0.875 . . . . 0.0 110.258 178.72 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 72' ' ' GLU . 26.0 Cg_endo -67.15 135.09 36.04 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.89 1.469 . . . . 0.0 110.273 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.636 ' HB ' HG23 ' A' ' 64' ' ' VAL . 87.2 m -140.13 147.21 39.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.164 -0.96 . . . . 0.0 110.488 -178.201 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.447 ' HA3' HG13 ' A' ' 85' ' ' ILE . . . 125.72 -168.88 17.72 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.797 ' HD3' HD21 ' A' ' 21' ' ' LEU . 43.0 Cg_endo -72.32 139.23 59.09 Favored 'Cis proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.847 -2.147 . . . . 0.0 110.732 -0.407 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.667 HD11 ' HB ' ' A' ' 64' ' ' VAL . 88.7 mt -92.99 169.37 10.48 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.3 -0.875 . . . . 0.0 110.633 -176.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 14.3 t60 -100.24 119.57 38.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.144 -0.972 . . . . 0.0 110.381 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.637 HG21 ' ND1' ' A' ' 84' ' ' HIS . 14.7 t -141.56 166.38 24.91 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.155 -0.965 . . . . 0.0 109.815 176.201 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.415 ' CG ' ' N ' ' A' ' 81' ' ' PHE . 15.8 pt20 -59.93 -34.75 73.66 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.121 -0.987 . . . . 0.0 110.397 -176.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.415 ' N ' ' CG ' ' A' ' 80' ' ' GLN . 94.4 m-85 -60.04 -27.26 66.78 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.271 -0.893 . . . . 0.0 110.208 178.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 141.63 -132.37 5.24 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -178.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.555 ' CZ ' ' HB2' ' A' ' 14' ' ' GLU . 81.3 m-85 -96.66 120.99 37.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -1.139 . . . . 0.0 109.876 175.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.637 ' ND1' HG21 ' A' ' 79' ' ' THR . 0.6 OUTLIER -113.29 113.64 25.55 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.566 -0.709 . . . . 0.0 110.9 -176.453 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.561 ' CG2' ' HB ' ' A' ' 9' ' ' ILE . 12.2 tt -109.82 133.9 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 120.616 -1.302 . . . . 0.0 109.579 170.073 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.528 HG12 ' ND1' ' A' ' 8' ' ' HIS . 85.9 mt -138.24 141.93 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.044 -1.035 . . . . 0.0 110.67 -172.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.915 ' HE3' HD12 ' A' ' 7' ' ' LEU . 20.1 pttp -119.53 142.06 48.67 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.048 -1.033 . . . . 0.0 109.511 171.156 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 62.5 t -107.9 129.97 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.913 -1.117 . . . . 0.0 111.302 -168.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' A' ' 91' ' ' ARG . 89.5 mt -114.26 -170.97 1.83 Allowed 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.305 -0.872 . . . . 0.0 109.204 172.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.435 ' C ' ' O ' ' A' ' 89' ' ' LEU . 71.0 m-85 32.85 -86.46 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.735 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.533 ' N ' ' O ' ' A' ' 89' ' ' LEU . 29.7 ttp85 60.82 48.63 6.75 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.696 -1.253 . . . . 0.0 110.617 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.9 t30 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.945 176.312 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.474 ' HA ' ' CB ' ' A' ' 92' ' ' ASN . . . . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.235 0.541 . . . . 0.0 110.16 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 32.0 mtpt -60.01 -41.93 93.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.222 -0.924 . . . . 0.0 109.174 177.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.579 HG22 ' HB3' ' A' ' 53' ' ' ARG . 28.1 p -139.98 156.64 46.55 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.192 0.52 . . . . 0.0 110.087 175.414 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.404 ' C ' ' HG3' ' A' ' 51' ' ' GLU . . . -129.88 160.12 34.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.254 -0.904 . . . . 0.0 109.656 178.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.555 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -95.52 127.39 41.51 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.121 -0.987 . . . . 0.0 109.551 179.091 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.823 ' HB3' ' HZ ' ' A' ' 52' ' ' PHE . . . -134.51 131.07 37.57 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.699 -1.25 . . . . 0.0 111.56 -170.68 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.517 ' C ' ' CD2' ' A' ' 8' ' ' HIS . 39.9 mt -102.28 147.31 26.82 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.078 -1.014 . . . . 0.0 109.33 170.036 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.672 ' NE2' ' HB1' ' A' ' 6' ' ' ALA . 31.4 m-70 -143.52 134.02 24.84 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.803 -1.185 . . . . 0.0 111.407 -175.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.564 HG13 ' CZ ' ' A' ' 30' ' ' PHE . 95.3 mt -119.99 125.69 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.776 -1.202 . . . . 0.0 109.763 165.036 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.592 ' HG ' ' CD2' ' A' ' 84' ' ' HIS . 0.2 OUTLIER -102.79 121.4 42.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.603 -0.686 . . . . 0.0 109.689 179.553 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.823 HG13 HD22 ' A' ' 16' ' ' LEU . 2.2 t -109.31 125.48 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.134 -0.979 . . . . 0.0 110.394 178.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -67.58 -39.97 84.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.445 -0.784 . . . . 0.0 110.446 175.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -108.11 136.84 47.11 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.217 -0.927 . . . . 0.0 110.966 -174.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.451 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 97.1 mt-10 -60.07 -40.84 90.93 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.4 -0.812 . . . . 0.0 110.115 173.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -58.86 -40.23 83.71 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.209 -0.932 . . . . 0.0 110.459 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.823 HD22 HG13 ' A' ' 11' ' ' VAL . 3.7 tt -68.31 -38.19 81.33 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.045 -1.034 . . . . 0.0 109.054 175.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.739 ' O ' HD12 ' A' ' 21' ' ' LEU . . . -58.76 -44.48 90.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.361 -0.837 . . . . 0.0 110.114 175.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.99 -42.72 94.84 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.221 -0.924 . . . . 0.0 109.611 176.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.456 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 65.1 t0 -59.94 -40.63 89.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.312 -0.867 . . . . 0.0 109.674 173.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.841 HD23 ' N ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -63.91 -55.32 23.55 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 121.587 0.708 . . . . 0.0 110.035 -179.786 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 1.08 HD11 ' HG3' ' A' ' 76' ' ' PRO . 0.4 OUTLIER -54.89 -40.07 69.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.564 -0.71 . . . . 0.0 109.779 179.5 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -60.58 -49.11 78.86 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.586 -0.696 . . . . 0.0 110.74 -176.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 19' ' ' ASP . 87.7 mm-40 -61.55 -40.04 93.25 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.116 -0.99 . . . . 0.0 110.375 -175.208 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.604 HG12 HD12 ' A' ' 33' ' ' LEU . 96.9 mt -59.97 -49.95 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.263 -0.898 . . . . 0.0 110.019 -177.267 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -62.18 -48.31 80.63 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.883 -1.136 . . . . 0.0 109.75 176.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.11 -55.79 29.54 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.341 -0.849 . . . . 0.0 110.28 178.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.747 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -105.28 -48.57 1.05 Allowed Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -174.393 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.747 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 81.81 96.03 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.173 0 O-C-N 122.151 -0.617 . . . . 0.0 110.228 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.44 ' HB3' ' HB2' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -176.0 84.61 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.466 -0.771 . . . . 0.0 109.935 -178.218 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.593 ' CG ' ' HE3' ' A' ' 87' ' ' LYS . 45.8 t80 -60.03 -48.5 81.45 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.314 -0.866 . . . . 0.0 110.573 -175.344 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.05 -47.84 89.03 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -176.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.44 ' HB2' ' HB3' ' A' ' 29' ' ' ASP . 36.6 mmtm -65.77 -40.16 91.75 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.055 -1.262 . . . . 0.0 110.561 -176.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.604 HD12 HG12 ' A' ' 24' ' ' ILE . 84.0 mt -66.76 -40.03 88.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.089 -1.007 . . . . 0.0 110.334 179.162 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.522 ' O ' ' CB ' ' A' ' 38' ' ' SER . . . -59.93 -47.35 86.16 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.121 -0.987 . . . . 0.0 109.992 179.327 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 66.8 tttt -60.01 -46.57 89.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.16 -0.963 . . . . 0.0 110.456 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.608 ' O ' HG23 ' A' ' 39' ' ' ILE . 55.7 mttt -70.03 -59.6 2.81 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.138 -0.976 . . . . 0.0 110.993 -176.742 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.453 ' HB3' HD21 ' A' ' 16' ' ' LEU . 79.9 m80 -71.73 -40.18 69.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.095 -1.003 . . . . 0.0 111.129 -172.101 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.527 ' O ' ' CG1' ' A' ' 39' ' ' ILE . 8.6 t -60.17 -49.25 78.37 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.135 -0.978 . . . . 0.0 110.509 -175.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.608 HG23 ' O ' ' A' ' 36' ' ' LYS . 36.4 pt 37.95 32.72 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-O 121.452 0.644 . . . . 0.0 110.465 -177.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.455 ' SG ' ' OG ' ' A' ' 38' ' ' SER . 14.9 p -125.93 166.21 22.7 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.393 -0.817 . . . . 0.0 109.658 178.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -51.7 -22.93 14.25 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.823 1.433 . . . . 0.0 110.425 -178.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.7 OUTLIER -101.63 12.99 36.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -0.908 . . . . 0.0 110.636 -179.025 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.08 -56.43 4.41 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 174.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 16.3 tttp -60.01 -40.0 87.73 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.343 -1.093 . . . . 0.0 110.368 177.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.473 ' HD2' HD23 ' A' ' 49' ' ' LEU . 8.7 tpp85 -98.86 -43.65 6.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 0.0 110.58 -175.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -60.0 -35.97 88.85 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.29 -4.21 35.68 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 110.016 -1.233 . . . . 0.0 110.016 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.427 ' HA ' ' CD2' ' A' ' 7' ' ' LEU . 9.7 t0 -171.32 69.37 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.016 -1.285 . . . . 0.0 109.449 178.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.493 HD13 ' SD ' ' A' ' 57' ' ' MET . 4.8 mt -70.03 -29.91 67.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.508 -0.745 . . . . 0.0 110.75 -176.208 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 112.23 -152.57 17.76 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.404 ' HG3' ' C ' ' A' ' 4' ' ' ALA . 79.1 tt0 -111.91 136.96 50.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.358 -1.084 . . . . 0.0 110.079 -178.092 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.823 ' HZ ' ' HB3' ' A' ' 6' ' ' ALA . 0.1 OUTLIER -160.18 168.17 26.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.198 -0.939 . . . . 0.0 110.243 -174.764 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.579 ' HB3' HG22 ' A' ' 3' ' ' THR . 48.7 ptt85 -94.52 -174.16 3.24 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.997 -1.064 . . . . 0.0 110.546 -176.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -63.51 -37.51 87.6 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.143 -0.973 . . . . 0.0 110.99 -176.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.427 ' HA3' ' NH2' ' A' ' 53' ' ' ARG . . . -85.67 61.45 4.56 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -173.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.541 ' NE2' ' HG2' ' A' ' 53' ' ' ARG . 5.0 mm-40 -134.83 -53.26 0.81 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.956 -1.32 . . . . 0.0 109.466 178.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.493 ' SD ' HD13 ' A' ' 49' ' ' LEU . 9.7 ttm -119.4 -150.73 0.46 Allowed 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.959 -162.338 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.495 ' O ' ' HB3' ' A' ' 61' ' ' PHE . 2.8 p -68.18 133.46 91.57 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.485 -0.759 . . . . 0.0 110.032 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.483 ' O ' ' N ' ' A' ' 61' ' ' PHE . 5.7 Cg_endo -52.68 -55.16 4.03 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.012 1.533 . . . . 0.0 110.484 -177.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.674 ' O ' HG13 ' A' ' 64' ' ' VAL . . . -37.5 -29.22 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.647 -0.658 . . . . 0.0 110.863 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.495 ' HB3' ' O ' ' A' ' 58' ' ' VAL . 32.0 t80 -60.03 -43.9 94.99 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.999 -1.063 . . . . 0.0 110.309 178.188 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 59' ' ' PRO . 7.7 t70 -60.04 -40.03 87.96 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.213 -0.929 . . . . 0.0 109.459 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 67' ' ' SER . 12.4 tptp -57.63 -49.95 74.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.391 -0.818 . . . . 0.0 110.876 177.143 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.674 HG13 ' O ' ' A' ' 60' ' ' ALA . 1.3 m -70.36 -48.64 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 120.929 -1.107 . . . . 0.0 110.832 -172.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.534 ' N ' ' CG2' ' A' ' 64' ' ' VAL . 13.2 p -57.01 -24.64 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.431 -1.418 . . . . 0.0 109.318 172.102 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.459 ' O ' ' CD1' ' A' ' 66' ' ' PHE . 17.2 t80 -96.57 -0.06 49.3 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.402 -0.811 . . . . 0.0 109.737 175.513 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.505 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 33.0 t -97.93 -49.13 4.9 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.431 -0.793 . . . . 0.0 110.006 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.481 ' HB2' ' OG1' ' A' ' 74' ' ' THR . 95.1 m -117.69 147.04 40.12 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.353 -0.842 . . . . 0.0 109.985 179.651 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.41 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 39.6 Cg_exo -57.14 146.43 81.33 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.015 1.534 . . . . 0.0 110.471 179.118 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.924 HG22 HD12 ' A' ' 71' ' ' LEU . 4.8 p -60.77 173.94 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.26 -0.9 . . . . 0.0 109.976 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.924 HD12 HG22 ' A' ' 70' ' ' VAL . 2.3 mp 59.61 20.11 8.69 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.335 -0.853 . . . . 0.0 109.642 -175.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.41 ' HB3' ' O ' ' A' ' 69' ' ' PRO . 1.0 OUTLIER -139.21 87.3 13.91 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.5 -0.75 . . . . 0.0 109.668 179.001 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.431 ' HG3' ' HD3' ' A' ' 87' ' ' LYS . 52.9 Cg_exo -45.3 115.22 0.87 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.052 1.554 . . . . 0.0 110.337 -176.563 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.481 ' OG1' ' HB2' ' A' ' 68' ' ' CYS . 54.9 m -108.61 122.91 48.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.255 -0.903 . . . . 0.0 110.405 -176.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 150.91 179.86 27.01 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 1.08 ' HG3' HD11 ' A' ' 21' ' ' LEU . 42.6 Cg_endo -72.15 170.14 68.28 Favored 'Cis proline' 0 C--N 1.315 -1.219 0 C-N-CA 121.674 -2.219 . . . . 0.0 110.588 -0.353 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.2 mt -139.17 160.55 39.54 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.355 -0.841 . . . . 0.0 110.284 -175.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -84.98 124.48 31.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.238 -0.914 . . . . 0.0 110.239 -179.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.816 HG21 ' CG ' ' A' ' 84' ' ' HIS . 8.8 t -137.63 158.17 44.94 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.105 -0.997 . . . . 0.0 109.895 175.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -59.99 -23.78 63.91 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -0.903 . . . . 0.0 110.225 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.449 ' CE2' HG23 ' A' ' 58' ' ' VAL . 92.5 m-85 -78.88 -10.08 59.69 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.226 -0.921 . . . . 0.0 110.583 -178.23 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.572 ' O ' HG22 ' A' ' 79' ' ' THR . . . 130.45 -137.36 9.44 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 -175.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.4 ' O ' HD23 ' A' ' 10' ' ' LEU . 0.2 OUTLIER -95.37 136.9 35.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.164 -1.198 . . . . 0.0 110.015 175.211 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.816 ' CG ' HG21 ' A' ' 79' ' ' THR . 3.9 m170 -127.99 114.79 17.56 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.472 -0.767 . . . . 0.0 110.835 -177.397 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.549 ' CG2' ' HB ' ' A' ' 9' ' ' ILE . 3.6 tt -111.12 130.96 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.09 -1.007 . . . . 0.0 109.515 171.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.574 HG23 ' CE1' ' A' ' 8' ' ' HIS . 78.4 mt -135.37 132.12 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.026 -1.046 . . . . 0.0 111.142 -169.25 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.593 ' HE3' ' CG ' ' A' ' 30' ' ' PHE . 23.1 mttt -99.27 140.45 33.43 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.876 -1.14 . . . . 0.0 109.985 171.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.777 HG12 HG23 ' A' ' 70' ' ' VAL . 37.5 t -109.95 129.97 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.367 -0.833 . . . . 0.0 110.078 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.555 ' HB2' ' HB3' ' A' ' 5' ' ' ALA . 88.1 mt -139.09 -164.59 1.69 Allowed 'General case' 0 C--N 1.307 -1.271 0 O-C-N 121.19 -0.944 . . . . 0.0 109.557 -178.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.495 ' CD1' ' CB ' ' A' ' 5' ' ' ALA . 44.2 m-85 34.68 -85.98 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.122 0 O-C-N 122.078 -0.389 . . . . 0.0 111.71 -178.509 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.554 ' N ' ' O ' ' A' ' 89' ' ' LEU . 36.1 ttp180 61.0 51.07 4.68 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.873 -1.142 . . . . 0.0 110.893 -178.346 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.474 ' CB ' ' HA ' ' A' ' 1' ' ' ALA . 23.7 t-20 . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 118.083 -0.961 . . . . 0.0 110.311 176.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.515 ' HB1' ' CB ' ' A' ' 92' ' ' ASN . . . . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.219 0.533 . . . . 0.0 110.222 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.512 ' N ' ' OXT' ' A' ' 92' ' ' ASN . 31.7 mmtm -124.38 144.63 49.93 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.259 -0.901 . . . . 0.0 110.635 178.493 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.751 HG22 ' HG2' ' A' ' 51' ' ' GLU . 0.2 OUTLIER 58.48 123.98 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.493 -0.755 . . . . 0.0 110.81 175.014 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.447 ' C ' ' HG3' ' A' ' 51' ' ' GLU . . . -119.88 146.59 45.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.43 -0.794 . . . . 0.0 109.515 174.29 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.571 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -92.57 125.69 37.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.039 -1.038 . . . . 0.0 109.461 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.542 ' HB3' ' CE2' ' A' ' 52' ' ' PHE . . . -136.33 135.1 38.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.833 -1.167 . . . . 0.0 111.556 -170.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.731 HD12 ' HD2' ' A' ' 87' ' ' LYS . 72.2 mt -109.11 143.89 37.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.207 -0.933 . . . . 0.0 108.877 168.356 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.702 ' HE2' ' HE1' ' A' ' 61' ' ' PHE . 45.7 m170 -130.89 129.5 42.33 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.723 -1.236 . . . . 0.0 111.365 -176.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.732 ' HB ' HG22 ' A' ' 85' ' ' ILE . 59.1 mt -109.99 129.96 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.106 -0.996 . . . . 0.0 109.229 168.434 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.745 HD13 ' C ' ' A' ' 10' ' ' LEU . 1.8 tm? -107.55 120.04 41.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.144 -0.972 . . . . 0.0 110.135 178.456 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 1.096 HG13 HD22 ' A' ' 16' ' ' LEU . 2.6 t -99.66 132.46 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.526 -0.734 . . . . 0.0 110.001 -179.449 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -64.28 -39.98 95.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.395 -0.815 . . . . 0.0 110.673 -178.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -136.36 153.93 50.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.067 -1.021 . . . . 0.0 110.707 -176.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.444 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 86.1 tt0 -59.75 -40.09 86.98 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.397 -0.814 . . . . 0.0 110.462 -177.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 29.9 tptt -51.57 -45.54 63.14 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.275 -0.89 . . . . 0.0 110.09 -177.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.096 HD22 HG13 ' A' ' 11' ' ' VAL . 7.4 tt -67.8 -39.92 83.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.111 -0.993 . . . . 0.0 109.409 175.246 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.002 ' O ' HD12 ' A' ' 21' ' ' LEU . . . -57.12 -42.7 81.34 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.392 -0.818 . . . . 0.0 109.71 176.329 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.425 HD12 ' HG2' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -60.09 -46.94 87.91 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.231 -0.918 . . . . 0.0 109.634 173.239 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -60.1 -40.02 88.21 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.422 -0.799 . . . . 0.0 110.184 177.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 1.018 HD13 ' CD2' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -63.15 -52.31 62.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.105 -0.997 . . . . 0.0 109.469 178.716 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 1.002 HD12 ' O ' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -56.55 -46.67 80.56 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.326 -0.859 . . . . 0.0 109.766 -177.689 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -60.04 -39.97 87.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.117 -0.989 . . . . 0.0 109.547 171.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.493 ' HB3' ' O ' ' A' ' 20' ' ' LEU . 61.5 tt0 -60.51 -39.97 89.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.435 -0.79 . . . . 0.0 111.047 -177.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.542 ' O ' ' CA ' ' A' ' 28' ' ' ALA . 18.9 mm -61.26 -39.99 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.796 -1.19 . . . . 0.0 109.724 -176.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -65.17 -56.48 12.65 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.676 -1.265 . . . . 0.0 110.14 177.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -60.11 -50.81 72.23 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.25 -0.906 . . . . 0.0 110.83 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 28' ' ' ALA . . . -105.64 -19.64 10.21 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -168.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.542 ' CA ' ' O ' ' A' ' 24' ' ' ILE . . . 34.18 94.48 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.821 -0.811 . . . . 0.0 111.474 -178.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -177.3 76.41 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.61 -0.681 . . . . 0.0 109.41 -178.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.539 ' HB3' ' CE ' ' A' ' 87' ' ' LYS . 2.5 m-85 -60.06 -43.2 95.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.876 . . . . 0.0 110.807 -173.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.4 -47.5 90.38 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -178.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' A' ' 35' ' ' LYS . 83.6 tttt -63.72 -40.03 95.76 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.19 -1.182 . . . . 0.0 110.23 -178.088 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.018 ' CD2' HD13 ' A' ' 20' ' ' LEU . 40.3 tp -64.1 -40.04 95.35 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.866 -1.146 . . . . 0.0 110.162 178.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.542 ' HB2' HG12 ' A' ' 9' ' ' ILE . . . -59.24 -52.83 64.01 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.162 -0.961 . . . . 0.0 110.366 -177.478 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 55.8 pttt -62.84 -41.21 99.25 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.817 -1.177 . . . . 0.0 110.425 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.467 ' N ' ' CG ' ' A' ' 35' ' ' LYS . 88.3 tttt -62.48 -48.32 80.09 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.197 -0.94 . . . . 0.0 111.446 -174.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.413 ' O ' HG12 ' A' ' 39' ' ' ILE . 41.1 m170 -102.89 -17.64 15.42 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.814 -1.179 . . . . 0.0 111.513 -169.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.527 ' O ' ' CG1' ' A' ' 39' ' ' ILE . 33.7 t -59.96 -44.2 94.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.813 -1.179 . . . . 0.0 110.651 -174.164 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.527 ' CG1' ' O ' ' A' ' 38' ' ' SER . 45.2 pt 36.69 30.05 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.696 -0.628 . . . . 0.0 110.636 -178.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.499 ' N ' ' O ' ' A' ' 38' ' ' SER . 43.2 t -125.46 144.57 48.26 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.423 -0.798 . . . . 0.0 109.853 -176.374 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.473 ' HD2' ' SG ' ' A' ' 40' ' ' CYS . 51.6 Cg_exo -49.31 -21.44 4.64 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 123.673 1.354 . . . . 0.0 110.491 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.51 ' O ' ' CA ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -101.27 16.98 23.77 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.212 -0.93 . . . . 0.0 110.184 176.801 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.411 ' CA ' ' OG ' ' A' ' 38' ' ' SER . . . -79.61 -56.52 3.34 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 173.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -60.04 -39.93 87.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.349 -1.089 . . . . 0.0 110.392 176.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -97.15 -39.79 9.12 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.069 -1.02 . . . . 0.0 110.619 -176.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.51 ' CA ' ' O ' ' A' ' 42' ' ' SER . . . -76.79 -18.27 79.05 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.74 0.09 62.37 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.276 -1.529 . . . . 0.0 109.276 173.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.528 ' HA ' ' CD2' ' A' ' 7' ' ' LEU . 33.9 t0 -172.51 73.13 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.299 -1.118 . . . . 0.0 108.966 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.452 ' HG ' ' HA2' ' A' ' 46' ' ' GLY . 5.5 mt -80.09 -13.26 59.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.419 -0.801 . . . . 0.0 109.899 -175.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.08 -148.04 20.61 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -178.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.751 ' HG2' HG22 ' A' ' 3' ' ' THR . 80.5 tt0 -110.92 131.8 54.75 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.336 -1.096 . . . . 0.0 110.173 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.619 ' HB2' ' NE2' ' A' ' 56' ' ' GLN . 3.8 p90 -139.52 158.17 44.59 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.389 -0.819 . . . . 0.0 110.266 -178.496 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.521 ' O ' ' CG ' ' A' ' 56' ' ' GLN . 30.7 ptt-85 -89.81 -178.32 5.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.354 -0.841 . . . . 0.0 110.043 -178.565 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -60.71 136.67 58.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.146 -0.971 . . . . 0.0 109.848 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 91.79 63.98 1.15 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.619 ' NE2' ' HB2' ' A' ' 52' ' ' PHE . 7.5 mm100 -129.47 -64.43 0.89 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.795 -1.415 . . . . 0.0 110.114 176.162 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 28.9 tpp -116.62 -63.44 1.45 Allowed 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 118.935 -1.106 . . . . 0.0 111.57 -163.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.474 HG13 ' O ' ' A' ' 58' ' ' VAL . 12.9 p -151.16 135.09 9.4 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 120.921 -1.112 . . . . 0.0 110.577 -169.002 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.497 ' O ' ' N ' ' A' ' 62' ' ' ASP . 10.3 Cg_endo -55.07 -53.01 6.6 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.971 1.511 . . . . 0.0 110.389 177.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.643 ' HB1' HD23 ' A' ' 77' ' ' LEU . . . -38.35 -33.1 0.09 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.711 -0.618 . . . . 0.0 110.498 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.702 ' HE1' ' HE2' ' A' ' 8' ' ' HIS . 68.3 t80 -60.05 -41.13 91.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.296 -0.878 . . . . 0.0 110.638 177.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' A' ' 59' ' ' PRO . 52.9 t0 -60.09 -39.94 87.87 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.26 -0.9 . . . . 0.0 110.104 -178.009 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.43 ' O ' ' HB2' ' A' ' 67' ' ' SER . 79.8 mttt -59.62 -40.06 86.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.874 . . . . 0.0 110.79 -176.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.843 HG21 HD12 ' A' ' 86' ' ' ILE . 0.9 OUTLIER -85.22 -48.0 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 120.996 -1.065 . . . . 0.0 111.125 -174.515 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.58 HG12 ' O ' ' A' ' 61' ' ' PHE . 7.5 p -54.6 -26.31 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.674 -1.266 . . . . 0.0 109.554 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -96.27 12.41 31.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.252 -0.905 . . . . 0.0 109.764 174.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.48 ' HB3' ' O ' ' A' ' 64' ' ' VAL . 44.4 t -101.27 -41.0 6.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.418 -0.801 . . . . 0.0 110.605 -177.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.514 ' CB ' ' OE1' ' A' ' 72' ' ' GLU . 59.7 m -126.23 154.22 74.49 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.15 -0.969 . . . . 0.0 110.727 -175.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.569 ' O ' ' O ' ' A' ' 70' ' ' VAL . 9.2 Cg_exo -68.05 67.1 0.96 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 124.036 1.545 . . . . 0.0 110.498 177.552 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.017 HG23 HG12 ' A' ' 88' ' ' VAL . 13.4 p 27.68 -169.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 C-N-CA 123.119 0.568 . . . . 0.0 111.891 176.051 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.003 HD12 HG13 ' A' ' 70' ' ' VAL . 4.7 mp 38.65 30.39 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 O-C-N 119.803 -1.811 . . . . 0.0 111.132 -168.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.514 ' OE1' ' CB ' ' A' ' 68' ' ' CYS . 2.0 tm-20 -147.64 94.4 4.42 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.19 -0.944 . . . . 0.0 110.241 -178.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -48.32 107.75 0.15 Allowed 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.908 1.478 . . . . 0.0 110.012 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 98.5 m -96.31 131.78 42.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.914 . . . . 0.0 110.388 -177.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 140.83 -163.2 26.62 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.827 ' CD ' HD11 ' A' ' 21' ' ' LEU . 44.0 Cg_endo -71.08 141.79 70.62 Favored 'Cis proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.872 -2.137 . . . . 0.0 110.647 1.109 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.643 HD23 ' HB1' ' A' ' 60' ' ' ALA . 42.9 tp -97.04 156.02 16.54 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.343 -0.848 . . . . 0.0 110.694 -177.088 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.449 ' N ' ' HG ' ' A' ' 77' ' ' LEU . 18.1 t-80 -75.38 127.09 32.35 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.154 -0.966 . . . . 0.0 110.349 178.147 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.7 HG22 ' O ' ' A' ' 82' ' ' GLY . 13.5 t -141.22 160.03 40.96 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.221 -0.925 . . . . 0.0 110.255 178.141 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -59.67 -26.61 65.7 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.186 -0.946 . . . . 0.0 110.521 -177.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.425 ' O ' HD21 ' A' ' 10' ' ' LEU . 97.0 m-85 -97.0 17.48 16.86 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.145 -0.972 . . . . 0.0 110.731 -176.29 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.7 ' O ' HG22 ' A' ' 79' ' ' THR . . . 121.09 -129.95 8.01 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 -178.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.528 ' HB3' ' HB2' ' A' ' 76' ' ' PRO . 84.5 m-85 -121.97 129.93 52.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.129 -1.218 . . . . 0.0 110.077 178.628 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.421 ' ND1' HD23 ' A' ' 10' ' ' LEU . 5.7 m-70 -101.29 125.28 47.91 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.188 -0.945 . . . . 0.0 110.726 176.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.732 HG22 ' HB ' ' A' ' 9' ' ' ILE . 3.8 tt -109.33 128.61 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.709 -1.245 . . . . 0.0 109.078 167.065 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.843 HD12 HG21 ' A' ' 64' ' ' VAL . 96.7 mt -116.22 123.63 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.018 -1.051 . . . . 0.0 111.28 -167.376 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.731 ' HD2' HD12 ' A' ' 7' ' ' LEU . 27.6 mttt -83.77 130.05 34.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.23 -0.919 . . . . 0.0 109.036 170.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 1.017 HG12 HG23 ' A' ' 70' ' ' VAL . 29.2 t -109.33 129.44 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.163 -0.961 . . . . 0.0 109.973 -179.089 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.571 ' HB2' ' HB3' ' A' ' 5' ' ' ALA . 91.6 mt -134.0 117.31 16.54 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.296 -0.878 . . . . 0.0 109.838 -178.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.524 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 50.8 m-85 70.75 -2.04 2.4 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.498 -0.751 . . . . 0.0 111.556 177.148 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.524 ' HG2' ' O ' ' A' ' 90' ' ' TYR . 22.3 ptt180 40.37 -163.14 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.249 -0.907 . . . . 0.0 110.264 174.014 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.515 ' CB ' ' HB1' ' A' ' 1' ' ' ALA . 91.4 m-20 . . . . . 0 N--CA 1.49 1.566 0 O-C-N 120.79 -1.193 . . . . 0.0 110.142 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 27.3 m . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.225 0.536 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.488 ' O ' ' HA ' ' A' ' 51' ' ' GLU . . . -143.26 159.02 43.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.075 -1.015 . . . . 0.0 110.039 177.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.506 ' HA ' ' O ' ' A' ' 50' ' ' GLY . . . -94.62 123.71 38.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.268 -0.895 . . . . 0.0 109.145 174.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.728 ' HB1' ' NE2' ' A' ' 8' ' ' HIS . . . -137.24 134.99 36.81 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.709 -1.244 . . . . 0.0 111.884 -169.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.524 ' CD2' ' HA ' ' A' ' 48' ' ' ASP . 33.8 mt -109.32 137.07 47.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.39 -0.819 . . . . 0.0 109.371 170.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.728 ' NE2' ' HB1' ' A' ' 6' ' ' ALA . 22.2 m170 -130.87 132.38 45.12 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.932 -1.105 . . . . 0.0 111.0 -176.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.683 ' HB ' HG22 ' A' ' 85' ' ' ILE . 84.4 mt -118.64 129.89 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.947 -1.095 . . . . 0.0 109.567 169.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.769 HD13 ' C ' ' A' ' 10' ' ' LEU . 2.7 tm? -110.0 120.41 42.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.361 -0.837 . . . . 0.0 109.896 178.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.758 HG13 HD22 ' A' ' 16' ' ' LEU . 3.1 t -103.94 128.97 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.179 -0.951 . . . . 0.0 110.053 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -68.5 -39.96 81.05 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.464 -0.773 . . . . 0.0 110.96 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -119.79 140.54 50.59 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.018 -1.051 . . . . 0.0 110.595 -175.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.458 ' HG2' ' CZ ' ' A' ' 83' ' ' TYR . 93.3 mt-10 -59.97 -39.99 87.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.527 -0.733 . . . . 0.0 110.939 -175.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.1 -41.86 68.75 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.024 -1.048 . . . . 0.0 110.343 -175.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.758 HD22 HG13 ' A' ' 11' ' ' VAL . 8.1 tt -67.84 -38.56 83.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.124 -0.985 . . . . 0.0 109.648 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.863 ' O ' HD12 ' A' ' 21' ' ' LEU . . . -58.66 -45.82 88.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.294 -0.879 . . . . 0.0 110.314 178.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.5 tp -60.06 -46.25 90.16 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.121 -0.987 . . . . 0.0 109.766 175.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.421 ' O ' ' HB2' ' A' ' 23' ' ' GLN . 47.9 t0 -59.97 -40.0 87.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.332 -0.855 . . . . 0.0 109.929 178.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.631 HD23 ' N ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -62.37 -53.54 53.45 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.357 -0.839 . . . . 0.0 109.471 177.675 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.892 HD11 ' HG3' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -54.57 -48.55 71.93 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.475 -0.766 . . . . 0.0 109.557 -176.717 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -65.1 -40.51 94.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.435 -0.791 . . . . 0.0 109.987 174.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.478 ' NE2' HD21 ' A' ' 33' ' ' LEU . 62.7 tt0 -61.54 -40.03 93.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.44 -0.787 . . . . 0.0 110.297 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.548 HG12 ' CD1' ' A' ' 33' ' ' LEU . 92.4 mt -67.07 -39.99 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.278 -0.889 . . . . 0.0 110.111 178.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -64.53 -54.54 30.65 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.948 -1.095 . . . . 0.0 110.226 176.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -60.01 -43.44 95.23 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.216 -0.927 . . . . 0.0 110.967 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.735 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -105.55 -59.43 0.64 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -177.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.735 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 83.92 104.65 0.05 Allowed 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 121.554 0.692 . . . . 0.0 110.053 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.427 ' CG ' ' O ' ' A' ' 28' ' ' ALA . 3.8 m-20 -175.08 70.48 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.582 -0.698 . . . . 0.0 109.501 -176.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -60.01 -44.24 94.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.925 . . . . 0.0 110.781 -174.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.59 -54.03 31.5 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 119.813 -1.184 . . . . 0.0 110.272 -177.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -66.7 -40.08 88.31 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.991 -1.299 . . . . 0.0 110.861 -175.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.548 ' CD1' HG12 ' A' ' 24' ' ' ILE . 64.5 mt -61.59 -42.94 99.58 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.91 -1.119 . . . . 0.0 110.266 178.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.535 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -59.98 -49.25 78.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 0.0 110.381 178.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -59.98 -47.19 86.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.103 -0.998 . . . . 0.0 110.653 -174.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -67.38 -50.08 61.22 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.971 -1.08 . . . . 0.0 110.998 -177.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 55.3 m170 -69.98 -39.92 75.64 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.047 -1.033 . . . . 0.0 111.103 -173.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.638 ' O ' HG22 ' A' ' 39' ' ' ILE . 22.9 t -60.08 -42.06 93.78 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.001 -1.062 . . . . 0.0 110.338 -174.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.638 HG22 ' O ' ' A' ' 38' ' ' SER . 21.3 tt 38.02 31.57 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.624 -0.673 . . . . 0.0 110.877 177.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.43 ' N ' ' O ' ' A' ' 38' ' ' SER . 15.5 p -120.25 166.15 16.07 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.253 -0.904 . . . . 0.0 110.206 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -53.05 -23.12 20.85 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.968 1.51 . . . . 0.0 110.273 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -107.58 21.27 17.71 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.276 -0.89 . . . . 0.0 109.836 177.006 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.4 -51.37 27.07 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 174.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 48.9 mttp -63.03 -40.03 96.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.442 -1.034 . . . . 0.0 110.849 176.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.652 ' HE ' HD23 ' A' ' 49' ' ' LEU . 11.9 tpt180 -102.59 -44.6 5.29 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.928 -1.108 . . . . 0.0 110.642 -172.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -63.75 -33.38 87.08 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.224 -1.551 . . . . 0.0 109.224 175.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.482 ' O ' HD22 ' A' ' 7' ' ' LEU . . . -74.36 0.11 55.72 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 175.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.524 ' HA ' ' CD2' ' A' ' 7' ' ' LEU . 49.7 t0 -170.82 71.96 0.05 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.24 -1.153 . . . . 0.0 108.916 178.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.652 HD23 ' HE ' ' A' ' 45' ' ' ARG . 11.0 mt -76.15 -6.94 53.54 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.622 -0.674 . . . . 0.0 109.814 -177.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 5' ' ' ALA . . . 70.39 -139.06 29.97 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -174.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.491 ' HG3' ' HB2' ' A' ' 5' ' ' ALA . 4.8 mt-10 -101.59 132.1 47.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.397 -1.061 . . . . 0.0 110.643 178.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.717 ' CE2' ' HB3' ' A' ' 6' ' ' ALA . 5.3 p90 -145.38 160.64 41.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.678 -0.639 . . . . 0.0 109.333 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 . . . . . 0 N--CA 1.493 1.71 0 O-C-N 121.039 -1.038 . . . . 0.0 110.526 -175.235 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.429 ' O ' ' C ' ' A' ' 60' ' ' ALA . 9.5 Cg_endo . . . . . 0 N--CA 1.485 1.004 0 N-CA-C 110.407 -0.651 . . . . 0.0 110.407 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 59' ' ' PRO . . . -41.23 -35.29 0.59 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.455 -0.778 . . . . 0.0 110.212 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.585 ' CE1' ' NE2' ' A' ' 8' ' ' HIS . 90.4 t80 -60.08 -41.34 92.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.288 -0.883 . . . . 0.0 110.72 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.466 ' O ' HG12 ' A' ' 65' ' ' VAL . 53.0 t0 -60.01 -41.54 92.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.023 -1.048 . . . . 0.0 109.96 -178.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 67' ' ' SER . 62.7 tttm -55.09 -58.56 7.15 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.338 -0.851 . . . . 0.0 110.777 178.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.616 HG11 ' CD1' ' A' ' 86' ' ' ILE . 2.9 p -70.0 -42.5 79.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.04 -1.038 . . . . 0.0 111.319 -170.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.466 HG12 ' O ' ' A' ' 62' ' ' ASP . 3.6 p -57.79 -28.26 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.388 -1.445 . . . . 0.0 109.584 174.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -92.33 -10.76 37.12 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.049 -1.032 . . . . 0.0 109.873 173.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.534 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 4.8 t -93.43 -66.21 0.94 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.409 -0.807 . . . . 0.0 109.715 175.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.534 ' SG ' HG22 ' A' ' 64' ' ' VAL . 24.1 p -76.01 155.97 84.38 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.37 -0.831 . . . . 0.0 110.245 177.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.478 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 53.7 Cg_endo -79.27 148.11 20.99 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.993 1.523 . . . . 0.0 110.223 175.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.75 HG13 HD12 ' A' ' 71' ' ' LEU . 6.3 p -54.63 168.4 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.146 -0.971 . . . . 0.0 109.887 177.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.75 HD12 HG13 ' A' ' 70' ' ' VAL . 1.3 mp 58.24 22.25 9.03 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.34 -0.85 . . . . 0.0 110.188 -176.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.478 ' HB3' ' O ' ' A' ' 69' ' ' PRO . 1.4 tp10 -130.77 94.3 29.16 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.254 -0.904 . . . . 0.0 110.251 -179.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -51.07 109.6 0.33 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.927 1.488 . . . . 0.0 109.809 177.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 94.3 m -115.65 130.02 56.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.208 -0.932 . . . . 0.0 110.069 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 140.77 -171.53 24.03 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -176.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.892 ' HG3' HD11 ' A' ' 21' ' ' LEU . 41.5 Cg_endo -69.88 138.66 50.6 Favored 'Cis proline' 0 C--N 1.312 -1.373 0 C-N-CA 121.749 -2.188 . . . . 0.0 110.89 -0.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.771 HD12 HD12 ' A' ' 86' ' ' ILE . 95.2 mt -92.94 172.89 8.04 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.52 -0.738 . . . . 0.0 110.484 -176.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -99.18 126.58 44.99 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.064 -1.023 . . . . 0.0 110.67 177.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.899 HG21 ' CG ' ' A' ' 84' ' ' HIS . 8.8 t -146.29 165.1 30.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.272 -0.893 . . . . 0.0 109.817 175.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -59.65 -40.0 86.26 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.104 -0.998 . . . . 0.0 110.769 -175.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -66.38 -15.37 63.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.135 -0.978 . . . . 0.0 110.331 -177.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.426 ' CA ' HD21 ' A' ' 10' ' ' LEU . . . 141.17 -135.69 7.05 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.036 -1.625 . . . . 0.0 109.036 -178.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.473 ' O ' ' HA ' ' A' ' 10' ' ' LEU . 4.3 m-85 -97.1 125.12 41.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.135 -1.215 . . . . 0.0 110.131 176.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.899 ' CG ' HG21 ' A' ' 79' ' ' THR . 7.4 m170 -102.73 115.97 31.65 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.607 -0.683 . . . . 0.0 110.345 177.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.683 HG22 ' HB ' ' A' ' 9' ' ' ILE . 4.4 tt -104.66 128.38 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.512 -1.367 . . . . 0.0 109.392 168.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.771 HD12 HD12 ' A' ' 77' ' ' LEU . 53.0 mt -118.96 125.72 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.369 -0.832 . . . . 0.0 111.051 -172.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.518 ' HB3' ' HB2' ' A' ' 7' ' ' LEU . 18.8 tttm -99.97 125.8 46.04 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.334 -0.854 . . . . 0.0 109.215 171.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.596 ' O ' HD23 ' A' ' 89' ' ' LEU . 21.3 t -101.43 136.49 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.177 -0.952 . . . . 0.0 110.121 -175.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.596 HD23 ' O ' ' A' ' 88' ' ' VAL . 88.9 mt -140.04 147.04 39.76 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.241 -0.912 . . . . 0.0 109.227 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.494 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 98.0 m-85 62.66 -55.35 0.16 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.598 -0.689 . . . . 0.0 111.732 174.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.504 ' N ' ' O ' ' A' ' 89' ' ' LEU . 68.5 ttp85 . . . . . 0 N--CA 1.493 1.719 0 O-C-N 120.93 -1.106 . . . . 0.0 110.859 -178.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.528 HG22 ' HD3' ' A' ' 53' ' ' ARG . 81.8 p . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 121.307 0.575 . . . . 0.0 110.601 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.614 ' HB2' ' HD2' ' A' ' 91' ' ' ARG . . . -140.52 150.53 43.83 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.422 -0.799 . . . . 0.0 110.265 -178.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.401 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -95.66 137.84 34.16 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.122 -0.986 . . . . 0.0 109.71 177.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.642 ' HB1' ' NE2' ' A' ' 8' ' ' HIS . . . -148.54 130.88 15.62 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.92 -1.112 . . . . 0.0 111.517 -173.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.564 HD12 ' HD2' ' A' ' 87' ' ' LYS . 78.1 mt -105.21 147.54 27.91 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.202 -0.936 . . . . 0.0 109.144 169.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.642 ' NE2' ' HB1' ' A' ' 6' ' ' ALA . 35.1 m-70 -138.34 125.26 21.19 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.749 -1.219 . . . . 0.0 111.303 -177.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.693 ' HB ' HG22 ' A' ' 85' ' ' ILE . 81.5 mt -110.04 129.97 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.016 -1.052 . . . . 0.0 109.857 169.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.768 ' O ' HD13 ' A' ' 10' ' ' LEU . 1.0 OUTLIER -110.38 119.97 40.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -0.894 . . . . 0.0 110.365 178.435 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.804 HG13 HD22 ' A' ' 16' ' ' LEU . 2.9 t -104.03 135.29 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.421 -0.8 . . . . 0.0 109.954 177.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -67.51 -37.12 82.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.273 -0.892 . . . . 0.0 110.769 -176.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.412 ' HG3' ' HB2' ' A' ' 16' ' ' LEU . 18.1 pt-20 -129.75 149.73 51.37 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.013 -1.054 . . . . 0.0 110.871 -175.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.468 ' HB2' ' CZ ' ' A' ' 83' ' ' TYR . 89.0 tt0 -59.97 -42.8 94.94 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.384 -0.822 . . . . 0.0 111.049 -178.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -55.08 -42.35 72.7 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.022 -1.049 . . . . 0.0 110.293 -177.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.804 HD22 HG13 ' A' ' 11' ' ' VAL . 3.6 tt -67.97 -39.83 83.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.211 -0.931 . . . . 0.0 109.341 177.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.513 ' N ' HG11 ' A' ' 11' ' ' VAL . . . -57.99 -46.8 84.62 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.32 -0.863 . . . . 0.0 109.737 175.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.458 ' CD1' ' HG2' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -59.99 -42.62 94.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.153 -0.967 . . . . 0.0 109.6 173.925 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -60.44 -45.44 93.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.414 -0.803 . . . . 0.0 109.904 175.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.417 ' CD1' ' HB3' ' A' ' 33' ' ' LEU . 7.9 tp -64.01 -44.23 93.25 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.406 -0.809 . . . . 0.0 109.972 176.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.892 HD21 ' HD3' ' A' ' 76' ' ' PRO . 3.6 mp -58.95 -46.15 88.74 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.547 -0.721 . . . . 0.0 110.008 -175.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -62.71 -40.05 95.95 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.627 -0.671 . . . . 0.0 110.109 177.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.616 ' HG2' HD21 ' A' ' 33' ' ' LEU . 72.9 tp60 -60.05 -39.9 87.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 0.0 109.939 -178.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.518 HG13 HD13 ' A' ' 33' ' ' LEU . 96.7 mt -65.06 -46.84 90.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.274 -0.891 . . . . 0.0 110.122 177.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 64.3 mttt -60.78 -44.17 97.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.136 -0.978 . . . . 0.0 109.557 175.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -59.12 -64.58 0.89 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.348 -0.845 . . . . 0.0 110.343 176.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.742 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -105.24 -40.02 2.16 Favored Glycine 0 N--CA 1.483 1.79 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 -171.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.742 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 77.46 105.49 0.07 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.716 -0.873 . . . . 0.0 109.942 -177.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -175.37 73.17 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.346 -0.846 . . . . 0.0 109.867 -177.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.579 ' CE1' HG13 ' A' ' 9' ' ' ILE . 23.6 t80 -59.95 -42.76 94.75 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.56 -0.712 . . . . 0.0 110.511 -175.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.82 -49.99 60.63 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -176.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.449 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 74.1 mttt -65.44 -39.95 92.69 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.973 -1.31 . . . . 0.0 110.049 -177.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.616 HD21 ' HG2' ' A' ' 23' ' ' GLN . 84.9 mt -64.95 -39.94 94.26 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.206 -0.934 . . . . 0.0 110.027 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.602 ' HB2' HG12 ' A' ' 9' ' ' ILE . . . -57.4 -50.2 73.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.218 -0.926 . . . . 0.0 110.034 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.473 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 21.4 mmtp -59.98 -43.4 95.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.276 -0.89 . . . . 0.0 110.745 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 32' ' ' LYS . 99.7 mttt -70.0 -43.16 71.96 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.09 -1.006 . . . . 0.0 111.424 -172.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.766 ' CD2' HD21 ' A' ' 16' ' ' LEU . 32.1 m80 -93.33 -36.0 12.76 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.97 -1.081 . . . . 0.0 110.912 -174.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.647 ' O ' HG22 ' A' ' 39' ' ' ILE . 31.6 t -60.03 -52.95 63.19 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.088 -1.007 . . . . 0.0 110.606 -174.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.647 HG22 ' O ' ' A' ' 38' ' ' SER . 13.6 tt 38.46 39.28 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.589 -0.695 . . . . 0.0 110.711 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.498 ' SG ' ' N ' ' A' ' 43' ' ' GLY . 12.8 p -127.88 163.61 42.23 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.214 -0.929 . . . . 0.0 109.841 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.46 ' HD2' ' HB2' ' A' ' 40' ' ' CYS . 5.7 Cg_endo -52.34 -27.87 32.68 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.722 1.38 . . . . 0.0 110.188 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.526 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.7 OUTLIER -101.03 14.59 31.47 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.893 . . . . 0.0 109.767 174.675 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.498 ' N ' ' SG ' ' A' ' 40' ' ' CYS . . . -77.08 -55.0 4.55 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 176.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.473 ' HA ' ' HE2' ' A' ' 35' ' ' LYS . 28.5 ttpt -60.03 -40.01 87.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.481 -1.011 . . . . 0.0 110.226 177.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.456 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 3.3 tpp180 -98.31 -44.27 6.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.097 -1.002 . . . . 0.0 110.615 -176.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -60.66 -33.74 83.51 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.38 -3.04 37.22 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 176.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.468 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 38.5 p-10 -167.93 62.45 0.07 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.267 -1.137 . . . . 0.0 109.279 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 6.2 mt -70.03 -29.09 66.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.637 -0.664 . . . . 0.0 110.317 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.81 -119.32 6.2 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -177.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.46 ' HG3' ' C ' ' A' ' 4' ' ' ALA . 82.5 tt0 -133.02 130.03 38.91 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.209 -1.171 . . . . 0.0 110.475 -175.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.469 ' CE2' ' HB3' ' A' ' 6' ' ' ALA . 1.5 p90 -127.05 -178.82 4.56 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.107 -0.995 . . . . 0.0 109.941 175.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.528 ' HD3' HG22 ' A' ' 3' ' ' THR . 26.6 mmt85 . . . . . 0 N--CA 1.492 1.656 0 O-C-N 120.995 -1.066 . . . . 0.0 110.183 -173.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.473 ' O ' ' N ' ' A' ' 62' ' ' ASP . 14.4 Cg_endo . . . . . 0 N--CA 1.487 1.124 0 N-CA-C 110.559 -0.593 . . . . 0.0 110.559 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.618 ' O ' HG12 ' A' ' 64' ' ' VAL . . . -41.17 -34.32 0.45 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.357 -0.839 . . . . 0.0 110.218 -178.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.871 ' CZ ' HG21 ' A' ' 65' ' ' VAL . 63.8 t80 -60.05 -39.75 87.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.274 -0.892 . . . . 0.0 110.388 177.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.473 ' N ' ' O ' ' A' ' 59' ' ' PRO . 8.0 t70 -60.0 -48.88 79.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.135 -0.978 . . . . 0.0 110.187 -176.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 67' ' ' SER . 38.8 tptt -59.91 -50.03 75.37 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.149 -0.969 . . . . 0.0 110.206 178.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.837 HG11 HD12 ' A' ' 86' ' ' ILE . 7.5 p -77.43 -41.19 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.103 -0.998 . . . . 0.0 111.554 -174.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.871 HG21 ' CZ ' ' A' ' 61' ' ' PHE . 1.9 p -56.32 -27.15 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.357 -1.464 . . . . 0.0 109.305 174.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -94.61 -7.58 40.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.493 -0.754 . . . . 0.0 109.859 176.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.522 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 8.9 t -93.95 -62.04 1.42 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.502 -0.749 . . . . 0.0 109.925 178.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.491 ' HB3' ' OG1' ' A' ' 74' ' ' THR . 27.4 p -71.11 156.51 91.83 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.278 -0.889 . . . . 0.0 110.418 177.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.518 ' O ' ' N ' ' A' ' 71' ' ' LEU . 43.6 Cg_endo -82.22 79.22 3.16 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.998 1.525 . . . . 0.0 110.785 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.058 HG13 HD12 ' A' ' 71' ' ' LEU . 10.9 p 20.19 47.19 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.345 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 177.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.058 HD12 HG13 ' A' ' 70' ' ' VAL . 0.3 OUTLIER -167.17 -40.25 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.453 -0.779 . . . . 0.0 111.068 178.263 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.474 ' HG3' ' HD2' ' A' ' 69' ' ' PRO . 23.5 mm-40 -70.03 130.93 89.34 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 120.836 -1.165 . . . . 0.0 110.732 -173.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -67.48 95.49 0.39 Allowed 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.76 1.4 . . . . 0.0 109.271 172.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.726 HG21 HG23 ' A' ' 64' ' ' VAL . 21.1 m -94.42 139.77 30.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.154 -0.966 . . . . 0.0 110.451 -172.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.49 -170.36 22.36 Favored Glycine 0 N--CA 1.485 1.919 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.892 ' HD3' HD21 ' A' ' 21' ' ' LEU . 42.9 Cg_endo -74.66 124.17 9.71 Favored 'Cis proline' 0 C--N 1.311 -1.437 0 C-N-CA 121.933 -2.111 . . . . 0.0 110.28 0.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.461 ' HG ' ' N ' ' A' ' 78' ' ' HIS . 39.7 tp -94.01 160.3 14.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.278 -0.889 . . . . 0.0 110.123 -174.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.461 ' N ' ' HG ' ' A' ' 77' ' ' LEU . 47.1 t-80 -78.77 123.91 27.66 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.029 -1.044 . . . . 0.0 110.579 -178.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.939 HG21 ' CE1' ' A' ' 84' ' ' HIS . 7.0 t -133.75 164.79 26.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.265 -0.897 . . . . 0.0 109.505 172.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.04 -29.85 68.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.121 -0.987 . . . . 0.0 110.29 -177.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.429 ' H ' HG23 ' A' ' 79' ' ' THR . 98.6 m-85 -83.01 -4.91 58.83 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.143 -0.973 . . . . 0.0 110.745 -176.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.667 ' O ' HG22 ' A' ' 79' ' ' THR . . . 133.35 -139.29 10.81 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 -177.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.507 ' HB3' ' HB2' ' A' ' 76' ' ' PRO . 95.8 m-85 -101.98 121.47 42.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.043 -1.269 . . . . 0.0 110.264 178.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.939 ' CE1' HG21 ' A' ' 79' ' ' THR . 34.3 m170 -103.55 128.79 50.73 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.09 -1.006 . . . . 0.0 110.895 178.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.693 HG22 ' HB ' ' A' ' 9' ' ' ILE . 4.5 tt -113.18 119.98 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.963 -1.086 . . . . 0.0 108.947 167.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.837 HD12 HG11 ' A' ' 64' ' ' VAL . 85.5 mt -114.84 131.75 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.919 -1.113 . . . . 0.0 111.322 -168.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.564 ' HD2' HD12 ' A' ' 7' ' ' LEU . 26.5 ttmt -100.01 124.12 45.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.345 -0.847 . . . . 0.0 109.614 173.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.652 HG12 ' HA ' ' A' ' 70' ' ' VAL . 57.7 t -113.85 131.5 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.15 -0.969 . . . . 0.0 110.438 -172.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.509 ' O ' ' N ' ' A' ' 91' ' ' ARG . 57.2 mt -138.04 170.76 15.47 Favored 'General case' 0 C--N 1.309 -1.154 0 O-C-N 121.186 -0.946 . . . . 0.0 109.867 -177.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.449 ' O ' ' HB2' ' A' ' 91' ' ' ARG . 45.9 m-85 54.07 -76.93 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.752 -0.593 . . . . 0.0 112.069 171.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.64 ' CG ' HG23 ' A' ' 70' ' ' VAL . 19.1 mmm180 . . . . . 0 N--CA 1.496 1.874 0 O-C-N 120.799 -1.188 . . . . 0.0 110.794 -172.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.45 ' O ' ' O ' ' A' ' 91' ' ' ARG . 69.6 p . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.246 0.546 . . . . 0.0 110.005 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' A' ' 51' ' ' GLU . . . -112.99 128.59 56.54 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -0.93 . . . . 0.0 109.952 178.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.594 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -91.49 126.25 36.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.41 -0.806 . . . . 0.0 109.213 176.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.814 ' HB1' ' NE2' ' A' ' 8' ' ' HIS . . . -135.23 126.09 27.46 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 118.915 -1.114 . . . . 0.0 111.486 -170.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.483 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 58.3 mt -102.68 137.91 40.28 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.144 -0.973 . . . . 0.0 109.132 169.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.814 ' NE2' ' HB1' ' A' ' 6' ' ' ALA . 38.1 m-70 -131.09 131.07 43.94 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.905 -1.122 . . . . 0.0 111.088 -176.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.736 ' HB ' HG22 ' A' ' 85' ' ' ILE . 71.3 mt -114.37 124.98 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.98 -1.075 . . . . 0.0 109.456 168.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.604 ' HG ' ' CD2' ' A' ' 84' ' ' HIS . 0.3 OUTLIER -97.67 101.27 12.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.323 -0.86 . . . . 0.0 109.505 179.496 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.661 HG11 ' HB2' ' A' ' 17' ' ' ALA . 3.6 t -67.63 -50.96 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.202 -0.936 . . . . 0.0 110.514 -175.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.539 ' CB ' ' O ' ' A' ' 11' ' ' VAL . 28.8 tttt 80.61 -17.26 0.59 Allowed 'General case' 0 N--CA 1.503 2.21 0 O-C-N 122.027 -0.42 . . . . 0.0 110.942 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -138.45 135.03 34.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.805 -1.185 . . . . 0.0 110.582 177.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -59.97 -45.23 93.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.458 -0.776 . . . . 0.0 110.285 177.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.7 mttm -59.83 -40.48 88.62 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.237 -0.914 . . . . 0.0 109.938 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.647 HD23 HG13 ' A' ' 11' ' ' VAL . 5.0 tt -67.87 -39.75 83.68 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.376 -0.827 . . . . 0.0 109.577 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.863 ' HB1' ' HG3' ' A' ' 76' ' ' PRO . . . -59.5 -43.93 93.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.233 -0.917 . . . . 0.0 109.775 175.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.589 ' HA ' HD12 ' A' ' 21' ' ' LEU . 0.1 OUTLIER -60.0 -40.87 90.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.352 -0.842 . . . . 0.0 110.056 175.495 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -60.83 -49.73 76.3 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.993 -1.067 . . . . 0.0 110.147 176.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 1.034 HD13 HD21 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -69.13 -50.34 48.83 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.135 -0.978 . . . . 0.0 110.915 -175.667 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 1.116 HD13 ' N ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -58.87 -29.63 67.13 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 120.742 -1.224 . . . . 0.0 108.961 -173.055 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 1.116 ' N ' HD13 ' A' ' 21' ' ' LEU . 87.9 tt0 -64.65 -39.93 94.54 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.36 -0.838 . . . . 0.0 109.931 170.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.415 ' HB3' ' O ' ' A' ' 20' ' ' LEU . 68.4 tp60 -60.05 -45.11 93.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.356 -0.84 . . . . 0.0 111.351 -173.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.557 HD11 ' CD2' ' A' ' 33' ' ' LEU . 27.6 mt -61.07 -47.96 91.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.041 -1.037 . . . . 0.0 110.592 -173.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.8 mttp -60.28 -49.01 79.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.943 -1.098 . . . . 0.0 110.256 177.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -60.01 -58.39 8.73 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.099 -1.001 . . . . 0.0 110.287 176.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.749 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -105.6 -46.76 1.18 Allowed Glycine 0 N--CA 1.484 1.849 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 -172.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.749 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 79.71 170.33 0.17 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.795 -0.826 . . . . 0.0 110.078 -176.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.613 ' CB ' ' O ' ' A' ' 28' ' ' ALA . 87.4 m-20 109.48 85.91 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.911 0 C-N-CA 124.656 1.182 . . . . 0.0 109.662 -174.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.512 ' CZ ' ' CB ' ' A' ' 73' ' ' PRO . 6.5 m-85 -60.02 -49.61 77.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.239 -0.913 . . . . 0.0 110.447 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.37 -46.28 94.19 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -177.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.437 ' HB3' ' HB3' ' A' ' 29' ' ' ASP . 33.1 tttp -62.84 -40.0 96.09 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.112 -1.228 . . . . 0.0 110.152 -177.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.034 HD21 HD13 ' A' ' 20' ' ' LEU . 47.3 tp -62.92 -40.03 96.34 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.213 -0.929 . . . . 0.0 110.337 177.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.487 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -59.66 -49.97 75.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.073 -1.017 . . . . 0.0 110.269 -178.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 46.8 tttm -60.05 -47.49 85.64 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.935 -1.103 . . . . 0.0 110.615 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -60.66 -42.28 96.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.134 -0.979 . . . . 0.0 111.03 -173.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 10.3 m80 -104.01 -4.38 23.4 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.928 -1.107 . . . . 0.0 111.022 -174.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.66 ' O ' HG22 ' A' ' 39' ' ' ILE . 1.2 t -60.04 -46.07 90.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.072 -1.017 . . . . 0.0 110.645 -177.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.66 HG22 ' O ' ' A' ' 38' ' ' SER . 16.0 tt 38.86 29.75 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.621 -0.674 . . . . 0.0 110.494 -177.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.453 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 13.4 t -131.7 135.63 27.13 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.358 -0.839 . . . . 0.0 110.032 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 40' ' ' CYS . 46.1 Cg_exo -51.6 -31.09 38.8 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.907 1.477 . . . . 0.0 110.776 -176.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 46' ' ' GLY . 0.3 OUTLIER -99.94 11.74 38.54 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.154 -0.966 . . . . 0.0 110.318 -179.695 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.464 ' HA3' ' OG ' ' A' ' 38' ' ' SER . . . -104.92 -62.87 0.65 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -60.07 -39.98 87.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.139 -1.212 . . . . 0.0 109.823 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -102.41 -33.33 9.59 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.444 -0.785 . . . . 0.0 110.029 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.478 ' O ' ' HG ' ' A' ' 49' ' ' LEU . . . -99.51 -4.78 55.96 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 -177.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.676 ' O ' HD12 ' A' ' 49' ' ' LEU . . . -51.31 -50.43 40.72 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.601 -1.799 . . . . 0.0 108.601 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -71.91 106.76 4.35 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.197 -1.178 . . . . 0.0 109.644 170.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.676 HD12 ' O ' ' A' ' 47' ' ' GLY . 0.8 OUTLIER -108.98 1.1 20.4 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.11 -0.994 . . . . 0.0 110.166 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.79 -134.09 25.52 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.507 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 13.7 mt-10 -121.47 138.47 54.27 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.298 -1.119 . . . . 0.0 111.234 -176.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.446 ' CE1' ' HB3' ' A' ' 4' ' ' ALA . 0.7 OUTLIER -121.72 173.1 7.67 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.399 -0.813 . . . . 0.0 109.555 173.548 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 9.6 ptp85 . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.057 -1.027 . . . . 0.0 110.021 -178.751 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 60' ' ' ALA . 3.0 Cg_endo . . . . . 0 N--CA 1.483 0.86 0 N-CA-C 110.41 -0.65 . . . . 0.0 110.41 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.416 ' O ' HG12 ' A' ' 64' ' ' VAL . . . -43.14 -36.12 1.58 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.233 -0.917 . . . . 0.0 110.441 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.516 ' HA ' ' CG1' ' A' ' 64' ' ' VAL . 71.9 t80 -59.99 -40.02 87.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.188 -0.945 . . . . 0.0 110.656 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.519 ' O ' HG12 ' A' ' 65' ' ' VAL . 29.4 t0 -59.97 -49.97 75.59 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.136 -0.977 . . . . 0.0 110.331 -177.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.475 ' O ' ' HB2' ' A' ' 67' ' ' SER . 33.9 tttt -60.0 -50.03 75.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.07 -1.019 . . . . 0.0 110.541 177.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.657 HG23 HG21 ' A' ' 74' ' ' THR . 14.6 p -72.27 -44.93 63.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.025 -1.047 . . . . 0.0 111.082 -173.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.586 ' N ' HG13 ' A' ' 64' ' ' VAL . 1.9 p -55.58 -28.44 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.458 -1.402 . . . . 0.0 109.162 173.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -93.43 -10.63 34.45 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.328 -0.858 . . . . 0.0 109.897 175.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.55 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 7.4 t -93.84 -57.27 2.6 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.381 -0.825 . . . . 0.0 109.963 175.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.597 ' CB ' ' HG1' ' A' ' 74' ' ' THR . 84.6 m -111.63 122.88 36.12 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.292 -0.88 . . . . 0.0 110.012 177.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.402 ' HB3' ' NH2' ' A' ' 91' ' ' ARG . 12.2 Cg_endo -61.73 -179.65 0.41 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.797 1.42 . . . . 0.0 110.643 -177.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.649 HG12 HG12 ' A' ' 88' ' ' VAL . 31.4 m -61.87 161.43 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.357 -0.839 . . . . 0.0 110.924 -175.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.523 HD12 ' HB ' ' A' ' 70' ' ' VAL . 5.5 mp 58.55 23.58 10.99 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.584 -0.698 . . . . 0.0 110.367 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -129.76 72.2 81.99 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.304 -0.872 . . . . 0.0 109.545 175.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.512 ' CB ' ' CZ ' ' A' ' 30' ' ' PHE . 65.1 Cg_exo -44.55 122.07 3.7 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.025 1.54 . . . . 0.0 110.071 -177.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.657 HG21 HG23 ' A' ' 64' ' ' VAL . 94.7 m -119.99 130.06 54.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.215 -0.928 . . . . 0.0 110.264 -175.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.424 ' HA3' HG13 ' A' ' 85' ' ' ILE . . . 137.33 -171.44 23.16 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 178.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.863 ' HG3' ' HB1' ' A' ' 17' ' ' ALA . 40.5 Cg_endo -68.24 153.89 88.57 Favored 'Cis proline' 0 C--N 1.313 -1.3 0 C-N-CA 121.695 -2.21 . . . . 0.0 110.297 1.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.501 ' HG ' ' N ' ' A' ' 78' ' ' HIS . 25.0 tp -132.94 157.68 44.52 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.986 -1.071 . . . . 0.0 110.576 -171.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.501 ' N ' ' HG ' ' A' ' 77' ' ' LEU . 44.8 m80 -62.91 132.73 53.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.305 -0.872 . . . . 0.0 110.685 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.69 HG22 ' O ' ' A' ' 82' ' ' GLY . 5.0 t -148.25 159.17 44.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.269 -0.895 . . . . 0.0 109.809 173.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.02 -26.93 66.47 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.209 -0.932 . . . . 0.0 110.118 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -88.59 -1.54 58.11 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.355 -0.841 . . . . 0.0 110.675 -176.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.69 ' O ' HG22 ' A' ' 79' ' ' THR . . . 129.66 -123.67 4.18 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -177.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.478 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 96.0 m-85 -114.18 122.49 46.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.193 -1.18 . . . . 0.0 110.189 178.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.667 ' CG ' HG21 ' A' ' 79' ' ' THR . 41.3 m170 -109.33 120.43 42.49 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.321 -0.862 . . . . 0.0 110.823 177.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.736 HG22 ' HB ' ' A' ' 9' ' ' ILE . 7.7 tt -103.19 116.81 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.474 -1.391 . . . . 0.0 109.077 165.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.512 HG21 ' HD1' ' A' ' 61' ' ' PHE . 85.5 mt -114.63 130.01 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.923 -1.111 . . . . 0.0 111.007 -170.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.483 ' HB3' ' HB2' ' A' ' 7' ' ' LEU . 22.9 tttm -100.16 120.7 40.28 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.427 -0.795 . . . . 0.0 109.232 174.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.649 HG12 HG12 ' A' ' 70' ' ' VAL . 90.9 t -101.17 139.23 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.085 -1.01 . . . . 0.0 110.609 -173.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.621 HD23 ' O ' ' A' ' 88' ' ' VAL . 84.8 mt -138.29 120.63 15.91 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 121.329 -0.857 . . . . 0.0 109.707 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.557 ' CB ' ' O ' ' A' ' 89' ' ' LEU . 2.5 m-85 82.33 -24.68 0.17 Allowed 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.586 -0.697 . . . . 0.0 111.217 175.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.539 ' HB2' ' CG1' ' A' ' 70' ' ' VAL . 35.1 ttm180 . . . . . 0 N--CA 1.493 1.72 0 O-C-N 120.866 -1.146 . . . . 0.0 110.371 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.499 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 35.4 p . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.204 0.525 . . . . 0.0 110.238 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.774 ' HB2' ' HG2' ' A' ' 91' ' ' ARG . . . -146.86 165.14 30.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.351 -0.843 . . . . 0.0 109.824 176.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.66 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -99.21 134.12 42.51 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.197 -0.94 . . . . 0.0 109.639 178.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.697 ' HB1' ' NE2' ' A' ' 8' ' ' HIS . . . -135.92 128.01 29.75 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.708 -1.245 . . . . 0.0 111.828 -171.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.542 HD12 ' HD3' ' A' ' 87' ' ' LYS . 75.5 mt -108.82 141.09 41.35 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.188 -0.945 . . . . 0.0 109.201 168.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.697 ' NE2' ' HB1' ' A' ' 6' ' ' ALA . 26.3 m-70 -135.37 125.82 26.71 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.787 -1.195 . . . . 0.0 111.081 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.568 ' HB ' ' CG2' ' A' ' 85' ' ' ILE . 87.6 mt -110.14 130.05 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.91 -1.119 . . . . 0.0 110.211 170.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.622 HD23 ' N ' ' A' ' 11' ' ' VAL . 0.7 OUTLIER -105.08 120.01 40.45 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.457 -0.777 . . . . 0.0 109.942 178.408 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.908 HG13 HD23 ' A' ' 16' ' ' LEU . 2.0 t -108.29 129.67 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.229 -0.919 . . . . 0.0 109.631 178.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -68.4 -39.46 81.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.258 -0.901 . . . . 0.0 110.558 -176.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -120.7 141.4 50.45 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.16 -0.962 . . . . 0.0 110.79 -177.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.585 ' HB2' ' CZ ' ' A' ' 83' ' ' TYR . 83.5 tt0 -60.0 -40.06 87.92 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.476 -0.765 . . . . 0.0 110.877 -178.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -55.88 -41.79 74.96 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.082 -1.011 . . . . 0.0 110.41 -174.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.908 HD23 HG13 ' A' ' 11' ' ' VAL . 1.4 tp -68.28 -40.01 81.96 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.214 -0.929 . . . . 0.0 109.563 177.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.401 ' HA ' ' HB3' ' A' ' 20' ' ' LEU . . . -59.72 -42.3 92.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.422 -0.799 . . . . 0.0 110.097 177.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.5 tp -60.06 -42.71 95.08 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.158 -0.964 . . . . 0.0 109.352 173.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.461 ' HB3' ' O ' ' A' ' 16' ' ' LEU . 56.1 t0 -59.99 -40.01 87.71 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -0.888 . . . . 0.0 109.387 174.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.741 HD13 HD21 ' A' ' 33' ' ' LEU . 0.6 OUTLIER -62.36 -43.28 99.2 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.494 -0.754 . . . . 0.0 109.463 175.68 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.787 HD21 ' HD3' ' A' ' 76' ' ' PRO . 4.0 mp -59.99 -49.61 77.0 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.765 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.421 ' HA ' ' OE1' ' A' ' 22' ' ' GLU . 51.7 tp10 -61.13 -40.0 92.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.287 -0.883 . . . . 0.0 109.85 173.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -61.14 -41.68 97.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.435 -0.791 . . . . 0.0 110.559 -176.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.717 HD11 HD11 ' A' ' 20' ' ' LEU . 33.0 mt -67.49 -40.08 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.007 -1.058 . . . . 0.0 110.281 176.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.402 ' HG3' ' O ' ' A' ' 21' ' ' LEU . 30.3 mttm -62.9 -53.93 46.5 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.099 -1.001 . . . . 0.0 109.987 -177.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -60.75 -50.78 72.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.194 -0.941 . . . . 0.0 110.048 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.757 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -105.97 -54.56 0.71 Allowed Glycine 0 N--CA 1.487 2.043 0 N-CA-C 110.014 -1.235 . . . . 0.0 110.014 -173.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.757 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 79.83 172.24 0.15 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.869 -0.783 . . . . 0.0 109.922 -176.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.614 ' CB ' ' O ' ' A' ' 28' ' ' ALA . 95.9 m-20 114.73 78.09 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.013 0 C-N-CA 124.859 1.264 . . . . 0.0 109.618 -175.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -60.03 -49.96 75.61 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.269 -0.895 . . . . 0.0 110.778 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.7 -49.91 65.35 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -175.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.491 ' HB2' ' HB3' ' A' ' 29' ' ' ASP . 94.6 mttt -64.59 -39.8 94.39 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.995 -1.297 . . . . 0.0 110.218 -175.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.741 HD21 HD13 ' A' ' 20' ' ' LEU . 9.8 tt -65.32 -40.04 93.23 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.176 -0.952 . . . . 0.0 110.127 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.564 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -59.81 -50.21 74.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.186 -0.946 . . . . 0.0 110.165 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.5 tttt -59.99 -50.0 75.44 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.382 -0.824 . . . . 0.0 110.717 -178.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.493 ' O ' HG12 ' A' ' 39' ' ' ILE . 88.8 tttt -65.93 -47.28 75.22 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.181 -0.949 . . . . 0.0 111.202 -174.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.501 ' CD2' ' HG ' ' A' ' 33' ' ' LEU . 67.2 m-70 -80.78 -50.01 10.4 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.874 -1.141 . . . . 0.0 111.674 -171.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.465 ' O ' ' C ' ' A' ' 39' ' ' ILE . 53.9 m -60.54 -40.07 90.19 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.915 -1.116 . . . . 0.0 110.765 -173.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.797 ' O ' HG22 ' A' ' 39' ' ' ILE . 31.9 mm 32.04 46.18 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 CA-C-O 121.5 0.667 . . . . 0.0 110.985 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.5 ' SG ' ' N ' ' A' ' 43' ' ' GLY . 17.0 p -133.79 170.14 12.1 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.348 -0.845 . . . . 0.0 109.945 -177.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.464 ' HD2' ' HB2' ' A' ' 40' ' ' CYS . 52.6 Cg_exo -49.96 -30.39 24.01 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.851 1.448 . . . . 0.0 109.982 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.473 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 6.1 p -108.84 27.29 9.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.22 -0.925 . . . . 0.0 109.61 173.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.5 ' N ' ' SG ' ' A' ' 40' ' ' CYS . . . -103.16 -67.16 0.75 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 108.607 -1.797 . . . . 0.0 108.607 176.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -59.99 -40.09 87.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -1.178 . . . . 0.0 109.961 172.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.463 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 13.7 tpt180 -99.8 -41.2 7.36 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.331 -0.856 . . . . 0.0 110.554 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.473 ' HA3' ' O ' ' A' ' 42' ' ' SER . . . -76.6 -22.81 71.71 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.32 -4.32 56.16 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 175.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.525 ' HA ' ' CD2' ' A' ' 7' ' ' LEU . 38.3 t0 -173.83 70.31 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.249 -1.148 . . . . 0.0 109.27 178.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.471 ' HG ' ' HA2' ' A' ' 46' ' ' GLY . 7.3 mt -70.08 -29.2 66.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.61 -0.681 . . . . 0.0 110.077 -176.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 111.78 -143.33 17.36 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -113.17 136.12 53.07 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.383 -1.069 . . . . 0.0 110.455 -177.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.691 ' CZ ' ' HB3' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -148.6 168.44 22.78 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.305 -0.872 . . . . 0.0 109.707 175.373 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.499 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 75.1 ttt180 . . . . . 0 N--CA 1.493 1.691 0 O-C-N 120.737 -1.227 . . . . 0.0 110.546 -172.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo . . . . . 0 N--CA 1.482 0.81 0 N-CA-C 110.247 -0.713 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -43.95 -37.85 3.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.293 -0.879 . . . . 0.0 110.544 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.649 ' HD1' HG21 ' A' ' 86' ' ' ILE . 37.7 t80 -59.9 -40.26 88.16 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.074 -1.016 . . . . 0.0 110.386 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.43 ' O ' HG12 ' A' ' 65' ' ' VAL . 32.9 t0 -59.97 -46.05 90.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.103 -0.998 . . . . 0.0 109.932 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -59.96 -49.99 75.51 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.293 -0.879 . . . . 0.0 110.623 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.725 HG11 HD12 ' A' ' 86' ' ' ILE . 8.9 p -73.2 -45.4 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.03 -1.044 . . . . 0.0 111.144 -174.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.549 ' N ' HG13 ' A' ' 64' ' ' VAL . 5.5 p -57.46 -24.24 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.359 -1.463 . . . . 0.0 109.156 172.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -97.29 -1.5 44.54 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.365 -0.834 . . . . 0.0 109.904 175.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.531 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 22.8 t -96.58 -67.42 0.85 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.449 -0.782 . . . . 0.0 109.573 174.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 73.4 m -92.48 128.54 44.12 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.29 -0.881 . . . . 0.0 110.063 175.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -50.62 165.81 0.38 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.815 1.429 . . . . 0.0 110.353 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.504 HG11 ' CB ' ' A' ' 91' ' ' ARG . 31.4 m -59.8 169.1 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.265 -0.897 . . . . 0.0 110.726 -178.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 70' ' ' VAL . 5.4 mp 59.94 26.17 15.4 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.699 -0.626 . . . . 0.0 110.583 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.06 90.96 37.6 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.085 -1.01 . . . . 0.0 110.17 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -52.22 110.64 0.47 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.771 1.406 . . . . 0.0 109.55 176.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 94.2 m -119.92 129.97 54.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.08 -1.012 . . . . 0.0 110.536 -173.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.512 ' HA2' ' CD2' ' A' ' 77' ' ' LEU . . . 148.41 -169.95 28.98 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.787 ' HD3' HD21 ' A' ' 21' ' ' LEU . 44.1 Cg_endo -75.6 139.16 59.51 Favored 'Cis proline' 0 C--N 1.313 -1.292 0 C-N-CA 121.854 -2.144 . . . . 0.0 110.481 1.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.512 ' CD2' ' HA2' ' A' ' 75' ' ' GLY . 1.1 mm? -98.15 174.83 6.33 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.241 -0.912 . . . . 0.0 110.699 -177.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.443 ' CD2' ' CE2' ' A' ' 83' ' ' TYR . 53.3 m170 -109.66 127.54 54.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.283 -0.885 . . . . 0.0 110.887 -176.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.998 HG21 ' CE1' ' A' ' 84' ' ' HIS . 11.1 t -140.42 168.77 19.02 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.457 -0.777 . . . . 0.0 109.775 174.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -59.95 -40.12 87.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.097 -1.002 . . . . 0.0 110.484 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -64.25 -16.69 62.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.086 -1.009 . . . . 0.0 110.583 -177.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.472 ' O ' HG22 ' A' ' 79' ' ' THR . . . 140.67 -143.62 13.68 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 -177.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.585 ' CZ ' ' HB2' ' A' ' 14' ' ' GLU . 68.9 m-85 -97.16 122.65 40.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.136 -1.214 . . . . 0.0 110.181 178.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.998 ' CE1' HG21 ' A' ' 79' ' ' THR . 24.7 m170 -105.79 120.07 40.77 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.46 -0.775 . . . . 0.0 110.603 178.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.568 ' CG2' ' HB ' ' A' ' 9' ' ' ILE . 6.5 tt -109.71 121.64 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.683 -1.261 . . . . 0.0 109.248 167.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.725 HD12 HG11 ' A' ' 64' ' ' VAL . 88.2 mt -115.53 130.04 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.108 -0.995 . . . . 0.0 111.289 -170.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.542 ' HD3' HD12 ' A' ' 7' ' ' LEU . 20.7 tttm -102.96 132.02 49.5 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.438 -0.789 . . . . 0.0 108.913 171.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.595 ' O ' HD23 ' A' ' 89' ' ' LEU . 20.0 m -119.78 138.58 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.026 -1.046 . . . . 0.0 110.546 -176.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.66 ' HB2' ' HB3' ' A' ' 5' ' ' ALA . 58.5 mt -140.02 -167.34 2.28 Favored 'General case' 0 C--N 1.309 -1.186 0 O-C-N 121.291 -0.881 . . . . 0.0 109.901 -173.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.44 ' C ' ' O ' ' A' ' 89' ' ' LEU . 53.5 m-85 30.41 -85.63 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.865 -177.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.774 ' HG2' ' HB2' ' A' ' 4' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 O-C-N 120.697 -1.252 . . . . 0.0 109.837 -175.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.557 HG22 ' HG2' ' A' ' 53' ' ' ARG . 67.9 p . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.214 0.53 . . . . 0.0 110.089 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.459 ' C ' ' HG3' ' A' ' 51' ' ' GLU . . . -130.71 154.78 47.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.054 -1.029 . . . . 0.0 110.463 -178.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.606 ' CB ' ' CD1' ' A' ' 90' ' ' TYR . . . -98.07 136.59 38.1 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.226 -0.921 . . . . 0.0 109.757 177.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.7 ' HB1' ' NE2' ' A' ' 8' ' ' HIS . . . -147.58 123.12 10.43 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.719 -1.238 . . . . 0.0 112.098 -172.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.601 ' N ' ' CD1' ' A' ' 7' ' ' LEU . 4.0 mp -96.17 147.0 24.2 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.024 -1.048 . . . . 0.0 108.995 167.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.894 ' CD2' HD12 ' A' ' 49' ' ' LEU . 37.5 m-70 -136.35 137.02 40.17 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.773 -1.204 . . . . 0.0 111.287 -175.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.719 ' HB ' HG22 ' A' ' 85' ' ' ILE . 79.3 mt -118.93 129.9 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.127 -0.983 . . . . 0.0 109.799 168.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.542 ' HG ' ' CD2' ' A' ' 84' ' ' HIS . 0.4 OUTLIER -102.16 118.08 36.14 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.509 -0.745 . . . . 0.0 110.262 -179.115 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.946 HG13 HD22 ' A' ' 16' ' ' LEU . 2.2 t -108.09 127.74 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.323 -0.861 . . . . 0.0 109.891 177.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -69.95 -39.95 75.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.352 -0.842 . . . . 0.0 110.296 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -120.03 140.36 51.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.216 -0.928 . . . . 0.0 110.496 -175.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -59.89 -39.95 87.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.382 -0.823 . . . . 0.0 110.617 -176.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -52.16 -41.48 62.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.086 -1.009 . . . . 0.0 110.254 -175.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.946 HD22 HG13 ' A' ' 11' ' ' VAL . 7.9 tt -67.73 -44.08 78.46 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.029 -1.045 . . . . 0.0 109.912 177.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.941 ' HB1' ' HG3' ' A' ' 76' ' ' PRO . . . -59.91 -45.93 90.98 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.249 -0.907 . . . . 0.0 109.936 177.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.601 ' HA ' HD12 ' A' ' 21' ' ' LEU . 10.1 tp -60.99 -39.18 88.68 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.932 -1.105 . . . . 0.0 109.405 170.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.432 ' HB3' ' O ' ' A' ' 16' ' ' LEU . 48.6 t0 -62.25 -49.79 74.29 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 120.999 -1.063 . . . . 0.0 110.312 176.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.83 HD12 ' N ' ' A' ' 21' ' ' LEU . 0.7 OUTLIER -69.94 -47.2 63.31 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.019 -1.051 . . . . 0.0 110.788 -175.574 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 1.141 HD13 ' N ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -59.96 -29.29 68.32 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.012 -1.055 . . . . 0.0 108.864 -173.185 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 1.141 ' N ' HD13 ' A' ' 21' ' ' LEU . 85.7 tt0 -61.87 -42.66 99.33 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.407 -0.808 . . . . 0.0 110.137 173.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.79 -39.99 95.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.298 -0.876 . . . . 0.0 110.574 -176.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.862 HD13 ' CE2' ' A' ' 30' ' ' PHE . 97.6 mt -61.89 -45.44 98.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -0.86 . . . . 0.0 109.824 -178.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.566 ' HE3' HD21 ' A' ' 21' ' ' LEU . 36.7 mttm -61.06 -46.26 91.4 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.228 -0.92 . . . . 0.0 109.716 176.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -59.95 -61.34 2.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.382 -0.824 . . . . 0.0 110.485 177.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.755 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -104.87 -39.58 2.3 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -172.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.755 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 81.19 102.56 0.06 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.953 -0.734 . . . . 0.0 110.142 -178.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -175.74 67.05 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.421 -0.799 . . . . 0.0 110.128 -177.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.862 ' CE2' HD13 ' A' ' 24' ' ' ILE . 2.0 m-85 -59.98 -44.15 94.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -0.923 . . . . 0.0 110.838 -178.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.4 -43.63 98.48 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -177.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -65.09 -40.2 94.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.175 -1.191 . . . . 0.0 110.345 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.566 ' CD1' HG13 ' A' ' 24' ' ' ILE . 88.9 mt -66.33 -39.93 89.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.112 -0.992 . . . . 0.0 110.491 178.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 38' ' ' SER . . . -60.0 -46.42 89.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.107 -0.996 . . . . 0.0 110.027 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -60.0 -50.21 74.61 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.363 -0.835 . . . . 0.0 110.785 -177.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.472 ' O ' HG13 ' A' ' 39' ' ' ILE . 51.3 mttt -75.91 -47.89 23.5 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.023 -1.048 . . . . 0.0 111.249 -174.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 60.9 m-70 -71.78 -40.04 69.51 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.932 -1.105 . . . . 0.0 111.198 -174.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.515 ' OG ' ' CA ' ' A' ' 43' ' ' GLY . 16.5 t -61.02 -50.04 74.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.035 -1.041 . . . . 0.0 111.045 -172.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.741 ' O ' HG22 ' A' ' 39' ' ' ILE . 96.3 mt 31.98 49.06 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 CA-C-O 121.318 0.58 . . . . 0.0 111.037 -177.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.501 ' SG ' ' N ' ' A' ' 43' ' ' GLY . 16.4 p -143.3 161.94 45.14 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.402 -0.811 . . . . 0.0 110.229 -176.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.457 ' HD2' ' HB2' ' A' ' 40' ' ' CYS . 6.1 Cg_endo -53.0 -26.12 30.79 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.947 1.498 . . . . 0.0 110.779 -178.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.532 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -109.05 19.77 19.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.074 -1.016 . . . . 0.0 110.087 177.816 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.515 ' CA ' ' OG ' ' A' ' 38' ' ' SER . . . -77.81 -53.13 5.09 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 108.583 -1.807 . . . . 0.0 108.583 172.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 61.8 mttt -60.21 -40.05 88.76 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.301 -1.117 . . . . 0.0 110.354 176.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.437 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 9.5 tpp180 -94.99 -41.22 9.26 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.982 -1.074 . . . . 0.0 110.262 -177.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -67.04 -28.09 73.67 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 178.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.86 -4.46 54.53 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 177.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.423 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 51.4 t0 -173.95 70.96 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.266 -1.138 . . . . 0.0 109.135 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.894 HD12 ' CD2' ' A' ' 8' ' ' HIS . 7.5 mt -69.94 -27.73 64.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.445 -0.784 . . . . 0.0 110.66 -174.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.56 -145.28 16.14 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 -176.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.459 ' HG3' ' C ' ' A' ' 4' ' ' ALA . 59.5 tt0 -113.14 132.14 55.57 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.161 -1.199 . . . . 0.0 110.544 -177.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 6' ' ' ALA . 1.9 p90 -136.83 161.95 34.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.34 -0.85 . . . . 0.0 109.768 177.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.557 ' HG2' HG22 ' A' ' 3' ' ' THR . 82.8 mtp180 . . . . . 0 N--CA 1.497 1.894 0 O-C-N 120.942 -1.099 . . . . 0.0 111.155 -173.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.41 ' O ' ' C ' ' A' ' 60' ' ' ALA . 13.0 Cg_endo . . . . . 0 N--CA 1.484 0.934 0 N-CA-C 110.245 -0.714 . . . . 0.0 110.245 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.426 ' O ' ' HB3' ' A' ' 63' ' ' LYS . . . -41.17 -34.29 0.45 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.48 -0.762 . . . . 0.0 110.399 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.505 ' O ' HG12 ' A' ' 64' ' ' VAL . 68.5 t80 -60.0 -39.99 87.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.114 -0.991 . . . . 0.0 110.005 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -59.92 -39.97 87.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.309 -0.87 . . . . 0.0 109.511 179.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.723 ' HD3' HD21 ' A' ' 77' ' ' LEU . 87.7 tttt -57.49 -40.56 78.88 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.466 -0.771 . . . . 0.0 110.379 176.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.76 HG23 HG21 ' A' ' 74' ' ' THR . 14.3 p -91.77 -41.9 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.974 -1.079 . . . . 0.0 111.52 -173.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.526 HG22 ' CZ ' ' A' ' 91' ' ' ARG . 2.5 p -52.65 -27.16 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.53 -1.356 . . . . 0.0 109.805 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -99.83 5.66 45.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.172 -0.955 . . . . 0.0 109.88 176.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.523 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 37.5 t -99.61 -80.06 0.48 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.382 -0.824 . . . . 0.0 110.181 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 84.3 m -78.51 156.95 77.98 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.153 -0.967 . . . . 0.0 110.352 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.539 ' O ' ' O ' ' A' ' 70' ' ' VAL . 38.6 Cg_endo -79.07 69.78 7.78 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.069 1.562 . . . . 0.0 110.585 179.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.016 ' C ' HD13 ' A' ' 71' ' ' LEU . 8.4 p 29.4 -174.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 178.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.016 HD13 ' C ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER 23.6 41.67 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.607 0 O-C-N 120.821 -1.174 . . . . 0.0 113.364 -164.139 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' A' ' 70' ' ' VAL . 9.7 tt0 -134.04 100.86 12.84 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.766 -1.209 . . . . 0.0 109.91 171.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.544 ' HB3' ' CZ ' ' A' ' 30' ' ' PHE . 50.9 Cg_exo -47.42 103.84 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.908 1.478 . . . . 0.0 110.38 -176.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.76 HG21 HG23 ' A' ' 64' ' ' VAL . 50.6 m -98.99 134.2 42.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.322 -0.861 . . . . 0.0 110.504 -177.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.447 ' HA3' HG13 ' A' ' 85' ' ' ILE . . . 135.78 -172.65 22.17 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 176.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.941 ' HG3' ' HB1' ' A' ' 17' ' ' ALA . 43.5 Cg_endo -70.13 127.95 12.11 Favored 'Cis proline' 0 N--CA 1.49 1.277 0 C-N-CA 121.798 -2.167 . . . . 0.0 110.292 2.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.723 HD21 ' HD3' ' A' ' 63' ' ' LYS . 62.3 tp -95.37 155.91 16.54 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.252 -0.905 . . . . 0.0 110.763 -174.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -71.41 123.97 23.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.335 -0.853 . . . . 0.0 110.514 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.811 HG21 ' CG ' ' A' ' 84' ' ' HIS . 12.9 t -140.12 156.11 46.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.205 -0.934 . . . . 0.0 109.727 174.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -60.12 -32.07 70.66 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.118 -0.989 . . . . 0.0 110.927 -175.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -75.68 -8.79 57.69 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.015 -1.053 . . . . 0.0 110.365 -178.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.725 ' O ' HG22 ' A' ' 79' ' ' THR . . . 138.34 -132.88 6.0 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 -175.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -107.86 125.78 51.88 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.092 -1.24 . . . . 0.0 110.1 175.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.811 ' CG ' HG21 ' A' ' 79' ' ' THR . 45.6 m170 -106.96 124.18 49.25 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.143 -0.973 . . . . 0.0 110.367 175.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.719 HG22 ' HB ' ' A' ' 9' ' ' ILE . 9.9 tt -108.54 125.47 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 118.719 -1.192 . . . . 0.0 109.398 168.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 86.0 mt -120.08 130.67 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.016 -1.052 . . . . 0.0 111.785 -167.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.598 ' HD3' ' CG ' ' A' ' 30' ' ' PHE . 13.5 mtmm -93.06 126.83 38.35 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.1 -1.0 . . . . 0.0 109.12 168.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.938 HG12 HG23 ' A' ' 70' ' ' VAL . 59.3 t -109.93 130.07 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.029 -1.044 . . . . 0.0 110.458 -175.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.597 HD23 ' O ' ' A' ' 88' ' ' VAL . 87.7 mt -139.71 -155.25 0.57 Allowed 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.272 -0.893 . . . . 0.0 110.109 -178.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.606 ' CD1' ' CB ' ' A' ' 5' ' ' ALA . 16.9 m-85 32.82 -89.0 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 O-C-N 122.104 -0.372 . . . . 0.0 111.268 -178.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.526 ' CZ ' HG22 ' A' ' 65' ' ' VAL . 13.5 tpt180 . . . . . 0 N--CA 1.493 1.678 0 O-C-N 120.878 -1.139 . . . . 0.0 110.62 177.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 67.6 m . . . . . 0 N--CA 1.493 1.71 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' A' ' 51' ' ' GLU . . . -150.42 158.48 44.2 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.816 -1.178 . . . . 0.0 111.247 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.619 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -101.25 136.96 40.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.491 -0.755 . . . . 0.0 109.45 176.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.709 ' HB1' ' NE2' ' A' ' 8' ' ' HIS . . . -150.19 129.74 13.07 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.981 -1.075 . . . . 0.0 111.224 -177.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.526 HD12 ' HD3' ' A' ' 87' ' ' LYS . 72.6 mt -99.5 135.09 41.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.253 -0.904 . . . . 0.0 109.168 169.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.709 ' NE2' ' HB1' ' A' ' 6' ' ' ALA . 40.8 m170 -130.34 129.39 43.1 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.025 -1.047 . . . . 0.0 110.827 -176.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.55 ' HB ' ' CG2' ' A' ' 85' ' ' ILE . 84.6 mt -114.45 129.8 69.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.179 -0.951 . . . . 0.0 109.547 169.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.797 ' O ' HD13 ' A' ' 10' ' ' LEU . 1.8 tm? -106.8 114.92 29.31 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.291 -0.88 . . . . 0.0 110.138 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.807 HG13 HD22 ' A' ' 16' ' ' LEU . 2.3 t -101.3 128.97 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.312 -0.868 . . . . 0.0 109.925 177.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -67.33 -40.04 85.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.306 -0.871 . . . . 0.0 110.705 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -109.02 138.99 44.5 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.06 -1.025 . . . . 0.0 111.159 -174.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.495 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 87.9 tt0 -60.09 -41.24 92.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.556 -0.715 . . . . 0.0 110.182 176.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -56.06 -43.76 78.22 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.257 -0.902 . . . . 0.0 109.848 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.807 HD22 HG13 ' A' ' 11' ' ' VAL . 3.2 tt -67.84 -36.02 79.6 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.342 -0.849 . . . . 0.0 109.5 177.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.529 ' HA ' ' HB3' ' A' ' 20' ' ' LEU . . . -57.52 -44.33 84.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.945 -1.097 . . . . 0.0 109.603 172.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.717 ' HA ' HD11 ' A' ' 21' ' ' LEU . 0.1 OUTLIER -60.04 -39.95 87.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.204 -0.935 . . . . 0.0 109.901 173.159 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.476 ' HB3' ' O ' ' A' ' 16' ' ' LEU . 60.4 t0 -61.06 -40.83 95.16 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.677 -1.264 . . . . 0.0 109.101 171.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.842 ' C ' HD12 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -64.17 -80.69 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.551 -0.718 . . . . 0.0 110.445 179.826 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.808 HD12 ' H ' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -49.99 -20.01 0.84 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.21 -1.556 . . . . 0.0 110.497 -164.719 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.808 ' H ' HD12 ' A' ' 21' ' ' LEU . 50.2 tp10 -64.49 -39.99 94.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.682 -1.262 . . . . 0.0 110.189 173.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.44 ' HG2' ' O ' ' A' ' 19' ' ' ASP . 85.4 mm-40 -60.44 -41.74 94.68 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.284 -0.885 . . . . 0.0 111.221 -172.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.608 HG13 HD12 ' A' ' 33' ' ' LEU . 1.7 mp -64.3 -43.67 97.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.016 -1.053 . . . . 0.0 110.768 -173.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -61.84 -50.05 73.82 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 120.775 -1.203 . . . . 0.0 110.164 178.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -63.26 -57.3 10.89 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.128 -0.983 . . . . 0.0 110.521 176.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.748 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -104.53 -39.98 2.29 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -172.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.748 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 82.99 -153.52 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.23 0 O-C-N 122.109 -0.642 . . . . 0.0 110.476 -179.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.486 ' HB2' ' O ' ' A' ' 28' ' ' ALA . 2.7 m-20 61.38 75.66 0.4 Allowed 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 122.082 0.944 . . . . 0.0 110.558 175.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.506 ' CZ ' HG13 ' A' ' 9' ' ' ILE . 62.8 t80 -59.97 -48.15 82.9 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.82 -0.55 . . . . 0.0 110.931 -178.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.0 -41.51 97.95 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -175.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.437 ' HD2' ' CG ' ' A' ' 29' ' ' ASP . 82.0 mttt -66.34 -39.94 89.54 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.042 -1.269 . . . . 0.0 110.194 -178.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.608 HD12 HG13 ' A' ' 24' ' ' ILE . 49.1 mt -64.91 -40.07 94.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.066 -1.021 . . . . 0.0 110.206 178.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.486 ' O ' ' CB ' ' A' ' 38' ' ' SER . . . -59.57 -47.11 86.86 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.076 -1.015 . . . . 0.0 109.862 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -59.93 -40.9 90.46 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.032 -1.042 . . . . 0.0 110.431 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.8 mtpt -73.02 -52.08 15.76 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.013 -1.054 . . . . 0.0 111.764 -175.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.576 ' CD2' ' O ' ' A' ' 33' ' ' LEU . 7.4 p80 -106.01 -17.43 14.34 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.406 -1.434 . . . . 0.0 112.111 -167.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.668 ' O ' HG22 ' A' ' 39' ' ' ILE . 64.9 p -60.02 -50.06 75.22 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.621 -1.3 . . . . 0.0 110.301 -173.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.668 HG22 ' O ' ' A' ' 38' ' ' SER . 17.3 tt 38.34 31.2 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.692 -0.63 . . . . 0.0 110.466 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.51 ' SG ' ' N ' ' A' ' 43' ' ' GLY . 20.4 p -125.61 169.04 12.17 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.316 -0.865 . . . . 0.0 110.307 -176.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.469 ' HD2' ' HB2' ' A' ' 40' ' ' CYS . 41.0 Cg_exo -51.76 -34.61 55.1 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.893 1.47 . . . . 0.0 110.729 -175.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.535 ' O ' ' CA ' ' A' ' 46' ' ' GLY . 1.2 p -107.01 16.59 24.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.154 -0.966 . . . . 0.0 109.891 177.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.51 ' N ' ' SG ' ' A' ' 40' ' ' CYS . . . -79.98 -60.0 2.5 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 108.681 -1.768 . . . . 0.0 108.681 176.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -59.94 -40.37 88.73 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.424 -1.045 . . . . 0.0 110.488 176.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.556 ' NE ' HD23 ' A' ' 49' ' ' LEU . 17.0 tpt180 -104.95 -44.38 4.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.097 -1.002 . . . . 0.0 110.93 -175.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.535 ' CA ' ' O ' ' A' ' 42' ' ' SER . . . -62.37 -29.1 72.25 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.79 0.48 44.22 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 177.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.502 ' HA ' ' CD2' ' A' ' 7' ' ' LEU . 40.6 t0 -169.65 76.25 0.09 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.132 -1.217 . . . . 0.0 109.101 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.556 HD23 ' NE ' ' A' ' 45' ' ' ARG . 10.6 mt -91.28 -6.19 53.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.573 -0.704 . . . . 0.0 110.196 -175.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.95 -131.26 28.13 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 -173.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 54.8 mp0 -116.63 145.95 43.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.101 -1.235 . . . . 0.0 110.546 177.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.636 ' CE2' ' HB3' ' A' ' 6' ' ' ALA . 0.3 OUTLIER -130.19 164.14 25.15 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.321 -0.862 . . . . 0.0 110.552 176.14 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 87.7 mtt180 . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.528 -0.732 . . . . 0.0 110.434 -175.307 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo . . . . . 0 N--CA 1.48 0.724 0 N-CA-C 110.845 -0.483 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.55 -39.35 79.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -0.893 . . . . 0.0 110.216 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.506 ' HA ' HG12 ' A' ' 64' ' ' VAL . 59.5 t80 -59.92 -41.69 92.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.284 -0.885 . . . . 0.0 110.451 178.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -60.02 -47.24 86.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.232 -0.918 . . . . 0.0 109.878 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 67' ' ' SER . 96.9 mttt -59.88 -44.23 94.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.285 -0.885 . . . . 0.0 110.419 178.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.611 HG22 ' SG ' ' A' ' 68' ' ' CYS . 6.2 p -83.57 -44.96 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.12 -0.987 . . . . 0.0 111.221 -172.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.565 ' N ' HG13 ' A' ' 64' ' ' VAL . 5.0 p -55.43 -24.3 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.206 -1.558 . . . . 0.0 109.142 172.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -92.86 -15.2 26.71 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.332 -0.855 . . . . 0.0 109.661 175.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.525 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 9.4 t -93.18 -47.61 6.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.378 -0.826 . . . . 0.0 109.936 175.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.611 ' SG ' HG22 ' A' ' 64' ' ' VAL . 29.3 p -102.98 136.92 19.16 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.352 -0.843 . . . . 0.0 109.965 175.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.42 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 10.1 Cg_exo -66.55 171.61 10.44 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.796 1.419 . . . . 0.0 110.261 178.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.753 ' HB ' HD12 ' A' ' 71' ' ' LEU . 12.7 m -57.69 171.41 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.372 -0.83 . . . . 0.0 110.422 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.753 HD12 ' HB ' ' A' ' 70' ' ' VAL . 4.3 mp 38.85 39.71 0.37 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.583 -0.698 . . . . 0.0 110.764 -177.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.42 ' HB3' ' O ' ' A' ' 69' ' ' PRO . 20.0 tp10 -137.78 83.98 23.04 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.162 -0.961 . . . . 0.0 110.01 177.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -50.08 124.87 13.55 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.027 1.541 . . . . 0.0 109.981 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.514 ' OG1' ' CB ' ' A' ' 68' ' ' CYS . 96.5 m -135.22 138.09 43.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.293 -0.879 . . . . 0.0 110.21 -177.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.441 ' HA3' HG13 ' A' ' 85' ' ' ILE . . . 147.92 -172.72 28.18 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -178.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.506 ' HG3' ' HB1' ' A' ' 17' ' ' ALA . 44.6 Cg_endo -70.49 173.29 47.84 Favored 'Cis proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.77 -2.179 . . . . 0.0 110.59 -0.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.544 HD11 ' CG2' ' A' ' 64' ' ' VAL . 25.2 mt -133.57 175.33 9.52 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.243 -0.911 . . . . 0.0 110.224 -178.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -95.97 119.53 34.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.059 -1.026 . . . . 0.0 110.753 -175.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.824 HG21 ' CG ' ' A' ' 84' ' ' HIS . 15.2 t -140.94 163.41 33.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.42 -0.8 . . . . 0.0 109.779 176.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -59.99 -39.99 87.64 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.979 -1.075 . . . . 0.0 110.437 -178.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -60.06 -18.38 46.23 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.222 -0.923 . . . . 0.0 110.451 179.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.541 ' O ' HG22 ' A' ' 79' ' ' THR . . . 134.1 -130.56 5.64 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 -177.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.438 ' O ' ' HA ' ' A' ' 10' ' ' LEU . 3.6 m-85 -93.06 121.06 34.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.085 -1.244 . . . . 0.0 110.245 177.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.824 ' CG ' HG21 ' A' ' 79' ' ' THR . 1.0 OUTLIER -102.64 116.16 32.03 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.432 -0.793 . . . . 0.0 110.502 177.17 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.55 ' CG2' ' HB ' ' A' ' 9' ' ' ILE . 7.8 tt -108.62 126.28 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.86 -1.15 . . . . 0.0 109.427 170.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.578 HG12 ' CD2' ' A' ' 8' ' ' HIS . 89.5 mt -120.1 129.94 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.119 -0.988 . . . . 0.0 111.735 -167.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.526 ' HD3' HD12 ' A' ' 7' ' ' LEU . 27.8 tttt -101.08 129.84 47.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.225 -0.922 . . . . 0.0 109.165 169.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 18.0 t -100.82 139.98 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.075 -1.016 . . . . 0.0 110.414 -175.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.619 ' HB2' ' HB3' ' A' ' 5' ' ' ALA . 88.7 mt -141.68 170.15 16.27 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.434 ' C ' ' O ' ' A' ' 89' ' ' LEU . 77.8 m-85 33.37 -87.28 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 O-C-N 122.212 -0.305 . . . . 0.0 111.665 -178.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.533 ' N ' ' O ' ' A' ' 89' ' ' LEU . 1.8 ttp180 . . . . . 0 N--CA 1.492 1.671 0 O-C-N 120.7 -1.25 . . . . 0.0 109.502 -176.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.476 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 11.5 p . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.521 ' O ' ' HA ' ' A' ' 51' ' ' GLU . . . -127.8 150.56 49.77 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.86 -1.15 . . . . 0.0 109.954 176.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.505 ' HB3' ' HB2' ' A' ' 90' ' ' TYR . . . -89.71 121.63 32.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.32 -0.862 . . . . 0.0 109.62 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.628 ' HB3' ' CE2' ' A' ' 52' ' ' PHE . . . -131.81 131.9 43.28 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 118.992 -1.083 . . . . 0.0 111.651 -169.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.562 HD12 ' HD2' ' A' ' 87' ' ' LYS . 85.7 mt -99.96 134.01 43.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.288 -0.882 . . . . 0.0 108.991 169.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.569 ' NE2' ' HB1' ' A' ' 6' ' ' ALA . 49.7 m170 -128.51 129.67 46.38 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.833 -1.167 . . . . 0.0 111.116 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.59 ' HB ' HG22 ' A' ' 85' ' ' ILE . 80.0 mt -116.69 128.65 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.07 -1.019 . . . . 0.0 109.718 169.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.593 HD13 ' C ' ' A' ' 10' ' ' LEU . 2.4 tm? -106.58 120.32 41.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.274 -0.891 . . . . 0.0 109.911 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 1.059 HG13 HD22 ' A' ' 16' ' ' LEU . 2.3 t -106.77 125.45 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.312 -0.867 . . . . 0.0 110.282 -178.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -70.03 -37.86 75.71 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.373 -0.829 . . . . 0.0 110.499 175.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -106.48 136.8 45.6 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.086 -1.009 . . . . 0.0 111.061 -173.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.589 ' HG2' ' CZ ' ' A' ' 83' ' ' TYR . 97.1 mt-10 -59.99 -39.99 87.62 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.356 -0.84 . . . . 0.0 110.294 175.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -56.24 -44.51 79.69 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -0.913 . . . . 0.0 110.035 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 1.059 HD22 HG13 ' A' ' 11' ' ' VAL . 7.9 tt -68.56 -39.93 80.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.296 -0.877 . . . . 0.0 109.935 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.05 ' O ' HD12 ' A' ' 21' ' ' LEU . . . -58.2 -41.85 84.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.178 -0.951 . . . . 0.0 109.384 176.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.04 -45.36 93.08 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.075 -1.016 . . . . 0.0 109.365 171.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.439 ' HB3' ' O ' ' A' ' 16' ' ' LEU . 55.1 t0 -60.03 -42.49 94.5 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.417 -0.802 . . . . 0.0 110.11 176.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.701 ' C ' HD12 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -64.49 -47.05 80.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.237 -0.915 . . . . 0.0 109.523 178.09 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 1.05 HD12 ' O ' ' A' ' 17' ' ' ALA . 0.4 OUTLIER -56.53 -47.41 79.46 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.496 -0.753 . . . . 0.0 109.797 -178.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -61.2 -39.65 91.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.55 -0.719 . . . . 0.0 110.141 177.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.5 ' HG2' HD22 ' A' ' 33' ' ' LEU . 50.4 tp60 -59.94 -47.19 86.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.281 -0.887 . . . . 0.0 110.817 -172.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.761 HG21 ' CE2' ' A' ' 30' ' ' PHE . 2.3 mt -66.48 -43.54 90.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.055 -1.028 . . . . 0.0 110.888 -176.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -61.3 -44.26 97.51 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.702 -1.249 . . . . 0.0 109.983 -178.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -60.8 -65.33 0.71 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.149 -0.969 . . . . 0.0 110.491 175.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.759 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -105.86 -34.84 3.15 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -172.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.759 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 87.09 -147.05 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.338 0 O-C-N 122.373 -0.486 . . . . 0.0 110.328 -178.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.535 ' CB ' ' O ' ' A' ' 28' ' ' ALA . 0.5 OUTLIER 75.91 65.35 0.06 Allowed 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.308 0.575 . . . . 0.0 110.523 176.324 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.761 ' CE2' HG21 ' A' ' 24' ' ' ILE . 7.2 m-85 -60.03 -41.91 93.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.355 -0.841 . . . . 0.0 110.572 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.23 -53.82 33.93 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.176 -1.169 . . . . 0.0 110.176 -176.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.429 ' HD2' ' CG ' ' A' ' 29' ' ' ASP . 97.9 mttt -66.5 -39.98 89.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.011 -1.288 . . . . 0.0 110.555 -174.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.514 HD11 ' O ' ' A' ' 28' ' ' ALA . 88.7 mt -63.81 -40.06 95.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.097 -1.002 . . . . 0.0 109.915 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.414 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -59.98 -47.71 84.7 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.403 -0.811 . . . . 0.0 110.323 177.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -60.09 -43.14 95.74 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.271 -0.893 . . . . 0.0 110.654 -176.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 49.2 tttt -69.31 -53.79 17.88 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.037 -1.039 . . . . 0.0 110.98 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -70.39 -40.03 74.17 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.054 -1.029 . . . . 0.0 111.535 -172.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.673 ' O ' HG22 ' A' ' 39' ' ' ILE . 21.0 t -60.0 -43.55 95.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.882 -1.136 . . . . 0.0 110.187 -174.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.673 HG22 ' O ' ' A' ' 38' ' ' SER . 16.8 tt 38.26 32.04 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.655 -0.653 . . . . 0.0 110.747 176.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.489 ' SG ' ' N ' ' A' ' 43' ' ' GLY . 16.3 p -127.42 166.38 23.42 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.055 -1.028 . . . . 0.0 110.379 -176.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -51.99 -35.69 61.91 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.993 1.522 . . . . 0.0 110.56 -178.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.53 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -97.64 18.75 14.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.983 -1.073 . . . . 0.0 109.743 174.544 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.489 ' N ' ' SG ' ' A' ' 40' ' ' CYS . . . -77.2 -54.26 4.83 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 108.303 -1.919 . . . . 0.0 108.303 172.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -60.86 -39.98 91.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.527 -0.984 . . . . 0.0 110.657 176.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.485 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 11.7 tpp180 -97.95 -45.21 6.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.177 -0.952 . . . . 0.0 110.154 -177.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -68.3 -30.3 73.48 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 178.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.41 -1.37 57.35 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 176.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -171.89 68.29 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.3 -1.118 . . . . 0.0 108.85 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 7.2 mt -70.03 -28.1 65.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.54 -0.725 . . . . 0.0 110.347 -174.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 5' ' ' ALA . . . 98.92 -144.18 17.05 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.351 -1.499 . . . . 0.0 109.351 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.521 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 3.5 mt-10 -99.54 130.78 45.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.528 -0.983 . . . . 0.0 110.571 -178.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.628 ' CE2' ' HB3' ' A' ' 6' ' ' ALA . 3.3 p90 -149.02 168.41 23.2 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.241 -0.912 . . . . 0.0 110.875 178.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.476 ' HB2' ' HA ' ' A' ' 3' ' ' THR . 32.2 ttt85 . . . . . 0 N--CA 1.494 1.727 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 173.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.519 ' O ' ' N ' ' A' ' 62' ' ' ASP . 6.5 Cg_endo . . . . . 0 N--CA 1.486 1.07 0 N-CA-C 110.997 -0.424 . . . . 0.0 110.997 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 59' ' ' PRO . . . -42.01 -33.76 0.61 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.284 -0.885 . . . . 0.0 110.019 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -62.48 -39.75 94.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.334 -0.854 . . . . 0.0 110.028 177.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 59' ' ' PRO . 51.5 t0 -60.04 -40.0 87.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.34 -0.85 . . . . 0.0 110.536 -177.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 67' ' ' SER . 49.4 mttm -58.15 -48.49 80.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.093 -1.004 . . . . 0.0 111.434 -174.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.539 ' HA ' ' HB3' ' A' ' 67' ' ' SER . 2.4 p -94.73 -37.64 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.725 -1.235 . . . . 0.0 111.561 -173.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.2 p -54.82 -26.18 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.532 -1.355 . . . . 0.0 109.788 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.485 ' CD2' ' O ' ' A' ' 66' ' ' PHE . 50.7 t80 -100.68 0.05 38.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.315 -0.866 . . . . 0.0 110.127 176.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.539 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 41.2 t -94.03 -74.58 0.53 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.263 -0.898 . . . . 0.0 110.37 -176.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.482 ' O ' ' N ' ' A' ' 70' ' ' VAL . 94.5 m -100.27 142.8 25.3 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.244 -0.91 . . . . 0.0 110.388 -178.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.495 ' O ' ' C ' ' A' ' 70' ' ' VAL . 35.4 Cg_exo -56.47 81.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.053 1.554 . . . . 0.0 110.222 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.824 ' O ' HD12 ' A' ' 71' ' ' LEU . 16.8 m 13.41 65.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.391 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.824 HD12 ' O ' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -166.95 -47.41 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.456 -0.778 . . . . 0.0 110.315 177.583 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -83.34 148.05 54.76 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.229 -0.92 . . . . 0.0 110.434 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -70.52 141.32 41.88 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.105 1.582 . . . . 0.0 110.622 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.455 ' HB ' ' CG2' ' A' ' 64' ' ' VAL . 94.5 m -138.01 137.8 38.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.25 -0.906 . . . . 0.0 110.189 178.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 140.89 -167.11 25.75 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.756 ' HD3' HD21 ' A' ' 21' ' ' LEU . 43.1 Cg_endo -72.1 140.6 66.84 Favored 'Cis proline' 0 C--N 1.315 -1.231 0 C-N-CA 121.783 -2.174 . . . . 0.0 110.586 1.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.519 HD11 ' HB ' ' A' ' 64' ' ' VAL . 96.2 mt -90.89 170.39 10.12 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.39 -0.819 . . . . 0.0 109.998 -177.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -106.82 123.67 48.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.857 -1.152 . . . . 0.0 110.898 -177.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.1 t -138.59 164.77 28.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.371 -0.83 . . . . 0.0 109.338 173.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -56.74 -39.76 74.53 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.941 -1.099 . . . . 0.0 110.253 -175.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -60.05 -26.98 66.56 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.183 -0.948 . . . . 0.0 110.535 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 149.26 -137.76 6.47 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -176.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.589 ' CZ ' ' HG2' ' A' ' 14' ' ' GLU . 66.3 m-85 -98.64 124.86 43.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.992 -1.299 . . . . 0.0 110.367 177.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.438 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 1.9 m170 -101.7 114.17 27.99 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.475 -0.766 . . . . 0.0 110.309 174.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.59 HG22 ' HB ' ' A' ' 9' ' ' ILE . 3.1 tt -102.05 118.84 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 120.761 -1.212 . . . . 0.0 109.408 170.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.561 HG12 ' CD2' ' A' ' 8' ' ' HIS . 96.1 mt -112.07 129.98 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.462 -0.774 . . . . 0.0 111.017 -172.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.562 ' HD2' HD12 ' A' ' 7' ' ' LEU . 10.5 ttmm -105.17 127.08 52.74 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.868 -1.145 . . . . 0.0 109.31 168.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.771 ' O ' HD23 ' A' ' 89' ' ' LEU . 26.8 t -110.29 139.97 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.208 -0.933 . . . . 0.0 110.335 -173.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.771 HD23 ' O ' ' A' ' 88' ' ' VAL . 81.1 mt -148.9 177.15 9.81 Favored 'General case' 0 C--N 1.308 -1.203 0 O-C-N 121.336 -0.852 . . . . 0.0 109.402 -177.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.505 ' HB2' ' HB3' ' A' ' 5' ' ' ALA . 0.3 OUTLIER 67.49 -61.01 0.37 Allowed 'General case' 0 C--N 1.293 -1.859 0 O-C-N 121.422 -0.799 . . . . 0.0 111.389 167.23 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.76 ' HD2' HG21 ' A' ' 70' ' ' VAL . 61.7 ttt-85 . . . . . 0 N--CA 1.495 1.784 0 O-C-N 121.04 -1.038 . . . . 0.0 110.567 -174.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 67.4 p . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 121.117 0.484 . . . . 0.0 110.262 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 91' ' ' ARG . . . -138.56 143.44 39.42 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.192 -0.942 . . . . 0.0 110.264 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.609 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -94.53 130.32 40.98 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.315 -0.866 . . . . 0.0 109.145 173.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.748 ' HB3' ' CZ ' ' A' ' 52' ' ' PHE . . . -146.8 134.91 21.57 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.845 -1.159 . . . . 0.0 111.534 -171.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.646 HD12 ' HD3' ' A' ' 87' ' ' LYS . 88.6 mt -107.35 149.88 27.34 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.298 -0.876 . . . . 0.0 109.581 173.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.864 ' CD2' HD12 ' A' ' 49' ' ' LEU . 21.2 m-70 -136.39 143.4 43.97 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.795 -1.19 . . . . 0.0 111.634 -176.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.618 HG12 ' HB2' ' A' ' 34' ' ' ALA . 91.1 mt -130.96 130.77 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.005 -1.059 . . . . 0.0 109.575 166.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.589 ' HG ' ' CD2' ' A' ' 84' ' ' HIS . 0.3 OUTLIER -104.72 119.96 40.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.428 -0.795 . . . . 0.0 110.053 179.782 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.749 HG11 ' N ' ' A' ' 17' ' ' ALA . 2.5 t -105.04 126.6 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.17 -0.956 . . . . 0.0 110.266 178.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 26.2 mmtm -69.19 -40.01 78.33 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.479 -0.763 . . . . 0.0 110.32 177.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -109.32 140.54 42.86 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.217 -0.927 . . . . 0.0 110.918 -173.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -60.13 -47.46 85.81 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.409 -0.807 . . . . 0.0 110.36 175.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -59.35 -40.71 87.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.276 -0.89 . . . . 0.0 110.335 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.42 ' CD2' HG13 ' A' ' 11' ' ' VAL . 2.5 tt -67.84 -39.98 83.8 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.312 -0.867 . . . . 0.0 109.627 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.995 ' O ' HD12 ' A' ' 21' ' ' LEU . . . -59.02 -43.76 91.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -0.923 . . . . 0.0 109.815 175.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.93 -43.1 95.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.192 -0.943 . . . . 0.0 109.942 175.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -60.01 -41.63 92.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.402 -0.811 . . . . 0.0 110.162 178.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.707 ' C ' HD12 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -64.18 -46.09 85.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.161 -0.962 . . . . 0.0 109.825 178.666 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.995 HD12 ' O ' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -58.21 -50.03 75.0 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.329 -0.857 . . . . 0.0 110.428 -178.05 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -60.01 -36.93 78.27 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.213 -0.93 . . . . 0.0 110.261 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.485 ' HG2' HD21 ' A' ' 33' ' ' LEU . 52.8 tp60 -59.99 -40.01 87.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.189 -0.944 . . . . 0.0 110.374 -175.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.823 HG21 ' HE1' ' A' ' 30' ' ' PHE . 3.9 mt -63.73 -41.96 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.112 -0.993 . . . . 0.0 110.715 -178.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -59.96 -45.69 91.86 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.824 -1.172 . . . . 0.0 109.565 176.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -59.78 -67.37 0.39 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.169 -0.957 . . . . 0.0 110.375 173.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.747 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -106.54 -35.03 2.94 Favored Glycine 0 N--CA 1.487 2.067 0 C-N-CA 120.057 -1.068 . . . . 0.0 110.617 -170.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.747 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 85.37 -156.91 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.402 0 O-C-N 122.001 -0.705 . . . . 0.0 110.196 -174.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.552 ' CB ' ' O ' ' A' ' 28' ' ' ALA . 0.7 OUTLIER 78.7 71.59 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 CA-C-O 121.487 0.66 . . . . 0.0 110.563 176.865 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.823 ' HE1' HG21 ' A' ' 24' ' ' ILE . 1.7 m-85 -62.43 -42.21 99.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.203 -0.935 . . . . 0.0 110.664 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.29 -44.4 97.54 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 -176.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.6 mmtt -63.79 -39.96 95.51 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.162 -1.199 . . . . 0.0 110.082 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.58 ' CD1' HG13 ' A' ' 24' ' ' ILE . 85.9 mt -62.55 -39.92 95.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.107 -0.995 . . . . 0.0 110.355 176.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.618 ' HB2' HG12 ' A' ' 9' ' ' ILE . . . -58.17 -48.65 79.62 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.095 -1.003 . . . . 0.0 110.186 -178.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -59.24 -49.08 79.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.281 -0.887 . . . . 0.0 110.159 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -70.0 -43.04 72.22 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.297 -0.877 . . . . 0.0 111.473 -176.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -80.07 -49.99 10.98 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.031 -1.043 . . . . 0.0 111.217 -173.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.649 ' O ' HG22 ' A' ' 39' ' ' ILE . 54.1 m -60.12 -39.91 87.89 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.053 -1.029 . . . . 0.0 111.064 -172.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.649 HG22 ' O ' ' A' ' 38' ' ' SER . 10.9 tp 39.02 28.95 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.528 -0.733 . . . . 0.0 110.375 -178.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.469 ' N ' ' O ' ' A' ' 38' ' ' SER . 17.5 p -122.8 160.16 50.29 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.328 -0.857 . . . . 0.0 109.823 -178.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -52.68 -20.68 12.99 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.84 1.442 . . . . 0.0 110.42 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.525 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -106.58 16.41 24.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.181 -0.949 . . . . 0.0 110.205 176.885 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.49 -51.41 5.61 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.611 -1.796 . . . . 0.0 108.611 172.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.468 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 48.5 tttp -60.02 -39.99 87.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.423 -1.045 . . . . 0.0 110.259 177.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.535 ' HA ' ' OD1' ' A' ' 48' ' ' ASP . 20.7 tpt180 -96.68 -42.05 8.21 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.369 -0.832 . . . . 0.0 110.479 -177.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -63.25 -28.98 73.12 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.94 0.16 53.13 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 176.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.535 ' OD1' ' HA ' ' A' ' 45' ' ' ARG . 43.8 p-10 -170.15 62.75 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.249 -1.147 . . . . 0.0 109.183 -177.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.864 HD12 ' CD2' ' A' ' 8' ' ' HIS . 10.3 mt -69.98 -29.23 66.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.398 -0.814 . . . . 0.0 110.749 -175.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.21 -145.06 17.49 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -178.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.406 ' HG3' ' C ' ' A' ' 4' ' ' ALA . 32.9 tt0 -112.27 136.38 51.77 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.19 -1.182 . . . . 0.0 110.217 -178.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.748 ' CZ ' ' HB3' ' A' ' 6' ' ' ALA . 0.1 OUTLIER -133.79 -166.1 1.73 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.299 -0.876 . . . . 0.0 109.705 174.411 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 . . . . . 0 N--CA 1.494 1.772 0 O-C-N 120.845 -1.159 . . . . 0.0 109.865 -178.576 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo . . . . . 0 N--CA 1.485 1.004 0 N-CA-C 110.408 -0.651 . . . . 0.0 110.408 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -44.8 -29.43 0.79 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.24 -0.912 . . . . 0.0 110.574 -179.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.8 ' CD1' HG21 ' A' ' 86' ' ' ILE . 59.4 t80 -60.01 -44.29 94.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.082 -1.011 . . . . 0.0 110.177 178.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -59.93 -42.0 93.02 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.05 -1.031 . . . . 0.0 109.549 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.493 ' O ' ' N ' ' A' ' 67' ' ' SER . 93.4 mttt -60.02 -47.42 85.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.512 -0.743 . . . . 0.0 111.011 -178.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.556 ' HB ' HD13 ' A' ' 77' ' ' LEU . 10.3 p -73.02 -46.57 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 120.872 -1.143 . . . . 0.0 110.98 -175.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.552 ' N ' HG13 ' A' ' 64' ' ' VAL . 9.8 p -60.2 -22.05 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.208 -1.558 . . . . 0.0 109.662 170.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -90.41 -13.62 34.59 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.85 -1.156 . . . . 0.0 109.366 171.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.511 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 12.4 t -87.5 -61.85 1.63 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.464 -0.773 . . . . 0.0 108.917 172.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.511 ' N ' ' O ' ' A' ' 64' ' ' VAL . 31.3 p -82.5 133.31 50.09 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 120.876 -1.14 . . . . 0.0 109.087 167.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.507 ' O ' ' NH1' ' A' ' 91' ' ' ARG . 41.3 Cg_exo -52.28 -68.66 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.713 1.375 . . . . 0.0 110.671 -174.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.005 HG22 HD12 ' A' ' 71' ' ' LEU . 7.6 p -179.01 162.16 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -177.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.005 HD12 HG22 ' A' ' 70' ' ' VAL . 3.3 mp 42.76 32.96 0.43 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.897 -1.127 . . . . 0.0 109.946 -170.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.487 ' CG ' ' O ' ' A' ' 70' ' ' VAL . 8.4 mm-40 -130.9 79.98 70.49 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.667 -0.646 . . . . 0.0 109.918 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -47.07 126.64 11.63 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 123.859 1.452 . . . . 0.0 110.012 -178.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.416 ' OG1' ' HB3' ' A' ' 68' ' ' CYS . 70.7 m -135.38 139.37 44.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.182 -0.949 . . . . 0.0 110.432 -176.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.94 -170.82 25.13 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.971 ' CD ' HD11 ' A' ' 21' ' ' LEU . 42.0 Cg_endo -69.53 136.46 38.39 Favored 'Cis proline' 0 C--N 1.314 -1.262 0 C-N-CA 121.767 -2.18 . . . . 0.0 110.455 0.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.556 HD13 ' HB ' ' A' ' 64' ' ' VAL . 1.0 OUTLIER -95.29 142.69 27.4 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.221 -0.924 . . . . 0.0 110.433 -175.017 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -64.75 130.06 42.12 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.107 -0.995 . . . . 0.0 110.633 -176.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.505 HG21 ' CE1' ' A' ' 84' ' ' HIS . 9.5 t -144.66 160.24 41.51 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.283 -0.886 . . . . 0.0 110.375 178.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.591 ' HG3' ' CD2' ' A' ' 81' ' ' PHE . 20.1 pt20 -63.06 -16.22 59.19 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.263 -0.898 . . . . 0.0 110.879 -177.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.591 ' CD2' ' HG3' ' A' ' 80' ' ' GLN . 98.4 m-85 -95.01 6.27 49.56 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.003 -1.061 . . . . 0.0 110.457 -178.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 126.39 -115.4 2.26 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 -175.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.469 ' HB3' ' HB2' ' A' ' 76' ' ' PRO . 69.2 m-85 -140.41 126.97 20.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.09 -1.241 . . . . 0.0 110.287 175.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.589 ' CD2' ' HG ' ' A' ' 10' ' ' LEU . 42.1 m170 -103.31 127.57 50.61 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.522 -0.736 . . . . 0.0 110.676 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.582 HG22 ' HB ' ' A' ' 9' ' ' ILE . 8.4 tt -109.15 129.59 63.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 120.605 -1.309 . . . . 0.0 109.065 166.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.8 HG21 ' CD1' ' A' ' 61' ' ' PHE . 72.2 mt -130.18 135.1 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.015 -1.053 . . . . 0.0 110.701 -169.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.646 ' HD3' HD12 ' A' ' 7' ' ' LEU . 12.5 mtpt -97.91 139.16 34.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.45 -0.781 . . . . 0.0 109.58 176.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.547 HG11 ' HA ' ' A' ' 70' ' ' VAL . 28.0 t -109.74 137.47 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.473 -0.767 . . . . 0.0 110.146 -178.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.609 ' HB2' ' HB3' ' A' ' 5' ' ' ALA . 92.3 mt -144.34 135.79 25.64 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.064 -1.022 . . . . 0.0 109.551 178.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.543 ' CD2' ' HB3' ' A' ' 89' ' ' LEU . 70.9 m-85 65.31 -63.42 0.2 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.332 -0.855 . . . . 0.0 111.076 177.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.507 ' NH1' ' O ' ' A' ' 69' ' ' PRO . 33.7 ttp180 . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.049 -1.032 . . . . 0.0 110.214 -175.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.494 1.774 0 CA-C-O 121.029 0.442 . . . . 0.0 109.972 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.54 ' O ' ' CD1' ' A' ' 52' ' ' PHE . . . -151.45 154.81 37.31 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.107 -0.995 . . . . 0.0 110.623 -174.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.529 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -101.32 140.0 36.22 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.009 -1.057 . . . . 0.0 109.14 171.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.727 ' HB3' ' CZ ' ' A' ' 52' ' ' PHE . . . -159.04 154.55 25.9 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.859 -1.151 . . . . 0.0 111.29 -178.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.803 HD12 ' HD2' ' A' ' 87' ' ' LYS . 82.2 mt -109.91 149.99 29.09 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.434 -0.791 . . . . 0.0 109.142 172.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.875 ' CD2' HD12 ' A' ' 49' ' ' LEU . 46.5 m-70 -137.2 133.55 35.29 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.789 -1.194 . . . . 0.0 111.383 -177.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.69 ' HB ' HG22 ' A' ' 85' ' ' ILE . 87.3 mt -120.01 120.99 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.113 -0.992 . . . . 0.0 109.605 168.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.782 HD13 ' C ' ' A' ' 10' ' ' LEU . 2.7 tm? -104.07 120.08 40.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.477 -0.765 . . . . 0.0 109.817 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.862 HG13 HD22 ' A' ' 16' ' ' LEU . 2.4 t -103.81 130.08 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.29 -0.881 . . . . 0.0 110.346 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -65.93 -40.08 91.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.459 -0.776 . . . . 0.0 110.551 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -119.54 140.02 51.2 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.126 -0.984 . . . . 0.0 110.531 -175.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.453 ' HB2' ' CE1' ' A' ' 83' ' ' TYR . 86.8 tt0 -59.91 -39.99 87.32 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.372 -0.83 . . . . 0.0 110.352 -178.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.6 mttt -52.46 -47.42 66.48 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.188 -0.945 . . . . 0.0 110.069 -176.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.862 HD22 HG13 ' A' ' 11' ' ' VAL . 8.4 tt -68.71 -37.07 79.22 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.104 -0.997 . . . . 0.0 109.546 176.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.665 ' HA ' HD23 ' A' ' 20' ' ' LEU . . . -56.94 -49.29 76.1 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.042 -1.036 . . . . 0.0 109.522 176.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.448 ' HA ' HD12 ' A' ' 21' ' ' LEU . 0.9 OUTLIER -58.31 -40.44 82.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.15 -0.969 . . . . 0.0 109.579 174.573 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.48 ' HB3' ' O ' ' A' ' 16' ' ' LEU . 51.5 t0 -60.0 -39.98 87.66 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.096 -1.002 . . . . 0.0 109.671 174.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 1.011 HD13 HD21 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -62.91 -44.27 96.55 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.16 -0.963 . . . . 0.0 109.668 178.125 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.841 HD21 ' HD3' ' A' ' 76' ' ' PRO . 1.3 mt -59.9 -50.14 74.93 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.381 -0.824 . . . . 0.0 110.07 -178.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -62.87 -39.92 95.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.314 -0.867 . . . . 0.0 110.247 177.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.451 ' O ' ' N ' ' A' ' 27' ' ' GLY . 64.9 tp60 -60.07 -40.95 91.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.305 -0.872 . . . . 0.0 110.311 -177.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.517 ' O ' ' N ' ' A' ' 28' ' ' ALA . 85.5 mt -67.32 -40.35 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.179 -0.95 . . . . 0.0 109.795 177.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -63.85 -59.96 3.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.139 -0.976 . . . . 0.0 109.598 176.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -60.32 -52.37 65.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.438 -0.789 . . . . 0.0 110.866 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 28' ' ' ALA . . . -106.18 -13.0 24.21 Favored Glycine 0 N--CA 1.487 2.041 0 C-N-CA 119.647 -1.263 . . . . 0.0 110.597 -166.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 24' ' ' ILE . . . 34.1 95.37 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.751 -0.853 . . . . 0.0 111.459 -177.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -171.68 86.35 0.09 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.466 -0.771 . . . . 0.0 109.827 -176.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.503 ' CG ' ' HE3' ' A' ' 87' ' ' LYS . 3.9 m-85 -69.8 -40.12 76.18 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.325 -0.859 . . . . 0.0 110.764 -176.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.36 -52.08 53.81 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -63.73 -41.1 98.12 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.185 -1.185 . . . . 0.0 110.513 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.011 HD21 HD13 ' A' ' 20' ' ' LEU . 33.0 tp -61.74 -50.06 73.91 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.074 -1.016 . . . . 0.0 110.716 -175.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.667 ' HB2' HG12 ' A' ' 9' ' ' ILE . . . -59.95 -47.88 83.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.198 -0.939 . . . . 0.0 110.383 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 50.3 mttm -60.02 -49.78 76.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.212 -0.93 . . . . 0.0 110.592 -176.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.456 ' O ' HG13 ' A' ' 39' ' ' ILE . 57.2 tptt -69.72 -52.5 24.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.156 -0.965 . . . . 0.0 111.235 -175.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.694 ' HB3' HD21 ' A' ' 16' ' ' LEU . 86.9 m-70 -83.21 -40.28 19.85 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.913 -1.117 . . . . 0.0 111.583 -170.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.483 ' HB3' ' O ' ' A' ' 34' ' ' ALA . 18.4 t -60.01 -45.2 93.54 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.973 -1.08 . . . . 0.0 110.443 -176.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.623 ' O ' HG22 ' A' ' 39' ' ' ILE . 80.2 mt 34.14 45.76 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 CA-C-O 121.322 0.582 . . . . 0.0 110.769 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.512 ' SG ' ' N ' ' A' ' 43' ' ' GLY . 17.2 p -133.91 160.04 70.09 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.254 -0.904 . . . . 0.0 110.093 -177.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.404 ' HD2' ' HB2' ' A' ' 40' ' ' CYS . 6.7 Cg_endo -54.02 -23.8 29.88 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.962 1.506 . . . . 0.0 110.522 -177.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.511 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -109.12 20.54 18.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.085 -1.009 . . . . 0.0 110.084 176.902 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.512 ' N ' ' SG ' ' A' ' 40' ' ' CYS . . . -79.11 -59.65 2.7 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 176.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -60.02 -33.91 72.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.41 -1.053 . . . . 0.0 110.39 176.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.458 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 16.0 tpt180 -91.57 -39.73 11.74 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.109 -0.994 . . . . 0.0 110.158 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -70.75 -29.02 69.9 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 177.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.97 0.54 58.06 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 173.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -168.76 63.34 0.06 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.291 -1.123 . . . . 0.0 109.134 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.875 HD12 ' CD2' ' A' ' 8' ' ' HIS . 12.7 mt -70.12 -28.89 65.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.599 -0.688 . . . . 0.0 110.155 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.27 -136.02 12.69 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.231 -1.547 . . . . 0.0 109.231 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -113.66 148.16 36.82 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.382 -1.069 . . . . 0.0 110.171 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.727 ' CZ ' ' HB3' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -131.45 160.41 35.23 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.205 -0.934 . . . . 0.0 109.879 -172.382 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 36.5 ptt-85 . . . . . 0 N--CA 1.494 1.756 0 O-C-N 121.297 -0.877 . . . . 0.0 110.468 -173.802 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 60' ' ' ALA . 32.9 Cg_endo . . . . . 0 N--CA 1.484 0.916 0 N-CA-C 111.059 -0.4 . . . . 0.0 111.059 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.5 ' O ' HG12 ' A' ' 64' ' ' VAL . . . -42.67 -34.64 0.93 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.116 -0.99 . . . . 0.0 110.469 -174.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.434 ' CE2' ' CE1' ' A' ' 52' ' ' PHE . 56.1 t80 -60.0 -44.07 94.79 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.233 -0.917 . . . . 0.0 110.092 -179.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.522 ' OD1' ' CD1' ' A' ' 66' ' ' PHE . 56.5 t0 -68.31 -45.26 73.48 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.295 -0.878 . . . . 0.0 110.553 -178.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' A' ' 67' ' ' SER . 11.3 tptt -56.36 -50.15 72.37 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.031 -1.043 . . . . 0.0 110.269 -176.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.522 ' HA ' ' HB3' ' A' ' 67' ' ' SER . 5.8 p -69.5 -46.73 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.089 -1.007 . . . . 0.0 111.443 -173.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.51 ' N ' HG13 ' A' ' 64' ' ' VAL . 6.8 p -58.15 -26.14 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.297 -1.502 . . . . 0.0 109.468 173.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.522 ' CD1' ' OD1' ' A' ' 62' ' ' ASP . 17.4 m-85 -96.2 -1.78 47.59 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.21 -0.931 . . . . 0.0 110.148 174.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.522 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 9.4 t -97.41 -59.03 1.87 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.348 -0.845 . . . . 0.0 109.67 173.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.536 ' CB ' ' HG1' ' A' ' 74' ' ' THR . 23.0 p -107.08 147.72 35.66 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.4 -0.813 . . . . 0.0 110.146 177.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -71.68 171.27 16.74 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 124.046 1.551 . . . . 0.0 110.682 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.066 HG22 HD12 ' A' ' 71' ' ' LEU . 7.1 p -58.7 158.6 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.465 -0.772 . . . . 0.0 110.145 178.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.066 HD12 HG22 ' A' ' 70' ' ' VAL . 3.2 mp 56.75 39.55 29.59 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.195 -0.941 . . . . 0.0 110.0 -175.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.419 ' C ' ' OE1' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -148.36 93.63 4.34 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.366 -0.834 . . . . 0.0 110.115 -179.907 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -63.15 130.52 29.13 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.981 1.516 . . . . 0.0 110.164 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.536 ' HG1' ' CB ' ' A' ' 68' ' ' CYS . 33.3 m -135.88 140.49 44.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.288 -0.882 . . . . 0.0 110.415 -178.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 149.16 -169.83 29.51 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.219 -1.553 . . . . 0.0 109.219 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.841 ' HD3' HD21 ' A' ' 21' ' ' LEU . 46.7 Cg_endo -76.03 136.36 44.24 Favored 'Cis proline' 0 C--N 1.313 -1.329 0 C-N-CA 121.825 -2.156 . . . . 0.0 110.663 -1.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 41.2 mt -93.36 -173.22 3.16 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.319 -0.863 . . . . 0.0 109.962 178.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -111.74 121.22 44.49 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.997 -1.064 . . . . 0.0 111.306 -173.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.478 HG21 ' CE1' ' A' ' 84' ' ' HIS . 9.8 t -138.06 164.28 29.48 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.274 -0.891 . . . . 0.0 109.438 170.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -54.92 -36.53 65.33 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.141 -0.975 . . . . 0.0 110.618 -175.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -63.13 -30.37 71.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.062 -1.024 . . . . 0.0 110.78 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 152.07 -135.58 5.06 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -177.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 10' ' ' LEU . 39.0 m-85 -93.98 131.12 39.76 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.35 -1.088 . . . . 0.0 109.96 177.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.558 ' CD2' HD23 ' A' ' 10' ' ' LEU . 0.1 OUTLIER -111.93 113.25 25.45 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.432 -0.792 . . . . 0.0 110.999 -178.863 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.713 HD13 HD11 ' A' ' 20' ' ' LEU . 4.5 tt -110.03 132.46 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.881 -1.137 . . . . 0.0 109.117 169.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.514 HG12 ' ND1' ' A' ' 8' ' ' HIS . 89.1 mt -135.98 140.12 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.598 -1.314 . . . . 0.0 111.899 -168.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.803 ' HD2' HD12 ' A' ' 7' ' ' LEU . 15.1 mttm -92.65 142.26 27.56 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.387 -0.821 . . . . 0.0 110.038 170.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.474 ' CG1' ' HD3' ' A' ' 91' ' ' ARG . 59.7 t -109.72 133.69 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.768 -0.582 . . . . 0.0 109.983 178.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.529 ' HB2' ' HB3' ' A' ' 5' ' ' ALA . 81.0 mt -141.89 129.09 20.99 Favored 'General case' 0 C--N 1.308 -1.2 0 O-C-N 121.005 -1.059 . . . . 0.0 109.947 -176.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.488 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 42.2 m-85 65.29 -55.29 0.32 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.228 -0.92 . . . . 0.0 111.587 173.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.527 ' NE ' ' HB ' ' A' ' 70' ' ' VAL . 84.6 mtm180 . . . . . 0 N--CA 1.495 1.792 0 O-C-N 121.037 -1.04 . . . . 0.0 110.894 -177.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.664 HG22 ' CB ' ' A' ' 53' ' ' ARG . 14.8 p . . . . . 0 N--CA 1.493 1.696 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.454 ' C ' ' HG3' ' A' ' 51' ' ' GLU . . . -149.96 153.61 36.88 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.839 -1.163 . . . . 0.0 111.029 -178.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.441 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -96.69 131.46 43.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.424 -0.798 . . . . 0.0 109.253 174.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.671 ' HB3' ' CZ ' ' A' ' 52' ' ' PHE . . . -147.41 122.73 10.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.834 -1.166 . . . . 0.0 111.688 -172.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.593 ' N ' ' CD1' ' A' ' 7' ' ' LEU . 3.5 mp -97.07 141.16 30.55 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.173 -0.954 . . . . 0.0 109.283 170.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.73 ' CD2' HD12 ' A' ' 49' ' ' LEU . 25.8 m-70 -134.54 128.17 32.78 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.887 -1.133 . . . . 0.0 110.947 -175.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.548 ' HB ' ' CG2' ' A' ' 85' ' ' ILE . 76.4 mt -109.96 129.96 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 120.882 -1.136 . . . . 0.0 110.136 168.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.597 ' HG ' ' CD2' ' A' ' 84' ' ' HIS . 0.3 OUTLIER -101.68 118.61 37.3 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.552 -0.717 . . . . 0.0 109.711 178.648 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.828 HG13 HD22 ' A' ' 16' ' ' LEU . 2.0 t -101.48 127.21 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.243 -0.911 . . . . 0.0 110.125 -177.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.1 mttp -69.28 -40.01 78.0 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.308 -0.87 . . . . 0.0 110.313 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -132.52 152.21 51.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.295 -0.878 . . . . 0.0 110.26 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.527 ' HG3' ' CZ ' ' A' ' 83' ' ' TYR . 95.2 mt-10 -59.04 -39.9 83.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.29 -0.881 . . . . 0.0 110.409 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -51.31 -44.62 61.97 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.191 -0.943 . . . . 0.0 110.34 -176.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.828 HD22 HG13 ' A' ' 11' ' ' VAL . 9.7 tt -68.89 -40.0 79.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.044 -1.035 . . . . 0.0 109.715 177.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.954 ' O ' HD12 ' A' ' 21' ' ' LEU . . . -59.87 -44.43 94.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.307 -0.871 . . . . 0.0 110.14 177.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.85 -45.8 89.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.218 -0.926 . . . . 0.0 109.819 178.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.49 ' O ' ' HB2' ' A' ' 23' ' ' GLN . 53.1 t0 -60.03 -42.2 93.86 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.345 -0.847 . . . . 0.0 110.187 177.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.727 ' C ' HD12 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -66.47 -43.56 85.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.147 -0.97 . . . . 0.0 110.047 -179.711 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.954 HD12 ' O ' ' A' ' 17' ' ' ALA . 0.3 OUTLIER -55.26 -59.93 4.1 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.38 -0.825 . . . . 0.0 110.072 -177.869 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -63.9 -40.0 95.48 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.394 -0.816 . . . . 0.0 110.707 177.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.574 ' HA ' ' OD1' ' A' ' 26' ' ' ASN . 62.2 tt0 -60.11 -29.49 68.64 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.118 -0.989 . . . . 0.0 110.185 -176.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.533 ' O ' ' CA ' ' A' ' 28' ' ' ALA . 91.6 mt -68.2 -40.01 82.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 120.687 -1.258 . . . . 0.0 109.606 173.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.4 tttp -66.69 -60.09 3.01 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.097 -1.002 . . . . 0.0 110.696 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.574 ' OD1' ' HA ' ' A' ' 23' ' ' GLN . 47.3 p30 -62.16 -33.68 74.96 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.105 -0.997 . . . . 0.0 110.501 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.758 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -106.23 -65.3 0.63 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.758 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 85.58 95.51 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.254 0 CA-C-O 121.624 0.725 . . . . 0.0 110.615 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -177.1 80.01 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.61 -0.681 . . . . 0.0 109.651 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.588 ' CG ' ' HE2' ' A' ' 87' ' ' LYS . 5.5 m-85 -60.1 -47.77 84.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.876 . . . . 0.0 110.903 -174.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.05 -50.33 68.8 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 119.715 -1.231 . . . . 0.0 110.045 -176.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -66.6 -40.04 88.66 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.131 -1.217 . . . . 0.0 110.78 -175.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.569 ' CD2' ' NE2' ' A' ' 23' ' ' GLN . 83.8 mt -66.3 -40.19 89.84 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.164 -0.96 . . . . 0.0 110.562 -178.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.529 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -60.06 -50.03 75.34 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.049 -1.032 . . . . 0.0 110.198 177.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -60.02 -49.95 75.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.229 -0.919 . . . . 0.0 111.158 -177.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.0 tttp -70.08 -45.17 67.6 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.005 -1.06 . . . . 0.0 111.165 -172.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -81.61 -32.02 32.19 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.101 -1.0 . . . . 0.0 110.832 -174.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.49 ' CB ' ' O ' ' A' ' 34' ' ' ALA . 27.5 t -60.19 -44.92 94.71 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.121 -0.987 . . . . 0.0 111.31 -173.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.627 ' O ' HG22 ' A' ' 39' ' ' ILE . 73.6 mt 44.69 25.93 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 120.904 -1.122 . . . . 0.0 109.762 -173.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.462 ' SG ' ' HD2' ' A' ' 41' ' ' PRO . 35.8 t -117.43 143.27 31.76 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.391 -0.818 . . . . 0.0 109.943 -178.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.462 ' HD2' ' SG ' ' A' ' 40' ' ' CYS . 52.7 Cg_exo -49.21 -20.92 3.85 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.849 1.447 . . . . 0.0 110.655 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.514 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -109.12 19.92 18.94 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.182 -0.949 . . . . 0.0 109.81 176.877 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' A' ' 47' ' ' GLY . . . -75.05 -59.46 3.65 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 174.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -60.05 -39.97 87.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.389 -1.066 . . . . 0.0 110.573 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -94.14 -42.3 9.06 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.924 -1.11 . . . . 0.0 110.413 -176.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -70.6 -24.52 76.8 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 174.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 43' ' ' GLY . . . -74.4 -1.0 59.76 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 173.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.436 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 49.0 t0 -173.06 70.29 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.352 -1.087 . . . . 0.0 109.122 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.73 HD12 ' CD2' ' A' ' 8' ' ' HIS . 11.9 mt -72.47 -6.59 44.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.633 -0.667 . . . . 0.0 110.156 -176.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 5' ' ' ALA . . . 76.55 -121.9 6.2 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -176.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.454 ' HG3' ' C ' ' A' ' 4' ' ' ALA . 71.3 tt0 -126.92 140.21 52.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.231 -1.158 . . . . 0.0 110.412 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.671 ' CZ ' ' HB3' ' A' ' 6' ' ' ALA . 2.4 p90 -142.63 169.16 18.09 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.302 -0.874 . . . . 0.0 110.263 178.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.664 ' CB ' HG22 ' A' ' 3' ' ' THR . 34.3 ptt180 . . . . . 0 N--CA 1.491 1.591 0 O-C-N 120.979 -1.076 . . . . 0.0 111.628 -172.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo . . . . . 0 C--O 1.215 -0.662 0 CA-C-O 121.009 0.337 . . . . 0.0 111.363 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.806 ' HB1' HD23 ' A' ' 77' ' ' LEU . . . -59.98 -39.25 85.06 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.034 -1.041 . . . . 0.0 110.334 -178.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.633 ' CD1' HG21 ' A' ' 86' ' ' ILE . 66.4 t80 -59.95 -37.85 80.74 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.321 -0.862 . . . . 0.0 110.344 -178.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.516 ' O ' HG12 ' A' ' 65' ' ' VAL . 55.2 t0 -59.96 -48.6 81.02 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.061 -1.025 . . . . 0.0 110.102 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.493 ' O ' ' HB2' ' A' ' 67' ' ' SER . 24.3 tptm -60.09 -51.13 70.93 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.048 -1.033 . . . . 0.0 110.46 178.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.687 HG11 HD12 ' A' ' 86' ' ' ILE . 8.8 p -70.26 -46.99 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.049 -1.032 . . . . 0.0 111.173 -174.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.578 ' N ' HG13 ' A' ' 64' ' ' VAL . 3.8 p -53.95 -28.87 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.59 -1.319 . . . . 0.0 109.268 174.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -95.62 -10.56 29.12 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.223 -0.923 . . . . 0.0 110.252 175.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.55 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 7.7 t -91.08 -69.23 0.74 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.246 -0.909 . . . . 0.0 109.951 176.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.486 ' CB ' ' HG1' ' A' ' 74' ' ' THR . 83.7 m -91.19 127.48 51.17 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.214 -0.929 . . . . 0.0 109.83 176.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.492 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 24.5 Cg_exo -58.69 160.95 16.05 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.797 1.42 . . . . 0.0 109.949 178.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.828 HG22 HD12 ' A' ' 71' ' ' LEU . 7.1 p -58.71 173.48 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.081 -1.012 . . . . 0.0 109.912 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.828 HD12 HG22 ' A' ' 70' ' ' VAL . 2.8 mp 58.7 19.7 7.07 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.298 -0.877 . . . . 0.0 109.964 -174.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.492 ' HB3' ' O ' ' A' ' 69' ' ' PRO . 4.1 tt0 -140.07 80.97 19.32 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.28 -0.888 . . . . 0.0 109.937 177.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.433 ' HG3' ' HG3' ' A' ' 87' ' ' LYS . 53.0 Cg_exo -48.88 131.88 25.81 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.948 1.499 . . . . 0.0 109.972 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.494 ' HB ' ' CG2' ' A' ' 64' ' ' VAL . 92.5 m -133.08 139.01 46.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.185 -0.947 . . . . 0.0 110.407 -176.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.441 ' HA3' HG13 ' A' ' 85' ' ' ILE . . . 145.71 -173.52 26.04 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.746 ' CD ' HD11 ' A' ' 21' ' ' LEU . 43.7 Cg_endo -75.24 137.59 51.01 Favored 'Cis proline' 0 C--N 1.314 -1.276 0 C-N-CA 121.791 -2.171 . . . . 0.0 110.538 -1.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.806 HD23 ' HB1' ' A' ' 60' ' ' ALA . 59.3 tp -96.53 156.35 16.38 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.243 -0.911 . . . . 0.0 110.45 -176.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -85.12 123.24 30.41 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.154 -0.966 . . . . 0.0 111.06 -175.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 1.037 HG21 ' CE1' ' A' ' 84' ' ' HIS . 10.3 t -141.53 164.93 28.89 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.269 -0.894 . . . . 0.0 109.806 173.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.501 ' CG ' ' CD2' ' A' ' 81' ' ' PHE . 20.1 pt20 -59.93 -31.62 70.02 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.044 -1.035 . . . . 0.0 111.016 -175.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.501 ' CD2' ' CG ' ' A' ' 80' ' ' GLN . 97.9 m-85 -75.91 -8.02 55.94 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.027 -1.045 . . . . 0.0 110.531 -176.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.441 ' O ' HG22 ' A' ' 79' ' ' THR . . . 137.47 -143.58 14.77 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 -175.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.527 ' CZ ' ' HG3' ' A' ' 14' ' ' GLU . 96.1 m-85 -107.32 122.35 46.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.899 -1.353 . . . . 0.0 109.89 174.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 1.037 ' CE1' HG21 ' A' ' 79' ' ' THR . 60.9 m170 -99.17 121.74 41.43 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.131 -0.981 . . . . 0.0 110.363 175.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.548 ' CG2' ' HB ' ' A' ' 9' ' ' ILE . 6.1 tt -107.68 121.66 60.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 C-N-CA 118.599 -1.24 . . . . 0.0 109.569 168.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.687 HD12 HG11 ' A' ' 64' ' ' VAL . 83.4 mt -114.1 130.02 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.241 -0.912 . . . . 0.0 111.081 -169.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.588 ' HE2' ' CG ' ' A' ' 30' ' ' PHE . 21.4 ttmm -98.04 126.58 43.54 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.106 -0.996 . . . . 0.0 109.258 169.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.522 HG12 HG23 ' A' ' 70' ' ' VAL . 61.9 t -106.54 134.93 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.296 -0.877 . . . . 0.0 110.204 -175.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.514 ' O ' ' N ' ' A' ' 91' ' ' ARG . 92.7 mt -140.13 161.31 37.95 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.348 -0.845 . . . . 0.0 109.131 -178.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.509 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 25.6 m-85 62.45 -61.45 0.12 Allowed 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.03 0.443 . . . . 0.0 111.04 177.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.514 ' N ' ' O ' ' A' ' 89' ' ' LEU . 14.1 tpt180 . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.001 -1.062 . . . . 0.0 110.209 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.562 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 27.3 p . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 121.08 0.467 . . . . 0.0 110.375 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.511 ' O ' ' HA ' ' A' ' 51' ' ' GLU . . . -109.95 151.24 27.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.097 -1.002 . . . . 0.0 109.886 175.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.65 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -90.76 122.69 33.71 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.699 -0.8 . . . . 0.0 109.651 -178.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.537 ' HB3' ' CE2' ' A' ' 52' ' ' PHE . . . -130.84 119.7 22.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.102 -0.999 . . . . 0.0 111.325 -172.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.613 HD12 ' HD2' ' A' ' 87' ' ' LYS . 83.2 mt -106.5 151.28 25.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.288 -0.882 . . . . 0.0 108.839 169.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.523 ' HB2' HG12 ' A' ' 86' ' ' ILE . 0.3 OUTLIER -168.66 170.53 9.38 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 118.287 -1.365 . . . . 0.0 112.158 -178.716 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.452 ' HB ' ' CG2' ' A' ' 85' ' ' ILE . 87.0 mt -139.97 138.81 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.876 -0.515 . . . . 0.0 109.65 178.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.588 ' HG ' ' CD2' ' A' ' 84' ' ' HIS . 0.5 OUTLIER -100.42 120.08 39.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.364 -0.835 . . . . 0.0 110.218 -178.731 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.969 HG13 HD22 ' A' ' 16' ' ' LEU . 2.4 t -112.74 128.44 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.204 -0.935 . . . . 0.0 109.964 178.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -69.43 -40.04 77.48 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.371 -0.831 . . . . 0.0 110.618 -178.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -130.43 155.81 45.79 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.023 -1.048 . . . . 0.0 110.728 -176.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.531 ' HG3' ' CZ ' ' A' ' 83' ' ' TYR . 95.7 mt-10 -60.09 -40.0 88.09 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.478 -0.764 . . . . 0.0 110.744 -178.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -55.4 -43.33 75.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.144 -0.973 . . . . 0.0 110.068 -175.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.969 HD22 HG13 ' A' ' 11' ' ' VAL . 5.9 tt -69.89 -41.01 75.32 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.086 -1.009 . . . . 0.0 109.378 174.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.933 ' O ' HD12 ' A' ' 21' ' ' LEU . . . -60.05 -41.32 92.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.407 -0.808 . . . . 0.0 110.098 175.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.463 HD12 ' O ' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -60.02 -42.27 94.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.329 -0.857 . . . . 0.0 109.474 178.051 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.477 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 47.8 t0 -59.94 -43.56 94.9 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.243 -0.91 . . . . 0.0 110.037 174.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.716 HD11 HD13 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -63.02 -46.78 85.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.113 -0.992 . . . . 0.0 109.79 179.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.933 HD12 ' O ' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -59.83 -49.94 75.74 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.395 -0.816 . . . . 0.0 110.185 -178.58 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -60.77 -43.13 98.43 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.326 -0.859 . . . . 0.0 110.637 -177.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.477 ' HG2' ' O ' ' A' ' 19' ' ' ASP . 96.5 mm-40 -60.59 -42.59 97.05 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.184 -0.948 . . . . 0.0 110.606 -177.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.505 ' O ' ' N ' ' A' ' 28' ' ' ALA . 88.1 mt -64.84 -44.09 96.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.15 -0.969 . . . . 0.0 109.937 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -61.08 -47.14 87.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.175 -0.953 . . . . 0.0 109.665 175.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -59.81 -60.93 3.05 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.43 -0.794 . . . . 0.0 110.331 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.755 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -105.21 -41.64 1.89 Allowed Glycine 0 N--CA 1.485 1.93 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -173.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.755 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 80.19 99.4 0.06 Allowed 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.837 -0.802 . . . . 0.0 110.075 -177.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.434 ' HB3' ' HB2' ' A' ' 32' ' ' LYS . 1.8 m-20 -175.7 82.82 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.273 -0.892 . . . . 0.0 110.177 -176.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.585 ' CG ' ' HE3' ' A' ' 87' ' ' LYS . 9.9 m-85 -65.87 -45.58 81.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.151 -0.968 . . . . 0.0 110.752 -178.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.09 -49.26 80.51 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -177.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.434 ' HB2' ' HB3' ' A' ' 29' ' ' ASP . 60.7 mttm -64.96 -40.0 94.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -1.169 . . . . 0.0 110.049 -177.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.572 HD21 ' HB2' ' A' ' 20' ' ' LEU . 63.2 tp -61.81 -40.24 94.55 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.226 -0.921 . . . . 0.0 110.352 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.518 ' O ' ' CB ' ' A' ' 38' ' ' SER . . . -60.03 -49.95 75.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.067 -1.021 . . . . 0.0 110.135 177.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -59.97 -43.63 94.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.774 -1.204 . . . . 0.0 110.689 -176.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.405 ' NZ ' ' HB3' ' A' ' 32' ' ' LYS . 43.5 mttp -69.95 -43.03 72.41 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.897 -1.127 . . . . 0.0 111.662 -175.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.452 ' O ' HG12 ' A' ' 39' ' ' ILE . 83.8 m-70 -105.77 -28.29 10.76 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.686 -1.259 . . . . 0.0 111.691 -169.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.52 ' O ' ' CG1' ' A' ' 39' ' ' ILE . 54.3 p -60.01 -44.29 94.65 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.724 -1.235 . . . . 0.0 110.763 -171.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.52 ' CG1' ' O ' ' A' ' 38' ' ' SER . 46.5 pt 36.31 31.63 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.614 -0.679 . . . . 0.0 110.918 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.479 ' N ' ' O ' ' A' ' 38' ' ' SER . 38.2 t -125.83 144.23 47.77 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.125 -0.984 . . . . 0.0 110.247 -175.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.465 ' HD2' ' SG ' ' A' ' 40' ' ' CYS . 58.1 Cg_exo -44.7 -24.85 1.28 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.819 1.431 . . . . 0.0 110.753 178.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.475 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 0.2 OUTLIER -109.88 19.79 18.7 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.142 -0.974 . . . . 0.0 110.196 178.566 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -95.63 -57.72 1.17 Allowed Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 175.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -59.93 -39.99 87.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.34 -1.094 . . . . 0.0 109.872 175.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 20.9 tpt180 -101.39 -37.15 8.59 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.328 -0.857 . . . . 0.0 110.58 -177.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.499 ' O ' ' CD2' ' A' ' 8' ' ' HIS . . . -82.88 -9.02 85.03 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -177.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.36 1.52 56.35 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 173.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.444 ' HA ' ' CD2' ' A' ' 7' ' ' LEU . 38.7 t0 -165.76 67.25 0.12 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.35 -1.088 . . . . 0.0 108.475 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.44 ' HG ' ' HA2' ' A' ' 46' ' ' GLY . 7.0 mt -69.99 -27.41 64.68 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.794 -0.566 . . . . 0.0 110.146 -175.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.34 -146.96 16.64 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.534 ' HG2' ' CB ' ' A' ' 3' ' ' THR . 49.9 tt0 -110.75 128.58 55.79 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.26 -1.141 . . . . 0.0 110.011 -178.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.537 ' CE2' ' HB3' ' A' ' 6' ' ' ALA . 3.5 p90 -144.88 -178.02 5.82 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.178 -0.951 . . . . 0.0 110.584 -176.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.562 ' HB2' ' HA ' ' A' ' 3' ' ' THR . 51.8 ttt-85 . . . . . 0 N--CA 1.495 1.789 0 O-C-N 120.93 -1.106 . . . . 0.0 110.23 173.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.477 ' O ' ' N ' ' A' ' 62' ' ' ASP . 29.0 Cg_endo . . . . . 0 N--CA 1.486 1.071 0 N-CA-C 110.709 -0.535 . . . . 0.0 110.709 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 59' ' ' PRO . . . -41.77 -37.39 1.22 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.381 -0.824 . . . . 0.0 110.029 -177.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.565 ' CE2' HG21 ' A' ' 65' ' ' VAL . 67.7 t80 -59.97 -43.66 94.95 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.308 -0.87 . . . . 0.0 110.056 177.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.477 ' N ' ' O ' ' A' ' 59' ' ' PRO . 54.0 t0 -60.0 -43.75 94.99 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.295 -0.878 . . . . 0.0 110.284 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 67' ' ' SER . 34.3 mttt -58.23 -50.02 75.05 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.163 -0.961 . . . . 0.0 109.735 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.537 ' HA ' ' HB3' ' A' ' 67' ' ' SER . 7.5 p -69.5 -41.32 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.451 -0.781 . . . . 0.0 110.763 -177.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.565 HG21 ' CE2' ' A' ' 61' ' ' PHE . 11.4 t -55.54 -31.85 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.727 -1.233 . . . . 0.0 108.929 171.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -102.37 10.32 39.16 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.621 -0.674 . . . . 0.0 110.258 177.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.537 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 8.1 t -103.27 -58.29 1.9 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.151 -0.968 . . . . 0.0 109.898 173.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.469 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 29.8 m -115.39 145.34 34.14 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.309 -0.869 . . . . 0.0 110.303 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.519 ' O ' ' N ' ' A' ' 71' ' ' LEU . 13.5 Cg_exo -64.98 76.52 0.21 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.807 1.425 . . . . 0.0 110.582 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.082 HG11 ' HG3' ' A' ' 91' ' ' ARG . 8.2 m 21.29 45.89 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.337 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 176.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.008 HD12 HG23 ' A' ' 70' ' ' VAL . 0.3 OUTLIER -166.55 46.86 0.07 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.45 -0.781 . . . . 0.0 110.057 178.259 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -170.66 123.97 0.6 Allowed Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.348 -0.845 . . . . 0.0 110.148 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -55.63 119.07 5.96 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.746 1.392 . . . . 0.0 110.196 178.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.424 ' OG1' ' SG ' ' A' ' 68' ' ' CYS . 74.9 m -126.61 128.35 46.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.197 -0.939 . . . . 0.0 110.219 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.44 ' HA3' HG13 ' A' ' 85' ' ' ILE . . . 145.85 -177.81 23.99 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.906 ' CD ' HD21 ' A' ' 21' ' ' LEU . 42.4 Cg_endo -71.02 161.61 89.44 Favored 'Cis proline' 0 C--N 1.313 -1.313 0 C-N-CA 121.754 -2.186 . . . . 0.0 110.463 -0.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.993 HD23 ' N ' ' A' ' 78' ' ' HIS . 8.0 tt -134.92 155.26 51.02 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.274 -0.891 . . . . 0.0 110.158 -175.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.993 ' N ' HD23 ' A' ' 77' ' ' LEU . 42.0 m80 -73.42 129.37 37.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.168 -0.958 . . . . 0.0 110.768 -176.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.776 HG21 ' CG ' ' A' ' 84' ' ' HIS . 9.0 t -144.2 163.42 33.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.367 -0.833 . . . . 0.0 109.848 175.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -60.0 -24.34 64.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.194 -0.941 . . . . 0.0 110.185 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.593 ' HB2' ' CE1' ' A' ' 84' ' ' HIS . 97.8 m-85 -86.68 -0.68 56.73 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.196 -0.94 . . . . 0.0 110.926 -175.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.695 ' O ' HG22 ' A' ' 79' ' ' THR . . . 123.64 -137.72 11.07 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 -174.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.531 ' CZ ' ' HG3' ' A' ' 14' ' ' GLU . 59.2 m-85 -100.16 130.04 46.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.1 -1.235 . . . . 0.0 109.948 173.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.776 ' CG ' HG21 ' A' ' 79' ' ' THR . 19.3 m170 -116.86 124.12 48.73 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.23 -0.918 . . . . 0.0 110.537 178.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.716 HD13 HD11 ' A' ' 20' ' ' LEU . 8.5 tt -110.07 130.06 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.925 -1.11 . . . . 0.0 109.596 170.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.523 HG12 ' HB2' ' A' ' 8' ' ' HIS . 20.5 mt -138.45 137.84 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.996 -1.065 . . . . 0.0 110.824 -172.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.613 ' HD2' HD12 ' A' ' 7' ' ' LEU . 15.8 ptpt -111.16 135.08 52.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.772 -1.205 . . . . 0.0 109.313 168.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.812 ' O ' HD23 ' A' ' 89' ' ' LEU . 37.6 t -110.49 144.17 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.253 -0.905 . . . . 0.0 110.345 -171.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.812 HD23 ' O ' ' A' ' 88' ' ' VAL . 63.2 mt -140.09 129.52 24.06 Favored 'General case' 0 C--N 1.31 -1.126 0 O-C-N 121.027 -1.046 . . . . 0.0 110.21 -175.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.554 ' CB ' ' O ' ' A' ' 89' ' ' LEU . 14.5 t80 81.27 -24.99 0.17 Allowed 'General case' 0 N--CA 1.507 2.391 0 O-C-N 121.4 -0.813 . . . . 0.0 111.833 169.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 1.082 ' HG3' HG11 ' A' ' 70' ' ' VAL . 7.0 ttm-85 . . . . . 0 N--CA 1.491 1.598 0 O-C-N 120.867 -1.146 . . . . 0.0 109.771 -175.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 46.0 p . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.227 0.537 . . . . 0.0 110.038 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.462 ' C ' ' HG3' ' A' ' 51' ' ' GLU . . . -134.59 142.26 46.88 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.166 -0.959 . . . . 0.0 110.241 178.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.683 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -93.44 119.97 33.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.242 -0.911 . . . . 0.0 108.952 175.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.693 ' HB3' ' CZ ' ' A' ' 52' ' ' PHE . . . -134.32 119.3 18.51 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.637 -1.289 . . . . 0.0 111.505 -168.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.6 ' N ' ' CD1' ' A' ' 7' ' ' LEU . 4.2 mp -96.63 146.98 24.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.177 -0.952 . . . . 0.0 109.288 171.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.616 ' NE2' ' HB1' ' A' ' 6' ' ' ALA . 56.2 m-70 -137.85 126.39 23.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.05 -1.031 . . . . 0.0 110.624 -176.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.774 ' HB ' HG22 ' A' ' 85' ' ' ILE . 68.8 mt -103.18 125.6 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 120.868 -1.145 . . . . 0.0 109.714 169.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.777 HD13 ' C ' ' A' ' 10' ' ' LEU . 2.7 tm? -103.43 119.98 39.94 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.605 -0.685 . . . . 0.0 109.684 177.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.942 HG13 HD22 ' A' ' 16' ' ' LEU . 3.0 t -111.84 132.34 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.319 -0.863 . . . . 0.0 110.286 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -65.99 -40.01 90.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.377 -0.827 . . . . 0.0 110.399 179.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -119.78 139.24 52.63 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.139 -0.976 . . . . 0.0 110.822 -173.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.455 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 88.4 tt0 -60.04 -47.22 86.76 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.556 -0.715 . . . . 0.0 111.282 -177.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.3 mttp -53.31 -36.54 61.36 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.14 -0.975 . . . . 0.0 110.185 -173.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.942 HD22 HG13 ' A' ' 11' ' ' VAL . 8.4 tt -65.26 -40.07 93.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.254 -0.904 . . . . 0.0 109.419 176.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.768 ' HB1' ' HG3' ' A' ' 76' ' ' PRO . . . -58.97 -46.46 88.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.384 -0.823 . . . . 0.0 109.994 176.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.98 -44.62 94.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.235 -0.916 . . . . 0.0 109.874 177.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -59.97 -43.41 95.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.147 -0.971 . . . . 0.0 109.754 175.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.478 ' O ' HG12 ' A' ' 24' ' ' ILE . 2.6 tp -64.14 -45.55 88.0 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.43 -0.793 . . . . 0.0 109.948 177.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.67 HD11 ' CD1' ' A' ' 85' ' ' ILE . 1.9 mp -57.99 -49.58 76.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.38 -0.825 . . . . 0.0 109.866 -174.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -61.03 -37.0 81.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.274 -0.891 . . . . 0.0 109.689 172.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.464 ' HB3' ' O ' ' A' ' 20' ' ' LEU . 60.5 tt0 -59.96 -34.79 73.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.456 -0.777 . . . . 0.0 110.443 -174.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.533 HD13 ' CD1' ' A' ' 33' ' ' LEU . 45.4 mm -59.92 -49.57 83.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.092 -1.005 . . . . 0.0 109.325 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -60.68 -46.43 90.4 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.097 -1.002 . . . . 0.0 109.789 178.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -60.08 -53.25 60.04 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.291 -0.88 . . . . 0.0 110.327 177.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.758 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -104.48 -54.71 0.77 Allowed Glycine 0 N--CA 1.486 1.992 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -173.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.758 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 79.19 95.03 0.06 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.862 -0.787 . . . . 0.0 110.58 178.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.485 ' OD2' ' HD2' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -177.6 80.42 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.422 -0.799 . . . . 0.0 109.751 -178.814 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.578 ' CG ' ' HD2' ' A' ' 87' ' ' LYS . 11.9 m-85 -60.09 -49.97 75.56 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.319 -0.863 . . . . 0.0 111.187 -174.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.08 -50.13 58.94 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.722 -1.228 . . . . 0.0 110.126 -174.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.485 ' HD2' ' OD2' ' A' ' 29' ' ' ASP . 32.3 mttm -66.57 -40.01 88.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.086 -1.244 . . . . 0.0 110.383 -175.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.533 ' CD1' HD13 ' A' ' 24' ' ' ILE . 67.7 mt -66.44 -40.01 89.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.062 -1.024 . . . . 0.0 110.477 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.554 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -59.22 -51.91 67.94 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.087 -1.008 . . . . 0.0 110.082 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -60.14 -45.84 91.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.327 -0.858 . . . . 0.0 110.722 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -68.32 -47.38 67.7 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.11 -0.994 . . . . 0.0 110.848 -175.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.487 ' HE1' HD22 ' A' ' 33' ' ' LEU . 35.4 m170 -74.79 -45.18 45.31 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.148 -0.97 . . . . 0.0 110.765 -175.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.563 ' O ' HG22 ' A' ' 39' ' ' ILE . 25.4 t -60.39 -46.27 90.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.203 -0.935 . . . . 0.0 110.133 -179.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.563 HG22 ' O ' ' A' ' 38' ' ' SER . 13.3 tt 36.02 30.04 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-O 121.445 0.64 . . . . 0.0 110.774 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.517 ' N ' ' O ' ' A' ' 38' ' ' SER . 14.2 p -121.56 171.63 5.91 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.286 -0.884 . . . . 0.0 110.024 -178.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.485 ' HD2' ' HB2' ' A' ' 40' ' ' CYS . 43.7 Cg_exo -48.94 -31.35 20.0 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.647 1.341 . . . . 0.0 110.352 -177.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.6 OUTLIER -101.65 15.11 29.96 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.306 -0.871 . . . . 0.0 110.028 177.788 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.29 -58.86 3.78 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.754 -1.738 . . . . 0.0 108.754 174.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.1 tptt -59.91 -40.08 87.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -1.114 . . . . 0.0 110.551 177.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.469 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 11.1 tpt180 -98.29 -41.1 8.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.085 -1.009 . . . . 0.0 110.567 -175.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -70.24 -30.33 69.58 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -178.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.48 -5.56 50.57 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.417 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 25.1 t0 -172.67 72.16 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.332 -1.099 . . . . 0.0 108.586 179.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.542 HD12 ' CD2' ' A' ' 8' ' ' HIS . 6.8 mt -70.03 -27.1 64.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.456 -0.777 . . . . 0.0 110.177 -173.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 113.58 -154.71 16.78 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.462 ' HG3' ' C ' ' A' ' 4' ' ' ALA . 84.6 tt0 -106.55 129.83 54.43 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.291 -1.123 . . . . 0.0 109.845 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.693 ' CZ ' ' HB3' ' A' ' 6' ' ' ALA . 0.1 OUTLIER -131.57 173.47 11.08 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.051 -1.031 . . . . 0.0 110.704 178.044 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 20.6 ptt180 . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.323 -0.861 . . . . 0.0 110.229 179.308 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.485 0.975 0 CA-C-O 121.049 0.354 . . . . 0.0 111.286 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.09 -38.45 79.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.009 -1.057 . . . . 0.0 109.938 -178.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.539 ' HD2' HG21 ' A' ' 86' ' ' ILE . 63.2 t80 -59.99 -38.79 83.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.268 -0.895 . . . . 0.0 110.282 174.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.44 ' O ' HG12 ' A' ' 65' ' ' VAL . 48.8 t0 -60.03 -43.75 95.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.204 -0.935 . . . . 0.0 110.117 -176.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 67' ' ' SER . 23.6 tttm -60.07 -47.03 87.58 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.216 -0.927 . . . . 0.0 110.417 177.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.658 HG11 HD12 ' A' ' 86' ' ' ILE . 13.1 p -79.25 -44.47 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.024 -1.047 . . . . 0.0 111.347 -173.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.548 ' N ' HG13 ' A' ' 64' ' ' VAL . 4.4 p -53.56 -25.8 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.361 -1.462 . . . . 0.0 109.008 173.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -94.97 -13.22 25.5 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.513 -0.742 . . . . 0.0 109.939 176.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.526 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 8.0 t -93.38 -61.65 1.52 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.354 -0.841 . . . . 0.0 110.053 177.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 78.6 m -99.98 132.01 23.47 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.38 -0.825 . . . . 0.0 110.272 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.498 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 12.1 Cg_endo -61.31 159.93 29.08 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.861 1.453 . . . . 0.0 110.082 178.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.981 HG23 HG12 ' A' ' 88' ' ' VAL . 8.1 p -60.46 177.41 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.198 -0.939 . . . . 0.0 109.891 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.833 HD12 HG13 ' A' ' 70' ' ' VAL . 4.7 mp 45.48 40.02 5.25 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.639 -1.288 . . . . 0.0 109.981 -168.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.498 ' HB3' ' O ' ' A' ' 69' ' ' PRO . 0.4 OUTLIER -150.57 89.65 4.4 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.384 -0.822 . . . . 0.0 109.729 175.497 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -59.26 126.55 21.19 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.827 1.435 . . . . 0.0 109.782 -177.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.433 HG21 HG23 ' A' ' 64' ' ' VAL . 53.3 m -130.7 136.72 49.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.095 -1.003 . . . . 0.0 110.453 -177.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.459 ' HA3' HG13 ' A' ' 85' ' ' ILE . . . 152.27 -171.38 31.54 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -178.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.768 ' HG3' ' HB1' ' A' ' 17' ' ' ALA . 41.7 Cg_endo -84.77 134.03 19.45 Favored 'Cis proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.209 -1.996 . . . . 0.0 110.42 3.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 74.8 mt -93.0 -178.52 4.82 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.254 -0.904 . . . . 0.0 110.735 -172.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -102.66 125.37 49.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.072 -1.018 . . . . 0.0 110.712 -176.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.898 HG21 ' CD2' ' A' ' 84' ' ' HIS . 12.5 t -140.05 162.43 35.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.428 -0.795 . . . . 0.0 109.813 176.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -60.05 -39.95 87.72 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.101 -0.999 . . . . 0.0 110.364 -178.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -70.31 -5.56 28.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.208 -0.933 . . . . 0.0 110.61 -177.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.65 ' O ' HG22 ' A' ' 79' ' ' THR . . . 134.43 -137.47 9.3 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.46 ' O ' ' HA ' ' A' ' 10' ' ' LEU . 75.1 m-85 -96.1 130.67 43.07 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.165 -1.197 . . . . 0.0 110.241 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.898 ' CD2' HG21 ' A' ' 79' ' ' THR . 6.0 m170 -107.89 112.43 25.04 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.674 -0.641 . . . . 0.0 110.643 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.774 HG22 ' HB ' ' A' ' 9' ' ' ILE . 2.5 tt -104.86 120.32 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.527 -1.358 . . . . 0.0 109.076 167.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.658 HD12 HG11 ' A' ' 64' ' ' VAL . 88.2 mt -110.02 130.02 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.936 -1.103 . . . . 0.0 111.298 -169.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.813 ' NZ ' HD21 ' A' ' 89' ' ' LEU . 63.0 tttm -101.71 126.41 48.56 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 172.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.981 HG12 HG23 ' A' ' 70' ' ' VAL . 24.5 t -103.42 136.46 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.13 -0.981 . . . . 0.0 110.297 -176.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.813 HD21 ' NZ ' ' A' ' 87' ' ' LYS . 58.0 mt -130.58 119.91 23.22 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.416 -0.802 . . . . 0.0 109.349 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.528 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 44.3 m-85 72.55 -58.9 0.58 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.648 -0.658 . . . . 0.0 110.856 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.443 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 67.1 ttp85 . . . . . 0 N--CA 1.494 1.728 0 O-C-N 121.234 -0.916 . . . . 0.0 110.622 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 91' ' ' ARG . 35.6 p . . . . . 0 N--CA 1.494 1.735 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.523 ' HB3' ' CE1' ' A' ' 52' ' ' PHE . . . -109.88 131.24 55.24 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.173 -0.955 . . . . 0.0 110.549 -175.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.563 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -99.32 122.05 41.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.405 -0.809 . . . . 0.0 109.64 177.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.86 ' HB1' ' NE2' ' A' ' 8' ' ' HIS . . . -140.05 132.03 27.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.856 -1.153 . . . . 0.0 111.212 -175.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.984 HD12 ' HD2' ' A' ' 87' ' ' LYS . 86.7 mt -98.32 139.78 33.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.138 -0.976 . . . . 0.0 108.806 168.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.86 ' NE2' ' HB1' ' A' ' 6' ' ' ALA . 34.7 m-70 -135.17 117.97 16.15 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.805 -1.185 . . . . 0.0 110.754 -177.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.761 ' HB ' HG22 ' A' ' 85' ' ' ILE . 92.6 mt -105.17 126.62 60.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.35 -0.844 . . . . 0.0 109.869 172.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.591 ' HG ' ' CD2' ' A' ' 84' ' ' HIS . 0.3 OUTLIER -101.8 117.94 35.89 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.561 -0.712 . . . . 0.0 109.898 -179.757 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.731 HG13 HD22 ' A' ' 16' ' ' LEU . 2.2 t -108.23 125.3 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.229 -0.919 . . . . 0.0 109.747 177.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.2 mmtp -68.48 -39.39 81.38 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.44 -0.788 . . . . 0.0 110.17 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -111.43 138.11 48.35 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.186 -0.946 . . . . 0.0 110.699 -178.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.66 ' HG2' HD12 ' A' ' 18' ' ' LEU . 88.8 tt0 -59.97 -42.12 93.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.366 -0.833 . . . . 0.0 109.939 177.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -56.94 -40.53 76.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.395 -0.816 . . . . 0.0 110.139 -178.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.731 HD22 HG13 ' A' ' 11' ' ' VAL . 5.5 tt -68.82 -40.04 79.72 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.025 -1.047 . . . . 0.0 109.301 174.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.997 ' O ' HD12 ' A' ' 21' ' ' LEU . . . -59.95 -40.72 89.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.386 -0.821 . . . . 0.0 110.021 175.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.66 HD12 ' HG2' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -59.94 -41.67 92.37 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.15 -0.969 . . . . 0.0 109.695 175.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -60.03 -44.75 94.42 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.32 -0.863 . . . . 0.0 110.246 176.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.71 ' C ' HD12 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -64.11 -43.74 94.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.075 -1.015 . . . . 0.0 109.544 178.51 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.997 HD12 ' O ' ' A' ' 17' ' ' ALA . 0.3 OUTLIER -56.19 -49.92 72.67 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.499 -0.75 . . . . 0.0 109.697 -179.588 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -61.7 -40.01 93.51 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.391 -0.818 . . . . 0.0 110.134 175.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.419 ' O ' ' N ' ' A' ' 27' ' ' GLY . 70.0 tp60 -60.1 -39.9 87.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.271 -0.893 . . . . 0.0 110.945 -174.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.518 ' O ' ' N ' ' A' ' 28' ' ' ALA . 96.7 mt -62.76 -40.55 89.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.104 -0.997 . . . . 0.0 110.289 -176.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -65.42 -58.75 5.09 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.964 -1.085 . . . . 0.0 110.067 175.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -60.05 -39.96 87.78 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.34 -0.85 . . . . 0.0 110.799 178.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.732 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -104.0 -63.03 0.68 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -176.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.732 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 81.79 93.04 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.175 0 O-C-N 122.06 -0.671 . . . . 0.0 110.508 178.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 179.74 78.32 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.423 -0.798 . . . . 0.0 109.952 -178.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.525 ' CZ ' HG23 ' A' ' 85' ' ' ILE . 17.1 t80 -61.12 -39.98 92.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.318 -0.864 . . . . 0.0 110.72 -174.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.435 ' O ' ' HG3' ' A' ' 35' ' ' LYS . . . -66.01 -53.65 29.04 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -176.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.463 ' HE3' ' HE3' ' A' ' 36' ' ' LYS . 82.5 tttt -64.8 -41.55 95.72 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.111 -1.229 . . . . 0.0 110.523 -178.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 85.7 mt -65.89 -40.04 91.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.238 -0.914 . . . . 0.0 109.931 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.548 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -60.25 -48.87 79.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.365 -0.835 . . . . 0.0 110.347 178.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.435 ' HG3' ' O ' ' A' ' 31' ' ' GLY . 72.4 mttt -59.99 -46.34 89.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 0.0 110.391 -175.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.463 ' HE3' ' HE3' ' A' ' 32' ' ' LYS . 41.5 mttt -69.41 -50.82 42.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.094 -1.004 . . . . 0.0 111.074 -176.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 53.9 m170 -70.05 -39.97 75.4 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.124 -0.985 . . . . 0.0 111.073 -173.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.655 ' O ' HG22 ' A' ' 39' ' ' ILE . 14.5 t -59.99 -45.6 92.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.037 -1.04 . . . . 0.0 110.313 -175.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.655 HG22 ' O ' ' A' ' 38' ' ' SER . 20.4 tt 38.73 34.18 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.589 -0.695 . . . . 0.0 110.603 178.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.483 ' HB2' ' HD2' ' A' ' 41' ' ' PRO . 15.0 p -127.36 165.68 27.91 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.288 -0.883 . . . . 0.0 109.764 -178.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' A' ' 40' ' ' CYS . 2.0 Cg_endo -49.2 -33.24 27.29 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.626 1.329 . . . . 0.0 110.172 179.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.2 OUTLIER -92.8 8.69 38.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.145 -0.972 . . . . 0.0 110.308 176.834 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.422 ' HA2' ' OG ' ' A' ' 38' ' ' SER . . . -56.17 -54.45 35.5 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.591 -1.804 . . . . 0.0 108.591 177.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -61.22 -39.97 92.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.355 -1.085 . . . . 0.0 110.658 175.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.541 ' HG3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -94.16 -68.91 0.78 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.124 -0.985 . . . . 0.0 110.353 -173.589 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -52.82 -38.12 53.44 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.95 -5.52 52.87 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 176.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.482 ' HA ' ' CD2' ' A' ' 7' ' ' LEU . 50.2 t0 -172.34 71.12 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.35 -1.088 . . . . 0.0 108.856 178.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.541 HD23 ' HG3' ' A' ' 45' ' ' ARG . 7.0 mt -69.85 -25.26 63.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.544 -0.722 . . . . 0.0 109.911 -174.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' A' ' 5' ' ' ALA . . . 82.79 -137.69 17.04 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.074 -1.611 . . . . 0.0 109.074 -178.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.516 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 1.8 mt-10 -102.27 129.65 48.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.443 -1.033 . . . . 0.0 110.635 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.655 ' CE2' ' HB3' ' A' ' 6' ' ' ALA . 1.5 p90 -134.62 159.2 41.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.544 -0.722 . . . . 0.0 109.799 178.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.448 ' HG2' HG22 ' A' ' 3' ' ' THR . 78.1 mtm180 . . . . . 0 N--CA 1.492 1.671 0 O-C-N 120.839 -1.163 . . . . 0.0 111.352 -170.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo . . . . . 0 C--O 1.215 -0.66 0 CA-C-O 121.052 0.355 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.562 ' HB2' ' HB ' ' A' ' 79' ' ' THR . . . -61.81 -42.69 99.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.091 -1.006 . . . . 0.0 110.553 178.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -60.06 -40.17 88.55 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.141 -0.975 . . . . 0.0 110.647 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.492 ' O ' HG12 ' A' ' 65' ' ' VAL . 54.8 t0 -63.34 -42.85 98.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.012 -1.055 . . . . 0.0 109.69 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -57.7 -55.77 30.61 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.285 -0.885 . . . . 0.0 110.266 178.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.626 HG11 HD12 ' A' ' 86' ' ' ILE . 2.7 p -70.0 -43.83 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.016 -1.052 . . . . 0.0 111.775 -172.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.492 HG12 ' O ' ' A' ' 62' ' ' ASP . 4.8 p -55.26 -27.11 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.223 -1.548 . . . . 0.0 108.94 174.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.452 ' HB2' ' O ' ' A' ' 62' ' ' ASP . 0.1 OUTLIER -94.97 -8.7 36.21 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.261 -0.899 . . . . 0.0 110.582 175.468 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.524 ' HB2' ' HA ' ' A' ' 64' ' ' VAL . 24.1 m -93.19 -41.89 9.66 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.003 -1.06 . . . . 0.0 110.042 176.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 88.2 m -120.71 150.58 52.87 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.166 -0.959 . . . . 0.0 110.205 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -73.41 156.34 50.29 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.977 1.514 . . . . 0.0 109.955 178.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.981 HG22 HD12 ' A' ' 71' ' ' LEU . 7.2 p -58.03 172.63 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.171 -0.956 . . . . 0.0 109.855 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.981 HD12 HG22 ' A' ' 70' ' ' VAL . 3.6 mp 57.44 39.78 27.8 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.413 -0.804 . . . . 0.0 110.077 -174.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -155.84 117.28 2.28 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.116 -0.99 . . . . 0.0 110.394 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 87' ' ' LYS . 30.6 Cg_endo -68.98 132.74 25.25 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.828 1.436 . . . . 0.0 110.182 179.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.522 HG21 HG23 ' A' ' 64' ' ' VAL . 87.0 m -139.58 147.15 40.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.157 -0.965 . . . . 0.0 110.295 -178.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.469 ' HA3' ' HA ' ' A' ' 85' ' ' ILE . . . 134.44 -176.11 20.07 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -178.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.853 ' CD ' HD11 ' A' ' 21' ' ' LEU . 44.1 Cg_endo -74.57 135.97 42.86 Favored 'Cis proline' 0 C--N 1.314 -1.271 0 C-N-CA 121.79 -2.171 . . . . 0.0 110.557 -0.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.462 HD23 ' HB1' ' A' ' 60' ' ' ALA . 59.8 tp -94.94 155.08 16.91 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.26 -0.9 . . . . 0.0 110.435 -178.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -77.89 119.74 21.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -0.891 . . . . 0.0 110.459 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.674 HG22 ' O ' ' A' ' 82' ' ' GLY . 10.8 t -134.21 165.57 24.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.214 -0.929 . . . . 0.0 109.55 173.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -59.97 -39.58 86.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.113 -0.992 . . . . 0.0 110.047 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -66.75 -11.55 55.15 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.226 -0.921 . . . . 0.0 110.717 -177.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.674 ' O ' HG22 ' A' ' 79' ' ' THR . . . 132.32 -139.75 11.22 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 -176.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.576 ' CE2' ' HB2' ' A' ' 14' ' ' GLU . 75.5 m-85 -102.64 122.14 43.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.108 -1.23 . . . . 0.0 110.291 178.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.626 ' CE1' HG21 ' A' ' 79' ' ' THR . 41.2 m170 -104.98 122.64 46.27 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.196 -0.94 . . . . 0.0 110.422 175.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.761 HG22 ' HB ' ' A' ' 9' ' ' ILE . 3.5 tt -103.52 119.23 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 118.376 -1.329 . . . . 0.0 109.361 167.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.724 HG23 ' CE1' ' A' ' 8' ' ' HIS . 85.5 mt -114.77 130.02 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.095 -1.003 . . . . 0.0 110.707 -170.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.984 ' HD2' HD12 ' A' ' 7' ' ' LEU . 34.9 ttmt -96.96 126.08 41.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.135 -0.978 . . . . 0.0 109.164 171.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.565 HG12 HG23 ' A' ' 70' ' ' VAL . 48.5 t -107.61 123.19 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.382 -0.824 . . . . 0.0 109.959 -175.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.563 ' HB2' ' HB3' ' A' ' 5' ' ' ALA . 60.1 mt -134.36 113.04 11.5 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.522 -0.736 . . . . 0.0 109.317 -176.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.545 ' CB ' ' O ' ' A' ' 89' ' ' LEU . 2.9 m-85 81.91 -43.37 0.16 Allowed 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.718 -0.614 . . . . 0.0 110.444 -178.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.472 ' O ' ' O ' ' A' ' 3' ' ' THR . 4.4 ttm180 . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.082 -1.011 . . . . 0.0 109.983 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.511 HG22 ' HG2' ' A' ' 53' ' ' ARG . 19.3 p . . . . . 0 N--CA 1.494 1.732 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -140.16 142.81 35.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.913 -1.117 . . . . 0.0 110.732 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.431 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -97.24 126.98 42.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.267 -0.895 . . . . 0.0 108.907 171.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.582 ' CB ' ' NE2' ' A' ' 8' ' ' HIS . . . -136.67 130.82 32.72 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.661 -1.274 . . . . 0.0 112.112 -168.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.511 ' C ' ' CD2' ' A' ' 8' ' ' HIS . 75.2 mt -103.48 144.42 31.42 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.263 -0.898 . . . . 0.0 109.411 167.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.977 ' CD2' HD12 ' A' ' 49' ' ' LEU . 10.0 m-70 -136.28 142.59 43.95 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.797 -1.19 . . . . 0.0 111.121 -175.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.565 ' HB ' ' CG2' ' A' ' 85' ' ' ILE . 96.7 mt -129.14 131.9 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.133 -0.98 . . . . 0.0 109.953 170.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.552 HD23 ' N ' ' A' ' 11' ' ' VAL . 0.3 OUTLIER -103.27 121.9 43.66 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.507 -0.746 . . . . 0.0 110.068 179.382 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.725 HG13 HD22 ' A' ' 16' ' ' LEU . 2.7 t -110.25 133.15 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.088 -1.008 . . . . 0.0 110.142 178.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.2 mttt -68.33 -40.02 81.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.238 -0.914 . . . . 0.0 110.646 -178.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -120.14 142.0 49.34 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.152 -0.968 . . . . 0.0 110.977 -176.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.583 ' HB2' ' CZ ' ' A' ' 83' ' ' TYR . 88.6 tt0 -59.99 -42.99 95.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.447 -0.783 . . . . 0.0 110.172 178.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -57.47 -40.06 77.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.682 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.725 HD22 HG13 ' A' ' 11' ' ' VAL . 5.5 tt -67.99 -40.28 83.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.2 -0.938 . . . . 0.0 109.704 177.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.6 ' N ' HG11 ' A' ' 11' ' ' VAL . . . -59.94 -44.1 94.59 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -0.933 . . . . 0.0 110.061 175.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.408 ' CD1' ' HG2' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -60.01 -43.24 95.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.303 -0.873 . . . . 0.0 109.707 175.829 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -59.99 -41.46 92.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.312 -0.867 . . . . 0.0 109.586 174.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.0 tp -63.08 -45.47 91.99 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.573 0.702 . . . . 0.0 109.88 176.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.676 HD11 ' CD1' ' A' ' 85' ' ' ILE . 2.4 mp -59.96 -44.98 94.1 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.659 -0.651 . . . . 0.0 110.376 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.5 tp10 -60.59 -40.07 90.4 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.421 -0.8 . . . . 0.0 110.411 -178.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -60.39 -41.14 93.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.277 -0.89 . . . . 0.0 110.133 -177.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.81 HG13 HD13 ' A' ' 33' ' ' LEU . 24.8 mt -67.14 -43.09 88.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.36 -0.837 . . . . 0.0 110.801 -178.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -60.2 -47.97 83.73 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.869 -1.145 . . . . 0.0 110.395 -175.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.7 -62.55 1.79 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.004 -1.06 . . . . 0.0 110.345 176.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.743 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -105.76 -39.23 2.22 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -172.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.743 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 81.47 -176.79 0.05 Allowed 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.811 -0.817 . . . . 0.0 109.623 -173.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.618 ' CB ' ' O ' ' A' ' 28' ' ' ALA . 95.9 m-20 115.11 71.84 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.954 0 C-N-CA 124.822 1.249 . . . . 0.0 109.623 -175.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.594 ' CG ' ' HE3' ' A' ' 87' ' ' LYS . 7.6 m-85 -63.42 -39.77 95.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.266 -0.897 . . . . 0.0 110.32 176.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.64 -55.75 28.16 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 -177.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.2 mttp -66.52 -40.62 89.27 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.923 -1.339 . . . . 0.0 110.912 -176.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.81 HD13 HG13 ' A' ' 24' ' ' ILE . 34.9 mt -66.59 -40.06 88.7 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.045 -1.035 . . . . 0.0 110.19 -179.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.546 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -59.98 -46.2 90.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.096 -1.003 . . . . 0.0 110.029 177.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -60.06 -48.89 79.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.273 -0.892 . . . . 0.0 110.44 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -64.11 -46.57 83.62 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.181 -0.949 . . . . 0.0 110.941 -174.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.4 ' CE1' HD21 ' A' ' 16' ' ' LEU . 57.1 m-70 -73.95 -44.93 53.27 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.917 -1.114 . . . . 0.0 111.334 -175.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.655 ' O ' HG22 ' A' ' 39' ' ' ILE . 6.7 t -59.97 -48.16 82.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.977 -1.077 . . . . 0.0 110.707 -172.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.655 HG22 ' O ' ' A' ' 38' ' ' SER . 20.1 tt 38.33 32.24 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.588 -0.695 . . . . 0.0 110.837 179.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.487 ' SG ' ' N ' ' A' ' 43' ' ' GLY . 18.7 p -128.71 164.2 40.0 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.143 -0.973 . . . . 0.0 110.366 -176.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.472 ' HD2' ' HB2' ' A' ' 40' ' ' CYS . 1.7 Cg_endo -50.66 -29.11 24.43 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.951 1.501 . . . . 0.0 110.454 178.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.485 ' O ' ' CA ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -100.57 17.93 20.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.065 -1.022 . . . . 0.0 109.65 175.4 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.488 ' HA2' ' OG ' ' A' ' 38' ' ' SER . . . -79.51 -57.85 3.03 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 175.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.467 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 86.8 tttt -59.99 -39.53 86.03 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.383 -1.069 . . . . 0.0 110.04 177.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.0 tpt180 -95.71 -42.36 8.42 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.089 -1.007 . . . . 0.0 110.767 -177.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.485 ' CA ' ' O ' ' A' ' 42' ' ' SER . . . -70.13 -25.63 75.36 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.86 -1.04 58.12 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 175.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' A' ' 44' ' ' LYS . 45.7 p-10 -171.01 66.85 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.326 -1.102 . . . . 0.0 108.755 -178.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.977 HD12 ' CD2' ' A' ' 8' ' ' HIS . 7.5 mt -69.96 -26.27 64.03 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.51 -0.744 . . . . 0.0 109.924 -175.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.03 -145.48 17.8 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 -178.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -109.95 137.57 47.55 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.226 -1.161 . . . . 0.0 110.383 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.565 ' CE2' ' HB3' ' A' ' 6' ' ' ALA . 3.4 p90 -148.09 163.01 38.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.434 -0.791 . . . . 0.0 110.1 -178.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.511 ' HG2' HG22 ' A' ' 3' ' ' THR . 96.4 mtt180 . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.24 -0.913 . . . . 0.0 109.354 176.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.447 ' O ' ' N ' ' A' ' 61' ' ' PHE . 14.2 Cg_endo . . . . . 0 N--CA 1.485 0.982 0 N-CA-C 110.205 -0.729 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.732 ' O ' HG13 ' A' ' 64' ' ' VAL . . . -39.76 -28.98 0.05 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.585 -0.697 . . . . 0.0 110.628 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.489 ' O ' HG22 ' A' ' 64' ' ' VAL . 62.5 t80 -60.03 -44.56 94.55 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.161 -0.962 . . . . 0.0 110.204 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.466 ' O ' HG12 ' A' ' 65' ' ' VAL . 47.8 t0 -59.93 -40.05 87.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.156 -0.965 . . . . 0.0 109.723 176.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.885 ' HD3' HD21 ' A' ' 77' ' ' LEU . 79.9 tttt -58.55 -41.92 86.72 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.387 -0.821 . . . . 0.0 110.348 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.732 HG13 ' O ' ' A' ' 60' ' ' ALA . 0.9 OUTLIER -77.69 -46.43 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.122 -0.986 . . . . 0.0 110.667 -177.153 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.5 ' N ' ' CG2' ' A' ' 64' ' ' VAL . 0.3 OUTLIER -56.14 -25.12 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.502 -1.374 . . . . 0.0 109.201 172.776 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -95.21 -5.17 44.46 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.493 -0.754 . . . . 0.0 109.917 175.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.532 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 29.7 t -96.32 -44.54 7.19 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.418 -0.801 . . . . 0.0 110.14 178.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 56.5 m -131.68 152.38 80.29 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.353 -0.842 . . . . 0.0 110.457 -177.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.437 ' HD2' ' OE1' ' A' ' 72' ' ' GLU . 13.5 Cg_endo -68.95 155.92 66.97 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.073 1.565 . . . . 0.0 110.377 178.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.888 HG22 HD12 ' A' ' 71' ' ' LEU . 8.9 p -61.3 169.69 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.349 -0.844 . . . . 0.0 110.616 -177.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.888 HD12 HG22 ' A' ' 70' ' ' VAL . 2.2 mp 59.45 16.02 4.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.629 -0.67 . . . . 0.0 110.277 -177.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.437 ' OE1' ' HD2' ' A' ' 69' ' ' PRO . 11.1 tt0 -137.2 85.15 22.61 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.206 -0.933 . . . . 0.0 109.472 173.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -43.75 145.27 1.95 Allowed 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 124.051 1.553 . . . . 0.0 110.712 -174.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 62.6 m -132.67 139.62 47.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.47 -0.769 . . . . 0.0 110.078 -178.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.42 ' HA3' HG13 ' A' ' 85' ' ' ILE . . . 141.72 -175.88 22.26 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.234 -1.547 . . . . 0.0 109.234 -178.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.549 ' HD3' HD21 ' A' ' 21' ' ' LEU . 43.5 Cg_endo -79.47 132.91 26.58 Favored 'Cis proline' 0 C--N 1.314 -1.275 0 C-N-CA 121.834 -2.152 . . . . 0.0 110.367 -0.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.885 HD21 ' HD3' ' A' ' 63' ' ' LYS . 43.7 tp -96.51 156.86 16.16 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.283 -0.885 . . . . 0.0 110.877 -174.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.461 ' N ' ' HG ' ' A' ' 77' ' ' LEU . 12.6 t60 -78.0 126.03 30.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.454 -0.779 . . . . 0.0 110.402 178.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.575 HG21 ' CG ' ' A' ' 84' ' ' HIS . 11.6 t -139.95 158.98 43.2 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.178 -0.951 . . . . 0.0 109.882 176.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -60.89 -25.74 66.93 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.16 -0.962 . . . . 0.0 110.864 -176.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -81.01 -9.94 59.78 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.007 -1.058 . . . . 0.0 110.639 -178.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.502 ' O ' HG22 ' A' ' 79' ' ' THR . . . 139.4 -128.43 3.99 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 108.653 -1.779 . . . . 0.0 108.653 -174.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.583 ' CZ ' ' HB2' ' A' ' 14' ' ' GLU . 91.6 m-85 -115.88 134.58 54.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.95 -1.323 . . . . 0.0 109.827 173.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.575 ' CG ' HG21 ' A' ' 79' ' ' THR . 31.3 m170 -114.34 125.51 53.96 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.18 -0.95 . . . . 0.0 110.564 177.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.676 ' CD1' HD11 ' A' ' 21' ' ' LEU . 6.7 tt -114.1 122.23 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.904 -1.122 . . . . 0.0 109.264 170.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.72 HD12 HG11 ' A' ' 64' ' ' VAL . 85.3 mt -117.43 129.96 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.167 -0.958 . . . . 0.0 111.07 -170.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.594 ' HE3' ' CG ' ' A' ' 30' ' ' PHE . 12.1 ttmm -94.87 125.65 39.67 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.126 -0.984 . . . . 0.0 109.341 170.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.613 HG12 HG23 ' A' ' 70' ' ' VAL . 62.4 t -104.75 131.96 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.294 -0.879 . . . . 0.0 110.221 -174.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.522 ' O ' ' N ' ' A' ' 91' ' ' ARG . 48.4 mt -133.74 154.07 51.24 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.507 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 2.2 m-85 64.19 -58.58 0.22 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.682 -0.637 . . . . 0.0 111.059 176.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.522 ' N ' ' O ' ' A' ' 89' ' ' LEU . 3.2 ttm180 . . . . . 0 N--CA 1.493 1.72 0 O-C-N 121.077 -1.014 . . . . 0.0 110.544 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.0 p . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 121.267 0.556 . . . . 0.0 110.58 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.448 ' C ' ' HG3' ' A' ' 51' ' ' GLU . . . -132.53 156.66 46.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.189 -0.944 . . . . 0.0 110.194 178.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.522 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -92.07 125.33 36.71 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.153 -0.967 . . . . 0.0 109.285 175.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.797 ' HB3' ' CE2' ' A' ' 52' ' ' PHE . . . -137.16 130.2 30.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.804 -1.185 . . . . 0.0 112.081 -169.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.74 HD12 ' HD2' ' A' ' 87' ' ' LYS . 85.0 mt -103.46 140.72 37.1 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.282 -0.886 . . . . 0.0 108.994 168.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.621 ' NE2' ' HB1' ' A' ' 6' ' ' ALA . 35.5 m170 -134.41 148.53 50.66 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.681 -1.262 . . . . 0.0 111.539 -176.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.68 ' HB ' HG22 ' A' ' 85' ' ' ILE . 97.0 mt -136.33 130.88 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.297 -0.877 . . . . 0.0 109.862 169.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.62 HD23 ' N ' ' A' ' 11' ' ' VAL . 0.4 OUTLIER -99.25 123.65 43.7 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.383 -0.823 . . . . 0.0 109.667 177.153 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.666 HG11 ' N ' ' A' ' 17' ' ' ALA . 2.6 t -115.86 129.78 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.183 -0.948 . . . . 0.0 110.028 177.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -69.25 -40.03 78.11 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.326 -0.859 . . . . 0.0 110.59 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -114.93 139.49 49.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.064 -1.022 . . . . 0.0 110.652 -177.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.507 ' HB2' ' CZ ' ' A' ' 83' ' ' TYR . 86.3 tt0 -59.94 -42.41 93.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.428 -0.795 . . . . 0.0 110.032 177.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -56.68 -42.84 79.75 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.325 -0.859 . . . . 0.0 110.2 179.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.615 HD22 HG13 ' A' ' 11' ' ' VAL . 7.4 tt -68.09 -42.4 80.41 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.052 -1.03 . . . . 0.0 109.875 179.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.666 ' N ' HG11 ' A' ' 11' ' ' VAL . . . -59.97 -46.53 89.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.133 -0.98 . . . . 0.0 109.714 174.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.789 HD23 HD22 ' A' ' 21' ' ' LEU . 25.5 mt -60.04 -39.97 87.77 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.889 . . . . 0.0 109.97 175.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.464 ' HB3' ' O ' ' A' ' 16' ' ' LEU . 48.1 t0 -59.97 -40.63 89.76 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.181 -0.949 . . . . 0.0 109.298 174.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.468 ' HA ' ' NE2' ' A' ' 23' ' ' GLN . 2.6 tp -63.28 -39.88 95.83 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.445 -0.784 . . . . 0.0 109.325 173.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.789 HD22 HD23 ' A' ' 18' ' ' LEU . 3.4 mp -59.29 -42.78 92.08 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.53 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -60.26 -40.06 88.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.393 -0.817 . . . . 0.0 109.92 174.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.616 ' NE2' HD22 ' A' ' 33' ' ' LEU . 27.1 mt-30 -61.83 -40.31 94.85 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.45 -0.781 . . . . 0.0 110.818 -177.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.526 ' O ' ' N ' ' A' ' 28' ' ' ALA . 96.9 mt -66.24 -40.02 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.104 -0.997 . . . . 0.0 109.843 -178.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -64.02 -53.73 45.46 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.084 -1.01 . . . . 0.0 109.802 176.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -60.49 -43.47 96.99 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.316 -0.865 . . . . 0.0 110.808 177.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.747 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -106.37 -59.78 0.6 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 -175.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.747 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 83.23 89.89 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 O-C-N 122.07 -0.665 . . . . 0.0 109.861 -175.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -176.92 78.79 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.395 -0.816 . . . . 0.0 109.904 -174.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.565 ' CD2' ' HE3' ' A' ' 87' ' ' LYS . 5.4 m-85 -60.06 -40.56 89.9 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.271 -0.893 . . . . 0.0 110.79 -175.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.63 -51.42 56.12 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.77 -1.205 . . . . 0.0 110.116 -176.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -66.21 -40.01 90.03 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.07 -1.253 . . . . 0.0 110.446 -175.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.616 HD22 ' NE2' ' A' ' 23' ' ' GLN . 67.3 mt -65.92 -39.98 91.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.226 -0.921 . . . . 0.0 110.113 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.563 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -59.29 -50.09 75.34 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.239 -0.913 . . . . 0.0 110.348 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.5 tttp -59.99 -48.25 82.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.913 . . . . 0.0 110.577 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.9 tttt -60.06 -49.54 77.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.208 -0.932 . . . . 0.0 110.987 -175.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -81.88 -40.54 22.24 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.934 -1.104 . . . . 0.0 111.637 -172.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.485 ' OG ' ' HA3' ' A' ' 43' ' ' GLY . 23.7 t -60.06 -49.99 75.49 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.91 -1.119 . . . . 0.0 111.074 -172.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.637 ' O ' HG22 ' A' ' 39' ' ' ILE . 83.7 mt 33.39 48.59 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 CA-C-O 121.195 0.521 . . . . 0.0 111.142 -177.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.42 ' HB2' ' CD ' ' A' ' 41' ' ' PRO . 15.3 p -139.98 176.06 2.79 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.132 -0.98 . . . . 0.0 110.407 -177.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.474 ' O ' ' CB ' ' A' ' 42' ' ' SER . 3.0 Cg_exo -68.87 66.26 1.28 Allowed 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.874 1.46 . . . . 0.0 109.849 -178.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 45' ' ' ARG . 0.1 OUTLIER 165.44 -41.95 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.779 -0.576 . . . . 0.0 109.69 179.594 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.485 ' HA3' ' OG ' ' A' ' 38' ' ' SER . . . -41.77 -37.36 1.99 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -178.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -60.31 -40.01 89.04 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.019 -1.283 . . . . 0.0 110.133 175.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.552 ' HG3' ' CD2' ' A' ' 49' ' ' LEU . 11.3 tpp180 -102.4 -43.2 5.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.526 -0.734 . . . . 0.0 110.596 -176.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.544 ' HA2' HD11 ' A' ' 49' ' ' LEU . . . -55.15 -35.33 59.69 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.926 -1.269 . . . . 0.0 109.926 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.49 ' O ' HD22 ' A' ' 7' ' ' LEU . . . -67.99 -5.96 42.79 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 176.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -169.84 64.71 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.285 -1.126 . . . . 0.0 109.176 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.552 ' CD2' ' HG3' ' A' ' 45' ' ' ARG . 5.0 mt -69.99 -27.63 64.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.539 -0.726 . . . . 0.0 110.07 -178.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 101.06 -143.42 16.17 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 -176.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.448 ' HG3' ' C ' ' A' ' 4' ' ' ALA . 72.2 tt0 -111.8 133.14 54.21 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.206 -1.173 . . . . 0.0 110.253 -179.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.797 ' CE2' ' HB3' ' A' ' 6' ' ' ALA . 4.7 p90 -145.56 166.43 25.74 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.322 -0.861 . . . . 0.0 109.985 -178.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 . . . . . 0 N--CA 1.495 1.824 0 O-C-N 121.036 -1.04 . . . . 0.0 110.215 179.559 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.426 ' O ' ' C ' ' A' ' 60' ' ' ALA . 14.5 Cg_endo . . . . . 0 N--CA 1.485 0.972 0 N-CA-C 110.025 -0.798 . . . . 0.0 110.025 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 59' ' ' PRO . . . -39.81 -33.32 0.19 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.606 -0.684 . . . . 0.0 110.845 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.655 ' CE2' HG21 ' A' ' 65' ' ' VAL . 65.1 t80 -60.01 -44.03 94.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.043 -1.036 . . . . 0.0 110.358 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -60.73 -39.92 90.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.179 -0.95 . . . . 0.0 110.163 -179.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.416 ' O ' ' HB2' ' A' ' 67' ' ' SER . 75.6 mmtt -58.97 -45.89 89.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.182 -0.949 . . . . 0.0 110.378 -178.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.709 HG23 HG21 ' A' ' 74' ' ' THR . 8.5 p -73.39 -39.98 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.059 -1.025 . . . . 0.0 110.53 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.655 HG21 ' CE2' ' A' ' 61' ' ' PHE . 9.6 t -55.75 -30.67 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.625 -1.297 . . . . 0.0 109.568 171.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -96.15 -0.36 50.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.37 -0.831 . . . . 0.0 109.844 176.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.454 ' CB ' ' HA ' ' A' ' 64' ' ' VAL . 6.9 t -96.44 -64.66 1.03 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.362 -0.836 . . . . 0.0 109.525 174.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.411 ' SG ' ' OG1' ' A' ' 74' ' ' THR . 91.1 m -89.57 130.73 42.33 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.326 -0.859 . . . . 0.0 110.016 175.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.548 ' O ' ' O ' ' A' ' 70' ' ' VAL . 25.2 Cg_endo -67.64 79.28 0.49 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.849 1.447 . . . . 0.0 110.79 -177.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.017 ' C ' HD13 ' A' ' 71' ' ' LEU . 1.8 m 37.17 177.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.445 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 177.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.017 HD13 ' C ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER 24.39 40.92 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.485 0 CA-C-O 121.636 0.731 . . . . 0.0 112.632 -170.72 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.554 ' N ' ' O ' ' A' ' 70' ' ' VAL . 3.4 tp10 -138.05 81.96 25.96 Favored Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 121.285 -0.885 . . . . 0.0 109.589 174.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -43.68 129.49 7.09 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 124.045 1.55 . . . . 0.0 110.204 -176.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.709 HG21 HG23 ' A' ' 64' ' ' VAL . 57.1 m -127.96 135.7 50.29 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.348 -0.845 . . . . 0.0 110.196 -175.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.421 ' HA3' HG13 ' A' ' 85' ' ' ILE . . . 133.6 -176.55 19.62 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 -178.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.605 ' CD ' HD21 ' A' ' 21' ' ' LEU . 43.3 Cg_endo -72.19 152.9 97.61 Favored 'Cis proline' 0 C--N 1.314 -1.276 0 C-N-CA 121.713 -2.203 . . . . 0.0 110.199 0.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.0 tp -131.38 154.51 48.54 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.129 -0.982 . . . . 0.0 110.329 -175.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 -76.64 130.92 38.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.244 -0.91 . . . . 0.0 110.761 -177.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.63 HG21 ' CG ' ' A' ' 84' ' ' HIS . 10.3 t -142.08 173.65 11.32 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.452 -0.78 . . . . 0.0 109.823 175.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -59.99 -27.72 67.1 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.158 -0.963 . . . . 0.0 110.517 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -96.39 9.97 39.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.999 -1.063 . . . . 0.0 110.902 -172.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.401 ' O ' HG22 ' A' ' 79' ' ' THR . . . 119.6 -124.65 6.04 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 -176.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.507 ' CZ ' ' HB2' ' A' ' 14' ' ' GLU . 87.1 m-85 -114.07 139.02 49.64 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.128 -1.219 . . . . 0.0 110.253 176.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.63 ' CG ' HG21 ' A' ' 79' ' ' THR . 21.9 m170 -121.7 121.63 37.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.35 -0.844 . . . . 0.0 110.377 177.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.68 HG22 ' HB ' ' A' ' 9' ' ' ILE . 6.1 tt -109.94 136.84 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.761 -1.212 . . . . 0.0 109.434 168.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.554 HG12 ' CD2' ' A' ' 8' ' ' HIS . 26.1 mt -133.48 131.67 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.076 -1.015 . . . . 0.0 111.223 -169.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.74 ' HD2' HD12 ' A' ' 7' ' ' LEU . 12.1 ttmm -105.25 128.03 53.23 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.237 -0.914 . . . . 0.0 109.411 170.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.771 HG12 HG12 ' A' ' 70' ' ' VAL . 60.8 t -108.77 139.3 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.204 -0.935 . . . . 0.0 110.363 -174.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.527 ' O ' ' CB ' ' A' ' 90' ' ' TYR . 81.6 mt -140.38 126.26 19.45 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.197 -0.94 . . . . 0.0 110.055 -177.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.527 ' CB ' ' O ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER 80.71 -57.97 0.3 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.415 -0.803 . . . . 0.0 111.53 171.985 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.657 ' HB2' HG11 ' A' ' 70' ' ' VAL . 47.5 ttp180 . . . . . 0 N--CA 1.493 1.692 0 O-C-N 120.863 -1.148 . . . . 0.0 110.631 -179.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 52' ' ' PHE . 72.6 m . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 120.834 0.35 . . . . 0.0 110.095 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.577 ' O ' ' CD1' ' A' ' 52' ' ' PHE . . . -153.4 157.77 40.45 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.914 -1.116 . . . . 0.0 110.786 -177.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.489 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -104.14 139.46 39.18 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.149 -0.969 . . . . 0.0 109.429 172.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.821 ' HB3' ' CZ ' ' A' ' 52' ' ' PHE . . . -149.83 130.79 14.3 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.694 -1.254 . . . . 0.0 111.457 -177.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.915 HD12 ' HE3' ' A' ' 87' ' ' LYS . 17.4 mt -100.75 146.17 27.58 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.454 -0.779 . . . . 0.0 109.746 172.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.678 ' CD2' HD12 ' A' ' 49' ' ' LEU . 8.0 m-70 -134.5 150.1 50.76 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.121 -0.987 . . . . 0.0 110.826 -175.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.561 ' HB ' ' CG2' ' A' ' 85' ' ' ILE . 89.8 mt -128.78 129.88 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.063 -1.023 . . . . 0.0 109.671 167.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.535 ' HG ' ' CD2' ' A' ' 84' ' ' HIS . 0.5 OUTLIER -106.5 119.33 39.01 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.497 -0.752 . . . . 0.0 110.1 -177.523 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.952 HG13 HD22 ' A' ' 16' ' ' LEU . 3.1 t -114.97 131.05 68.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.227 -0.921 . . . . 0.0 110.045 176.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 49.0 tttt -69.95 -40.01 75.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.083 -1.011 . . . . 0.0 110.614 -178.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -109.04 137.25 47.24 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.107 -0.995 . . . . 0.0 110.839 -176.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.555 ' HB2' ' CZ ' ' A' ' 83' ' ' TYR . 86.5 tt0 -59.99 -42.01 93.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.443 -0.785 . . . . 0.0 110.121 178.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -56.37 -41.16 75.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.322 -0.861 . . . . 0.0 110.212 178.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.952 HD22 HG13 ' A' ' 11' ' ' VAL . 4.7 tt -67.95 -39.91 83.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.014 -1.054 . . . . 0.0 109.076 175.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.674 ' O ' HD12 ' A' ' 21' ' ' LEU . . . -59.93 -40.63 89.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.303 -0.873 . . . . 0.0 110.095 175.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.03 -42.05 93.56 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.022 -1.049 . . . . 0.0 109.571 175.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -59.99 -38.99 84.22 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.275 -0.891 . . . . 0.0 109.706 173.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.711 ' C ' HD12 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -60.82 -50.38 73.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.313 -0.867 . . . . 0.0 109.885 178.822 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.797 HD21 ' HD3' ' A' ' 76' ' ' PRO . 1.4 mt -60.02 -49.26 78.38 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.339 -0.851 . . . . 0.0 110.181 -178.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -60.48 -40.08 89.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.454 -0.779 . . . . 0.0 109.999 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 70.0 tp60 -59.99 -41.31 91.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.365 -0.834 . . . . 0.0 110.529 -175.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.528 ' O ' ' N ' ' A' ' 28' ' ' ALA . 63.1 mt -63.65 -47.92 89.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.2 -0.938 . . . . 0.0 110.21 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -62.11 -45.08 95.08 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.903 -1.123 . . . . 0.0 109.659 177.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -59.97 -60.8 3.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.376 -0.827 . . . . 0.0 110.178 177.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.745 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -105.83 -45.8 1.26 Allowed Glycine 0 N--CA 1.486 1.992 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -175.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.745 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 80.16 158.69 0.16 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.811 -0.817 . . . . 0.0 110.462 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.592 ' CB ' ' O ' ' A' ' 28' ' ' ALA . 96.7 m-20 118.26 81.24 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.038 0 C-N-CA 125.053 1.341 . . . . 0.0 109.634 -175.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.439 ' CZ ' HD13 ' A' ' 24' ' ' ILE . 2.1 m-85 -60.02 -45.04 94.1 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.207 -0.933 . . . . 0.0 110.999 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.39 -54.64 25.38 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.765 -1.207 . . . . 0.0 110.141 -174.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -65.94 -39.95 90.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.048 -1.266 . . . . 0.0 110.306 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 46.8 mt -63.65 -39.97 95.68 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.134 -0.979 . . . . 0.0 109.643 176.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.546 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -55.18 -50.64 68.83 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.266 -0.896 . . . . 0.0 110.091 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -59.96 -51.97 67.39 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.055 -1.028 . . . . 0.0 110.677 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -60.96 -50.07 74.87 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.21 -0.931 . . . . 0.0 111.175 -176.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -70.43 -39.97 74.07 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.123 -0.986 . . . . 0.0 110.867 -177.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.658 ' O ' HG22 ' A' ' 39' ' ' ILE . 20.7 t -60.08 -46.35 89.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.138 -0.976 . . . . 0.0 110.349 -175.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.658 HG22 ' O ' ' A' ' 38' ' ' SER . 16.0 tt 37.99 29.87 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.7 -0.625 . . . . 0.0 110.58 178.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.47 ' N ' ' O ' ' A' ' 38' ' ' SER . 15.2 p -129.67 165.11 35.37 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.35 -0.844 . . . . 0.0 110.193 -176.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.47 ' HD2' ' HB2' ' A' ' 40' ' ' CYS . 1.1 Cg_endo -47.76 -28.43 9.61 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.802 1.422 . . . . 0.0 110.562 178.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.523 ' O ' ' CA ' ' A' ' 46' ' ' GLY . 0.2 OUTLIER -99.77 18.43 18.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.99 -1.069 . . . . 0.0 110.148 177.526 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.44 -55.01 5.27 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.549 -1.82 . . . . 0.0 108.549 171.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -61.12 -40.03 92.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.457 -1.025 . . . . 0.0 110.749 177.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.412 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 12.8 tpt180 -104.53 -41.26 5.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.089 -1.007 . . . . 0.0 110.795 -174.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.523 ' CA ' ' O ' ' A' ' 42' ' ' SER . . . -69.95 -31.88 69.8 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.55 0.9 59.47 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 177.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.521 ' HA ' ' CD2' ' A' ' 7' ' ' LEU . 47.8 t0 -170.38 76.17 0.08 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.296 -1.12 . . . . 0.0 109.065 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.678 HD12 ' CD2' ' A' ' 8' ' ' HIS . 19.2 mt -82.63 -14.96 53.81 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.602 -0.686 . . . . 0.0 110.193 -174.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.01 -137.96 14.29 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 177.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.499 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 3.4 mt-10 -108.79 158.59 17.5 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.453 -1.028 . . . . 0.0 110.421 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.821 ' CZ ' ' HB3' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -139.96 177.83 7.69 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.389 -0.82 . . . . 0.0 109.407 -175.583 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.616 -0.677 . . . . 0.0 109.849 179.356 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo . . . . . 0 N--CA 1.485 1.021 0 N-CA-C 110.88 -0.469 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -45.28 -44.63 11.54 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.219 -0.925 . . . . 0.0 110.578 -174.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -59.99 -41.68 92.57 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.185 -0.947 . . . . 0.0 110.118 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.516 ' O ' HG12 ' A' ' 65' ' ' VAL . 57.4 t0 -71.78 -38.4 70.3 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.317 -0.864 . . . . 0.0 110.298 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.521 ' O ' ' N ' ' A' ' 67' ' ' SER . 87.6 tttt -55.06 -49.96 70.31 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.24 -0.912 . . . . 0.0 110.216 -175.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.667 ' HB ' HD11 ' A' ' 77' ' ' LEU . 2.5 p -69.81 -47.1 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.129 -0.982 . . . . 0.0 111.814 -174.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.516 HG12 ' O ' ' A' ' 62' ' ' ASP . 3.0 p -57.4 -27.12 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.319 -1.488 . . . . 0.0 109.055 173.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -92.97 -11.19 33.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.407 -0.808 . . . . 0.0 109.846 175.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.544 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 9.4 t -91.62 -44.74 8.87 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.318 -0.864 . . . . 0.0 109.756 176.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.503 ' HB3' ' HB3' ' A' ' 72' ' ' GLU . 66.1 m -137.14 149.98 67.82 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.306 -0.871 . . . . 0.0 110.382 178.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.485 ' O ' ' HB2' ' A' ' 72' ' ' GLU . 52.1 Cg_endo -77.71 -179.48 5.48 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.054 1.555 . . . . 0.0 110.932 -178.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.938 HG22 ' CD1' ' A' ' 71' ' ' LEU . 7.2 p -60.04 157.65 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.424 -0.797 . . . . 0.0 110.06 177.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.938 ' CD1' HG22 ' A' ' 70' ' ' VAL . 4.4 mp 60.01 40.03 19.22 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.419 -0.8 . . . . 0.0 110.234 -175.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.503 ' HB3' ' HB3' ' A' ' 68' ' ' CYS . 0.0 OUTLIER -150.46 104.42 3.1 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.299 -0.875 . . . . 0.0 110.258 178.72 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 72' ' ' GLU . 26.0 Cg_endo -67.15 135.09 36.04 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.89 1.469 . . . . 0.0 110.273 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.636 ' HB ' HG23 ' A' ' 64' ' ' VAL . 87.2 m -140.13 147.21 39.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.164 -0.96 . . . . 0.0 110.488 -178.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.447 ' HA3' HG13 ' A' ' 85' ' ' ILE . . . 125.72 -168.88 17.72 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.797 ' HD3' HD21 ' A' ' 21' ' ' LEU . 43.0 Cg_endo -72.32 139.23 59.09 Favored 'Cis proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.847 -2.147 . . . . 0.0 110.732 -0.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.667 HD11 ' HB ' ' A' ' 64' ' ' VAL . 88.7 mt -92.99 169.37 10.48 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.3 -0.875 . . . . 0.0 110.633 -176.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 14.3 t60 -100.24 119.57 38.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.144 -0.972 . . . . 0.0 110.381 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.637 HG21 ' ND1' ' A' ' 84' ' ' HIS . 14.7 t -141.56 166.38 24.91 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.155 -0.965 . . . . 0.0 109.815 176.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.415 ' CG ' ' N ' ' A' ' 81' ' ' PHE . 15.8 pt20 -59.93 -34.75 73.66 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.121 -0.987 . . . . 0.0 110.397 -176.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.415 ' N ' ' CG ' ' A' ' 80' ' ' GLN . 94.4 m-85 -60.04 -27.26 66.78 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.271 -0.893 . . . . 0.0 110.208 178.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 141.63 -132.37 5.24 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -178.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.555 ' CZ ' ' HB2' ' A' ' 14' ' ' GLU . 81.3 m-85 -96.66 120.99 37.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -1.139 . . . . 0.0 109.876 175.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.637 ' ND1' HG21 ' A' ' 79' ' ' THR . 0.6 OUTLIER -113.29 113.64 25.55 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.566 -0.709 . . . . 0.0 110.9 -176.453 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.561 ' CG2' ' HB ' ' A' ' 9' ' ' ILE . 12.2 tt -109.82 133.9 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 120.616 -1.302 . . . . 0.0 109.579 170.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.528 HG12 ' ND1' ' A' ' 8' ' ' HIS . 85.9 mt -138.24 141.93 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.044 -1.035 . . . . 0.0 110.67 -172.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.915 ' HE3' HD12 ' A' ' 7' ' ' LEU . 20.1 pttp -119.53 142.06 48.67 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.048 -1.033 . . . . 0.0 109.511 171.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 62.5 t -107.9 129.97 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.913 -1.117 . . . . 0.0 111.302 -168.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' A' ' 91' ' ' ARG . 89.5 mt -114.26 -170.97 1.83 Allowed 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.305 -0.872 . . . . 0.0 109.204 172.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.435 ' C ' ' O ' ' A' ' 89' ' ' LEU . 71.0 m-85 32.85 -86.46 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.735 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.533 ' N ' ' O ' ' A' ' 89' ' ' LEU . 29.7 ttp85 . . . . . 0 N--CA 1.493 1.683 0 O-C-N 120.696 -1.253 . . . . 0.0 110.617 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.579 HG22 ' HB3' ' A' ' 53' ' ' ARG . 28.1 p . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.192 0.52 . . . . 0.0 110.087 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.404 ' C ' ' HG3' ' A' ' 51' ' ' GLU . . . -129.88 160.12 34.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.254 -0.904 . . . . 0.0 109.656 178.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.555 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -95.52 127.39 41.51 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.121 -0.987 . . . . 0.0 109.551 179.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.823 ' HB3' ' HZ ' ' A' ' 52' ' ' PHE . . . -134.51 131.07 37.57 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.699 -1.25 . . . . 0.0 111.56 -170.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.517 ' C ' ' CD2' ' A' ' 8' ' ' HIS . 39.9 mt -102.28 147.31 26.82 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.078 -1.014 . . . . 0.0 109.33 170.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.672 ' NE2' ' HB1' ' A' ' 6' ' ' ALA . 31.4 m-70 -143.52 134.02 24.84 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.803 -1.185 . . . . 0.0 111.407 -175.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.564 HG13 ' CZ ' ' A' ' 30' ' ' PHE . 95.3 mt -119.99 125.69 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.776 -1.202 . . . . 0.0 109.763 165.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.592 ' HG ' ' CD2' ' A' ' 84' ' ' HIS . 0.2 OUTLIER -102.79 121.4 42.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.603 -0.686 . . . . 0.0 109.689 179.553 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.823 HG13 HD22 ' A' ' 16' ' ' LEU . 2.2 t -109.31 125.48 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.134 -0.979 . . . . 0.0 110.394 178.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -67.58 -39.97 84.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.445 -0.784 . . . . 0.0 110.446 175.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -108.11 136.84 47.11 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.217 -0.927 . . . . 0.0 110.966 -174.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.451 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 97.1 mt-10 -60.07 -40.84 90.93 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.4 -0.812 . . . . 0.0 110.115 173.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -58.86 -40.23 83.71 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.209 -0.932 . . . . 0.0 110.459 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.823 HD22 HG13 ' A' ' 11' ' ' VAL . 3.7 tt -68.31 -38.19 81.33 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.045 -1.034 . . . . 0.0 109.054 175.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.739 ' O ' HD12 ' A' ' 21' ' ' LEU . . . -58.76 -44.48 90.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.361 -0.837 . . . . 0.0 110.114 175.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.99 -42.72 94.84 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.221 -0.924 . . . . 0.0 109.611 176.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.456 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 65.1 t0 -59.94 -40.63 89.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.312 -0.867 . . . . 0.0 109.674 173.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.841 HD23 ' N ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -63.91 -55.32 23.55 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 121.587 0.708 . . . . 0.0 110.035 -179.786 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 1.08 HD11 ' HG3' ' A' ' 76' ' ' PRO . 0.4 OUTLIER -54.89 -40.07 69.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.564 -0.71 . . . . 0.0 109.779 179.5 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -60.58 -49.11 78.86 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.586 -0.696 . . . . 0.0 110.74 -176.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 19' ' ' ASP . 87.7 mm-40 -61.55 -40.04 93.25 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.116 -0.99 . . . . 0.0 110.375 -175.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.604 HG12 HD12 ' A' ' 33' ' ' LEU . 96.9 mt -59.97 -49.95 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.263 -0.898 . . . . 0.0 110.019 -177.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -62.18 -48.31 80.63 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.883 -1.136 . . . . 0.0 109.75 176.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.11 -55.79 29.54 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.341 -0.849 . . . . 0.0 110.28 178.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.747 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -105.28 -48.57 1.05 Allowed Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -174.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.747 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 81.81 96.03 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.173 0 O-C-N 122.151 -0.617 . . . . 0.0 110.228 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.44 ' HB3' ' HB2' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -176.0 84.61 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.466 -0.771 . . . . 0.0 109.935 -178.218 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.593 ' CG ' ' HE3' ' A' ' 87' ' ' LYS . 45.8 t80 -60.03 -48.5 81.45 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.314 -0.866 . . . . 0.0 110.573 -175.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.05 -47.84 89.03 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -176.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.44 ' HB2' ' HB3' ' A' ' 29' ' ' ASP . 36.6 mmtm -65.77 -40.16 91.75 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.055 -1.262 . . . . 0.0 110.561 -176.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.604 HD12 HG12 ' A' ' 24' ' ' ILE . 84.0 mt -66.76 -40.03 88.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.089 -1.007 . . . . 0.0 110.334 179.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.522 ' O ' ' CB ' ' A' ' 38' ' ' SER . . . -59.93 -47.35 86.16 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.121 -0.987 . . . . 0.0 109.992 179.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 66.8 tttt -60.01 -46.57 89.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.16 -0.963 . . . . 0.0 110.456 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.608 ' O ' HG23 ' A' ' 39' ' ' ILE . 55.7 mttt -70.03 -59.6 2.81 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.138 -0.976 . . . . 0.0 110.993 -176.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.453 ' HB3' HD21 ' A' ' 16' ' ' LEU . 80.9 m-70 -71.73 -40.18 69.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.095 -1.003 . . . . 0.0 111.129 -172.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.527 ' O ' ' CG1' ' A' ' 39' ' ' ILE . 8.6 t -60.17 -49.25 78.37 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.135 -0.978 . . . . 0.0 110.509 -175.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.608 HG23 ' O ' ' A' ' 36' ' ' LYS . 36.4 pt 37.95 32.72 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-O 121.452 0.644 . . . . 0.0 110.465 -177.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.455 ' SG ' ' OG ' ' A' ' 38' ' ' SER . 14.9 p -125.93 166.21 22.7 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.393 -0.817 . . . . 0.0 109.658 178.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -51.7 -22.93 14.25 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.823 1.433 . . . . 0.0 110.425 -178.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.7 OUTLIER -101.63 12.99 36.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -0.908 . . . . 0.0 110.636 -179.025 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.08 -56.43 4.41 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 174.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 16.3 tttp -60.01 -40.0 87.73 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.343 -1.093 . . . . 0.0 110.368 177.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.473 ' HD2' HD23 ' A' ' 49' ' ' LEU . 8.7 tpp85 -98.86 -43.65 6.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 0.0 110.58 -175.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -60.0 -35.97 88.85 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.29 -4.21 35.68 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 110.016 -1.233 . . . . 0.0 110.016 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.427 ' HA ' ' CD2' ' A' ' 7' ' ' LEU . 9.7 t0 -171.32 69.37 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.016 -1.285 . . . . 0.0 109.449 178.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.473 HD23 ' HD2' ' A' ' 45' ' ' ARG . 4.8 mt -70.03 -29.91 67.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.508 -0.745 . . . . 0.0 110.75 -176.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 112.23 -152.57 17.76 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.404 ' HG3' ' C ' ' A' ' 4' ' ' ALA . 79.1 tt0 -111.91 136.96 50.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.358 -1.084 . . . . 0.0 110.079 -178.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.823 ' HZ ' ' HB3' ' A' ' 6' ' ' ALA . 0.1 OUTLIER -160.18 168.17 26.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.198 -0.939 . . . . 0.0 110.243 -174.764 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.579 ' HB3' HG22 ' A' ' 3' ' ' THR . 48.7 ptt85 . . . . . 0 N--CA 1.493 1.702 0 O-C-N 120.997 -1.064 . . . . 0.0 110.546 -176.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.483 ' O ' ' N ' ' A' ' 61' ' ' PHE . 5.7 Cg_endo . . . . . 0 N--CA 1.485 0.98 0 N-CA-C 110.484 -0.622 . . . . 0.0 110.484 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.674 ' O ' HG13 ' A' ' 64' ' ' VAL . . . -37.5 -29.22 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.647 -0.658 . . . . 0.0 110.863 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.483 ' N ' ' O ' ' A' ' 59' ' ' PRO . 32.0 t80 -60.03 -43.9 94.99 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.999 -1.063 . . . . 0.0 110.309 178.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 59' ' ' PRO . 7.7 t70 -60.04 -40.03 87.96 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.213 -0.929 . . . . 0.0 109.459 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 67' ' ' SER . 12.4 tptp -57.63 -49.95 74.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.391 -0.818 . . . . 0.0 110.876 177.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.674 HG13 ' O ' ' A' ' 60' ' ' ALA . 1.3 m -70.36 -48.64 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 120.929 -1.107 . . . . 0.0 110.832 -172.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.534 ' N ' ' CG2' ' A' ' 64' ' ' VAL . 13.2 p -57.01 -24.64 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.431 -1.418 . . . . 0.0 109.318 172.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.459 ' O ' ' CD1' ' A' ' 66' ' ' PHE . 17.2 t80 -96.57 -0.06 49.3 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.402 -0.811 . . . . 0.0 109.737 175.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.505 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 33.0 t -97.93 -49.13 4.9 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.431 -0.793 . . . . 0.0 110.006 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.481 ' HB2' ' OG1' ' A' ' 74' ' ' THR . 95.1 m -117.69 147.04 40.12 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.353 -0.842 . . . . 0.0 109.985 179.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.41 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 39.6 Cg_exo -57.14 146.43 81.33 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.015 1.534 . . . . 0.0 110.471 179.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.924 HG22 HD12 ' A' ' 71' ' ' LEU . 4.8 p -60.77 173.94 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.26 -0.9 . . . . 0.0 109.976 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.924 HD12 HG22 ' A' ' 70' ' ' VAL . 2.3 mp 59.61 20.11 8.69 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.335 -0.853 . . . . 0.0 109.642 -175.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.41 ' HB3' ' O ' ' A' ' 69' ' ' PRO . 1.0 OUTLIER -139.21 87.3 13.91 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.5 -0.75 . . . . 0.0 109.668 179.001 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.431 ' HG3' ' HD3' ' A' ' 87' ' ' LYS . 52.9 Cg_exo -45.3 115.22 0.87 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.052 1.554 . . . . 0.0 110.337 -176.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.481 ' OG1' ' HB2' ' A' ' 68' ' ' CYS . 54.9 m -108.61 122.91 48.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.255 -0.903 . . . . 0.0 110.405 -176.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 150.91 179.86 27.01 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 1.08 ' HG3' HD11 ' A' ' 21' ' ' LEU . 42.6 Cg_endo -72.15 170.14 68.28 Favored 'Cis proline' 0 C--N 1.315 -1.219 0 C-N-CA 121.674 -2.219 . . . . 0.0 110.588 -0.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.2 mt -139.17 160.55 39.54 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.355 -0.841 . . . . 0.0 110.284 -175.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -84.98 124.48 31.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.238 -0.914 . . . . 0.0 110.239 -179.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.816 HG21 ' CG ' ' A' ' 84' ' ' HIS . 8.8 t -137.63 158.17 44.94 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.105 -0.997 . . . . 0.0 109.895 175.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -59.99 -23.78 63.91 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -0.903 . . . . 0.0 110.225 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -78.88 -10.08 59.69 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.226 -0.921 . . . . 0.0 110.583 -178.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.572 ' O ' HG22 ' A' ' 79' ' ' THR . . . 130.45 -137.36 9.44 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 -175.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.4 ' O ' HD23 ' A' ' 10' ' ' LEU . 0.2 OUTLIER -95.37 136.9 35.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.164 -1.198 . . . . 0.0 110.015 175.211 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.816 ' CG ' HG21 ' A' ' 79' ' ' THR . 3.9 m170 -127.99 114.79 17.56 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.472 -0.767 . . . . 0.0 110.835 -177.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.549 ' CG2' ' HB ' ' A' ' 9' ' ' ILE . 3.6 tt -111.12 130.96 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.09 -1.007 . . . . 0.0 109.515 171.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.574 HG23 ' CE1' ' A' ' 8' ' ' HIS . 78.4 mt -135.37 132.12 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.026 -1.046 . . . . 0.0 111.142 -169.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.593 ' HE3' ' CG ' ' A' ' 30' ' ' PHE . 23.1 mttt -99.27 140.45 33.43 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.876 -1.14 . . . . 0.0 109.985 171.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.777 HG12 HG23 ' A' ' 70' ' ' VAL . 37.5 t -109.95 129.97 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.367 -0.833 . . . . 0.0 110.078 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.555 ' HB2' ' HB3' ' A' ' 5' ' ' ALA . 88.1 mt -139.09 -164.59 1.69 Allowed 'General case' 0 C--N 1.307 -1.271 0 O-C-N 121.19 -0.944 . . . . 0.0 109.557 -178.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.495 ' CD1' ' CB ' ' A' ' 5' ' ' ALA . 44.2 m-85 34.68 -85.98 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.122 0 O-C-N 122.078 -0.389 . . . . 0.0 111.71 -178.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.554 ' N ' ' O ' ' A' ' 89' ' ' LEU . 36.1 ttp180 . . . . . 0 N--CA 1.498 1.945 0 O-C-N 120.873 -1.142 . . . . 0.0 110.893 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.751 HG22 ' HG2' ' A' ' 51' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.365 0.602 . . . . 0.0 110.81 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.447 ' C ' ' HG3' ' A' ' 51' ' ' GLU . . . -119.88 146.59 45.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.43 -0.794 . . . . 0.0 109.515 174.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.571 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -92.57 125.69 37.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.039 -1.038 . . . . 0.0 109.461 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.542 ' HB3' ' CE2' ' A' ' 52' ' ' PHE . . . -136.33 135.1 38.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.833 -1.167 . . . . 0.0 111.556 -170.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.731 HD12 ' HD2' ' A' ' 87' ' ' LYS . 72.2 mt -109.11 143.89 37.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.207 -0.933 . . . . 0.0 108.877 168.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.702 ' HE2' ' HE1' ' A' ' 61' ' ' PHE . 45.7 m170 -130.89 129.5 42.33 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.723 -1.236 . . . . 0.0 111.365 -176.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.732 ' HB ' HG22 ' A' ' 85' ' ' ILE . 59.1 mt -109.99 129.96 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.106 -0.996 . . . . 0.0 109.229 168.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.745 HD13 ' C ' ' A' ' 10' ' ' LEU . 1.8 tm? -107.55 120.04 41.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.144 -0.972 . . . . 0.0 110.135 178.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 1.096 HG13 HD22 ' A' ' 16' ' ' LEU . 2.6 t -99.66 132.46 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.526 -0.734 . . . . 0.0 110.001 -179.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -64.28 -39.98 95.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.395 -0.815 . . . . 0.0 110.673 -178.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -136.36 153.93 50.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.067 -1.021 . . . . 0.0 110.707 -176.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.444 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 86.1 tt0 -59.75 -40.09 86.98 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.397 -0.814 . . . . 0.0 110.462 -177.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 29.9 tptt -51.57 -45.54 63.14 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.275 -0.89 . . . . 0.0 110.09 -177.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 1.096 HD22 HG13 ' A' ' 11' ' ' VAL . 7.4 tt -67.8 -39.92 83.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.111 -0.993 . . . . 0.0 109.409 175.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.002 ' O ' HD12 ' A' ' 21' ' ' LEU . . . -57.12 -42.7 81.34 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.392 -0.818 . . . . 0.0 109.71 176.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.425 HD12 ' HG2' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -60.09 -46.94 87.91 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.231 -0.918 . . . . 0.0 109.634 173.239 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -60.1 -40.02 88.21 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.422 -0.799 . . . . 0.0 110.184 177.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 1.018 HD13 ' CD2' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -63.15 -52.31 62.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.105 -0.997 . . . . 0.0 109.469 178.716 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 1.002 HD12 ' O ' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -56.55 -46.67 80.56 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.326 -0.859 . . . . 0.0 109.766 -177.689 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -60.04 -39.97 87.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.117 -0.989 . . . . 0.0 109.547 171.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.493 ' HB3' ' O ' ' A' ' 20' ' ' LEU . 61.5 tt0 -60.51 -39.97 89.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.435 -0.79 . . . . 0.0 111.047 -177.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.542 ' O ' ' CA ' ' A' ' 28' ' ' ALA . 18.9 mm -61.26 -39.99 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.796 -1.19 . . . . 0.0 109.724 -176.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -65.17 -56.48 12.65 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.676 -1.265 . . . . 0.0 110.14 177.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -60.11 -50.81 72.23 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.25 -0.906 . . . . 0.0 110.83 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 28' ' ' ALA . . . -105.64 -19.64 10.21 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -168.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.542 ' CA ' ' O ' ' A' ' 24' ' ' ILE . . . 34.18 94.48 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.821 -0.811 . . . . 0.0 111.474 -178.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -177.3 76.41 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.61 -0.681 . . . . 0.0 109.41 -178.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.539 ' HB3' ' CE ' ' A' ' 87' ' ' LYS . 2.5 m-85 -60.06 -43.2 95.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.876 . . . . 0.0 110.807 -173.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.4 -47.5 90.38 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -178.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' A' ' 35' ' ' LYS . 83.6 tttt -63.72 -40.03 95.76 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.19 -1.182 . . . . 0.0 110.23 -178.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.018 ' CD2' HD13 ' A' ' 20' ' ' LEU . 40.3 tp -64.1 -40.04 95.35 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.866 -1.146 . . . . 0.0 110.162 178.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.542 ' HB2' HG12 ' A' ' 9' ' ' ILE . . . -59.24 -52.83 64.01 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.162 -0.961 . . . . 0.0 110.366 -177.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 55.8 pttt -62.84 -41.21 99.25 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.817 -1.177 . . . . 0.0 110.425 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.467 ' N ' ' CG ' ' A' ' 35' ' ' LYS . 88.3 tttt -62.48 -48.32 80.09 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.197 -0.94 . . . . 0.0 111.446 -174.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.413 ' O ' HG12 ' A' ' 39' ' ' ILE . 41.1 m170 -102.89 -17.64 15.42 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.814 -1.179 . . . . 0.0 111.513 -169.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.527 ' O ' ' CG1' ' A' ' 39' ' ' ILE . 33.7 t -59.96 -44.2 94.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.813 -1.179 . . . . 0.0 110.651 -174.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.527 ' CG1' ' O ' ' A' ' 38' ' ' SER . 45.2 pt 36.69 30.05 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.696 -0.628 . . . . 0.0 110.636 -178.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.499 ' N ' ' O ' ' A' ' 38' ' ' SER . 43.2 t -125.46 144.57 48.26 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.423 -0.798 . . . . 0.0 109.853 -176.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.473 ' HD2' ' SG ' ' A' ' 40' ' ' CYS . 51.6 Cg_exo -49.31 -21.44 4.64 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 123.673 1.354 . . . . 0.0 110.491 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.51 ' O ' ' CA ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -101.27 16.98 23.77 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.212 -0.93 . . . . 0.0 110.184 176.801 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.411 ' CA ' ' OG ' ' A' ' 38' ' ' SER . . . -79.61 -56.52 3.34 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 173.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -60.04 -39.93 87.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.349 -1.089 . . . . 0.0 110.392 176.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -97.15 -39.79 9.12 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.069 -1.02 . . . . 0.0 110.619 -176.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.51 ' CA ' ' O ' ' A' ' 42' ' ' SER . . . -76.79 -18.27 79.05 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.74 0.09 62.37 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.276 -1.529 . . . . 0.0 109.276 173.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.528 ' HA ' ' CD2' ' A' ' 7' ' ' LEU . 33.9 t0 -172.51 73.13 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.299 -1.118 . . . . 0.0 108.966 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.452 ' HG ' ' HA2' ' A' ' 46' ' ' GLY . 5.5 mt -80.09 -13.26 59.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.419 -0.801 . . . . 0.0 109.899 -175.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.08 -148.04 20.61 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -178.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.751 ' HG2' HG22 ' A' ' 3' ' ' THR . 80.5 tt0 -110.92 131.8 54.75 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.336 -1.096 . . . . 0.0 110.173 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.542 ' CE2' ' HB3' ' A' ' 6' ' ' ALA . 3.8 p90 -139.52 158.17 44.59 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.389 -0.819 . . . . 0.0 110.266 -178.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 30.7 ptt-85 . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.354 -0.841 . . . . 0.0 110.043 -178.565 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.497 ' O ' ' N ' ' A' ' 62' ' ' ASP . 10.3 Cg_endo . . . . . 0 N--CA 1.487 1.101 0 N-CA-C 110.389 -0.658 . . . . 0.0 110.389 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.643 ' HB1' HD23 ' A' ' 77' ' ' LEU . . . -38.35 -33.1 0.09 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.711 -0.618 . . . . 0.0 110.498 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.702 ' HE1' ' HE2' ' A' ' 8' ' ' HIS . 68.3 t80 -60.05 -41.13 91.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.296 -0.878 . . . . 0.0 110.638 177.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' A' ' 59' ' ' PRO . 52.9 t0 -60.09 -39.94 87.87 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.26 -0.9 . . . . 0.0 110.104 -178.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.43 ' O ' ' HB2' ' A' ' 67' ' ' SER . 79.8 mttt -59.62 -40.06 86.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.874 . . . . 0.0 110.79 -176.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.843 HG21 HD12 ' A' ' 86' ' ' ILE . 0.9 OUTLIER -85.22 -48.0 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 120.996 -1.065 . . . . 0.0 111.125 -174.515 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.58 HG12 ' O ' ' A' ' 61' ' ' PHE . 7.5 p -54.6 -26.31 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.674 -1.266 . . . . 0.0 109.554 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -96.27 12.41 31.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.252 -0.905 . . . . 0.0 109.764 174.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.48 ' HB3' ' O ' ' A' ' 64' ' ' VAL . 44.4 t -101.27 -41.0 6.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.418 -0.801 . . . . 0.0 110.605 -177.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.514 ' CB ' ' OE1' ' A' ' 72' ' ' GLU . 59.7 m -126.23 154.22 74.49 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.15 -0.969 . . . . 0.0 110.727 -175.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.569 ' O ' ' O ' ' A' ' 70' ' ' VAL . 9.2 Cg_exo -68.05 67.1 0.96 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 124.036 1.545 . . . . 0.0 110.498 177.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.017 HG23 HG12 ' A' ' 88' ' ' VAL . 13.4 p 27.68 -169.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 C-N-CA 123.119 0.568 . . . . 0.0 111.891 176.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.003 HD12 HG13 ' A' ' 70' ' ' VAL . 4.7 mp 38.65 30.39 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 O-C-N 119.803 -1.811 . . . . 0.0 111.132 -168.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.514 ' OE1' ' CB ' ' A' ' 68' ' ' CYS . 2.0 tm-20 -147.64 94.4 4.42 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.19 -0.944 . . . . 0.0 110.241 -178.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -48.32 107.75 0.15 Allowed 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.908 1.478 . . . . 0.0 110.012 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 98.5 m -96.31 131.78 42.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.914 . . . . 0.0 110.388 -177.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 140.83 -163.2 26.62 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.827 ' CD ' HD11 ' A' ' 21' ' ' LEU . 44.0 Cg_endo -71.08 141.79 70.62 Favored 'Cis proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.872 -2.137 . . . . 0.0 110.647 1.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.643 HD23 ' HB1' ' A' ' 60' ' ' ALA . 42.9 tp -97.04 156.02 16.54 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.343 -0.848 . . . . 0.0 110.694 -177.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.449 ' N ' ' HG ' ' A' ' 77' ' ' LEU . 6.0 t60 -75.38 127.09 32.35 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.154 -0.966 . . . . 0.0 110.349 178.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.7 HG22 ' O ' ' A' ' 82' ' ' GLY . 13.5 t -141.22 160.03 40.96 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.221 -0.925 . . . . 0.0 110.255 178.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -59.67 -26.61 65.7 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.186 -0.946 . . . . 0.0 110.521 -177.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.425 ' O ' HD21 ' A' ' 10' ' ' LEU . 97.0 m-85 -97.0 17.48 16.86 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.145 -0.972 . . . . 0.0 110.731 -176.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.7 ' O ' HG22 ' A' ' 79' ' ' THR . . . 121.09 -129.95 8.01 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 -178.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.528 ' HB3' ' HB2' ' A' ' 76' ' ' PRO . 84.5 m-85 -121.97 129.93 52.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.129 -1.218 . . . . 0.0 110.077 178.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.626 ' CD2' HD23 ' A' ' 10' ' ' LEU . 44.6 m170 -101.29 125.28 47.91 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.188 -0.945 . . . . 0.0 110.726 176.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.732 HG22 ' HB ' ' A' ' 9' ' ' ILE . 3.8 tt -109.33 128.61 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.709 -1.245 . . . . 0.0 109.078 167.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.843 HD12 HG21 ' A' ' 64' ' ' VAL . 96.7 mt -116.22 123.63 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.018 -1.051 . . . . 0.0 111.28 -167.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.731 ' HD2' HD12 ' A' ' 7' ' ' LEU . 27.6 mttt -83.77 130.05 34.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.23 -0.919 . . . . 0.0 109.036 170.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 1.017 HG12 HG23 ' A' ' 70' ' ' VAL . 29.2 t -109.33 129.44 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.163 -0.961 . . . . 0.0 109.973 -179.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.571 ' HB2' ' HB3' ' A' ' 5' ' ' ALA . 91.6 mt -134.0 117.31 16.54 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.296 -0.878 . . . . 0.0 109.838 -178.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.524 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 50.8 m-85 70.75 -2.04 2.4 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.498 -0.751 . . . . 0.0 111.556 177.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.524 ' HG2' ' O ' ' A' ' 90' ' ' TYR . 22.3 ptt180 . . . . . 0 N--CA 1.496 1.837 0 O-C-N 121.249 -0.907 . . . . 0.0 110.264 174.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.113 0.482 . . . . 0.0 110.09 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 54' ' ' GLN . 93.5 mttt -69.99 -60.01 2.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.104 -0.997 . . . . 0.0 110.534 -177.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 27.3 m -105.22 139.01 40.51 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.409 -0.807 . . . . 0.0 110.722 -173.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.488 ' O ' ' HA ' ' A' ' 51' ' ' GLU . . . -143.26 159.02 43.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.075 -1.015 . . . . 0.0 110.039 177.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.506 ' HA ' ' O ' ' A' ' 50' ' ' GLY . . . -94.62 123.71 38.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.268 -0.895 . . . . 0.0 109.145 174.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.728 ' HB1' ' NE2' ' A' ' 8' ' ' HIS . . . -137.24 134.99 36.81 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.709 -1.244 . . . . 0.0 111.884 -169.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.524 ' CD2' ' HA ' ' A' ' 48' ' ' ASP . 33.8 mt -109.32 137.07 47.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.39 -0.819 . . . . 0.0 109.371 170.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.728 ' NE2' ' HB1' ' A' ' 6' ' ' ALA . 22.2 m170 -130.87 132.38 45.12 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.932 -1.105 . . . . 0.0 111.0 -176.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.683 ' HB ' HG22 ' A' ' 85' ' ' ILE . 84.4 mt -118.64 129.89 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.947 -1.095 . . . . 0.0 109.567 169.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.769 HD13 ' C ' ' A' ' 10' ' ' LEU . 2.7 tm? -110.0 120.41 42.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.361 -0.837 . . . . 0.0 109.896 178.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.758 HG13 HD22 ' A' ' 16' ' ' LEU . 3.1 t -103.94 128.97 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.179 -0.951 . . . . 0.0 110.053 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -68.5 -39.96 81.05 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.464 -0.773 . . . . 0.0 110.96 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -119.79 140.54 50.59 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.018 -1.051 . . . . 0.0 110.595 -175.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.458 ' HG2' ' CZ ' ' A' ' 83' ' ' TYR . 93.3 mt-10 -59.97 -39.99 87.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.527 -0.733 . . . . 0.0 110.939 -175.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.1 -41.86 68.75 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.024 -1.048 . . . . 0.0 110.343 -175.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.758 HD22 HG13 ' A' ' 11' ' ' VAL . 8.1 tt -67.84 -38.56 83.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.124 -0.985 . . . . 0.0 109.648 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.863 ' O ' HD12 ' A' ' 21' ' ' LEU . . . -58.66 -45.82 88.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.294 -0.879 . . . . 0.0 110.314 178.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.5 tp -60.06 -46.25 90.16 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.121 -0.987 . . . . 0.0 109.766 175.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.421 ' O ' ' HB2' ' A' ' 23' ' ' GLN . 47.9 t0 -59.97 -40.0 87.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.332 -0.855 . . . . 0.0 109.929 178.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.631 HD23 ' N ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -62.37 -53.54 53.45 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.357 -0.839 . . . . 0.0 109.471 177.675 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.892 HD11 ' HG3' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -54.57 -48.55 71.93 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.475 -0.766 . . . . 0.0 109.557 -176.717 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -65.1 -40.51 94.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.435 -0.791 . . . . 0.0 109.987 174.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.478 ' NE2' HD21 ' A' ' 33' ' ' LEU . 62.7 tt0 -61.54 -40.03 93.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.44 -0.787 . . . . 0.0 110.297 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.548 HG12 ' CD1' ' A' ' 33' ' ' LEU . 92.4 mt -67.07 -39.99 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.278 -0.889 . . . . 0.0 110.111 178.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -64.53 -54.54 30.65 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.948 -1.095 . . . . 0.0 110.226 176.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -60.01 -43.44 95.23 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.216 -0.927 . . . . 0.0 110.967 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.735 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -105.55 -59.43 0.64 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -177.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.735 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 83.92 104.65 0.05 Allowed 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 121.554 0.692 . . . . 0.0 110.053 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.427 ' CG ' ' O ' ' A' ' 28' ' ' ALA . 3.8 m-20 -175.08 70.48 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.582 -0.698 . . . . 0.0 109.501 -176.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -60.01 -44.24 94.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.925 . . . . 0.0 110.781 -174.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.59 -54.03 31.5 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 119.813 -1.184 . . . . 0.0 110.272 -177.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -66.7 -40.08 88.31 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.991 -1.299 . . . . 0.0 110.861 -175.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.548 ' CD1' HG12 ' A' ' 24' ' ' ILE . 64.5 mt -61.59 -42.94 99.58 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.91 -1.119 . . . . 0.0 110.266 178.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.535 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -59.98 -49.25 78.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 0.0 110.381 178.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -59.98 -47.19 86.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.103 -0.998 . . . . 0.0 110.653 -174.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -67.38 -50.08 61.22 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.971 -1.08 . . . . 0.0 110.998 -177.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 55.3 m170 -69.98 -39.92 75.64 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.047 -1.033 . . . . 0.0 111.103 -173.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.638 ' O ' HG22 ' A' ' 39' ' ' ILE . 22.9 t -60.08 -42.06 93.78 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.001 -1.062 . . . . 0.0 110.338 -174.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.638 HG22 ' O ' ' A' ' 38' ' ' SER . 21.3 tt 38.02 31.57 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.624 -0.673 . . . . 0.0 110.877 177.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.43 ' N ' ' O ' ' A' ' 38' ' ' SER . 15.5 p -120.25 166.15 16.07 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.253 -0.904 . . . . 0.0 110.206 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -53.05 -23.12 20.85 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.968 1.51 . . . . 0.0 110.273 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -107.58 21.27 17.71 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.276 -0.89 . . . . 0.0 109.836 177.006 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.4 -51.37 27.07 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 174.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 48.9 mttp -63.03 -40.03 96.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.442 -1.034 . . . . 0.0 110.849 176.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.652 ' HE ' HD23 ' A' ' 49' ' ' LEU . 11.9 tpt180 -102.59 -44.6 5.29 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.928 -1.108 . . . . 0.0 110.642 -172.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -63.75 -33.38 87.08 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.224 -1.551 . . . . 0.0 109.224 175.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.482 ' O ' HD22 ' A' ' 7' ' ' LEU . . . -74.36 0.11 55.72 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 175.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.524 ' HA ' ' CD2' ' A' ' 7' ' ' LEU . 49.7 t0 -170.82 71.96 0.05 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.24 -1.153 . . . . 0.0 108.916 178.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.652 HD23 ' HE ' ' A' ' 45' ' ' ARG . 11.0 mt -76.15 -6.94 53.54 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.622 -0.674 . . . . 0.0 109.814 -177.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 5' ' ' ALA . . . 70.39 -139.06 29.97 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -174.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.491 ' HG3' ' HB2' ' A' ' 5' ' ' ALA . 4.8 mt-10 -101.59 132.1 47.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.397 -1.061 . . . . 0.0 110.643 178.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.717 ' CE2' ' HB3' ' A' ' 6' ' ' ALA . 5.3 p90 -145.38 160.64 41.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.678 -0.639 . . . . 0.0 109.333 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.517 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 95.0 mtt180 -66.8 156.57 35.2 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.039 -1.038 . . . . 0.0 110.526 -175.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.534 ' N ' ' O ' ' A' ' 2' ' ' LYS . 14.3 pt20 -60.72 -11.1 6.46 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.008 -1.058 . . . . 0.0 110.883 -176.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -124.07 63.21 0.56 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -177.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.517 ' HG2' ' O ' ' A' ' 53' ' ' ARG . 3.5 mm-40 -113.77 -60.1 1.93 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.025 -1.28 . . . . 0.0 109.257 177.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 37.0 ttm -103.61 -77.75 0.56 Allowed 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.529 -0.869 . . . . 0.0 111.206 -167.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.504 HG13 ' O ' ' A' ' 58' ' ' VAL . 14.4 p -122.0 130.61 24.65 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.034 -1.041 . . . . 0.0 110.304 -176.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.429 ' O ' ' C ' ' A' ' 60' ' ' ALA . 9.5 Cg_endo -57.17 -49.5 13.91 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.882 1.464 . . . . 0.0 110.407 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 59' ' ' PRO . . . -41.23 -35.29 0.59 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.455 -0.778 . . . . 0.0 110.212 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.585 ' CE1' ' NE2' ' A' ' 8' ' ' HIS . 90.4 t80 -60.08 -41.34 92.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.288 -0.883 . . . . 0.0 110.72 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.466 ' O ' HG12 ' A' ' 65' ' ' VAL . 53.0 t0 -60.01 -41.54 92.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.023 -1.048 . . . . 0.0 109.96 -178.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 67' ' ' SER . 62.7 tttm -55.09 -58.56 7.15 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.338 -0.851 . . . . 0.0 110.777 178.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.616 HG11 ' CD1' ' A' ' 86' ' ' ILE . 2.9 p -70.0 -42.5 79.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.04 -1.038 . . . . 0.0 111.319 -170.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.466 HG12 ' O ' ' A' ' 62' ' ' ASP . 3.6 p -57.79 -28.26 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.388 -1.445 . . . . 0.0 109.584 174.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -92.33 -10.76 37.12 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.049 -1.032 . . . . 0.0 109.873 173.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.534 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 4.8 t -93.43 -66.21 0.94 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.409 -0.807 . . . . 0.0 109.715 175.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.534 ' SG ' HG22 ' A' ' 64' ' ' VAL . 24.1 p -76.01 155.97 84.38 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.37 -0.831 . . . . 0.0 110.245 177.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.478 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 53.7 Cg_endo -79.27 148.11 20.99 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.993 1.523 . . . . 0.0 110.223 175.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.75 HG13 HD12 ' A' ' 71' ' ' LEU . 6.3 p -54.63 168.4 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.146 -0.971 . . . . 0.0 109.887 177.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.75 HD12 HG13 ' A' ' 70' ' ' VAL . 1.3 mp 58.24 22.25 9.03 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.34 -0.85 . . . . 0.0 110.188 -176.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.478 ' HB3' ' O ' ' A' ' 69' ' ' PRO . 1.4 tp10 -130.77 94.3 29.16 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.254 -0.904 . . . . 0.0 110.251 -179.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -51.07 109.6 0.33 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.927 1.488 . . . . 0.0 109.809 177.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 94.3 m -115.65 130.02 56.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.208 -0.932 . . . . 0.0 110.069 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 140.77 -171.53 24.03 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -176.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.892 ' HG3' HD11 ' A' ' 21' ' ' LEU . 41.5 Cg_endo -69.88 138.66 50.6 Favored 'Cis proline' 0 C--N 1.312 -1.373 0 C-N-CA 121.749 -2.188 . . . . 0.0 110.89 -0.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.771 HD12 HD12 ' A' ' 86' ' ' ILE . 95.2 mt -92.94 172.89 8.04 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.52 -0.738 . . . . 0.0 110.484 -176.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -99.18 126.58 44.99 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.064 -1.023 . . . . 0.0 110.67 177.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.899 HG21 ' CG ' ' A' ' 84' ' ' HIS . 8.8 t -146.29 165.1 30.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.272 -0.893 . . . . 0.0 109.817 175.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -59.65 -40.0 86.26 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.104 -0.998 . . . . 0.0 110.769 -175.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -66.38 -15.37 63.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.135 -0.978 . . . . 0.0 110.331 -177.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.426 ' CA ' HD21 ' A' ' 10' ' ' LEU . . . 141.17 -135.69 7.05 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.036 -1.625 . . . . 0.0 109.036 -178.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.473 ' O ' ' HA ' ' A' ' 10' ' ' LEU . 4.3 m-85 -97.1 125.12 41.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.135 -1.215 . . . . 0.0 110.131 176.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.899 ' CG ' HG21 ' A' ' 79' ' ' THR . 7.4 m170 -102.73 115.97 31.65 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.607 -0.683 . . . . 0.0 110.345 177.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.683 HG22 ' HB ' ' A' ' 9' ' ' ILE . 4.4 tt -104.66 128.38 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.512 -1.367 . . . . 0.0 109.392 168.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.771 HD12 HD12 ' A' ' 77' ' ' LEU . 53.0 mt -118.96 125.72 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.369 -0.832 . . . . 0.0 111.051 -172.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.518 ' HB3' ' HB2' ' A' ' 7' ' ' LEU . 18.8 tttm -99.97 125.8 46.04 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.334 -0.854 . . . . 0.0 109.215 171.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.596 ' O ' HD23 ' A' ' 89' ' ' LEU . 21.3 t -101.43 136.49 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.177 -0.952 . . . . 0.0 110.121 -175.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.596 HD23 ' O ' ' A' ' 88' ' ' VAL . 88.9 mt -140.04 147.04 39.76 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.241 -0.912 . . . . 0.0 109.227 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.494 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 98.0 m-85 62.66 -55.35 0.16 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.598 -0.689 . . . . 0.0 111.732 174.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.504 ' N ' ' O ' ' A' ' 89' ' ' LEU . 68.5 ttp85 60.06 20.03 9.21 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.93 -1.106 . . . . 0.0 110.859 -178.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.431 ' OXT' ' OE2' ' A' ' 51' ' ' GLU . 10.1 t-20 . . . . . 0 N--CA 1.491 1.599 0 O-C-N 120.86 -1.15 . . . . 0.0 110.122 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.376 0.608 . . . . 0.0 110.035 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -67.62 -39.15 84.72 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.267 -0.896 . . . . 0.0 110.333 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.528 HG22 ' HD3' ' A' ' 53' ' ' ARG . 81.8 p -127.82 155.15 44.55 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.245 -0.91 . . . . 0.0 110.601 -176.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.614 ' HB2' ' HD2' ' A' ' 91' ' ' ARG . . . -140.52 150.53 43.83 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.422 -0.799 . . . . 0.0 110.265 -178.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.401 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -95.66 137.84 34.16 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.122 -0.986 . . . . 0.0 109.71 177.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.642 ' HB1' ' NE2' ' A' ' 8' ' ' HIS . . . -148.54 130.88 15.62 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.92 -1.112 . . . . 0.0 111.517 -173.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.564 HD12 ' HD2' ' A' ' 87' ' ' LYS . 78.1 mt -105.21 147.54 27.91 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.202 -0.936 . . . . 0.0 109.144 169.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.642 ' NE2' ' HB1' ' A' ' 6' ' ' ALA . 35.1 m-70 -138.34 125.26 21.19 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.749 -1.219 . . . . 0.0 111.303 -177.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.693 ' HB ' HG22 ' A' ' 85' ' ' ILE . 81.5 mt -110.04 129.97 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.016 -1.052 . . . . 0.0 109.857 169.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.768 ' O ' HD13 ' A' ' 10' ' ' LEU . 1.0 OUTLIER -110.38 119.97 40.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -0.894 . . . . 0.0 110.365 178.435 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.804 HG13 HD22 ' A' ' 16' ' ' LEU . 2.9 t -104.03 135.29 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.421 -0.8 . . . . 0.0 109.954 177.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -67.51 -37.12 82.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.273 -0.892 . . . . 0.0 110.769 -176.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.412 ' HG3' ' HB2' ' A' ' 16' ' ' LEU . 18.1 pt-20 -129.75 149.73 51.37 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.013 -1.054 . . . . 0.0 110.871 -175.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.468 ' HB2' ' CZ ' ' A' ' 83' ' ' TYR . 89.0 tt0 -59.97 -42.8 94.94 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.384 -0.822 . . . . 0.0 111.049 -178.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -55.08 -42.35 72.7 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.022 -1.049 . . . . 0.0 110.293 -177.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.804 HD22 HG13 ' A' ' 11' ' ' VAL . 3.6 tt -67.97 -39.83 83.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.211 -0.931 . . . . 0.0 109.341 177.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.513 ' N ' HG11 ' A' ' 11' ' ' VAL . . . -57.99 -46.8 84.62 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.32 -0.863 . . . . 0.0 109.737 175.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.458 ' CD1' ' HG2' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -59.99 -42.62 94.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.153 -0.967 . . . . 0.0 109.6 173.925 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -60.44 -45.44 93.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.414 -0.803 . . . . 0.0 109.904 175.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.417 ' CD1' ' HB3' ' A' ' 33' ' ' LEU . 7.9 tp -64.01 -44.23 93.25 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.406 -0.809 . . . . 0.0 109.972 176.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.892 HD21 ' HD3' ' A' ' 76' ' ' PRO . 3.6 mp -58.95 -46.15 88.74 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.547 -0.721 . . . . 0.0 110.008 -175.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -62.71 -40.05 95.95 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.627 -0.671 . . . . 0.0 110.109 177.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.616 ' HG2' HD21 ' A' ' 33' ' ' LEU . 72.9 tp60 -60.05 -39.9 87.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 0.0 109.939 -178.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.518 HG13 HD13 ' A' ' 33' ' ' LEU . 96.7 mt -65.06 -46.84 90.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.274 -0.891 . . . . 0.0 110.122 177.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 64.3 mttt -60.78 -44.17 97.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.136 -0.978 . . . . 0.0 109.557 175.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -59.12 -64.58 0.89 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.348 -0.845 . . . . 0.0 110.343 176.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.742 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -105.24 -40.02 2.16 Favored Glycine 0 N--CA 1.483 1.79 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 -171.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.742 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 77.46 105.49 0.07 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.716 -0.873 . . . . 0.0 109.942 -177.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -175.37 73.17 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.346 -0.846 . . . . 0.0 109.867 -177.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.579 ' CE1' HG13 ' A' ' 9' ' ' ILE . 23.6 t80 -59.95 -42.76 94.75 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.56 -0.712 . . . . 0.0 110.511 -175.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.82 -49.99 60.63 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -176.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.449 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 74.1 mttt -65.44 -39.95 92.69 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.973 -1.31 . . . . 0.0 110.049 -177.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.616 HD21 ' HG2' ' A' ' 23' ' ' GLN . 84.9 mt -64.95 -39.94 94.26 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.206 -0.934 . . . . 0.0 110.027 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.602 ' HB2' HG12 ' A' ' 9' ' ' ILE . . . -57.4 -50.2 73.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.218 -0.926 . . . . 0.0 110.034 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.473 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 21.4 mmtp -59.98 -43.4 95.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.276 -0.89 . . . . 0.0 110.745 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 32' ' ' LYS . 99.7 mttt -70.0 -43.16 71.96 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.09 -1.006 . . . . 0.0 111.424 -172.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.766 ' CD2' HD21 ' A' ' 16' ' ' LEU . 32.1 m80 -93.33 -36.0 12.76 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.97 -1.081 . . . . 0.0 110.912 -174.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.647 ' O ' HG22 ' A' ' 39' ' ' ILE . 31.6 t -60.03 -52.95 63.19 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.088 -1.007 . . . . 0.0 110.606 -174.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.647 HG22 ' O ' ' A' ' 38' ' ' SER . 13.6 tt 38.46 39.28 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.589 -0.695 . . . . 0.0 110.711 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.498 ' SG ' ' N ' ' A' ' 43' ' ' GLY . 12.8 p -127.88 163.61 42.23 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.214 -0.929 . . . . 0.0 109.841 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.46 ' HD2' ' HB2' ' A' ' 40' ' ' CYS . 5.7 Cg_endo -52.34 -27.87 32.68 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.722 1.38 . . . . 0.0 110.188 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.526 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.7 OUTLIER -101.03 14.59 31.47 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.893 . . . . 0.0 109.767 174.675 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.498 ' N ' ' SG ' ' A' ' 40' ' ' CYS . . . -77.08 -55.0 4.55 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 176.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.473 ' HA ' ' HE2' ' A' ' 35' ' ' LYS . 28.5 ttpt -60.03 -40.01 87.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.481 -1.011 . . . . 0.0 110.226 177.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.456 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 3.3 tpp180 -98.31 -44.27 6.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.097 -1.002 . . . . 0.0 110.615 -176.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -60.66 -33.74 83.51 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.38 -3.04 37.22 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 176.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.468 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 38.5 p-10 -167.93 62.45 0.07 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.267 -1.137 . . . . 0.0 109.279 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 6.2 mt -70.03 -29.09 66.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.637 -0.664 . . . . 0.0 110.317 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.81 -119.32 6.2 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -177.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.46 ' HG3' ' C ' ' A' ' 4' ' ' ALA . 82.5 tt0 -133.02 130.03 38.91 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.209 -1.171 . . . . 0.0 110.475 -175.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.469 ' CE2' ' HB3' ' A' ' 6' ' ' ALA . 1.5 p90 -127.05 -178.82 4.56 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.107 -0.995 . . . . 0.0 109.941 175.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.528 ' HD3' HG22 ' A' ' 3' ' ' THR . 26.6 mmt85 -63.6 -138.6 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.995 -1.066 . . . . 0.0 110.183 -173.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -61.43 -19.96 62.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.14 -0.975 . . . . 0.0 111.25 -174.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 140.76 89.6 0.16 Allowed Glycine 0 N--CA 1.496 2.652 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 -173.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.457 ' NE2' ' HG2' ' A' ' 53' ' ' ARG . 2.4 mt-30 -114.72 -43.69 3.12 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 119.951 -1.911 . . . . 0.0 110.745 -165.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.445 ' SD ' ' CD1' ' A' ' 49' ' ' LEU . 56.3 ttp -60.17 -40.06 88.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.153 -0.967 . . . . 0.0 110.948 -172.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.468 HG13 ' O ' ' A' ' 58' ' ' VAL . 12.3 p -145.65 133.12 10.27 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.074 -1.016 . . . . 0.0 110.423 -174.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.473 ' O ' ' N ' ' A' ' 62' ' ' ASP . 14.4 Cg_endo -61.03 -51.53 4.52 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.968 1.51 . . . . 0.0 110.559 178.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.618 ' O ' HG12 ' A' ' 64' ' ' VAL . . . -41.17 -34.32 0.45 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.357 -0.839 . . . . 0.0 110.218 -178.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.871 ' CZ ' HG21 ' A' ' 65' ' ' VAL . 63.8 t80 -60.05 -39.75 87.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.274 -0.892 . . . . 0.0 110.388 177.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.473 ' N ' ' O ' ' A' ' 59' ' ' PRO . 8.0 t70 -60.0 -48.88 79.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.135 -0.978 . . . . 0.0 110.187 -176.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 67' ' ' SER . 38.8 tptt -59.91 -50.03 75.37 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.149 -0.969 . . . . 0.0 110.206 178.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.837 HG11 HD12 ' A' ' 86' ' ' ILE . 7.5 p -77.43 -41.19 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.103 -0.998 . . . . 0.0 111.554 -174.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.871 HG21 ' CZ ' ' A' ' 61' ' ' PHE . 1.9 p -56.32 -27.15 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.357 -1.464 . . . . 0.0 109.305 174.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -94.61 -7.58 40.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.493 -0.754 . . . . 0.0 109.859 176.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.522 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 8.9 t -93.95 -62.04 1.42 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.502 -0.749 . . . . 0.0 109.925 178.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.491 ' HB3' ' OG1' ' A' ' 74' ' ' THR . 27.4 p -71.11 156.51 91.83 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.278 -0.889 . . . . 0.0 110.418 177.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.518 ' O ' ' N ' ' A' ' 71' ' ' LEU . 43.6 Cg_endo -82.22 79.22 3.16 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.998 1.525 . . . . 0.0 110.785 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.058 HG13 HD12 ' A' ' 71' ' ' LEU . 10.9 p 20.19 47.19 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.345 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 177.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.058 HD12 HG13 ' A' ' 70' ' ' VAL . 0.3 OUTLIER -167.17 -40.25 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.453 -0.779 . . . . 0.0 111.068 178.263 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.474 ' HG3' ' HD2' ' A' ' 69' ' ' PRO . 23.5 mm-40 -70.03 130.93 89.34 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 120.836 -1.165 . . . . 0.0 110.732 -173.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -67.48 95.49 0.39 Allowed 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.76 1.4 . . . . 0.0 109.271 172.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.726 HG21 HG23 ' A' ' 64' ' ' VAL . 21.1 m -94.42 139.77 30.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.154 -0.966 . . . . 0.0 110.451 -172.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.49 -170.36 22.36 Favored Glycine 0 N--CA 1.485 1.919 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.892 ' HD3' HD21 ' A' ' 21' ' ' LEU . 42.9 Cg_endo -74.66 124.17 9.71 Favored 'Cis proline' 0 C--N 1.311 -1.437 0 C-N-CA 121.933 -2.111 . . . . 0.0 110.28 0.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.461 ' HG ' ' N ' ' A' ' 78' ' ' HIS . 39.7 tp -94.01 160.3 14.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.278 -0.889 . . . . 0.0 110.123 -174.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.461 ' N ' ' HG ' ' A' ' 77' ' ' LEU . 47.1 t-80 -78.77 123.91 27.66 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.029 -1.044 . . . . 0.0 110.579 -178.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.939 HG21 ' CE1' ' A' ' 84' ' ' HIS . 7.0 t -133.75 164.79 26.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.265 -0.897 . . . . 0.0 109.505 172.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.04 -29.85 68.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.121 -0.987 . . . . 0.0 110.29 -177.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.429 ' H ' HG23 ' A' ' 79' ' ' THR . 98.6 m-85 -83.01 -4.91 58.83 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.143 -0.973 . . . . 0.0 110.745 -176.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.667 ' O ' HG22 ' A' ' 79' ' ' THR . . . 133.35 -139.29 10.81 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 -177.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.507 ' HB3' ' HB2' ' A' ' 76' ' ' PRO . 95.8 m-85 -101.98 121.47 42.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.043 -1.269 . . . . 0.0 110.264 178.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.939 ' CE1' HG21 ' A' ' 79' ' ' THR . 34.3 m170 -103.55 128.79 50.73 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.09 -1.006 . . . . 0.0 110.895 178.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.693 HG22 ' HB ' ' A' ' 9' ' ' ILE . 4.5 tt -113.18 119.98 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.963 -1.086 . . . . 0.0 108.947 167.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.837 HD12 HG11 ' A' ' 64' ' ' VAL . 85.5 mt -114.84 131.75 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.919 -1.113 . . . . 0.0 111.322 -168.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.564 ' HD2' HD12 ' A' ' 7' ' ' LEU . 26.5 ttmt -100.01 124.12 45.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.345 -0.847 . . . . 0.0 109.614 173.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.652 HG12 ' HA ' ' A' ' 70' ' ' VAL . 57.7 t -113.85 131.5 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.15 -0.969 . . . . 0.0 110.438 -172.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.509 ' O ' ' N ' ' A' ' 91' ' ' ARG . 57.2 mt -138.04 170.76 15.47 Favored 'General case' 0 C--N 1.309 -1.154 0 O-C-N 121.186 -0.946 . . . . 0.0 109.867 -177.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.449 ' O ' ' HB2' ' A' ' 91' ' ' ARG . 45.9 m-85 54.07 -76.93 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.752 -0.593 . . . . 0.0 112.069 171.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.64 ' CG ' HG23 ' A' ' 70' ' ' VAL . 19.1 mmm180 55.58 40.03 31.03 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.799 -1.188 . . . . 0.0 110.794 -172.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 91' ' ' ARG . 7.6 t-20 . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.041 -1.037 . . . . 0.0 110.254 176.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.465 ' O ' ' O ' ' A' ' 92' ' ' ASN . . . . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.216 0.532 . . . . 0.0 110.432 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.462 ' O ' ' ND2' ' A' ' 92' ' ' ASN . 22.1 ttpt -59.99 -40.07 87.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.213 -0.929 . . . . 0.0 110.175 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.45 ' O ' ' O ' ' A' ' 91' ' ' ARG . 69.6 p -133.34 169.99 16.12 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.477 -0.764 . . . . 0.0 110.005 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' A' ' 51' ' ' GLU . . . -112.99 128.59 56.54 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -0.93 . . . . 0.0 109.952 178.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.594 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -91.49 126.25 36.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.41 -0.806 . . . . 0.0 109.213 176.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.814 ' HB1' ' NE2' ' A' ' 8' ' ' HIS . . . -135.23 126.09 27.46 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 118.915 -1.114 . . . . 0.0 111.486 -170.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.483 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 58.3 mt -102.68 137.91 40.28 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.144 -0.973 . . . . 0.0 109.132 169.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.814 ' NE2' ' HB1' ' A' ' 6' ' ' ALA . 38.1 m-70 -131.09 131.07 43.94 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.905 -1.122 . . . . 0.0 111.088 -176.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.736 ' HB ' HG22 ' A' ' 85' ' ' ILE . 71.3 mt -114.37 124.98 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.98 -1.075 . . . . 0.0 109.456 168.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.604 ' HG ' ' CD2' ' A' ' 84' ' ' HIS . 0.3 OUTLIER -97.67 101.27 12.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.323 -0.86 . . . . 0.0 109.505 179.496 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.661 HG11 ' HB2' ' A' ' 17' ' ' ALA . 3.6 t -67.63 -50.96 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.202 -0.936 . . . . 0.0 110.514 -175.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.539 ' CB ' ' O ' ' A' ' 11' ' ' VAL . 28.8 tttt 80.61 -17.26 0.59 Allowed 'General case' 0 N--CA 1.503 2.21 0 O-C-N 122.027 -0.42 . . . . 0.0 110.942 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -138.45 135.03 34.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.805 -1.185 . . . . 0.0 110.582 177.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -59.97 -45.23 93.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.458 -0.776 . . . . 0.0 110.285 177.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.7 mttm -59.83 -40.48 88.62 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.237 -0.914 . . . . 0.0 109.938 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.647 HD23 HG13 ' A' ' 11' ' ' VAL . 5.0 tt -67.87 -39.75 83.68 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.376 -0.827 . . . . 0.0 109.577 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.863 ' HB1' ' HG3' ' A' ' 76' ' ' PRO . . . -59.5 -43.93 93.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.233 -0.917 . . . . 0.0 109.775 175.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.589 ' HA ' HD12 ' A' ' 21' ' ' LEU . 0.1 OUTLIER -60.0 -40.87 90.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.352 -0.842 . . . . 0.0 110.056 175.495 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -60.83 -49.73 76.3 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.993 -1.067 . . . . 0.0 110.147 176.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 1.034 HD13 HD21 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -69.13 -50.34 48.83 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.135 -0.978 . . . . 0.0 110.915 -175.667 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 1.116 HD13 ' N ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -58.87 -29.63 67.13 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 120.742 -1.224 . . . . 0.0 108.961 -173.055 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 1.116 ' N ' HD13 ' A' ' 21' ' ' LEU . 87.9 tt0 -64.65 -39.93 94.54 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.36 -0.838 . . . . 0.0 109.931 170.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.415 ' HB3' ' O ' ' A' ' 20' ' ' LEU . 68.4 tp60 -60.05 -45.11 93.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.356 -0.84 . . . . 0.0 111.351 -173.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.557 HD11 ' CD2' ' A' ' 33' ' ' LEU . 27.6 mt -61.07 -47.96 91.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.041 -1.037 . . . . 0.0 110.592 -173.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.8 mttp -60.28 -49.01 79.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.943 -1.098 . . . . 0.0 110.256 177.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -60.01 -58.39 8.73 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.099 -1.001 . . . . 0.0 110.287 176.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.749 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -105.6 -46.76 1.18 Allowed Glycine 0 N--CA 1.484 1.849 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 -172.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.749 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 79.71 170.33 0.17 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.795 -0.826 . . . . 0.0 110.078 -176.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.613 ' CB ' ' O ' ' A' ' 28' ' ' ALA . 87.4 m-20 109.48 85.91 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.911 0 C-N-CA 124.656 1.182 . . . . 0.0 109.662 -174.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.512 ' CZ ' ' CB ' ' A' ' 73' ' ' PRO . 6.5 m-85 -60.02 -49.61 77.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.239 -0.913 . . . . 0.0 110.447 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.37 -46.28 94.19 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -177.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.437 ' HB3' ' HB3' ' A' ' 29' ' ' ASP . 33.1 tttp -62.84 -40.0 96.09 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.112 -1.228 . . . . 0.0 110.152 -177.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.034 HD21 HD13 ' A' ' 20' ' ' LEU . 47.3 tp -62.92 -40.03 96.34 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.213 -0.929 . . . . 0.0 110.337 177.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.487 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -59.66 -49.97 75.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.073 -1.017 . . . . 0.0 110.269 -178.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 46.8 tttm -60.05 -47.49 85.64 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.935 -1.103 . . . . 0.0 110.615 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -60.66 -42.28 96.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.134 -0.979 . . . . 0.0 111.03 -173.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 10.3 m80 -104.01 -4.38 23.4 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.928 -1.107 . . . . 0.0 111.022 -174.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.66 ' O ' HG22 ' A' ' 39' ' ' ILE . 1.2 t -60.04 -46.07 90.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.072 -1.017 . . . . 0.0 110.645 -177.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.66 HG22 ' O ' ' A' ' 38' ' ' SER . 16.0 tt 38.86 29.75 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.621 -0.674 . . . . 0.0 110.494 -177.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.453 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 13.4 t -131.7 135.63 27.13 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.358 -0.839 . . . . 0.0 110.032 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 40' ' ' CYS . 46.1 Cg_exo -51.6 -31.09 38.8 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.907 1.477 . . . . 0.0 110.776 -176.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 46' ' ' GLY . 0.3 OUTLIER -99.94 11.74 38.54 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.154 -0.966 . . . . 0.0 110.318 -179.695 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.464 ' HA3' ' OG ' ' A' ' 38' ' ' SER . . . -104.92 -62.87 0.65 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -60.07 -39.98 87.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.139 -1.212 . . . . 0.0 109.823 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -102.41 -33.33 9.59 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.444 -0.785 . . . . 0.0 110.029 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.478 ' O ' ' HG ' ' A' ' 49' ' ' LEU . . . -99.51 -4.78 55.96 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 -177.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.676 ' O ' HD12 ' A' ' 49' ' ' LEU . . . -51.31 -50.43 40.72 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.601 -1.799 . . . . 0.0 108.601 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -71.91 106.76 4.35 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.197 -1.178 . . . . 0.0 109.644 170.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.676 HD12 ' O ' ' A' ' 47' ' ' GLY . 0.8 OUTLIER -108.98 1.1 20.4 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.11 -0.994 . . . . 0.0 110.166 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.79 -134.09 25.52 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.507 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 13.7 mt-10 -121.47 138.47 54.27 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.298 -1.119 . . . . 0.0 111.234 -176.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.538 ' HB2' ' NE2' ' A' ' 56' ' ' GLN . 0.7 OUTLIER -121.72 173.1 7.67 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.399 -0.813 . . . . 0.0 109.555 173.548 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.538 ' O ' ' HB2' ' A' ' 54' ' ' GLN . 9.6 ptp85 -124.01 144.09 50.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.057 -1.027 . . . . 0.0 110.021 -178.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.538 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 43.4 mt-30 83.5 -41.89 0.09 Allowed 'General case' 0 N--CA 1.503 2.175 0 CA-C-O 121.337 0.589 . . . . 0.0 109.615 -174.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.548 ' O ' ' N ' ' A' ' 57' ' ' MET . . . 133.53 -55.07 0.75 Allowed Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 -178.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.538 ' NE2' ' HB2' ' A' ' 52' ' ' PHE . 1.1 pt20 35.25 -89.24 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 122.218 -0.578 . . . . 0.0 111.111 174.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.784 ' HG3' HG12 ' A' ' 58' ' ' VAL . 5.5 tpt -1.22 -71.74 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 176.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.784 HG12 ' HG3' ' A' ' 57' ' ' MET . 12.6 p -155.46 133.18 6.67 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.303 -0.873 . . . . 0.0 110.074 -179.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 60' ' ' ALA . 3.0 Cg_endo -50.35 -53.6 6.84 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.849 1.447 . . . . 0.0 110.41 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.416 ' O ' HG12 ' A' ' 64' ' ' VAL . . . -43.14 -36.12 1.58 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.233 -0.917 . . . . 0.0 110.441 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.555 ' HB2' ' CG1' ' A' ' 58' ' ' VAL . 71.9 t80 -59.99 -40.02 87.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.188 -0.945 . . . . 0.0 110.656 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.519 ' O ' HG12 ' A' ' 65' ' ' VAL . 29.4 t0 -59.97 -49.97 75.59 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.136 -0.977 . . . . 0.0 110.331 -177.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.475 ' O ' ' HB2' ' A' ' 67' ' ' SER . 33.9 tttt -60.0 -50.03 75.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.07 -1.019 . . . . 0.0 110.541 177.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.657 HG23 HG21 ' A' ' 74' ' ' THR . 14.6 p -72.27 -44.93 63.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.025 -1.047 . . . . 0.0 111.082 -173.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.586 ' N ' HG13 ' A' ' 64' ' ' VAL . 1.9 p -55.58 -28.44 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.458 -1.402 . . . . 0.0 109.162 173.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -93.43 -10.63 34.45 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.328 -0.858 . . . . 0.0 109.897 175.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.55 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 7.4 t -93.84 -57.27 2.6 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.381 -0.825 . . . . 0.0 109.963 175.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.597 ' CB ' ' HG1' ' A' ' 74' ' ' THR . 84.6 m -111.63 122.88 36.12 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.292 -0.88 . . . . 0.0 110.012 177.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.402 ' HB3' ' NH2' ' A' ' 91' ' ' ARG . 12.2 Cg_endo -61.73 -179.65 0.41 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.797 1.42 . . . . 0.0 110.643 -177.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.649 HG12 HG12 ' A' ' 88' ' ' VAL . 31.4 m -61.87 161.43 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.357 -0.839 . . . . 0.0 110.924 -175.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.523 HD12 ' HB ' ' A' ' 70' ' ' VAL . 5.5 mp 58.55 23.58 10.99 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.584 -0.698 . . . . 0.0 110.367 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -129.76 72.2 81.99 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.304 -0.872 . . . . 0.0 109.545 175.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.512 ' CB ' ' CZ ' ' A' ' 30' ' ' PHE . 65.1 Cg_exo -44.55 122.07 3.7 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.025 1.54 . . . . 0.0 110.071 -177.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.657 HG21 HG23 ' A' ' 64' ' ' VAL . 94.7 m -119.99 130.06 54.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.215 -0.928 . . . . 0.0 110.264 -175.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.424 ' HA3' HG13 ' A' ' 85' ' ' ILE . . . 137.33 -171.44 23.16 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 178.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.863 ' HG3' ' HB1' ' A' ' 17' ' ' ALA . 40.5 Cg_endo -68.24 153.89 88.57 Favored 'Cis proline' 0 C--N 1.313 -1.3 0 C-N-CA 121.695 -2.21 . . . . 0.0 110.297 1.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.501 ' HG ' ' N ' ' A' ' 78' ' ' HIS . 25.0 tp -132.94 157.68 44.52 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.986 -1.071 . . . . 0.0 110.576 -171.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.501 ' N ' ' HG ' ' A' ' 77' ' ' LEU . 44.8 m80 -62.91 132.73 53.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.305 -0.872 . . . . 0.0 110.685 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.69 HG22 ' O ' ' A' ' 82' ' ' GLY . 5.0 t -148.25 159.17 44.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.269 -0.895 . . . . 0.0 109.809 173.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.02 -26.93 66.47 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.209 -0.932 . . . . 0.0 110.118 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -88.59 -1.54 58.11 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.355 -0.841 . . . . 0.0 110.675 -176.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.69 ' O ' HG22 ' A' ' 79' ' ' THR . . . 129.66 -123.67 4.18 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -177.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.478 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 96.0 m-85 -114.18 122.49 46.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.193 -1.18 . . . . 0.0 110.189 178.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.667 ' CG ' HG21 ' A' ' 79' ' ' THR . 41.3 m170 -109.33 120.43 42.49 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.321 -0.862 . . . . 0.0 110.823 177.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.736 HG22 ' HB ' ' A' ' 9' ' ' ILE . 7.7 tt -103.19 116.81 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.474 -1.391 . . . . 0.0 109.077 165.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.512 HG21 ' HD1' ' A' ' 61' ' ' PHE . 85.5 mt -114.63 130.01 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.923 -1.111 . . . . 0.0 111.007 -170.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.483 ' HB3' ' HB2' ' A' ' 7' ' ' LEU . 22.9 tttm -100.16 120.7 40.28 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.427 -0.795 . . . . 0.0 109.232 174.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.649 HG12 HG12 ' A' ' 70' ' ' VAL . 90.9 t -101.17 139.23 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.085 -1.01 . . . . 0.0 110.609 -173.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.621 HD23 ' O ' ' A' ' 88' ' ' VAL . 84.8 mt -138.29 120.63 15.91 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 121.329 -0.857 . . . . 0.0 109.707 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.557 ' CB ' ' O ' ' A' ' 89' ' ' LEU . 2.5 m-85 82.33 -24.68 0.17 Allowed 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.586 -0.697 . . . . 0.0 111.217 175.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.539 ' HB2' ' CG1' ' A' ' 70' ' ' VAL . 35.1 ttm180 55.99 164.8 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.866 -1.146 . . . . 0.0 110.371 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.465 ' O ' ' O ' ' A' ' 1' ' ' ALA . 4.0 t-20 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.971 176.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.564 ' CB ' ' HB3' ' A' ' 92' ' ' ASN . . . . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.209 0.528 . . . . 0.0 110.365 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 53' ' ' ARG . 72.1 mmtt -67.98 -36.68 80.45 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.318 -0.864 . . . . 0.0 109.966 176.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.499 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 35.4 p -128.72 162.36 27.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.334 -0.853 . . . . 0.0 110.238 -178.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.774 ' HB2' ' HG2' ' A' ' 91' ' ' ARG . . . -146.86 165.14 30.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.351 -0.843 . . . . 0.0 109.824 176.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.66 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -99.21 134.12 42.51 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.197 -0.94 . . . . 0.0 109.639 178.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.697 ' HB1' ' NE2' ' A' ' 8' ' ' HIS . . . -135.92 128.01 29.75 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.708 -1.245 . . . . 0.0 111.828 -171.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.542 HD12 ' HD3' ' A' ' 87' ' ' LYS . 75.5 mt -108.82 141.09 41.35 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.188 -0.945 . . . . 0.0 109.201 168.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.697 ' NE2' ' HB1' ' A' ' 6' ' ' ALA . 26.3 m-70 -135.37 125.82 26.71 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.787 -1.195 . . . . 0.0 111.081 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.568 ' HB ' ' CG2' ' A' ' 85' ' ' ILE . 87.6 mt -110.14 130.05 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.91 -1.119 . . . . 0.0 110.211 170.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.622 HD23 ' N ' ' A' ' 11' ' ' VAL . 0.7 OUTLIER -105.08 120.01 40.45 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.457 -0.777 . . . . 0.0 109.942 178.408 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.908 HG13 HD23 ' A' ' 16' ' ' LEU . 2.0 t -108.29 129.67 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.229 -0.919 . . . . 0.0 109.631 178.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -68.4 -39.46 81.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.258 -0.901 . . . . 0.0 110.558 -176.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -120.7 141.4 50.45 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.16 -0.962 . . . . 0.0 110.79 -177.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.585 ' HB2' ' CZ ' ' A' ' 83' ' ' TYR . 83.5 tt0 -60.0 -40.06 87.92 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.476 -0.765 . . . . 0.0 110.877 -178.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -55.88 -41.79 74.96 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.082 -1.011 . . . . 0.0 110.41 -174.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.908 HD23 HG13 ' A' ' 11' ' ' VAL . 1.4 tp -68.28 -40.01 81.96 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.214 -0.929 . . . . 0.0 109.563 177.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.401 ' HA ' ' HB3' ' A' ' 20' ' ' LEU . . . -59.72 -42.3 92.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.422 -0.799 . . . . 0.0 110.097 177.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.5 tp -60.06 -42.71 95.08 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.158 -0.964 . . . . 0.0 109.352 173.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.461 ' HB3' ' O ' ' A' ' 16' ' ' LEU . 56.1 t0 -59.99 -40.01 87.71 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -0.888 . . . . 0.0 109.387 174.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.741 HD13 HD21 ' A' ' 33' ' ' LEU . 0.6 OUTLIER -62.36 -43.28 99.2 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.494 -0.754 . . . . 0.0 109.463 175.68 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.787 HD21 ' HD3' ' A' ' 76' ' ' PRO . 4.0 mp -59.99 -49.61 77.0 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.765 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.421 ' HA ' ' OE1' ' A' ' 22' ' ' GLU . 51.7 tp10 -61.13 -40.0 92.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.287 -0.883 . . . . 0.0 109.85 173.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -61.14 -41.68 97.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.435 -0.791 . . . . 0.0 110.559 -176.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.717 HD11 HD11 ' A' ' 20' ' ' LEU . 33.0 mt -67.49 -40.08 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.007 -1.058 . . . . 0.0 110.281 176.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.402 ' HG3' ' O ' ' A' ' 21' ' ' LEU . 30.3 mttm -62.9 -53.93 46.5 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.099 -1.001 . . . . 0.0 109.987 -177.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -60.75 -50.78 72.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.194 -0.941 . . . . 0.0 110.048 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.757 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -105.97 -54.56 0.71 Allowed Glycine 0 N--CA 1.487 2.043 0 N-CA-C 110.014 -1.235 . . . . 0.0 110.014 -173.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.757 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 79.83 172.24 0.15 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.869 -0.783 . . . . 0.0 109.922 -176.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.614 ' CB ' ' O ' ' A' ' 28' ' ' ALA . 95.9 m-20 114.73 78.09 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.013 0 C-N-CA 124.859 1.264 . . . . 0.0 109.618 -175.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -60.03 -49.96 75.61 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.269 -0.895 . . . . 0.0 110.778 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.7 -49.91 65.35 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -175.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.491 ' HB2' ' HB3' ' A' ' 29' ' ' ASP . 94.6 mttt -64.59 -39.8 94.39 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.995 -1.297 . . . . 0.0 110.218 -175.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.741 HD21 HD13 ' A' ' 20' ' ' LEU . 9.8 tt -65.32 -40.04 93.23 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.176 -0.952 . . . . 0.0 110.127 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.564 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -59.81 -50.21 74.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.186 -0.946 . . . . 0.0 110.165 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.5 tttt -59.99 -50.0 75.44 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.382 -0.824 . . . . 0.0 110.717 -178.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.493 ' O ' HG12 ' A' ' 39' ' ' ILE . 88.8 tttt -65.93 -47.28 75.22 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.181 -0.949 . . . . 0.0 111.202 -174.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.501 ' CD2' ' HG ' ' A' ' 33' ' ' LEU . 67.2 m-70 -80.78 -50.01 10.4 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.874 -1.141 . . . . 0.0 111.674 -171.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.465 ' O ' ' C ' ' A' ' 39' ' ' ILE . 53.9 m -60.54 -40.07 90.19 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.915 -1.116 . . . . 0.0 110.765 -173.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.797 ' O ' HG22 ' A' ' 39' ' ' ILE . 31.9 mm 32.04 46.18 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 CA-C-O 121.5 0.667 . . . . 0.0 110.985 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.5 ' SG ' ' N ' ' A' ' 43' ' ' GLY . 17.0 p -133.79 170.14 12.1 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.348 -0.845 . . . . 0.0 109.945 -177.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.464 ' HD2' ' HB2' ' A' ' 40' ' ' CYS . 52.6 Cg_exo -49.96 -30.39 24.01 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.851 1.448 . . . . 0.0 109.982 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.473 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 6.1 p -108.84 27.29 9.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.22 -0.925 . . . . 0.0 109.61 173.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.5 ' N ' ' SG ' ' A' ' 40' ' ' CYS . . . -103.16 -67.16 0.75 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 108.607 -1.797 . . . . 0.0 108.607 176.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -59.99 -40.09 87.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -1.178 . . . . 0.0 109.961 172.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.463 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 13.7 tpt180 -99.8 -41.2 7.36 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.331 -0.856 . . . . 0.0 110.554 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.473 ' HA3' ' O ' ' A' ' 42' ' ' SER . . . -76.6 -22.81 71.71 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.32 -4.32 56.16 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 175.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.525 ' HA ' ' CD2' ' A' ' 7' ' ' LEU . 38.3 t0 -173.83 70.31 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.249 -1.148 . . . . 0.0 109.27 178.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.471 ' HG ' ' HA2' ' A' ' 46' ' ' GLY . 7.3 mt -70.08 -29.2 66.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.61 -0.681 . . . . 0.0 110.077 -176.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 111.78 -143.33 17.36 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -113.17 136.12 53.07 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.383 -1.069 . . . . 0.0 110.455 -177.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.691 ' CZ ' ' HB3' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -148.6 168.44 22.78 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.305 -0.872 . . . . 0.0 109.707 175.373 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.503 ' HA ' ' O ' ' A' ' 2' ' ' LYS . 75.1 ttt180 -50.43 -84.19 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.737 -1.227 . . . . 0.0 110.546 -172.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.462 ' HG2' ' HG2' ' A' ' 53' ' ' ARG . 10.9 pt20 -177.35 133.4 0.17 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.995 -1.066 . . . . 0.0 110.507 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.92 -9.99 75.39 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 174.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.628 ' NE2' ' CD1' ' A' ' 52' ' ' PHE . 0.5 OUTLIER -60.01 -36.57 77.52 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.05 -1.265 . . . . 0.0 111.157 -173.662 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.478 ' HE1' ' HB2' ' A' ' 8' ' ' HIS . 27.7 ttt -83.51 -42.09 17.25 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.591 -1.318 . . . . 0.0 110.852 -167.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.493 ' O ' ' HB3' ' A' ' 61' ' ' PHE . 7.3 p -173.04 133.85 0.67 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.271 -0.893 . . . . 0.0 109.799 -173.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -49.37 -53.38 7.13 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 O-C-N 123.793 1.417 . . . . 0.0 110.247 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -43.95 -37.85 3.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.293 -0.879 . . . . 0.0 110.544 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.649 ' HD1' HG21 ' A' ' 86' ' ' ILE . 37.7 t80 -59.9 -40.26 88.16 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.074 -1.016 . . . . 0.0 110.386 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.43 ' O ' HG12 ' A' ' 65' ' ' VAL . 32.9 t0 -59.97 -46.05 90.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.103 -0.998 . . . . 0.0 109.932 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -59.96 -49.99 75.51 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.293 -0.879 . . . . 0.0 110.623 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.725 HG11 HD12 ' A' ' 86' ' ' ILE . 8.9 p -73.2 -45.4 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.03 -1.044 . . . . 0.0 111.144 -174.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.549 ' N ' HG13 ' A' ' 64' ' ' VAL . 5.5 p -57.46 -24.24 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.359 -1.463 . . . . 0.0 109.156 172.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -97.29 -1.5 44.54 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.365 -0.834 . . . . 0.0 109.904 175.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.531 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 22.8 t -96.58 -67.42 0.85 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.449 -0.782 . . . . 0.0 109.573 174.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 73.4 m -92.48 128.54 44.12 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.29 -0.881 . . . . 0.0 110.063 175.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -50.62 165.81 0.38 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.815 1.429 . . . . 0.0 110.353 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.504 HG11 ' CB ' ' A' ' 91' ' ' ARG . 31.4 m -59.8 169.1 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.265 -0.897 . . . . 0.0 110.726 -178.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 70' ' ' VAL . 5.4 mp 59.94 26.17 15.4 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.699 -0.626 . . . . 0.0 110.583 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.06 90.96 37.6 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.085 -1.01 . . . . 0.0 110.17 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -52.22 110.64 0.47 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.771 1.406 . . . . 0.0 109.55 176.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 94.2 m -119.92 129.97 54.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.08 -1.012 . . . . 0.0 110.536 -173.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.512 ' HA2' ' CD2' ' A' ' 77' ' ' LEU . . . 148.41 -169.95 28.98 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.787 ' HD3' HD21 ' A' ' 21' ' ' LEU . 44.1 Cg_endo -75.6 139.16 59.51 Favored 'Cis proline' 0 C--N 1.313 -1.292 0 C-N-CA 121.854 -2.144 . . . . 0.0 110.481 1.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.512 ' CD2' ' HA2' ' A' ' 75' ' ' GLY . 1.1 mm? -98.15 174.83 6.33 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.241 -0.912 . . . . 0.0 110.699 -177.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.443 ' CD2' ' CE2' ' A' ' 83' ' ' TYR . 53.3 m170 -109.66 127.54 54.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.283 -0.885 . . . . 0.0 110.887 -176.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.998 HG21 ' CE1' ' A' ' 84' ' ' HIS . 11.1 t -140.42 168.77 19.02 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.457 -0.777 . . . . 0.0 109.775 174.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -59.95 -40.12 87.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.097 -1.002 . . . . 0.0 110.484 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -64.25 -16.69 62.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.086 -1.009 . . . . 0.0 110.583 -177.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.472 ' O ' HG22 ' A' ' 79' ' ' THR . . . 140.67 -143.62 13.68 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 -177.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.585 ' CZ ' ' HB2' ' A' ' 14' ' ' GLU . 68.9 m-85 -97.16 122.65 40.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.136 -1.214 . . . . 0.0 110.181 178.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.998 ' CE1' HG21 ' A' ' 79' ' ' THR . 24.7 m170 -105.79 120.07 40.77 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.46 -0.775 . . . . 0.0 110.603 178.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.568 ' CG2' ' HB ' ' A' ' 9' ' ' ILE . 6.5 tt -109.71 121.64 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.683 -1.261 . . . . 0.0 109.248 167.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.725 HD12 HG11 ' A' ' 64' ' ' VAL . 88.2 mt -115.53 130.04 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.108 -0.995 . . . . 0.0 111.289 -170.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.542 ' HD3' HD12 ' A' ' 7' ' ' LEU . 20.7 tttm -102.96 132.02 49.5 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.438 -0.789 . . . . 0.0 108.913 171.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.595 ' O ' HD23 ' A' ' 89' ' ' LEU . 20.0 m -119.78 138.58 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.026 -1.046 . . . . 0.0 110.546 -176.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.66 ' HB2' ' HB3' ' A' ' 5' ' ' ALA . 58.5 mt -140.02 -167.34 2.28 Favored 'General case' 0 C--N 1.309 -1.186 0 O-C-N 121.291 -0.881 . . . . 0.0 109.901 -173.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.44 ' C ' ' O ' ' A' ' 89' ' ' LEU . 53.5 m-85 30.41 -85.63 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.865 -177.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.774 ' HG2' ' HB2' ' A' ' 4' ' ' ALA . 0.0 OUTLIER 54.44 50.23 16.63 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.697 -1.252 . . . . 0.0 109.837 -175.262 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.564 ' HB3' ' CB ' ' A' ' 1' ' ' ALA . 4.6 t-20 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 118.074 -0.965 . . . . 0.0 110.332 -178.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.43 ' HA ' ' OXT' ' A' ' 92' ' ' ASN . . . . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.224 0.535 . . . . 0.0 110.248 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 66.5 mmtt -60.21 -39.97 88.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.183 -0.948 . . . . 0.0 110.026 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.557 HG22 ' HG2' ' A' ' 53' ' ' ARG . 67.9 p -124.39 150.57 45.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.272 -0.892 . . . . 0.0 110.089 178.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.459 ' C ' ' HG3' ' A' ' 51' ' ' GLU . . . -130.71 154.78 47.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.054 -1.029 . . . . 0.0 110.463 -178.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.606 ' CB ' ' CD1' ' A' ' 90' ' ' TYR . . . -98.07 136.59 38.1 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.226 -0.921 . . . . 0.0 109.757 177.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.7 ' HB1' ' NE2' ' A' ' 8' ' ' HIS . . . -147.58 123.12 10.43 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.719 -1.238 . . . . 0.0 112.098 -172.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.601 ' N ' ' CD1' ' A' ' 7' ' ' LEU . 4.0 mp -96.17 147.0 24.2 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.024 -1.048 . . . . 0.0 108.995 167.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.894 ' CD2' HD12 ' A' ' 49' ' ' LEU . 37.5 m-70 -136.35 137.02 40.17 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.773 -1.204 . . . . 0.0 111.287 -175.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.719 ' HB ' HG22 ' A' ' 85' ' ' ILE . 79.3 mt -118.93 129.9 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.127 -0.983 . . . . 0.0 109.799 168.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.542 ' HG ' ' CD2' ' A' ' 84' ' ' HIS . 0.4 OUTLIER -102.16 118.08 36.14 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.509 -0.745 . . . . 0.0 110.262 -179.115 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.946 HG13 HD22 ' A' ' 16' ' ' LEU . 2.2 t -108.09 127.74 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.323 -0.861 . . . . 0.0 109.891 177.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -69.95 -39.95 75.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.352 -0.842 . . . . 0.0 110.296 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -120.03 140.36 51.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.216 -0.928 . . . . 0.0 110.496 -175.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -59.89 -39.95 87.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.382 -0.823 . . . . 0.0 110.617 -176.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -52.16 -41.48 62.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.086 -1.009 . . . . 0.0 110.254 -175.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.946 HD22 HG13 ' A' ' 11' ' ' VAL . 7.9 tt -67.73 -44.08 78.46 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.029 -1.045 . . . . 0.0 109.912 177.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.941 ' HB1' ' HG3' ' A' ' 76' ' ' PRO . . . -59.91 -45.93 90.98 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.249 -0.907 . . . . 0.0 109.936 177.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.601 ' HA ' HD12 ' A' ' 21' ' ' LEU . 10.1 tp -60.99 -39.18 88.68 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.932 -1.105 . . . . 0.0 109.405 170.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.432 ' HB3' ' O ' ' A' ' 16' ' ' LEU . 48.6 t0 -62.25 -49.79 74.29 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 120.999 -1.063 . . . . 0.0 110.312 176.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.83 HD12 ' N ' ' A' ' 21' ' ' LEU . 0.7 OUTLIER -69.94 -47.2 63.31 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.019 -1.051 . . . . 0.0 110.788 -175.574 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 1.141 HD13 ' N ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -59.96 -29.29 68.32 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.012 -1.055 . . . . 0.0 108.864 -173.185 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 1.141 ' N ' HD13 ' A' ' 21' ' ' LEU . 85.7 tt0 -61.87 -42.66 99.33 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.407 -0.808 . . . . 0.0 110.137 173.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.79 -39.99 95.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.298 -0.876 . . . . 0.0 110.574 -176.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.862 HD13 ' CE2' ' A' ' 30' ' ' PHE . 97.6 mt -61.89 -45.44 98.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -0.86 . . . . 0.0 109.824 -178.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.566 ' HE3' HD21 ' A' ' 21' ' ' LEU . 36.7 mttm -61.06 -46.26 91.4 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.228 -0.92 . . . . 0.0 109.716 176.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -59.95 -61.34 2.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.382 -0.824 . . . . 0.0 110.485 177.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.755 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -104.87 -39.58 2.3 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -172.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.755 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 81.19 102.56 0.06 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.953 -0.734 . . . . 0.0 110.142 -178.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -175.74 67.05 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.421 -0.799 . . . . 0.0 110.128 -177.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.862 ' CE2' HD13 ' A' ' 24' ' ' ILE . 2.0 m-85 -59.98 -44.15 94.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -0.923 . . . . 0.0 110.838 -178.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.4 -43.63 98.48 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -177.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -65.09 -40.2 94.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.175 -1.191 . . . . 0.0 110.345 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.566 ' CD1' HG13 ' A' ' 24' ' ' ILE . 88.9 mt -66.33 -39.93 89.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.112 -0.992 . . . . 0.0 110.491 178.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 38' ' ' SER . . . -60.0 -46.42 89.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.107 -0.996 . . . . 0.0 110.027 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -60.0 -50.21 74.61 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.363 -0.835 . . . . 0.0 110.785 -177.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.472 ' O ' HG13 ' A' ' 39' ' ' ILE . 51.3 mttt -75.91 -47.89 23.5 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.023 -1.048 . . . . 0.0 111.249 -174.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 60.9 m-70 -71.78 -40.04 69.51 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.932 -1.105 . . . . 0.0 111.198 -174.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.515 ' OG ' ' CA ' ' A' ' 43' ' ' GLY . 16.5 t -61.02 -50.04 74.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.035 -1.041 . . . . 0.0 111.045 -172.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.741 ' O ' HG22 ' A' ' 39' ' ' ILE . 96.3 mt 31.98 49.06 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 CA-C-O 121.318 0.58 . . . . 0.0 111.037 -177.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.501 ' SG ' ' N ' ' A' ' 43' ' ' GLY . 16.4 p -143.3 161.94 45.14 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.402 -0.811 . . . . 0.0 110.229 -176.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.457 ' HD2' ' HB2' ' A' ' 40' ' ' CYS . 6.1 Cg_endo -53.0 -26.12 30.79 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.947 1.498 . . . . 0.0 110.779 -178.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.532 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -109.05 19.77 19.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.074 -1.016 . . . . 0.0 110.087 177.816 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.515 ' CA ' ' OG ' ' A' ' 38' ' ' SER . . . -77.81 -53.13 5.09 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 108.583 -1.807 . . . . 0.0 108.583 172.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 61.8 mttt -60.21 -40.05 88.76 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.301 -1.117 . . . . 0.0 110.354 176.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.437 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 9.5 tpp180 -94.99 -41.22 9.26 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.982 -1.074 . . . . 0.0 110.262 -177.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -67.04 -28.09 73.67 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 178.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.86 -4.46 54.53 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 177.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.423 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 51.4 t0 -173.95 70.96 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.266 -1.138 . . . . 0.0 109.135 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.894 HD12 ' CD2' ' A' ' 8' ' ' HIS . 7.5 mt -69.94 -27.73 64.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.445 -0.784 . . . . 0.0 110.66 -174.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.56 -145.28 16.14 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 -176.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.459 ' HG3' ' C ' ' A' ' 4' ' ' ALA . 59.5 tt0 -113.14 132.14 55.57 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.161 -1.199 . . . . 0.0 110.544 -177.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 6' ' ' ALA . 1.9 p90 -136.83 161.95 34.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.34 -0.85 . . . . 0.0 109.768 177.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.557 ' HG2' HG22 ' A' ' 3' ' ' THR . 82.8 mtp180 -69.25 57.2 0.11 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.942 -1.099 . . . . 0.0 111.155 -173.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.48 ' C ' ' O ' ' A' ' 53' ' ' ARG . 15.9 pt20 27.48 39.32 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.19 0 CA-C-O 121.037 0.446 . . . . 0.0 112.09 174.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . -175.7 53.77 0.12 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.475 ' OE1' ' HB2' ' A' ' 52' ' ' PHE . 0.0 OUTLIER -155.72 -62.48 0.11 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.261 -1.141 . . . . 0.0 110.304 178.931 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.78 ' HG2' HD13 ' A' ' 49' ' ' LEU . 29.7 tpp -59.93 -41.11 91.08 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.164 -0.96 . . . . 0.0 110.818 -175.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 58' ' ' VAL . 11.0 p -162.45 131.48 3.07 Favored Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.138 -0.976 . . . . 0.0 110.352 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.41 ' O ' ' C ' ' A' ' 60' ' ' ALA . 13.0 Cg_endo -60.41 -49.63 8.7 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.904 1.476 . . . . 0.0 110.245 178.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.426 ' O ' ' HB3' ' A' ' 63' ' ' LYS . . . -41.17 -34.29 0.45 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.48 -0.762 . . . . 0.0 110.399 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.505 ' O ' HG12 ' A' ' 64' ' ' VAL . 68.5 t80 -60.0 -39.99 87.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.114 -0.991 . . . . 0.0 110.005 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -59.92 -39.97 87.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.309 -0.87 . . . . 0.0 109.511 179.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.723 ' HD3' HD21 ' A' ' 77' ' ' LEU . 87.7 tttt -57.49 -40.56 78.88 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.466 -0.771 . . . . 0.0 110.379 176.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.76 HG23 HG21 ' A' ' 74' ' ' THR . 14.3 p -91.77 -41.9 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.974 -1.079 . . . . 0.0 111.52 -173.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.526 HG22 ' CZ ' ' A' ' 91' ' ' ARG . 2.5 p -52.65 -27.16 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.53 -1.356 . . . . 0.0 109.805 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -99.83 5.66 45.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.172 -0.955 . . . . 0.0 109.88 176.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.523 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 37.5 t -99.61 -80.06 0.48 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.382 -0.824 . . . . 0.0 110.181 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 84.3 m -78.51 156.95 77.98 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.153 -0.967 . . . . 0.0 110.352 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.539 ' O ' ' O ' ' A' ' 70' ' ' VAL . 38.6 Cg_endo -79.07 69.78 7.78 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.069 1.562 . . . . 0.0 110.585 179.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.016 ' C ' HD13 ' A' ' 71' ' ' LEU . 8.4 p 29.4 -174.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 178.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.016 HD13 ' C ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER 23.6 41.67 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.607 0 O-C-N 120.821 -1.174 . . . . 0.0 113.364 -164.139 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' A' ' 70' ' ' VAL . 9.7 tt0 -134.04 100.86 12.84 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.766 -1.209 . . . . 0.0 109.91 171.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.544 ' HB3' ' CZ ' ' A' ' 30' ' ' PHE . 50.9 Cg_exo -47.42 103.84 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.908 1.478 . . . . 0.0 110.38 -176.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.76 HG21 HG23 ' A' ' 64' ' ' VAL . 50.6 m -98.99 134.2 42.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.322 -0.861 . . . . 0.0 110.504 -177.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.447 ' HA3' HG13 ' A' ' 85' ' ' ILE . . . 135.78 -172.65 22.17 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 176.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.941 ' HG3' ' HB1' ' A' ' 17' ' ' ALA . 43.5 Cg_endo -70.13 127.95 12.11 Favored 'Cis proline' 0 N--CA 1.49 1.277 0 C-N-CA 121.798 -2.167 . . . . 0.0 110.292 2.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.723 HD21 ' HD3' ' A' ' 63' ' ' LYS . 62.3 tp -95.37 155.91 16.54 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.252 -0.905 . . . . 0.0 110.763 -174.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -71.41 123.97 23.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.335 -0.853 . . . . 0.0 110.514 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.811 HG21 ' CG ' ' A' ' 84' ' ' HIS . 12.9 t -140.12 156.11 46.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.205 -0.934 . . . . 0.0 109.727 174.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -60.12 -32.07 70.66 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.118 -0.989 . . . . 0.0 110.927 -175.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -75.68 -8.79 57.69 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.015 -1.053 . . . . 0.0 110.365 -178.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.725 ' O ' HG22 ' A' ' 79' ' ' THR . . . 138.34 -132.88 6.0 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 -175.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -107.86 125.78 51.88 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.092 -1.24 . . . . 0.0 110.1 175.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.811 ' CG ' HG21 ' A' ' 79' ' ' THR . 45.6 m170 -106.96 124.18 49.25 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.143 -0.973 . . . . 0.0 110.367 175.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.719 HG22 ' HB ' ' A' ' 9' ' ' ILE . 9.9 tt -108.54 125.47 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 118.719 -1.192 . . . . 0.0 109.398 168.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 86.0 mt -120.08 130.67 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.016 -1.052 . . . . 0.0 111.785 -167.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.598 ' HD3' ' CG ' ' A' ' 30' ' ' PHE . 13.5 mtmm -93.06 126.83 38.35 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.1 -1.0 . . . . 0.0 109.12 168.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.938 HG12 HG23 ' A' ' 70' ' ' VAL . 59.3 t -109.93 130.07 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.029 -1.044 . . . . 0.0 110.458 -175.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.597 HD23 ' O ' ' A' ' 88' ' ' VAL . 87.7 mt -139.71 -155.25 0.57 Allowed 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.272 -0.893 . . . . 0.0 110.109 -178.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.606 ' CD1' ' CB ' ' A' ' 5' ' ' ALA . 16.9 m-85 32.82 -89.0 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 O-C-N 122.104 -0.372 . . . . 0.0 111.268 -178.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.526 ' CZ ' HG22 ' A' ' 65' ' ' VAL . 13.5 tpt180 59.55 46.82 11.58 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.878 -1.139 . . . . 0.0 110.62 177.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.43 ' OXT' ' HA ' ' A' ' 1' ' ' ALA . 4.6 p30 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.322 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.115 0.483 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 53' ' ' ARG . 24.6 mttm -59.98 -52.29 66.02 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.236 -0.915 . . . . 0.0 109.896 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 67.6 m -133.77 135.38 43.86 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.779 177.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' A' ' 51' ' ' GLU . . . -150.42 158.48 44.2 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.816 -1.178 . . . . 0.0 111.247 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.619 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -101.25 136.96 40.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.491 -0.755 . . . . 0.0 109.45 176.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.709 ' HB1' ' NE2' ' A' ' 8' ' ' HIS . . . -150.19 129.74 13.07 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.981 -1.075 . . . . 0.0 111.224 -177.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.526 HD12 ' HD3' ' A' ' 87' ' ' LYS . 72.6 mt -99.5 135.09 41.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.253 -0.904 . . . . 0.0 109.168 169.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.709 ' NE2' ' HB1' ' A' ' 6' ' ' ALA . 40.8 m170 -130.34 129.39 43.1 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.025 -1.047 . . . . 0.0 110.827 -176.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.55 ' HB ' ' CG2' ' A' ' 85' ' ' ILE . 84.6 mt -114.45 129.8 69.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.179 -0.951 . . . . 0.0 109.547 169.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.797 ' O ' HD13 ' A' ' 10' ' ' LEU . 1.8 tm? -106.8 114.92 29.31 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.291 -0.88 . . . . 0.0 110.138 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.807 HG13 HD22 ' A' ' 16' ' ' LEU . 2.3 t -101.3 128.97 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.312 -0.868 . . . . 0.0 109.925 177.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -67.33 -40.04 85.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.306 -0.871 . . . . 0.0 110.705 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -109.02 138.99 44.5 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.06 -1.025 . . . . 0.0 111.159 -174.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.495 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 87.9 tt0 -60.09 -41.24 92.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.556 -0.715 . . . . 0.0 110.182 176.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -56.06 -43.76 78.22 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.257 -0.902 . . . . 0.0 109.848 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.807 HD22 HG13 ' A' ' 11' ' ' VAL . 3.2 tt -67.84 -36.02 79.6 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.342 -0.849 . . . . 0.0 109.5 177.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.529 ' HA ' ' HB3' ' A' ' 20' ' ' LEU . . . -57.52 -44.33 84.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.945 -1.097 . . . . 0.0 109.603 172.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.717 ' HA ' HD11 ' A' ' 21' ' ' LEU . 0.1 OUTLIER -60.04 -39.95 87.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.204 -0.935 . . . . 0.0 109.901 173.159 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.476 ' HB3' ' O ' ' A' ' 16' ' ' LEU . 60.4 t0 -61.06 -40.83 95.16 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.677 -1.264 . . . . 0.0 109.101 171.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.842 ' C ' HD12 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -64.17 -80.69 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.551 -0.718 . . . . 0.0 110.445 179.826 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.808 HD12 ' H ' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -49.99 -20.01 0.84 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.21 -1.556 . . . . 0.0 110.497 -164.719 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.808 ' H ' HD12 ' A' ' 21' ' ' LEU . 50.2 tp10 -64.49 -39.99 94.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.682 -1.262 . . . . 0.0 110.189 173.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.44 ' HG2' ' O ' ' A' ' 19' ' ' ASP . 85.4 mm-40 -60.44 -41.74 94.68 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.284 -0.885 . . . . 0.0 111.221 -172.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.608 HG13 HD12 ' A' ' 33' ' ' LEU . 1.7 mp -64.3 -43.67 97.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.016 -1.053 . . . . 0.0 110.768 -173.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -61.84 -50.05 73.82 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 120.775 -1.203 . . . . 0.0 110.164 178.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -63.26 -57.3 10.89 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.128 -0.983 . . . . 0.0 110.521 176.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.748 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -104.53 -39.98 2.29 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -172.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.748 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 82.99 -153.52 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.23 0 O-C-N 122.109 -0.642 . . . . 0.0 110.476 -179.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.486 ' HB2' ' O ' ' A' ' 28' ' ' ALA . 2.7 m-20 61.38 75.66 0.4 Allowed 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 122.082 0.944 . . . . 0.0 110.558 175.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.506 ' CZ ' HG13 ' A' ' 9' ' ' ILE . 62.8 t80 -59.97 -48.15 82.9 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.82 -0.55 . . . . 0.0 110.931 -178.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.0 -41.51 97.95 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -175.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.437 ' HD2' ' CG ' ' A' ' 29' ' ' ASP . 82.0 mttt -66.34 -39.94 89.54 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.042 -1.269 . . . . 0.0 110.194 -178.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.608 HD12 HG13 ' A' ' 24' ' ' ILE . 49.1 mt -64.91 -40.07 94.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.066 -1.021 . . . . 0.0 110.206 178.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.486 ' O ' ' CB ' ' A' ' 38' ' ' SER . . . -59.57 -47.11 86.86 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.076 -1.015 . . . . 0.0 109.862 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -59.93 -40.9 90.46 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.032 -1.042 . . . . 0.0 110.431 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.8 mtpt -73.02 -52.08 15.76 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.013 -1.054 . . . . 0.0 111.764 -175.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.576 ' CD2' ' O ' ' A' ' 33' ' ' LEU . 7.4 p80 -106.01 -17.43 14.34 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.406 -1.434 . . . . 0.0 112.111 -167.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.668 ' O ' HG22 ' A' ' 39' ' ' ILE . 64.9 p -60.02 -50.06 75.22 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.621 -1.3 . . . . 0.0 110.301 -173.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.668 HG22 ' O ' ' A' ' 38' ' ' SER . 17.3 tt 38.34 31.2 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.692 -0.63 . . . . 0.0 110.466 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.51 ' SG ' ' N ' ' A' ' 43' ' ' GLY . 20.4 p -125.61 169.04 12.17 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.316 -0.865 . . . . 0.0 110.307 -176.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.469 ' HD2' ' HB2' ' A' ' 40' ' ' CYS . 41.0 Cg_exo -51.76 -34.61 55.1 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.893 1.47 . . . . 0.0 110.729 -175.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.535 ' O ' ' CA ' ' A' ' 46' ' ' GLY . 1.2 p -107.01 16.59 24.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.154 -0.966 . . . . 0.0 109.891 177.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.51 ' N ' ' SG ' ' A' ' 40' ' ' CYS . . . -79.98 -60.0 2.5 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 108.681 -1.768 . . . . 0.0 108.681 176.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -59.94 -40.37 88.73 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.424 -1.045 . . . . 0.0 110.488 176.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.556 ' NE ' HD23 ' A' ' 49' ' ' LEU . 17.0 tpt180 -104.95 -44.38 4.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.097 -1.002 . . . . 0.0 110.93 -175.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.535 ' CA ' ' O ' ' A' ' 42' ' ' SER . . . -62.37 -29.1 72.25 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.79 0.48 44.22 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 177.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.502 ' HA ' ' CD2' ' A' ' 7' ' ' LEU . 40.6 t0 -169.65 76.25 0.09 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.132 -1.217 . . . . 0.0 109.101 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.556 HD23 ' NE ' ' A' ' 45' ' ' ARG . 10.6 mt -91.28 -6.19 53.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.573 -0.704 . . . . 0.0 110.196 -175.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.95 -131.26 28.13 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 -173.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 54.8 mp0 -116.63 145.95 43.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.101 -1.235 . . . . 0.0 110.546 177.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.636 ' CE2' ' HB3' ' A' ' 6' ' ' ALA . 0.3 OUTLIER -130.19 164.14 25.15 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.321 -0.862 . . . . 0.0 110.552 176.14 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 2' ' ' LYS . 87.7 mtt180 -108.7 -169.03 1.42 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.528 -0.732 . . . . 0.0 110.434 -175.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -61.22 -14.68 27.43 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.314 -0.866 . . . . 0.0 110.253 178.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.462 ' O ' ' OE1' ' A' ' 56' ' ' GLN . . . -87.77 25.65 8.31 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.044 -1.223 . . . . 0.0 110.044 -174.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.57 ' HG3' ' HB2' ' A' ' 52' ' ' PHE . 0.0 OUTLIER -167.52 -93.94 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.918 -1.343 . . . . 0.0 110.363 173.187 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.6 ' HG2' ' CE1' ' A' ' 52' ' ' PHE . 17.3 mtm 40.14 -166.66 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.397 -0.815 . . . . 0.0 110.709 -176.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.547 HG13 ' H ' ' A' ' 61' ' ' PHE . 5.6 p -149.95 132.24 7.94 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.159 -0.963 . . . . 0.0 109.9 -177.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -39.05 -49.17 2.87 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.917 1.483 . . . . 0.0 110.845 -175.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.55 -39.35 79.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -0.893 . . . . 0.0 110.216 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.547 ' H ' HG13 ' A' ' 58' ' ' VAL . 59.5 t80 -59.92 -41.69 92.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.284 -0.885 . . . . 0.0 110.451 178.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -60.02 -47.24 86.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.232 -0.918 . . . . 0.0 109.878 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 67' ' ' SER . 96.9 mttt -59.88 -44.23 94.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.285 -0.885 . . . . 0.0 110.419 178.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.611 HG22 ' SG ' ' A' ' 68' ' ' CYS . 6.2 p -83.57 -44.96 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.12 -0.987 . . . . 0.0 111.221 -172.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.565 ' N ' HG13 ' A' ' 64' ' ' VAL . 5.0 p -55.43 -24.3 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.206 -1.558 . . . . 0.0 109.142 172.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -92.86 -15.2 26.71 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.332 -0.855 . . . . 0.0 109.661 175.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.525 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 9.4 t -93.18 -47.61 6.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.378 -0.826 . . . . 0.0 109.936 175.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.611 ' SG ' HG22 ' A' ' 64' ' ' VAL . 29.3 p -102.98 136.92 19.16 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.352 -0.843 . . . . 0.0 109.965 175.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.42 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 10.1 Cg_exo -66.55 171.61 10.44 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.796 1.419 . . . . 0.0 110.261 178.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.753 ' HB ' HD12 ' A' ' 71' ' ' LEU . 12.7 m -57.69 171.41 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.372 -0.83 . . . . 0.0 110.422 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.753 HD12 ' HB ' ' A' ' 70' ' ' VAL . 4.3 mp 38.85 39.71 0.37 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.583 -0.698 . . . . 0.0 110.764 -177.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.42 ' HB3' ' O ' ' A' ' 69' ' ' PRO . 20.0 tp10 -137.78 83.98 23.04 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.162 -0.961 . . . . 0.0 110.01 177.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -50.08 124.87 13.55 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.027 1.541 . . . . 0.0 109.981 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.514 ' OG1' ' CB ' ' A' ' 68' ' ' CYS . 96.5 m -135.22 138.09 43.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.293 -0.879 . . . . 0.0 110.21 -177.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.441 ' HA3' HG13 ' A' ' 85' ' ' ILE . . . 147.92 -172.72 28.18 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -178.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.506 ' HG3' ' HB1' ' A' ' 17' ' ' ALA . 44.6 Cg_endo -70.49 173.29 47.84 Favored 'Cis proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.77 -2.179 . . . . 0.0 110.59 -0.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.544 HD11 ' CG2' ' A' ' 64' ' ' VAL . 25.2 mt -133.57 175.33 9.52 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.243 -0.911 . . . . 0.0 110.224 -178.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -95.97 119.53 34.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.059 -1.026 . . . . 0.0 110.753 -175.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.824 HG21 ' CG ' ' A' ' 84' ' ' HIS . 15.2 t -140.94 163.41 33.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.42 -0.8 . . . . 0.0 109.779 176.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -59.99 -39.99 87.64 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.979 -1.075 . . . . 0.0 110.437 -178.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -60.06 -18.38 46.23 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.222 -0.923 . . . . 0.0 110.451 179.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.541 ' O ' HG22 ' A' ' 79' ' ' THR . . . 134.1 -130.56 5.64 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 -177.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.438 ' O ' ' HA ' ' A' ' 10' ' ' LEU . 3.6 m-85 -93.06 121.06 34.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.085 -1.244 . . . . 0.0 110.245 177.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.824 ' CG ' HG21 ' A' ' 79' ' ' THR . 1.0 OUTLIER -102.64 116.16 32.03 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.432 -0.793 . . . . 0.0 110.502 177.17 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.55 ' CG2' ' HB ' ' A' ' 9' ' ' ILE . 7.8 tt -108.62 126.28 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.86 -1.15 . . . . 0.0 109.427 170.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.578 HG12 ' CD2' ' A' ' 8' ' ' HIS . 89.5 mt -120.1 129.94 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.119 -0.988 . . . . 0.0 111.735 -167.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.526 ' HD3' HD12 ' A' ' 7' ' ' LEU . 27.8 tttt -101.08 129.84 47.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.225 -0.922 . . . . 0.0 109.165 169.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 18.0 t -100.82 139.98 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.075 -1.016 . . . . 0.0 110.414 -175.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.619 ' HB2' ' HB3' ' A' ' 5' ' ' ALA . 88.7 mt -141.68 170.15 16.27 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.434 ' C ' ' O ' ' A' ' 89' ' ' LEU . 77.8 m-85 33.37 -87.28 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 O-C-N 122.212 -0.305 . . . . 0.0 111.665 -178.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.533 ' N ' ' O ' ' A' ' 89' ' ' LEU . 1.8 ttp180 59.98 -159.9 0.3 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.7 -1.25 . . . . 0.0 109.502 -176.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.073 -1.017 . . . . 0.0 110.206 -179.532 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.791 ' HB2' ' HG2' ' A' ' 91' ' ' ARG . . . . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.105 0.479 . . . . 0.0 110.311 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.529 ' O ' ' CB ' ' A' ' 53' ' ' ARG . 88.1 tttt -59.96 -40.04 87.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.192 -0.942 . . . . 0.0 109.824 177.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.476 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 11.5 p -150.23 165.01 34.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.433 -0.792 . . . . 0.0 109.336 176.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.521 ' O ' ' HA ' ' A' ' 51' ' ' GLU . . . -127.8 150.56 49.77 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.86 -1.15 . . . . 0.0 109.954 176.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.505 ' HB3' ' HB2' ' A' ' 90' ' ' TYR . . . -89.71 121.63 32.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.32 -0.862 . . . . 0.0 109.62 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.628 ' HB3' ' CE2' ' A' ' 52' ' ' PHE . . . -131.81 131.9 43.28 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 118.992 -1.083 . . . . 0.0 111.651 -169.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.562 HD12 ' HD2' ' A' ' 87' ' ' LYS . 85.7 mt -99.96 134.01 43.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.288 -0.882 . . . . 0.0 108.991 169.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.569 ' NE2' ' HB1' ' A' ' 6' ' ' ALA . 49.7 m170 -128.51 129.67 46.38 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.833 -1.167 . . . . 0.0 111.116 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.59 ' HB ' HG22 ' A' ' 85' ' ' ILE . 80.0 mt -116.69 128.65 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.07 -1.019 . . . . 0.0 109.718 169.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.593 HD13 ' C ' ' A' ' 10' ' ' LEU . 2.4 tm? -106.58 120.32 41.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.274 -0.891 . . . . 0.0 109.911 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 1.059 HG13 HD22 ' A' ' 16' ' ' LEU . 2.3 t -106.77 125.45 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.312 -0.867 . . . . 0.0 110.282 -178.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -70.03 -37.86 75.71 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.373 -0.829 . . . . 0.0 110.499 175.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -106.48 136.8 45.6 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.086 -1.009 . . . . 0.0 111.061 -173.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.589 ' HG2' ' CZ ' ' A' ' 83' ' ' TYR . 97.1 mt-10 -59.99 -39.99 87.62 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.356 -0.84 . . . . 0.0 110.294 175.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -56.24 -44.51 79.69 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -0.913 . . . . 0.0 110.035 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.059 HD22 HG13 ' A' ' 11' ' ' VAL . 7.9 tt -68.56 -39.93 80.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.296 -0.877 . . . . 0.0 109.935 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.05 ' O ' HD12 ' A' ' 21' ' ' LEU . . . -58.2 -41.85 84.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.178 -0.951 . . . . 0.0 109.384 176.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.04 -45.36 93.08 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.075 -1.016 . . . . 0.0 109.365 171.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.439 ' HB3' ' O ' ' A' ' 16' ' ' LEU . 55.1 t0 -60.03 -42.49 94.5 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.417 -0.802 . . . . 0.0 110.11 176.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.701 ' C ' HD12 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -64.49 -47.05 80.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.237 -0.915 . . . . 0.0 109.523 178.09 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 1.05 HD12 ' O ' ' A' ' 17' ' ' ALA . 0.4 OUTLIER -56.53 -47.41 79.46 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.496 -0.753 . . . . 0.0 109.797 -178.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -61.2 -39.65 91.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.55 -0.719 . . . . 0.0 110.141 177.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.5 ' HG2' HD22 ' A' ' 33' ' ' LEU . 50.4 tp60 -59.94 -47.19 86.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.281 -0.887 . . . . 0.0 110.817 -172.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.761 HG21 ' CE2' ' A' ' 30' ' ' PHE . 2.3 mt -66.48 -43.54 90.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.055 -1.028 . . . . 0.0 110.888 -176.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -61.3 -44.26 97.51 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.702 -1.249 . . . . 0.0 109.983 -178.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -60.8 -65.33 0.71 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.149 -0.969 . . . . 0.0 110.491 175.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.759 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -105.86 -34.84 3.15 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -172.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.759 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 87.09 -147.05 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.338 0 O-C-N 122.373 -0.486 . . . . 0.0 110.328 -178.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.535 ' CB ' ' O ' ' A' ' 28' ' ' ALA . 0.5 OUTLIER 75.91 65.35 0.06 Allowed 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.308 0.575 . . . . 0.0 110.523 176.324 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.761 ' CE2' HG21 ' A' ' 24' ' ' ILE . 7.2 m-85 -60.03 -41.91 93.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.355 -0.841 . . . . 0.0 110.572 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.23 -53.82 33.93 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.176 -1.169 . . . . 0.0 110.176 -176.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.429 ' HD2' ' CG ' ' A' ' 29' ' ' ASP . 97.9 mttt -66.5 -39.98 89.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.011 -1.288 . . . . 0.0 110.555 -174.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.514 HD11 ' O ' ' A' ' 28' ' ' ALA . 88.7 mt -63.81 -40.06 95.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.097 -1.002 . . . . 0.0 109.915 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.414 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -59.98 -47.71 84.7 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.403 -0.811 . . . . 0.0 110.323 177.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -60.09 -43.14 95.74 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.271 -0.893 . . . . 0.0 110.654 -176.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 49.2 tttt -69.31 -53.79 17.88 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.037 -1.039 . . . . 0.0 110.98 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -70.39 -40.03 74.17 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.054 -1.029 . . . . 0.0 111.535 -172.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.673 ' O ' HG22 ' A' ' 39' ' ' ILE . 21.0 t -60.0 -43.55 95.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.882 -1.136 . . . . 0.0 110.187 -174.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.673 HG22 ' O ' ' A' ' 38' ' ' SER . 16.8 tt 38.26 32.04 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.655 -0.653 . . . . 0.0 110.747 176.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.489 ' SG ' ' N ' ' A' ' 43' ' ' GLY . 16.3 p -127.42 166.38 23.42 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.055 -1.028 . . . . 0.0 110.379 -176.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -51.99 -35.69 61.91 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.993 1.522 . . . . 0.0 110.56 -178.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.53 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -97.64 18.75 14.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.983 -1.073 . . . . 0.0 109.743 174.544 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.489 ' N ' ' SG ' ' A' ' 40' ' ' CYS . . . -77.2 -54.26 4.83 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 108.303 -1.919 . . . . 0.0 108.303 172.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -60.86 -39.98 91.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.527 -0.984 . . . . 0.0 110.657 176.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.485 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 11.7 tpp180 -97.95 -45.21 6.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.177 -0.952 . . . . 0.0 110.154 -177.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -68.3 -30.3 73.48 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 178.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.41 -1.37 57.35 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 176.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -171.89 68.29 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.3 -1.118 . . . . 0.0 108.85 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 7.2 mt -70.03 -28.1 65.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.54 -0.725 . . . . 0.0 110.347 -174.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 5' ' ' ALA . . . 98.92 -144.18 17.05 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.351 -1.499 . . . . 0.0 109.351 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.521 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 3.5 mt-10 -99.54 130.78 45.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.528 -0.983 . . . . 0.0 110.571 -178.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.628 ' CE2' ' HB3' ' A' ' 6' ' ' ALA . 3.3 p90 -149.02 168.41 23.2 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.241 -0.912 . . . . 0.0 110.875 178.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.529 ' CB ' ' O ' ' A' ' 2' ' ' LYS . 32.2 ttt85 -163.06 -65.18 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 173.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -68.88 136.7 53.04 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.488 -0.757 . . . . 0.0 109.655 169.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.486 ' C ' ' NE2' ' A' ' 56' ' ' GLN . . . 84.67 21.12 56.92 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 178.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.536 ' HG3' ' CD1' ' A' ' 52' ' ' PHE . 40.3 mm-40 -124.22 -64.05 1.15 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.048 -1.266 . . . . 0.0 109.763 177.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.602 ' C ' HG12 ' A' ' 58' ' ' VAL . 52.6 ttm 45.6 -107.13 0.13 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.78 -0.575 . . . . 0.0 110.874 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.602 HG12 ' C ' ' A' ' 57' ' ' MET . 7.2 p 45.41 127.51 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.551 0 CA-C-O 121.817 0.817 . . . . 0.0 113.079 -178.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.519 ' O ' ' N ' ' A' ' 62' ' ' ASP . 6.5 Cg_endo -51.69 -52.33 9.23 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 121.382 1.388 . . . . 0.0 110.997 -175.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 59' ' ' PRO . . . -42.01 -33.76 0.61 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.284 -0.885 . . . . 0.0 110.019 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.47 ' HB2' HG13 ' A' ' 58' ' ' VAL . 44.0 t80 -62.48 -39.75 94.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.334 -0.854 . . . . 0.0 110.028 177.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 59' ' ' PRO . 51.5 t0 -60.04 -40.0 87.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.34 -0.85 . . . . 0.0 110.536 -177.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 67' ' ' SER . 49.4 mttm -58.15 -48.49 80.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.093 -1.004 . . . . 0.0 111.434 -174.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.539 ' HA ' ' HB3' ' A' ' 67' ' ' SER . 2.4 p -94.73 -37.64 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.725 -1.235 . . . . 0.0 111.561 -173.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.2 p -54.82 -26.18 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.532 -1.355 . . . . 0.0 109.788 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.485 ' CD2' ' O ' ' A' ' 66' ' ' PHE . 50.7 t80 -100.68 0.05 38.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.315 -0.866 . . . . 0.0 110.127 176.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.539 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 41.2 t -94.03 -74.58 0.53 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.263 -0.898 . . . . 0.0 110.37 -176.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.482 ' O ' ' N ' ' A' ' 70' ' ' VAL . 94.5 m -100.27 142.8 25.3 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.244 -0.91 . . . . 0.0 110.388 -178.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.495 ' O ' ' C ' ' A' ' 70' ' ' VAL . 35.4 Cg_exo -56.47 81.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.053 1.554 . . . . 0.0 110.222 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.824 ' O ' HD12 ' A' ' 71' ' ' LEU . 16.8 m 13.41 65.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.391 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.824 HD12 ' O ' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -166.95 -47.41 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.456 -0.778 . . . . 0.0 110.315 177.583 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -83.34 148.05 54.76 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.229 -0.92 . . . . 0.0 110.434 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -70.52 141.32 41.88 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.105 1.582 . . . . 0.0 110.622 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.455 ' HB ' ' CG2' ' A' ' 64' ' ' VAL . 94.5 m -138.01 137.8 38.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.25 -0.906 . . . . 0.0 110.189 178.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 140.89 -167.11 25.75 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.756 ' HD3' HD21 ' A' ' 21' ' ' LEU . 43.1 Cg_endo -72.1 140.6 66.84 Favored 'Cis proline' 0 C--N 1.315 -1.231 0 C-N-CA 121.783 -2.174 . . . . 0.0 110.586 1.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.519 HD11 ' HB ' ' A' ' 64' ' ' VAL . 96.2 mt -90.89 170.39 10.12 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.39 -0.819 . . . . 0.0 109.998 -177.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -106.82 123.67 48.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.857 -1.152 . . . . 0.0 110.898 -177.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.1 t -138.59 164.77 28.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.371 -0.83 . . . . 0.0 109.338 173.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -56.74 -39.76 74.53 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.941 -1.099 . . . . 0.0 110.253 -175.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -60.05 -26.98 66.56 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.183 -0.948 . . . . 0.0 110.535 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 149.26 -137.76 6.47 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -176.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.589 ' CZ ' ' HG2' ' A' ' 14' ' ' GLU . 66.3 m-85 -98.64 124.86 43.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.992 -1.299 . . . . 0.0 110.367 177.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.438 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 1.9 m170 -101.7 114.17 27.99 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.475 -0.766 . . . . 0.0 110.309 174.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.59 HG22 ' HB ' ' A' ' 9' ' ' ILE . 3.1 tt -102.05 118.84 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 120.761 -1.212 . . . . 0.0 109.408 170.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.561 HG12 ' CD2' ' A' ' 8' ' ' HIS . 96.1 mt -112.07 129.98 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.462 -0.774 . . . . 0.0 111.017 -172.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.562 ' HD2' HD12 ' A' ' 7' ' ' LEU . 10.5 ttmm -105.17 127.08 52.74 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.868 -1.145 . . . . 0.0 109.31 168.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.771 ' O ' HD23 ' A' ' 89' ' ' LEU . 26.8 t -110.29 139.97 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.208 -0.933 . . . . 0.0 110.335 -173.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.771 HD23 ' O ' ' A' ' 88' ' ' VAL . 81.1 mt -148.9 177.15 9.81 Favored 'General case' 0 C--N 1.308 -1.203 0 O-C-N 121.336 -0.852 . . . . 0.0 109.402 -177.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.505 ' HB2' ' HB3' ' A' ' 5' ' ' ALA . 0.3 OUTLIER 67.49 -61.01 0.37 Allowed 'General case' 0 C--N 1.293 -1.859 0 O-C-N 121.422 -0.799 . . . . 0.0 111.389 167.23 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.791 ' HG2' ' HB2' ' A' ' 1' ' ' ALA . 61.7 ttt-85 54.85 40.08 31.79 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.04 -1.038 . . . . 0.0 110.567 -174.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.095 -1.003 . . . . 0.0 110.308 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.276 0.56 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.8 tttt -59.9 -40.0 87.31 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.235 -0.916 . . . . 0.0 110.052 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.454 ' O ' ' N ' ' A' ' 92' ' ' ASN . 67.4 p -139.69 156.53 46.76 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.366 -0.834 . . . . 0.0 110.262 177.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 91' ' ' ARG . . . -138.56 143.44 39.42 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.192 -0.942 . . . . 0.0 110.264 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.609 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -94.53 130.32 40.98 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.315 -0.866 . . . . 0.0 109.145 173.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.748 ' HB3' ' CZ ' ' A' ' 52' ' ' PHE . . . -146.8 134.91 21.57 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.845 -1.159 . . . . 0.0 111.534 -171.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.646 HD12 ' HD3' ' A' ' 87' ' ' LYS . 88.6 mt -107.35 149.88 27.34 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.298 -0.876 . . . . 0.0 109.581 173.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.864 ' CD2' HD12 ' A' ' 49' ' ' LEU . 21.2 m-70 -136.39 143.4 43.97 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.795 -1.19 . . . . 0.0 111.634 -176.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.618 HG12 ' HB2' ' A' ' 34' ' ' ALA . 91.1 mt -130.96 130.77 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.005 -1.059 . . . . 0.0 109.575 166.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.589 ' HG ' ' CD2' ' A' ' 84' ' ' HIS . 0.3 OUTLIER -104.72 119.96 40.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.428 -0.795 . . . . 0.0 110.053 179.782 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.749 HG11 ' N ' ' A' ' 17' ' ' ALA . 2.5 t -105.04 126.6 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.17 -0.956 . . . . 0.0 110.266 178.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 26.2 mmtm -69.19 -40.01 78.33 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.479 -0.763 . . . . 0.0 110.32 177.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -109.32 140.54 42.86 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.217 -0.927 . . . . 0.0 110.918 -173.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -60.13 -47.46 85.81 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.409 -0.807 . . . . 0.0 110.36 175.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -59.35 -40.71 87.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.276 -0.89 . . . . 0.0 110.335 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.42 ' CD2' HG13 ' A' ' 11' ' ' VAL . 2.5 tt -67.84 -39.98 83.8 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.312 -0.867 . . . . 0.0 109.627 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.995 ' O ' HD12 ' A' ' 21' ' ' LEU . . . -59.02 -43.76 91.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -0.923 . . . . 0.0 109.815 175.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.93 -43.1 95.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.192 -0.943 . . . . 0.0 109.942 175.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -60.01 -41.63 92.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.402 -0.811 . . . . 0.0 110.162 178.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.707 ' C ' HD12 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -64.18 -46.09 85.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.161 -0.962 . . . . 0.0 109.825 178.666 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.995 HD12 ' O ' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -58.21 -50.03 75.0 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.329 -0.857 . . . . 0.0 110.428 -178.05 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -60.01 -36.93 78.27 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.213 -0.93 . . . . 0.0 110.261 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.485 ' HG2' HD21 ' A' ' 33' ' ' LEU . 52.8 tp60 -59.99 -40.01 87.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.189 -0.944 . . . . 0.0 110.374 -175.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.823 HG21 ' HE1' ' A' ' 30' ' ' PHE . 3.9 mt -63.73 -41.96 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.112 -0.993 . . . . 0.0 110.715 -178.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -59.96 -45.69 91.86 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.824 -1.172 . . . . 0.0 109.565 176.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -59.78 -67.37 0.39 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.169 -0.957 . . . . 0.0 110.375 173.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.747 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -106.54 -35.03 2.94 Favored Glycine 0 N--CA 1.487 2.067 0 C-N-CA 120.057 -1.068 . . . . 0.0 110.617 -170.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.747 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 85.37 -156.91 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.402 0 O-C-N 122.001 -0.705 . . . . 0.0 110.196 -174.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.552 ' CB ' ' O ' ' A' ' 28' ' ' ALA . 0.7 OUTLIER 78.7 71.59 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 CA-C-O 121.487 0.66 . . . . 0.0 110.563 176.865 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.823 ' HE1' HG21 ' A' ' 24' ' ' ILE . 1.7 m-85 -62.43 -42.21 99.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.203 -0.935 . . . . 0.0 110.664 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.29 -44.4 97.54 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 -176.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.6 mmtt -63.79 -39.96 95.51 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.162 -1.199 . . . . 0.0 110.082 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.58 ' CD1' HG13 ' A' ' 24' ' ' ILE . 85.9 mt -62.55 -39.92 95.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.107 -0.995 . . . . 0.0 110.355 176.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.618 ' HB2' HG12 ' A' ' 9' ' ' ILE . . . -58.17 -48.65 79.62 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.095 -1.003 . . . . 0.0 110.186 -178.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -59.24 -49.08 79.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.281 -0.887 . . . . 0.0 110.159 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -70.0 -43.04 72.22 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.297 -0.877 . . . . 0.0 111.473 -176.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -80.07 -49.99 10.98 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.031 -1.043 . . . . 0.0 111.217 -173.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.649 ' O ' HG22 ' A' ' 39' ' ' ILE . 54.1 m -60.12 -39.91 87.89 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.053 -1.029 . . . . 0.0 111.064 -172.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.649 HG22 ' O ' ' A' ' 38' ' ' SER . 10.9 tp 39.02 28.95 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.528 -0.733 . . . . 0.0 110.375 -178.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.469 ' N ' ' O ' ' A' ' 38' ' ' SER . 17.5 p -122.8 160.16 50.29 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.328 -0.857 . . . . 0.0 109.823 -178.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -52.68 -20.68 12.99 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.84 1.442 . . . . 0.0 110.42 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.525 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -106.58 16.41 24.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.181 -0.949 . . . . 0.0 110.205 176.885 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.49 -51.41 5.61 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.611 -1.796 . . . . 0.0 108.611 172.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.468 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 48.5 tttp -60.02 -39.99 87.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.423 -1.045 . . . . 0.0 110.259 177.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.535 ' HA ' ' OD1' ' A' ' 48' ' ' ASP . 20.7 tpt180 -96.68 -42.05 8.21 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.369 -0.832 . . . . 0.0 110.479 -177.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -63.25 -28.98 73.12 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.94 0.16 53.13 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 176.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.535 ' OD1' ' HA ' ' A' ' 45' ' ' ARG . 43.8 p-10 -170.15 62.75 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.249 -1.147 . . . . 0.0 109.183 -177.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.864 HD12 ' CD2' ' A' ' 8' ' ' HIS . 10.3 mt -69.98 -29.23 66.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.398 -0.814 . . . . 0.0 110.749 -175.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.21 -145.06 17.49 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -178.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.406 ' HG3' ' C ' ' A' ' 4' ' ' ALA . 32.9 tt0 -112.27 136.38 51.77 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.19 -1.182 . . . . 0.0 110.217 -178.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.748 ' CZ ' ' HB3' ' A' ' 6' ' ' ALA . 0.1 OUTLIER -133.79 -166.1 1.73 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.299 -0.876 . . . . 0.0 109.705 174.411 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.456 ' O ' ' HB3' ' A' ' 54' ' ' GLN . 95.9 mtt-85 -65.0 -40.31 94.74 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.845 -1.159 . . . . 0.0 109.865 -178.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.507 ' O ' ' CE2' ' A' ' 61' ' ' PHE . 14.1 pt20 -178.1 30.14 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.474 -0.766 . . . . 0.0 110.302 177.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.491 ' HA3' ' CD2' ' A' ' 61' ' ' PHE . . . 117.81 -69.58 0.31 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.554 ' NE2' ' HB2' ' A' ' 52' ' ' PHE . 12.8 mt-30 68.93 -56.27 0.53 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.407 -1.054 . . . . 0.0 109.949 175.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.467 ' N ' ' O ' ' A' ' 55' ' ' GLY . 59.2 ttp -55.11 -43.44 74.05 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.75 -0.594 . . . . 0.0 110.941 -176.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.483 HG13 ' O ' ' A' ' 58' ' ' VAL . 15.0 p -141.92 132.24 12.76 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.142 -0.974 . . . . 0.0 110.286 -175.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -60.92 -49.67 7.83 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.879 1.462 . . . . 0.0 110.408 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -44.8 -29.43 0.79 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.24 -0.912 . . . . 0.0 110.574 -179.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.8 ' CD1' HG21 ' A' ' 86' ' ' ILE . 59.4 t80 -60.01 -44.29 94.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.082 -1.011 . . . . 0.0 110.177 178.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -59.93 -42.0 93.02 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.05 -1.031 . . . . 0.0 109.549 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.493 ' O ' ' N ' ' A' ' 67' ' ' SER . 93.4 mttt -60.02 -47.42 85.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.512 -0.743 . . . . 0.0 111.011 -178.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.556 ' HB ' HD13 ' A' ' 77' ' ' LEU . 10.3 p -73.02 -46.57 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 120.872 -1.143 . . . . 0.0 110.98 -175.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.552 ' N ' HG13 ' A' ' 64' ' ' VAL . 9.8 p -60.2 -22.05 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.208 -1.558 . . . . 0.0 109.662 170.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -90.41 -13.62 34.59 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.85 -1.156 . . . . 0.0 109.366 171.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.511 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 12.4 t -87.5 -61.85 1.63 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.464 -0.773 . . . . 0.0 108.917 172.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.511 ' N ' ' O ' ' A' ' 64' ' ' VAL . 31.3 p -82.5 133.31 50.09 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 120.876 -1.14 . . . . 0.0 109.087 167.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.507 ' O ' ' NH1' ' A' ' 91' ' ' ARG . 41.3 Cg_exo -52.28 -68.66 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.713 1.375 . . . . 0.0 110.671 -174.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.005 HG22 HD12 ' A' ' 71' ' ' LEU . 7.6 p -179.01 162.16 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -177.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.005 HD12 HG22 ' A' ' 70' ' ' VAL . 3.3 mp 42.76 32.96 0.43 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.897 -1.127 . . . . 0.0 109.946 -170.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.487 ' CG ' ' O ' ' A' ' 70' ' ' VAL . 8.4 mm-40 -130.9 79.98 70.49 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.667 -0.646 . . . . 0.0 109.918 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -47.07 126.64 11.63 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 123.859 1.452 . . . . 0.0 110.012 -178.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.416 ' OG1' ' HB3' ' A' ' 68' ' ' CYS . 70.7 m -135.38 139.37 44.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.182 -0.949 . . . . 0.0 110.432 -176.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.94 -170.82 25.13 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.971 ' CD ' HD11 ' A' ' 21' ' ' LEU . 42.0 Cg_endo -69.53 136.46 38.39 Favored 'Cis proline' 0 C--N 1.314 -1.262 0 C-N-CA 121.767 -2.18 . . . . 0.0 110.455 0.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.556 HD13 ' HB ' ' A' ' 64' ' ' VAL . 1.0 OUTLIER -95.29 142.69 27.4 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.221 -0.924 . . . . 0.0 110.433 -175.017 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -64.75 130.06 42.12 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.107 -0.995 . . . . 0.0 110.633 -176.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.505 HG21 ' CE1' ' A' ' 84' ' ' HIS . 9.5 t -144.66 160.24 41.51 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.283 -0.886 . . . . 0.0 110.375 178.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.591 ' HG3' ' CD2' ' A' ' 81' ' ' PHE . 20.1 pt20 -63.06 -16.22 59.19 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.263 -0.898 . . . . 0.0 110.879 -177.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.591 ' CD2' ' HG3' ' A' ' 80' ' ' GLN . 98.4 m-85 -95.01 6.27 49.56 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.003 -1.061 . . . . 0.0 110.457 -178.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 126.39 -115.4 2.26 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 -175.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.469 ' HB3' ' HB2' ' A' ' 76' ' ' PRO . 69.2 m-85 -140.41 126.97 20.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.09 -1.241 . . . . 0.0 110.287 175.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.589 ' CD2' ' HG ' ' A' ' 10' ' ' LEU . 42.1 m170 -103.31 127.57 50.61 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.522 -0.736 . . . . 0.0 110.676 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.582 HG22 ' HB ' ' A' ' 9' ' ' ILE . 8.4 tt -109.15 129.59 63.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 120.605 -1.309 . . . . 0.0 109.065 166.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.8 HG21 ' CD1' ' A' ' 61' ' ' PHE . 72.2 mt -130.18 135.1 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.015 -1.053 . . . . 0.0 110.701 -169.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.646 ' HD3' HD12 ' A' ' 7' ' ' LEU . 12.5 mtpt -97.91 139.16 34.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.45 -0.781 . . . . 0.0 109.58 176.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.547 HG11 ' HA ' ' A' ' 70' ' ' VAL . 28.0 t -109.74 137.47 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.473 -0.767 . . . . 0.0 110.146 -178.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.609 ' HB2' ' HB3' ' A' ' 5' ' ' ALA . 92.3 mt -144.34 135.79 25.64 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.064 -1.022 . . . . 0.0 109.551 178.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.543 ' CD2' ' HB3' ' A' ' 89' ' ' LEU . 70.9 m-85 65.31 -63.42 0.2 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.332 -0.855 . . . . 0.0 111.076 177.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.507 ' NH1' ' O ' ' A' ' 69' ' ' PRO . 33.7 ttp180 49.95 38.65 16.8 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.049 -1.032 . . . . 0.0 110.214 -175.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.454 ' N ' ' O ' ' A' ' 3' ' ' THR . 7.1 t-20 . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 117.965 -1.017 . . . . 0.0 110.229 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.265 0.555 . . . . 0.0 110.243 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -66.43 -39.97 89.24 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.887 0.851 . . . . 0.0 109.807 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.6 t -159.49 155.46 26.5 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.972 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.54 ' O ' ' CD1' ' A' ' 52' ' ' PHE . . . -151.45 154.81 37.31 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.107 -0.995 . . . . 0.0 110.623 -174.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.529 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -101.32 140.0 36.22 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.009 -1.057 . . . . 0.0 109.14 171.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.727 ' HB3' ' CZ ' ' A' ' 52' ' ' PHE . . . -159.04 154.55 25.9 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.859 -1.151 . . . . 0.0 111.29 -178.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.803 HD12 ' HD2' ' A' ' 87' ' ' LYS . 82.2 mt -109.91 149.99 29.09 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.434 -0.791 . . . . 0.0 109.142 172.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.875 ' CD2' HD12 ' A' ' 49' ' ' LEU . 46.5 m-70 -137.2 133.55 35.29 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.789 -1.194 . . . . 0.0 111.383 -177.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.69 ' HB ' HG22 ' A' ' 85' ' ' ILE . 87.3 mt -120.01 120.99 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.113 -0.992 . . . . 0.0 109.605 168.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.782 HD13 ' C ' ' A' ' 10' ' ' LEU . 2.7 tm? -104.07 120.08 40.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.477 -0.765 . . . . 0.0 109.817 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.862 HG13 HD22 ' A' ' 16' ' ' LEU . 2.4 t -103.81 130.08 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.29 -0.881 . . . . 0.0 110.346 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -65.93 -40.08 91.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.459 -0.776 . . . . 0.0 110.551 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -119.54 140.02 51.2 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.126 -0.984 . . . . 0.0 110.531 -175.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.453 ' HB2' ' CE1' ' A' ' 83' ' ' TYR . 86.8 tt0 -59.91 -39.99 87.32 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.372 -0.83 . . . . 0.0 110.352 -178.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.6 mttt -52.46 -47.42 66.48 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.188 -0.945 . . . . 0.0 110.069 -176.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.862 HD22 HG13 ' A' ' 11' ' ' VAL . 8.4 tt -68.71 -37.07 79.22 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.104 -0.997 . . . . 0.0 109.546 176.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.665 ' HA ' HD23 ' A' ' 20' ' ' LEU . . . -56.94 -49.29 76.1 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.042 -1.036 . . . . 0.0 109.522 176.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.448 ' HA ' HD12 ' A' ' 21' ' ' LEU . 0.9 OUTLIER -58.31 -40.44 82.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.15 -0.969 . . . . 0.0 109.579 174.573 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.48 ' HB3' ' O ' ' A' ' 16' ' ' LEU . 51.5 t0 -60.0 -39.98 87.66 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.096 -1.002 . . . . 0.0 109.671 174.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 1.011 HD13 HD21 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -62.91 -44.27 96.55 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.16 -0.963 . . . . 0.0 109.668 178.125 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.841 HD21 ' HD3' ' A' ' 76' ' ' PRO . 1.3 mt -59.9 -50.14 74.93 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.381 -0.824 . . . . 0.0 110.07 -178.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -62.87 -39.92 95.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.314 -0.867 . . . . 0.0 110.247 177.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.451 ' O ' ' N ' ' A' ' 27' ' ' GLY . 64.9 tp60 -60.07 -40.95 91.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.305 -0.872 . . . . 0.0 110.311 -177.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.517 ' O ' ' N ' ' A' ' 28' ' ' ALA . 85.5 mt -67.32 -40.35 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.179 -0.95 . . . . 0.0 109.795 177.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -63.85 -59.96 3.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.139 -0.976 . . . . 0.0 109.598 176.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -60.32 -52.37 65.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.438 -0.789 . . . . 0.0 110.866 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 28' ' ' ALA . . . -106.18 -13.0 24.21 Favored Glycine 0 N--CA 1.487 2.041 0 C-N-CA 119.647 -1.263 . . . . 0.0 110.597 -166.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 24' ' ' ILE . . . 34.1 95.37 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.751 -0.853 . . . . 0.0 111.459 -177.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -171.68 86.35 0.09 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.466 -0.771 . . . . 0.0 109.827 -176.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.503 ' CG ' ' HE3' ' A' ' 87' ' ' LYS . 3.9 m-85 -69.8 -40.12 76.18 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.325 -0.859 . . . . 0.0 110.764 -176.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.36 -52.08 53.81 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -63.73 -41.1 98.12 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.185 -1.185 . . . . 0.0 110.513 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.011 HD21 HD13 ' A' ' 20' ' ' LEU . 33.0 tp -61.74 -50.06 73.91 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.074 -1.016 . . . . 0.0 110.716 -175.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.667 ' HB2' HG12 ' A' ' 9' ' ' ILE . . . -59.95 -47.88 83.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.198 -0.939 . . . . 0.0 110.383 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 50.3 mttm -60.02 -49.78 76.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.212 -0.93 . . . . 0.0 110.592 -176.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.456 ' O ' HG13 ' A' ' 39' ' ' ILE . 57.2 tptt -69.72 -52.5 24.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.156 -0.965 . . . . 0.0 111.235 -175.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.694 ' HB3' HD21 ' A' ' 16' ' ' LEU . 86.9 m-70 -83.21 -40.28 19.85 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.913 -1.117 . . . . 0.0 111.583 -170.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.483 ' HB3' ' O ' ' A' ' 34' ' ' ALA . 18.4 t -60.01 -45.2 93.54 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.973 -1.08 . . . . 0.0 110.443 -176.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.623 ' O ' HG22 ' A' ' 39' ' ' ILE . 80.2 mt 34.14 45.76 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 CA-C-O 121.322 0.582 . . . . 0.0 110.769 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.512 ' SG ' ' N ' ' A' ' 43' ' ' GLY . 17.2 p -133.91 160.04 70.09 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.254 -0.904 . . . . 0.0 110.093 -177.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.404 ' HD2' ' HB2' ' A' ' 40' ' ' CYS . 6.7 Cg_endo -54.02 -23.8 29.88 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.962 1.506 . . . . 0.0 110.522 -177.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.511 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -109.12 20.54 18.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.085 -1.009 . . . . 0.0 110.084 176.902 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.512 ' N ' ' SG ' ' A' ' 40' ' ' CYS . . . -79.11 -59.65 2.7 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 176.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -60.02 -33.91 72.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.41 -1.053 . . . . 0.0 110.39 176.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.458 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 16.0 tpt180 -91.57 -39.73 11.74 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.109 -0.994 . . . . 0.0 110.158 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -70.75 -29.02 69.9 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 177.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.97 0.54 58.06 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 173.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -168.76 63.34 0.06 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.291 -1.123 . . . . 0.0 109.134 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.875 HD12 ' CD2' ' A' ' 8' ' ' HIS . 12.7 mt -70.12 -28.89 65.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.599 -0.688 . . . . 0.0 110.155 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.27 -136.02 12.69 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.231 -1.547 . . . . 0.0 109.231 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -113.66 148.16 36.82 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.382 -1.069 . . . . 0.0 110.171 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.727 ' CZ ' ' HB3' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -131.45 160.41 35.23 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.205 -0.934 . . . . 0.0 109.879 -172.382 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.543 ' O ' ' N ' ' A' ' 55' ' ' GLY . 36.5 ptt-85 -154.54 176.87 11.85 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.297 -0.877 . . . . 0.0 110.468 -173.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.495 ' O ' ' O ' ' A' ' 55' ' ' GLY . 87.2 mt-30 27.18 -84.16 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.274 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . -55.13 -117.7 0.01 OUTLIER Glycine 0 N--CA 1.495 2.614 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -175.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.513 ' OE1' ' HB3' ' A' ' 52' ' ' PHE . 44.3 mm-40 65.99 -65.4 0.18 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.137 -1.214 . . . . 0.0 109.944 -176.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.523 ' N ' ' O ' ' A' ' 55' ' ' GLY . 37.5 ttp 65.29 -56.47 0.31 Allowed 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.861 172.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.554 HG23 ' HD2' ' A' ' 59' ' ' PRO . 2.0 p -42.94 137.95 2.45 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 120.821 -1.175 . . . . 0.0 110.426 -169.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.554 ' HD2' HG23 ' A' ' 58' ' ' VAL . 32.9 Cg_endo -70.28 -55.01 0.17 Allowed 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.126 1.593 . . . . 0.0 111.059 -173.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.5 ' O ' HG12 ' A' ' 64' ' ' VAL . . . -42.67 -34.64 0.93 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.116 -0.99 . . . . 0.0 110.469 -174.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.434 ' CE2' ' CE1' ' A' ' 52' ' ' PHE . 56.1 t80 -60.0 -44.07 94.79 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.233 -0.917 . . . . 0.0 110.092 -179.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.522 ' OD1' ' CD1' ' A' ' 66' ' ' PHE . 56.5 t0 -68.31 -45.26 73.48 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.295 -0.878 . . . . 0.0 110.553 -178.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' A' ' 67' ' ' SER . 11.3 tptt -56.36 -50.15 72.37 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.031 -1.043 . . . . 0.0 110.269 -176.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.522 ' HA ' ' HB3' ' A' ' 67' ' ' SER . 5.8 p -69.5 -46.73 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.089 -1.007 . . . . 0.0 111.443 -173.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.51 ' N ' HG13 ' A' ' 64' ' ' VAL . 6.8 p -58.15 -26.14 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.297 -1.502 . . . . 0.0 109.468 173.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.522 ' CD1' ' OD1' ' A' ' 62' ' ' ASP . 17.4 m-85 -96.2 -1.78 47.59 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.21 -0.931 . . . . 0.0 110.148 174.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.522 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 9.4 t -97.41 -59.03 1.87 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.348 -0.845 . . . . 0.0 109.67 173.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.536 ' CB ' ' HG1' ' A' ' 74' ' ' THR . 23.0 p -107.08 147.72 35.66 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.4 -0.813 . . . . 0.0 110.146 177.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -71.68 171.27 16.74 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 124.046 1.551 . . . . 0.0 110.682 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.066 HG22 HD12 ' A' ' 71' ' ' LEU . 7.1 p -58.7 158.6 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.465 -0.772 . . . . 0.0 110.145 178.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.066 HD12 HG22 ' A' ' 70' ' ' VAL . 3.2 mp 56.75 39.55 29.59 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.195 -0.941 . . . . 0.0 110.0 -175.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.419 ' C ' ' OE1' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -148.36 93.63 4.34 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.366 -0.834 . . . . 0.0 110.115 -179.907 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -63.15 130.52 29.13 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.981 1.516 . . . . 0.0 110.164 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.536 ' HG1' ' CB ' ' A' ' 68' ' ' CYS . 33.3 m -135.88 140.49 44.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.288 -0.882 . . . . 0.0 110.415 -178.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 149.16 -169.83 29.51 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.219 -1.553 . . . . 0.0 109.219 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.841 ' HD3' HD21 ' A' ' 21' ' ' LEU . 46.7 Cg_endo -76.03 136.36 44.24 Favored 'Cis proline' 0 C--N 1.313 -1.329 0 C-N-CA 121.825 -2.156 . . . . 0.0 110.663 -1.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 41.2 mt -93.36 -173.22 3.16 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.319 -0.863 . . . . 0.0 109.962 178.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -111.74 121.22 44.49 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.997 -1.064 . . . . 0.0 111.306 -173.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.478 HG21 ' CE1' ' A' ' 84' ' ' HIS . 9.8 t -138.06 164.28 29.48 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.274 -0.891 . . . . 0.0 109.438 170.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -54.92 -36.53 65.33 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.141 -0.975 . . . . 0.0 110.618 -175.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -63.13 -30.37 71.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.062 -1.024 . . . . 0.0 110.78 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 152.07 -135.58 5.06 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -177.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 10' ' ' LEU . 39.0 m-85 -93.98 131.12 39.76 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.35 -1.088 . . . . 0.0 109.96 177.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.558 ' CD2' HD23 ' A' ' 10' ' ' LEU . 0.1 OUTLIER -111.93 113.25 25.45 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.432 -0.792 . . . . 0.0 110.999 -178.863 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.713 HD13 HD11 ' A' ' 20' ' ' LEU . 4.5 tt -110.03 132.46 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.881 -1.137 . . . . 0.0 109.117 169.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.514 HG12 ' ND1' ' A' ' 8' ' ' HIS . 89.1 mt -135.98 140.12 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.598 -1.314 . . . . 0.0 111.899 -168.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.803 ' HD2' HD12 ' A' ' 7' ' ' LEU . 15.1 mttm -92.65 142.26 27.56 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.387 -0.821 . . . . 0.0 110.038 170.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.474 ' CG1' ' HD3' ' A' ' 91' ' ' ARG . 59.7 t -109.72 133.69 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.768 -0.582 . . . . 0.0 109.983 178.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.529 ' HB2' ' HB3' ' A' ' 5' ' ' ALA . 81.0 mt -141.89 129.09 20.99 Favored 'General case' 0 C--N 1.308 -1.2 0 O-C-N 121.005 -1.059 . . . . 0.0 109.947 -176.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.488 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 42.2 m-85 65.29 -55.29 0.32 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.228 -0.92 . . . . 0.0 111.587 173.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.527 ' NE ' ' HB ' ' A' ' 70' ' ' VAL . 84.6 mtm180 56.27 40.23 29.98 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.037 -1.04 . . . . 0.0 110.894 -177.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 91' ' ' ARG . 3.6 t-20 . . . . . 0 N--CA 1.492 1.649 0 O-C-N 120.967 -1.083 . . . . 0.0 110.272 177.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.196 0.522 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 58.0 mmtt -61.8 -40.14 94.17 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.298 -0.876 . . . . 0.0 110.251 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.664 HG22 ' CB ' ' A' ' 53' ' ' ARG . 14.8 p -143.16 162.77 34.71 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.391 -0.818 . . . . 0.0 109.596 -178.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.454 ' C ' ' HG3' ' A' ' 51' ' ' GLU . . . -149.96 153.61 36.88 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.839 -1.163 . . . . 0.0 111.029 -178.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.441 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -96.69 131.46 43.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.424 -0.798 . . . . 0.0 109.253 174.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.671 ' HB3' ' CZ ' ' A' ' 52' ' ' PHE . . . -147.41 122.73 10.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.834 -1.166 . . . . 0.0 111.688 -172.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.593 ' N ' ' CD1' ' A' ' 7' ' ' LEU . 3.5 mp -97.07 141.16 30.55 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.173 -0.954 . . . . 0.0 109.283 170.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.73 ' CD2' HD12 ' A' ' 49' ' ' LEU . 25.8 m-70 -134.54 128.17 32.78 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.887 -1.133 . . . . 0.0 110.947 -175.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.548 ' HB ' ' CG2' ' A' ' 85' ' ' ILE . 76.4 mt -109.96 129.96 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 120.882 -1.136 . . . . 0.0 110.136 168.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.597 ' HG ' ' CD2' ' A' ' 84' ' ' HIS . 0.3 OUTLIER -101.68 118.61 37.3 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.552 -0.717 . . . . 0.0 109.711 178.648 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.828 HG13 HD22 ' A' ' 16' ' ' LEU . 2.0 t -101.48 127.21 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.243 -0.911 . . . . 0.0 110.125 -177.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.1 mttp -69.28 -40.01 78.0 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.308 -0.87 . . . . 0.0 110.313 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -132.52 152.21 51.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.295 -0.878 . . . . 0.0 110.26 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.527 ' HG3' ' CZ ' ' A' ' 83' ' ' TYR . 95.2 mt-10 -59.04 -39.9 83.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.29 -0.881 . . . . 0.0 110.409 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -51.31 -44.62 61.97 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.191 -0.943 . . . . 0.0 110.34 -176.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.828 HD22 HG13 ' A' ' 11' ' ' VAL . 9.7 tt -68.89 -40.0 79.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.044 -1.035 . . . . 0.0 109.715 177.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.954 ' O ' HD12 ' A' ' 21' ' ' LEU . . . -59.87 -44.43 94.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.307 -0.871 . . . . 0.0 110.14 177.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.85 -45.8 89.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.218 -0.926 . . . . 0.0 109.819 178.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.49 ' O ' ' HB2' ' A' ' 23' ' ' GLN . 53.1 t0 -60.03 -42.2 93.86 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.345 -0.847 . . . . 0.0 110.187 177.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.727 ' C ' HD12 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -66.47 -43.56 85.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.147 -0.97 . . . . 0.0 110.047 -179.711 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.954 HD12 ' O ' ' A' ' 17' ' ' ALA . 0.3 OUTLIER -55.26 -59.93 4.1 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.38 -0.825 . . . . 0.0 110.072 -177.869 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -63.9 -40.0 95.48 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.394 -0.816 . . . . 0.0 110.707 177.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.574 ' HA ' ' OD1' ' A' ' 26' ' ' ASN . 62.2 tt0 -60.11 -29.49 68.64 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.118 -0.989 . . . . 0.0 110.185 -176.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.533 ' O ' ' CA ' ' A' ' 28' ' ' ALA . 91.6 mt -68.2 -40.01 82.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 120.687 -1.258 . . . . 0.0 109.606 173.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.4 tttp -66.69 -60.09 3.01 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.097 -1.002 . . . . 0.0 110.696 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.574 ' OD1' ' HA ' ' A' ' 23' ' ' GLN . 47.3 p30 -62.16 -33.68 74.96 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.105 -0.997 . . . . 0.0 110.501 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.758 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -106.23 -65.3 0.63 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.758 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 85.58 95.51 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.254 0 CA-C-O 121.624 0.725 . . . . 0.0 110.615 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -177.1 80.01 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.61 -0.681 . . . . 0.0 109.651 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.588 ' CG ' ' HE2' ' A' ' 87' ' ' LYS . 5.5 m-85 -60.1 -47.77 84.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.876 . . . . 0.0 110.903 -174.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.05 -50.33 68.8 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 119.715 -1.231 . . . . 0.0 110.045 -176.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -66.6 -40.04 88.66 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.131 -1.217 . . . . 0.0 110.78 -175.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.569 ' CD2' ' NE2' ' A' ' 23' ' ' GLN . 83.8 mt -66.3 -40.19 89.84 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.164 -0.96 . . . . 0.0 110.562 -178.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.529 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -60.06 -50.03 75.34 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.049 -1.032 . . . . 0.0 110.198 177.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -60.02 -49.95 75.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.229 -0.919 . . . . 0.0 111.158 -177.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.0 tttp -70.08 -45.17 67.6 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.005 -1.06 . . . . 0.0 111.165 -172.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -81.61 -32.02 32.19 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.101 -1.0 . . . . 0.0 110.832 -174.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.49 ' CB ' ' O ' ' A' ' 34' ' ' ALA . 27.5 t -60.19 -44.92 94.71 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.121 -0.987 . . . . 0.0 111.31 -173.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.627 ' O ' HG22 ' A' ' 39' ' ' ILE . 73.6 mt 44.69 25.93 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 120.904 -1.122 . . . . 0.0 109.762 -173.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.462 ' SG ' ' HD2' ' A' ' 41' ' ' PRO . 35.8 t -117.43 143.27 31.76 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.391 -0.818 . . . . 0.0 109.943 -178.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.462 ' HD2' ' SG ' ' A' ' 40' ' ' CYS . 52.7 Cg_exo -49.21 -20.92 3.85 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.849 1.447 . . . . 0.0 110.655 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.514 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -109.12 19.92 18.94 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.182 -0.949 . . . . 0.0 109.81 176.877 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' A' ' 47' ' ' GLY . . . -75.05 -59.46 3.65 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 174.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -60.05 -39.97 87.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.389 -1.066 . . . . 0.0 110.573 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -94.14 -42.3 9.06 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.924 -1.11 . . . . 0.0 110.413 -176.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -70.6 -24.52 76.8 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 174.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 43' ' ' GLY . . . -74.4 -1.0 59.76 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 173.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.436 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 49.0 t0 -173.06 70.29 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.352 -1.087 . . . . 0.0 109.122 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.73 HD12 ' CD2' ' A' ' 8' ' ' HIS . 11.9 mt -72.47 -6.59 44.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.633 -0.667 . . . . 0.0 110.156 -176.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 5' ' ' ALA . . . 76.55 -121.9 6.2 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -176.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.454 ' HG3' ' C ' ' A' ' 4' ' ' ALA . 71.3 tt0 -126.92 140.21 52.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.231 -1.158 . . . . 0.0 110.412 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.671 ' CZ ' ' HB3' ' A' ' 6' ' ' ALA . 2.4 p90 -142.63 169.16 18.09 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.302 -0.874 . . . . 0.0 110.263 178.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.664 ' CB ' HG22 ' A' ' 3' ' ' THR . 34.3 ptt180 -155.05 145.0 21.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.979 -1.076 . . . . 0.0 111.628 -172.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.459 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 15.9 pt20 24.98 47.09 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 170.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 56' ' ' GLN . . . 179.97 47.06 0.08 OUTLIER Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.204 -1.474 . . . . 0.0 110.393 174.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.471 ' OE1' ' O ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER 173.54 -113.56 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.159 -1.2 . . . . 0.0 109.76 178.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.461 ' HB2' ' O ' ' A' ' 56' ' ' GLN . 95.9 mtp 55.89 -174.48 0.05 Allowed 'General case' 0 N--CA 1.485 1.292 0 O-C-N 120.91 -1.119 . . . . 0.0 111.458 173.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.55 ' CG1' ' HB2' ' A' ' 61' ' ' PHE . 4.2 p -151.55 134.78 9.07 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.694 -0.629 . . . . 0.0 109.462 -176.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.4 ' C ' ' O ' ' A' ' 58' ' ' VAL . 49.1 Cg_exo -36.45 -49.3 1.31 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.8 1.421 . . . . 0.0 111.363 -174.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.806 ' HB1' HD23 ' A' ' 77' ' ' LEU . . . -59.98 -39.25 85.06 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.034 -1.041 . . . . 0.0 110.334 -178.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.633 ' CD1' HG21 ' A' ' 86' ' ' ILE . 66.4 t80 -59.95 -37.85 80.74 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.321 -0.862 . . . . 0.0 110.344 -178.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.516 ' O ' HG12 ' A' ' 65' ' ' VAL . 55.2 t0 -59.96 -48.6 81.02 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.061 -1.025 . . . . 0.0 110.102 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.493 ' O ' ' HB2' ' A' ' 67' ' ' SER . 24.3 tptm -60.09 -51.13 70.93 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.048 -1.033 . . . . 0.0 110.46 178.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.687 HG11 HD12 ' A' ' 86' ' ' ILE . 8.8 p -70.26 -46.99 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.049 -1.032 . . . . 0.0 111.173 -174.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.578 ' N ' HG13 ' A' ' 64' ' ' VAL . 3.8 p -53.95 -28.87 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.59 -1.319 . . . . 0.0 109.268 174.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -95.62 -10.56 29.12 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.223 -0.923 . . . . 0.0 110.252 175.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.55 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 7.7 t -91.08 -69.23 0.74 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.246 -0.909 . . . . 0.0 109.951 176.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.486 ' CB ' ' HG1' ' A' ' 74' ' ' THR . 83.7 m -91.19 127.48 51.17 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.214 -0.929 . . . . 0.0 109.83 176.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.492 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 24.5 Cg_exo -58.69 160.95 16.05 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.797 1.42 . . . . 0.0 109.949 178.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.828 HG22 HD12 ' A' ' 71' ' ' LEU . 7.1 p -58.71 173.48 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.081 -1.012 . . . . 0.0 109.912 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.828 HD12 HG22 ' A' ' 70' ' ' VAL . 2.8 mp 58.7 19.7 7.07 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.298 -0.877 . . . . 0.0 109.964 -174.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.492 ' HB3' ' O ' ' A' ' 69' ' ' PRO . 4.1 tt0 -140.07 80.97 19.32 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.28 -0.888 . . . . 0.0 109.937 177.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.433 ' HG3' ' HG3' ' A' ' 87' ' ' LYS . 53.0 Cg_exo -48.88 131.88 25.81 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.948 1.499 . . . . 0.0 109.972 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.494 ' HB ' ' CG2' ' A' ' 64' ' ' VAL . 92.5 m -133.08 139.01 46.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.185 -0.947 . . . . 0.0 110.407 -176.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.441 ' HA3' HG13 ' A' ' 85' ' ' ILE . . . 145.71 -173.52 26.04 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.746 ' CD ' HD11 ' A' ' 21' ' ' LEU . 43.7 Cg_endo -75.24 137.59 51.01 Favored 'Cis proline' 0 C--N 1.314 -1.276 0 C-N-CA 121.791 -2.171 . . . . 0.0 110.538 -1.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.806 HD23 ' HB1' ' A' ' 60' ' ' ALA . 59.3 tp -96.53 156.35 16.38 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.243 -0.911 . . . . 0.0 110.45 -176.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -85.12 123.24 30.41 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.154 -0.966 . . . . 0.0 111.06 -175.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 1.037 HG21 ' CE1' ' A' ' 84' ' ' HIS . 10.3 t -141.53 164.93 28.89 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.269 -0.894 . . . . 0.0 109.806 173.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.501 ' CG ' ' CD2' ' A' ' 81' ' ' PHE . 20.1 pt20 -59.93 -31.62 70.02 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.044 -1.035 . . . . 0.0 111.016 -175.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.501 ' CD2' ' CG ' ' A' ' 80' ' ' GLN . 97.9 m-85 -75.91 -8.02 55.94 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.027 -1.045 . . . . 0.0 110.531 -176.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.441 ' O ' HG22 ' A' ' 79' ' ' THR . . . 137.47 -143.58 14.77 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 -175.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.527 ' CZ ' ' HG3' ' A' ' 14' ' ' GLU . 96.1 m-85 -107.32 122.35 46.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.899 -1.353 . . . . 0.0 109.89 174.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 1.037 ' CE1' HG21 ' A' ' 79' ' ' THR . 60.9 m170 -99.17 121.74 41.43 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.131 -0.981 . . . . 0.0 110.363 175.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.548 ' CG2' ' HB ' ' A' ' 9' ' ' ILE . 6.1 tt -107.68 121.66 60.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 C-N-CA 118.599 -1.24 . . . . 0.0 109.569 168.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.687 HD12 HG11 ' A' ' 64' ' ' VAL . 83.4 mt -114.1 130.02 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.241 -0.912 . . . . 0.0 111.081 -169.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.588 ' HE2' ' CG ' ' A' ' 30' ' ' PHE . 21.4 ttmm -98.04 126.58 43.54 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.106 -0.996 . . . . 0.0 109.258 169.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.522 HG12 HG23 ' A' ' 70' ' ' VAL . 61.9 t -106.54 134.93 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.296 -0.877 . . . . 0.0 110.204 -175.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.514 ' O ' ' N ' ' A' ' 91' ' ' ARG . 92.7 mt -140.13 161.31 37.95 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.348 -0.845 . . . . 0.0 109.131 -178.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.509 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 25.6 m-85 62.45 -61.45 0.12 Allowed 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.03 0.443 . . . . 0.0 111.04 177.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.514 ' N ' ' O ' ' A' ' 89' ' ' LEU . 14.1 tpt180 54.93 39.93 31.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.001 -1.062 . . . . 0.0 110.209 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.168 -179.485 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 1.074 ' HB1' ' CB ' ' A' ' 92' ' ' ASN . . . . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.237 0.542 . . . . 0.0 110.174 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.522 ' O ' ' CD ' ' A' ' 53' ' ' ARG . 27.9 mtpt -90.03 -79.92 0.33 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.133 -0.98 . . . . 0.0 110.768 -177.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.562 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 27.3 p -137.21 152.52 49.96 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.234 -0.916 . . . . 0.0 110.375 -175.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.511 ' O ' ' HA ' ' A' ' 51' ' ' GLU . . . -109.95 151.24 27.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.097 -1.002 . . . . 0.0 109.886 175.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.65 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -90.76 122.69 33.71 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.699 -0.8 . . . . 0.0 109.651 -178.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.537 ' HB3' ' CE2' ' A' ' 52' ' ' PHE . . . -130.84 119.7 22.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.102 -0.999 . . . . 0.0 111.325 -172.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.613 HD12 ' HD2' ' A' ' 87' ' ' LYS . 83.2 mt -106.5 151.28 25.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.288 -0.882 . . . . 0.0 108.839 169.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.523 ' HB2' HG12 ' A' ' 86' ' ' ILE . 0.3 OUTLIER -168.66 170.53 9.38 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 118.287 -1.365 . . . . 0.0 112.158 -178.716 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.452 ' HB ' ' CG2' ' A' ' 85' ' ' ILE . 87.0 mt -139.97 138.81 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.876 -0.515 . . . . 0.0 109.65 178.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.588 ' HG ' ' CD2' ' A' ' 84' ' ' HIS . 0.5 OUTLIER -100.42 120.08 39.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.364 -0.835 . . . . 0.0 110.218 -178.731 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.969 HG13 HD22 ' A' ' 16' ' ' LEU . 2.4 t -112.74 128.44 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.204 -0.935 . . . . 0.0 109.964 178.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -69.43 -40.04 77.48 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.371 -0.831 . . . . 0.0 110.618 -178.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -130.43 155.81 45.79 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.023 -1.048 . . . . 0.0 110.728 -176.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.531 ' HG3' ' CZ ' ' A' ' 83' ' ' TYR . 95.7 mt-10 -60.09 -40.0 88.09 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.478 -0.764 . . . . 0.0 110.744 -178.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -55.4 -43.33 75.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.144 -0.973 . . . . 0.0 110.068 -175.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.969 HD22 HG13 ' A' ' 11' ' ' VAL . 5.9 tt -69.89 -41.01 75.32 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.086 -1.009 . . . . 0.0 109.378 174.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.933 ' O ' HD12 ' A' ' 21' ' ' LEU . . . -60.05 -41.32 92.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.407 -0.808 . . . . 0.0 110.098 175.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.463 HD12 ' O ' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -60.02 -42.27 94.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.329 -0.857 . . . . 0.0 109.474 178.051 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.477 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 47.8 t0 -59.94 -43.56 94.9 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.243 -0.91 . . . . 0.0 110.037 174.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.716 HD11 HD13 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -63.02 -46.78 85.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.113 -0.992 . . . . 0.0 109.79 179.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.933 HD12 ' O ' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -59.83 -49.94 75.74 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.395 -0.816 . . . . 0.0 110.185 -178.58 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -60.77 -43.13 98.43 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.326 -0.859 . . . . 0.0 110.637 -177.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.477 ' HG2' ' O ' ' A' ' 19' ' ' ASP . 96.5 mm-40 -60.59 -42.59 97.05 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.184 -0.948 . . . . 0.0 110.606 -177.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.505 ' O ' ' N ' ' A' ' 28' ' ' ALA . 88.1 mt -64.84 -44.09 96.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.15 -0.969 . . . . 0.0 109.937 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -61.08 -47.14 87.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.175 -0.953 . . . . 0.0 109.665 175.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -59.81 -60.93 3.05 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.43 -0.794 . . . . 0.0 110.331 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.755 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -105.21 -41.64 1.89 Allowed Glycine 0 N--CA 1.485 1.93 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -173.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.755 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 80.19 99.4 0.06 Allowed 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.837 -0.802 . . . . 0.0 110.075 -177.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.434 ' HB3' ' HB2' ' A' ' 32' ' ' LYS . 1.8 m-20 -175.7 82.82 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.273 -0.892 . . . . 0.0 110.177 -176.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.585 ' CG ' ' HE3' ' A' ' 87' ' ' LYS . 9.9 m-85 -65.87 -45.58 81.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.151 -0.968 . . . . 0.0 110.752 -178.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.09 -49.26 80.51 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -177.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.434 ' HB2' ' HB3' ' A' ' 29' ' ' ASP . 60.7 mttm -64.96 -40.0 94.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -1.169 . . . . 0.0 110.049 -177.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.572 HD21 ' HB2' ' A' ' 20' ' ' LEU . 63.2 tp -61.81 -40.24 94.55 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.226 -0.921 . . . . 0.0 110.352 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.518 ' O ' ' CB ' ' A' ' 38' ' ' SER . . . -60.03 -49.95 75.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.067 -1.021 . . . . 0.0 110.135 177.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -59.97 -43.63 94.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.774 -1.204 . . . . 0.0 110.689 -176.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.405 ' NZ ' ' HB3' ' A' ' 32' ' ' LYS . 43.5 mttp -69.95 -43.03 72.41 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.897 -1.127 . . . . 0.0 111.662 -175.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.452 ' O ' HG12 ' A' ' 39' ' ' ILE . 83.8 m-70 -105.77 -28.29 10.76 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.686 -1.259 . . . . 0.0 111.691 -169.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.52 ' O ' ' CG1' ' A' ' 39' ' ' ILE . 54.3 p -60.01 -44.29 94.65 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.724 -1.235 . . . . 0.0 110.763 -171.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.52 ' CG1' ' O ' ' A' ' 38' ' ' SER . 46.5 pt 36.31 31.63 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.614 -0.679 . . . . 0.0 110.918 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.479 ' N ' ' O ' ' A' ' 38' ' ' SER . 38.2 t -125.83 144.23 47.77 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.125 -0.984 . . . . 0.0 110.247 -175.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.465 ' HD2' ' SG ' ' A' ' 40' ' ' CYS . 58.1 Cg_exo -44.7 -24.85 1.28 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.819 1.431 . . . . 0.0 110.753 178.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.475 ' O ' ' HA3' ' A' ' 46' ' ' GLY . 0.2 OUTLIER -109.88 19.79 18.7 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.142 -0.974 . . . . 0.0 110.196 178.566 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -95.63 -57.72 1.17 Allowed Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 175.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -59.93 -39.99 87.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.34 -1.094 . . . . 0.0 109.872 175.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 20.9 tpt180 -101.39 -37.15 8.59 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.328 -0.857 . . . . 0.0 110.58 -177.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.499 ' O ' ' CD2' ' A' ' 8' ' ' HIS . . . -82.88 -9.02 85.03 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -177.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.36 1.52 56.35 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 173.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.444 ' HA ' ' CD2' ' A' ' 7' ' ' LEU . 38.7 t0 -165.76 67.25 0.12 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.35 -1.088 . . . . 0.0 108.475 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.44 ' HG ' ' HA2' ' A' ' 46' ' ' GLY . 7.0 mt -69.99 -27.41 64.68 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.794 -0.566 . . . . 0.0 110.146 -175.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.34 -146.96 16.64 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.534 ' HG2' ' CB ' ' A' ' 3' ' ' THR . 49.9 tt0 -110.75 128.58 55.79 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.26 -1.141 . . . . 0.0 110.011 -178.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.537 ' CE2' ' HB3' ' A' ' 6' ' ' ALA . 3.5 p90 -144.88 -178.02 5.82 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.178 -0.951 . . . . 0.0 110.584 -176.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.562 ' HB2' ' HA ' ' A' ' 3' ' ' THR . 51.8 ttt-85 -171.29 -46.86 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.93 -1.106 . . . . 0.0 110.23 173.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -60.04 -49.03 79.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.262 -0.899 . . . . 0.0 110.885 -168.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 57' ' ' MET . . . -87.15 -104.51 0.84 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 178.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.537 ' NE2' ' CG ' ' A' ' 52' ' ' PHE . 3.0 mm100 64.94 -69.32 0.1 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.369 -1.077 . . . . 0.0 109.547 172.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.536 ' N ' ' O ' ' A' ' 55' ' ' GLY . 30.5 ttp 62.91 -58.92 0.15 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.781 -0.574 . . . . 0.0 112.236 170.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.492 ' N ' ' O ' ' A' ' 56' ' ' GLN . 1.9 p -41.37 132.96 2.08 Favored Pre-proline 0 N--CA 1.498 1.931 0 O-C-N 120.907 -1.12 . . . . 0.0 110.605 -168.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.477 ' O ' ' N ' ' A' ' 62' ' ' ASP . 29.0 Cg_endo -67.59 -50.52 0.89 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.08 1.568 . . . . 0.0 110.709 -174.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 59' ' ' PRO . . . -41.77 -37.39 1.22 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.381 -0.824 . . . . 0.0 110.029 -177.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.565 ' CE2' HG21 ' A' ' 65' ' ' VAL . 67.7 t80 -59.97 -43.66 94.95 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.308 -0.87 . . . . 0.0 110.056 177.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.477 ' N ' ' O ' ' A' ' 59' ' ' PRO . 54.0 t0 -60.0 -43.75 94.99 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.295 -0.878 . . . . 0.0 110.284 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 67' ' ' SER . 34.3 mttt -58.23 -50.02 75.05 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.163 -0.961 . . . . 0.0 109.735 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.537 ' HA ' ' HB3' ' A' ' 67' ' ' SER . 7.5 p -69.5 -41.32 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.451 -0.781 . . . . 0.0 110.763 -177.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.565 HG21 ' CE2' ' A' ' 61' ' ' PHE . 11.4 t -55.54 -31.85 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.727 -1.233 . . . . 0.0 108.929 171.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -102.37 10.32 39.16 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.621 -0.674 . . . . 0.0 110.258 177.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.537 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 8.1 t -103.27 -58.29 1.9 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.151 -0.968 . . . . 0.0 109.898 173.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.469 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 29.8 m -115.39 145.34 34.14 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.309 -0.869 . . . . 0.0 110.303 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.519 ' O ' ' N ' ' A' ' 71' ' ' LEU . 13.5 Cg_exo -64.98 76.52 0.21 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.807 1.425 . . . . 0.0 110.582 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.082 HG11 ' HG3' ' A' ' 91' ' ' ARG . 8.2 m 21.29 45.89 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.337 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 176.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.008 HD12 HG23 ' A' ' 70' ' ' VAL . 0.3 OUTLIER -166.55 46.86 0.07 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.45 -0.781 . . . . 0.0 110.057 178.259 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -170.66 123.97 0.6 Allowed Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.348 -0.845 . . . . 0.0 110.148 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -55.63 119.07 5.96 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.746 1.392 . . . . 0.0 110.196 178.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.424 ' OG1' ' SG ' ' A' ' 68' ' ' CYS . 74.9 m -126.61 128.35 46.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.197 -0.939 . . . . 0.0 110.219 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.44 ' HA3' HG13 ' A' ' 85' ' ' ILE . . . 145.85 -177.81 23.99 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.906 ' CD ' HD21 ' A' ' 21' ' ' LEU . 42.4 Cg_endo -71.02 161.61 89.44 Favored 'Cis proline' 0 C--N 1.313 -1.313 0 C-N-CA 121.754 -2.186 . . . . 0.0 110.463 -0.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.993 HD23 ' N ' ' A' ' 78' ' ' HIS . 8.0 tt -134.92 155.26 51.02 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.274 -0.891 . . . . 0.0 110.158 -175.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.993 ' N ' HD23 ' A' ' 77' ' ' LEU . 42.0 m80 -73.42 129.37 37.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.168 -0.958 . . . . 0.0 110.768 -176.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.776 HG21 ' CG ' ' A' ' 84' ' ' HIS . 9.0 t -144.2 163.42 33.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.367 -0.833 . . . . 0.0 109.848 175.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -60.0 -24.34 64.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.194 -0.941 . . . . 0.0 110.185 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.593 ' HB2' ' CE1' ' A' ' 84' ' ' HIS . 97.8 m-85 -86.68 -0.68 56.73 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.196 -0.94 . . . . 0.0 110.926 -175.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.695 ' O ' HG22 ' A' ' 79' ' ' THR . . . 123.64 -137.72 11.07 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 -174.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.531 ' CZ ' ' HG3' ' A' ' 14' ' ' GLU . 59.2 m-85 -100.16 130.04 46.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.1 -1.235 . . . . 0.0 109.948 173.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.776 ' CG ' HG21 ' A' ' 79' ' ' THR . 19.3 m170 -116.86 124.12 48.73 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.23 -0.918 . . . . 0.0 110.537 178.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.716 HD13 HD11 ' A' ' 20' ' ' LEU . 8.5 tt -110.07 130.06 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.925 -1.11 . . . . 0.0 109.596 170.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.523 HG12 ' HB2' ' A' ' 8' ' ' HIS . 20.5 mt -138.45 137.84 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.996 -1.065 . . . . 0.0 110.824 -172.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.613 ' HD2' HD12 ' A' ' 7' ' ' LEU . 15.8 ptpt -111.16 135.08 52.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.772 -1.205 . . . . 0.0 109.313 168.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.812 ' O ' HD23 ' A' ' 89' ' ' LEU . 37.6 t -110.49 144.17 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.253 -0.905 . . . . 0.0 110.345 -171.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.812 HD23 ' O ' ' A' ' 88' ' ' VAL . 63.2 mt -140.09 129.52 24.06 Favored 'General case' 0 C--N 1.31 -1.126 0 O-C-N 121.027 -1.046 . . . . 0.0 110.21 -175.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.554 ' CB ' ' O ' ' A' ' 89' ' ' LEU . 14.5 t80 81.27 -24.99 0.17 Allowed 'General case' 0 N--CA 1.507 2.391 0 O-C-N 121.4 -0.813 . . . . 0.0 111.833 169.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 1.082 ' HG3' HG11 ' A' ' 70' ' ' VAL . 7.0 ttm-85 59.74 -160.13 0.29 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.867 -1.146 . . . . 0.0 109.771 -175.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 1.074 ' CB ' ' HB1' ' A' ' 1' ' ' ALA . 25.7 m120 . . . . . 0 N--CA 1.489 1.519 0 O-C-N 120.953 -1.092 . . . . 0.0 110.335 177.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.199 0.523 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -59.95 -40.9 90.59 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.214 -0.928 . . . . 0.0 110.132 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.505 ' O ' ' N ' ' A' ' 92' ' ' ASN . 46.0 p -132.79 144.19 50.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.397 -0.815 . . . . 0.0 110.038 177.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.462 ' C ' ' HG3' ' A' ' 51' ' ' GLU . . . -134.59 142.26 46.88 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.166 -0.959 . . . . 0.0 110.241 178.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.683 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -93.44 119.97 33.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.242 -0.911 . . . . 0.0 108.952 175.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.693 ' HB3' ' CZ ' ' A' ' 52' ' ' PHE . . . -134.32 119.3 18.51 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.637 -1.289 . . . . 0.0 111.505 -168.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.6 ' N ' ' CD1' ' A' ' 7' ' ' LEU . 4.2 mp -96.63 146.98 24.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.177 -0.952 . . . . 0.0 109.288 171.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.616 ' NE2' ' HB1' ' A' ' 6' ' ' ALA . 56.2 m-70 -137.85 126.39 23.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.05 -1.031 . . . . 0.0 110.624 -176.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.774 ' HB ' HG22 ' A' ' 85' ' ' ILE . 68.8 mt -103.18 125.6 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 120.868 -1.145 . . . . 0.0 109.714 169.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.777 HD13 ' C ' ' A' ' 10' ' ' LEU . 2.7 tm? -103.43 119.98 39.94 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.605 -0.685 . . . . 0.0 109.684 177.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.942 HG13 HD22 ' A' ' 16' ' ' LEU . 3.0 t -111.84 132.34 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.319 -0.863 . . . . 0.0 110.286 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -65.99 -40.01 90.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.377 -0.827 . . . . 0.0 110.399 179.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -119.78 139.24 52.63 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.139 -0.976 . . . . 0.0 110.822 -173.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.455 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 88.4 tt0 -60.04 -47.22 86.76 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.556 -0.715 . . . . 0.0 111.282 -177.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.3 mttp -53.31 -36.54 61.36 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.14 -0.975 . . . . 0.0 110.185 -173.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.942 HD22 HG13 ' A' ' 11' ' ' VAL . 8.4 tt -65.26 -40.07 93.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.254 -0.904 . . . . 0.0 109.419 176.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.768 ' HB1' ' HG3' ' A' ' 76' ' ' PRO . . . -58.97 -46.46 88.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.384 -0.823 . . . . 0.0 109.994 176.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.98 -44.62 94.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.235 -0.916 . . . . 0.0 109.874 177.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -59.97 -43.41 95.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.147 -0.971 . . . . 0.0 109.754 175.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.478 ' O ' HG12 ' A' ' 24' ' ' ILE . 2.6 tp -64.14 -45.55 88.0 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.43 -0.793 . . . . 0.0 109.948 177.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.67 HD11 ' CD1' ' A' ' 85' ' ' ILE . 1.9 mp -57.99 -49.58 76.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.38 -0.825 . . . . 0.0 109.866 -174.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -61.03 -37.0 81.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.274 -0.891 . . . . 0.0 109.689 172.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.464 ' HB3' ' O ' ' A' ' 20' ' ' LEU . 60.5 tt0 -59.96 -34.79 73.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.456 -0.777 . . . . 0.0 110.443 -174.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.533 HD13 ' CD1' ' A' ' 33' ' ' LEU . 45.4 mm -59.92 -49.57 83.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.092 -1.005 . . . . 0.0 109.325 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -60.68 -46.43 90.4 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.097 -1.002 . . . . 0.0 109.789 178.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -60.08 -53.25 60.04 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.291 -0.88 . . . . 0.0 110.327 177.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.758 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -104.48 -54.71 0.77 Allowed Glycine 0 N--CA 1.486 1.992 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -173.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.758 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 79.19 95.03 0.06 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.862 -0.787 . . . . 0.0 110.58 178.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.485 ' OD2' ' HD2' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -177.6 80.42 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.422 -0.799 . . . . 0.0 109.751 -178.814 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.578 ' CG ' ' HD2' ' A' ' 87' ' ' LYS . 11.9 m-85 -60.09 -49.97 75.56 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.319 -0.863 . . . . 0.0 111.187 -174.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.08 -50.13 58.94 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.722 -1.228 . . . . 0.0 110.126 -174.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.485 ' HD2' ' OD2' ' A' ' 29' ' ' ASP . 32.3 mttm -66.57 -40.01 88.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.086 -1.244 . . . . 0.0 110.383 -175.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.533 ' CD1' HD13 ' A' ' 24' ' ' ILE . 67.7 mt -66.44 -40.01 89.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.062 -1.024 . . . . 0.0 110.477 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.554 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -59.22 -51.91 67.94 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.087 -1.008 . . . . 0.0 110.082 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -60.14 -45.84 91.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.327 -0.858 . . . . 0.0 110.722 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -68.32 -47.38 67.7 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.11 -0.994 . . . . 0.0 110.848 -175.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.487 ' HE1' HD22 ' A' ' 33' ' ' LEU . 35.4 m170 -74.79 -45.18 45.31 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.148 -0.97 . . . . 0.0 110.765 -175.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.563 ' O ' HG22 ' A' ' 39' ' ' ILE . 25.4 t -60.39 -46.27 90.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.203 -0.935 . . . . 0.0 110.133 -179.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.563 HG22 ' O ' ' A' ' 38' ' ' SER . 13.3 tt 36.02 30.04 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-O 121.445 0.64 . . . . 0.0 110.774 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.517 ' N ' ' O ' ' A' ' 38' ' ' SER . 14.2 p -121.56 171.63 5.91 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.286 -0.884 . . . . 0.0 110.024 -178.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.485 ' HD2' ' HB2' ' A' ' 40' ' ' CYS . 43.7 Cg_exo -48.94 -31.35 20.0 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.647 1.341 . . . . 0.0 110.352 -177.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.6 OUTLIER -101.65 15.11 29.96 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.306 -0.871 . . . . 0.0 110.028 177.788 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.29 -58.86 3.78 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.754 -1.738 . . . . 0.0 108.754 174.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.1 tptt -59.91 -40.08 87.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -1.114 . . . . 0.0 110.551 177.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.469 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 11.1 tpt180 -98.29 -41.1 8.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.085 -1.009 . . . . 0.0 110.567 -175.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -70.24 -30.33 69.58 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -178.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.48 -5.56 50.57 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.417 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 25.1 t0 -172.67 72.16 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.332 -1.099 . . . . 0.0 108.586 179.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.542 HD12 ' CD2' ' A' ' 8' ' ' HIS . 6.8 mt -70.03 -27.1 64.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.456 -0.777 . . . . 0.0 110.177 -173.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 113.58 -154.71 16.78 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.462 ' HG3' ' C ' ' A' ' 4' ' ' ALA . 84.6 tt0 -106.55 129.83 54.43 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.291 -1.123 . . . . 0.0 109.845 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.693 ' CZ ' ' HB3' ' A' ' 6' ' ' ALA . 0.1 OUTLIER -131.57 173.47 11.08 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.051 -1.031 . . . . 0.0 110.704 178.044 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.554 ' HG2' ' NE2' ' A' ' 56' ' ' GLN . 20.6 ptt180 -112.52 176.5 4.99 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.323 -0.861 . . . . 0.0 110.229 179.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -61.06 -11.2 7.69 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.205 -0.935 . . . . 0.0 111.27 -173.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.46 ' C ' ' HG2' ' A' ' 56' ' ' GLN . . . -84.54 42.41 3.11 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 177.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.554 ' NE2' ' HG2' ' A' ' 53' ' ' ARG . 2.0 pt20 -178.08 -32.96 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.196 -1.179 . . . . 0.0 110.298 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.476 ' HG3' ' O ' ' A' ' 53' ' ' ARG . 62.6 mtt -47.23 142.28 3.99 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.074 -1.016 . . . . 0.0 110.97 -169.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.487 HG13 ' H ' ' A' ' 61' ' ' PHE . 7.5 p -71.6 130.97 86.61 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.515 -0.741 . . . . 0.0 110.098 177.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -43.95 -44.77 11.9 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 121.627 1.551 . . . . 0.0 111.286 -174.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.09 -38.45 79.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.009 -1.057 . . . . 0.0 109.938 -178.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.539 ' HD2' HG21 ' A' ' 86' ' ' ILE . 63.2 t80 -59.99 -38.79 83.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.268 -0.895 . . . . 0.0 110.282 174.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.44 ' O ' HG12 ' A' ' 65' ' ' VAL . 48.8 t0 -60.03 -43.75 95.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.204 -0.935 . . . . 0.0 110.117 -176.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 67' ' ' SER . 23.6 tttm -60.07 -47.03 87.58 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.216 -0.927 . . . . 0.0 110.417 177.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.658 HG11 HD12 ' A' ' 86' ' ' ILE . 13.1 p -79.25 -44.47 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.024 -1.047 . . . . 0.0 111.347 -173.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.548 ' N ' HG13 ' A' ' 64' ' ' VAL . 4.4 p -53.56 -25.8 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.361 -1.462 . . . . 0.0 109.008 173.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -94.97 -13.22 25.5 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.513 -0.742 . . . . 0.0 109.939 176.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.526 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 8.0 t -93.38 -61.65 1.52 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.354 -0.841 . . . . 0.0 110.053 177.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 78.6 m -99.98 132.01 23.47 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.38 -0.825 . . . . 0.0 110.272 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.498 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 12.1 Cg_endo -61.31 159.93 29.08 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.861 1.453 . . . . 0.0 110.082 178.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.981 HG23 HG12 ' A' ' 88' ' ' VAL . 8.1 p -60.46 177.41 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.198 -0.939 . . . . 0.0 109.891 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.833 HD12 HG13 ' A' ' 70' ' ' VAL . 4.7 mp 45.48 40.02 5.25 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.639 -1.288 . . . . 0.0 109.981 -168.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.498 ' HB3' ' O ' ' A' ' 69' ' ' PRO . 0.4 OUTLIER -150.57 89.65 4.4 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.384 -0.822 . . . . 0.0 109.729 175.497 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -59.26 126.55 21.19 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.827 1.435 . . . . 0.0 109.782 -177.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.433 HG21 HG23 ' A' ' 64' ' ' VAL . 53.3 m -130.7 136.72 49.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.095 -1.003 . . . . 0.0 110.453 -177.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.459 ' HA3' HG13 ' A' ' 85' ' ' ILE . . . 152.27 -171.38 31.54 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -178.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.768 ' HG3' ' HB1' ' A' ' 17' ' ' ALA . 41.7 Cg_endo -84.77 134.03 19.45 Favored 'Cis proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.209 -1.996 . . . . 0.0 110.42 3.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 74.8 mt -93.0 -178.52 4.82 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.254 -0.904 . . . . 0.0 110.735 -172.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -102.66 125.37 49.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.072 -1.018 . . . . 0.0 110.712 -176.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.898 HG21 ' CD2' ' A' ' 84' ' ' HIS . 12.5 t -140.05 162.43 35.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.428 -0.795 . . . . 0.0 109.813 176.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -60.05 -39.95 87.72 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.101 -0.999 . . . . 0.0 110.364 -178.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -70.31 -5.56 28.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.208 -0.933 . . . . 0.0 110.61 -177.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.65 ' O ' HG22 ' A' ' 79' ' ' THR . . . 134.43 -137.47 9.3 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.46 ' O ' ' HA ' ' A' ' 10' ' ' LEU . 75.1 m-85 -96.1 130.67 43.07 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.165 -1.197 . . . . 0.0 110.241 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.898 ' CD2' HG21 ' A' ' 79' ' ' THR . 6.0 m170 -107.89 112.43 25.04 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.674 -0.641 . . . . 0.0 110.643 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.774 HG22 ' HB ' ' A' ' 9' ' ' ILE . 2.5 tt -104.86 120.32 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.527 -1.358 . . . . 0.0 109.076 167.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.658 HD12 HG11 ' A' ' 64' ' ' VAL . 88.2 mt -110.02 130.02 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.936 -1.103 . . . . 0.0 111.298 -169.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.813 ' NZ ' HD21 ' A' ' 89' ' ' LEU . 63.0 tttm -101.71 126.41 48.56 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 172.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.981 HG12 HG23 ' A' ' 70' ' ' VAL . 24.5 t -103.42 136.46 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.13 -0.981 . . . . 0.0 110.297 -176.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.813 HD21 ' NZ ' ' A' ' 87' ' ' LYS . 58.0 mt -130.58 119.91 23.22 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.416 -0.802 . . . . 0.0 109.349 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.528 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 44.3 m-85 72.55 -58.9 0.58 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.648 -0.658 . . . . 0.0 110.856 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.443 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 67.1 ttp85 57.11 39.91 28.73 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.234 -0.916 . . . . 0.0 110.622 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.505 ' N ' ' O ' ' A' ' 3' ' ' THR . 24.3 t-20 . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.202 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.461 ' O ' ' OD1' ' A' ' 92' ' ' ASN . . . . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.221 0.534 . . . . 0.0 110.286 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.8 tttp -63.36 -40.06 96.24 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.213 -0.929 . . . . 0.0 110.285 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 91' ' ' ARG . 35.6 p -135.77 162.29 33.2 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.352 -0.843 . . . . 0.0 109.817 178.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.523 ' HB3' ' CE1' ' A' ' 52' ' ' PHE . . . -109.88 131.24 55.24 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.173 -0.955 . . . . 0.0 110.549 -175.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.563 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -99.32 122.05 41.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.405 -0.809 . . . . 0.0 109.64 177.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.86 ' HB1' ' NE2' ' A' ' 8' ' ' HIS . . . -140.05 132.03 27.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.856 -1.153 . . . . 0.0 111.212 -175.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.984 HD12 ' HD2' ' A' ' 87' ' ' LYS . 86.7 mt -98.32 139.78 33.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.138 -0.976 . . . . 0.0 108.806 168.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.86 ' NE2' ' HB1' ' A' ' 6' ' ' ALA . 34.7 m-70 -135.17 117.97 16.15 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.805 -1.185 . . . . 0.0 110.754 -177.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.761 ' HB ' HG22 ' A' ' 85' ' ' ILE . 92.6 mt -105.17 126.62 60.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.35 -0.844 . . . . 0.0 109.869 172.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.591 ' HG ' ' CD2' ' A' ' 84' ' ' HIS . 0.3 OUTLIER -101.8 117.94 35.89 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.561 -0.712 . . . . 0.0 109.898 -179.757 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.731 HG13 HD22 ' A' ' 16' ' ' LEU . 2.2 t -108.23 125.3 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.229 -0.919 . . . . 0.0 109.747 177.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.2 mmtp -68.48 -39.39 81.38 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.44 -0.788 . . . . 0.0 110.17 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -111.43 138.11 48.35 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.186 -0.946 . . . . 0.0 110.699 -178.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.66 ' HG2' HD12 ' A' ' 18' ' ' LEU . 88.8 tt0 -59.97 -42.12 93.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.366 -0.833 . . . . 0.0 109.939 177.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -56.94 -40.53 76.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.395 -0.816 . . . . 0.0 110.139 -178.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.731 HD22 HG13 ' A' ' 11' ' ' VAL . 5.5 tt -68.82 -40.04 79.72 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.025 -1.047 . . . . 0.0 109.301 174.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.997 ' O ' HD12 ' A' ' 21' ' ' LEU . . . -59.95 -40.72 89.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.386 -0.821 . . . . 0.0 110.021 175.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.66 HD12 ' HG2' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -59.94 -41.67 92.37 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.15 -0.969 . . . . 0.0 109.695 175.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -60.03 -44.75 94.42 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.32 -0.863 . . . . 0.0 110.246 176.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.71 ' C ' HD12 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -64.11 -43.74 94.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.075 -1.015 . . . . 0.0 109.544 178.51 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.997 HD12 ' O ' ' A' ' 17' ' ' ALA . 0.3 OUTLIER -56.19 -49.92 72.67 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.499 -0.75 . . . . 0.0 109.697 -179.588 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -61.7 -40.01 93.51 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.391 -0.818 . . . . 0.0 110.134 175.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.419 ' O ' ' N ' ' A' ' 27' ' ' GLY . 70.0 tp60 -60.1 -39.9 87.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.271 -0.893 . . . . 0.0 110.945 -174.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.518 ' O ' ' N ' ' A' ' 28' ' ' ALA . 96.7 mt -62.76 -40.55 89.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.104 -0.997 . . . . 0.0 110.289 -176.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -65.42 -58.75 5.09 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.964 -1.085 . . . . 0.0 110.067 175.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -60.05 -39.96 87.78 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.34 -0.85 . . . . 0.0 110.799 178.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.732 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -104.0 -63.03 0.68 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -176.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.732 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 81.79 93.04 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.175 0 O-C-N 122.06 -0.671 . . . . 0.0 110.508 178.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 179.74 78.32 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.423 -0.798 . . . . 0.0 109.952 -178.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.525 ' CZ ' HG23 ' A' ' 85' ' ' ILE . 17.1 t80 -61.12 -39.98 92.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.318 -0.864 . . . . 0.0 110.72 -174.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.435 ' O ' ' HG3' ' A' ' 35' ' ' LYS . . . -66.01 -53.65 29.04 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -176.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.463 ' HE3' ' HE3' ' A' ' 36' ' ' LYS . 82.5 tttt -64.8 -41.55 95.72 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.111 -1.229 . . . . 0.0 110.523 -178.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 85.7 mt -65.89 -40.04 91.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.238 -0.914 . . . . 0.0 109.931 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.548 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -60.25 -48.87 79.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.365 -0.835 . . . . 0.0 110.347 178.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.435 ' HG3' ' O ' ' A' ' 31' ' ' GLY . 72.4 mttt -59.99 -46.34 89.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 0.0 110.391 -175.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.463 ' HE3' ' HE3' ' A' ' 32' ' ' LYS . 41.5 mttt -69.41 -50.82 42.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.094 -1.004 . . . . 0.0 111.074 -176.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 53.9 m170 -70.05 -39.97 75.4 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.124 -0.985 . . . . 0.0 111.073 -173.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.655 ' O ' HG22 ' A' ' 39' ' ' ILE . 14.5 t -59.99 -45.6 92.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.037 -1.04 . . . . 0.0 110.313 -175.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.655 HG22 ' O ' ' A' ' 38' ' ' SER . 20.4 tt 38.73 34.18 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.589 -0.695 . . . . 0.0 110.603 178.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.483 ' HB2' ' HD2' ' A' ' 41' ' ' PRO . 15.0 p -127.36 165.68 27.91 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.288 -0.883 . . . . 0.0 109.764 -178.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' A' ' 40' ' ' CYS . 2.0 Cg_endo -49.2 -33.24 27.29 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.626 1.329 . . . . 0.0 110.172 179.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.2 OUTLIER -92.8 8.69 38.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.145 -0.972 . . . . 0.0 110.308 176.834 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.422 ' HA2' ' OG ' ' A' ' 38' ' ' SER . . . -56.17 -54.45 35.5 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.591 -1.804 . . . . 0.0 108.591 177.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -61.22 -39.97 92.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.355 -1.085 . . . . 0.0 110.658 175.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.541 ' HG3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -94.16 -68.91 0.78 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.124 -0.985 . . . . 0.0 110.353 -173.589 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -52.82 -38.12 53.44 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.95 -5.52 52.87 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 176.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.482 ' HA ' ' CD2' ' A' ' 7' ' ' LEU . 50.2 t0 -172.34 71.12 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.35 -1.088 . . . . 0.0 108.856 178.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.541 HD23 ' HG3' ' A' ' 45' ' ' ARG . 7.0 mt -69.85 -25.26 63.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.544 -0.722 . . . . 0.0 109.911 -174.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' A' ' 5' ' ' ALA . . . 82.79 -137.69 17.04 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.074 -1.611 . . . . 0.0 109.074 -178.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.516 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 1.8 mt-10 -102.27 129.65 48.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.443 -1.033 . . . . 0.0 110.635 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.655 ' CE2' ' HB3' ' A' ' 6' ' ' ALA . 1.5 p90 -134.62 159.2 41.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.544 -0.722 . . . . 0.0 109.799 178.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.51 ' O ' ' N ' ' A' ' 55' ' ' GLY . 78.1 mtm180 -116.62 143.83 45.13 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.839 -1.163 . . . . 0.0 111.352 -170.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.505 ' O ' ' N ' ' A' ' 56' ' ' GLN . 89.5 mt-30 31.35 -88.71 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 176.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . -64.81 61.76 0.07 OUTLIER Glycine 0 N--CA 1.495 2.62 0 O-C-N 120.965 -1.084 . . . . 0.0 110.63 -169.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.505 ' N ' ' O ' ' A' ' 54' ' ' GLN . 55.9 mm-40 -132.67 3.96 3.87 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.951 -1.323 . . . . 0.0 110.616 178.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.447 ' HG2' ' CE2' ' A' ' 61' ' ' PHE . 75.4 mtm -91.78 -175.99 4.32 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.266 -1.521 . . . . 0.0 112.086 -162.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.602 HG13 ' CB ' ' A' ' 61' ' ' PHE . 1.6 p -171.29 137.58 1.08 Allowed Pre-proline 0 N--CA 1.488 1.445 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -174.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.439 ' C ' ' O ' ' A' ' 58' ' ' VAL . 14.7 Cg_exo -32.88 -52.1 0.4 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 121.754 1.636 . . . . 0.0 111.185 -172.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.562 ' HB2' ' HB ' ' A' ' 79' ' ' THR . . . -61.81 -42.69 99.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.091 -1.006 . . . . 0.0 110.553 178.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.602 ' CB ' HG13 ' A' ' 58' ' ' VAL . 60.9 t80 -60.06 -40.17 88.55 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.141 -0.975 . . . . 0.0 110.647 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.492 ' O ' HG12 ' A' ' 65' ' ' VAL . 54.8 t0 -63.34 -42.85 98.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.012 -1.055 . . . . 0.0 109.69 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -57.7 -55.77 30.61 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.285 -0.885 . . . . 0.0 110.266 178.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.626 HG11 HD12 ' A' ' 86' ' ' ILE . 2.7 p -70.0 -43.83 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.016 -1.052 . . . . 0.0 111.775 -172.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.492 HG12 ' O ' ' A' ' 62' ' ' ASP . 4.8 p -55.26 -27.11 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.223 -1.548 . . . . 0.0 108.94 174.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.452 ' HB2' ' O ' ' A' ' 62' ' ' ASP . 0.1 OUTLIER -94.97 -8.7 36.21 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.261 -0.899 . . . . 0.0 110.582 175.468 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.524 ' HB2' ' HA ' ' A' ' 64' ' ' VAL . 24.1 m -93.19 -41.89 9.66 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.003 -1.06 . . . . 0.0 110.042 176.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 88.2 m -120.71 150.58 52.87 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.166 -0.959 . . . . 0.0 110.205 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -73.41 156.34 50.29 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.977 1.514 . . . . 0.0 109.955 178.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.981 HG22 HD12 ' A' ' 71' ' ' LEU . 7.2 p -58.03 172.63 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.171 -0.956 . . . . 0.0 109.855 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.981 HD12 HG22 ' A' ' 70' ' ' VAL . 3.6 mp 57.44 39.78 27.8 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.413 -0.804 . . . . 0.0 110.077 -174.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -155.84 117.28 2.28 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.116 -0.99 . . . . 0.0 110.394 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 87' ' ' LYS . 30.6 Cg_endo -68.98 132.74 25.25 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.828 1.436 . . . . 0.0 110.182 179.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.522 HG21 HG23 ' A' ' 64' ' ' VAL . 87.0 m -139.58 147.15 40.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.157 -0.965 . . . . 0.0 110.295 -178.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.469 ' HA3' ' HA ' ' A' ' 85' ' ' ILE . . . 134.44 -176.11 20.07 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -178.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.853 ' CD ' HD11 ' A' ' 21' ' ' LEU . 44.1 Cg_endo -74.57 135.97 42.86 Favored 'Cis proline' 0 C--N 1.314 -1.271 0 C-N-CA 121.79 -2.171 . . . . 0.0 110.557 -0.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.462 HD23 ' HB1' ' A' ' 60' ' ' ALA . 59.8 tp -94.94 155.08 16.91 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.26 -0.9 . . . . 0.0 110.435 -178.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -77.89 119.74 21.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -0.891 . . . . 0.0 110.459 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.674 HG22 ' O ' ' A' ' 82' ' ' GLY . 10.8 t -134.21 165.57 24.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.214 -0.929 . . . . 0.0 109.55 173.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -59.97 -39.58 86.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.113 -0.992 . . . . 0.0 110.047 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -66.75 -11.55 55.15 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.226 -0.921 . . . . 0.0 110.717 -177.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.674 ' O ' HG22 ' A' ' 79' ' ' THR . . . 132.32 -139.75 11.22 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 -176.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.576 ' CE2' ' HB2' ' A' ' 14' ' ' GLU . 75.5 m-85 -102.64 122.14 43.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.108 -1.23 . . . . 0.0 110.291 178.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.626 ' CE1' HG21 ' A' ' 79' ' ' THR . 41.2 m170 -104.98 122.64 46.27 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.196 -0.94 . . . . 0.0 110.422 175.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.761 HG22 ' HB ' ' A' ' 9' ' ' ILE . 3.5 tt -103.52 119.23 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 118.376 -1.329 . . . . 0.0 109.361 167.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.724 HG23 ' CE1' ' A' ' 8' ' ' HIS . 85.5 mt -114.77 130.02 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.095 -1.003 . . . . 0.0 110.707 -170.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.984 ' HD2' HD12 ' A' ' 7' ' ' LEU . 34.9 ttmt -96.96 126.08 41.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.135 -0.978 . . . . 0.0 109.164 171.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.565 HG12 HG23 ' A' ' 70' ' ' VAL . 48.5 t -107.61 123.19 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.382 -0.824 . . . . 0.0 109.959 -175.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.563 ' HB2' ' HB3' ' A' ' 5' ' ' ALA . 60.1 mt -134.36 113.04 11.5 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.522 -0.736 . . . . 0.0 109.317 -176.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.545 ' CB ' ' O ' ' A' ' 89' ' ' LEU . 2.9 m-85 81.91 -43.37 0.16 Allowed 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.718 -0.614 . . . . 0.0 110.444 -178.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.472 ' O ' ' O ' ' A' ' 3' ' ' THR . 4.4 ttm180 59.9 -159.52 0.3 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.082 -1.011 . . . . 0.0 109.983 -178.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.461 ' OD1' ' O ' ' A' ' 1' ' ' ALA . 52.7 t-20 . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.048 -1.033 . . . . 0.0 110.319 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.245 0.545 . . . . 0.0 110.253 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 40.8 mttt -123.64 145.33 49.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.25 -0.906 . . . . 0.0 110.133 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.511 HG22 ' HG2' ' A' ' 53' ' ' ARG . 19.3 p 47.4 -164.76 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.213 -0.93 . . . . 0.0 109.516 -176.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -140.16 142.81 35.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.913 -1.117 . . . . 0.0 110.732 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.431 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -97.24 126.98 42.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.267 -0.895 . . . . 0.0 108.907 171.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.582 ' CB ' ' NE2' ' A' ' 8' ' ' HIS . . . -136.67 130.82 32.72 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.661 -1.274 . . . . 0.0 112.112 -168.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.511 ' C ' ' CD2' ' A' ' 8' ' ' HIS . 75.2 mt -103.48 144.42 31.42 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.263 -0.898 . . . . 0.0 109.411 167.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.977 ' CD2' HD12 ' A' ' 49' ' ' LEU . 10.0 m-70 -136.28 142.59 43.95 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.797 -1.19 . . . . 0.0 111.121 -175.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.565 ' HB ' ' CG2' ' A' ' 85' ' ' ILE . 96.7 mt -129.14 131.9 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.133 -0.98 . . . . 0.0 109.953 170.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.552 HD23 ' N ' ' A' ' 11' ' ' VAL . 0.3 OUTLIER -103.27 121.9 43.66 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.507 -0.746 . . . . 0.0 110.068 179.382 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.725 HG13 HD22 ' A' ' 16' ' ' LEU . 2.7 t -110.25 133.15 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.088 -1.008 . . . . 0.0 110.142 178.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.2 mttt -68.33 -40.02 81.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.238 -0.914 . . . . 0.0 110.646 -178.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -120.14 142.0 49.34 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.152 -0.968 . . . . 0.0 110.977 -176.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.583 ' HB2' ' CZ ' ' A' ' 83' ' ' TYR . 88.6 tt0 -59.99 -42.99 95.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.447 -0.783 . . . . 0.0 110.172 178.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -57.47 -40.06 77.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.682 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.725 HD22 HG13 ' A' ' 11' ' ' VAL . 5.5 tt -67.99 -40.28 83.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.2 -0.938 . . . . 0.0 109.704 177.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.6 ' N ' HG11 ' A' ' 11' ' ' VAL . . . -59.94 -44.1 94.59 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -0.933 . . . . 0.0 110.061 175.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.408 ' CD1' ' HG2' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -60.01 -43.24 95.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.303 -0.873 . . . . 0.0 109.707 175.829 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -59.99 -41.46 92.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.312 -0.867 . . . . 0.0 109.586 174.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.0 tp -63.08 -45.47 91.99 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.573 0.702 . . . . 0.0 109.88 176.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.676 HD11 ' CD1' ' A' ' 85' ' ' ILE . 2.4 mp -59.96 -44.98 94.1 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.659 -0.651 . . . . 0.0 110.376 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.5 tp10 -60.59 -40.07 90.4 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.421 -0.8 . . . . 0.0 110.411 -178.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -60.39 -41.14 93.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.277 -0.89 . . . . 0.0 110.133 -177.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.81 HG13 HD13 ' A' ' 33' ' ' LEU . 24.8 mt -67.14 -43.09 88.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.36 -0.837 . . . . 0.0 110.801 -178.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -60.2 -47.97 83.73 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.869 -1.145 . . . . 0.0 110.395 -175.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.7 -62.55 1.79 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.004 -1.06 . . . . 0.0 110.345 176.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.743 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -105.76 -39.23 2.22 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -172.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.743 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 81.47 -176.79 0.05 Allowed 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.811 -0.817 . . . . 0.0 109.623 -173.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.618 ' CB ' ' O ' ' A' ' 28' ' ' ALA . 95.9 m-20 115.11 71.84 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.954 0 C-N-CA 124.822 1.249 . . . . 0.0 109.623 -175.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.594 ' CG ' ' HE3' ' A' ' 87' ' ' LYS . 7.6 m-85 -63.42 -39.77 95.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.266 -0.897 . . . . 0.0 110.32 176.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.64 -55.75 28.16 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 -177.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.2 mttp -66.52 -40.62 89.27 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.923 -1.339 . . . . 0.0 110.912 -176.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.81 HD13 HG13 ' A' ' 24' ' ' ILE . 34.9 mt -66.59 -40.06 88.7 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.045 -1.035 . . . . 0.0 110.19 -179.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.546 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -59.98 -46.2 90.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.096 -1.003 . . . . 0.0 110.029 177.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -60.06 -48.89 79.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.273 -0.892 . . . . 0.0 110.44 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -64.11 -46.57 83.62 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.181 -0.949 . . . . 0.0 110.941 -174.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.4 ' CE1' HD21 ' A' ' 16' ' ' LEU . 57.1 m-70 -73.95 -44.93 53.27 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.917 -1.114 . . . . 0.0 111.334 -175.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.655 ' O ' HG22 ' A' ' 39' ' ' ILE . 6.7 t -59.97 -48.16 82.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.977 -1.077 . . . . 0.0 110.707 -172.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.655 HG22 ' O ' ' A' ' 38' ' ' SER . 20.1 tt 38.33 32.24 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.588 -0.695 . . . . 0.0 110.837 179.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.487 ' SG ' ' N ' ' A' ' 43' ' ' GLY . 18.7 p -128.71 164.2 40.0 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.143 -0.973 . . . . 0.0 110.366 -176.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.472 ' HD2' ' HB2' ' A' ' 40' ' ' CYS . 1.7 Cg_endo -50.66 -29.11 24.43 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.951 1.501 . . . . 0.0 110.454 178.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.485 ' O ' ' CA ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -100.57 17.93 20.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.065 -1.022 . . . . 0.0 109.65 175.4 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.488 ' HA2' ' OG ' ' A' ' 38' ' ' SER . . . -79.51 -57.85 3.03 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 175.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.467 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 86.8 tttt -59.99 -39.53 86.03 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.383 -1.069 . . . . 0.0 110.04 177.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.0 tpt180 -95.71 -42.36 8.42 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.089 -1.007 . . . . 0.0 110.767 -177.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.485 ' CA ' ' O ' ' A' ' 42' ' ' SER . . . -70.13 -25.63 75.36 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.86 -1.04 58.12 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 175.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' A' ' 44' ' ' LYS . 45.7 p-10 -171.01 66.85 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.326 -1.102 . . . . 0.0 108.755 -178.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.977 HD12 ' CD2' ' A' ' 8' ' ' HIS . 7.5 mt -69.96 -26.27 64.03 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.51 -0.744 . . . . 0.0 109.924 -175.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.03 -145.48 17.8 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 -178.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -109.95 137.57 47.55 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.226 -1.161 . . . . 0.0 110.383 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.565 ' CE2' ' HB3' ' A' ' 6' ' ' ALA . 3.4 p90 -148.09 163.01 38.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.434 -0.791 . . . . 0.0 110.1 -178.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.514 ' O ' ' NE2' ' A' ' 56' ' ' GLN . 96.4 mtt180 -75.58 158.59 32.26 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.24 -0.913 . . . . 0.0 109.354 176.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -62.31 123.99 19.7 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.084 -1.01 . . . . 0.0 109.368 176.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 105.74 66.0 0.66 Allowed Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -174.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.533 ' HG3' ' CD1' ' A' ' 52' ' ' PHE . 21.7 mm-40 -128.89 -63.7 0.95 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.881 -1.364 . . . . 0.0 109.571 176.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 45.0 ttm -115.33 -62.92 1.53 Allowed 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.376 -0.929 . . . . 0.0 111.209 -166.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 58' ' ' VAL . 10.8 p -123.21 133.13 24.34 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.181 -0.949 . . . . 0.0 110.528 -173.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.447 ' O ' ' N ' ' A' ' 61' ' ' PHE . 14.2 Cg_endo -60.42 -52.93 3.32 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.869 1.458 . . . . 0.0 110.205 176.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.732 ' O ' HG13 ' A' ' 64' ' ' VAL . . . -39.76 -28.98 0.05 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.585 -0.697 . . . . 0.0 110.628 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.506 ' HB2' ' CG1' ' A' ' 58' ' ' VAL . 62.5 t80 -60.03 -44.56 94.55 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.161 -0.962 . . . . 0.0 110.204 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.466 ' O ' HG12 ' A' ' 65' ' ' VAL . 47.8 t0 -59.93 -40.05 87.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.156 -0.965 . . . . 0.0 109.723 176.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.885 ' HD3' HD21 ' A' ' 77' ' ' LEU . 79.9 tttt -58.55 -41.92 86.72 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.387 -0.821 . . . . 0.0 110.348 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.732 HG13 ' O ' ' A' ' 60' ' ' ALA . 0.9 OUTLIER -77.69 -46.43 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.122 -0.986 . . . . 0.0 110.667 -177.153 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.5 ' N ' ' CG2' ' A' ' 64' ' ' VAL . 0.3 OUTLIER -56.14 -25.12 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.502 -1.374 . . . . 0.0 109.201 172.776 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -95.21 -5.17 44.46 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.493 -0.754 . . . . 0.0 109.917 175.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.532 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 29.7 t -96.32 -44.54 7.19 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.418 -0.801 . . . . 0.0 110.14 178.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 56.5 m -131.68 152.38 80.29 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.353 -0.842 . . . . 0.0 110.457 -177.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.437 ' HD2' ' OE1' ' A' ' 72' ' ' GLU . 13.5 Cg_endo -68.95 155.92 66.97 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.073 1.565 . . . . 0.0 110.377 178.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.888 HG22 HD12 ' A' ' 71' ' ' LEU . 8.9 p -61.3 169.69 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.349 -0.844 . . . . 0.0 110.616 -177.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.888 HD12 HG22 ' A' ' 70' ' ' VAL . 2.2 mp 59.45 16.02 4.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.629 -0.67 . . . . 0.0 110.277 -177.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.437 ' OE1' ' HD2' ' A' ' 69' ' ' PRO . 11.1 tt0 -137.2 85.15 22.61 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.206 -0.933 . . . . 0.0 109.472 173.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -43.75 145.27 1.95 Allowed 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 124.051 1.553 . . . . 0.0 110.712 -174.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 62.6 m -132.67 139.62 47.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.47 -0.769 . . . . 0.0 110.078 -178.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.42 ' HA3' HG13 ' A' ' 85' ' ' ILE . . . 141.72 -175.88 22.26 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.234 -1.547 . . . . 0.0 109.234 -178.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.549 ' HD3' HD21 ' A' ' 21' ' ' LEU . 43.5 Cg_endo -79.47 132.91 26.58 Favored 'Cis proline' 0 C--N 1.314 -1.275 0 C-N-CA 121.834 -2.152 . . . . 0.0 110.367 -0.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.885 HD21 ' HD3' ' A' ' 63' ' ' LYS . 43.7 tp -96.51 156.86 16.16 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.283 -0.885 . . . . 0.0 110.877 -174.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.461 ' N ' ' HG ' ' A' ' 77' ' ' LEU . 12.6 t60 -78.0 126.03 30.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.454 -0.779 . . . . 0.0 110.402 178.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.575 HG21 ' CG ' ' A' ' 84' ' ' HIS . 11.6 t -139.95 158.98 43.2 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.178 -0.951 . . . . 0.0 109.882 176.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -60.89 -25.74 66.93 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.16 -0.962 . . . . 0.0 110.864 -176.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -81.01 -9.94 59.78 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.007 -1.058 . . . . 0.0 110.639 -178.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.502 ' O ' HG22 ' A' ' 79' ' ' THR . . . 139.4 -128.43 3.99 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 108.653 -1.779 . . . . 0.0 108.653 -174.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.583 ' CZ ' ' HB2' ' A' ' 14' ' ' GLU . 91.6 m-85 -115.88 134.58 54.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.95 -1.323 . . . . 0.0 109.827 173.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.575 ' CG ' HG21 ' A' ' 79' ' ' THR . 31.3 m170 -114.34 125.51 53.96 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.18 -0.95 . . . . 0.0 110.564 177.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.676 ' CD1' HD11 ' A' ' 21' ' ' LEU . 6.7 tt -114.1 122.23 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.904 -1.122 . . . . 0.0 109.264 170.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.72 HD12 HG11 ' A' ' 64' ' ' VAL . 85.3 mt -117.43 129.96 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.167 -0.958 . . . . 0.0 111.07 -170.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.594 ' HE3' ' CG ' ' A' ' 30' ' ' PHE . 12.1 ttmm -94.87 125.65 39.67 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.126 -0.984 . . . . 0.0 109.341 170.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.613 HG12 HG23 ' A' ' 70' ' ' VAL . 62.4 t -104.75 131.96 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.294 -0.879 . . . . 0.0 110.221 -174.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.522 ' O ' ' N ' ' A' ' 91' ' ' ARG . 48.4 mt -133.74 154.07 51.24 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.507 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 2.2 m-85 64.19 -58.58 0.22 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.682 -0.637 . . . . 0.0 111.059 176.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.522 ' N ' ' O ' ' A' ' 89' ' ' LEU . 3.2 ttm180 60.44 178.75 0.1 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.077 -1.014 . . . . 0.0 110.544 -179.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 48.5 t30 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 118.045 -0.979 . . . . 0.0 110.187 -179.413 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.61 ' HB1' ' O ' ' A' ' 91' ' ' ARG . . . . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.197 0.523 . . . . 0.0 110.09 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 53' ' ' ARG . 15.5 ttpp -59.97 -40.03 87.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.223 -0.923 . . . . 0.0 110.325 -177.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.0 p -140.99 150.95 43.73 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.301 -0.874 . . . . 0.0 110.58 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.448 ' C ' ' HG3' ' A' ' 51' ' ' GLU . . . -132.53 156.66 46.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.189 -0.944 . . . . 0.0 110.194 178.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.522 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -92.07 125.33 36.71 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.153 -0.967 . . . . 0.0 109.285 175.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.797 ' HB3' ' CE2' ' A' ' 52' ' ' PHE . . . -137.16 130.2 30.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.804 -1.185 . . . . 0.0 112.081 -169.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.74 HD12 ' HD2' ' A' ' 87' ' ' LYS . 85.0 mt -103.46 140.72 37.1 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.282 -0.886 . . . . 0.0 108.994 168.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.621 ' NE2' ' HB1' ' A' ' 6' ' ' ALA . 35.5 m170 -134.41 148.53 50.66 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.681 -1.262 . . . . 0.0 111.539 -176.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.68 ' HB ' HG22 ' A' ' 85' ' ' ILE . 97.0 mt -136.33 130.88 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.297 -0.877 . . . . 0.0 109.862 169.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.62 HD23 ' N ' ' A' ' 11' ' ' VAL . 0.4 OUTLIER -99.25 123.65 43.7 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.383 -0.823 . . . . 0.0 109.667 177.153 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.666 HG11 ' N ' ' A' ' 17' ' ' ALA . 2.6 t -115.86 129.78 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.183 -0.948 . . . . 0.0 110.028 177.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -69.25 -40.03 78.11 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.326 -0.859 . . . . 0.0 110.59 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -114.93 139.49 49.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.064 -1.022 . . . . 0.0 110.652 -177.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.507 ' HB2' ' CZ ' ' A' ' 83' ' ' TYR . 86.3 tt0 -59.94 -42.41 93.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.428 -0.795 . . . . 0.0 110.032 177.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -56.68 -42.84 79.75 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.325 -0.859 . . . . 0.0 110.2 179.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.615 HD22 HG13 ' A' ' 11' ' ' VAL . 7.4 tt -68.09 -42.4 80.41 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.052 -1.03 . . . . 0.0 109.875 179.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.666 ' N ' HG11 ' A' ' 11' ' ' VAL . . . -59.97 -46.53 89.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.133 -0.98 . . . . 0.0 109.714 174.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.789 HD23 HD22 ' A' ' 21' ' ' LEU . 25.5 mt -60.04 -39.97 87.77 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.889 . . . . 0.0 109.97 175.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.464 ' HB3' ' O ' ' A' ' 16' ' ' LEU . 48.1 t0 -59.97 -40.63 89.76 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.181 -0.949 . . . . 0.0 109.298 174.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.468 ' HA ' ' NE2' ' A' ' 23' ' ' GLN . 2.6 tp -63.28 -39.88 95.83 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.445 -0.784 . . . . 0.0 109.325 173.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.789 HD22 HD23 ' A' ' 18' ' ' LEU . 3.4 mp -59.29 -42.78 92.08 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.53 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -60.26 -40.06 88.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.393 -0.817 . . . . 0.0 109.92 174.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.616 ' NE2' HD22 ' A' ' 33' ' ' LEU . 27.1 mt-30 -61.83 -40.31 94.85 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.45 -0.781 . . . . 0.0 110.818 -177.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.526 ' O ' ' N ' ' A' ' 28' ' ' ALA . 96.9 mt -66.24 -40.02 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.104 -0.997 . . . . 0.0 109.843 -178.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -64.02 -53.73 45.46 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.084 -1.01 . . . . 0.0 109.802 176.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -60.49 -43.47 96.99 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.316 -0.865 . . . . 0.0 110.808 177.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.747 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -106.37 -59.78 0.6 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 -175.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.747 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 83.23 89.89 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 O-C-N 122.07 -0.665 . . . . 0.0 109.861 -175.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -176.92 78.79 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.395 -0.816 . . . . 0.0 109.904 -174.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.565 ' CD2' ' HE3' ' A' ' 87' ' ' LYS . 5.4 m-85 -60.06 -40.56 89.9 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.271 -0.893 . . . . 0.0 110.79 -175.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.63 -51.42 56.12 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.77 -1.205 . . . . 0.0 110.116 -176.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -66.21 -40.01 90.03 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.07 -1.253 . . . . 0.0 110.446 -175.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.616 HD22 ' NE2' ' A' ' 23' ' ' GLN . 67.3 mt -65.92 -39.98 91.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.226 -0.921 . . . . 0.0 110.113 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.563 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -59.29 -50.09 75.34 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.239 -0.913 . . . . 0.0 110.348 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.5 tttp -59.99 -48.25 82.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.913 . . . . 0.0 110.577 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.9 tttt -60.06 -49.54 77.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.208 -0.932 . . . . 0.0 110.987 -175.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -81.88 -40.54 22.24 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.934 -1.104 . . . . 0.0 111.637 -172.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.485 ' OG ' ' HA3' ' A' ' 43' ' ' GLY . 23.7 t -60.06 -49.99 75.49 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.91 -1.119 . . . . 0.0 111.074 -172.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.637 ' O ' HG22 ' A' ' 39' ' ' ILE . 83.7 mt 33.39 48.59 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 CA-C-O 121.195 0.521 . . . . 0.0 111.142 -177.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.42 ' HB2' ' CD ' ' A' ' 41' ' ' PRO . 15.3 p -139.98 176.06 2.79 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.132 -0.98 . . . . 0.0 110.407 -177.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.474 ' O ' ' CB ' ' A' ' 42' ' ' SER . 3.0 Cg_exo -68.87 66.26 1.28 Allowed 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.874 1.46 . . . . 0.0 109.849 -178.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 45' ' ' ARG . 0.1 OUTLIER 165.44 -41.95 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.779 -0.576 . . . . 0.0 109.69 179.594 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.485 ' HA3' ' OG ' ' A' ' 38' ' ' SER . . . -41.77 -37.36 1.99 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -178.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -60.31 -40.01 89.04 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.019 -1.283 . . . . 0.0 110.133 175.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.552 ' HG3' ' CD2' ' A' ' 49' ' ' LEU . 11.3 tpp180 -102.4 -43.2 5.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.526 -0.734 . . . . 0.0 110.596 -176.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.544 ' HA2' HD11 ' A' ' 49' ' ' LEU . . . -55.15 -35.33 59.69 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.926 -1.269 . . . . 0.0 109.926 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.49 ' O ' HD22 ' A' ' 7' ' ' LEU . . . -67.99 -5.96 42.79 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 176.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -169.84 64.71 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.285 -1.126 . . . . 0.0 109.176 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.552 ' CD2' ' HG3' ' A' ' 45' ' ' ARG . 5.0 mt -69.99 -27.63 64.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.539 -0.726 . . . . 0.0 110.07 -178.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 101.06 -143.42 16.17 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 -176.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.448 ' HG3' ' C ' ' A' ' 4' ' ' ALA . 72.2 tt0 -111.8 133.14 54.21 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.206 -1.173 . . . . 0.0 110.253 -179.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.797 ' CE2' ' HB3' ' A' ' 6' ' ' ALA . 4.7 p90 -145.56 166.43 25.74 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.322 -0.861 . . . . 0.0 109.985 -178.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.545 ' O ' ' N ' ' A' ' 55' ' ' GLY . 87.6 mtt180 -68.75 144.34 54.4 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.036 -1.04 . . . . 0.0 110.215 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.458 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 15.4 pt20 -63.44 64.06 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.572 -0.705 . . . . 0.0 110.76 -177.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . 165.08 61.96 0.02 OUTLIER Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 -179.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.486 ' OE1' ' HB2' ' A' ' 52' ' ' PHE . 3.1 mm-40 -117.94 -62.42 1.55 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.071 -1.252 . . . . 0.0 109.193 177.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 56.3 ttp -93.89 -51.41 4.89 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.706 -170.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.504 HG13 ' O ' ' A' ' 58' ' ' VAL . 13.3 p -143.26 132.8 11.77 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.358 -0.839 . . . . 0.0 110.164 -174.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.426 ' O ' ' C ' ' A' ' 60' ' ' ALA . 14.5 Cg_endo -61.9 -48.57 8.36 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.902 1.475 . . . . 0.0 110.025 178.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 59' ' ' PRO . . . -39.81 -33.32 0.19 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.606 -0.684 . . . . 0.0 110.845 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.655 ' CE2' HG21 ' A' ' 65' ' ' VAL . 65.1 t80 -60.01 -44.03 94.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.043 -1.036 . . . . 0.0 110.358 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -60.73 -39.92 90.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.179 -0.95 . . . . 0.0 110.163 -179.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.416 ' O ' ' HB2' ' A' ' 67' ' ' SER . 75.6 mmtt -58.97 -45.89 89.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.182 -0.949 . . . . 0.0 110.378 -178.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.709 HG23 HG21 ' A' ' 74' ' ' THR . 8.5 p -73.39 -39.98 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.059 -1.025 . . . . 0.0 110.53 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.655 HG21 ' CE2' ' A' ' 61' ' ' PHE . 9.6 t -55.75 -30.67 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.625 -1.297 . . . . 0.0 109.568 171.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -96.15 -0.36 50.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.37 -0.831 . . . . 0.0 109.844 176.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.454 ' CB ' ' HA ' ' A' ' 64' ' ' VAL . 6.9 t -96.44 -64.66 1.03 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.362 -0.836 . . . . 0.0 109.525 174.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.411 ' SG ' ' OG1' ' A' ' 74' ' ' THR . 91.1 m -89.57 130.73 42.33 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.326 -0.859 . . . . 0.0 110.016 175.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.548 ' O ' ' O ' ' A' ' 70' ' ' VAL . 25.2 Cg_endo -67.64 79.28 0.49 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.849 1.447 . . . . 0.0 110.79 -177.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.017 ' C ' HD13 ' A' ' 71' ' ' LEU . 1.8 m 37.17 177.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.445 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 177.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.017 HD13 ' C ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER 24.39 40.92 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.485 0 CA-C-O 121.636 0.731 . . . . 0.0 112.632 -170.72 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.554 ' N ' ' O ' ' A' ' 70' ' ' VAL . 3.4 tp10 -138.05 81.96 25.96 Favored Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 121.285 -0.885 . . . . 0.0 109.589 174.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -43.68 129.49 7.09 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 124.045 1.55 . . . . 0.0 110.204 -176.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.709 HG21 HG23 ' A' ' 64' ' ' VAL . 57.1 m -127.96 135.7 50.29 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.348 -0.845 . . . . 0.0 110.196 -175.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.421 ' HA3' HG13 ' A' ' 85' ' ' ILE . . . 133.6 -176.55 19.62 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 -178.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.605 ' CD ' HD21 ' A' ' 21' ' ' LEU . 43.3 Cg_endo -72.19 152.9 97.61 Favored 'Cis proline' 0 C--N 1.314 -1.276 0 C-N-CA 121.713 -2.203 . . . . 0.0 110.199 0.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.0 tp -131.38 154.51 48.54 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.129 -0.982 . . . . 0.0 110.329 -175.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 -76.64 130.92 38.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.244 -0.91 . . . . 0.0 110.761 -177.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.63 HG21 ' CG ' ' A' ' 84' ' ' HIS . 10.3 t -142.08 173.65 11.32 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.452 -0.78 . . . . 0.0 109.823 175.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -59.99 -27.72 67.1 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.158 -0.963 . . . . 0.0 110.517 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -96.39 9.97 39.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.999 -1.063 . . . . 0.0 110.902 -172.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.401 ' O ' HG22 ' A' ' 79' ' ' THR . . . 119.6 -124.65 6.04 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 -176.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.507 ' CZ ' ' HB2' ' A' ' 14' ' ' GLU . 87.1 m-85 -114.07 139.02 49.64 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.128 -1.219 . . . . 0.0 110.253 176.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.63 ' CG ' HG21 ' A' ' 79' ' ' THR . 21.9 m170 -121.7 121.63 37.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.35 -0.844 . . . . 0.0 110.377 177.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.68 HG22 ' HB ' ' A' ' 9' ' ' ILE . 6.1 tt -109.94 136.84 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.761 -1.212 . . . . 0.0 109.434 168.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.554 HG12 ' CD2' ' A' ' 8' ' ' HIS . 26.1 mt -133.48 131.67 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.076 -1.015 . . . . 0.0 111.223 -169.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.74 ' HD2' HD12 ' A' ' 7' ' ' LEU . 12.1 ttmm -105.25 128.03 53.23 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.237 -0.914 . . . . 0.0 109.411 170.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.771 HG12 HG12 ' A' ' 70' ' ' VAL . 60.8 t -108.77 139.3 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.204 -0.935 . . . . 0.0 110.363 -174.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.527 ' O ' ' CB ' ' A' ' 90' ' ' TYR . 81.6 mt -140.38 126.26 19.45 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.197 -0.94 . . . . 0.0 110.055 -177.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.527 ' CB ' ' O ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER 80.71 -57.97 0.3 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.415 -0.803 . . . . 0.0 111.53 171.985 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.657 ' HB2' HG11 ' A' ' 70' ' ' VAL . 47.5 ttp180 55.63 39.97 30.95 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.863 -1.148 . . . . 0.0 110.631 -179.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.46 ' ND2' ' HA ' ' A' ' 1' ' ' ALA . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 118.076 -0.964 . . . . 0.0 110.123 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.276 0.56 . . . . 0.0 110.39 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -61.35 -33.03 72.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.169 -0.957 . . . . 0.0 110.377 178.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 52' ' ' PHE . 72.6 m -132.46 150.02 52.23 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.147 -0.971 . . . . 0.0 110.095 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.577 ' O ' ' CD1' ' A' ' 52' ' ' PHE . . . -153.4 157.77 40.45 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.914 -1.116 . . . . 0.0 110.786 -177.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.489 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -104.14 139.46 39.18 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.149 -0.969 . . . . 0.0 109.429 172.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.821 ' HB3' ' CZ ' ' A' ' 52' ' ' PHE . . . -149.83 130.79 14.3 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.694 -1.254 . . . . 0.0 111.457 -177.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.915 HD12 ' HE3' ' A' ' 87' ' ' LYS . 17.4 mt -100.75 146.17 27.58 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.454 -0.779 . . . . 0.0 109.746 172.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.678 ' CD2' HD12 ' A' ' 49' ' ' LEU . 8.0 m-70 -134.5 150.1 50.76 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.121 -0.987 . . . . 0.0 110.826 -175.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.561 ' HB ' ' CG2' ' A' ' 85' ' ' ILE . 89.8 mt -128.78 129.88 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.063 -1.023 . . . . 0.0 109.671 167.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.535 ' HG ' ' CD2' ' A' ' 84' ' ' HIS . 0.5 OUTLIER -106.5 119.33 39.01 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.497 -0.752 . . . . 0.0 110.1 -177.523 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.952 HG13 HD22 ' A' ' 16' ' ' LEU . 3.1 t -114.97 131.05 68.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.227 -0.921 . . . . 0.0 110.045 176.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 49.0 tttt -69.95 -40.01 75.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.083 -1.011 . . . . 0.0 110.614 -178.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -109.04 137.25 47.24 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.107 -0.995 . . . . 0.0 110.839 -176.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.555 ' HB2' ' CZ ' ' A' ' 83' ' ' TYR . 86.5 tt0 -59.99 -42.01 93.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.443 -0.785 . . . . 0.0 110.121 178.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -56.37 -41.16 75.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.322 -0.861 . . . . 0.0 110.212 178.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.952 HD22 HG13 ' A' ' 11' ' ' VAL . 4.7 tt -67.95 -39.91 83.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.014 -1.054 . . . . 0.0 109.076 175.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.674 ' O ' HD12 ' A' ' 21' ' ' LEU . . . -59.93 -40.63 89.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.303 -0.873 . . . . 0.0 110.095 175.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.03 -42.05 93.56 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.022 -1.049 . . . . 0.0 109.571 175.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -59.99 -38.99 84.22 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.275 -0.891 . . . . 0.0 109.706 173.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.711 ' C ' HD12 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -60.82 -50.38 73.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.313 -0.867 . . . . 0.0 109.885 178.822 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.797 HD21 ' HD3' ' A' ' 76' ' ' PRO . 1.4 mt -60.02 -49.26 78.38 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.339 -0.851 . . . . 0.0 110.181 -178.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -60.48 -40.08 89.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.454 -0.779 . . . . 0.0 109.999 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 70.0 tp60 -59.99 -41.31 91.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.365 -0.834 . . . . 0.0 110.529 -175.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.528 ' O ' ' N ' ' A' ' 28' ' ' ALA . 63.1 mt -63.65 -47.92 89.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.2 -0.938 . . . . 0.0 110.21 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -62.11 -45.08 95.08 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.903 -1.123 . . . . 0.0 109.659 177.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -59.97 -60.8 3.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.376 -0.827 . . . . 0.0 110.178 177.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.745 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -105.83 -45.8 1.26 Allowed Glycine 0 N--CA 1.486 1.992 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -175.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.745 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 80.16 158.69 0.16 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.811 -0.817 . . . . 0.0 110.462 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.592 ' CB ' ' O ' ' A' ' 28' ' ' ALA . 96.7 m-20 118.26 81.24 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.038 0 C-N-CA 125.053 1.341 . . . . 0.0 109.634 -175.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.439 ' CZ ' HD13 ' A' ' 24' ' ' ILE . 2.1 m-85 -60.02 -45.04 94.1 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.207 -0.933 . . . . 0.0 110.999 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.39 -54.64 25.38 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.765 -1.207 . . . . 0.0 110.141 -174.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -65.94 -39.95 90.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.048 -1.266 . . . . 0.0 110.306 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 46.8 mt -63.65 -39.97 95.68 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.134 -0.979 . . . . 0.0 109.643 176.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.546 ' CB ' HG12 ' A' ' 9' ' ' ILE . . . -55.18 -50.64 68.83 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.266 -0.896 . . . . 0.0 110.091 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -59.96 -51.97 67.39 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.055 -1.028 . . . . 0.0 110.677 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -60.96 -50.07 74.87 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.21 -0.931 . . . . 0.0 111.175 -176.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -70.43 -39.97 74.07 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.123 -0.986 . . . . 0.0 110.867 -177.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.658 ' O ' HG22 ' A' ' 39' ' ' ILE . 20.7 t -60.08 -46.35 89.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.138 -0.976 . . . . 0.0 110.349 -175.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.658 HG22 ' O ' ' A' ' 38' ' ' SER . 16.0 tt 37.99 29.87 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.7 -0.625 . . . . 0.0 110.58 178.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.47 ' N ' ' O ' ' A' ' 38' ' ' SER . 15.2 p -129.67 165.11 35.37 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.35 -0.844 . . . . 0.0 110.193 -176.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.47 ' HD2' ' HB2' ' A' ' 40' ' ' CYS . 1.1 Cg_endo -47.76 -28.43 9.61 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.802 1.422 . . . . 0.0 110.562 178.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.523 ' O ' ' CA ' ' A' ' 46' ' ' GLY . 0.2 OUTLIER -99.77 18.43 18.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.99 -1.069 . . . . 0.0 110.148 177.526 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.44 -55.01 5.27 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.549 -1.82 . . . . 0.0 108.549 171.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -61.12 -40.03 92.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.457 -1.025 . . . . 0.0 110.749 177.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.412 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 12.8 tpt180 -104.53 -41.26 5.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.089 -1.007 . . . . 0.0 110.795 -174.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.523 ' CA ' ' O ' ' A' ' 42' ' ' SER . . . -69.95 -31.88 69.8 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.55 0.9 59.47 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 177.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.521 ' HA ' ' CD2' ' A' ' 7' ' ' LEU . 47.8 t0 -170.38 76.17 0.08 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.296 -1.12 . . . . 0.0 109.065 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.678 HD12 ' CD2' ' A' ' 8' ' ' HIS . 19.2 mt -82.63 -14.96 53.81 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.602 -0.686 . . . . 0.0 110.193 -174.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.01 -137.96 14.29 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 177.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.499 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 3.4 mt-10 -108.79 158.59 17.5 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.453 -1.028 . . . . 0.0 110.421 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.821 ' CZ ' ' HB3' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -139.96 177.83 7.69 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.389 -0.82 . . . . 0.0 109.407 -175.583 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.539 ' O ' ' N ' ' A' ' 55' ' ' GLY . 29.8 ptt180 -167.32 -175.88 3.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.616 -0.677 . . . . 0.0 109.849 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.481 ' O ' ' O ' ' A' ' 55' ' ' GLY . 96.7 mt-30 32.08 -87.47 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 O-C-N 122.006 -0.434 . . . . 0.0 112.135 178.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 53' ' ' ARG . . . -53.23 -111.51 0.01 OUTLIER Glycine 0 N--CA 1.496 2.695 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 -174.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.522 ' OE1' ' CB ' ' A' ' 52' ' ' PHE . 51.0 mm-40 60.0 22.91 12.04 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.788 -1.419 . . . . 0.0 109.667 -178.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.443 ' O ' ' C ' ' A' ' 58' ' ' VAL . 54.5 ttm -60.02 -45.86 91.4 Favored 'General case' 0 C--N 1.289 -2.049 0 O-C-N 120.8 -1.188 . . . . 0.0 111.539 -160.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.443 ' C ' ' O ' ' A' ' 57' ' ' MET . 1.4 p -39.35 132.75 1.26 Allowed Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.575 -0.703 . . . . 0.0 110.307 -174.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -56.77 -52.81 6.07 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.005 1.529 . . . . 0.0 110.88 -171.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -45.28 -44.63 11.54 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.219 -0.925 . . . . 0.0 110.578 -174.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -59.99 -41.68 92.57 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.185 -0.947 . . . . 0.0 110.118 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.516 ' O ' HG12 ' A' ' 65' ' ' VAL . 57.4 t0 -71.78 -38.4 70.3 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.317 -0.864 . . . . 0.0 110.298 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.521 ' O ' ' N ' ' A' ' 67' ' ' SER . 87.6 tttt -55.06 -49.96 70.31 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.24 -0.912 . . . . 0.0 110.216 -175.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.667 ' HB ' HD11 ' A' ' 77' ' ' LEU . 2.5 p -69.81 -47.1 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.129 -0.982 . . . . 0.0 111.814 -174.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.516 HG12 ' O ' ' A' ' 62' ' ' ASP . 3.0 p -57.4 -27.12 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.319 -1.488 . . . . 0.0 109.055 173.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -92.97 -11.19 33.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.407 -0.808 . . . . 0.0 109.846 175.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.544 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 9.4 t -91.62 -44.74 8.87 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.318 -0.864 . . . . 0.0 109.756 176.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.503 ' HB3' ' HB3' ' A' ' 72' ' ' GLU . 66.1 m -137.14 149.98 67.82 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.306 -0.871 . . . . 0.0 110.382 178.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.485 ' O ' ' HB2' ' A' ' 72' ' ' GLU . 52.1 Cg_endo -77.71 -179.48 5.48 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.054 1.555 . . . . 0.0 110.932 -178.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.938 HG22 ' CD1' ' A' ' 71' ' ' LEU . 7.2 p -60.04 157.65 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.424 -0.797 . . . . 0.0 110.06 177.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.938 ' CD1' HG22 ' A' ' 70' ' ' VAL . 4.4 mp 60.01 40.03 19.22 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.419 -0.8 . . . . 0.0 110.234 -175.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.503 ' HB3' ' HB3' ' A' ' 68' ' ' CYS . 0.0 OUTLIER -150.46 104.42 3.1 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.299 -0.875 . . . . 0.0 110.258 178.72 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 72' ' ' GLU . 26.0 Cg_endo -67.15 135.09 36.04 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.89 1.469 . . . . 0.0 110.273 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.636 ' HB ' HG23 ' A' ' 64' ' ' VAL . 87.2 m -140.13 147.21 39.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.164 -0.96 . . . . 0.0 110.488 -178.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.447 ' HA3' HG13 ' A' ' 85' ' ' ILE . . . 125.72 -168.88 17.72 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.797 ' HD3' HD21 ' A' ' 21' ' ' LEU . 43.0 Cg_endo -72.32 139.23 59.09 Favored 'Cis proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.847 -2.147 . . . . 0.0 110.732 -0.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.667 HD11 ' HB ' ' A' ' 64' ' ' VAL . 88.7 mt -92.99 169.37 10.48 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.3 -0.875 . . . . 0.0 110.633 -176.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 14.3 t60 -100.24 119.57 38.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.144 -0.972 . . . . 0.0 110.381 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.637 HG21 ' ND1' ' A' ' 84' ' ' HIS . 14.7 t -141.56 166.38 24.91 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.155 -0.965 . . . . 0.0 109.815 176.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.415 ' CG ' ' N ' ' A' ' 81' ' ' PHE . 15.8 pt20 -59.93 -34.75 73.66 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.121 -0.987 . . . . 0.0 110.397 -176.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.415 ' N ' ' CG ' ' A' ' 80' ' ' GLN . 94.4 m-85 -60.04 -27.26 66.78 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.271 -0.893 . . . . 0.0 110.208 178.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 141.63 -132.37 5.24 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -178.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.555 ' CZ ' ' HB2' ' A' ' 14' ' ' GLU . 81.3 m-85 -96.66 120.99 37.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -1.139 . . . . 0.0 109.876 175.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.637 ' ND1' HG21 ' A' ' 79' ' ' THR . 0.6 OUTLIER -113.29 113.64 25.55 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.566 -0.709 . . . . 0.0 110.9 -176.453 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.561 ' CG2' ' HB ' ' A' ' 9' ' ' ILE . 12.2 tt -109.82 133.9 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 120.616 -1.302 . . . . 0.0 109.579 170.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.528 HG12 ' ND1' ' A' ' 8' ' ' HIS . 85.9 mt -138.24 141.93 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.044 -1.035 . . . . 0.0 110.67 -172.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.915 ' HE3' HD12 ' A' ' 7' ' ' LEU . 20.1 pttp -119.53 142.06 48.67 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.048 -1.033 . . . . 0.0 109.511 171.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 62.5 t -107.9 129.97 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.913 -1.117 . . . . 0.0 111.302 -168.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' A' ' 91' ' ' ARG . 89.5 mt -114.26 -170.97 1.83 Allowed 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.305 -0.872 . . . . 0.0 109.204 172.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.435 ' C ' ' O ' ' A' ' 89' ' ' LEU . 71.0 m-85 32.85 -86.46 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.735 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.533 ' N ' ' O ' ' A' ' 89' ' ' LEU . 29.7 ttp85 60.82 48.63 6.75 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.696 -1.253 . . . . 0.0 110.617 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.444 ' ND2' ' C ' ' A' ' 92' ' ' ASN . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.945 176.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.474 ' HA ' ' CB ' ' A' ' 92' ' ' ASN . . . . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.235 0.541 . . . . 0.0 110.16 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 32.0 mtpt -60.01 -41.93 93.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.222 -0.924 . . . . 0.0 109.174 177.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.579 HG22 ' HB3' ' A' ' 53' ' ' ARG . 28.1 p -139.98 156.64 46.55 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.192 0.52 . . . . 0.0 110.087 175.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.404 ' C ' ' HG3' ' A' ' 51' ' ' GLU . . . -129.88 160.12 34.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.254 -0.904 . . . . 0.0 109.656 178.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.555 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -95.52 127.39 41.51 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.121 -0.987 . . . . 0.0 109.551 179.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.823 ' HB3' ' HZ ' ' A' ' 52' ' ' PHE . . . -134.51 131.07 37.57 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.699 -1.25 . . . . 0.0 111.56 -170.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.517 ' C ' ' CD2' ' A' ' 8' ' ' HIS . 39.9 mt -102.28 147.31 26.82 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.078 -1.014 . . . . 0.0 109.33 170.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.672 ' NE2' ' HB1' ' A' ' 6' ' ' ALA . 31.4 m-70 -143.52 134.02 24.84 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.803 -1.185 . . . . 0.0 111.407 -175.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.564 HG13 ' CZ ' ' A' ' 30' ' ' PHE . 95.3 mt -119.99 125.69 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.776 -1.202 . . . . 0.0 109.763 165.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.592 ' HG ' ' CD2' ' A' ' 84' ' ' HIS . 0.2 OUTLIER -102.79 121.4 42.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.603 -0.686 . . . . 0.0 109.689 179.553 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.823 HG13 HD22 ' A' ' 16' ' ' LEU . 2.2 t -109.31 125.48 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.134 -0.979 . . . . 0.0 110.394 178.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -67.58 -39.97 84.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.445 -0.784 . . . . 0.0 110.446 175.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -108.11 136.84 47.11 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.217 -0.927 . . . . 0.0 110.966 -174.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.451 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 97.1 mt-10 -60.07 -40.84 90.93 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.4 -0.812 . . . . 0.0 110.115 173.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -58.86 -40.23 83.71 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.209 -0.932 . . . . 0.0 110.459 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.823 HD22 HG13 ' A' ' 11' ' ' VAL . 3.7 tt -68.31 -38.19 81.33 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.045 -1.034 . . . . 0.0 109.054 175.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.739 ' O ' HD12 ' A' ' 21' ' ' LEU . . . -58.76 -44.48 90.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.361 -0.837 . . . . 0.0 110.114 175.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.99 -42.72 94.84 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.221 -0.924 . . . . 0.0 109.611 176.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.456 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 65.1 t0 -59.94 -40.63 89.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.312 -0.867 . . . . 0.0 109.674 173.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.841 HD23 ' N ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -63.91 -55.32 23.55 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 121.587 0.708 . . . . 0.0 110.035 -179.786 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 1.08 HD11 ' HG3' ' A' ' 76' ' ' PRO . 0.4 OUTLIER -54.89 -40.07 69.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.564 -0.71 . . . . 0.0 109.779 179.5 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -60.58 -49.11 78.86 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.586 -0.696 . . . . 0.0 110.74 -176.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 19' ' ' ASP . 87.7 mm-40 -61.55 -40.04 93.25 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.116 -0.99 . . . . 0.0 110.375 -175.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.604 HG12 HD12 ' A' ' 33' ' ' LEU . 96.9 mt -59.97 -49.95 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.263 -0.898 . . . . 0.0 110.019 -177.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -62.18 -48.31 80.63 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.883 -1.136 . . . . 0.0 109.75 176.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.11 -55.79 29.54 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.341 -0.849 . . . . 0.0 110.28 178.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.747 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -105.28 -48.57 1.05 Allowed Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -174.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.747 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 81.81 96.03 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.173 0 O-C-N 122.151 -0.617 . . . . 0.0 110.228 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.44 ' HB3' ' HB2' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -176.0 84.61 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.466 -0.771 . . . . 0.0 109.935 -178.218 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.593 ' CG ' ' HE3' ' A' ' 87' ' ' LYS . 45.8 t80 -60.03 -48.5 81.45 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.314 -0.866 . . . . 0.0 110.573 -175.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.05 -47.84 89.03 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -176.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.44 ' HB2' ' HB3' ' A' ' 29' ' ' ASP . 36.6 mmtm -65.77 -40.16 91.75 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.055 -1.262 . . . . 0.0 110.561 -176.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.604 HD12 HG12 ' A' ' 24' ' ' ILE . 84.0 mt -66.76 -40.03 88.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.089 -1.007 . . . . 0.0 110.334 179.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.522 ' O ' ' CB ' ' A' ' 38' ' ' SER . . . -59.93 -47.35 86.16 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.121 -0.987 . . . . 0.0 109.992 179.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 66.8 tttt -60.01 -46.57 89.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.16 -0.963 . . . . 0.0 110.456 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.608 ' O ' HG23 ' A' ' 39' ' ' ILE . 55.7 mttt -70.03 -59.6 2.81 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.138 -0.976 . . . . 0.0 110.993 -176.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.453 ' HB3' HD21 ' A' ' 16' ' ' LEU . 80.9 m-70 -71.73 -40.18 69.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.095 -1.003 . . . . 0.0 111.129 -172.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.527 ' O ' ' CG1' ' A' ' 39' ' ' ILE . 8.6 t -60.17 -49.25 78.37 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.135 -0.978 . . . . 0.0 110.509 -175.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.608 HG23 ' O ' ' A' ' 36' ' ' LYS . 36.4 pt 37.95 32.72 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-O 121.452 0.644 . . . . 0.0 110.465 -177.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.455 ' SG ' ' OG ' ' A' ' 38' ' ' SER . 14.9 p -125.93 166.21 22.7 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.393 -0.817 . . . . 0.0 109.658 178.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -51.7 -22.93 14.25 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.823 1.433 . . . . 0.0 110.425 -178.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.7 OUTLIER -101.63 12.99 36.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -0.908 . . . . 0.0 110.636 -179.025 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.08 -56.43 4.41 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 174.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 16.3 tttp -60.01 -40.0 87.73 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.343 -1.093 . . . . 0.0 110.368 177.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.473 ' HD2' HD23 ' A' ' 49' ' ' LEU . 8.7 tpp85 -98.86 -43.65 6.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 0.0 110.58 -175.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -60.0 -35.97 88.85 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.29 -4.21 35.68 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 110.016 -1.233 . . . . 0.0 110.016 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.427 ' HA ' ' CD2' ' A' ' 7' ' ' LEU . 9.7 t0 -171.32 69.37 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.016 -1.285 . . . . 0.0 109.449 178.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.493 HD13 ' SD ' ' A' ' 57' ' ' MET . 4.8 mt -70.03 -29.91 67.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.508 -0.745 . . . . 0.0 110.75 -176.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 112.23 -152.57 17.76 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.404 ' HG3' ' C ' ' A' ' 4' ' ' ALA . 79.1 tt0 -111.91 136.96 50.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.358 -1.084 . . . . 0.0 110.079 -178.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.823 ' HZ ' ' HB3' ' A' ' 6' ' ' ALA . 0.1 OUTLIER -160.18 168.17 26.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.198 -0.939 . . . . 0.0 110.243 -174.764 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.579 ' HB3' HG22 ' A' ' 3' ' ' THR . 48.7 ptt85 -94.52 -174.16 3.24 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.997 -1.064 . . . . 0.0 110.546 -176.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -63.51 -37.51 87.6 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.143 -0.973 . . . . 0.0 110.99 -176.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.427 ' HA3' ' NH2' ' A' ' 53' ' ' ARG . . . -85.67 61.45 4.56 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -173.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.541 ' NE2' ' HG2' ' A' ' 53' ' ' ARG . 5.0 mm-40 -134.83 -53.26 0.81 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.956 -1.32 . . . . 0.0 109.466 178.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.493 ' SD ' HD13 ' A' ' 49' ' ' LEU . 9.7 ttm -119.4 -150.73 0.46 Allowed 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.959 -162.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.495 ' O ' ' HB3' ' A' ' 61' ' ' PHE . 2.8 p -68.18 133.46 91.57 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.485 -0.759 . . . . 0.0 110.032 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.483 ' O ' ' N ' ' A' ' 61' ' ' PHE . 5.7 Cg_endo -52.68 -55.16 4.03 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.012 1.533 . . . . 0.0 110.484 -177.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.674 ' O ' HG13 ' A' ' 64' ' ' VAL . . . -37.5 -29.22 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.647 -0.658 . . . . 0.0 110.863 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.495 ' HB3' ' O ' ' A' ' 58' ' ' VAL . 32.0 t80 -60.03 -43.9 94.99 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.999 -1.063 . . . . 0.0 110.309 178.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 59' ' ' PRO . 7.7 t70 -60.04 -40.03 87.96 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.213 -0.929 . . . . 0.0 109.459 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 67' ' ' SER . 12.4 tptp -57.63 -49.95 74.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.391 -0.818 . . . . 0.0 110.876 177.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.674 HG13 ' O ' ' A' ' 60' ' ' ALA . 1.3 m -70.36 -48.64 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 120.929 -1.107 . . . . 0.0 110.832 -172.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.534 ' N ' ' CG2' ' A' ' 64' ' ' VAL . 13.2 p -57.01 -24.64 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.431 -1.418 . . . . 0.0 109.318 172.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.459 ' O ' ' CD1' ' A' ' 66' ' ' PHE . 17.2 t80 -96.57 -0.06 49.3 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.402 -0.811 . . . . 0.0 109.737 175.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.505 ' HB3' ' HA ' ' A' ' 64' ' ' VAL . 33.0 t -97.93 -49.13 4.9 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.431 -0.793 . . . . 0.0 110.006 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.481 ' HB2' ' OG1' ' A' ' 74' ' ' THR . 95.1 m -117.69 147.04 40.12 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.353 -0.842 . . . . 0.0 109.985 179.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.41 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 39.6 Cg_exo -57.14 146.43 81.33 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.015 1.534 . . . . 0.0 110.471 179.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.924 HG22 HD12 ' A' ' 71' ' ' LEU . 4.8 p -60.77 173.94 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.26 -0.9 . . . . 0.0 109.976 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.924 HD12 HG22 ' A' ' 70' ' ' VAL . 2.3 mp 59.61 20.11 8.69 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.335 -0.853 . . . . 0.0 109.642 -175.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.41 ' HB3' ' O ' ' A' ' 69' ' ' PRO . 1.0 OUTLIER -139.21 87.3 13.91 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.5 -0.75 . . . . 0.0 109.668 179.001 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.431 ' HG3' ' HD3' ' A' ' 87' ' ' LYS . 52.9 Cg_exo -45.3 115.22 0.87 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.052 1.554 . . . . 0.0 110.337 -176.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.481 ' OG1' ' HB2' ' A' ' 68' ' ' CYS . 54.9 m -108.61 122.91 48.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.255 -0.903 . . . . 0.0 110.405 -176.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 150.91 179.86 27.01 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 1.08 ' HG3' HD11 ' A' ' 21' ' ' LEU . 42.6 Cg_endo -72.15 170.14 68.28 Favored 'Cis proline' 0 C--N 1.315 -1.219 0 C-N-CA 121.674 -2.219 . . . . 0.0 110.588 -0.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.2 mt -139.17 160.55 39.54 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.355 -0.841 . . . . 0.0 110.284 -175.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -84.98 124.48 31.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.238 -0.914 . . . . 0.0 110.239 -179.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.816 HG21 ' CG ' ' A' ' 84' ' ' HIS . 8.8 t -137.63 158.17 44.94 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.105 -0.997 . . . . 0.0 109.895 175.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -59.99 -23.78 63.91 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -0.903 . . . . 0.0 110.225 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.449 ' CE2' HG23 ' A' ' 58' ' ' VAL . 92.5 m-85 -78.88 -10.08 59.69 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.226 -0.921 . . . . 0.0 110.583 -178.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.572 ' O ' HG22 ' A' ' 79' ' ' THR . . . 130.45 -137.36 9.44 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 -175.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.4 ' O ' HD23 ' A' ' 10' ' ' LEU . 0.2 OUTLIER -95.37 136.9 35.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.164 -1.198 . . . . 0.0 110.015 175.211 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.816 ' CG ' HG21 ' A' ' 79' ' ' THR . 3.9 m170 -127.99 114.79 17.56 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.472 -0.767 . . . . 0.0 110.835 -177.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.549 ' CG2' ' HB ' ' A' ' 9' ' ' ILE . 3.6 tt -111.12 130.96 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.09 -1.007 . . . . 0.0 109.515 171.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.574 HG23 ' CE1' ' A' ' 8' ' ' HIS . 78.4 mt -135.37 132.12 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.026 -1.046 . . . . 0.0 111.142 -169.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.593 ' HE3' ' CG ' ' A' ' 30' ' ' PHE . 23.1 mttt -99.27 140.45 33.43 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.876 -1.14 . . . . 0.0 109.985 171.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.777 HG12 HG23 ' A' ' 70' ' ' VAL . 37.5 t -109.95 129.97 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.367 -0.833 . . . . 0.0 110.078 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.555 ' HB2' ' HB3' ' A' ' 5' ' ' ALA . 88.1 mt -139.09 -164.59 1.69 Allowed 'General case' 0 C--N 1.307 -1.271 0 O-C-N 121.19 -0.944 . . . . 0.0 109.557 -178.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.495 ' CD1' ' CB ' ' A' ' 5' ' ' ALA . 44.2 m-85 34.68 -85.98 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.122 0 O-C-N 122.078 -0.389 . . . . 0.0 111.71 -178.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.554 ' N ' ' O ' ' A' ' 89' ' ' LEU . 36.1 ttp180 61.0 51.07 4.68 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.873 -1.142 . . . . 0.0 110.893 -178.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.474 ' CB ' ' HA ' ' A' ' 1' ' ' ALA . 23.7 t-20 . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 118.083 -0.961 . . . . 0.0 110.311 176.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.515 ' HB1' ' CB ' ' A' ' 92' ' ' ASN . . . . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.219 0.533 . . . . 0.0 110.222 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.512 ' N ' ' OXT' ' A' ' 92' ' ' ASN . 31.7 mmtm -124.38 144.63 49.93 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.259 -0.901 . . . . 0.0 110.635 178.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.751 HG22 ' HG2' ' A' ' 51' ' ' GLU . 0.2 OUTLIER 58.48 123.98 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.493 -0.755 . . . . 0.0 110.81 175.014 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.447 ' C ' ' HG3' ' A' ' 51' ' ' GLU . . . -119.88 146.59 45.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.43 -0.794 . . . . 0.0 109.515 174.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.571 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -92.57 125.69 37.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.039 -1.038 . . . . 0.0 109.461 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.542 ' HB3' ' CE2' ' A' ' 52' ' ' PHE . . . -136.33 135.1 38.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.833 -1.167 . . . . 0.0 111.556 -170.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.731 HD12 ' HD2' ' A' ' 87' ' ' LYS . 72.2 mt -109.11 143.89 37.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.207 -0.933 . . . . 0.0 108.877 168.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.702 ' HE2' ' HE1' ' A' ' 61' ' ' PHE . 45.7 m170 -130.89 129.5 42.33 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.723 -1.236 . . . . 0.0 111.365 -176.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.732 ' HB ' HG22 ' A' ' 85' ' ' ILE . 59.1 mt -109.99 129.96 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.106 -0.996 . . . . 0.0 109.229 168.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.745 HD13 ' C ' ' A' ' 10' ' ' LEU . 1.8 tm? -107.55 120.04 41.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.144 -0.972 . . . . 0.0 110.135 178.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 1.096 HG13 HD22 ' A' ' 16' ' ' LEU . 2.6 t -99.66 132.46 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.526 -0.734 . . . . 0.0 110.001 -179.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -64.28 -39.98 95.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.395 -0.815 . . . . 0.0 110.673 -178.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -136.36 153.93 50.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.067 -1.021 . . . . 0.0 110.707 -176.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.444 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 86.1 tt0 -59.75 -40.09 86.98 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.397 -0.814 . . . . 0.0 110.462 -177.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 29.9 tptt -51.57 -45.54 63.14 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.275 -0.89 . . . . 0.0 110.09 -177.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.096 HD22 HG13 ' A' ' 11' ' ' VAL . 7.4 tt -67.8 -39.92 83.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.111 -0.993 . . . . 0.0 109.409 175.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.002 ' O ' HD12 ' A' ' 21' ' ' LEU . . . -57.12 -42.7 81.34 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.392 -0.818 . . . . 0.0 109.71 176.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.425 HD12 ' HG2' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -60.09 -46.94 87.91 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.231 -0.918 . . . . 0.0 109.634 173.239 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -60.1 -40.02 88.21 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.422 -0.799 . . . . 0.0 110.184 177.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 1.018 HD13 ' CD2' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -63.15 -52.31 62.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.105 -0.997 . . . . 0.0 109.469 178.716 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 1.002 HD12 ' O ' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -56.55 -46.67 80.56 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.326 -0.859 . . . . 0.0 109.766 -177.689 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -60.04 -39.97 87.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.117 -0.989 . . . . 0.0 109.547 171.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.493 ' HB3' ' O ' ' A' ' 20' ' ' LEU . 61.5 tt0 -60.51 -39.97 89.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.435 -0.79 . . . . 0.0 111.047 -177.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.542 ' O ' ' CA ' ' A' ' 28' ' ' ALA . 18.9 mm -61.26 -39.99 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.796 -1.19 . . . . 0.0 109.724 -176.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -65.17 -56.48 12.65 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.676 -1.265 . . . . 0.0 110.14 177.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -60.11 -50.81 72.23 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.25 -0.906 . . . . 0.0 110.83 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 28' ' ' ALA . . . -105.64 -19.64 10.21 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -168.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.542 ' CA ' ' O ' ' A' ' 24' ' ' ILE . . . 34.18 94.48 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.821 -0.811 . . . . 0.0 111.474 -178.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -177.3 76.41 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.61 -0.681 . . . . 0.0 109.41 -178.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.539 ' HB3' ' CE ' ' A' ' 87' ' ' LYS . 2.5 m-85 -60.06 -43.2 95.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.876 . . . . 0.0 110.807 -173.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.4 -47.5 90.38 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -178.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' A' ' 35' ' ' LYS . 83.6 tttt -63.72 -40.03 95.76 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.19 -1.182 . . . . 0.0 110.23 -178.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.018 ' CD2' HD13 ' A' ' 20' ' ' LEU . 40.3 tp -64.1 -40.04 95.35 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.866 -1.146 . . . . 0.0 110.162 178.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.542 ' HB2' HG12 ' A' ' 9' ' ' ILE . . . -59.24 -52.83 64.01 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.162 -0.961 . . . . 0.0 110.366 -177.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 55.8 pttt -62.84 -41.21 99.25 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.817 -1.177 . . . . 0.0 110.425 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.467 ' N ' ' CG ' ' A' ' 35' ' ' LYS . 88.3 tttt -62.48 -48.32 80.09 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.197 -0.94 . . . . 0.0 111.446 -174.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.413 ' O ' HG12 ' A' ' 39' ' ' ILE . 41.1 m170 -102.89 -17.64 15.42 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.814 -1.179 . . . . 0.0 111.513 -169.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.527 ' O ' ' CG1' ' A' ' 39' ' ' ILE . 33.7 t -59.96 -44.2 94.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.813 -1.179 . . . . 0.0 110.651 -174.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.527 ' CG1' ' O ' ' A' ' 38' ' ' SER . 45.2 pt 36.69 30.05 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.696 -0.628 . . . . 0.0 110.636 -178.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.499 ' N ' ' O ' ' A' ' 38' ' ' SER . 43.2 t -125.46 144.57 48.26 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.423 -0.798 . . . . 0.0 109.853 -176.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.473 ' HD2' ' SG ' ' A' ' 40' ' ' CYS . 51.6 Cg_exo -49.31 -21.44 4.64 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 123.673 1.354 . . . . 0.0 110.491 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.51 ' O ' ' CA ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -101.27 16.98 23.77 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.212 -0.93 . . . . 0.0 110.184 176.801 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.411 ' CA ' ' OG ' ' A' ' 38' ' ' SER . . . -79.61 -56.52 3.34 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 173.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -60.04 -39.93 87.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.349 -1.089 . . . . 0.0 110.392 176.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -97.15 -39.79 9.12 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.069 -1.02 . . . . 0.0 110.619 -176.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.51 ' CA ' ' O ' ' A' ' 42' ' ' SER . . . -76.79 -18.27 79.05 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.74 0.09 62.37 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.276 -1.529 . . . . 0.0 109.276 173.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.528 ' HA ' ' CD2' ' A' ' 7' ' ' LEU . 33.9 t0 -172.51 73.13 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.299 -1.118 . . . . 0.0 108.966 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.452 ' HG ' ' HA2' ' A' ' 46' ' ' GLY . 5.5 mt -80.09 -13.26 59.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.419 -0.801 . . . . 0.0 109.899 -175.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.08 -148.04 20.61 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -178.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.751 ' HG2' HG22 ' A' ' 3' ' ' THR . 80.5 tt0 -110.92 131.8 54.75 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.336 -1.096 . . . . 0.0 110.173 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.596 ' CD1' ' HG3' ' A' ' 56' ' ' GLN . 3.8 p90 -139.52 158.17 44.59 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.389 -0.819 . . . . 0.0 110.266 -178.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.521 ' O ' ' CG ' ' A' ' 56' ' ' GLN . 30.7 ptt-85 -89.81 -178.32 5.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.354 -0.841 . . . . 0.0 110.043 -178.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -60.71 136.67 58.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.146 -0.971 . . . . 0.0 109.848 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 91.79 63.98 1.15 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.596 ' HG3' ' CD1' ' A' ' 52' ' ' PHE . 33.1 mm-40 -129.47 -64.43 0.89 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.795 -1.415 . . . . 0.0 110.114 176.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 28.9 tpp -116.62 -63.44 1.45 Allowed 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 118.935 -1.106 . . . . 0.0 111.57 -163.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.474 HG13 ' O ' ' A' ' 58' ' ' VAL . 12.9 p -151.16 135.09 9.4 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 120.921 -1.112 . . . . 0.0 110.577 -169.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.497 ' O ' ' N ' ' A' ' 62' ' ' ASP . 10.3 Cg_endo -55.07 -53.01 6.6 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.971 1.511 . . . . 0.0 110.389 177.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.643 ' HB1' HD23 ' A' ' 77' ' ' LEU . . . -38.35 -33.1 0.09 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.711 -0.618 . . . . 0.0 110.498 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.702 ' HE1' ' HE2' ' A' ' 8' ' ' HIS . 68.3 t80 -60.05 -41.13 91.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.296 -0.878 . . . . 0.0 110.638 177.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' A' ' 59' ' ' PRO . 52.9 t0 -60.09 -39.94 87.87 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.26 -0.9 . . . . 0.0 110.104 -178.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.43 ' O ' ' HB2' ' A' ' 67' ' ' SER . 79.8 mttt -59.62 -40.06 86.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.874 . . . . 0.0 110.79 -176.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.843 HG21 HD12 ' A' ' 86' ' ' ILE . 0.9 OUTLIER -85.22 -48.0 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 120.996 -1.065 . . . . 0.0 111.125 -174.515 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.58 HG12 ' O ' ' A' ' 61' ' ' PHE . 7.5 p -54.6 -26.31 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.674 -1.266 . . . . 0.0 109.554 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -96.27 12.41 31.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.252 -0.905 . . . . 0.0 109.764 174.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.48 ' HB3' ' O ' ' A' ' 64' ' ' VAL . 44.4 t -101.27 -41.0 6.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.418 -0.801 . . . . 0.0 110.605 -177.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.514 ' CB ' ' OE1' ' A' ' 72' ' ' GLU . 59.7 m -126.23 154.22 74.49 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.15 -0.969 . . . . 0.0 110.727 -175.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.569 ' O ' ' O ' ' A' ' 70' ' ' VAL . 9.2 Cg_exo -68.05 67.1 0.96 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 124.036 1.545 . . . . 0.0 110.498 177.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.017 HG23 HG12 ' A' ' 88' ' ' VAL . 13.4 p 27.68 -169.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 C-N-CA 123.119 0.568 . . . . 0.0 111.891 176.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.003 HD12 HG13 ' A' ' 70' ' ' VAL . 4.7 mp 38.65 30.39 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 O-C-N 119.803 -1.811 . . . . 0.0 111.132 -168.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.514 ' OE1' ' CB ' ' A' ' 68' ' ' CYS . 2.0 tm-20 -147.64 94.4 4.42 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.19 -0.944 . . . . 0.0 110.241 -178.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -48.32 107.75 0.15 Allowed 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.908 1.478 . . . . 0.0 110.012 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 98.5 m -96.31 131.78 42.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.914 . . . . 0.0 110.388 -177.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 140.83 -163.2 26.62 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.827 ' CD ' HD11 ' A' ' 21' ' ' LEU . 44.0 Cg_endo -71.08 141.79 70.62 Favored 'Cis proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.872 -2.137 . . . . 0.0 110.647 1.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.643 HD23 ' HB1' ' A' ' 60' ' ' ALA . 42.9 tp -97.04 156.02 16.54 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.343 -0.848 . . . . 0.0 110.694 -177.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.449 ' N ' ' HG ' ' A' ' 77' ' ' LEU . 6.0 t60 -75.38 127.09 32.35 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.154 -0.966 . . . . 0.0 110.349 178.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.7 HG22 ' O ' ' A' ' 82' ' ' GLY . 13.5 t -141.22 160.03 40.96 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.221 -0.925 . . . . 0.0 110.255 178.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -59.67 -26.61 65.7 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.186 -0.946 . . . . 0.0 110.521 -177.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.425 ' O ' HD21 ' A' ' 10' ' ' LEU . 97.0 m-85 -97.0 17.48 16.86 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.145 -0.972 . . . . 0.0 110.731 -176.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.7 ' O ' HG22 ' A' ' 79' ' ' THR . . . 121.09 -129.95 8.01 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 -178.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.528 ' HB3' ' HB2' ' A' ' 76' ' ' PRO . 84.5 m-85 -121.97 129.93 52.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.129 -1.218 . . . . 0.0 110.077 178.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.626 ' CD2' HD23 ' A' ' 10' ' ' LEU . 44.6 m170 -101.29 125.28 47.91 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.188 -0.945 . . . . 0.0 110.726 176.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.732 HG22 ' HB ' ' A' ' 9' ' ' ILE . 3.8 tt -109.33 128.61 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.709 -1.245 . . . . 0.0 109.078 167.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.843 HD12 HG21 ' A' ' 64' ' ' VAL . 96.7 mt -116.22 123.63 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.018 -1.051 . . . . 0.0 111.28 -167.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.731 ' HD2' HD12 ' A' ' 7' ' ' LEU . 27.6 mttt -83.77 130.05 34.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.23 -0.919 . . . . 0.0 109.036 170.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 1.017 HG12 HG23 ' A' ' 70' ' ' VAL . 29.2 t -109.33 129.44 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.163 -0.961 . . . . 0.0 109.973 -179.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.571 ' HB2' ' HB3' ' A' ' 5' ' ' ALA . 91.6 mt -134.0 117.31 16.54 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.296 -0.878 . . . . 0.0 109.838 -178.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.524 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 50.8 m-85 70.75 -2.04 2.4 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.498 -0.751 . . . . 0.0 111.556 177.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.524 ' HG2' ' O ' ' A' ' 90' ' ' TYR . 22.3 ptt180 40.37 -163.14 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.249 -0.907 . . . . 0.0 110.264 174.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.515 ' CB ' ' HB1' ' A' ' 1' ' ' ALA . 91.4 m-20 . . . . . 0 N--CA 1.49 1.566 0 O-C-N 120.79 -1.193 . . . . 0.0 110.142 179.175 . . . . . . . . 1 1 . 1 stop_ save_